data_1de2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1de2 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 34.6 ttm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.412 ' CE1' ' CZ ' ' A' ' 86' ' ' PHE . 95.9 m-85 -78.11 143.9 36.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.461 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.719 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -104.94 118.9 37.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.444 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' A' ' 33' ' ' PHE . 5.9 t -101.66 117.32 46.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.083 0.468 . . . . 0.0 111.146 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.7 m-30 -92.6 98.76 11.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.616 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' C ' ' CD1' ' A' ' 7' ' ' TYR . . . -160.57 -140.21 2.84 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.747 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.691 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 5.4 m-85 -131.82 134.24 45.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 120.735 0.302 . . . . 0.0 111.539 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.469 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -128.39 62.36 1.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.102 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -172.78 -172.1 0.84 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.163 0.506 . . . . 0.0 111.845 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.13 2.18 47.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.603 HG22 ' HA ' ' A' ' 40' ' ' LYS . 0.8 OUTLIER -87.37 -4.02 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.989 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.691 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 11.1 t-80 -169.98 145.09 2.84 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.929 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.89 168.72 18.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.024 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -177.88 110.59 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.295 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.407 HG21 ' N ' ' A' ' 16' ' ' TYR . 27.7 m -90.58 -46.02 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.49 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.407 ' N ' HG21 ' A' ' 15' ' ' VAL . 24.2 m-85 -62.17 -22.27 65.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.032 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.0 t -63.07 -41.13 99.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.798 0.332 . . . . 0.0 111.038 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -62.0 -54.5 40.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.437 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 4.7 p30 -69.45 -51.66 34.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.398 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.82 -36.44 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.341 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -62.12 -57.83 10.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.472 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -65.18 -23.79 67.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.433 HD11 ' CE1' ' A' ' 79' ' ' PHE . 5.5 tt -58.54 -58.7 7.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.085 0.469 . . . . 0.0 110.386 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.477 ' CD2' ' CZ ' ' A' ' 86' ' ' PHE . 9.5 mt -63.23 -39.2 93.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.68 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.9 m -62.92 -39.51 94.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.436 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.78 -45.95 90.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.688 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -12.17 61.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.237 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.93 52.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.896 0.379 . . . . 0.0 111.274 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -136.74 138.17 25.55 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.752 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 1' ' ' MET . 63.1 Cg_endo -80.7 159.82 21.78 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.589 2.193 . . . . 0.0 111.775 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.405 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 30.3 p90 -161.63 170.75 19.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.842 0.353 . . . . 0.0 111.559 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.96 135.21 35.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.724 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 8.7 t80 -89.61 158.51 17.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.308 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.442 HD11 ' CE1' ' A' ' 5' ' ' TYR . 13.3 mt -147.69 121.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.212 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -89.61 127.34 35.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.297 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 5.0 pt -99.56 22.39 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.047 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.531 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -155.7 77.39 4.69 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.791 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.29 22.13 0.78 Allowed 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.825 2.35 . . . . 0.0 113.026 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -147.74 157.65 43.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.587 0.232 . . . . 0.0 111.134 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.603 ' HA ' HG22 ' A' ' 11' ' ' ILE . 6.0 ptmt -47.4 -8.87 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 39' ' ' GLU . . . 176.21 46.69 0.06 OUTLIER Glycine 0 C--N 1.308 -0.988 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.553 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 t -150.13 120.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.516 . . . . 0.0 111.849 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.602 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -68.64 170.29 9.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.358 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -95.1 105.77 17.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.372 . . . . 0.0 110.862 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -56.27 -29.18 60.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.88 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.46 -56.0 11.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 111.329 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -43.19 73.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.939 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.412 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 1.5 mp -52.01 -47.22 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.741 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.69 -54.81 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.16 -30.56 71.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.518 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.5 tt -59.22 -53.33 59.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.528 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 48' ' ' ILE . 14.2 mt -54.25 -50.44 67.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.041 0.448 . . . . 0.0 111.103 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.0 m -60.85 -36.59 79.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.367 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -66.47 -39.09 88.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.794 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -52.5 65.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.096 0.474 . . . . 0.0 110.347 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.68 -114.42 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.89 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -150.48 30.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.102 0.477 . . . . 0.0 110.671 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -121.08 -143.62 0.34 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.467 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -119.55 170.34 9.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.734 0.302 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.65 98.11 8.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.253 0.549 . . . . 0.0 110.636 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 tp -80.5 85.51 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.864 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.27 29.67 69.3 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.988 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -44.97 119.4 1.97 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.38 . . . . 0.0 111.172 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.2 p -110.09 170.27 8.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.251 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 154.01 61.01 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.939 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.1 Cg_endo -86.64 152.51 45.56 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 124.258 -1.143 . . . . 0.0 112.406 0.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 8.5 mm-40 -117.91 113.06 21.16 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -83.34 163.06 3.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.131 0.491 . . . . 0.0 111.902 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 50.9 m-85 -142.52 141.57 32.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.335 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB1' ' N ' ' A' ' 74' ' ' SER . . . -53.2 132.44 51.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.614 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.577 ' HB3' ' N ' ' A' ' 1' ' ' MET . 33.7 Cg_exo -53.48 -21.88 19.82 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.56 2.173 . . . . 0.0 111.795 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -161.61 41.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.29 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.95 -110.72 0.63 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.998 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.4 ' N ' ' HB1' ' A' ' 70' ' ' ALA . 37.1 m -137.85 178.62 6.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.136 0.493 . . . . 0.0 111.274 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 37.9 t-80 -55.75 132.36 49.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.116 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.4 mt -100.98 -42.65 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.921 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.05 -154.95 22.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.028 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.13 -141.39 10.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.843 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 19' ' ' ASN . 26.5 t80 -72.42 -70.64 0.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.767 0.317 . . . . 0.0 111.332 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -56.93 -49.53 75.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 110.663 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -53.11 -37.64 61.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.45 HD22 ' CE1' ' A' ' 86' ' ' PHE . 5.4 tt -77.82 -34.49 51.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.212 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 -51.98 -31.37 29.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -68.8 -32.43 72.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.286 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 26.3 t80 -68.43 -29.99 68.77 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.589 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.477 ' CZ ' ' CD2' ' A' ' 24' ' ' LEU . 22.6 m-85 -92.33 -25.49 18.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.416 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.2 mttt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.793 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.529 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 34.2 ttp . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.902 0.382 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.446 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 65.0 m-85 -50.05 169.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.785 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -143.28 117.48 9.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.496 -178.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.466 HG11 ' CE1' ' A' ' 33' ' ' PHE . 77.1 t -108.88 144.64 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.201 0.524 . . . . 0.0 111.535 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.446 ' CZ ' HD13 ' A' ' 34' ' ' ILE . 10.9 m-85 -125.47 99.95 6.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.196 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.36 -137.46 2.22 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.257 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.43 ' HE1' ' HE1' ' A' ' 37' ' ' MET . 81.2 m-85 -114.08 159.34 20.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.738 0.304 . . . . 0.0 110.905 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -84.73 -73.7 0.42 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p 167.83 -33.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 110.638 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -85.12 -23.15 28.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.493 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 ' CG2' ' HG2' ' A' ' 37' ' ' MET . 4.1 mp -91.73 -44.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.222 0.534 . . . . 0.0 110.733 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -150.08 139.8 21.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.004 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.82 146.0 43.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.276 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.98 112.12 0.64 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.322 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 m -90.56 -30.74 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.451 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -65.02 -27.28 68.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.51 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.1 t -56.8 -53.86 52.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.352 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.16 -35.62 64.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.176 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -72.92 -58.96 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.989 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.12 -37.69 64.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.213 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -59.5 -54.27 48.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.691 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -66.33 -28.87 69.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.049 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.6 tt -54.57 -53.71 50.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.477 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.18 -40.76 94.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.536 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 m -61.8 -34.02 75.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.329 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.9 t -74.13 -28.51 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.01 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.471 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -83.45 -12.57 56.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.293 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.49 55.95 0.08 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -142.19 142.39 24.14 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' O ' ' HA ' ' A' ' 1' ' ' MET . 98.5 Cg_endo -79.09 148.54 21.73 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.485 2.123 . . . . 0.0 111.323 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.51 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 36.8 p90 -156.74 170.64 21.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -141.68 134.92 29.33 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.026 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.466 ' CE1' HG11 ' A' ' 4' ' ' VAL . 30.3 t80 -89.68 161.97 15.83 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.093 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.446 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 17.0 mt -147.22 121.4 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.602 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -99.45 131.77 45.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.938 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pp -96.82 7.19 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.763 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.43 ' HE1' ' HE1' ' A' ' 7' ' ' TYR . 1.5 tpp -140.62 69.41 31.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.705 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 3.8 Cg_exo -80.96 43.65 1.59 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.296 2.664 . . . . 0.0 112.899 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.18 170.36 16.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.57 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.5 tptt -66.41 -7.69 20.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.199 0.523 . . . . 0.0 111.975 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.49 50.0 0.02 OUTLIER Glycine 0 C--N 1.313 -0.739 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.667 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -150.48 120.2 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.213 0.53 . . . . 0.0 111.818 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -65.61 136.61 56.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.157 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -97.83 113.76 25.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.831 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -63.37 -17.27 62.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.46 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -62.3 -57.29 11.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.862 0.363 . . . . 0.0 110.646 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -72.13 -39.29 68.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.206 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.6 mt -60.48 -48.46 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.26 96.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.375 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.01 -37.63 88.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.323 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.434 HD13 ' CD2' ' A' ' 5' ' ' TYR . 26.7 tp -59.3 -51.9 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.6 -47.46 70.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.093 0.473 . . . . 0.0 111.192 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.0 m -62.63 -32.25 73.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.42 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 2.8 mmmt -67.71 -34.98 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.491 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.83 -39.15 84.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.466 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.5 -105.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.865 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -150.33 31.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.041 0.448 . . . . 0.0 110.636 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.01 -147.19 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.445 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 t -120.21 170.29 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 0.0 110.668 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.15 98.24 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 110.405 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mt -80.2 84.21 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.201 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.29 24.89 53.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.639 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.71 143.12 47.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 110.685 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -124.07 168.12 13.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 111.444 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.6 mtm -110.67 154.55 43.13 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.732 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.27 140.65 58.2 Favored 'Cis proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.749 -1.355 . . . . 0.0 112.759 0.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -97.02 114.69 26.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.031 179.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 6.5 t -95.71 160.27 2.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.996 0.427 . . . . 0.0 111.73 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.59 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 92.5 m-85 -142.44 153.44 43.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.723 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.502 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -61.62 147.35 88.74 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.271 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 1' ' ' MET . 64.2 Cg_exo -55.17 -23.89 38.65 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.293 2.662 . . . . 0.0 112.507 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -99.06 -29.0 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.397 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 132.26 93.83 0.58 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.756 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.85 159.85 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -90.2 125.55 35.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.017 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.502 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 3.1 mp -117.05 -27.28 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.488 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.14 -157.62 15.62 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.939 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.5 -140.65 11.56 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.675 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.447 ' CE1' HD12 ' A' ' 23' ' ' LEU . 24.4 t80 -65.96 -70.58 0.23 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.823 0.344 . . . . 0.0 111.145 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.19 -49.99 75.11 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.826 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -51.09 -43.09 61.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.438 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' A' ' 86' ' ' PHE . 4.7 tt -74.76 -34.07 62.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.107 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.4 ttp180 -51.84 -28.62 16.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.14 -32.62 70.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.0 t80 -67.45 -32.02 72.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.67 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.471 ' CD1' ' HG2' ' A' ' 27' ' ' LYS . 10.2 m-85 -96.71 -70.61 0.71 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.651 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 83' ' ' ARG . 9.5 mmtp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.625 ' HG3' ' HA ' ' A' ' 31' ' ' PHE . 1.1 tpp . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.769 0.319 . . . . 0.0 111.687 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.472 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 65.8 m-85 -58.83 166.28 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.344 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -140.86 117.57 10.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.022 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.487 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 39.0 t -107.5 147.43 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.223 0.535 . . . . 0.0 111.48 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 14.8 m-85 -129.64 101.19 5.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.289 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.71 -138.67 2.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.174 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD2' ' CB ' ' A' ' 12' ' ' HIS . 16.3 m-85 -116.03 158.56 22.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.619 0.247 . . . . 0.0 110.706 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -74.23 -69.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.689 0.28 . . . . 0.0 111.462 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 166.31 -38.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.038 0.447 . . . . 0.0 110.179 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -85.29 -22.82 28.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.623 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.65 -42.77 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.25 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.646 ' CD2' ' HE3' ' A' ' 37' ' ' MET . 12.2 t-80 -144.3 158.34 43.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.795 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -80.6 144.96 31.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.963 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 p -174.3 117.75 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.307 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.14 -32.08 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -67.01 -24.61 66.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.42 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -65.79 -61.09 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 110.439 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -26.01 63.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.913 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 28.4 m-20 -78.66 -60.04 2.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.193 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.01 -45.97 71.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.172 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -58.19 -52.53 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.567 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -61.01 -40.76 94.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.576 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 86' ' ' PHE . 1.1 tt -57.55 -53.82 53.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.416 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 mt -55.77 -46.72 77.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.732 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.1 m -56.77 -37.08 70.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.14 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -77.83 -31.08 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.656 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -9.68 58.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.15 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt 68.13 53.36 0.63 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.947 0.403 . . . . 0.0 110.69 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -133.23 136.38 27.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.108 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 1' ' ' MET . 54.1 Cg_endo -81.29 137.14 10.41 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.547 2.165 . . . . 0.0 110.837 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.625 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 42.3 p90 -153.6 170.1 21.65 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.684 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -136.43 132.87 36.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.487 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 34.7 t80 -89.67 160.84 16.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.44 HD12 ' CE1' ' A' ' 5' ' ' TYR . 18.4 mt -146.63 121.14 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.323 0.582 . . . . 0.0 110.517 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -90.51 121.82 32.79 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.897 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pt -91.45 -6.65 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.337 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.646 ' HE3' ' CD2' ' A' ' 12' ' ' HIS . 22.4 ttm -118.57 99.88 51.35 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.661 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.454 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.8 Cg_endo -76.16 -27.5 8.15 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.477 2.118 . . . . 0.0 111.768 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -140.28 150.14 43.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.217 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -64.38 -8.37 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.355 0.598 . . . . 0.0 111.801 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.51 -56.55 3.13 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.685 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.73 147.18 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -66.45 168.75 8.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.606 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.454 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 41.6 t0 -91.37 122.11 33.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -66.6 -26.5 67.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.886 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.02 -56.25 23.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.476 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -64.41 -44.24 91.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.136 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.9 mt -55.79 -42.95 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.392 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.74 -47.87 76.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.728 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.12 -36.56 82.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.335 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.437 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 34.2 tp -63.05 -60.29 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.445 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' A' ' 55' ' ' LEU . 88.0 mt -44.91 -41.91 7.6 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.261 0.553 . . . . 0.0 111.747 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.9 m -69.03 -30.33 68.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.406 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 51' ' ' LEU . 4.4 tttp -69.05 -44.28 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.836 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.437 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -59.1 -67.09 0.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.381 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.77 -31.55 0.14 Allowed Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.901 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -135.69 -169.99 2.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.323 . . . . 0.0 110.919 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -103.63 20.18 18.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.231 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 t -120.09 165.68 14.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.826 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -128.98 100.69 5.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.008 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.5 mt -80.29 84.28 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.012 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.62 27.56 55.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.162 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -55.42 143.18 29.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.995 0.426 . . . . 0.0 111.238 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 152.58 45.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.3 mmt -108.75 148.92 38.76 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.727 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.3 Cg_exo -80.53 148.0 76.02 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 124.026 -1.239 . . . . 0.0 112.952 0.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 5' ' ' TYR . 6.7 tp60 -104.38 126.24 51.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.384 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -103.01 166.39 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.74 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 81.1 m-85 -142.53 153.03 43.22 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -65.11 149.71 96.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.264 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.587 ' HB3' ' N ' ' A' ' 1' ' ' MET . 40.9 Cg_exo -59.97 -25.76 80.48 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.026 2.484 . . . . 0.0 112.196 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.16 -25.95 17.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.246 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.4 91.11 0.84 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.658 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -179.17 161.21 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.791 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.419 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 10.5 t-160 -85.6 126.67 34.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 70' ' ' ALA . 18.6 mt -101.21 -45.42 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.033 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.39 -152.42 18.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.912 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.25 -146.38 12.0 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.859 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 19.3 t80 -72.27 -70.98 0.31 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.672 0.272 . . . . 0.0 111.327 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -55.84 -44.46 78.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.158 0.504 . . . . 0.0 110.508 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -52.54 -40.75 62.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.995 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' TYR . 6.0 tt -73.63 -32.09 63.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.284 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.0 mmm-85 -51.81 -35.11 43.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.34 -34.57 78.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.3 t80 -61.82 -35.36 78.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.07 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.463 ' CE2' HD23 ' A' ' 82' ' ' LEU . 7.7 m-85 -91.51 -9.7 43.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.07 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.1 pttp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.964 179.831 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.587 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 8.2 ttm . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.1 144.54 38.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.097 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.68 118.81 37.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.333 -178.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.468 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 55.0 t -104.73 142.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.184 0.516 . . . . 0.0 111.042 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CE1' ' CD2' ' A' ' 69' ' ' PHE . 9.8 m-85 -121.27 99.15 6.32 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.08 -151.99 6.3 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.848 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.711 ' CD1' ' CG ' ' A' ' 12' ' ' HIS . 60.7 m-85 -102.74 125.12 49.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.754 0.311 . . . . 0.0 111.318 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.517 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 6.1 t0 -137.1 65.36 1.5 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.634 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.36 -171.62 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.144 0.497 . . . . 0.0 111.631 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.85 -2.61 58.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.96 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.16 -13.22 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.955 0.407 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.711 ' CG ' ' CD1' ' A' ' 7' ' ' TYR . 42.9 t-80 -165.59 141.02 5.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -80.78 174.97 11.09 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.11 92.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.932 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -79.28 -32.25 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.719 0.295 . . . . 0.0 111.445 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -63.91 -26.67 68.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.447 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -59.31 -42.08 90.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 110.329 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.39 -43.42 67.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.771 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -76.99 -55.21 5.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.846 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.57 -41.92 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.003 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -59.65 -53.74 54.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.589 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -64.76 -28.65 69.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.48 HD12 ' CE1' ' A' ' 79' ' ' PHE . 2.0 tt -60.05 -59.8 4.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.397 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 mt -58.52 -40.29 82.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.433 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.4 m -60.44 -38.06 82.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.878 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -78.84 -30.28 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.627 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -70.13 -15.73 63.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.917 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 76.13 45.59 0.11 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.935 0.398 . . . . 0.0 111.0 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -144.01 137.62 14.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.023 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.6 Cg_endo -75.24 162.94 35.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.491 2.127 . . . . 0.0 111.117 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.404 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 53.9 p90 -161.72 171.03 18.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.38 125.4 19.86 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.36 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 1.4 t80 -90.74 124.97 35.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.361 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.453 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 8.0 mt -106.48 114.22 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.477 0.656 . . . . 0.0 110.526 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -82.52 144.62 30.28 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.383 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 2.6 pt -100.89 -12.7 8.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.666 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 19.1 ttm -124.81 107.76 28.64 Favored Pre-proline 0 C--N 1.334 -0.089 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 44' ' ' ASP . 95.6 Cg_endo -79.96 -28.05 3.46 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.353 2.035 . . . . 0.0 110.927 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.62 151.09 36.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.231 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -8.52 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.225 0.536 . . . . 0.0 111.99 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 -54.56 4.5 Favored Glycine 0 C--N 1.311 -0.86 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.126 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -150.87 134.16 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -56.99 170.14 0.46 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.449 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -87.1 106.19 17.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.658 0.266 . . . . 0.0 111.7 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.73 -27.48 59.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -59.03 -53.4 58.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.88 0.371 . . . . 0.0 110.581 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -40.66 75.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.03 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 44' ' ' ASP . 44.9 mm -58.13 -45.94 88.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.69 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.51 -56.58 11.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.296 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -60.62 -30.66 69.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.919 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -58.24 -53.26 60.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.572 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.6 mt -54.28 -46.58 72.76 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 111.204 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.8 m -63.86 -34.12 77.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.227 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.412 ' HE3' ' CG ' ' A' ' 69' ' ' PHE . 2.0 mmmt -65.77 -36.93 84.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.438 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.33 -42.98 96.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.489 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.75 -107.31 0.31 Allowed Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.751 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -150.55 26.78 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.074 0.464 . . . . 0.0 110.834 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -121.67 -153.71 0.56 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.31 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -120.88 161.18 21.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.477 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.401 ' NE2' ' HG ' ' A' ' 63' ' ' LEU . 7.8 pt20 -115.04 98.75 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 110.785 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.63 87.72 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.557 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.07 33.37 5.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.412 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' NE2' ' A' ' 60' ' ' GLN . 2.1 tm? -44.56 130.71 6.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.759 0.314 . . . . 0.0 110.904 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.6 m -112.33 148.3 34.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.082 0.467 . . . . 0.0 111.551 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -119.65 155.72 54.33 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.791 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.8 Cg_exo -80.53 137.55 40.78 Favored 'Cis proline' 0 C--N 1.344 0.327 0 C-N-CA 123.861 -1.308 . . . . 0.0 112.858 0.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.5 tp60 -99.78 118.32 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.172 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.3 t -93.44 161.53 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.328 0.585 . . . . 0.0 112.145 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 86.2 m-85 -143.2 152.31 41.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.99 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.445 ' CB ' HD11 ' A' ' 76' ' ' ILE . . . -65.47 143.56 98.72 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.78 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.587 ' HB3' ' N ' ' A' ' 1' ' ' MET . 21.8 Cg_exo -61.63 -17.48 54.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.354 2.036 . . . . 0.0 111.988 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -103.19 -25.91 13.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.862 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.48 86.21 0.49 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.697 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.58 118.97 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 110.823 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -55.53 131.79 47.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.3 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.445 HD11 ' CB ' ' A' ' 70' ' ' ALA . 2.0 mp -116.76 -31.94 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.62 -161.13 13.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.718 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -90.31 -147.99 19.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.028 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.48 ' CE1' HD12 ' A' ' 23' ' ' LEU . 46.5 t80 -69.54 -53.84 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.347 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -57.82 -49.51 76.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.758 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -64.73 -36.08 83.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 78' ' ' GLY . 1.4 tm? -66.02 -44.13 85.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.348 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HG2' HD12 ' A' ' 23' ' ' LEU . 3.2 mmm-85 -54.42 -37.92 65.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.38 -37.17 74.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -62.07 -35.44 78.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.127 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.509 ' CE1' ' HG2' ' A' ' 27' ' ' LYS . 8.2 m-85 -86.52 -26.76 24.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.217 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.1 mttt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.86 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.525 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.3 ttp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.843 0.354 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.469 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 94.7 m-85 -59.26 160.83 6.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.9 mppp? -135.72 118.08 15.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.198 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.526 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 19.4 t -108.53 141.13 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.183 0.515 . . . . 0.0 111.926 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.473 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 4.6 m-85 -121.68 105.34 10.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.249 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.38 -139.0 2.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.392 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.584 ' CE1' ' HE1' ' A' ' 37' ' ' MET . 38.7 m-85 -109.91 153.35 24.62 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.4 t70 -82.22 -2.63 53.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 2.3 p 81.82 -22.85 0.24 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.984 0.421 . . . . 0.0 110.921 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -75.71 -35.29 60.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.9 0.381 . . . . 0.0 111.124 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.7 ' O ' HG22 ' A' ' 11' ' ' ILE . 9.8 mm -104.6 -7.02 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -176.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.488 ' HD2' ' CE ' ' A' ' 37' ' ' MET . 1.3 t-80 -166.64 108.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -176.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -39.39 134.23 1.24 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.5 m -166.23 109.23 0.76 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.401 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 m -87.0 -29.71 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 110.732 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -58.12 -30.7 66.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.596 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.5 m -61.73 -55.0 34.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 110.059 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -53.56 -31.64 47.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.248 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.24 -59.68 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.19 -42.01 69.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.296 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -62.12 -57.79 10.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.471 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -57.0 -39.12 74.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.238 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tt -57.02 -54.2 49.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.197 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.5 mt -57.32 -45.49 84.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.616 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.5 m -58.27 -36.06 72.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.079 0.466 . . . . 0.0 109.977 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -79.82 -30.62 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.425 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -16.59 59.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.916 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt 72.53 57.32 0.14 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.93 0.395 . . . . 0.0 110.978 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -139.08 139.0 21.93 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.373 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.447 ' O ' ' HA ' ' A' ' 1' ' ' MET . 71.6 Cg_endo -80.14 140.12 13.82 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.56 2.174 . . . . 0.0 111.241 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.525 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 22.9 p90 -160.26 171.27 19.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -142.06 137.84 31.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.962 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.526 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 39.6 t80 -89.41 159.74 17.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.833 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.473 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 11.3 mt -143.68 119.11 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.279 0.561 . . . . 0.0 110.456 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -80.66 135.94 36.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.394 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pt -97.01 -17.38 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.421 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.605 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 4.4 ttp -131.41 90.37 38.02 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.482 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -71.17 -4.32 14.66 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.661 2.241 . . . . 0.0 113.207 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -139.65 144.11 37.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.068 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -68.09 -8.55 39.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.241 0.543 . . . . 0.0 111.945 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.91 -58.02 1.35 Allowed Glycine 0 C--N 1.313 -0.75 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.293 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.84 140.93 27.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -72.73 167.16 21.41 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.616 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -91.37 103.46 16.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.382 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.9 -24.65 16.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.696 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -56.53 -50.16 72.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.922 0.391 . . . . 0.0 111.006 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -75.93 -32.06 59.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.459 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.0 mm -65.0 -47.25 88.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.004 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.98 -55.99 18.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.027 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -56.73 -31.97 65.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.608 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 5' ' ' TYR . 15.4 tp -61.34 -58.41 8.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.189 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 72.5 mt -44.04 -40.92 5.12 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.301 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.1 m -70.22 -35.64 74.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.301 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' LEU . 5.0 tttp -60.2 -41.86 93.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.679 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.441 HD21 ' CE1' ' A' ' 75' ' ' HIS . 4.8 mp -58.64 -69.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.239 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.08 -35.08 0.31 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -102.8 -175.1 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.798 0.332 . . . . 0.0 111.009 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.73 -31.9 10.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.825 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -105.32 170.19 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -122.72 101.51 7.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.757 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -80.06 85.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.309 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.92 27.25 70.99 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.579 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -49.84 171.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 111.235 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.4 ' N ' HD21 ' A' ' 63' ' ' LEU . 6.9 p -143.29 156.67 44.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.1 0.476 . . . . 0.0 111.591 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 mtt -126.32 154.65 74.73 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.567 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 7.5 Cg_exo -75.52 150.34 94.47 Favored 'Cis proline' 0 C--N 1.344 0.308 0 C-N-CA 124.008 -1.247 . . . . 0.0 112.77 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -102.58 123.15 45.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.495 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -97.03 166.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.343 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.504 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 81.6 m-85 -142.47 140.98 32.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.071 0.462 . . . . 0.0 110.895 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.407 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -53.4 134.98 52.39 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.411 -178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.5 ' HB3' ' N ' ' A' ' 1' ' ' MET . 89.0 Cg_exo -45.92 -27.68 4.35 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.012 2.475 . . . . 0.0 112.074 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -165.43 38.8 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.153 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.56 -109.15 0.99 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.101 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.5 m -138.47 177.34 7.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.237 0.542 . . . . 0.0 111.335 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.441 ' CE1' HD21 ' A' ' 55' ' ' LEU . 17.9 t-80 -53.06 122.3 9.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.096 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 70' ' ' ALA . 4.4 mt -83.83 -43.64 17.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.988 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.04 -149.84 17.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.526 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.6 -159.25 31.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.209 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -60.92 -57.85 10.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.767 0.318 . . . . 0.0 110.704 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -54.01 -43.95 70.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -57.16 -32.81 66.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.625 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD21 ' CD2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -71.49 -47.47 55.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.655 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.28 -30.17 26.73 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -74.81 -33.65 62.25 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 82' ' ' LEU . 21.0 t80 -66.86 -32.43 73.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.392 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.424 ' CD2' HD21 ' A' ' 82' ' ' LEU . 7.1 m-85 -92.08 -70.31 0.7 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.336 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.87 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.697 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 12.4 tpp . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.429 0.157 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -39.85 120.92 1.2 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.511 0.672 . . . . 0.0 112.233 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -90.91 125.36 35.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.267 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 33' ' ' PHE . 22.7 t -109.55 110.24 31.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.01 0.433 . . . . 0.0 111.107 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 16.4 m-85 -89.64 99.26 12.3 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.3 -141.07 3.02 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.031 -1.081 . . . . 0.0 112.723 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.481 ' CE1' ' CD1' ' A' ' 36' ' ' ILE . 30.4 m-85 -127.11 149.2 50.05 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.747 0.308 . . . . 0.0 111.261 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -102.23 22.02 13.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.7 9.63 7.44 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.445 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -85.87 -50.7 6.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.782 0.325 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.8 mm -103.0 -32.04 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.638 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -140.62 154.83 46.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.277 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 166.73 22.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 p 174.0 95.08 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.671 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.7 -44.39 79.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.553 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -57.3 -29.37 63.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.233 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -56.74 11.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.02 -33.77 53.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.173 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 91.2 m-20 -69.92 -49.88 47.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.896 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -61.01 -32.59 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -60.61 -54.06 49.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -25.52 67.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tt -57.79 -55.23 37.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.324 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 mt -63.17 -35.1 79.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.567 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.3 m -68.72 -41.64 78.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.177 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -66.79 -31.99 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.523 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -84.65 -10.49 57.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.07 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 2.6 mtmt 68.54 53.36 0.56 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.969 0.414 . . . . 0.0 110.986 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.31 113.17 7.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.697 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 88.4 Cg_exo -45.72 174.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.643 2.229 . . . . 0.0 112.766 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -163.99 169.89 17.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.811 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.3 tm-20 -129.03 109.41 11.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.14 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.436 ' CE1' HG11 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -90.54 150.97 21.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.04 0.448 . . . . 0.0 111.461 -179.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.419 HG13 ' C ' ' A' ' 33' ' ' PHE . 30.2 mt -149.73 127.02 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.301 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -82.69 110.31 17.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.401 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.481 ' CD1' ' CE1' ' A' ' 7' ' ' TYR . 3.2 pt -73.46 -19.96 18.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.8 ttp -129.49 86.13 56.86 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.338 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.82 -3.05 13.34 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.663 2.242 . . . . 0.0 112.407 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 37' ' ' MET . 3.1 tt0 -139.89 136.46 33.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.43 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -7.86 12.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.222 0.534 . . . . 0.0 111.963 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.49 -63.48 1.56 Allowed Glycine 0 C--N 1.313 -0.747 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.409 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.14 140.47 26.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.66 0.267 . . . . 0.0 111.229 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -66.23 170.97 5.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.082 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.402 ' O ' HG12 ' A' ' 48' ' ' ILE . 1.3 t70 -83.2 95.23 8.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.958 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.39 -20.64 30.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.441 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.94 -60.62 3.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.022 0.439 . . . . 0.0 110.535 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -67.09 -40.3 86.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.302 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 48' ' ' ILE . 34.3 mm -59.83 -37.68 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.779 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.52 -51.91 67.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.06 -32.48 64.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.256 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.571 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.3 tt -60.64 -53.35 58.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -50.95 -42.23 59.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.017 0.437 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.0 m -59.48 -45.62 91.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.707 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -61.96 -32.52 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.75 -50.35 73.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.5 -19.24 2.43 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.119 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -148.14 -162.26 1.51 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 110.397 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -113.63 21.66 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.149 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -120.19 164.22 16.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.74 0.305 . . . . 0.0 110.965 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.4 102.59 6.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.729 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.9 pt -71.77 79.68 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.344 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.75 26.44 5.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.535 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' CD1' ' NE2' ' A' ' 67' ' ' GLN . 1.5 tp -56.6 169.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.338 . . . . 0.0 111.154 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.9 p -150.84 158.8 44.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -104.29 159.13 30.32 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.596 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.6 Cg_exo -80.01 145.69 73.0 Favored 'Cis proline' 0 C--N 1.344 0.31 0 C-N-CA 124.134 -1.194 . . . . 0.0 112.978 0.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.402 ' NE2' ' CD1' ' A' ' 63' ' ' LEU . 56.4 mm-40 -108.24 120.78 43.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.773 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -90.62 155.07 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.166 0.508 . . . . 0.0 111.927 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 75' ' ' HIS . 33.8 m-85 -143.16 137.76 29.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.635 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -47.88 156.46 0.71 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.717 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.24 -38.68 88.36 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.727 2.285 . . . . 0.0 112.037 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.47 -21.65 20.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.184 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.76 89.36 0.81 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.649 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.55 116.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.372 . . . . 0.0 110.624 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 2.1 t-160 -55.14 112.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.307 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' A' ' 70' ' ' ALA . 6.7 mt -98.53 -35.48 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.365 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.43 -151.92 20.07 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.233 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 82' ' ' LEU . . . -104.57 -141.05 10.74 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.118 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.443 ' HB3' ' CD2' ' A' ' 16' ' ' TYR . 13.0 t80 -73.63 -66.43 0.7 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 0.0 110.725 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -63.04 -42.68 99.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.948 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.43 -49.22 75.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.626 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.435 ' O ' ' HB3' ' A' ' 85' ' ' TYR . 3.0 tt -74.43 -38.82 62.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.88 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -49.64 -27.61 4.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.958 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.75 -35.33 72.6 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.724 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.48 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -64.8 -37.32 87.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.408 ' CD2' HD21 ' A' ' 82' ' ' LEU . 14.8 m-85 -86.55 -20.28 28.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.583 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.992 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.595 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 38.2 ttm . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -79.35 147.45 32.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.239 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.18 120.53 42.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.221 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 67' ' ' GLN . 53.6 t -112.35 123.71 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.32 0.581 . . . . 0.0 111.996 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.1 m-85 -99.98 99.53 10.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.967 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.07 -141.69 3.22 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.335 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -121.7 159.02 27.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.0 111.402 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.59 -67.93 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 166.28 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.556 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.25 -27.74 47.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.2 mp -91.11 -37.04 8.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.261 0.553 . . . . 0.0 110.654 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -155.1 142.05 19.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.199 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.75 146.39 31.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.295 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.98 107.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.816 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.4 m -71.74 -40.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.421 . . . . 0.0 110.577 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -51.82 -25.75 8.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.387 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -65.94 -62.85 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.125 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -57.01 -31.79 65.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.52 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -53.15 52.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.852 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.64 71.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.007 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -61.13 -35.75 77.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.083 0.468 . . . . 0.0 110.121 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -76.74 -27.62 55.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.604 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -57.35 -56.56 20.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.212 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.6 mt -63.04 -45.85 90.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.654 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 m -56.03 -35.44 66.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.366 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -75.99 -29.54 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.682 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 1.5 mmtm -76.11 -12.91 60.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.226 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 76.16 38.7 0.31 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.03 0.443 . . . . 0.0 110.796 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -129.74 139.76 36.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.697 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 1' ' ' MET . 93.5 Cg_endo -77.74 160.98 30.93 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.471 2.114 . . . . 0.0 111.619 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -161.47 170.89 19.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.413 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -136.89 125.11 23.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.898 0.38 . . . . 0.0 110.792 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.437 ' CE1' HG11 ' A' ' 4' ' ' VAL . 13.0 t80 -89.84 156.96 18.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.162 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.407 HG13 ' C ' ' A' ' 33' ' ' PHE . 18.4 mt -150.43 123.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.275 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -86.12 110.58 19.65 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.534 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -70.38 -14.19 17.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.311 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.597 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.9 ttp -126.38 89.57 51.94 Favored Pre-proline 0 N--CA 1.455 -0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 110.931 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.48 0.07 10.32 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.57 2.18 . . . . 0.0 112.239 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 37' ' ' MET . 38.4 tt0 -140.02 136.25 33.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.603 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -63.93 -8.05 10.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.169 0.509 . . . . 0.0 112.114 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.89 -63.07 1.7 Allowed Glycine 0 C--N 1.313 -0.728 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.079 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -147.49 149.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.673 0.273 . . . . 0.0 111.142 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -69.14 171.27 8.58 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.873 0.368 . . . . 0.0 111.588 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.408 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -95.98 110.97 23.1 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.158 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -64.4 -23.19 67.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.808 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -58.62 -52.6 65.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 110.797 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.09 -44.64 68.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.248 0.547 . . . . 0.0 109.736 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.434 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 16.0 mm -54.91 -40.64 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.693 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.48 -51.4 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.645 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -32.35 64.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.228 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.591 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.7 tt -60.99 -50.13 74.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.193 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -52.49 -43.49 65.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.565 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 m -54.5 -46.39 73.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.665 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' CB ' ' CE2' ' A' ' 69' ' ' PHE . 2.8 mtmm -63.31 -36.53 83.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.628 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mt -61.28 -52.66 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.723 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.6 -113.9 0.58 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.065 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -150.33 31.74 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.118 0.485 . . . . 0.0 110.509 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -121.01 -146.52 0.38 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.276 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -117.19 170.13 8.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.694 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -73.26 98.26 2.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.181 0.515 . . . . 0.0 110.455 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.402 ' CD1' ' O ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -79.9 79.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.148 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.68 21.71 71.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.472 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.79 131.69 51.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.962 0.41 . . . . 0.0 110.804 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -123.61 163.65 20.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.356 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.4 mtm -107.98 152.25 41.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.55 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.7 Cg_endo -83.0 137.9 32.8 Favored 'Cis proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.968 -1.263 . . . . 0.0 112.883 0.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.453 ' NE2' ' CD2' ' A' ' 75' ' ' HIS . 48.0 tp60 -96.29 138.59 33.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.861 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.6 t -109.78 154.91 11.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.051 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.434 ' CE2' ' CB ' ' A' ' 54' ' ' LYS . 48.0 m-85 -143.39 143.21 31.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.547 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.434 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.58 155.21 14.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.264 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.595 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -72.47 -16.11 27.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.87 2.38 . . . . 0.0 112.097 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -104.72 -7.85 19.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.095 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.07 89.82 1.95 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.512 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -175.93 156.85 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.762 0.315 . . . . 0.0 111.093 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.453 ' CD2' ' NE2' ' A' ' 67' ' ' GLN . 7.4 t-160 -90.23 126.51 35.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.845 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.434 HD11 ' HA ' ' A' ' 70' ' ' ALA . 16.7 mt -113.8 -45.82 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.257 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 124.22 -151.58 17.19 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.91 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -99.14 -129.43 6.55 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.439 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.527 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -80.88 -70.35 0.54 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.713 0.256 . . . . 0.0 110.69 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -52.17 -46.9 65.7 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.235 0.54 . . . . 0.0 110.221 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.427 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -58.88 -41.41 87.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.615 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' GLY . 2.3 tt -74.54 -35.99 63.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.384 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.4 ttt180 -52.03 -32.84 35.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -34.42 74.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.291 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' LEU . 43.3 t80 -65.95 -32.05 73.32 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.447 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.451 ' CD1' ' HD2' ' A' ' 27' ' ' LYS . 24.9 m-85 -97.84 -9.11 26.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.67 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 83' ' ' ARG . 3.5 mtpm? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.885 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.741 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.519 0.199 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 66.0 m-85 -39.78 110.06 0.13 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.985 0.898 . . . . 0.0 111.667 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.819 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -89.74 127.0 35.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.95 -1.477 . . . . 0.0 111.281 -179.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.457 HG12 ' CE1' ' A' ' 33' ' ' PHE . 25.3 t -106.43 112.25 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.01 0.433 . . . . 0.0 111.296 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 11.2 m-85 -89.79 99.01 12.1 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.27 -143.12 3.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.537 ' CD2' ' CB ' ' A' ' 12' ' ' HIS . 31.2 m-85 -117.68 143.46 46.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.84 0.352 . . . . 0.0 111.578 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.91 -76.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.522 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 170.32 -34.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 110.606 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -81.36 -27.94 34.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.46 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.83 -45.24 15.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.353 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.633 ' CD2' ' HE3' ' A' ' 37' ' ' MET . 18.7 t-80 -143.93 159.62 42.25 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -80.24 149.91 30.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.539 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.4 p -157.27 93.52 1.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.149 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.5 m -82.01 -31.77 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.214 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -28.12 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.153 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 t -63.52 -45.3 91.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.038 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.76 -36.01 34.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.145 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -70.54 -56.88 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.669 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.49 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -57.31 -28.94 63.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.926 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -64.82 -44.3 90.29 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -63.28 -36.13 82.66 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' HG ' HD21 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -59.05 -61.85 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.346 178.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.569 HD21 ' HG ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -61.03 -53.39 57.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.93 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.5 m -52.63 -37.43 58.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.859 0.362 . . . . 0.0 111.235 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.78 -17.81 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.778 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -89.0 -30.34 18.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.557 0.218 . . . . 0.0 111.527 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.32 67.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.498 HE22 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -150.15 129.9 6.6 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.536 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.741 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 75.8 Cg_exo -49.75 167.41 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.327 1.351 . . . . 0.0 110.706 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -165.15 160.48 18.71 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.792 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 19.2 mt-10 -124.78 122.3 37.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 111.054 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.457 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.5 t80 -103.93 143.15 33.24 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.045 0.45 . . . . 0.0 110.954 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.404 HG13 ' C ' ' A' ' 33' ' ' PHE . 18.1 mt -144.32 127.69 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.224 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -82.43 121.55 26.88 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.863 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.471 ' HB ' HD12 ' A' ' 48' ' ' ILE . 2.6 pt -77.56 -15.49 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.996 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.633 ' HE3' ' CD2' ' A' ' 12' ' ' HIS . 33.0 ttm -125.01 79.53 65.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.769 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 60.4 Cg_endo -72.97 -5.34 17.04 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.753 2.302 . . . . 0.0 112.418 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.54 136.6 34.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.182 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -63.01 -8.84 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.183 0.515 . . . . 0.0 111.884 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.94 -61.19 2.16 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.542 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.1 t -150.29 155.58 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 111.485 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -62.41 166.67 4.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.615 179.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.442 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 3.4 t70 -83.33 123.93 30.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.959 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -78.04 -27.98 48.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.232 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.22 -59.77 3.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 110.862 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -62.71 -46.55 87.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.471 HD12 ' HB ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -59.94 -31.07 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.635 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.99 -47.22 84.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -36.9 80.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.46 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.3 tt -58.4 -50.03 75.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.159 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 52' ' ' LEU . 81.7 mt -51.88 -45.12 64.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.353 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.4 m -57.3 -46.76 82.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.612 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -60.9 -39.0 87.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.679 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.89 -62.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.83 -116.58 0.47 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.967 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -150.58 26.87 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.941 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -121.58 -149.28 0.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.297 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 t -120.58 166.61 13.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.526 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -115.95 98.87 6.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.92 0.39 . . . . 0.0 110.808 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.7 tp -81.45 85.57 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.463 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.54 30.45 7.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.497 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -47.15 135.65 9.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.799 0.333 . . . . 0.0 110.785 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.6 p -107.93 146.37 32.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.264 0.554 . . . . 0.0 111.854 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -122.01 159.36 51.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.474 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_exo -78.96 151.87 88.28 Favored 'Cis proline' 0 C--N 1.343 0.258 0 C-N-CA 124.211 -1.162 . . . . 0.0 112.679 0.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -113.58 116.39 29.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.842 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.819 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -88.7 154.41 3.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.103 0.478 . . . . 0.0 112.158 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 2' ' ' PHE . 35.7 m-85 -142.61 139.16 31.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.546 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -57.14 144.22 70.18 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.048 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -34.88 -35.31 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.74 2.96 . . . . 0.0 112.685 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.43 33.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.198 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.54 -105.1 2.66 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.644 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 m -137.93 179.45 6.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.031 0.443 . . . . 0.0 110.869 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -63.76 125.08 23.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.941 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.6 mp -97.74 -28.4 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.524 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 120.89 -160.07 15.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.012 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.14 -131.77 7.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.587 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 9.6 t80 -76.49 -70.65 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.705 0.288 . . . . 0.0 111.032 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -57.4 -48.22 79.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.386 . . . . 0.0 110.648 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.411 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -54.53 -46.12 73.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.476 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.436 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.3 tt -66.94 -38.9 87.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.016 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -51.73 -29.94 20.5 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -72.19 -34.94 68.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.203 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 82' ' ' LEU . 59.2 t80 -64.76 -32.48 74.18 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.313 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.436 ' CE2' HD22 ' A' ' 82' ' ' LEU . 27.3 m-85 -95.77 -12.11 25.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.582 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.888 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.581 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 33.6 ttm . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -77.08 145.32 37.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.118 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.0 mptt -106.83 119.17 38.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.618 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.44 HG12 ' CE1' ' A' ' 33' ' ' PHE . 17.1 t -102.94 121.5 54.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.221 0.534 . . . . 0.0 111.122 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.6 m-30 -98.87 99.36 10.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.882 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.29 -135.65 1.86 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.972 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.656 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 57.1 m-85 -125.86 146.77 49.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.735 0.302 . . . . 0.0 111.076 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.459 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -137.52 51.86 1.91 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.967 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 t -167.88 -173.22 2.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.308 0.575 . . . . 0.0 112.011 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -86.58 4.65 39.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.757 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.6 mm -86.86 -13.44 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.539 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.656 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 9.6 t-80 -163.08 122.68 2.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.664 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 168.68 7.98 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.54 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 174.7 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.662 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.33 -41.88 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.702 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -60.89 -18.94 59.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.574 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.8 -58.43 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.4 . . . . 0.0 110.565 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -50.66 -40.9 54.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.049 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -64.1 -46.83 82.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.397 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -63.87 -49.91 70.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.381 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 10.5 ttmt -50.47 -34.54 25.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.895 0.378 . . . . 0.0 110.586 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -66.74 -40.5 88.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.413 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.421 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.56 -55.62 32.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.235 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 6.4 mt -55.24 -45.17 76.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.61 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.7 m -57.3 -37.31 72.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.842 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.19 -34.21 18.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.505 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -17.96 62.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.852 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.47 53.2 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -140.03 136.13 16.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.195 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.581 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.6 Cg_endo -81.24 162.57 20.03 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.625 2.217 . . . . 0.0 110.761 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.4 p90 -161.34 171.1 18.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 111.981 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -136.2 134.16 37.88 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.568 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 10.9 t80 -89.69 158.74 17.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.534 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.439 HD11 ' CE1' ' A' ' 5' ' ' TYR . 15.4 mt -148.31 121.96 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.385 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -86.05 133.34 33.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.052 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.441 HD13 ' OH ' ' A' ' 7' ' ' TYR . 20.8 pt -98.77 2.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.362 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.565 ' HE1' ' HE2' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -145.1 90.82 6.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.676 0.274 . . . . 0.0 110.434 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 44.8 Cg_endo -68.48 -26.42 34.4 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.698 2.265 . . . . 0.0 112.31 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -139.52 146.68 40.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.993 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -62.09 -8.8 5.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.295 0.569 . . . . 0.0 111.73 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.2 -53.47 6.13 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.522 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.7 t -151.36 146.87 15.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.413 ' HB3' HD12 ' A' ' 48' ' ' ILE . 46.6 m-85 -57.43 169.55 0.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.399 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.446 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -81.56 98.04 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.614 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -57.77 -21.05 39.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.31 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.13 -57.2 6.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.18 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 7.2 mmtp -72.3 -50.77 24.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.662 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.428 HD12 ' HB ' ' A' ' 36' ' ' ILE . 1.6 mp -49.91 -35.72 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.43 -61.39 2.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.037 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 2.4 pt-20 -63.33 -25.47 68.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.465 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.3 tt -57.27 -54.36 47.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.961 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.4 mt -55.81 -49.48 73.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.08 0.467 . . . . 0.0 110.917 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.8 m -60.13 -36.08 76.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.321 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -71.02 -36.01 72.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.959 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.46 -41.6 90.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.026 0.441 . . . . 0.0 110.501 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.31 -164.58 31.54 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.853 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -94.39 31.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -121.11 -150.81 0.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.247 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 t -120.87 170.3 9.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.734 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.4 98.46 11.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.127 0.489 . . . . 0.0 110.254 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 tp -80.28 86.9 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.497 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.54 29.89 61.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.512 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.72 134.86 4.13 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.813 0.339 . . . . 0.0 111.044 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.22 170.11 8.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.224 0.535 . . . . 0.0 111.793 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.8 mmt -124.9 154.81 70.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.572 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -80.64 145.12 69.36 Favored 'Cis proline' 0 C--N 1.343 0.284 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.73 0.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.444 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 0.7 OUTLIER -111.58 117.66 33.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.915 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.3 t -89.86 161.45 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.255 0.55 . . . . 0.0 111.878 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -142.51 143.91 32.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.407 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' N ' ' A' ' 74' ' ' SER . . . -56.42 131.57 76.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.447 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.569 ' HB3' ' N ' ' A' ' 1' ' ' MET . 32.3 Cg_exo -52.71 -24.02 22.0 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.63 2.22 . . . . 0.0 112.091 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.06 38.38 0.18 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.349 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.8 -109.29 0.78 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.705 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.401 ' N ' ' HB2' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -140.8 -178.45 5.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.14 0.495 . . . . 0.0 111.142 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.444 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 17.2 t-80 -56.9 128.19 35.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.074 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.6 mt -100.21 -44.74 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.901 0.381 . . . . 0.0 110.777 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.13 -153.31 19.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.827 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.38 -138.85 8.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.119 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -75.43 -70.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.829 0.315 . . . . 0.0 110.642 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -47.36 -41.26 19.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.256 0.551 . . . . 0.0 110.323 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -39.58 94.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.412 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -75.03 -41.38 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.714 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -51.35 -33.48 29.79 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -68.6 -35.11 76.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.4 t80 -63.93 -34.12 77.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.562 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.451 ' CD2' HD22 ' A' ' 82' ' ' LEU . 6.7 m-85 -88.9 -70.52 0.64 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.296 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.9 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.566 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.0 ttm . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.818 0.342 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.453 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 70.0 m-85 -63.22 157.02 23.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.03 0.443 . . . . 0.0 110.687 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.735 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.95 119.28 20.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.965 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.502 HG11 ' CE1' ' A' ' 33' ' ' PHE . 12.4 t -105.06 132.18 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.551 . . . . 0.0 112.038 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.4 m-85 -108.46 99.61 8.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.349 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.66 -141.55 3.16 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.327 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -118.74 151.68 37.56 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.845 0.355 . . . . 0.0 110.928 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.84 -75.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.072 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 t 170.99 -41.98 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.525 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -76.47 -26.3 55.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.862 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 mp -89.96 -41.3 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.978 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -149.76 149.56 30.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.049 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 143.27 48.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.54 102.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.002 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 m -87.02 -19.47 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.378 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -75.67 -20.35 58.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.595 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 p -71.18 -44.08 66.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.673 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.17 -41.45 99.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -59.67 -51.05 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.789 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 -28.82 69.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.035 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -43.29 99.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.288 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -27.68 65.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.711 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.501 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -57.55 -57.14 13.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.414 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.1 mt -60.25 -40.01 88.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.658 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 m -60.5 -31.39 70.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.092 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -73.76 -27.51 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.915 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -83.11 -17.64 42.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.322 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 74.09 55.57 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.939 0.4 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -137.26 145.17 48.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.764 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.423 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.1 Cg_endo -77.33 139.2 18.42 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.428 2.085 . . . . 0.0 111.587 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 14.6 p90 -153.12 170.5 20.35 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -143.99 146.44 32.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.978 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.502 ' CE1' HG11 ' A' ' 4' ' ' VAL . 11.0 t80 -89.24 156.62 18.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.024 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.463 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 9.4 mt -143.3 118.58 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.242 0.544 . . . . 0.0 110.387 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -94.63 129.5 41.47 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.119 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.8 pt -86.81 -17.98 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.732 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.7 ttp -122.61 92.56 48.99 Favored Pre-proline 0 N--CA 1.454 -0.243 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.3 -15.45 28.29 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.681 2.254 . . . . 0.0 112.722 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -139.64 142.9 36.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.838 0.352 . . . . 0.0 110.85 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -65.58 -8.58 20.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.272 0.558 . . . . 0.0 111.851 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.94 -60.4 2.17 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.082 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 t -150.17 127.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.329 . . . . 0.0 110.837 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.56 170.43 1.05 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.446 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.11 96.56 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.124 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.77 -28.82 37.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.213 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -52.58 -44.62 66.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.927 0.394 . . . . 0.0 110.812 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -31.03 39.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.227 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.4 mm -63.31 -43.77 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.601 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.91 -55.76 11.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.078 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.58 -31.09 61.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.91 0.386 . . . . 0.0 110.389 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' A' ' 5' ' ' TYR . 12.8 tp -59.22 -59.12 5.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.08 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.445 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 71.1 mt -44.53 -44.08 8.43 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.303 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.9 m -69.68 -30.96 68.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.588 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 51' ' ' LEU . 5.1 tttp -65.39 -40.8 93.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.887 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.45 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 4.7 mp -59.34 -56.72 18.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.956 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.61 -110.5 0.27 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.165 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.33 31.32 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.04 0.448 . . . . 0.0 110.774 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -121.01 -148.53 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.288 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 t -120.34 170.26 9.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -92.01 98.8 11.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.201 0.525 . . . . 0.0 110.432 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.74 85.08 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.264 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.21 27.34 46.12 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.52 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.407 ' CD1' ' NE2' ' A' ' 67' ' ' GLN . 1.4 mm? -52.72 148.55 7.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.849 0.356 . . . . 0.0 110.993 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.1 p -121.68 170.15 10.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.146 0.498 . . . . 0.0 111.528 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.08 158.92 39.7 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.9 Cg_endo -85.81 151.44 49.84 Favored 'Cis proline' 0 N--CA 1.461 -0.406 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.898 0.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 5' ' ' TYR . 12.0 mm100 -111.71 117.9 34.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.223 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.735 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -91.28 166.31 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 0.0 111.837 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 64.1 m-85 -141.94 143.78 33.42 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.191 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -53.84 152.4 10.13 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.524 ' HB3' ' N ' ' A' ' 1' ' ' MET . 43.3 Cg_exo -59.3 -28.72 88.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.171 2.581 . . . . 0.0 112.54 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.85 -21.0 18.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.66 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.7 84.5 0.65 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.89 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.14 162.72 15.41 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -90.54 129.6 36.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.72 0.295 . . . . 0.0 110.971 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.4 mp -115.57 -43.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.789 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.14 -155.94 15.89 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.107 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.52 -134.1 7.33 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.535 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.501 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.71 -70.11 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.845 -0.209 . . . . 0.0 111.05 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -48.9 -44.63 40.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.176 0.512 . . . . 0.0 110.602 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -63.66 -44.77 92.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.885 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 85' ' ' TYR . 0.9 OUTLIER -69.88 -43.7 71.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.76 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 87' ' ' LYS . 6.2 ttp180 -51.56 -31.57 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -72.82 -32.63 65.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.333 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' CD2' HG12 ' A' ' 76' ' ' ILE . 54.0 t80 -68.6 -32.24 71.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.648 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.504 ' CD1' ' HG2' ' A' ' 27' ' ' LYS . 20.1 m-85 -96.61 -70.74 0.7 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.528 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.773 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.822 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 28.1 tpp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 110.502 -0.185 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.426 ' H ' ' HG3' ' A' ' 1' ' ' MET . 96.9 m-85 -43.13 137.57 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.805 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -115.48 120.51 39.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.978 -179.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.529 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 53.4 t -107.82 121.25 60.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.245 0.545 . . . . 0.0 111.845 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 20.0 m-85 -100.14 101.51 12.57 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.289 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.24 -139.01 2.54 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.521 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.637 ' CE1' ' CD2' ' A' ' 12' ' ' HIS . 64.2 m-85 -118.31 159.98 22.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.974 0.416 . . . . 0.0 111.478 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -96.84 -73.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.03 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m 170.64 -42.08 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.307 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -69.88 -32.44 70.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.189 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.4 mm -100.18 -32.86 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.637 ' CD2' ' CE1' ' A' ' 7' ' ' TYR . 1.4 t-80 -157.33 122.14 4.44 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 148.5 51.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.98 118.89 1.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.297 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 m -84.78 -36.79 11.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.906 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.23 -29.23 69.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.252 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.7 t -56.27 -49.38 74.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.274 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -56.64 -34.57 67.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.342 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 38.4 m-80 -72.74 -51.21 20.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 111.021 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -55.06 -45.32 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.125 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -64.99 -40.74 95.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.323 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 -62.54 -37.02 84.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.313 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' CD2' ' CD2' ' A' ' 24' ' ' LEU . 1.8 tt -57.57 -56.86 16.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.073 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.515 ' CD2' ' CE2' ' A' ' 86' ' ' PHE . 59.5 mt -62.76 -30.36 71.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.354 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.4 m -71.19 -36.43 71.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.201 0.524 . . . . 0.0 109.629 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.78 -48.61 29.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.513 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.15 -19.9 62.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.788 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt 71.33 55.04 0.21 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.944 0.402 . . . . 0.0 110.634 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -139.9 122.68 10.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.822 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 5.0 Cg_endo -48.53 159.33 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.602 2.201 . . . . 0.0 112.732 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.569 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 35.0 p90 -163.44 170.73 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.884 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.8 tt0 -141.04 115.34 9.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.645 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.529 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 36.3 t80 -89.03 154.36 20.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.833 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 mt -148.13 122.07 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.484 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -75.05 113.15 12.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.577 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.475 HD11 ' CE1' ' A' ' 7' ' ' TYR . 2.2 pp -64.7 -29.37 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.775 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.1 ttp -118.61 92.25 43.62 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.733 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HG3' ' HB2' ' A' ' 44' ' ' ASP . 88.0 Cg_endo -79.73 3.69 7.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.695 2.263 . . . . 0.0 112.957 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -139.2 144.16 38.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.488 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -66.89 -8.11 26.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.206 0.527 . . . . 0.0 111.574 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.69 -66.8 0.79 Allowed Glycine 0 C--N 1.315 -0.633 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.293 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.32 136.58 58.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 1.1 p90 -66.4 170.97 5.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.729 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.423 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 7.5 t0 -77.85 124.58 28.16 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.244 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -80.07 -28.74 39.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.536 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -63.89 -56.72 13.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.328 . . . . 0.0 111.171 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -67.0 -38.15 85.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.41 ' N ' ' CD1' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -71.57 -25.72 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.704 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.62 -48.55 63.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.972 0.415 . . . . 0.0 110.578 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.17 -34.71 76.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.233 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.5 tt -58.16 -50.79 72.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.397 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.1 mt -54.15 -45.85 72.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.139 0.495 . . . . 0.0 111.404 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.9 m -61.2 -42.27 98.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.436 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -31.5 72.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.733 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.421 ' CD1' ' CD1' ' A' ' 63' ' ' LEU . 2.1 mt -62.43 -32.07 72.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.017 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.93 -26.57 8.76 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.234 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -124.11 -165.45 1.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.695 0.283 . . . . 0.0 110.647 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -103.82 -30.52 10.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.018 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -92.58 170.25 9.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -112.54 99.94 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.701 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.434 HD12 HG21 ' A' ' 61' ' ' ILE . 31.4 mt -66.6 82.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.375 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.88 25.04 36.0 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.643 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.421 ' CD1' ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.11 155.7 16.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.923 0.392 . . . . 0.0 111.65 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -144.59 170.15 16.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.274 0.559 . . . . 0.0 112.058 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.2 mtt -115.82 154.94 48.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.568 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.6 Cg_exo -76.97 142.34 72.29 Favored 'Cis proline' 0 C--N 1.344 0.312 0 C-N-CA 123.846 -1.314 . . . . 0.0 112.644 0.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.68 116.91 33.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.938 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.3 t -92.12 152.7 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.193 0.52 . . . . 0.0 111.62 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -143.57 139.88 29.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.564 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.27 165.17 1.15 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.684 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.11 -24.61 77.42 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.777 2.318 . . . . 0.0 111.918 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.24 -26.06 19.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.268 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.65 -6.56 5.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.101 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.35 154.57 23.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.876 0.338 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -90.42 118.52 29.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.331 . . . . 0.0 110.962 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -97.06 -48.46 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.41 -156.86 22.63 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.777 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.41 -141.45 10.91 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.839 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 25.8 t80 -67.79 -70.46 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 0.0 111.019 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.49 -47.42 84.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.088 0.471 . . . . 0.0 110.593 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -51.4 -37.18 46.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 85' ' ' TYR . 4.3 tt -74.12 -35.99 64.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.18 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.18 -31.25 30.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.78 -31.8 71.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.495 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 14.1 t80 -71.05 -27.96 64.02 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.836 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 24' ' ' LEU . 29.7 m-85 -99.92 -13.45 19.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.088 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.04 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.707 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 18.7 tpp . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.412 0.149 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -39.7 127.59 2.0 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.667 0.746 . . . . 0.0 112.118 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -94.56 123.81 38.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.344 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 67' ' ' GLN . 24.6 t -111.96 114.64 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.379 . . . . 0.0 111.579 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 13.9 m-85 -93.27 99.9 12.36 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.19 -136.58 2.13 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.613 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -125.75 160.33 30.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.898 0.38 . . . . 0.0 111.895 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 9' ' ' SER . 5.3 m-20 -88.96 -68.12 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.645 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.7 OUTLIER 162.08 -29.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -76.61 -39.32 52.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.444 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 HG21 ' N ' ' A' ' 40' ' ' LYS . 7.5 mm -89.84 -46.25 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.582 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -140.66 149.79 42.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -77.38 161.46 28.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.735 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 p -176.89 98.18 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.221 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 m -77.76 -33.43 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.052 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -66.67 -28.12 68.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.051 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.6 t -62.66 -46.79 86.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 110.466 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -59.37 -31.08 68.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.051 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.25 -53.49 14.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.954 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.39 -49.06 70.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 110.943 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 1.5 ttmm -60.01 -50.02 75.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.627 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -42.69 95.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.246 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.08 -54.13 50.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.05 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.423 HD21 ' CZ ' ' A' ' 86' ' ' PHE . 8.8 mt -56.84 -42.69 80.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.518 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -59.16 -38.13 78.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.68 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.9 t -76.46 -34.09 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.48 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -9.83 58.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.866 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.13 51.69 1.62 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.002 0.429 . . . . 0.0 110.45 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -142.63 113.92 6.05 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.386 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.707 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 89.3 Cg_exo -49.25 178.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.386 2.057 . . . . 0.0 111.973 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 3.9 p90 -163.94 170.54 16.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.958 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 14.4 tp10 -134.44 112.38 10.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.471 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.483 ' CE1' HG13 ' A' ' 4' ' ' VAL . 7.0 t80 -89.1 155.96 19.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.292 0.567 . . . . 0.0 111.733 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.421 HD13 ' CE1' ' A' ' 5' ' ' TYR . 45.3 mt -150.26 125.5 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.814 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -88.65 126.12 35.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.035 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.6 18.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.965 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.441 ' HE3' ' CE2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -157.78 90.69 2.3 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.52 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 37.5 Cg_endo -66.07 -23.31 53.64 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.571 2.181 . . . . 0.0 112.021 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 37' ' ' MET . 2.7 mm-40 -139.56 143.93 37.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.148 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.407 ' N ' HG21 ' A' ' 11' ' ' ILE . 8.2 ttpt -64.33 -7.99 11.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.29 0.567 . . . . 0.0 111.866 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.72 -37.87 12.91 Favored Glycine 0 C--N 1.313 -0.731 0 CA-C-N 115.227 -0.897 . . . . 0.0 113.201 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -150.24 151.71 12.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.3 0.572 . . . . 0.0 112.157 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CE2' ' HE3' ' A' ' 37' ' ' MET . 46.1 m-85 -75.27 169.01 18.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.313 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.462 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 2.8 t0 -94.88 103.36 15.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.753 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 5.5 t0 -69.7 -21.58 63.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.936 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -67.46 -57.19 6.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.108 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -69.95 -36.08 74.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.527 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.4 mt -70.89 -26.37 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.412 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 45' ' ' ASP . . . -68.01 -55.5 12.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.305 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.4 -36.06 73.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.828 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.41 HD13 ' CE2' ' A' ' 69' ' ' PHE . 6.7 tp -56.27 -50.42 71.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.528 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.0 mt -53.36 -47.08 69.73 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.376 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.2 m -63.65 -39.39 94.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.425 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -59.22 -37.31 77.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.498 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.17 -56.43 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.552 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.58 -110.4 0.3 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.982 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -150.44 31.39 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.977 0.418 . . . . 0.0 110.68 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -120.96 -145.87 0.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.416 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.1 t -115.27 170.45 8.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.749 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 98.27 1.2 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.39 0.614 . . . . 0.0 110.452 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.04 84.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.254 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.93 26.45 58.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.432 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -56.04 132.54 50.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -126.03 153.47 44.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.274 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.82 155.55 36.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.636 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.7 Cg_exo -82.79 136.9 30.69 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 124.04 -1.233 . . . . 0.0 112.796 0.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 3.4 mm100 -92.67 148.36 22.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -122.24 149.82 25.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.172 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.41 ' CE2' HD13 ' A' ' 51' ' ' LEU . 53.1 m-85 -142.27 137.43 30.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.36 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.435 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -46.9 164.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.931 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.99 -19.82 57.43 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.797 2.331 . . . . 0.0 112.071 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.84 -19.71 13.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.432 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.06 -19.38 3.9 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.09 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.41 ' N ' ' HB1' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -56.69 109.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.876 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -54.65 134.74 47.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.447 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 70' ' ' ALA . 7.2 mt -115.9 -39.1 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.557 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.74 -153.69 20.37 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.702 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -94.24 -136.17 8.1 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.946 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -82.85 -55.02 4.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.578 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -57.31 -49.94 74.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.619 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -41.06 98.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.443 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -61.65 -53.53 54.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.62 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -49.73 -39.2 36.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.87 0.367 . . . . 0.0 110.13 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -67.93 -37.95 82.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 82' ' ' LEU . 14.0 t80 -61.43 -34.5 75.52 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.576 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.452 ' CD2' HD21 ' A' ' 82' ' ' LEU . 12.1 m-85 -78.59 -62.44 1.69 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.003 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.674 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 34.2 ttp . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.743 0.306 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 84.7 m-85 -80.33 154.77 27.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.419 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -137.78 123.96 20.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.107 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.487 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 53.9 t -108.04 141.59 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.222 0.534 . . . . 0.0 111.592 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.455 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 4.8 m-85 -123.35 100.54 6.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.41 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.44 -139.12 2.58 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.39 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -110.58 160.05 17.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.776 0.322 . . . . 0.0 110.902 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -79.1 -78.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.703 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 t 166.43 -35.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.689 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.42 -22.6 28.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.196 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.473 HG21 ' N ' ' A' ' 40' ' ' LYS . 35.4 mm -91.79 -42.26 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -142.0 151.49 42.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.035 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -72.01 156.31 39.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.928 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 169.69 106.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.829 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -90.57 -32.15 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.377 . . . . 0.0 111.533 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.79 -31.73 71.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.649 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 p -62.23 -43.58 98.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -55.27 -33.38 63.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -73.76 -52.87 11.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.02 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.39 63.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.888 0.375 . . . . 0.0 111.029 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -60.9 -55.33 34.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.503 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -60.67 -29.32 69.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.733 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 79' ' ' PHE . 3.4 tt -55.97 -53.55 55.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.592 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -69.07 -41.48 77.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 m -61.4 -37.13 82.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.082 0.468 . . . . 0.0 110.151 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.4 t -77.63 -32.33 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.654 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -71.26 -15.78 62.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.218 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? 73.91 54.52 0.1 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 111.221 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -138.47 141.92 32.97 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.81 137.32 19.83 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.454 2.103 . . . . 0.0 111.623 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.674 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 4.6 p90 -154.56 168.48 26.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.073 0.463 . . . . 0.0 112.216 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -141.62 137.55 31.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.5 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.487 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 40.9 t80 -89.39 156.71 18.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.455 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 14.1 mt -142.15 117.38 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.349 0.595 . . . . 0.0 110.419 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -100.11 130.39 46.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.018 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.401 ' HB ' HG13 ' A' ' 48' ' ' ILE . 32.5 pt -97.6 28.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.024 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 18.0 ttm -155.55 98.55 2.3 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.909 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 60.2 Cg_endo -71.32 -27.93 18.91 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.371 2.047 . . . . 0.0 112.098 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -139.68 156.01 47.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.994 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.473 ' N ' HG21 ' A' ' 11' ' ' ILE . 1.4 ttmp? -70.81 -7.74 47.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.269 0.557 . . . . 0.0 111.675 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.99 -25.29 8.5 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.487 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 t -142.74 127.01 15.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.289 0.566 . . . . 0.0 112.453 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -71.83 164.11 26.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.215 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -93.08 94.66 8.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.194 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.92 -27.86 68.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.601 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.95 -54.15 48.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.695 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -69.84 -34.3 73.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.068 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.401 HG13 ' HB ' ' A' ' 36' ' ' ILE . 43.8 mt -65.97 -39.66 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.39 -56.35 10.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.175 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.48 -35.43 72.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.835 0.35 . . . . 0.0 110.796 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.92 -50.49 72.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.558 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -53.39 -48.11 68.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.01 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.4 m -64.0 -35.38 80.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.031 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -38.19 90.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.131 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.11 -53.62 46.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.521 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.66 -109.95 0.33 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.045 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.63 30.83 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.942 0.401 . . . . 0.0 110.812 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -121.13 -149.2 0.42 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.463 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 t -120.49 170.47 9.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.583 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -82.6 98.2 8.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.188 0.518 . . . . 0.0 110.34 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 pt -80.36 84.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.28 25.6 57.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.499 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.79 157.92 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 p -130.71 170.34 14.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 0.0 111.666 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -120.48 154.8 56.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.588 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.99 152.34 81.01 Favored 'Cis proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.908 -1.288 . . . . 0.0 112.803 0.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 5' ' ' TYR . 10.0 mt-30 -109.08 113.01 25.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.181 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.746 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -90.79 166.34 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.409 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.484 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 70.1 m-85 -141.73 139.61 32.91 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.031 0.443 . . . . 0.0 110.628 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -61.42 156.77 50.13 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.496 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.479 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 51.9 Cg_exo -55.73 -31.75 81.39 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.15 2.567 . . . . 0.0 112.185 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -78.93 -35.54 43.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.22 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.6 41.27 0.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.821 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.7 m -120.65 169.12 10.68 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -90.16 117.56 29.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.776 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 70' ' ' ALA . 27.9 mt -90.35 -49.37 13.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.986 0.422 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.43 -151.47 19.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.619 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.69 -149.28 25.46 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.595 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 23' ' ' LEU . 18.2 t80 -64.75 -70.16 0.25 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.756 0.313 . . . . 0.0 110.775 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -56.55 -46.52 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.523 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.33 -35.81 68.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.272 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.438 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.4 tt -76.74 -37.03 56.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.287 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -52.38 -31.6 34.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -70.66 -33.66 71.19 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.166 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 82' ' ' LEU . 40.1 t80 -67.13 -27.42 67.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.604 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CE2' HD21 ' A' ' 82' ' ' LEU . 23.9 m-85 -99.29 -17.63 17.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.922 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.5 mttm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.809 -179.712 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.71 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 21.7 tpp . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.35 0.119 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -39.5 119.01 0.89 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.862 0.839 . . . . 0.0 112.069 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -89.38 126.5 35.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.296 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.481 HG11 ' CE1' ' A' ' 33' ' ' PHE . 11.5 t -115.93 133.94 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.142 0.496 . . . . 0.0 111.463 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 2.5 m-85 -110.69 99.91 8.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -160.2 -137.26 2.18 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.855 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -125.05 141.8 51.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.792 0.33 . . . . 0.0 111.01 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -99.82 26.36 6.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 110.998 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.72 8.44 5.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.682 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -85.52 -49.67 7.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 40' ' ' LYS . 39.4 mm -104.06 -32.57 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.293 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -141.14 140.26 34.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.835 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -81.26 174.78 11.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.504 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 173.74 109.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.349 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 m -71.82 -35.02 53.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.975 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.38 -29.67 70.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.132 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 t -60.93 -45.67 93.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.916 0.389 . . . . 0.0 110.656 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.39 -24.39 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.319 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 28.6 m-80 -79.96 -46.74 16.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.202 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.84 -53.1 61.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.787 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 13.1 ttpt -59.76 -44.66 93.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.495 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -62.41 -42.6 99.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.414 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 tt -56.97 -53.49 57.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.135 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.29 -43.96 92.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.538 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.6 m -59.34 -43.65 92.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.995 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.9 t -70.81 -38.73 73.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.46 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -74.16 -9.76 58.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.796 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 1.2 ttpt 64.3 59.9 0.99 Allowed 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 121.434 0.635 . . . . 0.0 110.221 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.27 108.83 4.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.088 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.71 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 92.6 Cg_exo -47.08 176.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.618 2.212 . . . . 0.0 112.299 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 4.2 p90 -164.06 170.65 16.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.3 tt0 -133.1 118.16 18.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.313 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.481 ' CE1' HG11 ' A' ' 4' ' ' VAL . 4.1 t80 -89.51 158.86 17.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.738 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.502 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 33.8 mt -146.33 122.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.62 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -83.65 123.18 29.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.183 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 pt -100.36 -26.93 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.52 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.532 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.8 ttp -121.24 93.49 48.8 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.504 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.4 Cg_endo -82.56 1.26 9.26 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.726 2.284 . . . . 0.0 112.264 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -141.13 137.65 32.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.669 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' N ' HG23 ' A' ' 11' ' ' ILE . 17.1 mtmm -65.53 -8.37 19.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.234 0.54 . . . . 0.0 111.69 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.96 -68.46 1.14 Allowed Glycine 0 C--N 1.312 -0.753 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.104 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 t -134.58 135.48 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.795 0.331 . . . . 0.0 111.151 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -63.29 169.58 3.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.102 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 t0 -80.86 121.54 26.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.039 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -60.47 -22.4 63.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -64.84 -57.58 8.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.955 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -64.97 -47.2 78.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.716 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.72 -39.26 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.434 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.39 82.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.427 . . . . 0.0 110.418 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -67.13 -40.99 86.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.382 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.6 tp -57.51 -50.41 73.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.3 mt -52.92 -45.93 67.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.084 0.469 . . . . 0.0 111.284 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.3 m -68.06 -33.16 74.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.283 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.42 ' HE3' ' CD1' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -64.3 -39.27 93.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.399 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.17 -66.77 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.967 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.67 -27.06 0.59 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.326 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.67 -175.27 2.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.722 0.296 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.51 -27.44 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.043 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -95.89 170.05 9.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -116.25 100.38 7.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.783 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mt -79.67 84.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.201 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.5 25.56 55.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.588 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -60.01 139.49 57.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.972 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.7 p -122.3 160.08 26.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.8 mtm -117.55 154.47 50.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.673 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.3 Cg_exo -79.52 155.41 89.41 Favored 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 124.105 -1.206 . . . . 0.0 112.74 0.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.419 ' NE2' ' NE2' ' A' ' 75' ' ' HIS . 14.6 mm100 -109.85 125.9 53.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.045 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -97.97 159.82 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.991 0.424 . . . . 0.0 111.977 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 94.3 m-85 -142.9 148.16 36.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.588 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.16 141.3 69.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.31 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -40.69 -30.94 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.935 2.423 . . . . 0.0 112.168 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -167.86 34.08 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.142 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -125.1 -108.99 1.75 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.774 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.0 -179.6 5.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.442 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 47.0 t-80 -64.39 134.35 54.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.118 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mt -104.07 -41.27 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.651 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 137.19 -152.4 21.43 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.003 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.97 -131.05 7.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.502 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 32.6 t80 -76.07 -70.22 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.687 0.28 . . . . 0.0 111.131 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -54.47 -45.42 73.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.939 0.399 . . . . 0.0 110.954 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.454 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.9 OUTLIER -56.43 -45.84 80.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.605 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.46 -41.44 96.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.477 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -52.96 -33.8 52.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.54 -34.19 73.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.16 -33.3 75.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.49 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.507 ' CD1' ' HD2' ' A' ' 27' ' ' LYS . 21.1 m-85 -90.1 -69.8 0.7 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.471 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.961 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.564 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 2.8 ttt . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -75.1 146.46 41.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.728 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -108.42 118.03 35.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.297 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 66' ' ' PRO . 92.9 t -113.07 129.71 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.407 0.622 . . . . 0.0 112.196 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.599 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 21.9 m-85 -104.61 101.18 10.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.849 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.7 -142.18 3.32 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.516 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.446 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 57.8 m-85 -119.17 154.78 32.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.849 0.357 . . . . 0.0 111.422 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 9' ' ' SER . 22.0 p-10 -89.85 11.57 19.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.799 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER 80.0 -5.73 1.82 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.639 0.257 . . . . 0.0 111.527 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -86.48 -48.63 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.415 ' CG2' ' HA ' ' A' ' 40' ' ' LYS . 30.1 mm -94.11 -16.45 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -155.85 142.92 19.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -66.5 115.78 6.75 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.99 0.424 . . . . 0.0 111.761 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p -130.16 89.32 2.78 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.579 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.6 m -81.3 -32.05 11.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.441 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -65.8 -26.64 67.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.178 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.1 t -63.77 -51.91 62.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.408 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.12 -29.54 63.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.196 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -70.6 -57.66 4.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.879 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.23 -41.89 80.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -57.2 -51.19 70.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.812 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -60.31 -43.6 96.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.462 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.431 HD22 ' CD2' ' A' ' 86' ' ' PHE . 3.7 tt -58.87 -54.75 43.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.386 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.71 -46.34 81.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.682 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.6 m -55.83 -38.4 69.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.141 0.496 . . . . 0.0 110.031 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.6 t -78.8 -31.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.548 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -73.08 -9.78 59.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.16 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 71.13 45.21 0.51 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.914 0.388 . . . . 0.0 110.957 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -132.44 130.48 21.86 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.56 ' O ' ' HA ' ' A' ' 1' ' ' MET . 44.3 Cg_endo -82.8 161.1 16.28 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.636 2.224 . . . . 0.0 111.191 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 5.1 p90 -161.31 171.2 18.75 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.916 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -132.45 121.19 23.0 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.536 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -89.82 150.87 22.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.763 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 mt -142.41 122.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.413 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -87.08 118.04 26.2 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.424 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.0 pt -97.07 33.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.007 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.423 ' HE3' ' CE1' ' A' ' 7' ' ' TYR . 42.9 ttm -160.59 82.59 2.11 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.57 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.01 -4.76 16.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.032 2.488 . . . . 0.0 112.875 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 37' ' ' MET . 1.8 mm-40 -139.21 155.64 47.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -71.12 -7.13 44.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.06 18.01 3.36 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.205 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 t -150.83 116.46 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.446 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 9.0 m-85 -72.31 170.22 14.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.676 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -100.42 93.32 5.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.03 -24.86 67.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.46 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.43 -58.7 5.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -69.16 -34.06 74.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.301 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.1 mt -71.01 -32.69 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.639 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.34 -55.17 34.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -61.52 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.599 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 4.3 tt -59.54 -53.33 59.34 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.223 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 52' ' ' LEU . 3.9 mt -52.88 -47.9 67.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.064 0.459 . . . . 0.0 110.959 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.4 m -53.39 -40.74 65.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.687 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 23.4 mtpp -70.11 -39.41 75.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.74 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -44.42 93.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.486 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.19 -137.03 5.07 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.897 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -122.85 30.34 6.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.123 0.487 . . . . 0.0 110.485 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.25 -156.72 0.69 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.211 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -121.17 170.57 9.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.632 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -79.47 98.14 6.69 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.286 0.565 . . . . 0.0 110.182 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.436 ' CG2' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -80.32 86.7 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.909 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.07 27.93 60.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.505 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -179.8 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.615 0.245 . . . . 0.0 110.684 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.4 p -150.36 159.72 44.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.154 0.502 . . . . 0.0 111.897 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.9 mtt -115.49 158.0 42.72 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.189 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HB2' HG12 ' A' ' 4' ' ' VAL . 2.8 Cg_exo -79.7 145.48 73.56 Favored 'Cis proline' 0 C--N 1.345 0.347 0 C-N-CA 124.47 -1.054 . . . . 0.0 113.27 0.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -105.52 126.77 52.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.133 178.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 5.7 t -96.99 159.02 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.99 0.424 . . . . 0.0 111.645 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.44 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 32.0 m-85 -142.83 144.26 32.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.729 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.45 ' CA ' ' CD1' ' A' ' 76' ' ' ILE . . . -53.81 133.38 56.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.263 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.564 ' HB3' ' N ' ' A' ' 1' ' ' MET . 35.1 Cg_exo -55.05 -17.03 13.46 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.523 2.149 . . . . 0.0 112.312 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.73 39.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.386 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.86 -114.81 0.76 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.273 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.1 p -125.56 -173.02 2.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.142 0.496 . . . . 0.0 111.32 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 35.9 t-80 -66.35 145.18 56.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.45 ' CD1' ' CA ' ' A' ' 70' ' ' ALA . 1.7 mp -120.04 -35.4 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.939 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.83 -156.55 18.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.093 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.27 -137.33 8.65 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.418 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -69.61 -70.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.723 0.297 . . . . 0.0 111.05 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -57.19 -48.98 77.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.964 0.412 . . . . 0.0 110.71 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -50.42 -36.66 34.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.359 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.513 ' CD2' ' CE2' ' A' ' 86' ' ' PHE . 5.4 tt -82.67 -29.85 29.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.232 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -51.63 -31.37 25.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -65.67 -34.73 78.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.112 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 82' ' ' LEU . 22.1 t80 -64.89 -33.22 75.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.542 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.513 ' CE2' ' CD2' ' A' ' 82' ' ' LEU . 6.5 m-85 -86.49 -65.03 1.06 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.454 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.001 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.66 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 19.5 ttm . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.921 0.391 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -82.43 151.39 26.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.764 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.1 mppp? -126.47 120.62 30.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.857 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.484 HG13 ' CE1' ' A' ' 33' ' ' PHE . 6.2 t -109.49 116.64 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.115 0.483 . . . . 0.0 111.848 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 21.8 m-85 -96.04 100.54 12.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.901 178.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.69 -137.96 2.32 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.352 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.678 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 3.1 m-85 -127.24 151.75 48.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.48 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -144.83 38.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.953 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.518 ' HB2' HG12 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -163.94 -162.82 0.73 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.108 0.48 . . . . 0.0 111.856 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -86.52 8.48 21.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.083 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.518 HG12 ' HB2' ' A' ' 9' ' ' SER . 0.6 OUTLIER -87.54 -8.13 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.678 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 20.6 t-80 -170.17 144.07 2.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.329 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 155.47 26.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.281 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 168.82 82.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.97 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 m -73.97 -41.23 52.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -59.57 -20.4 55.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 t -66.76 -60.23 2.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.778 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.74 -40.04 39.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 110.624 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -65.64 -43.99 87.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.576 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -67.41 -33.29 74.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -56.97 -44.39 82.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -70.94 -25.14 62.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.325 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.511 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -54.1 -57.29 11.64 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.241 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' CD2' HD23 ' A' ' 82' ' ' LEU . 13.8 mt -64.31 -41.41 96.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.52 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.2 m -60.39 -34.5 73.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.297 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.2 t -72.24 -42.94 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.933 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -72.6 -19.75 61.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.209 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 2.7 tppt? 79.79 71.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 111.382 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -143.46 143.28 23.41 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.0 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.45 130.12 11.59 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.474 2.116 . . . . 0.0 111.968 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.66 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 6.1 p90 -151.54 166.96 29.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.89 0.376 . . . . 0.0 111.959 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -143.09 136.13 27.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.883 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.484 ' CE1' HG13 ' A' ' 4' ' ' VAL . 13.1 t80 -89.75 159.79 16.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.224 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.5 mt -150.09 126.09 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.123 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 8' ' ' ASP . 68.6 m-80 -86.72 111.24 20.51 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.176 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.479 HD13 ' CZ ' ' A' ' 7' ' ' TYR . 21.9 pt -75.22 -5.79 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.505 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.475 ' HE2' ' CE1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -135.33 69.77 68.35 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.448 179.548 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.48 -13.74 35.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.596 2.197 . . . . 0.0 112.135 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -139.16 135.79 34.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.352 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.437 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.86 -9.01 3.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.31 0.576 . . . . 0.0 111.429 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.06 -61.08 3.87 Favored Glycine 0 C--N 1.312 -0.767 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.352 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.95 157.0 5.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.475 ' CE1' ' HE2' ' A' ' 37' ' ' MET . 24.1 m-85 -58.83 170.3 0.84 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.902 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 36' ' ' ILE . 7.5 t70 -100.24 113.0 25.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.64 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -73.01 -18.79 61.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.07 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.45 -63.29 1.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 111.152 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -64.17 -40.08 95.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.55 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 43' ' ' PHE . 34.9 mt -66.13 -28.53 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.654 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.23 -49.76 70.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.684 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -37.68 77.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.425 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' A' ' 69' ' ' PHE . 5.9 tp -57.3 -50.85 71.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.689 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -52.86 -45.94 67.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.516 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.7 m -62.99 -35.75 81.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.672 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -65.81 -38.59 89.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.788 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.6 -70.15 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.77 -106.95 0.2 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.144 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -150.35 32.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 111.045 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -120.97 -145.42 0.36 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.365 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.01 170.18 9.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.837 0.351 . . . . 0.0 110.712 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.1 98.43 1.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.4 0.619 . . . . 0.0 110.352 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.9 mt -79.67 85.5 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.346 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.21 28.23 54.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.489 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -46.58 123.51 5.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.393 . . . . 0.0 111.158 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 24.9 p -104.51 136.52 43.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.077 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.5 mmt -102.92 152.16 38.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.7 Cg_endo -83.56 144.64 49.42 Favored 'Cis proline' 0 C--N 1.346 0.405 0 C-N-CA 124.246 -1.148 . . . . 0.0 112.653 0.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 25.3 mm-40 -104.33 154.08 20.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -123.35 159.35 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.459 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CE2' HD11 ' A' ' 51' ' ' LEU . 25.3 m-85 -142.3 132.7 25.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.932 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 150.16 96.36 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.239 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.568 ' HB3' ' N ' ' A' ' 1' ' ' MET . 71.1 Cg_exo -45.73 -42.98 19.28 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.215 2.61 . . . . 0.0 112.746 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -29.03 64.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.98 79.64 0.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.467 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.9 127.57 3.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.939 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -58.54 108.94 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mt -81.5 -41.79 19.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.938 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.48 -149.52 17.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.491 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -98.22 -132.42 7.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.32 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.511 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -83.02 -69.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.578 0.189 . . . . 0.0 110.877 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.7 -43.53 47.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.175 0.512 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -42.34 95.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.483 HD23 ' CE1' ' A' ' 86' ' ' PHE . 1.6 tt -71.77 -41.58 68.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.752 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -51.12 -35.24 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.85 -35.57 77.09 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.122 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' LEU . 59.5 t80 -64.49 -32.36 73.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.588 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.483 ' CE1' HD23 ' A' ' 82' ' ' LEU . 27.7 m-85 -89.79 -27.1 20.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.058 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.701 179.701 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.557 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.8 ttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.897 0.379 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.484 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 68.9 m-85 -60.19 157.44 13.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.771 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -134.11 116.32 15.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.702 -179.53 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.493 HG11 ' CE1' ' A' ' 33' ' ' PHE . 19.0 t -105.91 125.62 61.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.266 0.555 . . . . 0.0 111.829 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.0 m-30 -101.96 99.47 9.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.532 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.68 -138.02 2.33 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.413 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 22.6 m-85 -120.06 139.97 51.73 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 120.626 0.25 . . . . 0.0 110.502 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -92.97 22.28 5.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 4.5 m 65.74 5.73 3.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -81.89 -44.02 17.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.074 0.464 . . . . 0.0 110.521 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.8 mm -124.95 1.5 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.263 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.59 ' CD2' ' HE1' ' A' ' 37' ' ' MET . 13.3 t-80 -157.04 131.19 8.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.538 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -80.99 159.57 24.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.348 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 176.75 123.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.118 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.0 m -83.13 -39.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.818 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -55.45 -28.85 56.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.728 0.299 . . . . 0.0 111.284 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.5 m -62.16 -53.84 49.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.55 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.26 -34.19 56.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.167 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -70.22 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.963 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.51 -31.95 48.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.288 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -60.69 -56.01 26.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.571 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -64.65 -27.09 68.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.772 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.31 -57.4 12.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.385 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mt -59.85 -41.89 92.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.599 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -37.16 79.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.094 0.474 . . . . 0.0 110.063 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.64 -25.36 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.867 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HE3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -77.71 -15.74 58.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? 70.34 42.28 0.93 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.066 0.46 . . . . 0.0 110.524 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -128.33 143.75 49.29 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 1' ' ' MET . 92.1 Cg_endo -77.01 136.96 16.96 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.389 2.06 . . . . 0.0 111.674 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.557 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 12.6 p90 -149.12 170.31 18.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.915 0.388 . . . . 0.0 112.008 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -147.75 141.21 25.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.196 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CE1' HG11 ' A' ' 4' ' ' VAL . 8.3 t80 -89.71 162.87 15.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.043 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.437 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.9 mt -146.12 119.78 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.262 0.554 . . . . 0.0 110.417 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -82.08 125.23 30.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.346 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.465 HD13 ' CZ ' ' A' ' 7' ' ' TYR . 6.9 pt -100.31 -12.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.171 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.59 ' HE1' ' CD2' ' A' ' 12' ' ' HIS . 21.7 ttm -123.07 79.04 51.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.767 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' CG ' ' HB3' ' A' ' 44' ' ' ASP . 17.9 Cg_exo -65.56 -22.1 58.91 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.283 1.989 . . . . 0.0 111.608 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -139.22 137.46 35.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.704 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -61.35 -9.18 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.22 0.533 . . . . 0.0 112.245 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.31 -55.72 4.6 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.449 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 t -150.46 139.25 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.616 0.246 . . . . 0.0 111.559 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -58.76 170.33 0.82 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.045 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.461 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 12.6 p30 -88.89 109.49 20.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 111.875 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -58.06 -31.12 66.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.619 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -52.99 -42.35 65.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.786 0.327 . . . . 0.0 110.971 -179.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -80.62 -39.15 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.254 0.55 . . . . 0.0 109.887 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 44' ' ' ASP . 43.9 mm -55.93 -46.01 80.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.722 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.68 -56.44 12.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.322 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -60.68 -28.78 68.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.583 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.11 -56.44 22.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.362 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 1.8 mt -52.35 -45.24 65.62 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.9 m -60.72 -38.81 86.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.278 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -65.27 -37.7 87.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.521 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -20.17 56.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.935 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.27 -88.81 1.53 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.124 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -139.4 31.53 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.454 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -121.61 110.55 16.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.376 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.4 t -78.25 142.06 38.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.452 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.9 pt20 -70.8 97.57 1.41 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.378 0.608 . . . . 0.0 111.036 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 tp -80.88 79.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.481 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.76 24.37 69.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.101 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -54.48 159.91 1.92 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.858 0.361 . . . . 0.0 111.08 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.3 m -125.49 165.76 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.226 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.412 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 13.0 mmt -97.94 155.69 36.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.452 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.6 Cg_endo -86.34 149.81 42.92 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 124.211 -1.162 . . . . 0.0 113.106 0.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -108.71 112.61 25.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.918 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.2 t -89.5 163.02 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.219 0.533 . . . . 0.0 112.183 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 44.9 m-85 -141.58 137.3 31.84 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.132 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.482 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -50.99 152.22 3.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.065 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.48 ' HB3' ' N ' ' A' ' 1' ' ' MET . 53.0 Cg_exo -54.87 -24.32 38.24 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.728 2.286 . . . . 0.0 112.028 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -101.63 -22.52 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.991 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.3 85.66 0.78 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.707 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -165.79 126.68 1.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.736 0.303 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -61.28 117.72 5.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.794 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.482 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 2.4 mp -110.11 -27.9 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.961 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.12 -155.46 16.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.901 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.06 -134.36 7.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.419 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -74.3 -67.12 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.625 0.25 . . . . 0.0 111.033 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.81 -52.68 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -51.05 -41.85 60.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.402 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.516 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.6 tt -78.83 -29.03 44.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.129 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 87' ' ' LYS . 14.2 ttt85 -52.81 -30.66 34.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -67.77 -30.39 69.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' LEU . 24.0 t80 -68.64 -33.65 74.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.574 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.516 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.2 m-85 -95.51 -70.72 0.7 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.819 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' ARG . 1.3 mtpm? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.93 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.589 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 28.5 ttm . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.08 143.37 35.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.146 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.15 120.14 41.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.617 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.44 HG12 ' CE1' ' A' ' 33' ' ' PHE . 67.6 t -104.39 126.8 59.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.268 0.556 . . . . 0.0 111.727 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.8 m-30 -103.8 99.53 9.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.457 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.74 -141.05 3.04 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.33 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -116.61 160.63 20.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 120.675 0.274 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -81.59 -78.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 t 170.49 -35.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.799 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -84.55 -22.94 29.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.38 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.1 -39.01 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.74 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -155.93 145.0 20.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.272 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -68.39 158.26 33.99 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 p 175.38 113.9 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.815 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.6 m -90.29 -36.76 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.927 0.394 . . . . 0.0 111.1 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -62.25 -29.18 70.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.996 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 m -58.08 -48.04 81.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.028 0.442 . . . . 0.0 110.289 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -28.07 68.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.486 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.19 -57.22 4.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.765 0.317 . . . . 0.0 111.156 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.17 -26.16 37.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.319 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -68.53 -58.12 4.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 110.327 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -63.17 -28.63 70.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.544 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.443 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -55.98 -56.53 19.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.197 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' A' ' 86' ' ' PHE . 1.5 mt -57.26 -40.01 76.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.58 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.4 m -60.06 -34.93 74.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.311 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.41 -51.16 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.408 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' CE ' ' CE2' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -66.48 -16.74 64.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.375 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.82 42.82 0.19 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.141 0.496 . . . . 0.0 110.119 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -120.21 138.58 27.32 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.124 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.574 ' O ' ' HA ' ' A' ' 1' ' ' MET . 97.2 Cg_endo -74.31 158.24 44.94 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.013 1.809 . . . . 0.0 111.012 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -161.37 171.05 18.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.8 0.334 . . . . 0.0 111.668 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -141.57 130.83 23.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.512 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.44 ' CE1' HG12 ' A' ' 4' ' ' VAL . 21.0 t80 -89.14 159.56 17.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.955 0.407 . . . . 0.0 111.298 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.2 mt -146.85 120.11 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.552 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -91.66 112.48 24.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.543 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.42 ' CD1' ' CG1' ' A' ' 48' ' ' ILE . 6.6 tt -87.18 49.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.422 ' HE2' ' CZ ' ' A' ' 43' ' ' PHE . 12.3 ttm -171.38 98.81 0.4 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.566 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 35.7 Cg_endo -65.1 -30.3 55.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.374 2.05 . . . . 0.0 112.288 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -143.01 158.71 43.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.419 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -71.0 -7.78 48.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.313 0.577 . . . . 0.0 111.498 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.61 -20.25 8.67 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.925 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 t -141.36 122.74 13.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.413 0.625 . . . . 0.0 112.5 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.422 ' CZ ' ' HE2' ' A' ' 37' ' ' MET . 31.6 m-85 -73.41 161.92 29.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.3 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.406 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 1.1 t70 -83.7 87.39 7.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.77 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -24.86 64.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.297 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -61.06 -55.86 27.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 110.713 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 6.4 mmtt -70.74 -43.55 68.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.112 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.42 ' CG1' ' CD1' ' A' ' 36' ' ' ILE . 63.0 mt -50.43 -38.22 15.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.672 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.47 -59.26 3.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 8.8 pt-20 -60.26 -30.03 69.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.159 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.458 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 1.9 tt -58.23 -50.14 74.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.146 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.1 mt -54.88 -48.4 73.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.097 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.9 m -66.18 -35.34 80.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.372 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -65.4 -37.14 86.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.829 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.25 -67.34 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.85 -27.18 0.29 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.678 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.05 -165.5 1.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.898 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -91.56 -31.35 15.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.789 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -110.67 170.15 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 62' ' ' GLY . 9.9 pt20 -114.36 100.54 8.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.489 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -58.8 82.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.482 0.658 . . . . 0.0 111.598 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 60' ' ' GLN . . . 62.33 20.96 61.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.983 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.94 135.07 36.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.6 p -136.83 170.93 15.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.465 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.0 155.64 47.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.561 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -75.72 143.13 76.06 Favored 'Cis proline' 0 C--N 1.344 0.323 0 C-N-CA 123.8 -1.333 . . . . 0.0 112.83 0.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.7 mt-30 -111.97 113.76 26.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.879 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -87.91 161.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.111 0.482 . . . . 0.0 111.587 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 57.4 m-85 -143.08 139.04 30.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.345 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.53 132.52 54.43 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.294 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.589 ' HB3' ' N ' ' A' ' 1' ' ' MET . 38.2 Cg_exo -54.87 -20.74 23.56 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.448 2.099 . . . . 0.0 111.911 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.57 39.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.279 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.48 -111.35 0.68 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.923 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 t -137.4 179.88 6.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.179 0.514 . . . . 0.0 111.273 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 41.0 t-80 -56.34 126.9 28.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.025 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.0 mt -94.66 -42.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.78 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.22 -154.86 21.58 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.8 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.62 -149.07 24.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.372 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.443 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 58.3 t80 -67.66 -59.14 3.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.757 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -62.09 -54.74 37.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.051 0.453 . . . . 0.0 110.818 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -52.02 -41.04 61.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.6 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.485 HD21 ' CE1' ' A' ' 86' ' ' PHE . 6.1 tt -79.69 -28.19 40.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.24 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 87' ' ' LYS . 2.2 mmm180 -52.28 -35.05 49.22 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -60.12 -32.59 71.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.2 t80 -68.4 -28.5 67.14 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.929 178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.518 ' CE2' ' CE ' ' A' ' 27' ' ' LYS . 15.7 m-85 -100.11 -70.86 0.72 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.833 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.53 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 56.2 ttp . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.442 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 81.0 m-85 -51.01 149.12 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.198 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.1 mptp? -117.23 116.99 28.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.219 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.538 HG11 ' CE1' ' A' ' 33' ' ' PHE . 44.1 t -110.67 128.55 66.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.513 0.673 . . . . 0.0 112.577 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 22.0 m-85 -108.74 106.44 16.47 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.592 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.68 -137.26 2.29 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.831 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CE1' ' HE1' ' A' ' 37' ' ' MET . 16.9 m-85 -123.94 134.11 53.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 122.449 0.3 . . . . 0.0 110.324 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -100.39 39.14 1.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 111.318 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 t 60.15 14.05 4.24 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.627 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -85.83 -53.29 5.21 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.901 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 37' ' ' MET . 18.6 mt -110.97 -15.26 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -160.67 148.42 15.99 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.07 159.28 33.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.62 119.07 1.0 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.433 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -90.38 -31.21 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.032 0.444 . . . . 0.0 111.125 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -62.7 -28.84 70.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.805 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 t -59.32 -47.07 86.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.049 0.452 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -62.52 -33.89 75.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.214 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.412 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 83.4 m-20 -74.61 -46.53 37.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.017 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.52 88.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.92 0.39 . . . . 0.0 110.803 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -57.49 10.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.787 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -58.0 -40.12 79.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.387 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.42 HD21 ' CD2' ' A' ' 86' ' ' PHE . 1.8 tt -59.15 -54.82 42.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.129 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mt -55.97 -45.97 78.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.665 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -55.98 -38.01 69.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.157 0.504 . . . . 0.0 109.928 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.5 t -79.29 -29.71 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.497 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -75.25 -13.73 60.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.114 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm 68.56 46.31 1.01 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.0 0.429 . . . . 0.0 110.926 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -126.83 141.04 39.27 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.847 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.5 Cg_endo -82.06 140.38 11.21 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.514 2.143 . . . . 0.0 111.404 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.53 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 42.6 p90 -157.94 169.74 23.91 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.639 -0.424 . . . . 0.0 112.077 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.86 139.68 23.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.241 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.538 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.6 t80 -89.42 161.44 16.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.521 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.1 mt -149.88 122.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -79.31 110.65 14.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.274 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 pt -86.01 -2.28 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.599 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.488 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 38.5 ttm -119.41 107.22 41.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.87 -28.28 4.14 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.568 2.178 . . . . 0.0 111.546 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -139.95 152.77 46.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.665 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -65.6 -8.46 20.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.236 0.541 . . . . 0.0 112.048 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.41 -54.03 3.65 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.495 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.72 154.79 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.805 0.336 . . . . 0.0 111.378 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -77.45 170.39 16.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.96 114.42 25.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.687 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -63.7 -15.62 58.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.412 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -62.7 -55.99 21.73 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.826 0.345 . . . . 0.0 110.839 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -70.09 -35.81 74.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.5 mt -70.43 -32.98 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.1 -57.42 12.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.64 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -63.17 -25.78 68.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.144 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.565 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 3.7 tt -60.36 -56.17 24.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.991 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 2.1 mt -52.96 -45.17 67.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.065 0.46 . . . . 0.0 111.093 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 m -56.87 -49.02 76.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.379 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 11.3 mtpp -60.78 -36.28 78.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.404 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.78 -24.04 67.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.95 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.97 -132.65 11.38 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.925 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.56 31.24 2.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.102 0.477 . . . . 0.0 110.665 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.72 109.41 14.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.542 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 t -78.39 152.1 32.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.389 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.89 97.63 1.15 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.398 0.618 . . . . 0.0 110.898 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.54 81.32 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.714 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.93 24.79 67.15 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.167 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.23 173.28 0.11 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.756 0.312 . . . . 0.0 110.778 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.8 p -133.16 169.05 17.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.193 0.52 . . . . 0.0 111.636 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.408 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 15.5 mmt -111.36 155.11 43.31 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.261 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.3 Cg_exo -84.33 143.01 40.18 Favored 'Cis proline' 0 N--CA 1.462 -0.341 0 C-N-CA 124.223 -1.157 . . . . 0.0 113.108 0.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -97.4 130.49 44.53 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.671 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.1 t -99.77 160.56 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.02 0.438 . . . . 0.0 111.696 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.532 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 20.7 m-85 -141.55 138.1 32.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.527 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -44.82 138.51 4.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.502 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.494 ' HB3' ' N ' ' A' ' 1' ' ' MET . 90.6 Cg_exo -46.38 -25.73 3.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.917 2.411 . . . . 0.0 111.992 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.98 39.16 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.044 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.05 -112.37 1.09 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.366 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 t -127.18 -172.55 2.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.086 0.47 . . . . 0.0 111.495 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.445 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 28.5 t-80 -67.21 145.83 54.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.087 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 2.3 mp -123.04 -35.9 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.134 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.01 -156.44 20.72 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.774 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.73 -138.16 8.44 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.471 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -71.85 -70.53 0.32 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.74 0.305 . . . . 0.0 110.773 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -56.43 -49.3 74.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.99 0.424 . . . . 0.0 110.48 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -36.34 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.291 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.505 HD22 ' CE2' ' A' ' 86' ' ' PHE . 5.9 tt -84.32 -29.77 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.023 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -51.7 -31.05 24.56 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.94 -34.42 78.08 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.219 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' CD2' HG12 ' A' ' 76' ' ' ILE . 15.4 t80 -65.27 -33.01 74.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.426 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 82' ' ' LEU . 6.8 m-85 -87.95 -26.27 22.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.275 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 mttt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.9 -179.969 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.578 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 29.8 ttp . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -79.88 143.66 34.1 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.395 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.716 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -105.21 121.77 44.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.398 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.458 HG11 ' CE1' ' A' ' 33' ' ' PHE . 38.6 t -103.38 126.58 57.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.82 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.6 m-30 -102.51 99.26 9.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.404 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.39 -138.33 2.46 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.503 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -131.41 157.05 44.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.937 0.398 . . . . 0.0 111.543 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.588 ' O ' ' O ' ' A' ' 12' ' ' HIS . 32.6 p30 -80.25 -177.91 6.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.587 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -91.77 -13.7 31.11 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.698 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -85.67 -41.94 14.72 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mm -89.54 -45.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.588 ' O ' ' O ' ' A' ' 8' ' ' ASP . 20.8 t60 -139.64 115.51 10.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.68 0.752 . . . . 0.0 110.618 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.87 148.04 14.02 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.682 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 p -158.03 104.96 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 m -82.33 -33.37 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.723 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.97 -25.7 64.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.348 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.28 -48.78 80.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.626 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -55.29 -24.4 28.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.549 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.403 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 8.9 m-80 -74.68 -50.05 19.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.303 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.79 95.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.791 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -61.41 -57.58 11.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.344 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -62.04 -33.8 75.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 0.0 109.709 179.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -57.55 -54.6 45.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.914 178.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -58.49 -47.46 84.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.515 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -53.07 -39.99 63.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.116 0.484 . . . . 0.0 109.946 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.98 -31.01 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.457 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HD3' ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -78.13 -9.81 59.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.043 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.35 37.25 1.2 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.051 0.453 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -123.51 133.13 24.37 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.015 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.9 Cg_endo -82.01 158.08 18.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.543 2.162 . . . . 0.0 111.227 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 9.1 p90 -161.72 171.57 17.67 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.767 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -136.86 137.42 39.66 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.458 ' CE1' HG11 ' A' ' 4' ' ' VAL . 10.9 t80 -89.36 158.42 17.79 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.196 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.1 mt -147.5 122.32 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.339 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -92.77 127.22 38.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.182 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 pt -89.53 -9.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.929 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.572 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 18.1 ttm -125.25 100.31 32.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.642 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.28 -22.99 28.94 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.647 2.232 . . . . 0.0 112.357 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -139.92 145.13 37.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -9.3 4.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.308 0.575 . . . . 0.0 111.78 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.91 -59.7 2.41 Favored Glycine 0 C--N 1.313 -0.708 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.741 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -146.85 134.69 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.685 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -69.49 170.64 10.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -89.73 95.97 10.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.048 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -57.41 -18.68 19.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.104 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.47 -53.21 60.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -71.83 -36.29 70.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.362 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 mm -53.16 -48.24 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.966 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.3 -53.14 57.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.627 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.49 -28.53 65.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.37 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 2.0 tt -58.23 -58.1 9.94 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.503 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 4.1 mt -48.66 -48.14 40.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.307 0.575 . . . . 0.0 111.335 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.9 m -71.09 -22.06 62.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.192 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -73.09 -42.87 62.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.93 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.503 ' CD1' ' HA ' ' A' ' 52' ' ' LEU . 1.5 mp -59.33 -39.28 82.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.001 0.429 . . . . 0.0 110.886 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.94 -109.07 0.27 Allowed Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.057 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -150.5 32.53 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.241 0.544 . . . . 0.0 110.725 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -120.98 -152.09 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.385 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -120.98 170.6 9.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.863 0.363 . . . . 0.0 110.831 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -90.38 98.8 11.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.304 0.573 . . . . 0.0 110.476 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.6 mm -79.27 84.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.192 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.87 25.53 56.38 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.448 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.05 145.53 36.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 110.781 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.4 p -127.86 170.52 12.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.43 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.28 156.37 35.23 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.648 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.8 Cg_endo -85.19 145.12 40.18 Favored 'Cis proline' 0 N--CA 1.461 -0.419 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.834 0.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 3.3 mm-40 -107.68 113.35 26.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.743 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.8 t -87.25 161.36 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.291 0.567 . . . . 0.0 111.829 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -142.75 143.17 32.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.016 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.437 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -52.91 149.77 11.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.113 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.57 ' HB3' ' N ' ' A' ' 1' ' ' MET . 8.8 Cg_exo -68.79 -9.88 27.49 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.701 2.267 . . . . 0.0 112.39 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.6 -18.53 13.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.204 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.19 91.34 1.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.665 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m 176.29 158.24 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.537 0.208 . . . . 0.0 110.655 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.459 ' CE1' HD23 ' A' ' 55' ' ' LEU . 9.8 t-160 -90.46 133.52 34.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.437 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 2.5 mt -122.28 -40.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.986 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.23 -161.38 20.6 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.928 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.26 -139.04 8.13 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.785 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -71.11 -70.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.602 0.239 . . . . 0.0 111.144 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -55.21 -50.83 68.39 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.198 0.523 . . . . 0.0 110.436 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -50.99 -43.71 60.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.231 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 ' CE2' ' A' ' 86' ' ' PHE . 6.1 tt -77.62 -29.1 51.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.312 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -52.25 -30.78 29.34 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.57 -35.56 79.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.5 t80 -61.79 -34.95 76.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.153 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.531 ' CE2' HD22 ' A' ' 82' ' ' LEU . 6.7 m-85 -87.22 -27.53 22.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.266 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.8 mttt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.922 -179.85 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.587 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 17.9 ttp . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.402 ' CD1' ' CD2' ' A' ' 24' ' ' LEU . 71.2 m-85 -76.77 153.83 34.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.09 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -113.0 119.58 38.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.777 -179.468 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.47 HG11 ' CE1' ' A' ' 33' ' ' PHE . 56.0 t -111.22 126.6 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.21 0.529 . . . . 0.0 111.865 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.629 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 22.7 m-85 -105.45 101.15 10.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.094 178.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.28 -137.46 2.24 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.498 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CE1' ' HE3' ' A' ' 37' ' ' MET . 46.8 m-85 -122.99 159.26 28.71 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -86.43 -70.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t 170.97 -37.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.743 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -79.09 -27.62 43.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.997 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.59 -42.14 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.854 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -153.32 154.62 34.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.9 157.91 32.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.776 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p 179.12 86.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -72.76 -34.95 48.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.285 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.02 -19.07 65.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.343 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 t -69.17 -62.41 1.39 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.83 0.348 . . . . 0.0 110.515 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -49.82 -36.34 26.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.741 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -62.28 -54.26 43.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.768 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.0 -45.98 85.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.258 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -50.0 -38.35 36.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.943 0.402 . . . . 0.0 110.299 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -68.52 -31.44 70.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.957 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.509 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 1.1 tt -56.52 -55.65 31.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.956 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' CD2' ' CD1' ' A' ' 2' ' ' PHE . 1.3 mt -60.28 -52.32 65.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.696 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.1 m -51.13 -41.37 60.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.621 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.19 -31.99 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.459 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.74 -9.8 57.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.107 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.49 51.41 0.12 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.941 0.4 . . . . 0.0 110.52 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -132.04 133.69 24.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.211 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.565 ' O ' ' HA ' ' A' ' 1' ' ' MET . 57.8 Cg_endo -81.7 161.57 19.02 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.547 2.165 . . . . 0.0 111.215 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 5.3 p90 -161.45 171.45 18.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 111.544 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -133.13 126.25 31.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.826 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.47 ' CE1' HG11 ' A' ' 4' ' ' VAL . 10.7 t80 -89.79 158.22 17.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.432 HG13 ' C ' ' A' ' 33' ' ' PHE . 24.1 mt -150.71 125.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.313 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -80.14 115.69 19.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.749 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.6 -20.3 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.071 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.9 ttp -124.22 85.76 54.89 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.146 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.94 -3.64 14.11 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.903 2.402 . . . . 0.0 112.429 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 37' ' ' MET . 9.2 tt0 -139.52 136.78 34.87 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.705 0.288 . . . . 0.0 110.732 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -64.27 -8.9 14.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.222 0.534 . . . . 0.0 112.131 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.47 -63.38 1.64 Allowed Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.93 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.79 146.79 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.645 0.259 . . . . 0.0 110.75 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -72.32 168.88 17.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 111.263 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.22 119.92 27.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.465 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.23 -19.7 58.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.099 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.8 -58.73 6.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.965 0.412 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -64.39 -40.59 96.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.095 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.4 mt -65.41 -32.34 57.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.564 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.23 -48.45 81.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.86 -37.44 82.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.376 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.629 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.5 tt -58.98 -57.67 12.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.751 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.522 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 77.0 mt -46.27 -43.75 15.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.803 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 m -70.95 -28.79 64.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' CD ' ' CD2' ' A' ' 69' ' ' PHE . 2.9 ttmm -65.19 -45.14 86.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.597 -179.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.522 ' CD1' ' HA ' ' A' ' 52' ' ' LEU . 1.5 mp -59.43 -63.98 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.98 0.419 . . . . 0.0 111.127 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.33 -113.54 0.31 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.134 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.41 29.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 111.029 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -121.37 -154.76 0.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.308 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 t -120.98 166.04 14.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.729 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -118.42 99.15 6.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 110.99 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mm -80.93 84.89 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.175 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.02 29.75 3.67 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.357 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.34 131.66 33.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 110.798 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -116.84 152.7 33.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.227 0.537 . . . . 0.0 111.635 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -117.14 158.57 44.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.449 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.5 Cg_endo -87.02 134.88 15.97 Favored 'Cis proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.197 -1.168 . . . . 0.0 112.762 0.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 1.9 tp60 -92.68 139.15 30.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.878 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.7 t -108.12 157.54 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.59 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.413 ' CD2' ' CD ' ' A' ' 54' ' ' LYS . 28.5 m-85 -144.15 141.32 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.66 148.4 26.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.587 ' HB3' ' N ' ' A' ' 1' ' ' MET . 12.8 Cg_exo -67.45 -14.04 41.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.902 2.401 . . . . 0.0 112.198 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.51 -21.54 14.73 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.148 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.78 88.54 0.83 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.674 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m 179.39 158.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.633 0.254 . . . . 0.0 110.743 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.421 ' CE1' HD21 ' A' ' 55' ' ' LEU . 8.4 t-160 -90.34 133.49 34.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.1 mt -116.97 -45.55 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.979 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.01 -152.17 16.87 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.026 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -95.68 -131.07 6.48 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.562 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.509 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -77.55 -70.15 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.653 0.227 . . . . 0.0 111.048 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -51.56 -50.76 59.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.366 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -55.96 -39.59 71.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.614 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.505 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.8 tt -78.42 -32.52 48.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.598 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.0 mmm-85 -51.48 -33.1 29.78 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.52 -35.0 78.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.156 178.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.8 t80 -63.54 -35.75 81.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.505 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -91.79 -9.88 41.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.559 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.0 mttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.972 179.975 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 9.4 ttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.95 0.405 . . . . 0.0 111.627 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.459 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 86.9 m-85 -62.47 155.7 24.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.641 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.765 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -128.22 121.41 29.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.116 -179.717 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.46 HG12 ' CE1' ' A' ' 33' ' ' PHE . 12.8 t -115.1 124.67 71.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.539 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 2.0 m-85 -103.99 104.38 14.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.2 -132.23 1.37 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.394 -178.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.069 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 93.9 m-85 -134.12 149.49 51.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.631 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 18.8 p-10 -156.47 -51.33 0.08 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.615 ' N ' ' HB3' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -52.84 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -177.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -47.98 81.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.442 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.481 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -86.65 22.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.601 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 1.069 ' CD2' ' HA ' ' A' ' 7' ' ' TYR 0.301 0.3 OUTLIER -149.0 77.74 1.38 Allowed 'General case' 0 N--CA 1.417 -2.103 0 C-N-CA 117.845 -1.542 . . . . 0.0 108.612 -171.98 . . . . . . . . 4 4 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -61.05 166.64 3.43 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.33 -1.759 . . . . 0.0 113.481 -177.522 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.626 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 31.5 p 169.96 111.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.342 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 13' ' ' LYS . 2.2 m -91.77 -37.33 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.706 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -75.15 -19.03 60.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.574 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.9 t -60.42 -51.76 68.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.783 0.325 . . . . 0.0 110.621 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.89 -31.8 7.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.551 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -78.19 -57.2 3.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.825 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.45 -45.36 80.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -57.33 -52.09 66.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.368 . . . . 0.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -55.12 -42.22 72.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.079 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.448 HD23 ' CD2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -57.51 -53.45 58.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.296 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 10.1 mt -57.96 -46.88 84.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.873 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.3 m -55.59 -36.98 67.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.131 0.491 . . . . 0.0 109.865 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.28 -30.04 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.559 179.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.503 ' HE3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -71.5 -12.14 61.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.105 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt 64.38 42.23 5.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.107 0.479 . . . . 0.0 110.169 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -122.75 129.04 25.17 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.146 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' A' ' 1' ' ' MET . 88.2 Cg_endo -77.21 140.05 19.39 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.274 1.983 . . . . 0.0 110.987 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 18.5 p90 -155.51 170.49 21.85 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.311 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.439 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 7.5 tt0 -136.57 134.56 37.59 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.193 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 8' ' ' ASP . 8.6 t80 -90.45 156.94 17.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.539 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 29.8 mt -133.29 120.07 37.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.582 0.706 . . . . 0.0 110.196 179.16 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.622 ' HB2' ' CE1' ' A' ' 12' ' ' HIS . 5.6 p-10 -99.62 118.13 35.49 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.568 -1.197 . . . . 0.0 112.718 -177.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.651 ' N ' ' CE1' ' A' ' 12' ' ' HIS . 20.1 pt -101.42 67.99 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 178.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.606 ' N ' ' HE1' ' A' ' 12' ' ' HIS . 2.3 mtm -168.15 85.26 0.73 Allowed Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 122.678 0.391 . . . . 0.0 111.283 177.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 59.5 Cg_endo -71.79 -12.93 29.22 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.04 1.827 . . . . 0.0 110.526 178.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -150.24 150.04 31.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.37 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.19 -6.9 4.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.343 0.592 . . . . 0.0 111.528 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.92 -56.76 3.42 Favored Glycine 0 C--N 1.313 -0.697 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.158 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.2 t -150.63 157.54 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.546 ' HD1' ' HG3' ' A' ' 37' ' ' MET . 1.8 m-85 -59.91 170.27 1.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.867 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.412 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -86.49 98.69 11.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.776 179.447 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -49.52 -28.06 5.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.158 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -61.47 -56.4 20.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.379 . . . . 0.0 110.467 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -61.49 -46.04 91.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.331 179.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.01 -44.06 77.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.372 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.39 84.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.218 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -42.5 99.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.451 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -54.24 -46.0 72.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.468 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.2 mt -56.22 -50.74 70.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.969 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.0 m -63.16 -33.51 75.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.441 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -63.61 -39.53 94.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.457 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 mt -60.02 -54.19 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.678 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.92 -112.82 0.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.125 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.8 ttt85 -150.49 33.0 0.63 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.034 0.445 . . . . 0.0 110.689 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -120.73 -146.87 0.38 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.501 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 t -120.18 170.3 9.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.805 0.336 . . . . 0.0 110.645 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -107.05 101.45 10.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.653 0.74 . . . . 0.0 110.709 179.633 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -80.31 86.52 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.479 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.55 29.87 75.92 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -43.74 153.39 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 p -123.45 168.53 12.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.162 0.506 . . . . 0.0 111.62 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.9 mmt -122.53 153.15 62.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.558 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.96 159.74 65.77 Favored 'Cis proline' 0 N--CA 1.462 -0.374 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.94 0.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.409 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 5.7 tp60 -112.75 109.73 19.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.119 179.178 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.765 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.2 t -90.63 164.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.781 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 85.4 m-85 -142.52 146.41 34.66 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.671 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -58.32 148.55 63.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.436 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.549 ' HB3' ' N ' ' A' ' 1' ' ' MET . 51.0 Cg_exo -57.76 -29.92 87.43 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.104 2.536 . . . . 0.0 112.264 179.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -89.83 -26.88 20.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.426 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.11 89.23 0.62 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.754 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 m -176.53 164.77 2.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.468 0.175 . . . . 0.0 110.589 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.409 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 10.7 t-160 -90.93 119.92 31.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.004 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 70' ' ' ALA . 32.2 mt -98.94 -49.3 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.667 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.28 -153.19 21.11 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.782 -179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.7 -138.02 9.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.541 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.21 -70.42 0.29 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.741 0.305 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.7 -49.33 76.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -51.27 -39.23 56.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.578 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.493 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -78.52 -31.93 47.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.371 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -52.43 -30.71 30.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.5 -35.84 78.07 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' LEU . 32.0 t80 -60.04 -36.87 78.23 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.197 178.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CE1' ' HE3' ' A' ' 27' ' ' LYS . 7.0 m-85 -89.17 -22.47 22.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.552 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.885 -179.877 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.866 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 23.0 tpp . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.604 -0.147 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 32' ' ' GLU . 97.2 m-85 -42.89 135.55 2.98 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.108 0.48 . . . . 0.0 110.53 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.26 124.09 50.32 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.622 -178.379 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.474 HG11 ' CE1' ' A' ' 33' ' ' PHE . 53.9 t -111.87 144.19 20.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.257 0.551 . . . . 0.0 111.4 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 7.9 m-85 -124.78 103.43 8.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.261 178.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.65 -141.28 3.08 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.248 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.493 ' CE1' ' HE1' ' A' ' 37' ' ' MET . 32.3 m-85 -124.15 160.74 27.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.733 0.301 . . . . 0.0 110.601 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -103.11 29.32 5.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.417 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.2 p 65.97 9.83 6.47 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.305 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -87.12 -54.95 4.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 111.97 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.498 ' CG2' ' HA ' ' A' ' 40' ' ' LYS . 3.6 mp -94.22 -25.38 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -146.52 134.87 21.85 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.81 -178.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -61.57 129.62 41.99 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.2 -178.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.1 m -159.01 89.29 0.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.259 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 16' ' ' TYR . 15.7 m -74.25 -37.84 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.406 ' N ' HG23 ' A' ' 15' ' ' VAL . 3.7 m-85 -55.89 -29.23 59.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 0.0 111.349 -179.048 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 t -65.03 -60.69 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.229 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -56.93 -36.07 69.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.966 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -66.27 -38.39 87.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.444 -179.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -72.62 -35.85 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.319 . . . . 0.0 110.946 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 9.9 tttt -60.2 -34.9 74.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.024 0.44 . . . . 0.0 109.867 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -39.65 81.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.959 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.49 -52.84 62.33 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.891 179.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.95 -37.36 74.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.227 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 m -60.72 -39.77 89.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -74.86 -33.11 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.894 178.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -75.77 -9.48 58.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.761 179.252 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 58.86 37.25 24.84 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.275 0.56 . . . . 0.0 110.392 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.464 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -120.65 104.95 41.72 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.708 -179.699 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.866 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 2.0 Cg_endo -45.23 168.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.682 2.255 . . . . 0.0 112.351 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.537 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 5.0 p90 -162.8 170.78 17.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.425 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 2' ' ' PHE . 2.1 tm-20 -137.86 122.94 19.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.454 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.474 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.3 t80 -89.33 159.66 17.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.997 0.427 . . . . 0.0 111.68 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.454 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 20.8 mt -145.41 120.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.095 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -82.8 131.17 35.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.728 -178.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.439 ' CD1' ' CE1' ' A' ' 7' ' ' TYR . 5.2 pt -100.33 -28.16 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.024 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.613 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.9 ttp -123.93 91.39 49.68 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.841 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.02 3.44 7.8 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.841 2.361 . . . . 0.0 112.962 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -139.52 146.89 40.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.791 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.498 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 6.8 tmtt? -71.42 -7.76 49.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.285 0.564 . . . . 0.0 111.692 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.93 -60.62 1.25 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.048 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 t -147.0 144.1 20.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 112.041 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.613 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -64.21 169.37 4.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.973 179.723 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -98.57 116.34 30.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -57.89 -24.05 55.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.584 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -55.4 -48.82 73.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.848 0.356 . . . . 0.0 110.99 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -76.5 -36.96 57.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.061 0.458 . . . . 0.0 110.216 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.0 mm -58.1 -50.43 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.692 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -44.15 96.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.437 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.56 -37.89 89.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.373 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 ' CD2' ' A' ' 5' ' ' TYR . 25.4 tp -61.09 -54.23 47.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.563 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.3 mt -50.7 -42.66 57.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.8 m -65.55 -35.13 79.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.192 179.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.464 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 2.8 tttp -64.47 -39.96 94.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.304 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.45 -45.34 91.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.526 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.05 -110.84 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.89 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -150.55 32.5 0.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.996 0.427 . . . . 0.0 110.621 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.89 -146.75 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.431 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -119.99 170.43 9.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.708 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.74 98.39 8.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.137 0.494 . . . . 0.0 110.562 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -81.08 86.53 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.15 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.19 29.23 72.15 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.272 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.7 tt -46.73 152.55 0.47 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.343 . . . . 0.0 111.347 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.6 p -130.28 166.01 21.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.173 0.511 . . . . 0.0 111.683 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.41 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 1.3 mpt? -125.33 154.96 72.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.629 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.6 Cg_endo -83.86 143.46 44.05 Favored 'Cis proline' 0 C--N 1.344 0.333 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.916 0.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.9 OUTLIER -103.25 128.28 50.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 179.089 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 5.9 t -100.99 160.5 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 112.14 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 97.2 m-85 -143.7 159.29 42.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.416 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.47 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -70.12 144.6 92.81 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.141 -179.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -37.78 -31.96 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.487 2.792 . . . . 0.0 112.446 179.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.82 36.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.118 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.25 -109.49 1.85 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.955 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -127.37 -173.95 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.121 0.486 . . . . 0.0 111.335 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.477 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 35.5 t-80 -70.71 137.33 49.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.116 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.8 mp -109.65 -31.36 2.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.706 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 75' ' ' HIS . . . 117.95 -156.62 15.56 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.205 179.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.64 -124.61 5.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.147 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.468 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -80.09 -70.46 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.618 0.209 . . . . 0.0 111.299 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -52.29 -47.97 65.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.125 0.488 . . . . 0.0 110.6 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -57.66 -45.04 86.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.679 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.46 HD23 ' CE2' ' A' ' 86' ' ' PHE . 3.9 tt -74.31 -32.6 62.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.448 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 87' ' ' LYS . 5.9 ttp85 -52.59 -33.1 44.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -65.01 -33.65 76.55 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.12 178.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LEU . 17.3 t80 -64.72 -34.22 77.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.483 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.485 ' CE1' ' HE3' ' A' ' 27' ' ' LYS . 7.5 m-85 -90.8 -71.03 0.65 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.558 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 83' ' ' ARG . 37.6 mttt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.912 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.538 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 55.6 ttm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.818 0.342 . . . . 0.0 111.449 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.47 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 46.6 m-85 -55.23 155.0 5.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.067 0.46 . . . . 0.0 111.016 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -124.56 119.29 28.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.033 -179.37 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.53 HG12 ' CE1' ' A' ' 33' ' ' PHE . 24.4 t -114.44 127.1 72.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.203 0.525 . . . . 0.0 112.067 179.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.28 104.58 13.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.103 177.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.17 -139.19 2.58 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.684 -179.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -121.71 160.52 24.35 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.908 0.385 . . . . 0.0 111.344 -179.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.79 -72.99 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.778 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t 172.97 -36.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.981 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -64.72 -44.96 88.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.229 -179.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.47 HG23 HD11 ' A' ' 11' ' ' ILE . 20.4 mm -90.16 -40.11 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.431 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -149.96 152.49 35.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.012 0.434 . . . . 0.0 111.15 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -80.66 169.84 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.895 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 p 173.88 117.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.06 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -87.05 -34.35 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -22.63 66.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.014 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.8 t -72.05 -64.51 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.796 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -50.18 -35.48 26.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 51.8 m-20 -72.13 -59.0 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.17 -31.3 63.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.859 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -61.11 -54.46 44.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.659 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -66.5 -24.65 66.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.025 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD13 ' CE1' ' A' ' 79' ' ' PHE . 1.3 tt -59.86 -58.18 9.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 110.501 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 5.5 mt -60.38 -42.76 96.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.795 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.5 m -60.96 -41.08 95.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.49 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.1 t -73.68 -26.74 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.032 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 1.5 tpmp? -68.46 -44.35 75.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.79 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.645 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 112.71 30.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.331 1.052 . . . . 0.0 110.997 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -125.74 141.86 40.45 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.857 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -80.35 143.43 15.54 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.531 2.154 . . . . 0.0 111.669 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.538 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 33.9 p90 -145.87 167.8 22.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.947 0.403 . . . . 0.0 111.973 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.66 126.13 26.82 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.53 ' CE1' HG12 ' A' ' 4' ' ' VAL . 24.7 t80 -89.94 155.73 18.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.23 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 mt -150.51 122.63 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.399 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -78.1 110.17 12.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.639 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 pt -62.87 -21.15 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.72 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.565 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.1 ttp -128.05 88.6 52.54 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.03 1.25 8.87 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.638 2.225 . . . . 0.0 112.569 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -139.46 139.29 36.99 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.513 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -66.94 -8.53 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.269 0.557 . . . . 0.0 111.895 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.3 -63.54 1.5 Allowed Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.429 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 t -145.9 143.78 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.717 0.294 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -65.6 168.2 7.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 111.235 -179.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.9 118.06 30.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.178 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -71.43 -14.05 62.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.96 -61.07 2.51 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -41.42 95.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.193 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.8 mt -64.53 -33.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.57 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.87 82.25 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.712 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.95 -38.11 84.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.349 179.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.425 HD11 ' CE1' ' A' ' 69' ' ' PHE . 5.5 tp -57.96 -52.3 66.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.538 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.8 mt -51.45 -44.41 62.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.101 0.477 . . . . 0.0 111.278 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 m -63.27 -35.59 80.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.484 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.49 -40.34 89.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.657 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.94 -67.73 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.642 179.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.19 -107.02 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.033 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -150.45 31.42 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.004 0.43 . . . . 0.0 110.704 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.91 -149.44 0.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.353 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -120.53 170.19 9.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.755 0.312 . . . . 0.0 110.855 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -89.82 99.04 12.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.253 0.549 . . . . 0.0 110.309 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.501 HD11 HG22 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -78.22 88.02 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.039 -179.76 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.3 29.89 31.15 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.685 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -46.57 156.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 110.999 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.8 p -105.62 147.87 27.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.101 0.477 . . . . 0.0 111.614 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.4 mmt -119.53 153.23 53.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.4 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HB2' HG11 ' A' ' 4' ' ' VAL . 2.8 Cg_exo -78.82 148.8 83.75 Favored 'Cis proline' 0 C--N 1.344 0.298 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.948 0.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.41 ' CG ' ' NE2' ' A' ' 75' ' ' HIS . 2.1 tp60 -96.0 129.58 43.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.819 178.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.6 t -107.79 157.04 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.055 0.455 . . . . 0.0 111.947 -179.053 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 40.9 m-85 -143.01 137.29 29.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.646 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.429 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -47.08 160.85 0.32 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.376 -178.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.466 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.3 Cg_exo -60.24 -30.54 91.43 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.175 2.583 . . . . 0.0 112.12 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -94.3 -19.73 20.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.188 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.85 88.72 1.3 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.597 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.52 126.74 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.802 0.334 . . . . 0.0 110.686 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.422 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 5.1 t-160 -62.47 114.06 3.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.158 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 70' ' ' ALA . 8.7 mt -104.67 -39.88 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.764 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.98 -153.93 21.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.571 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.1 -135.8 9.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.651 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 13.4 t80 -71.62 -70.87 0.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 111.129 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.99 -47.16 86.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.71 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -52.38 -41.25 62.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.633 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.484 HD23 ' CE2' ' A' ' 86' ' ' PHE . 4.9 tt -75.87 -35.25 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 87' ' ' LYS . 7.8 ttp180 -51.14 -30.0 15.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -71.46 -34.3 70.09 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.142 178.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 82' ' ' LEU . 53.6 t80 -62.89 -35.55 80.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.35 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.484 ' CE2' HD23 ' A' ' 82' ' ' LEU . 8.8 m-85 -89.1 -27.62 20.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.454 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 83' ' ' ARG . 21.0 mtpp . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.955 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.665 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 2.0 tpt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.391 0.138 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -40.07 119.78 1.07 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.749 0.785 . . . . 0.0 111.613 -177.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.35 126.51 35.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.295 -179.102 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.497 HG13 ' CE1' ' A' ' 33' ' ' PHE . 59.3 t -109.2 148.21 13.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.392 0.615 . . . . 0.0 111.186 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 46.6 m-85 -128.05 99.77 5.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.737 178.613 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.63 -137.21 2.24 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.727 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.78 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 59.0 m-85 -121.24 108.02 13.25 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.669 0.271 . . . . 0.0 111.373 -179.042 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.533 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -110.94 51.0 0.79 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.003 179.816 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.44 -169.8 1.13 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -87.17 8.72 22.63 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.327 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 37' ' ' MET . 3.7 pt -86.59 -14.0 10.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.459 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 11.5 t-80 -162.61 153.79 17.59 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.139 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HE2' HG23 ' A' ' 15' ' ' VAL . 5.5 ptmt -79.02 171.57 15.03 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.8 p -165.04 89.54 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.728 0.299 . . . . 0.0 111.069 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.446 HG23 ' HE2' ' A' ' 13' ' ' LYS . 1.9 m -91.49 -40.7 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.606 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.07 -23.27 64.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.654 -179.233 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.61 -47.03 80.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.23 -32.69 64.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -73.87 -55.65 5.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.682 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.19 -51.11 71.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 110.837 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -55.03 -47.16 75.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 179.69 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -61.62 -40.5 95.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.028 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.56 -53.48 57.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.999 179.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.438 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 10.3 mt -59.55 -44.54 93.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.411 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 m -57.67 -40.87 80.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.8 t -75.31 -33.42 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.483 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -75.59 -12.11 60.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.929 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.8 41.72 1.15 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.849 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.15 118.07 16.1 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.407 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 77.8 Cg_exo -52.31 -177.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.308 2.005 . . . . 0.0 111.565 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.419 ' CE2' ' HE3' ' A' ' 21' ' ' LYS . 5.0 p90 -164.92 170.84 14.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.921 0.391 . . . . 0.0 111.367 178.012 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.647 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 34.7 tt0 -141.66 121.0 13.12 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.028 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 10.7 t80 -92.32 165.86 12.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.115 0.483 . . . . 0.0 112.078 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.453 HD11 ' CE1' ' A' ' 5' ' ' TYR . 25.4 mt -150.65 128.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.184 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.11 125.92 32.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.8 -178.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.9 pt -100.78 -25.11 3.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.718 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.739 ' HE1' ' CD2' ' A' ' 12' ' ' HIS . 2.3 ttm -108.91 105.19 56.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.012 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 37.5 Cg_endo -66.11 -29.65 47.74 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 121.769 1.646 . . . . 0.0 110.244 178.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -146.15 155.94 43.07 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.212 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -6.57 6.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.33 0.586 . . . . 0.0 111.568 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.34 -55.36 2.91 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 115.11 -0.95 . . . . 0.0 114.009 -178.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 t -148.2 135.87 14.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.951 0.376 . . . . 0.0 111.754 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -59.83 168.72 1.66 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.875 179.785 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.42 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -89.05 129.72 35.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.483 -179.907 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.37 -35.16 79.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.855 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -66.68 -50.9 61.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -68.32 -41.32 80.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.858 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.416 HD11 ' O ' ' A' ' 44' ' ' ASP . 1.3 mp -66.62 -35.19 74.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.661 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.01 -57.95 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.307 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -55.93 -29.62 60.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.984 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 24.4 tp -61.44 -61.16 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.078 179.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.427 ' HA ' HD13 ' A' ' 55' ' ' LEU . 86.2 mt -46.28 -35.73 5.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.692 179.442 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 m -69.29 -34.26 74.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.831 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 7.5 mtpp -68.36 -43.49 77.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.818 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 52' ' ' LEU . 4.8 mp -58.6 -20.26 45.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.418 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.11 -29.45 7.57 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.765 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -89.88 -174.82 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -108.43 -31.8 7.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -109.85 169.96 8.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -112.87 99.94 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.57 82.75 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.162 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.59 23.77 55.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.646 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.78 140.77 58.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.699 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.3 p -131.95 170.69 14.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.107 0.479 . . . . 0.0 111.474 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -104.09 155.5 37.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.664 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.4 Cg_exo -82.14 135.58 29.17 Favored 'Cis proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.678 0.463 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -92.99 128.37 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.18 179.187 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.0 t -102.88 157.11 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.015 0.436 . . . . 0.0 111.669 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 78.3 m-85 -143.09 147.21 34.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.775 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -56.16 140.9 70.24 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.37 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.85 -31.99 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.005 2.47 . . . . 0.0 112.115 179.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.43 34.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.932 179.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.87 -108.1 2.01 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.998 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.9 t -133.96 175.44 9.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.266 0.555 . . . . 0.0 111.511 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.48 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 10.1 t-80 -59.32 129.26 41.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.019 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 70' ' ' ALA . 9.3 mt -102.09 -42.14 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.977 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.54 -153.3 20.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.757 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.09 -142.4 13.27 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.379 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -69.43 -70.62 0.27 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 110.811 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -58.79 -48.73 80.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.517 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.74 -42.54 62.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.451 179.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.547 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.6 tt -79.77 -28.73 40.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.028 179.471 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -51.38 -32.6 26.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.93 -35.25 80.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.6 t80 -63.14 -34.07 76.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.354 178.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.547 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.7 m-85 -93.09 -12.43 30.52 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.589 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.97 179.92 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.554 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 36.5 ttm . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.877 0.37 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.47 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 68.8 m-85 -58.62 163.98 2.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.833 -179.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.723 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -138.67 119.27 13.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.684 -179.305 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.537 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 24.0 t -108.54 147.91 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.239 0.542 . . . . 0.0 111.508 179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 27.9 m-85 -130.87 101.55 5.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.466 178.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.62 -136.5 2.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.57 -179.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -108.27 157.26 18.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.846 0.355 . . . . 0.0 111.304 -179.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 9' ' ' SER . 20.3 t0 -85.14 -4.66 59.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.979 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 86.28 -36.63 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.955 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.33 -33.79 61.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.691 0.281 . . . . 0.0 111.089 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 40' ' ' LYS . 1.5 mt -89.79 -32.14 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.337 -179.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -141.24 132.03 25.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 110.621 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 151.25 41.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.573 -179.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 168.96 91.04 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.836 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.2 m -57.43 -37.05 55.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.53 -23.43 50.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -65.05 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.499 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.06 -34.97 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -60.88 -46.97 88.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.896 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.425 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -60.54 -43.44 97.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.294 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -53.98 -36.89 63.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.004 0.431 . . . . 0.0 110.132 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -70.18 -28.54 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.204 179.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -57.42 -55.96 27.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.927 179.414 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' CD2' HD22 ' A' ' 82' ' ' LEU . 24.8 mt -64.2 -42.54 96.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.578 179.459 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.8 m -58.59 -34.35 71.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.205 179.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.0 t -76.8 -31.25 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.616 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HG3' ' CD1' ' A' ' 86' ' ' PHE . 15.0 mmtt -76.07 -19.59 58.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.195 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.76 60.38 0.11 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -139.76 142.45 31.27 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.953 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.415 ' O ' ' HA ' ' A' ' 1' ' ' MET . 87.4 Cg_endo -75.91 137.31 19.61 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.405 2.07 . . . . 0.0 111.405 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.554 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 20.0 p90 -151.91 170.33 20.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -138.38 129.43 27.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.545 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.537 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 49.0 t80 -89.94 160.02 16.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.054 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.434 HD13 ' CE1' ' A' ' 5' ' ' TYR . 15.3 mt -145.57 121.43 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.295 0.569 . . . . 0.0 110.274 179.29 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -91.27 121.36 32.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.157 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 pt -80.64 -4.4 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.057 179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.428 ' HE3' ' CE2' ' A' ' 43' ' ' PHE . 36.9 ttm -132.85 110.97 13.28 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.778 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 71.9 Cg_endo -76.91 -30.73 4.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.552 2.168 . . . . 0.0 112.474 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -139.69 155.33 47.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.639 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.455 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -64.54 -8.03 12.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.296 0.57 . . . . 0.0 111.524 179.966 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.41 -52.21 4.6 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 115.177 -0.919 . . . . 0.0 113.193 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 t -149.24 153.4 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.105 0.479 . . . . 0.0 112.235 -179.188 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.428 ' CE2' ' HE3' ' A' ' 37' ' ' MET . 62.4 m-85 -73.74 168.72 18.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.124 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.409 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -99.71 111.62 23.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.891 179.345 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -62.48 -26.57 68.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.747 0.308 . . . . 0.0 110.556 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.32 -56.05 19.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -36.68 81.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.302 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.5 mt -67.27 -38.18 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.35 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.44 -56.07 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.273 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.31 -28.89 56.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.429 HD13 ' CG ' ' A' ' 5' ' ' TYR . 26.0 tp -62.96 -60.85 2.9 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.212 179.519 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.4 mt -45.54 -39.42 7.43 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.207 0.527 . . . . 0.0 111.288 179.229 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.8 m -67.11 -36.12 81.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.001 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HG2' ' CD2' ' A' ' 69' ' ' PHE . 7.9 tttp -63.22 -50.28 70.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.333 179.383 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 5.0 mp -58.92 -55.05 40.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.68 -126.39 0.9 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.376 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -150.4 33.23 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.991 0.424 . . . . 0.0 110.861 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -120.74 -144.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 t -105.06 170.06 8.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.72 0.295 . . . . 0.0 110.624 179.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.69 98.31 11.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.299 0.571 . . . . 0.0 110.546 179.841 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.4 mt -80.37 86.41 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.07 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.23 30.31 75.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.039 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.5 tt -48.03 151.32 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 111.512 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 p -142.26 170.18 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.39 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -132.13 149.76 74.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.648 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -85.59 149.36 47.05 Favored 'Cis proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.758 0.354 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 8.1 mt-30 -114.44 133.99 55.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.451 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -105.88 168.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.302 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 78.8 m-85 -142.33 146.11 34.66 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.431 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -57.16 138.3 80.2 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.235 -178.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HB3' ' N ' ' A' ' 1' ' ' MET . 87.1 Cg_exo -46.17 -28.4 5.47 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.878 2.385 . . . . 0.0 111.902 178.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.91 33.55 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.91 179.578 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.92 -108.89 1.76 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.934 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.419 ' N ' ' HB1' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -145.36 179.36 7.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.29 0.566 . . . . 0.0 111.421 -179.537 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.41 ' CE1' ' OE1' ' A' ' 67' ' ' GLN . 16.3 t-160 -49.76 118.79 3.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.355 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 70' ' ' ALA . 6.7 mt -84.83 -47.51 17.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.891 0.376 . . . . 0.0 111.076 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.83 -152.36 18.02 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.493 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -93.37 -155.3 31.82 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.405 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.549 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -61.61 -67.76 0.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 O-C-N 122.83 -0.218 . . . . 0.0 110.859 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -48.39 -42.18 31.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.068 0.461 . . . . 0.0 110.541 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -67.37 -42.32 83.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.417 179.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.462 HD22 ' CD2' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -66.71 -45.83 77.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.316 179.726 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -51.13 -36.61 41.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -70.29 -34.95 73.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.233 178.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -66.54 -30.61 70.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.751 178.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CD2' HD23 ' A' ' 82' ' ' LEU . 24.8 m-85 -90.9 -66.72 0.9 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.69 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.2 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.577 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.3 ttm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.897 0.38 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.46 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 87.4 m-85 -64.4 156.34 29.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.011 0.434 . . . . 0.0 110.689 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.58 120.22 22.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.561 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.489 HG11 ' CE1' ' A' ' 33' ' ' PHE . 21.1 t -108.62 137.38 40.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.18 0.514 . . . . 0.0 111.755 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 2.5 m-85 -115.73 101.08 8.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.927 178.488 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.25 -138.19 2.39 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.286 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -126.22 157.11 39.09 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.647 0.261 . . . . 0.0 111.039 -179.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.01 -69.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.807 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 t 170.87 -39.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.813 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -76.77 -24.74 52.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.844 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.82 -43.62 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.153 0.501 . . . . 0.0 110.17 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -152.18 147.21 26.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.131 179.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.55 159.14 26.99 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.239 -179.382 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -177.06 106.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.585 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.92 -36.65 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.697 -179.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -62.87 -21.22 65.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.495 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.6 t -64.54 -52.84 55.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.955 0.407 . . . . 0.0 110.571 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -55.55 -32.46 63.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.323 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -72.34 -53.76 11.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.224 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.4 -48.6 74.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.982 0.42 . . . . 0.0 111.139 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -51.15 71.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -42.19 78.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.5 -54.67 44.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.394 179.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -55.38 -44.97 76.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.771 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.1 m -58.36 -34.62 70.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.133 0.492 . . . . 0.0 110.059 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.84 -30.18 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.734 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 2.1 mmtt -79.17 -14.38 59.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 66.31 60.81 0.61 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.999 0.428 . . . . 0.0 110.804 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -133.62 143.1 46.37 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 1' ' ' MET . 75.8 Cg_endo -80.17 132.86 9.55 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.606 2.204 . . . . 0.0 111.445 179.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.577 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 29.1 p90 -155.18 170.43 21.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.921 0.391 . . . . 0.0 112.012 -179.682 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -144.84 145.72 31.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.058 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.29 158.44 17.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.099 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 16.8 mt -142.28 117.66 5.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.213 179.352 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -81.33 119.44 23.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.54 -179.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.5 tt -85.86 -27.86 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.193 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 7.4 ttp -129.93 95.86 27.5 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 179.418 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -78.14 -5.06 14.88 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.563 2.175 . . . . 0.0 112.691 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -139.9 139.89 36.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.755 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.91 -8.63 23.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.237 0.542 . . . . 0.0 111.989 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.16 -61.68 1.8 Allowed Glycine 0 C--N 1.312 -0.787 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.228 179.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.52 133.01 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.735 0.302 . . . . 0.0 111.094 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.03 167.59 1.6 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.01 0.433 . . . . 0.0 111.29 -179.804 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.45 108.79 18.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.102 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -53.09 -25.89 14.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.163 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -55.83 -49.94 71.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.773 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -74.98 -34.45 62.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.125 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.0 mm -59.82 -49.92 82.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.775 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.55 -50.61 72.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.488 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.23 -41.05 98.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.353 179.44 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 tp -57.07 -49.61 75.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.75 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.76 -49.89 69.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.086 0.47 . . . . 0.0 111.153 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.4 m -60.98 -33.19 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.272 179.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -64.29 -41.36 96.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.354 179.505 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.84 -56.11 25.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.567 179.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.96 -109.03 0.27 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.953 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -150.65 30.89 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.414 . . . . 0.0 110.698 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -121.03 -148.84 0.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.377 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 t -120.62 170.32 9.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 0.0 110.687 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -98.09 98.85 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.041 0.448 . . . . 0.0 110.471 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -80.25 85.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.242 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.64 27.89 55.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.444 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -47.41 154.27 0.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.829 0.347 . . . . 0.0 111.01 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.3 p -113.84 157.94 21.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.089 0.471 . . . . 0.0 111.636 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -120.84 158.15 52.9 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.8 Cg_exo -82.18 148.58 69.11 Favored 'Cis proline' 0 C--N 1.343 0.253 0 C-N-CA 124.017 -1.243 . . . . 0.0 112.887 0.469 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -105.07 125.6 51.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.167 179.023 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -97.25 167.98 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.878 0.37 . . . . 0.0 111.607 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.485 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 75.7 m-85 -142.63 141.45 31.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.74 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.66 147.64 29.69 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.13 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.496 ' HB3' ' N ' ' A' ' 1' ' ' MET . 51.6 Cg_exo -54.57 -27.81 52.37 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.804 2.336 . . . . 0.0 111.813 179.099 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -97.69 -22.32 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.014 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.16 82.82 0.6 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.63 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.78 115.66 0.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.727 0.299 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -50.71 116.71 2.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.177 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.6 mt -88.82 -41.02 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.162 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.59 -150.09 17.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.633 -179.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.48 -140.12 9.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.399 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -75.84 -61.24 1.99 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.59 -42.72 67.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.24 -44.36 92.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.636 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -49.0 79.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.464 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 ttt-85 -52.34 -32.44 38.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -75.06 -32.34 61.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.162 178.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -67.22 -32.2 73.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.357 178.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' A' ' 27' ' ' LYS . 26.1 m-85 -93.34 -70.47 0.7 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.504 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.923 179.983 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.53 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 58.1 ttm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.99 0.424 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.486 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 93.0 m-85 -53.17 152.51 4.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.039 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -126.92 120.44 29.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.954 -179.15 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.459 HG13 ' CE1' ' A' ' 33' ' ' PHE . 27.3 t -111.01 138.03 40.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 0.0 111.438 179.467 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 2.8 m-85 -114.73 99.03 7.21 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.128 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.76 -138.36 2.48 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.237 -0.983 . . . . 0.0 112.561 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 17.6 m-85 -118.91 148.45 42.92 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.592 0.234 . . . . 0.0 110.674 -179.191 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.3 t0 -78.36 7.09 7.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.2 m 80.97 -15.78 0.71 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -85.93 -47.82 9.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 111.788 -179.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.0 mt -89.86 -15.34 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.971 -179.298 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.702 ' CD2' ' HE1' ' A' ' 37' ' ' MET . 12.1 t-80 -150.76 163.33 38.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.997 -178.23 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.06 157.84 23.98 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.062 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 176.84 108.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.92 0.39 . . . . 0.0 111.94 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.9 m -91.75 -28.97 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.391 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -71.44 -22.17 61.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.224 -178.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 p -67.26 -34.47 77.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.058 0.456 . . . . 0.0 110.45 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -56.27 12.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.59 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -49.77 72.1 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.392 -179.248 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.72 -45.19 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 111.038 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -64.74 -50.37 67.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.803 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -39.3 69.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.76 -54.28 48.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.451 179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 mt -56.89 -44.94 82.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.732 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.2 m -59.24 -39.53 83.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.097 0.475 . . . . 0.0 110.171 179.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.08 -32.63 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.66 179.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -76.56 -9.74 58.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.048 179.787 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.45 61.17 0.46 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.931 0.396 . . . . 0.0 110.778 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -140.76 138.73 18.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.175 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 1' ' ' MET . 52.4 Cg_endo -83.05 142.09 10.81 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.685 2.257 . . . . 0.0 111.499 179.249 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.53 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 49.7 p90 -153.1 170.27 20.9 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.66 140.64 35.01 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.094 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 4' ' ' VAL . 11.1 t80 -89.73 161.57 15.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.349 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.489 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 16.9 mt -147.4 120.65 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.198 179.459 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -95.71 131.21 42.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.536 -179.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -100.46 -24.54 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.912 179.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.702 ' HE1' ' CD2' ' A' ' 12' ' ' HIS . 21.9 ttm -114.5 82.0 7.35 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.755 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.53 7.81 4.79 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.715 2.276 . . . . 0.0 112.527 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -139.37 129.9 25.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.353 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -59.79 -8.28 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.183 0.516 . . . . 0.0 112.04 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.77 -71.52 1.04 Allowed Glycine 0 C--N 1.314 -0.657 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.374 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.07 133.95 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -67.69 165.65 16.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.011 0.434 . . . . 0.0 111.46 -179.637 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -81.28 124.89 29.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.346 -179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.28 -24.89 57.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.199 179.865 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.0 -51.35 68.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.85 0.357 . . . . 0.0 110.616 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -71.05 -39.23 72.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.119 179.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.29 -37.87 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.551 179.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.56 -49.68 70.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.49 -40.64 97.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.419 179.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.13 -51.19 70.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.707 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.6 mt -51.99 -46.64 64.95 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.132 0.492 . . . . 0.0 111.167 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -65.92 -32.97 74.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.105 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -63.43 -42.02 98.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.379 179.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.81 -69.85 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.074 179.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.0 -35.14 0.29 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.554 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -109.41 -166.48 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.333 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -109.48 -30.4 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -90.23 164.44 14.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.798 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.97 100.26 7.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.7 tp -78.96 83.92 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.091 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.99 25.63 56.9 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.571 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.26 137.05 42.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.939 0.399 . . . . 0.0 110.889 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.5 p -122.03 170.29 9.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 111.448 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.67 157.9 64.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.709 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.1 Cg_endo -85.25 149.81 50.29 Favored 'Cis proline' 0 N--CA 1.463 -0.304 0 C-N-CA 124.093 -1.211 . . . . 0.0 112.681 0.275 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -109.75 127.88 54.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.113 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -98.85 165.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.958 0.408 . . . . 0.0 111.672 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.514 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 84.5 m-85 -142.3 142.49 32.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.781 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.37 137.23 40.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.254 -178.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.451 ' HB3' ' N ' ' A' ' 1' ' ' MET . 98.5 Cg_exo -44.36 -29.89 3.37 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.08 2.52 . . . . 0.0 112.265 179.106 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.38 36.25 0.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.248 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.26 -109.29 1.12 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.837 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.9 p -135.86 176.11 8.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.021 0.438 . . . . 0.0 111.2 -179.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 41.8 t-80 -52.37 125.72 16.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.285 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 85' ' ' TYR . 19.0 mt -91.23 -45.3 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.41 ' HA2' ' CE1' ' A' ' 75' ' ' HIS . . . 132.0 -151.09 19.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.747 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.93 -136.72 7.83 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.61 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -77.17 -63.12 1.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 111.123 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -53.65 -45.68 70.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.902 0.382 . . . . 0.0 110.84 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -45.28 85.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.539 179.673 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.31 -47.81 83.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.702 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -52.38 -33.32 42.83 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.072 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.73 66.7 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.408 ' HB2' ' CG2' ' A' ' 76' ' ' ILE . 54.9 t80 -66.11 -33.94 76.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.404 178.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.525 ' CD1' ' HD2' ' A' ' 27' ' ' LYS . 18.7 m-85 -90.02 -26.95 20.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.428 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.194 -0.907 . . . . 0.0 110.857 -179.904 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.543 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 21.2 ttm . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.831 0.348 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.495 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 92.4 m-85 -60.04 148.57 35.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.621 -179.654 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -125.36 118.13 25.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 -179.378 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' A' ' 66' ' ' PRO . 70.7 t -108.82 144.6 16.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.179 0.514 . . . . 0.0 111.387 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.476 ' CZ ' HD13 ' A' ' 34' ' ' ILE . 6.8 m-85 -124.98 99.49 6.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.051 178.201 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.74 -149.14 5.7 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.891 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.463 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 63.3 m-85 -105.95 152.23 23.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.754 0.311 . . . . 0.0 111.273 -179.857 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.5 p30 -72.32 -63.12 1.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.576 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.4 p 160.2 -32.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.046 0.45 . . . . 0.0 110.849 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -85.13 -22.82 28.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.467 -179.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.448 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 9.6 mt -88.42 -38.7 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.603 0.239 . . . . 0.0 110.949 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -147.75 141.56 25.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 111.154 179.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 140.23 58.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.192 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 173.8 106.38 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.222 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 m -85.72 -25.65 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.399 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.27 -34.76 72.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.396 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -67.05 -42.73 84.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.71 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -24.83 68.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.971 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 87.9 m-20 -78.12 -53.59 7.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.234 -179.634 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -53.43 -45.2 69.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.968 0.413 . . . . 0.0 110.942 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -51.49 69.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.807 179.794 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -57.8 -39.26 77.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.669 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.417 HD21 ' CE2' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -56.63 -53.09 61.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.354 179.385 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.441 HD21 ' CD2' ' A' ' 2' ' ' PHE . 6.7 mt -56.33 -46.17 80.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.597 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -55.75 -36.62 67.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.053 0.454 . . . . 0.0 109.825 179.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.2 t -80.11 -30.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.491 179.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -13.49 60.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.046 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.26 59.85 0.51 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.99 0.424 . . . . 0.0 111.079 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -140.48 140.41 22.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.037 179.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' A' ' 1' ' ' MET . 71.7 Cg_endo -79.84 137.87 12.85 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.557 2.171 . . . . 0.0 111.376 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.543 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 13.2 p90 -154.89 170.28 22.06 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -138.8 129.87 26.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.972 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.457 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 1.2 t80 -92.62 122.34 34.94 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.901 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.476 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 7.7 mt -104.43 109.8 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.629 0.728 . . . . 0.0 110.469 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -81.6 118.93 23.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.253 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.422 ' HB ' ' CD1' ' A' ' 48' ' ' ILE . 20.3 pt -100.21 45.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.356 179.574 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.492 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.4 ttt -162.72 99.79 1.07 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.075 -179.659 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 56.3 Cg_endo -71.19 -33.14 11.91 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.265 1.976 . . . . 0.0 111.719 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.91 157.86 45.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.349 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 11' ' ' ILE . 4.8 mttt -64.96 -8.46 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.301 0.572 . . . . 0.0 111.453 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.68 -56.73 2.06 Favored Glycine 0 C--N 1.313 -0.721 0 CA-C-N 115.201 -0.908 . . . . 0.0 113.557 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.3 144.84 29.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 13.5 m-85 -71.08 170.65 12.43 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.153 179.438 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.415 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -95.15 115.84 27.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.753 179.151 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -56.72 -28.23 60.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.23 -52.87 62.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -70.78 -47.87 57.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.81 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 43' ' ' PHE . 1.8 mp -55.78 -48.71 77.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.62 96.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.521 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.78 -35.25 79.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.617 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 tp -58.71 -54.55 45.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.533 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.8 mt -53.56 -46.27 70.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.175 179.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 m -62.47 -32.1 72.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.386 179.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -69.67 -36.41 76.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.472 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.68 -61.16 2.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.555 179.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.5 -105.82 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.993 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -146.1 30.14 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.077 0.465 . . . . 0.0 110.547 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -120.91 -153.65 0.55 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.544 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 t -120.84 170.61 9.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.3 98.38 8.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.55 . . . . 0.0 110.282 179.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.0 mm -79.71 84.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.191 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.6 25.11 57.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.463 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.12 143.26 55.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.785 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.4 p -121.69 153.21 38.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.277 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.0 mmt -102.65 153.97 37.81 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.495 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.464 ' HB2' HG12 ' A' ' 4' ' ' VAL . 3.2 Cg_exo -77.7 141.33 66.8 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.022 0.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' TYR . 35.5 mt-30 -99.31 122.4 42.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.488 179.223 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -96.5 165.76 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.897 0.38 . . . . 0.0 111.67 -179.483 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 72.2 m-85 -142.8 142.29 31.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.742 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -54.07 134.45 58.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.163 -178.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.521 ' HB3' ' N ' ' A' ' 1' ' ' MET . 98.0 Cg_exo -44.68 -29.41 3.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.912 2.408 . . . . 0.0 112.116 178.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -163.74 42.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.256 179.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.08 -107.93 0.7 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.741 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.58 176.13 8.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.154 0.502 . . . . 0.0 111.27 -179.646 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 68' ' ' VAL . 38.1 t-80 -52.51 123.2 10.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.178 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.5 mt -85.8 -44.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.09 -151.22 20.19 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 -179.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.51 -155.11 30.23 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.74 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.414 ' CE1' ' HA ' ' A' ' 20' ' ' ALA . 10.5 t80 -63.14 -70.58 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 110.835 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -57.53 -44.9 85.47 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.501 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.09 -31.62 31.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.379 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.5 HD22 ' CE2' ' A' ' 86' ' ' PHE . 3.6 tt -80.78 -34.98 33.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.269 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttp85 -52.16 -30.44 26.8 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -68.72 -35.22 76.86 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.514 -0.766 . . . . 0.0 108.974 178.067 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 28.2 t80 -62.54 -34.62 77.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.274 178.329 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.5 ' CE2' HD22 ' A' ' 82' ' ' LEU . 6.7 m-85 -87.61 -70.28 0.64 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.348 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.914 -179.939 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.525 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 58.5 ttm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.947 0.403 . . . . 0.0 111.469 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.494 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 64.2 m-85 -49.75 170.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.87 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -145.3 114.57 7.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.661 -179.341 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.478 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 61.7 t -107.63 143.16 18.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.296 0.569 . . . . 0.0 112.04 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 7.3 m-85 -121.71 105.64 10.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.623 177.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.47 -135.3 1.86 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.75 -179.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.436 ' HE1' ' HE1' ' A' ' 37' ' ' MET . 67.6 m-85 -110.45 150.49 28.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.88 0.371 . . . . 0.0 111.274 -179.33 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.32 6.94 46.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.229 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p 78.46 -8.86 1.6 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -85.2 -40.09 17.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.629 0.252 . . . . 0.0 111.301 -179.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.467 HG21 ' O ' ' A' ' 39' ' ' GLU . 2.4 mp -99.02 -38.25 6.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.847 0.356 . . . . 0.0 111.676 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 17.7 t60 -139.8 152.0 46.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.493 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 162.8 28.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.078 0.466 . . . . 0.0 112.067 -178.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -178.62 117.18 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.127 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 m -89.61 -34.59 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.992 0.425 . . . . 0.0 110.949 179.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -60.48 -23.25 64.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.333 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.52 -40.65 56.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.917 0.389 . . . . 0.0 110.42 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -63.88 -51.72 63.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.472 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 6.2 p30 -66.91 -49.0 66.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.163 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -53.5 -43.72 68.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.933 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -65.33 -58.44 5.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.796 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 ttm-85 -55.51 -40.19 71.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.523 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.97 -54.02 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.407 179.305 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 6.2 mt -56.29 -42.37 77.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.548 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -60.13 -36.5 77.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.86 179.255 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.67 -31.12 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.563 179.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -9.72 58.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.025 179.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm 67.89 60.82 0.43 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.148 0.499 . . . . 0.0 110.657 -179.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -146.44 132.55 9.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.978 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.4 Cg_endo -78.35 147.75 23.22 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.436 2.09 . . . . 0.0 111.134 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.525 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 12.7 p90 -157.33 170.9 21.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.607 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -140.74 135.02 31.12 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.983 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.478 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 28.4 t80 -89.47 164.26 14.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.221 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.459 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 11.0 mt -147.28 119.59 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.398 179.527 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -95.8 133.19 40.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.277 -179.332 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.437 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 2.0 pp -100.24 -13.96 8.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.219 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.436 ' HE1' ' HE1' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -122.65 75.55 45.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.464 179.967 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 77.8 Cg_endo -88.24 37.46 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.078 2.519 . . . . 0.0 112.926 -179.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.467 ' O ' HG21 ' A' ' 11' ' ' ILE . 38.6 mt-10 -139.0 170.74 15.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -61.52 -7.99 3.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.22 0.533 . . . . 0.0 112.046 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.29 55.37 0.02 OUTLIER Glycine 0 C--N 1.314 -0.669 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.758 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -150.31 118.93 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.23 0.538 . . . . 0.0 111.838 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.437 ' CZ ' HD13 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -64.89 137.25 57.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.358 178.901 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 36' ' ' ILE . 1.8 t70 -95.04 105.53 17.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.098 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.11 -21.52 32.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.663 -179.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.0 -51.27 70.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.677 0.275 . . . . 0.0 111.045 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.91 -41.15 64.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.386 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 44' ' ' ASP . 2.5 mp -59.83 -40.3 82.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.328 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.87 -48.52 71.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.235 179.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -39.28 93.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.439 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.402 HD22 ' NE2' ' A' ' 67' ' ' GLN . 28.2 tp -58.06 -50.65 72.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.613 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.6 mt -51.26 -45.08 61.94 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.145 0.498 . . . . 0.0 111.11 179.458 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.5 m -66.48 -31.16 71.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.134 179.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.81 -31.72 70.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.31 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.46 -70.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.87 179.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.02 -30.18 0.99 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.173 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -105.57 -174.97 2.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.691 0.282 . . . . 0.0 110.831 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -101.35 -30.65 11.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.102 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -104.43 166.05 10.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.998 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -117.26 100.32 7.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.688 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 pt -75.54 82.7 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.456 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.7 20.08 77.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.928 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.45 132.65 44.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 110.754 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.09 170.22 14.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.067 0.46 . . . . 0.0 111.429 -179.669 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.448 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -105.5 157.36 34.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.772 179.767 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.7 Cg_exo -76.82 152.77 95.74 Favored 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.977 -1.26 . . . . 0.0 112.98 0.467 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 5' ' ' TYR . 5.0 mt-30 -118.62 116.18 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.314 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -93.18 165.55 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.658 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 76.6 m-85 -143.2 148.15 36.02 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.697 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -58.22 144.73 76.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.182 -178.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.484 ' HB3' ' N ' ' A' ' 1' ' ' MET . 66.7 Cg_exo -54.62 -27.87 53.14 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.059 2.506 . . . . 0.0 112.434 179.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -90.78 -32.01 16.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.379 -179.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.37 80.89 0.17 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.798 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.74 164.09 21.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -90.54 118.42 29.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.144 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.3 mt -96.21 -46.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.031 0.443 . . . . 0.0 110.726 179.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.9 -147.9 17.56 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.022 -179.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.82 -161.9 36.74 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.207 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 19' ' ' ASN . 35.0 t80 -69.53 -49.59 52.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.405 179.734 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -55.76 -49.0 74.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.628 179.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -31.81 73.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.483 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.467 HD12 ' CD2' ' A' ' 86' ' ' PHE . 2.7 tm? -73.93 -42.54 60.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.653 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.6 ttt-85 -56.08 -43.92 78.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.678 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -61.84 -38.79 89.51 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.479 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -60.56 -40.28 91.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.89 177.795 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.467 ' CD2' HD12 ' A' ' 82' ' ' LEU . 3.9 m-30 -82.07 -10.12 59.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.141 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.152 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 34.6 ttm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.412 ' CE1' ' CZ ' ' A' ' 86' ' ' PHE . 95.9 m-85 -78.11 143.9 36.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.461 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.719 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -104.94 118.9 37.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.444 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' A' ' 33' ' ' PHE . 5.9 t -101.66 117.32 46.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.083 0.468 . . . . 0.0 111.146 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.7 m-30 -92.6 98.76 11.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.616 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' C ' ' CD1' ' A' ' 7' ' ' TYR . . . -160.57 -140.21 2.84 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.747 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.691 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 5.4 m-85 -131.82 134.24 45.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 120.735 0.302 . . . . 0.0 111.539 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.469 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -128.39 62.36 1.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.102 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -172.78 -172.1 0.84 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.163 0.506 . . . . 0.0 111.845 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.13 2.18 47.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.603 HG22 ' HA ' ' A' ' 40' ' ' LYS . 0.8 OUTLIER -87.37 -4.02 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.989 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.691 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 11.1 t-80 -169.98 145.09 2.84 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.929 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.89 168.72 18.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.024 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -177.88 110.59 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.295 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.407 HG21 ' N ' ' A' ' 16' ' ' TYR . 27.7 m -90.58 -46.02 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.49 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.407 ' N ' HG21 ' A' ' 15' ' ' VAL . 24.2 m-85 -62.17 -22.27 65.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.032 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.0 t -63.07 -41.13 99.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.798 0.332 . . . . 0.0 111.038 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -62.0 -54.5 40.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.437 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 4.7 p30 -69.45 -51.66 34.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.398 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.82 -36.44 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.341 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -62.12 -57.83 10.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.472 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -65.18 -23.79 67.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.433 HD11 ' CE1' ' A' ' 79' ' ' PHE . 5.5 tt -58.54 -58.7 7.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.085 0.469 . . . . 0.0 110.386 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.477 ' CD2' ' CZ ' ' A' ' 86' ' ' PHE . 9.5 mt -63.23 -39.2 93.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.68 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.9 m -62.92 -39.51 94.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.436 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.78 -45.95 90.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.688 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -12.17 61.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.237 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.93 52.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.896 0.379 . . . . 0.0 111.274 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -136.74 138.17 25.55 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.752 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 1' ' ' MET . 63.1 Cg_endo -80.7 159.82 21.78 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.589 2.193 . . . . 0.0 111.775 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.405 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 30.3 p90 -161.63 170.75 19.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.842 0.353 . . . . 0.0 111.559 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.96 135.21 35.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.724 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 8.7 t80 -89.61 158.51 17.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.308 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.442 HD11 ' CE1' ' A' ' 5' ' ' TYR . 13.3 mt -147.69 121.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.212 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -89.61 127.34 35.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.297 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 5.0 pt -99.56 22.39 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.047 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.531 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -155.7 77.39 4.69 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.791 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.29 22.13 0.78 Allowed 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.825 2.35 . . . . 0.0 113.026 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -147.74 157.65 43.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.587 0.232 . . . . 0.0 111.134 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.603 ' HA ' HG22 ' A' ' 11' ' ' ILE . 6.0 ptmt -47.4 -8.87 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 39' ' ' GLU . . . 176.21 46.69 0.06 OUTLIER Glycine 0 C--N 1.308 -0.988 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.553 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 t -150.13 120.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.516 . . . . 0.0 111.849 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.602 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -68.64 170.29 9.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.358 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -95.1 105.77 17.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.372 . . . . 0.0 110.862 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -56.27 -29.18 60.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.88 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.46 -56.0 11.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 111.329 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -43.19 73.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.939 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.412 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 1.5 mp -52.01 -47.22 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.741 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.69 -54.81 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.16 -30.56 71.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.518 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.5 tt -59.22 -53.33 59.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.528 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 48' ' ' ILE . 14.2 mt -54.25 -50.44 67.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.041 0.448 . . . . 0.0 111.103 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.0 m -60.85 -36.59 79.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.367 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -66.47 -39.09 88.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.794 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -52.5 65.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.096 0.474 . . . . 0.0 110.347 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.68 -114.42 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.89 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -150.48 30.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.102 0.477 . . . . 0.0 110.671 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -121.08 -143.62 0.34 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.467 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -119.55 170.34 9.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.734 0.302 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.65 98.11 8.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.253 0.549 . . . . 0.0 110.636 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 tp -80.5 85.51 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.864 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.27 29.67 69.3 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.988 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -44.97 119.4 1.97 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.38 . . . . 0.0 111.172 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.2 p -110.09 170.27 8.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.251 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 154.01 61.01 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.939 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.1 Cg_endo -86.64 152.51 45.56 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 124.258 -1.143 . . . . 0.0 112.406 0.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 8.5 mm-40 -117.91 113.06 21.16 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -83.34 163.06 3.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.131 0.491 . . . . 0.0 111.902 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 50.9 m-85 -142.52 141.57 32.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.335 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB1' ' N ' ' A' ' 74' ' ' SER . . . -53.2 132.44 51.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.614 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.577 ' HB3' ' N ' ' A' ' 1' ' ' MET . 33.7 Cg_exo -53.48 -21.88 19.82 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.56 2.173 . . . . 0.0 111.795 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -161.61 41.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.29 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.95 -110.72 0.63 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.998 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.4 ' N ' ' HB1' ' A' ' 70' ' ' ALA . 37.1 m -137.85 178.62 6.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.136 0.493 . . . . 0.0 111.274 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 37.9 t-80 -55.75 132.36 49.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.116 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.4 mt -100.98 -42.65 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.921 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.05 -154.95 22.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.028 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.13 -141.39 10.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.843 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 19' ' ' ASN . 26.5 t80 -72.42 -70.64 0.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.767 0.317 . . . . 0.0 111.332 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -56.93 -49.53 75.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 110.663 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -53.11 -37.64 61.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.45 HD22 ' CE1' ' A' ' 86' ' ' PHE . 5.4 tt -77.82 -34.49 51.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.212 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 -51.98 -31.37 29.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -68.8 -32.43 72.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.286 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 26.3 t80 -68.43 -29.99 68.77 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.589 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.477 ' CZ ' ' CD2' ' A' ' 24' ' ' LEU . 22.6 m-85 -92.33 -25.49 18.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.416 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.2 mttt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.793 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 34.2 ttp . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.902 0.382 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.446 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 65.0 m-85 -50.05 169.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.785 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -143.28 117.48 9.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.496 -178.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.466 HG11 ' CE1' ' A' ' 33' ' ' PHE . 77.1 t -108.88 144.64 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.201 0.524 . . . . 0.0 111.535 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.446 ' CZ ' HD13 ' A' ' 34' ' ' ILE . 10.9 m-85 -125.47 99.95 6.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.196 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.36 -137.46 2.22 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.257 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.43 ' HE1' ' HE1' ' A' ' 37' ' ' MET . 81.2 m-85 -114.08 159.34 20.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.738 0.304 . . . . 0.0 110.905 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -84.73 -73.7 0.42 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p 167.83 -33.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 110.638 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -85.12 -23.15 28.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.493 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' CG2' ' HG2' ' A' ' 37' ' ' MET . 4.1 mp -91.73 -44.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.222 0.534 . . . . 0.0 110.733 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -150.08 139.8 21.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.004 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.82 146.0 43.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.276 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.98 112.12 0.64 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.322 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 m -90.56 -30.74 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.451 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -65.02 -27.28 68.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.51 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.1 t -56.8 -53.86 52.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.352 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.16 -35.62 64.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.176 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -72.92 -58.96 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.989 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.12 -37.69 64.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.213 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -59.5 -54.27 48.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.691 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -66.33 -28.87 69.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.049 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.6 tt -54.57 -53.71 50.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.477 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.18 -40.76 94.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.536 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 m -61.8 -34.02 75.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.329 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.9 t -74.13 -28.51 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.01 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.471 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -83.45 -12.57 56.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.293 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.49 55.95 0.08 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -142.19 142.39 24.14 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' O ' ' HA ' ' A' ' 1' ' ' MET . 98.5 Cg_endo -79.09 148.54 21.73 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.485 2.123 . . . . 0.0 111.323 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.51 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 36.8 p90 -156.74 170.64 21.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -141.68 134.92 29.33 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.026 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.466 ' CE1' HG11 ' A' ' 4' ' ' VAL . 30.3 t80 -89.68 161.97 15.83 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.093 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.446 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 17.0 mt -147.22 121.4 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.602 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -99.45 131.77 45.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.938 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pp -96.82 7.19 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.763 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.43 ' HE1' ' HE1' ' A' ' 7' ' ' TYR . 1.5 tpp -140.62 69.41 31.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.705 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 3.8 Cg_exo -80.96 43.65 1.59 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.296 2.664 . . . . 0.0 112.899 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.18 170.36 16.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.57 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.5 tptt -66.41 -7.69 20.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.199 0.523 . . . . 0.0 111.975 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.49 50.0 0.02 OUTLIER Glycine 0 C--N 1.313 -0.739 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.667 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -150.48 120.2 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.213 0.53 . . . . 0.0 111.818 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -65.61 136.61 56.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.157 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -97.83 113.76 25.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.831 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -63.37 -17.27 62.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.46 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -62.3 -57.29 11.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.862 0.363 . . . . 0.0 110.646 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -72.13 -39.29 68.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.206 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.6 mt -60.48 -48.46 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.26 96.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.375 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.01 -37.63 88.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.323 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.434 HD13 ' CD2' ' A' ' 5' ' ' TYR . 26.7 tp -59.3 -51.9 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.6 -47.46 70.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.093 0.473 . . . . 0.0 111.192 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.0 m -62.63 -32.25 73.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.42 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 2.8 mmmt -67.71 -34.98 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.491 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.83 -39.15 84.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.466 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.5 -105.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.865 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -150.33 31.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.041 0.448 . . . . 0.0 110.636 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.01 -147.19 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.445 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 t -120.21 170.29 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 0.0 110.668 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.15 98.24 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 110.405 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mt -80.2 84.21 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.201 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.29 24.89 53.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.639 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.71 143.12 47.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 110.685 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -124.07 168.12 13.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 111.444 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.6 mtm -110.67 154.55 43.13 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.732 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.27 140.65 58.2 Favored 'Cis proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.749 -1.355 . . . . 0.0 112.759 0.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -97.02 114.69 26.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.031 179.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 6.5 t -95.71 160.27 2.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.996 0.427 . . . . 0.0 111.73 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.59 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 92.5 m-85 -142.44 153.44 43.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.723 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.502 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -61.62 147.35 88.74 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.271 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 1' ' ' MET . 64.2 Cg_exo -55.17 -23.89 38.65 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.293 2.662 . . . . 0.0 112.507 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -99.06 -29.0 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.397 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 132.26 93.83 0.58 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.756 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.85 159.85 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -90.2 125.55 35.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.017 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.502 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 3.1 mp -117.05 -27.28 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.488 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.14 -157.62 15.62 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.939 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.5 -140.65 11.56 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.675 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.447 ' CE1' HD12 ' A' ' 23' ' ' LEU . 24.4 t80 -65.96 -70.58 0.23 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.823 0.344 . . . . 0.0 111.145 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.19 -49.99 75.11 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.826 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -51.09 -43.09 61.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.438 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' A' ' 86' ' ' PHE . 4.7 tt -74.76 -34.07 62.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.107 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.4 ttp180 -51.84 -28.62 16.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.14 -32.62 70.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.0 t80 -67.45 -32.02 72.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.67 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.471 ' CD1' ' HG2' ' A' ' 27' ' ' LYS . 10.2 m-85 -96.71 -70.61 0.71 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.651 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 83' ' ' ARG . 9.5 mmtp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.625 ' HG3' ' HA ' ' A' ' 31' ' ' PHE . 1.1 tpp . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.769 0.319 . . . . 0.0 111.687 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.472 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 65.8 m-85 -58.83 166.28 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.344 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -140.86 117.57 10.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.022 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.487 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 39.0 t -107.5 147.43 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.223 0.535 . . . . 0.0 111.48 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 14.8 m-85 -129.64 101.19 5.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.289 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.71 -138.67 2.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.174 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD2' ' CB ' ' A' ' 12' ' ' HIS . 16.3 m-85 -116.03 158.56 22.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.619 0.247 . . . . 0.0 110.706 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -74.23 -69.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.689 0.28 . . . . 0.0 111.462 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 166.31 -38.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.038 0.447 . . . . 0.0 110.179 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -85.29 -22.82 28.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.623 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.65 -42.77 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.25 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.646 ' CD2' ' HE3' ' A' ' 37' ' ' MET . 12.2 t-80 -144.3 158.34 43.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.795 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -80.6 144.96 31.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.963 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 p -174.3 117.75 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.307 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.14 -32.08 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -67.01 -24.61 66.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.42 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -65.79 -61.09 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 110.439 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -26.01 63.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.913 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 28.4 m-20 -78.66 -60.04 2.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.193 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.01 -45.97 71.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.172 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -58.19 -52.53 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.567 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -61.01 -40.76 94.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.576 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 86' ' ' PHE . 1.1 tt -57.55 -53.82 53.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.416 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.6 mt -55.77 -46.72 77.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.732 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.1 m -56.77 -37.08 70.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.14 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -77.83 -31.08 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.656 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -9.68 58.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.15 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt 68.13 53.36 0.63 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.947 0.403 . . . . 0.0 110.69 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -133.23 136.38 27.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.108 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 1' ' ' MET . 54.1 Cg_endo -81.29 137.14 10.41 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.547 2.165 . . . . 0.0 110.837 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.625 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 42.3 p90 -153.6 170.1 21.65 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.684 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -136.43 132.87 36.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.487 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 34.7 t80 -89.67 160.84 16.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.44 HD12 ' CE1' ' A' ' 5' ' ' TYR . 18.4 mt -146.63 121.14 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.323 0.582 . . . . 0.0 110.517 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -90.51 121.82 32.79 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.897 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pt -91.45 -6.65 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.337 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.646 ' HE3' ' CD2' ' A' ' 12' ' ' HIS . 22.4 ttm -118.57 99.88 51.35 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.661 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.454 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.8 Cg_endo -76.16 -27.5 8.15 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.477 2.118 . . . . 0.0 111.768 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -140.28 150.14 43.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.217 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -64.38 -8.37 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.355 0.598 . . . . 0.0 111.801 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.51 -56.55 3.13 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.685 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.73 147.18 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -66.45 168.75 8.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.606 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.454 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 41.6 t0 -91.37 122.11 33.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -66.6 -26.5 67.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.886 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.02 -56.25 23.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.476 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -64.41 -44.24 91.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.136 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.9 mt -55.79 -42.95 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.392 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.74 -47.87 76.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.728 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.12 -36.56 82.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.335 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.437 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 34.2 tp -63.05 -60.29 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.445 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' A' ' 55' ' ' LEU . 88.0 mt -44.91 -41.91 7.6 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.261 0.553 . . . . 0.0 111.747 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.9 m -69.03 -30.33 68.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.406 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 51' ' ' LEU . 4.4 tttp -69.05 -44.28 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.836 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.437 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -59.1 -67.09 0.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.381 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.77 -31.55 0.14 Allowed Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.901 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -135.69 -169.99 2.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.323 . . . . 0.0 110.919 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -103.63 20.18 18.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.231 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 t -120.09 165.68 14.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.826 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -128.98 100.69 5.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.008 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.5 mt -80.29 84.28 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.012 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.62 27.56 55.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.162 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -55.42 143.18 29.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.995 0.426 . . . . 0.0 111.238 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 152.58 45.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.3 mmt -108.75 148.92 38.76 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.727 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.3 Cg_exo -80.53 148.0 76.02 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 124.026 -1.239 . . . . 0.0 112.952 0.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 5' ' ' TYR . 6.7 tp60 -104.38 126.24 51.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.384 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -103.01 166.39 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.74 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 81.1 m-85 -142.53 153.03 43.22 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -65.11 149.71 96.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.264 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.587 ' HB3' ' N ' ' A' ' 1' ' ' MET . 40.9 Cg_exo -59.97 -25.76 80.48 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.026 2.484 . . . . 0.0 112.196 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.16 -25.95 17.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.246 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.4 91.11 0.84 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.658 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -179.17 161.21 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.791 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.419 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 10.5 t-160 -85.6 126.67 34.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 70' ' ' ALA . 18.6 mt -101.21 -45.42 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.033 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.39 -152.42 18.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.912 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.25 -146.38 12.0 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.859 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 19.3 t80 -72.27 -70.98 0.31 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.672 0.272 . . . . 0.0 111.327 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -55.84 -44.46 78.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.158 0.504 . . . . 0.0 110.508 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -52.54 -40.75 62.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.995 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' TYR . 6.0 tt -73.63 -32.09 63.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.284 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.0 mmm-85 -51.81 -35.11 43.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.34 -34.57 78.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.3 t80 -61.82 -35.36 78.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.07 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.463 ' CE2' HD23 ' A' ' 82' ' ' LEU . 7.7 m-85 -91.51 -9.7 43.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.07 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.1 pttp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.964 179.831 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.587 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 8.2 ttm . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.1 144.54 38.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.097 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.68 118.81 37.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.333 -178.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.468 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 55.0 t -104.73 142.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.184 0.516 . . . . 0.0 111.042 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CE1' ' CD2' ' A' ' 69' ' ' PHE . 9.8 m-85 -121.27 99.15 6.32 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.08 -151.99 6.3 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.848 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.711 ' CD1' ' CG ' ' A' ' 12' ' ' HIS . 60.7 m-85 -102.74 125.12 49.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.754 0.311 . . . . 0.0 111.318 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.517 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 6.1 t0 -137.1 65.36 1.5 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.634 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.36 -171.62 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.144 0.497 . . . . 0.0 111.631 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.85 -2.61 58.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.96 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.16 -13.22 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.955 0.407 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.711 ' CG ' ' CD1' ' A' ' 7' ' ' TYR . 42.9 t-80 -165.59 141.02 5.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -80.78 174.97 11.09 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.11 92.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.932 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -79.28 -32.25 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.719 0.295 . . . . 0.0 111.445 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -63.91 -26.67 68.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.447 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -59.31 -42.08 90.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 110.329 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.39 -43.42 67.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.771 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -76.99 -55.21 5.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.846 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.57 -41.92 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.003 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -59.65 -53.74 54.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.589 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -64.76 -28.65 69.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.48 HD12 ' CE1' ' A' ' 79' ' ' PHE . 2.0 tt -60.05 -59.8 4.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.397 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 mt -58.52 -40.29 82.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.433 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.4 m -60.44 -38.06 82.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.878 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -78.84 -30.28 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.627 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -70.13 -15.73 63.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.917 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 76.13 45.59 0.11 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.935 0.398 . . . . 0.0 111.0 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -144.01 137.62 14.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.023 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.6 Cg_endo -75.24 162.94 35.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.491 2.127 . . . . 0.0 111.117 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.404 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 53.9 p90 -161.72 171.03 18.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.38 125.4 19.86 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.36 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 1.4 t80 -90.74 124.97 35.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.361 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.453 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 8.0 mt -106.48 114.22 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.477 0.656 . . . . 0.0 110.526 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -82.52 144.62 30.28 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.383 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 2.6 pt -100.89 -12.7 8.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.666 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 19.1 ttm -124.81 107.76 28.64 Favored Pre-proline 0 C--N 1.334 -0.089 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 44' ' ' ASP . 95.6 Cg_endo -79.96 -28.05 3.46 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.353 2.035 . . . . 0.0 110.927 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.62 151.09 36.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.231 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -8.52 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.225 0.536 . . . . 0.0 111.99 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 -54.56 4.5 Favored Glycine 0 C--N 1.311 -0.86 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.126 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -150.87 134.16 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -56.99 170.14 0.46 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.449 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -87.1 106.19 17.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.658 0.266 . . . . 0.0 111.7 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.73 -27.48 59.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -59.03 -53.4 58.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.88 0.371 . . . . 0.0 110.581 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -40.66 75.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.03 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 44' ' ' ASP . 44.9 mm -58.13 -45.94 88.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.69 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.51 -56.58 11.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.296 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -60.62 -30.66 69.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.919 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -58.24 -53.26 60.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.572 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.6 mt -54.28 -46.58 72.76 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 111.204 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.8 m -63.86 -34.12 77.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.227 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.412 ' HE3' ' CG ' ' A' ' 69' ' ' PHE . 2.0 mmmt -65.77 -36.93 84.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.438 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.33 -42.98 96.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.489 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.75 -107.31 0.31 Allowed Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.751 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -150.55 26.78 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.074 0.464 . . . . 0.0 110.834 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -121.67 -153.71 0.56 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.31 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -120.88 161.18 21.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.477 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.401 ' NE2' ' HG ' ' A' ' 63' ' ' LEU . 7.8 pt20 -115.04 98.75 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 110.785 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.63 87.72 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.557 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.07 33.37 5.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.412 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' NE2' ' A' ' 60' ' ' GLN . 2.1 tm? -44.56 130.71 6.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.759 0.314 . . . . 0.0 110.904 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.6 m -112.33 148.3 34.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.082 0.467 . . . . 0.0 111.551 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -119.65 155.72 54.33 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.791 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.8 Cg_exo -80.53 137.55 40.78 Favored 'Cis proline' 0 C--N 1.344 0.327 0 C-N-CA 123.861 -1.308 . . . . 0.0 112.858 0.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.5 tp60 -99.78 118.32 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.172 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.3 t -93.44 161.53 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.328 0.585 . . . . 0.0 112.145 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 86.2 m-85 -143.2 152.31 41.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.99 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.445 ' CB ' HD11 ' A' ' 76' ' ' ILE . . . -65.47 143.56 98.72 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.78 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.587 ' HB3' ' N ' ' A' ' 1' ' ' MET . 21.8 Cg_exo -61.63 -17.48 54.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.354 2.036 . . . . 0.0 111.988 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -103.19 -25.91 13.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.862 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.48 86.21 0.49 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.697 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.58 118.97 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 110.823 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -55.53 131.79 47.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.3 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.445 HD11 ' CB ' ' A' ' 70' ' ' ALA . 2.0 mp -116.76 -31.94 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.62 -161.13 13.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.718 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -90.31 -147.99 19.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.028 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.48 ' CE1' HD12 ' A' ' 23' ' ' LEU . 46.5 t80 -69.54 -53.84 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.347 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -57.82 -49.51 76.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.758 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -64.73 -36.08 83.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 78' ' ' GLY . 1.4 tm? -66.02 -44.13 85.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.348 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HG2' HD12 ' A' ' 23' ' ' LEU . 3.2 mmm-85 -54.42 -37.92 65.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.38 -37.17 74.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -62.07 -35.44 78.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.127 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.509 ' CE1' ' HG2' ' A' ' 27' ' ' LYS . 8.2 m-85 -86.52 -26.76 24.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.217 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.1 mttt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.86 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.3 ttp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.843 0.354 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.469 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 94.7 m-85 -59.26 160.83 6.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.9 mppp? -135.72 118.08 15.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.198 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.526 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 19.4 t -108.53 141.13 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.183 0.515 . . . . 0.0 111.926 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.473 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 4.6 m-85 -121.68 105.34 10.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.249 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.38 -139.0 2.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.392 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.584 ' CE1' ' HE1' ' A' ' 37' ' ' MET . 38.7 m-85 -109.91 153.35 24.62 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.4 t70 -82.22 -2.63 53.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 2.3 p 81.82 -22.85 0.24 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.984 0.421 . . . . 0.0 110.921 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -75.71 -35.29 60.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.9 0.381 . . . . 0.0 111.124 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.7 ' O ' HG22 ' A' ' 11' ' ' ILE . 9.8 mm -104.6 -7.02 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -176.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.488 ' HD2' ' CE ' ' A' ' 37' ' ' MET . 1.3 t-80 -166.64 108.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -176.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -39.39 134.23 1.24 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.5 m -166.23 109.23 0.76 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.401 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 m -87.0 -29.71 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 110.732 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -58.12 -30.7 66.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.596 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.5 m -61.73 -55.0 34.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 110.059 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -53.56 -31.64 47.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.248 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.24 -59.68 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.19 -42.01 69.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.296 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -62.12 -57.79 10.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.471 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -57.0 -39.12 74.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.238 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tt -57.02 -54.2 49.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.197 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.5 mt -57.32 -45.49 84.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.616 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.5 m -58.27 -36.06 72.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.079 0.466 . . . . 0.0 109.977 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -79.82 -30.62 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.425 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -16.59 59.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.916 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt 72.53 57.32 0.14 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.93 0.395 . . . . 0.0 110.978 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -139.08 139.0 21.93 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.373 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' O ' ' HA ' ' A' ' 1' ' ' MET . 71.6 Cg_endo -80.14 140.12 13.82 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.56 2.174 . . . . 0.0 111.241 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.525 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 22.9 p90 -160.26 171.27 19.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -142.06 137.84 31.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.962 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.526 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 39.6 t80 -89.41 159.74 17.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.833 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.473 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 11.3 mt -143.68 119.11 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.279 0.561 . . . . 0.0 110.456 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -80.66 135.94 36.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.394 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pt -97.01 -17.38 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.421 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.605 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 4.4 ttp -131.41 90.37 38.02 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.482 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -71.17 -4.32 14.66 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.661 2.241 . . . . 0.0 113.207 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -139.65 144.11 37.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.068 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -68.09 -8.55 39.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.241 0.543 . . . . 0.0 111.945 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.91 -58.02 1.35 Allowed Glycine 0 C--N 1.313 -0.75 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.293 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.84 140.93 27.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -72.73 167.16 21.41 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.616 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -91.37 103.46 16.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.382 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.9 -24.65 16.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.696 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -56.53 -50.16 72.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.922 0.391 . . . . 0.0 111.006 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -75.93 -32.06 59.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.459 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.0 mm -65.0 -47.25 88.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.004 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.98 -55.99 18.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.027 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -56.73 -31.97 65.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.608 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 5' ' ' TYR . 15.4 tp -61.34 -58.41 8.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.189 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 72.5 mt -44.04 -40.92 5.12 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.301 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.1 m -70.22 -35.64 74.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.301 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' LEU . 5.0 tttp -60.2 -41.86 93.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.679 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.441 HD21 ' CE1' ' A' ' 75' ' ' HIS . 4.8 mp -58.64 -69.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.239 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.08 -35.08 0.31 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -102.8 -175.1 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.798 0.332 . . . . 0.0 111.009 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.73 -31.9 10.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.825 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -105.32 170.19 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -122.72 101.51 7.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.757 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -80.06 85.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.309 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.92 27.25 70.99 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.579 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -49.84 171.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 111.235 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.4 ' N ' HD21 ' A' ' 63' ' ' LEU . 6.9 p -143.29 156.67 44.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.1 0.476 . . . . 0.0 111.591 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 mtt -126.32 154.65 74.73 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.567 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 7.5 Cg_exo -75.52 150.34 94.47 Favored 'Cis proline' 0 C--N 1.344 0.308 0 C-N-CA 124.008 -1.247 . . . . 0.0 112.77 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -102.58 123.15 45.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.495 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -97.03 166.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.343 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.504 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 81.6 m-85 -142.47 140.98 32.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.071 0.462 . . . . 0.0 110.895 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.407 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -53.4 134.98 52.39 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.411 -178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.5 ' HB3' ' N ' ' A' ' 1' ' ' MET . 89.0 Cg_exo -45.92 -27.68 4.35 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.012 2.475 . . . . 0.0 112.074 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -165.43 38.8 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.153 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.56 -109.15 0.99 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.101 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.5 m -138.47 177.34 7.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.237 0.542 . . . . 0.0 111.335 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.441 ' CE1' HD21 ' A' ' 55' ' ' LEU . 17.9 t-80 -53.06 122.3 9.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.096 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 70' ' ' ALA . 4.4 mt -83.83 -43.64 17.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.988 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.04 -149.84 17.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.526 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.6 -159.25 31.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.209 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -60.92 -57.85 10.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.767 0.318 . . . . 0.0 110.704 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -54.01 -43.95 70.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -57.16 -32.81 66.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.625 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD21 ' CD2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -71.49 -47.47 55.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.655 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.28 -30.17 26.73 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -74.81 -33.65 62.25 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 82' ' ' LEU . 21.0 t80 -66.86 -32.43 73.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.392 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.424 ' CD2' HD21 ' A' ' 82' ' ' LEU . 7.1 m-85 -92.08 -70.31 0.7 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.336 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.87 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.697 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 12.4 tpp . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.429 0.157 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -39.85 120.92 1.2 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.511 0.672 . . . . 0.0 112.233 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -90.91 125.36 35.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.267 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 33' ' ' PHE . 22.7 t -109.55 110.24 31.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.01 0.433 . . . . 0.0 111.107 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 16.4 m-85 -89.64 99.26 12.3 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.3 -141.07 3.02 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.031 -1.081 . . . . 0.0 112.723 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.481 ' CE1' ' CD1' ' A' ' 36' ' ' ILE . 30.4 m-85 -127.11 149.2 50.05 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.747 0.308 . . . . 0.0 111.261 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -102.23 22.02 13.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.7 9.63 7.44 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.445 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -85.87 -50.7 6.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.782 0.325 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.8 mm -103.0 -32.04 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.638 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -140.62 154.83 46.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.277 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 166.73 22.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 p 174.0 95.08 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.671 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.7 -44.39 79.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.553 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -57.3 -29.37 63.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.233 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -56.74 11.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.02 -33.77 53.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.173 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 91.2 m-20 -69.92 -49.88 47.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.896 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -61.01 -32.59 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -60.61 -54.06 49.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -25.52 67.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tt -57.79 -55.23 37.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.324 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 mt -63.17 -35.1 79.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.567 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.3 m -68.72 -41.64 78.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.177 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -66.79 -31.99 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.523 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -84.65 -10.49 57.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.07 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 2.6 mtmt 68.54 53.36 0.56 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.969 0.414 . . . . 0.0 110.986 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.31 113.17 7.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.697 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 88.4 Cg_exo -45.72 174.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.643 2.229 . . . . 0.0 112.766 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -163.99 169.89 17.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.811 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.3 tm-20 -129.03 109.41 11.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.14 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.436 ' CE1' HG11 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -90.54 150.97 21.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.04 0.448 . . . . 0.0 111.461 -179.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.419 HG13 ' C ' ' A' ' 33' ' ' PHE . 30.2 mt -149.73 127.02 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.301 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -82.69 110.31 17.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.401 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.481 ' CD1' ' CE1' ' A' ' 7' ' ' TYR . 3.2 pt -73.46 -19.96 18.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.8 ttp -129.49 86.13 56.86 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.338 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.82 -3.05 13.34 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.663 2.242 . . . . 0.0 112.407 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 37' ' ' MET . 3.1 tt0 -139.89 136.46 33.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.43 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -7.86 12.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.222 0.534 . . . . 0.0 111.963 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.49 -63.48 1.56 Allowed Glycine 0 C--N 1.313 -0.747 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.409 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.14 140.47 26.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.66 0.267 . . . . 0.0 111.229 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -66.23 170.97 5.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.082 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.402 ' O ' HG12 ' A' ' 48' ' ' ILE . 1.3 t70 -83.2 95.23 8.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.958 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.39 -20.64 30.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.441 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.94 -60.62 3.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.022 0.439 . . . . 0.0 110.535 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -67.09 -40.3 86.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.302 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 48' ' ' ILE . 34.3 mm -59.83 -37.68 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.779 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.52 -51.91 67.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.06 -32.48 64.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.256 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.3 tt -60.64 -53.35 58.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -50.95 -42.23 59.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.017 0.437 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.0 m -59.48 -45.62 91.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.707 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -61.96 -32.52 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.75 -50.35 73.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.5 -19.24 2.43 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.119 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -148.14 -162.26 1.51 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 110.397 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -113.63 21.66 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.149 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -120.19 164.22 16.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.74 0.305 . . . . 0.0 110.965 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.4 102.59 6.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.729 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.9 pt -71.77 79.68 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.344 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.75 26.44 5.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.535 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' CD1' ' NE2' ' A' ' 67' ' ' GLN . 1.5 tp -56.6 169.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.338 . . . . 0.0 111.154 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.9 p -150.84 158.8 44.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -104.29 159.13 30.32 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.596 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.6 Cg_exo -80.01 145.69 73.0 Favored 'Cis proline' 0 C--N 1.344 0.31 0 C-N-CA 124.134 -1.194 . . . . 0.0 112.978 0.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.402 ' NE2' ' CD1' ' A' ' 63' ' ' LEU . 56.4 mm-40 -108.24 120.78 43.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.773 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -90.62 155.07 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.166 0.508 . . . . 0.0 111.927 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 75' ' ' HIS . 33.8 m-85 -143.16 137.76 29.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.635 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -47.88 156.46 0.71 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.717 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.24 -38.68 88.36 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.727 2.285 . . . . 0.0 112.037 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.47 -21.65 20.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.184 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.76 89.36 0.81 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.649 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.55 116.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.372 . . . . 0.0 110.624 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 2.1 t-160 -55.14 112.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.307 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' A' ' 70' ' ' ALA . 6.7 mt -98.53 -35.48 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.365 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.43 -151.92 20.07 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.233 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 82' ' ' LEU . . . -104.57 -141.05 10.74 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.118 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.443 ' HB3' ' CD2' ' A' ' 16' ' ' TYR . 13.0 t80 -73.63 -66.43 0.7 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 0.0 110.725 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -63.04 -42.68 99.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.948 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.43 -49.22 75.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.626 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.435 ' O ' ' HB3' ' A' ' 85' ' ' TYR . 3.0 tt -74.43 -38.82 62.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.88 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -49.64 -27.61 4.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.958 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.75 -35.33 72.6 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.724 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.48 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -64.8 -37.32 87.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.408 ' CD2' HD21 ' A' ' 82' ' ' LEU . 14.8 m-85 -86.55 -20.28 28.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.583 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.992 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.595 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 38.2 ttm . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -79.35 147.45 32.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.239 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.18 120.53 42.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.221 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 67' ' ' GLN . 53.6 t -112.35 123.71 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.32 0.581 . . . . 0.0 111.996 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.1 m-85 -99.98 99.53 10.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.967 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.07 -141.69 3.22 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.335 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -121.7 159.02 27.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.0 111.402 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.59 -67.93 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 166.28 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.556 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.25 -27.74 47.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.2 mp -91.11 -37.04 8.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.261 0.553 . . . . 0.0 110.654 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -155.1 142.05 19.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.199 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.75 146.39 31.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.295 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.98 107.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.816 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.4 m -71.74 -40.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.421 . . . . 0.0 110.577 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -51.82 -25.75 8.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.387 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -65.94 -62.85 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.125 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -57.01 -31.79 65.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.52 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -53.15 52.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.852 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.64 71.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.007 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -61.13 -35.75 77.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.083 0.468 . . . . 0.0 110.121 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -76.74 -27.62 55.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.604 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -57.35 -56.56 20.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.212 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.6 mt -63.04 -45.85 90.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.654 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 m -56.03 -35.44 66.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.366 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -75.99 -29.54 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.682 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 1.5 mmtm -76.11 -12.91 60.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.226 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 76.16 38.7 0.31 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.03 0.443 . . . . 0.0 110.796 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -129.74 139.76 36.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.697 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 1' ' ' MET . 93.5 Cg_endo -77.74 160.98 30.93 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.471 2.114 . . . . 0.0 111.619 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -161.47 170.89 19.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.413 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -136.89 125.11 23.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.898 0.38 . . . . 0.0 110.792 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.437 ' CE1' HG11 ' A' ' 4' ' ' VAL . 13.0 t80 -89.84 156.96 18.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.162 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.407 HG13 ' C ' ' A' ' 33' ' ' PHE . 18.4 mt -150.43 123.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.275 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -86.12 110.58 19.65 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.534 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -70.38 -14.19 17.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.311 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.597 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.9 ttp -126.38 89.57 51.94 Favored Pre-proline 0 N--CA 1.455 -0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 110.931 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.48 0.07 10.32 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.57 2.18 . . . . 0.0 112.239 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 37' ' ' MET . 38.4 tt0 -140.02 136.25 33.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.603 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -63.93 -8.05 10.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.169 0.509 . . . . 0.0 112.114 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.89 -63.07 1.7 Allowed Glycine 0 C--N 1.313 -0.728 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.079 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -147.49 149.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.673 0.273 . . . . 0.0 111.142 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -69.14 171.27 8.58 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.873 0.368 . . . . 0.0 111.588 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.408 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -95.98 110.97 23.1 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.158 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -64.4 -23.19 67.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.808 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -58.62 -52.6 65.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 110.797 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.09 -44.64 68.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.248 0.547 . . . . 0.0 109.736 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.434 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 16.0 mm -54.91 -40.64 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.693 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.48 -51.4 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.645 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -32.35 64.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.228 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.591 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.7 tt -60.99 -50.13 74.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.193 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -52.49 -43.49 65.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.565 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 m -54.5 -46.39 73.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.665 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' CB ' ' CE2' ' A' ' 69' ' ' PHE . 2.8 mtmm -63.31 -36.53 83.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.628 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mt -61.28 -52.66 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.723 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.6 -113.9 0.58 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.065 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -150.33 31.74 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.118 0.485 . . . . 0.0 110.509 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -121.01 -146.52 0.38 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.276 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -117.19 170.13 8.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.694 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -73.26 98.26 2.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.181 0.515 . . . . 0.0 110.455 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.402 ' CD1' ' O ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -79.9 79.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.148 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.68 21.71 71.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.472 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.79 131.69 51.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.962 0.41 . . . . 0.0 110.804 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -123.61 163.65 20.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.356 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.4 mtm -107.98 152.25 41.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.55 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.7 Cg_endo -83.0 137.9 32.8 Favored 'Cis proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.968 -1.263 . . . . 0.0 112.883 0.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.453 ' NE2' ' CD2' ' A' ' 75' ' ' HIS . 48.0 tp60 -96.29 138.59 33.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.861 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.6 t -109.78 154.91 11.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.051 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.434 ' CE2' ' CB ' ' A' ' 54' ' ' LYS . 48.0 m-85 -143.39 143.21 31.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.547 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.434 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.58 155.21 14.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.264 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.595 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -72.47 -16.11 27.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.87 2.38 . . . . 0.0 112.097 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -104.72 -7.85 19.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.095 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.07 89.82 1.95 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.512 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -175.93 156.85 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.762 0.315 . . . . 0.0 111.093 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.453 ' CD2' ' NE2' ' A' ' 67' ' ' GLN . 7.4 t-160 -90.23 126.51 35.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.845 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.434 HD11 ' HA ' ' A' ' 70' ' ' ALA . 16.7 mt -113.8 -45.82 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.257 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 124.22 -151.58 17.19 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.91 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -99.14 -129.43 6.55 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.439 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.527 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -80.88 -70.35 0.54 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.713 0.256 . . . . 0.0 110.69 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -52.17 -46.9 65.7 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.235 0.54 . . . . 0.0 110.221 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.427 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -58.88 -41.41 87.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.615 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' GLY . 2.3 tt -74.54 -35.99 63.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.384 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.4 ttt180 -52.03 -32.84 35.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -34.42 74.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.291 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' LEU . 43.3 t80 -65.95 -32.05 73.32 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.447 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.451 ' CD1' ' HD2' ' A' ' 27' ' ' LYS . 24.9 m-85 -97.84 -9.11 26.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.67 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 83' ' ' ARG . 3.5 mtpm? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.885 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.741 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.519 0.199 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 66.0 m-85 -39.78 110.06 0.13 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.985 0.898 . . . . 0.0 111.667 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.819 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -89.74 127.0 35.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.95 -1.477 . . . . 0.0 111.281 -179.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.457 HG12 ' CE1' ' A' ' 33' ' ' PHE . 25.3 t -106.43 112.25 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.01 0.433 . . . . 0.0 111.296 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 11.2 m-85 -89.79 99.01 12.1 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.27 -143.12 3.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.537 ' CD2' ' CB ' ' A' ' 12' ' ' HIS . 31.2 m-85 -117.68 143.46 46.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.84 0.352 . . . . 0.0 111.578 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.91 -76.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.522 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 170.32 -34.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 110.606 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -81.36 -27.94 34.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.46 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.83 -45.24 15.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.353 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.633 ' CD2' ' HE3' ' A' ' 37' ' ' MET . 18.7 t-80 -143.93 159.62 42.25 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -80.24 149.91 30.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.539 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.4 p -157.27 93.52 1.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.149 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.5 m -82.01 -31.77 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.214 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -28.12 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.153 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 t -63.52 -45.3 91.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.038 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.76 -36.01 34.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.145 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -70.54 -56.88 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.669 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -57.31 -28.94 63.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.926 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -64.82 -44.3 90.29 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -63.28 -36.13 82.66 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' HG ' HD21 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -59.05 -61.85 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.346 178.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.569 HD21 ' HG ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -61.03 -53.39 57.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.93 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.5 m -52.63 -37.43 58.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.859 0.362 . . . . 0.0 111.235 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.78 -17.81 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.778 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -89.0 -30.34 18.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.557 0.218 . . . . 0.0 111.527 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.32 67.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.498 HE22 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -150.15 129.9 6.6 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.536 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.741 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 75.8 Cg_exo -49.75 167.41 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.327 1.351 . . . . 0.0 110.706 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -165.15 160.48 18.71 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.792 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 19.2 mt-10 -124.78 122.3 37.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 111.054 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.457 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.5 t80 -103.93 143.15 33.24 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.045 0.45 . . . . 0.0 110.954 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.404 HG13 ' C ' ' A' ' 33' ' ' PHE . 18.1 mt -144.32 127.69 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.224 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -82.43 121.55 26.88 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.863 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.471 ' HB ' HD12 ' A' ' 48' ' ' ILE . 2.6 pt -77.56 -15.49 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.996 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.633 ' HE3' ' CD2' ' A' ' 12' ' ' HIS . 33.0 ttm -125.01 79.53 65.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.769 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 60.4 Cg_endo -72.97 -5.34 17.04 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.753 2.302 . . . . 0.0 112.418 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.54 136.6 34.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.182 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -63.01 -8.84 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.183 0.515 . . . . 0.0 111.884 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.94 -61.19 2.16 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.542 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.1 t -150.29 155.58 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 111.485 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -62.41 166.67 4.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.615 179.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 3.4 t70 -83.33 123.93 30.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.959 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -78.04 -27.98 48.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.232 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.22 -59.77 3.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 110.862 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -62.71 -46.55 87.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.471 HD12 ' HB ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -59.94 -31.07 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.635 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.99 -47.22 84.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -36.9 80.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.46 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.3 tt -58.4 -50.03 75.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.159 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 52' ' ' LEU . 81.7 mt -51.88 -45.12 64.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.353 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.4 m -57.3 -46.76 82.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.612 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -60.9 -39.0 87.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.679 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.89 -62.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.83 -116.58 0.47 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.967 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -150.58 26.87 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.941 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -121.58 -149.28 0.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.297 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 t -120.58 166.61 13.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.526 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -115.95 98.87 6.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.92 0.39 . . . . 0.0 110.808 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.7 tp -81.45 85.57 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.463 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.54 30.45 7.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.497 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -47.15 135.65 9.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.799 0.333 . . . . 0.0 110.785 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.6 p -107.93 146.37 32.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.264 0.554 . . . . 0.0 111.854 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -122.01 159.36 51.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.474 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_exo -78.96 151.87 88.28 Favored 'Cis proline' 0 C--N 1.343 0.258 0 C-N-CA 124.211 -1.162 . . . . 0.0 112.679 0.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -113.58 116.39 29.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.842 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.819 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -88.7 154.41 3.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.103 0.478 . . . . 0.0 112.158 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 2' ' ' PHE . 35.7 m-85 -142.61 139.16 31.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.546 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -57.14 144.22 70.18 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.048 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -34.88 -35.31 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.74 2.96 . . . . 0.0 112.685 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.43 33.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.198 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.54 -105.1 2.66 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.644 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 m -137.93 179.45 6.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.031 0.443 . . . . 0.0 110.869 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -63.76 125.08 23.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.941 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.6 mp -97.74 -28.4 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.524 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 120.89 -160.07 15.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.012 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.14 -131.77 7.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.587 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 9.6 t80 -76.49 -70.65 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.705 0.288 . . . . 0.0 111.032 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -57.4 -48.22 79.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.386 . . . . 0.0 110.648 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.411 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -54.53 -46.12 73.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.476 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.436 HD22 ' CE2' ' A' ' 86' ' ' PHE . 2.3 tt -66.94 -38.9 87.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.016 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -51.73 -29.94 20.5 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -72.19 -34.94 68.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.203 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 82' ' ' LEU . 59.2 t80 -64.76 -32.48 74.18 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.313 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.436 ' CE2' HD22 ' A' ' 82' ' ' LEU . 27.3 m-85 -95.77 -12.11 25.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.582 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.888 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.581 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 33.6 ttm . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -77.08 145.32 37.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.118 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.0 mptt -106.83 119.17 38.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.618 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.44 HG12 ' CE1' ' A' ' 33' ' ' PHE . 17.1 t -102.94 121.5 54.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.221 0.534 . . . . 0.0 111.122 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.6 m-30 -98.87 99.36 10.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.882 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.29 -135.65 1.86 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.972 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.656 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 57.1 m-85 -125.86 146.77 49.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.735 0.302 . . . . 0.0 111.076 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.459 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -137.52 51.86 1.91 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.967 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 t -167.88 -173.22 2.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.308 0.575 . . . . 0.0 112.011 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -86.58 4.65 39.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.757 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.6 mm -86.86 -13.44 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.539 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.656 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 9.6 t-80 -163.08 122.68 2.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.664 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 168.68 7.98 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.54 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 174.7 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.662 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.33 -41.88 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.702 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -60.89 -18.94 59.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.574 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.8 -58.43 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.4 . . . . 0.0 110.565 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -50.66 -40.9 54.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.049 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -64.1 -46.83 82.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.397 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -63.87 -49.91 70.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.381 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 10.5 ttmt -50.47 -34.54 25.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.895 0.378 . . . . 0.0 110.586 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -66.74 -40.5 88.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.413 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.421 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.56 -55.62 32.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.235 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 6.4 mt -55.24 -45.17 76.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.61 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.7 m -57.3 -37.31 72.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.842 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.19 -34.21 18.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.505 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -17.96 62.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.852 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.47 53.2 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -140.03 136.13 16.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.195 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.6 Cg_endo -81.24 162.57 20.03 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.625 2.217 . . . . 0.0 110.761 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.4 p90 -161.34 171.1 18.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 111.981 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -136.2 134.16 37.88 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.568 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 10.9 t80 -89.69 158.74 17.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.534 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.439 HD11 ' CE1' ' A' ' 5' ' ' TYR . 15.4 mt -148.31 121.96 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.385 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -86.05 133.34 33.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.052 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.441 HD13 ' OH ' ' A' ' 7' ' ' TYR . 20.8 pt -98.77 2.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.362 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.565 ' HE1' ' HE2' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -145.1 90.82 6.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.676 0.274 . . . . 0.0 110.434 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 44.8 Cg_endo -68.48 -26.42 34.4 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.698 2.265 . . . . 0.0 112.31 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -139.52 146.68 40.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.993 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -62.09 -8.8 5.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.295 0.569 . . . . 0.0 111.73 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.2 -53.47 6.13 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.522 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.7 t -151.36 146.87 15.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.413 ' HB3' HD12 ' A' ' 48' ' ' ILE . 46.6 m-85 -57.43 169.55 0.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.399 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -81.56 98.04 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.614 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -57.77 -21.05 39.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.31 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.13 -57.2 6.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.18 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 7.2 mmtp -72.3 -50.77 24.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.662 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.428 HD12 ' HB ' ' A' ' 36' ' ' ILE . 1.6 mp -49.91 -35.72 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.43 -61.39 2.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.037 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 2.4 pt-20 -63.33 -25.47 68.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.465 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.3 tt -57.27 -54.36 47.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.961 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.4 mt -55.81 -49.48 73.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.08 0.467 . . . . 0.0 110.917 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.8 m -60.13 -36.08 76.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.321 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -71.02 -36.01 72.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.959 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.46 -41.6 90.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.026 0.441 . . . . 0.0 110.501 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.31 -164.58 31.54 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.853 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -94.39 31.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -121.11 -150.81 0.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.247 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 t -120.87 170.3 9.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.734 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.4 98.46 11.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.127 0.489 . . . . 0.0 110.254 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 tp -80.28 86.9 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.497 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.54 29.89 61.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.512 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.72 134.86 4.13 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.813 0.339 . . . . 0.0 111.044 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.22 170.11 8.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.224 0.535 . . . . 0.0 111.793 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.8 mmt -124.9 154.81 70.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.572 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -80.64 145.12 69.36 Favored 'Cis proline' 0 C--N 1.343 0.284 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.73 0.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.444 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 0.7 OUTLIER -111.58 117.66 33.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.915 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.3 t -89.86 161.45 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.255 0.55 . . . . 0.0 111.878 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -142.51 143.91 32.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.407 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' N ' ' A' ' 74' ' ' SER . . . -56.42 131.57 76.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.447 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.569 ' HB3' ' N ' ' A' ' 1' ' ' MET . 32.3 Cg_exo -52.71 -24.02 22.0 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.63 2.22 . . . . 0.0 112.091 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.06 38.38 0.18 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.349 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.8 -109.29 0.78 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.705 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.401 ' N ' ' HB2' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -140.8 -178.45 5.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.14 0.495 . . . . 0.0 111.142 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.444 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 17.2 t-80 -56.9 128.19 35.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.074 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.6 mt -100.21 -44.74 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.901 0.381 . . . . 0.0 110.777 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.13 -153.31 19.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.827 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.38 -138.85 8.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.119 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -75.43 -70.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.829 0.315 . . . . 0.0 110.642 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -47.36 -41.26 19.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.256 0.551 . . . . 0.0 110.323 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -39.58 94.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.412 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -75.03 -41.38 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.714 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -51.35 -33.48 29.79 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -68.6 -35.11 76.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.4 t80 -63.93 -34.12 77.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.562 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.451 ' CD2' HD22 ' A' ' 82' ' ' LEU . 6.7 m-85 -88.9 -70.52 0.64 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.296 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.9 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.566 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.0 ttm . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.818 0.342 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.453 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 70.0 m-85 -63.22 157.02 23.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.03 0.443 . . . . 0.0 110.687 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.735 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.95 119.28 20.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.965 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.502 HG11 ' CE1' ' A' ' 33' ' ' PHE . 12.4 t -105.06 132.18 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.551 . . . . 0.0 112.038 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.4 m-85 -108.46 99.61 8.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.349 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.66 -141.55 3.16 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.327 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -118.74 151.68 37.56 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.845 0.355 . . . . 0.0 110.928 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.84 -75.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.072 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 t 170.99 -41.98 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.525 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -76.47 -26.3 55.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.862 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 mp -89.96 -41.3 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.978 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -149.76 149.56 30.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.049 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 143.27 48.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.54 102.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.002 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 m -87.02 -19.47 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.378 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -75.67 -20.35 58.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.595 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 p -71.18 -44.08 66.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.673 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.17 -41.45 99.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -59.67 -51.05 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.789 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 -28.82 69.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.035 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -43.29 99.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.288 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -27.68 65.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.711 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.501 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -57.55 -57.14 13.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.414 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.1 mt -60.25 -40.01 88.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.658 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 m -60.5 -31.39 70.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.092 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -73.76 -27.51 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.915 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -83.11 -17.64 42.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.322 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 74.09 55.57 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.939 0.4 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -137.26 145.17 48.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.764 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.423 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.1 Cg_endo -77.33 139.2 18.42 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.428 2.085 . . . . 0.0 111.587 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 14.6 p90 -153.12 170.5 20.35 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -143.99 146.44 32.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.978 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.502 ' CE1' HG11 ' A' ' 4' ' ' VAL . 11.0 t80 -89.24 156.62 18.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.024 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.463 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 9.4 mt -143.3 118.58 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.242 0.544 . . . . 0.0 110.387 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -94.63 129.5 41.47 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.119 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.8 pt -86.81 -17.98 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.732 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.7 ttp -122.61 92.56 48.99 Favored Pre-proline 0 N--CA 1.454 -0.243 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.3 -15.45 28.29 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.681 2.254 . . . . 0.0 112.722 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -139.64 142.9 36.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.838 0.352 . . . . 0.0 110.85 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -65.58 -8.58 20.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.272 0.558 . . . . 0.0 111.851 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.94 -60.4 2.17 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.082 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 t -150.17 127.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.329 . . . . 0.0 110.837 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.56 170.43 1.05 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.446 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.11 96.56 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.124 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.77 -28.82 37.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.213 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -52.58 -44.62 66.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.927 0.394 . . . . 0.0 110.812 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -31.03 39.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.227 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.4 mm -63.31 -43.77 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.601 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.91 -55.76 11.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.078 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.58 -31.09 61.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.91 0.386 . . . . 0.0 110.389 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' A' ' 5' ' ' TYR . 12.8 tp -59.22 -59.12 5.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.08 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.445 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 71.1 mt -44.53 -44.08 8.43 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.303 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.9 m -69.68 -30.96 68.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.588 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 51' ' ' LEU . 5.1 tttp -65.39 -40.8 93.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.887 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.45 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 4.7 mp -59.34 -56.72 18.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.956 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.61 -110.5 0.27 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.165 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.33 31.32 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.04 0.448 . . . . 0.0 110.774 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -121.01 -148.53 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.288 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 t -120.34 170.26 9.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -92.01 98.8 11.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.201 0.525 . . . . 0.0 110.432 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.74 85.08 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.264 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.21 27.34 46.12 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.52 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.407 ' CD1' ' NE2' ' A' ' 67' ' ' GLN . 1.4 mm? -52.72 148.55 7.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.849 0.356 . . . . 0.0 110.993 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.1 p -121.68 170.15 10.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.146 0.498 . . . . 0.0 111.528 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.08 158.92 39.7 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.9 Cg_endo -85.81 151.44 49.84 Favored 'Cis proline' 0 N--CA 1.461 -0.406 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.898 0.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 5' ' ' TYR . 12.0 mm100 -111.71 117.9 34.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.223 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.735 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -91.28 166.31 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 0.0 111.837 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 64.1 m-85 -141.94 143.78 33.42 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.191 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -53.84 152.4 10.13 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.524 ' HB3' ' N ' ' A' ' 1' ' ' MET . 43.3 Cg_exo -59.3 -28.72 88.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.171 2.581 . . . . 0.0 112.54 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.85 -21.0 18.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.66 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.7 84.5 0.65 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.89 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.14 162.72 15.41 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -90.54 129.6 36.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.72 0.295 . . . . 0.0 110.971 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.4 mp -115.57 -43.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.789 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.14 -155.94 15.89 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.107 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.52 -134.1 7.33 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.535 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.501 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.71 -70.11 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.845 -0.209 . . . . 0.0 111.05 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -48.9 -44.63 40.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.176 0.512 . . . . 0.0 110.602 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -63.66 -44.77 92.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.885 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 85' ' ' TYR . 0.9 OUTLIER -69.88 -43.7 71.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.76 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 87' ' ' LYS . 6.2 ttp180 -51.56 -31.57 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -72.82 -32.63 65.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.333 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.446 ' CD2' HG12 ' A' ' 76' ' ' ILE . 54.0 t80 -68.6 -32.24 71.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.648 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.504 ' CD1' ' HG2' ' A' ' 27' ' ' LYS . 20.1 m-85 -96.61 -70.74 0.7 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.528 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.773 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.822 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 28.1 tpp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 110.502 -0.185 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.426 ' H ' ' HG3' ' A' ' 1' ' ' MET . 96.9 m-85 -43.13 137.57 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.805 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -115.48 120.51 39.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.978 -179.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.529 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 53.4 t -107.82 121.25 60.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.245 0.545 . . . . 0.0 111.845 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 20.0 m-85 -100.14 101.51 12.57 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.289 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.24 -139.01 2.54 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.521 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.637 ' CE1' ' CD2' ' A' ' 12' ' ' HIS . 64.2 m-85 -118.31 159.98 22.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.974 0.416 . . . . 0.0 111.478 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -96.84 -73.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.03 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m 170.64 -42.08 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.307 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -69.88 -32.44 70.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.189 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.4 mm -100.18 -32.86 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.637 ' CD2' ' CE1' ' A' ' 7' ' ' TYR . 1.4 t-80 -157.33 122.14 4.44 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 148.5 51.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.98 118.89 1.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.297 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 m -84.78 -36.79 11.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.906 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.23 -29.23 69.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.252 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.7 t -56.27 -49.38 74.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.274 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -56.64 -34.57 67.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.342 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 38.4 m-80 -72.74 -51.21 20.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 111.021 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -55.06 -45.32 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.125 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -64.99 -40.74 95.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.323 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 -62.54 -37.02 84.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.313 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' CD2' ' CD2' ' A' ' 24' ' ' LEU . 1.8 tt -57.57 -56.86 16.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.073 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.515 ' CD2' ' CE2' ' A' ' 86' ' ' PHE . 59.5 mt -62.76 -30.36 71.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.354 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.4 m -71.19 -36.43 71.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.201 0.524 . . . . 0.0 109.629 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.78 -48.61 29.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.513 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.15 -19.9 62.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.788 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt 71.33 55.04 0.21 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.944 0.402 . . . . 0.0 110.634 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -139.9 122.68 10.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.822 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 5.0 Cg_endo -48.53 159.33 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.602 2.201 . . . . 0.0 112.732 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.569 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 35.0 p90 -163.44 170.73 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.884 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.8 tt0 -141.04 115.34 9.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.645 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.529 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 36.3 t80 -89.03 154.36 20.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.833 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 mt -148.13 122.07 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.484 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -75.05 113.15 12.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.577 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.475 HD11 ' CE1' ' A' ' 7' ' ' TYR . 2.2 pp -64.7 -29.37 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.775 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.1 ttp -118.61 92.25 43.62 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.733 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HG3' ' HB2' ' A' ' 44' ' ' ASP . 88.0 Cg_endo -79.73 3.69 7.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.695 2.263 . . . . 0.0 112.957 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -139.2 144.16 38.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.488 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -66.89 -8.11 26.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.206 0.527 . . . . 0.0 111.574 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.69 -66.8 0.79 Allowed Glycine 0 C--N 1.315 -0.633 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.293 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.32 136.58 58.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 1.1 p90 -66.4 170.97 5.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.729 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.423 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 7.5 t0 -77.85 124.58 28.16 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.244 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -80.07 -28.74 39.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.536 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -63.89 -56.72 13.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.328 . . . . 0.0 111.171 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -67.0 -38.15 85.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.41 ' N ' ' CD1' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -71.57 -25.72 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.704 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.62 -48.55 63.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.972 0.415 . . . . 0.0 110.578 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.17 -34.71 76.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.233 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.5 tt -58.16 -50.79 72.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.397 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.1 mt -54.15 -45.85 72.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.139 0.495 . . . . 0.0 111.404 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.9 m -61.2 -42.27 98.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.436 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -31.5 72.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.733 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.421 ' CD1' ' CD1' ' A' ' 63' ' ' LEU . 2.1 mt -62.43 -32.07 72.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.017 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.93 -26.57 8.76 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.234 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -124.11 -165.45 1.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.695 0.283 . . . . 0.0 110.647 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -103.82 -30.52 10.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.018 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -92.58 170.25 9.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -112.54 99.94 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.701 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.434 HD12 HG21 ' A' ' 61' ' ' ILE . 31.4 mt -66.6 82.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.375 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.88 25.04 36.0 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.643 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.421 ' CD1' ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.11 155.7 16.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.923 0.392 . . . . 0.0 111.65 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -144.59 170.15 16.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.274 0.559 . . . . 0.0 112.058 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.2 mtt -115.82 154.94 48.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.568 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.6 Cg_exo -76.97 142.34 72.29 Favored 'Cis proline' 0 C--N 1.344 0.312 0 C-N-CA 123.846 -1.314 . . . . 0.0 112.644 0.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.68 116.91 33.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.938 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.3 t -92.12 152.7 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.193 0.52 . . . . 0.0 111.62 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -143.57 139.88 29.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.564 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.27 165.17 1.15 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.684 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.11 -24.61 77.42 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.777 2.318 . . . . 0.0 111.918 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.24 -26.06 19.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.268 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.65 -6.56 5.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.101 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.35 154.57 23.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.876 0.338 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -90.42 118.52 29.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.331 . . . . 0.0 110.962 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -97.06 -48.46 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.41 -156.86 22.63 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.777 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.41 -141.45 10.91 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.839 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 25.8 t80 -67.79 -70.46 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 0.0 111.019 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.49 -47.42 84.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.088 0.471 . . . . 0.0 110.593 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -51.4 -37.18 46.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 85' ' ' TYR . 4.3 tt -74.12 -35.99 64.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.18 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.18 -31.25 30.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.78 -31.8 71.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.495 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 14.1 t80 -71.05 -27.96 64.02 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.836 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 24' ' ' LEU . 29.7 m-85 -99.92 -13.45 19.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.088 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.04 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.707 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 18.7 tpp . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.412 0.149 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -39.7 127.59 2.0 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.667 0.746 . . . . 0.0 112.118 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -94.56 123.81 38.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.344 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 67' ' ' GLN . 24.6 t -111.96 114.64 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.379 . . . . 0.0 111.579 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 13.9 m-85 -93.27 99.9 12.36 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.19 -136.58 2.13 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.613 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -125.75 160.33 30.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.898 0.38 . . . . 0.0 111.895 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 9' ' ' SER . 5.3 m-20 -88.96 -68.12 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.645 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.7 OUTLIER 162.08 -29.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -76.61 -39.32 52.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.444 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 HG21 ' N ' ' A' ' 40' ' ' LYS . 7.5 mm -89.84 -46.25 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.582 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -140.66 149.79 42.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -77.38 161.46 28.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.735 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 p -176.89 98.18 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.221 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 m -77.76 -33.43 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.052 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -66.67 -28.12 68.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.051 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.6 t -62.66 -46.79 86.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 110.466 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -59.37 -31.08 68.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.051 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.25 -53.49 14.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.954 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.39 -49.06 70.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 110.943 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 1.5 ttmm -60.01 -50.02 75.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.627 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -42.69 95.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.246 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.08 -54.13 50.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.05 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.423 HD21 ' CZ ' ' A' ' 86' ' ' PHE . 8.8 mt -56.84 -42.69 80.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.518 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -59.16 -38.13 78.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.68 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.9 t -76.46 -34.09 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.48 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -9.83 58.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.866 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.13 51.69 1.62 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.002 0.429 . . . . 0.0 110.45 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -142.63 113.92 6.05 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.386 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.707 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 89.3 Cg_exo -49.25 178.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.386 2.057 . . . . 0.0 111.973 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 3.9 p90 -163.94 170.54 16.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.958 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 14.4 tp10 -134.44 112.38 10.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.471 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.483 ' CE1' HG13 ' A' ' 4' ' ' VAL . 7.0 t80 -89.1 155.96 19.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.292 0.567 . . . . 0.0 111.733 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.421 HD13 ' CE1' ' A' ' 5' ' ' TYR . 45.3 mt -150.26 125.5 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.814 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -88.65 126.12 35.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.035 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.6 18.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.965 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.441 ' HE3' ' CE2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -157.78 90.69 2.3 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.52 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 37.5 Cg_endo -66.07 -23.31 53.64 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.571 2.181 . . . . 0.0 112.021 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 37' ' ' MET . 2.7 mm-40 -139.56 143.93 37.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.148 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.407 ' N ' HG21 ' A' ' 11' ' ' ILE . 8.2 ttpt -64.33 -7.99 11.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.29 0.567 . . . . 0.0 111.866 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.72 -37.87 12.91 Favored Glycine 0 C--N 1.313 -0.731 0 CA-C-N 115.227 -0.897 . . . . 0.0 113.201 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -150.24 151.71 12.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.3 0.572 . . . . 0.0 112.157 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CE2' ' HE3' ' A' ' 37' ' ' MET . 46.1 m-85 -75.27 169.01 18.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.313 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.462 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 2.8 t0 -94.88 103.36 15.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.753 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 49' ' ' ALA . 5.5 t0 -69.7 -21.58 63.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.936 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -67.46 -57.19 6.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.108 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -69.95 -36.08 74.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.527 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.4 mt -70.89 -26.37 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.412 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 45' ' ' ASP . . . -68.01 -55.5 12.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.305 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.4 -36.06 73.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.828 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.41 HD13 ' CE2' ' A' ' 69' ' ' PHE . 6.7 tp -56.27 -50.42 71.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.528 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.0 mt -53.36 -47.08 69.73 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.376 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.2 m -63.65 -39.39 94.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.425 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -59.22 -37.31 77.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.498 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.17 -56.43 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.552 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.58 -110.4 0.3 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.982 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -150.44 31.39 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.977 0.418 . . . . 0.0 110.68 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -120.96 -145.87 0.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.416 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.1 t -115.27 170.45 8.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.749 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 98.27 1.2 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.39 0.614 . . . . 0.0 110.452 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.04 84.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.254 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.93 26.45 58.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.432 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -56.04 132.54 50.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -126.03 153.47 44.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.274 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.82 155.55 36.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.636 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.7 Cg_exo -82.79 136.9 30.69 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 124.04 -1.233 . . . . 0.0 112.796 0.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 3.4 mm100 -92.67 148.36 22.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -122.24 149.82 25.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.172 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.41 ' CE2' HD13 ' A' ' 51' ' ' LEU . 53.1 m-85 -142.27 137.43 30.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.36 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.435 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -46.9 164.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.931 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.99 -19.82 57.43 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.797 2.331 . . . . 0.0 112.071 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.84 -19.71 13.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.432 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.06 -19.38 3.9 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.09 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.41 ' N ' ' HB1' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -56.69 109.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.876 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -54.65 134.74 47.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.447 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 70' ' ' ALA . 7.2 mt -115.9 -39.1 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.557 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.74 -153.69 20.37 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.702 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -94.24 -136.17 8.1 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.946 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -82.85 -55.02 4.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.578 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -57.31 -49.94 74.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.619 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -41.06 98.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.443 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 85' ' ' TYR . 0.7 OUTLIER -61.65 -53.53 54.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.62 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -49.73 -39.2 36.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.87 0.367 . . . . 0.0 110.13 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -67.93 -37.95 82.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 82' ' ' LEU . 14.0 t80 -61.43 -34.5 75.52 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.576 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.452 ' CD2' HD21 ' A' ' 82' ' ' LEU . 12.1 m-85 -78.59 -62.44 1.69 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.003 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.674 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 34.2 ttp . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.743 0.306 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 84.7 m-85 -80.33 154.77 27.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.419 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -137.78 123.96 20.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.107 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.487 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 53.9 t -108.04 141.59 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.222 0.534 . . . . 0.0 111.592 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.455 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 4.8 m-85 -123.35 100.54 6.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.41 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.44 -139.12 2.58 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.39 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -110.58 160.05 17.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.776 0.322 . . . . 0.0 110.902 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -79.1 -78.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.703 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 t 166.43 -35.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.689 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.42 -22.6 28.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.196 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.473 HG21 ' N ' ' A' ' 40' ' ' LYS . 35.4 mm -91.79 -42.26 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -142.0 151.49 42.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.035 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -72.01 156.31 39.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.928 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 169.69 106.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.829 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -90.57 -32.15 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.377 . . . . 0.0 111.533 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.79 -31.73 71.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.649 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 p -62.23 -43.58 98.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -55.27 -33.38 63.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -73.76 -52.87 11.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.02 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.39 63.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.888 0.375 . . . . 0.0 111.029 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -60.9 -55.33 34.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.503 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -60.67 -29.32 69.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.733 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 79' ' ' PHE . 3.4 tt -55.97 -53.55 55.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.592 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -69.07 -41.48 77.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 m -61.4 -37.13 82.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.082 0.468 . . . . 0.0 110.151 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.4 t -77.63 -32.33 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.654 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -71.26 -15.78 62.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.218 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? 73.91 54.52 0.1 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 111.221 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -138.47 141.92 32.97 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.81 137.32 19.83 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.454 2.103 . . . . 0.0 111.623 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.674 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 4.6 p90 -154.56 168.48 26.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.073 0.463 . . . . 0.0 112.216 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -141.62 137.55 31.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.5 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.487 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 40.9 t80 -89.39 156.71 18.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.455 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 14.1 mt -142.15 117.38 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.349 0.595 . . . . 0.0 110.419 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -100.11 130.39 46.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.018 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.401 ' HB ' HG13 ' A' ' 48' ' ' ILE . 32.5 pt -97.6 28.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.024 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 18.0 ttm -155.55 98.55 2.3 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.909 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 60.2 Cg_endo -71.32 -27.93 18.91 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.371 2.047 . . . . 0.0 112.098 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -139.68 156.01 47.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.994 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' N ' HG21 ' A' ' 11' ' ' ILE . 1.4 ttmp? -70.81 -7.74 47.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.269 0.557 . . . . 0.0 111.675 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.99 -25.29 8.5 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.487 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 t -142.74 127.01 15.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.289 0.566 . . . . 0.0 112.453 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -71.83 164.11 26.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.215 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -93.08 94.66 8.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.194 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.92 -27.86 68.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.601 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.95 -54.15 48.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.695 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -69.84 -34.3 73.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.068 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.401 HG13 ' HB ' ' A' ' 36' ' ' ILE . 43.8 mt -65.97 -39.66 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.39 -56.35 10.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.175 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.48 -35.43 72.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.835 0.35 . . . . 0.0 110.796 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.92 -50.49 72.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.558 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -53.39 -48.11 68.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.01 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.4 m -64.0 -35.38 80.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.031 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -38.19 90.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.131 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.11 -53.62 46.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.521 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.66 -109.95 0.33 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.045 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.63 30.83 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.942 0.401 . . . . 0.0 110.812 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -121.13 -149.2 0.42 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.463 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 t -120.49 170.47 9.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.583 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -82.6 98.2 8.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.188 0.518 . . . . 0.0 110.34 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 pt -80.36 84.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.28 25.6 57.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.499 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.79 157.92 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 p -130.71 170.34 14.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 0.0 111.666 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -120.48 154.8 56.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.588 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.99 152.34 81.01 Favored 'Cis proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.908 -1.288 . . . . 0.0 112.803 0.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 5' ' ' TYR . 10.0 mt-30 -109.08 113.01 25.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.181 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.746 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -90.79 166.34 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.409 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.484 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 70.1 m-85 -141.73 139.61 32.91 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.031 0.443 . . . . 0.0 110.628 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -61.42 156.77 50.13 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.496 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.479 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 51.9 Cg_exo -55.73 -31.75 81.39 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.15 2.567 . . . . 0.0 112.185 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -78.93 -35.54 43.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.22 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.6 41.27 0.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.821 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.7 m -120.65 169.12 10.68 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -90.16 117.56 29.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.776 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 70' ' ' ALA . 27.9 mt -90.35 -49.37 13.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.986 0.422 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.43 -151.47 19.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.619 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.69 -149.28 25.46 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.595 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 23' ' ' LEU . 18.2 t80 -64.75 -70.16 0.25 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.756 0.313 . . . . 0.0 110.775 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -56.55 -46.52 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.523 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.33 -35.81 68.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.272 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.438 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.4 tt -76.74 -37.03 56.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.287 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -52.38 -31.6 34.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -70.66 -33.66 71.19 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.166 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 82' ' ' LEU . 40.1 t80 -67.13 -27.42 67.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.604 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CE2' HD21 ' A' ' 82' ' ' LEU . 23.9 m-85 -99.29 -17.63 17.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.922 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.5 mttm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.809 -179.712 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.71 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 21.7 tpp . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.35 0.119 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -39.5 119.01 0.89 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.862 0.839 . . . . 0.0 112.069 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -89.38 126.5 35.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.296 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.481 HG11 ' CE1' ' A' ' 33' ' ' PHE . 11.5 t -115.93 133.94 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.142 0.496 . . . . 0.0 111.463 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 2.5 m-85 -110.69 99.91 8.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -160.2 -137.26 2.18 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.855 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -125.05 141.8 51.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.792 0.33 . . . . 0.0 111.01 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -99.82 26.36 6.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 110.998 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.72 8.44 5.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.682 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -85.52 -49.67 7.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 40' ' ' LYS . 39.4 mm -104.06 -32.57 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.293 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -141.14 140.26 34.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.835 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -81.26 174.78 11.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.504 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 173.74 109.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.349 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 m -71.82 -35.02 53.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.975 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.38 -29.67 70.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.132 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 t -60.93 -45.67 93.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.916 0.389 . . . . 0.0 110.656 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.39 -24.39 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.319 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 28.6 m-80 -79.96 -46.74 16.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.202 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.84 -53.1 61.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.787 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 13.1 ttpt -59.76 -44.66 93.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.495 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -62.41 -42.6 99.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.414 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 tt -56.97 -53.49 57.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.135 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.29 -43.96 92.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.538 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.6 m -59.34 -43.65 92.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.995 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.9 t -70.81 -38.73 73.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.46 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -74.16 -9.76 58.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.796 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 1.2 ttpt 64.3 59.9 0.99 Allowed 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 121.434 0.635 . . . . 0.0 110.221 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.27 108.83 4.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.088 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.71 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 92.6 Cg_exo -47.08 176.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.618 2.212 . . . . 0.0 112.299 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 4.2 p90 -164.06 170.65 16.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.3 tt0 -133.1 118.16 18.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.313 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.481 ' CE1' HG11 ' A' ' 4' ' ' VAL . 4.1 t80 -89.51 158.86 17.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.738 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.502 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 33.8 mt -146.33 122.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.62 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -83.65 123.18 29.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.183 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 pt -100.36 -26.93 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.52 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.532 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.8 ttp -121.24 93.49 48.8 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.504 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.4 Cg_endo -82.56 1.26 9.26 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.726 2.284 . . . . 0.0 112.264 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -141.13 137.65 32.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.669 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' N ' HG23 ' A' ' 11' ' ' ILE . 17.1 mtmm -65.53 -8.37 19.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.234 0.54 . . . . 0.0 111.69 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.96 -68.46 1.14 Allowed Glycine 0 C--N 1.312 -0.753 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.104 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 t -134.58 135.48 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.795 0.331 . . . . 0.0 111.151 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -63.29 169.58 3.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.102 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 t0 -80.86 121.54 26.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.039 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -60.47 -22.4 63.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -64.84 -57.58 8.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.955 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -64.97 -47.2 78.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.716 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.72 -39.26 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.434 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.39 82.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.427 . . . . 0.0 110.418 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -67.13 -40.99 86.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.382 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.6 tp -57.51 -50.41 73.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.3 mt -52.92 -45.93 67.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.084 0.469 . . . . 0.0 111.284 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.3 m -68.06 -33.16 74.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.283 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.42 ' HE3' ' CD1' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -64.3 -39.27 93.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.399 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.17 -66.77 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.967 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.67 -27.06 0.59 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.326 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.67 -175.27 2.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.722 0.296 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.51 -27.44 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.043 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -95.89 170.05 9.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -116.25 100.38 7.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.783 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mt -79.67 84.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.201 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.5 25.56 55.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.588 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -60.01 139.49 57.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.972 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.7 p -122.3 160.08 26.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.8 mtm -117.55 154.47 50.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.673 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.3 Cg_exo -79.52 155.41 89.41 Favored 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 124.105 -1.206 . . . . 0.0 112.74 0.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.419 ' NE2' ' NE2' ' A' ' 75' ' ' HIS . 14.6 mm100 -109.85 125.9 53.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.045 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -97.97 159.82 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.991 0.424 . . . . 0.0 111.977 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 94.3 m-85 -142.9 148.16 36.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.588 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.16 141.3 69.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.31 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -40.69 -30.94 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.935 2.423 . . . . 0.0 112.168 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -167.86 34.08 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.142 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -125.1 -108.99 1.75 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.774 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.0 -179.6 5.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.442 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 47.0 t-80 -64.39 134.35 54.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.118 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mt -104.07 -41.27 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.651 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 137.19 -152.4 21.43 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.003 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.97 -131.05 7.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.502 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 32.6 t80 -76.07 -70.22 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.687 0.28 . . . . 0.0 111.131 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -54.47 -45.42 73.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.939 0.399 . . . . 0.0 110.954 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.454 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.9 OUTLIER -56.43 -45.84 80.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.605 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.46 -41.44 96.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.477 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -52.96 -33.8 52.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.54 -34.19 73.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.16 -33.3 75.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.49 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.507 ' CD1' ' HD2' ' A' ' 27' ' ' LYS . 21.1 m-85 -90.1 -69.8 0.7 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.471 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.961 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 2.8 ttt . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -75.1 146.46 41.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.728 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -108.42 118.03 35.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.297 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 66' ' ' PRO . 92.9 t -113.07 129.71 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.407 0.622 . . . . 0.0 112.196 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.599 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 21.9 m-85 -104.61 101.18 10.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.849 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.7 -142.18 3.32 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.516 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 57.8 m-85 -119.17 154.78 32.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.849 0.357 . . . . 0.0 111.422 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 9' ' ' SER . 22.0 p-10 -89.85 11.57 19.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.799 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER 80.0 -5.73 1.82 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.639 0.257 . . . . 0.0 111.527 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -86.48 -48.63 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.415 ' CG2' ' HA ' ' A' ' 40' ' ' LYS . 30.1 mm -94.11 -16.45 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -155.85 142.92 19.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -66.5 115.78 6.75 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.99 0.424 . . . . 0.0 111.761 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p -130.16 89.32 2.78 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.579 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.6 m -81.3 -32.05 11.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.441 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -65.8 -26.64 67.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.178 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.1 t -63.77 -51.91 62.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.408 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.12 -29.54 63.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.196 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -70.6 -57.66 4.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.879 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.23 -41.89 80.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -57.2 -51.19 70.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.812 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -60.31 -43.6 96.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.462 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.431 HD22 ' CD2' ' A' ' 86' ' ' PHE . 3.7 tt -58.87 -54.75 43.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.386 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.71 -46.34 81.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.682 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.6 m -55.83 -38.4 69.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.141 0.496 . . . . 0.0 110.031 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.6 t -78.8 -31.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.548 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -73.08 -9.78 59.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.16 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 71.13 45.21 0.51 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.914 0.388 . . . . 0.0 110.957 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -132.44 130.48 21.86 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.56 ' O ' ' HA ' ' A' ' 1' ' ' MET . 44.3 Cg_endo -82.8 161.1 16.28 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.636 2.224 . . . . 0.0 111.191 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 5.1 p90 -161.31 171.2 18.75 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.916 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -132.45 121.19 23.0 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.536 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -89.82 150.87 22.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.763 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 mt -142.41 122.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.413 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -87.08 118.04 26.2 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.424 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.0 pt -97.07 33.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.007 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.423 ' HE3' ' CE1' ' A' ' 7' ' ' TYR . 42.9 ttm -160.59 82.59 2.11 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.57 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.01 -4.76 16.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.032 2.488 . . . . 0.0 112.875 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 37' ' ' MET . 1.8 mm-40 -139.21 155.64 47.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -71.12 -7.13 44.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.06 18.01 3.36 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.205 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 t -150.83 116.46 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.446 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 9.0 m-85 -72.31 170.22 14.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.676 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -100.42 93.32 5.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.03 -24.86 67.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.46 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.43 -58.7 5.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -69.16 -34.06 74.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.301 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.1 mt -71.01 -32.69 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.639 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.34 -55.17 34.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -61.52 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.599 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 4.3 tt -59.54 -53.33 59.34 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.223 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 52' ' ' LEU . 3.9 mt -52.88 -47.9 67.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.064 0.459 . . . . 0.0 110.959 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.4 m -53.39 -40.74 65.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.687 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 23.4 mtpp -70.11 -39.41 75.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.74 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -44.42 93.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.486 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.19 -137.03 5.07 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.897 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -122.85 30.34 6.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.123 0.487 . . . . 0.0 110.485 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.25 -156.72 0.69 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.211 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -121.17 170.57 9.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.632 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -79.47 98.14 6.69 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.286 0.565 . . . . 0.0 110.182 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.436 ' CG2' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -80.32 86.7 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.909 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.07 27.93 60.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.505 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -179.8 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.615 0.245 . . . . 0.0 110.684 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.4 p -150.36 159.72 44.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.154 0.502 . . . . 0.0 111.897 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.9 mtt -115.49 158.0 42.72 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.189 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HB2' HG12 ' A' ' 4' ' ' VAL . 2.8 Cg_exo -79.7 145.48 73.56 Favored 'Cis proline' 0 C--N 1.345 0.347 0 C-N-CA 124.47 -1.054 . . . . 0.0 113.27 0.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -105.52 126.77 52.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.133 178.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 5.7 t -96.99 159.02 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.99 0.424 . . . . 0.0 111.645 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.44 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 32.0 m-85 -142.83 144.26 32.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.729 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.45 ' CA ' ' CD1' ' A' ' 76' ' ' ILE . . . -53.81 133.38 56.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.263 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.564 ' HB3' ' N ' ' A' ' 1' ' ' MET . 35.1 Cg_exo -55.05 -17.03 13.46 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.523 2.149 . . . . 0.0 112.312 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.73 39.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.386 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.86 -114.81 0.76 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.273 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.1 p -125.56 -173.02 2.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.142 0.496 . . . . 0.0 111.32 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 35.9 t-80 -66.35 145.18 56.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.45 ' CD1' ' CA ' ' A' ' 70' ' ' ALA . 1.7 mp -120.04 -35.4 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.939 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.83 -156.55 18.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.093 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.27 -137.33 8.65 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.418 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -69.61 -70.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.723 0.297 . . . . 0.0 111.05 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -57.19 -48.98 77.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.964 0.412 . . . . 0.0 110.71 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -50.42 -36.66 34.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.359 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.513 ' CD2' ' CE2' ' A' ' 86' ' ' PHE . 5.4 tt -82.67 -29.85 29.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.232 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -51.63 -31.37 25.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -65.67 -34.73 78.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.112 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 82' ' ' LEU . 22.1 t80 -64.89 -33.22 75.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.542 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.513 ' CE2' ' CD2' ' A' ' 82' ' ' LEU . 6.5 m-85 -86.49 -65.03 1.06 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.454 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.001 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.66 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 19.5 ttm . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.921 0.391 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -82.43 151.39 26.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.764 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.1 mppp? -126.47 120.62 30.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.857 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.484 HG13 ' CE1' ' A' ' 33' ' ' PHE . 6.2 t -109.49 116.64 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.115 0.483 . . . . 0.0 111.848 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 21.8 m-85 -96.04 100.54 12.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.901 178.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.69 -137.96 2.32 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.352 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.678 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 3.1 m-85 -127.24 151.75 48.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.48 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -144.83 38.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.953 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.518 ' HB2' HG12 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -163.94 -162.82 0.73 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.108 0.48 . . . . 0.0 111.856 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -86.52 8.48 21.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.083 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.518 HG12 ' HB2' ' A' ' 9' ' ' SER . 0.6 OUTLIER -87.54 -8.13 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.678 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 20.6 t-80 -170.17 144.07 2.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.329 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 155.47 26.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.281 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 168.82 82.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.97 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 m -73.97 -41.23 52.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -59.57 -20.4 55.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 t -66.76 -60.23 2.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.778 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.74 -40.04 39.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 110.624 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -65.64 -43.99 87.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.576 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -67.41 -33.29 74.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -56.97 -44.39 82.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -70.94 -25.14 62.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.325 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.511 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -54.1 -57.29 11.64 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.241 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' CD2' HD23 ' A' ' 82' ' ' LEU . 13.8 mt -64.31 -41.41 96.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.52 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.2 m -60.39 -34.5 73.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.297 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.2 t -72.24 -42.94 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.933 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -72.6 -19.75 61.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.209 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 2.7 tppt? 79.79 71.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 111.382 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -143.46 143.28 23.41 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.0 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.45 130.12 11.59 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.474 2.116 . . . . 0.0 111.968 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.66 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 6.1 p90 -151.54 166.96 29.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.89 0.376 . . . . 0.0 111.959 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -143.09 136.13 27.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.883 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.484 ' CE1' HG13 ' A' ' 4' ' ' VAL . 13.1 t80 -89.75 159.79 16.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.224 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.5 mt -150.09 126.09 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.123 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 8' ' ' ASP . 68.6 m-80 -86.72 111.24 20.51 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.176 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.479 HD13 ' CZ ' ' A' ' 7' ' ' TYR . 21.9 pt -75.22 -5.79 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.505 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.475 ' HE2' ' CE1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -135.33 69.77 68.35 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.448 179.548 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.48 -13.74 35.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.596 2.197 . . . . 0.0 112.135 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -139.16 135.79 34.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.352 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.437 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.86 -9.01 3.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.31 0.576 . . . . 0.0 111.429 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.06 -61.08 3.87 Favored Glycine 0 C--N 1.312 -0.767 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.352 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.95 157.0 5.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.475 ' CE1' ' HE2' ' A' ' 37' ' ' MET . 24.1 m-85 -58.83 170.3 0.84 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.902 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 36' ' ' ILE . 7.5 t70 -100.24 113.0 25.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.64 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -73.01 -18.79 61.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.07 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.45 -63.29 1.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 111.152 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -64.17 -40.08 95.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.55 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 43' ' ' PHE . 34.9 mt -66.13 -28.53 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.654 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.23 -49.76 70.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.684 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -37.68 77.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.425 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' A' ' 69' ' ' PHE . 5.9 tp -57.3 -50.85 71.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.689 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -52.86 -45.94 67.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.516 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.7 m -62.99 -35.75 81.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.672 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -65.81 -38.59 89.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.788 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.6 -70.15 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.77 -106.95 0.2 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.144 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -150.35 32.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 111.045 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -120.97 -145.42 0.36 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.365 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.01 170.18 9.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.837 0.351 . . . . 0.0 110.712 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.1 98.43 1.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.4 0.619 . . . . 0.0 110.352 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.9 mt -79.67 85.5 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.346 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.21 28.23 54.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.489 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -46.58 123.51 5.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.393 . . . . 0.0 111.158 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 24.9 p -104.51 136.52 43.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.077 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.5 mmt -102.92 152.16 38.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.7 Cg_endo -83.56 144.64 49.42 Favored 'Cis proline' 0 C--N 1.346 0.405 0 C-N-CA 124.246 -1.148 . . . . 0.0 112.653 0.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 25.3 mm-40 -104.33 154.08 20.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -123.35 159.35 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.459 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CE2' HD11 ' A' ' 51' ' ' LEU . 25.3 m-85 -142.3 132.7 25.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.932 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 150.16 96.36 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.239 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.568 ' HB3' ' N ' ' A' ' 1' ' ' MET . 71.1 Cg_exo -45.73 -42.98 19.28 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.215 2.61 . . . . 0.0 112.746 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -29.03 64.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.98 79.64 0.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.467 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.9 127.57 3.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.939 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -58.54 108.94 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mt -81.5 -41.79 19.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.938 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.48 -149.52 17.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.491 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -98.22 -132.42 7.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.32 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.511 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -83.02 -69.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.578 0.189 . . . . 0.0 110.877 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.7 -43.53 47.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.175 0.512 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -42.34 95.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.483 HD23 ' CE1' ' A' ' 86' ' ' PHE . 1.6 tt -71.77 -41.58 68.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.752 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -51.12 -35.24 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.85 -35.57 77.09 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.122 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' LEU . 59.5 t80 -64.49 -32.36 73.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.588 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.483 ' CE1' HD23 ' A' ' 82' ' ' LEU . 27.7 m-85 -89.79 -27.1 20.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.058 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.701 179.701 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.557 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.8 ttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.897 0.379 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.484 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 68.9 m-85 -60.19 157.44 13.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.771 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -134.11 116.32 15.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.702 -179.53 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.493 HG11 ' CE1' ' A' ' 33' ' ' PHE . 19.0 t -105.91 125.62 61.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.266 0.555 . . . . 0.0 111.829 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.0 m-30 -101.96 99.47 9.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.532 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.68 -138.02 2.33 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.413 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 22.6 m-85 -120.06 139.97 51.73 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 120.626 0.25 . . . . 0.0 110.502 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -92.97 22.28 5.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 4.5 m 65.74 5.73 3.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -81.89 -44.02 17.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.074 0.464 . . . . 0.0 110.521 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.8 mm -124.95 1.5 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.263 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.59 ' CD2' ' HE1' ' A' ' 37' ' ' MET . 13.3 t-80 -157.04 131.19 8.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.538 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -80.99 159.57 24.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.348 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 176.75 123.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.118 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.0 m -83.13 -39.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.818 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -55.45 -28.85 56.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.728 0.299 . . . . 0.0 111.284 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.5 m -62.16 -53.84 49.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.55 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.26 -34.19 56.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.167 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -70.22 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.963 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.51 -31.95 48.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.288 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -60.69 -56.01 26.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.571 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -64.65 -27.09 68.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.772 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.31 -57.4 12.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.385 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mt -59.85 -41.89 92.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.599 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -37.16 79.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.094 0.474 . . . . 0.0 110.063 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.64 -25.36 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.867 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HE3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -77.71 -15.74 58.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? 70.34 42.28 0.93 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.066 0.46 . . . . 0.0 110.524 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -128.33 143.75 49.29 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 1' ' ' MET . 92.1 Cg_endo -77.01 136.96 16.96 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.389 2.06 . . . . 0.0 111.674 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.557 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 12.6 p90 -149.12 170.31 18.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.915 0.388 . . . . 0.0 112.008 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -147.75 141.21 25.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.196 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CE1' HG11 ' A' ' 4' ' ' VAL . 8.3 t80 -89.71 162.87 15.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.043 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.437 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.9 mt -146.12 119.78 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.262 0.554 . . . . 0.0 110.417 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -82.08 125.23 30.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.346 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.465 HD13 ' CZ ' ' A' ' 7' ' ' TYR . 6.9 pt -100.31 -12.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.171 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.59 ' HE1' ' CD2' ' A' ' 12' ' ' HIS . 21.7 ttm -123.07 79.04 51.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.767 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' CG ' ' HB3' ' A' ' 44' ' ' ASP . 17.9 Cg_exo -65.56 -22.1 58.91 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.283 1.989 . . . . 0.0 111.608 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -139.22 137.46 35.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.704 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -61.35 -9.18 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.22 0.533 . . . . 0.0 112.245 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.31 -55.72 4.6 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.449 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 t -150.46 139.25 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.616 0.246 . . . . 0.0 111.559 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -58.76 170.33 0.82 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.045 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.461 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 12.6 p30 -88.89 109.49 20.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 111.875 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -58.06 -31.12 66.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.619 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -52.99 -42.35 65.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.786 0.327 . . . . 0.0 110.971 -179.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -80.62 -39.15 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.254 0.55 . . . . 0.0 109.887 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 44' ' ' ASP . 43.9 mm -55.93 -46.01 80.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.722 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.68 -56.44 12.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.322 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -60.68 -28.78 68.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.583 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.11 -56.44 22.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.362 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 1.8 mt -52.35 -45.24 65.62 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.9 m -60.72 -38.81 86.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.278 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -65.27 -37.7 87.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.521 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -20.17 56.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.935 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.27 -88.81 1.53 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.124 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -139.4 31.53 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.454 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -121.61 110.55 16.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.376 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.4 t -78.25 142.06 38.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.452 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.9 pt20 -70.8 97.57 1.41 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.378 0.608 . . . . 0.0 111.036 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.5 tp -80.88 79.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.481 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.76 24.37 69.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.101 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -54.48 159.91 1.92 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.858 0.361 . . . . 0.0 111.08 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.3 m -125.49 165.76 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.226 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.412 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 13.0 mmt -97.94 155.69 36.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.452 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.6 Cg_endo -86.34 149.81 42.92 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 124.211 -1.162 . . . . 0.0 113.106 0.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -108.71 112.61 25.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.918 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.2 t -89.5 163.02 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.219 0.533 . . . . 0.0 112.183 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 44.9 m-85 -141.58 137.3 31.84 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.132 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.482 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -50.99 152.22 3.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.065 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.48 ' HB3' ' N ' ' A' ' 1' ' ' MET . 53.0 Cg_exo -54.87 -24.32 38.24 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.728 2.286 . . . . 0.0 112.028 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -101.63 -22.52 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.991 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.3 85.66 0.78 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.707 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -165.79 126.68 1.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.736 0.303 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -61.28 117.72 5.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.794 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.482 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 2.4 mp -110.11 -27.9 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.961 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.12 -155.46 16.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.901 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.06 -134.36 7.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.419 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -74.3 -67.12 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.625 0.25 . . . . 0.0 111.033 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.81 -52.68 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -51.05 -41.85 60.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.402 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.516 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.6 tt -78.83 -29.03 44.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.129 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 87' ' ' LYS . 14.2 ttt85 -52.81 -30.66 34.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -67.77 -30.39 69.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' LEU . 24.0 t80 -68.64 -33.65 74.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.574 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.516 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.2 m-85 -95.51 -70.72 0.7 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.819 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' ARG . 1.3 mtpm? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.93 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.589 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 28.5 ttm . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.08 143.37 35.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.146 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.15 120.14 41.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.617 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.44 HG12 ' CE1' ' A' ' 33' ' ' PHE . 67.6 t -104.39 126.8 59.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.268 0.556 . . . . 0.0 111.727 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.8 m-30 -103.8 99.53 9.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.457 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.74 -141.05 3.04 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.33 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -116.61 160.63 20.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 120.675 0.274 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -81.59 -78.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 t 170.49 -35.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.799 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -84.55 -22.94 29.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.38 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.1 -39.01 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.74 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -155.93 145.0 20.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.272 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -68.39 158.26 33.99 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 p 175.38 113.9 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.815 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.6 m -90.29 -36.76 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.927 0.394 . . . . 0.0 111.1 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -62.25 -29.18 70.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.996 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 m -58.08 -48.04 81.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.028 0.442 . . . . 0.0 110.289 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -28.07 68.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.486 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.19 -57.22 4.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.765 0.317 . . . . 0.0 111.156 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.17 -26.16 37.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.319 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -68.53 -58.12 4.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 110.327 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -63.17 -28.63 70.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.544 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.443 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -55.98 -56.53 19.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.197 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' A' ' 86' ' ' PHE . 1.5 mt -57.26 -40.01 76.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.58 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.4 m -60.06 -34.93 74.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.311 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.41 -51.16 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.408 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' CE ' ' CE2' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -66.48 -16.74 64.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.375 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.82 42.82 0.19 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.141 0.496 . . . . 0.0 110.119 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -120.21 138.58 27.32 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.124 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.574 ' O ' ' HA ' ' A' ' 1' ' ' MET . 97.2 Cg_endo -74.31 158.24 44.94 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.013 1.809 . . . . 0.0 111.012 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -161.37 171.05 18.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.8 0.334 . . . . 0.0 111.668 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -141.57 130.83 23.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.512 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.44 ' CE1' HG12 ' A' ' 4' ' ' VAL . 21.0 t80 -89.14 159.56 17.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.955 0.407 . . . . 0.0 111.298 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.2 mt -146.85 120.11 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.552 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -91.66 112.48 24.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.543 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.42 ' CD1' ' CG1' ' A' ' 48' ' ' ILE . 6.6 tt -87.18 49.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.422 ' HE2' ' CZ ' ' A' ' 43' ' ' PHE . 12.3 ttm -171.38 98.81 0.4 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.566 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 35.7 Cg_endo -65.1 -30.3 55.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.374 2.05 . . . . 0.0 112.288 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -143.01 158.71 43.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.419 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -71.0 -7.78 48.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.313 0.577 . . . . 0.0 111.498 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.61 -20.25 8.67 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.925 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 t -141.36 122.74 13.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.413 0.625 . . . . 0.0 112.5 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.422 ' CZ ' ' HE2' ' A' ' 37' ' ' MET . 31.6 m-85 -73.41 161.92 29.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.3 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.406 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 1.1 t70 -83.7 87.39 7.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.77 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -24.86 64.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.297 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -61.06 -55.86 27.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 110.713 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 6.4 mmtt -70.74 -43.55 68.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.112 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.42 ' CG1' ' CD1' ' A' ' 36' ' ' ILE . 63.0 mt -50.43 -38.22 15.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.672 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.47 -59.26 3.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 8.8 pt-20 -60.26 -30.03 69.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.159 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.458 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 1.9 tt -58.23 -50.14 74.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.146 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.1 mt -54.88 -48.4 73.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.097 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.9 m -66.18 -35.34 80.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.372 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -65.4 -37.14 86.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.829 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.25 -67.34 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.85 -27.18 0.29 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.678 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.05 -165.5 1.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.898 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -91.56 -31.35 15.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.789 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -110.67 170.15 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 62' ' ' GLY . 9.9 pt20 -114.36 100.54 8.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.489 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -58.8 82.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.482 0.658 . . . . 0.0 111.598 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 60' ' ' GLN . . . 62.33 20.96 61.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.983 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.94 135.07 36.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.6 p -136.83 170.93 15.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.465 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.0 155.64 47.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.561 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -75.72 143.13 76.06 Favored 'Cis proline' 0 C--N 1.344 0.323 0 C-N-CA 123.8 -1.333 . . . . 0.0 112.83 0.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.7 mt-30 -111.97 113.76 26.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.879 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -87.91 161.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.111 0.482 . . . . 0.0 111.587 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 57.4 m-85 -143.08 139.04 30.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.345 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.53 132.52 54.43 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.294 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.589 ' HB3' ' N ' ' A' ' 1' ' ' MET . 38.2 Cg_exo -54.87 -20.74 23.56 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.448 2.099 . . . . 0.0 111.911 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.57 39.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.279 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.48 -111.35 0.68 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.923 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 t -137.4 179.88 6.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.179 0.514 . . . . 0.0 111.273 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 41.0 t-80 -56.34 126.9 28.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.025 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.0 mt -94.66 -42.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.78 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.22 -154.86 21.58 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.8 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.62 -149.07 24.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.372 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.443 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 58.3 t80 -67.66 -59.14 3.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.757 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -62.09 -54.74 37.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.051 0.453 . . . . 0.0 110.818 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -52.02 -41.04 61.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.6 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD21 ' CE1' ' A' ' 86' ' ' PHE . 6.1 tt -79.69 -28.19 40.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.24 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 87' ' ' LYS . 2.2 mmm180 -52.28 -35.05 49.22 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -60.12 -32.59 71.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.2 t80 -68.4 -28.5 67.14 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.929 178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.518 ' CE2' ' CE ' ' A' ' 27' ' ' LYS . 15.7 m-85 -100.11 -70.86 0.72 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.833 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.53 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 56.2 ttp . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.442 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 81.0 m-85 -51.01 149.12 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.198 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.1 mptp? -117.23 116.99 28.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.219 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.538 HG11 ' CE1' ' A' ' 33' ' ' PHE . 44.1 t -110.67 128.55 66.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.513 0.673 . . . . 0.0 112.577 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 22.0 m-85 -108.74 106.44 16.47 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.592 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.68 -137.26 2.29 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.831 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CE1' ' HE1' ' A' ' 37' ' ' MET . 16.9 m-85 -123.94 134.11 53.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 122.449 0.3 . . . . 0.0 110.324 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -100.39 39.14 1.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 111.318 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 t 60.15 14.05 4.24 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.627 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -85.83 -53.29 5.21 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.901 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 37' ' ' MET . 18.6 mt -110.97 -15.26 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -160.67 148.42 15.99 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.07 159.28 33.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.62 119.07 1.0 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.433 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -90.38 -31.21 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.032 0.444 . . . . 0.0 111.125 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -62.7 -28.84 70.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.805 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 t -59.32 -47.07 86.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.049 0.452 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -62.52 -33.89 75.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.214 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.412 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 83.4 m-20 -74.61 -46.53 37.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.017 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.52 88.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.92 0.39 . . . . 0.0 110.803 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -57.49 10.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.787 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -58.0 -40.12 79.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.387 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.42 HD21 ' CD2' ' A' ' 86' ' ' PHE . 1.8 tt -59.15 -54.82 42.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.129 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mt -55.97 -45.97 78.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.665 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -55.98 -38.01 69.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.157 0.504 . . . . 0.0 109.928 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.5 t -79.29 -29.71 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.497 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -75.25 -13.73 60.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.114 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm 68.56 46.31 1.01 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.0 0.429 . . . . 0.0 110.926 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -126.83 141.04 39.27 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.847 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.5 Cg_endo -82.06 140.38 11.21 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.514 2.143 . . . . 0.0 111.404 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.53 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 42.6 p90 -157.94 169.74 23.91 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.639 -0.424 . . . . 0.0 112.077 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.86 139.68 23.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.241 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.538 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.6 t80 -89.42 161.44 16.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.521 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.1 mt -149.88 122.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -79.31 110.65 14.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.274 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 pt -86.01 -2.28 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.599 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.488 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 38.5 ttm -119.41 107.22 41.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.87 -28.28 4.14 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.568 2.178 . . . . 0.0 111.546 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -139.95 152.77 46.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.665 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -65.6 -8.46 20.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.236 0.541 . . . . 0.0 112.048 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.41 -54.03 3.65 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.495 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.72 154.79 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.805 0.336 . . . . 0.0 111.378 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -77.45 170.39 16.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.96 114.42 25.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.687 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -63.7 -15.62 58.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.412 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -62.7 -55.99 21.73 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.826 0.345 . . . . 0.0 110.839 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -70.09 -35.81 74.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.5 mt -70.43 -32.98 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.1 -57.42 12.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.64 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -63.17 -25.78 68.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.144 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.565 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 3.7 tt -60.36 -56.17 24.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.991 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 2.1 mt -52.96 -45.17 67.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.065 0.46 . . . . 0.0 111.093 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 m -56.87 -49.02 76.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.379 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 11.3 mtpp -60.78 -36.28 78.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.404 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.78 -24.04 67.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.95 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.97 -132.65 11.38 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.925 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.56 31.24 2.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.102 0.477 . . . . 0.0 110.665 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.72 109.41 14.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.542 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 t -78.39 152.1 32.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.389 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.89 97.63 1.15 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.398 0.618 . . . . 0.0 110.898 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.54 81.32 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.714 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.93 24.79 67.15 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.167 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.23 173.28 0.11 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.756 0.312 . . . . 0.0 110.778 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.8 p -133.16 169.05 17.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.193 0.52 . . . . 0.0 111.636 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.408 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 15.5 mmt -111.36 155.11 43.31 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.261 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.3 Cg_exo -84.33 143.01 40.18 Favored 'Cis proline' 0 N--CA 1.462 -0.341 0 C-N-CA 124.223 -1.157 . . . . 0.0 113.108 0.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -97.4 130.49 44.53 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.671 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.1 t -99.77 160.56 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.02 0.438 . . . . 0.0 111.696 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.532 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 20.7 m-85 -141.55 138.1 32.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.527 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -44.82 138.51 4.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.502 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' HB3' ' N ' ' A' ' 1' ' ' MET . 90.6 Cg_exo -46.38 -25.73 3.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.917 2.411 . . . . 0.0 111.992 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.98 39.16 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.044 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.05 -112.37 1.09 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.366 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 t -127.18 -172.55 2.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.086 0.47 . . . . 0.0 111.495 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.445 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 28.5 t-80 -67.21 145.83 54.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.087 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 2.3 mp -123.04 -35.9 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.134 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.01 -156.44 20.72 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.774 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.73 -138.16 8.44 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.471 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -71.85 -70.53 0.32 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.74 0.305 . . . . 0.0 110.773 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -56.43 -49.3 74.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.99 0.424 . . . . 0.0 110.48 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -36.34 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.291 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.505 HD22 ' CE2' ' A' ' 86' ' ' PHE . 5.9 tt -84.32 -29.77 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.023 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -51.7 -31.05 24.56 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.94 -34.42 78.08 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.219 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' CD2' HG12 ' A' ' 76' ' ' ILE . 15.4 t80 -65.27 -33.01 74.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.426 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 82' ' ' LEU . 6.8 m-85 -87.95 -26.27 22.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.275 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 mttt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.9 -179.969 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.578 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 29.8 ttp . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -79.88 143.66 34.1 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.395 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.716 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -105.21 121.77 44.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.398 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.458 HG11 ' CE1' ' A' ' 33' ' ' PHE . 38.6 t -103.38 126.58 57.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.82 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.6 m-30 -102.51 99.26 9.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.404 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.39 -138.33 2.46 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.503 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -131.41 157.05 44.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.937 0.398 . . . . 0.0 111.543 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.588 ' O ' ' O ' ' A' ' 12' ' ' HIS . 32.6 p30 -80.25 -177.91 6.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.587 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -91.77 -13.7 31.11 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.698 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -85.67 -41.94 14.72 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mm -89.54 -45.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.588 ' O ' ' O ' ' A' ' 8' ' ' ASP . 20.8 t60 -139.64 115.51 10.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.68 0.752 . . . . 0.0 110.618 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.87 148.04 14.02 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.682 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 p -158.03 104.96 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 m -82.33 -33.37 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.723 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.97 -25.7 64.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.348 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.28 -48.78 80.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.626 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -55.29 -24.4 28.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.549 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.403 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 8.9 m-80 -74.68 -50.05 19.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.303 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.79 95.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.791 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -61.41 -57.58 11.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.344 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -62.04 -33.8 75.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 0.0 109.709 179.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -57.55 -54.6 45.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.914 178.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -58.49 -47.46 84.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.515 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -53.07 -39.99 63.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.116 0.484 . . . . 0.0 109.946 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.98 -31.01 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.457 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HD3' ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -78.13 -9.81 59.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.043 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.35 37.25 1.2 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.051 0.453 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -123.51 133.13 24.37 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.015 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.9 Cg_endo -82.01 158.08 18.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.543 2.162 . . . . 0.0 111.227 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 9.1 p90 -161.72 171.57 17.67 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.767 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -136.86 137.42 39.66 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.458 ' CE1' HG11 ' A' ' 4' ' ' VAL . 10.9 t80 -89.36 158.42 17.79 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.196 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.1 mt -147.5 122.32 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.339 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -92.77 127.22 38.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.182 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 pt -89.53 -9.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.929 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.572 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 18.1 ttm -125.25 100.31 32.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.642 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.28 -22.99 28.94 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.647 2.232 . . . . 0.0 112.357 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -139.92 145.13 37.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -9.3 4.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.308 0.575 . . . . 0.0 111.78 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.91 -59.7 2.41 Favored Glycine 0 C--N 1.313 -0.708 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.741 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -146.85 134.69 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.685 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -69.49 170.64 10.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -89.73 95.97 10.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.048 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -57.41 -18.68 19.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.104 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.47 -53.21 60.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -71.83 -36.29 70.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.362 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 mm -53.16 -48.24 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.966 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.3 -53.14 57.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.627 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.49 -28.53 65.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.37 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 2.0 tt -58.23 -58.1 9.94 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.503 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 4.1 mt -48.66 -48.14 40.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.307 0.575 . . . . 0.0 111.335 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.9 m -71.09 -22.06 62.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.192 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -73.09 -42.87 62.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.93 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.503 ' CD1' ' HA ' ' A' ' 52' ' ' LEU . 1.5 mp -59.33 -39.28 82.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.001 0.429 . . . . 0.0 110.886 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.94 -109.07 0.27 Allowed Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.057 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -150.5 32.53 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.241 0.544 . . . . 0.0 110.725 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -120.98 -152.09 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.385 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -120.98 170.6 9.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.863 0.363 . . . . 0.0 110.831 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -90.38 98.8 11.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.304 0.573 . . . . 0.0 110.476 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.6 mm -79.27 84.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.192 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.87 25.53 56.38 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.448 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.05 145.53 36.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 110.781 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.4 p -127.86 170.52 12.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.43 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.28 156.37 35.23 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.648 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.8 Cg_endo -85.19 145.12 40.18 Favored 'Cis proline' 0 N--CA 1.461 -0.419 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.834 0.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 3.3 mm-40 -107.68 113.35 26.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.743 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.8 t -87.25 161.36 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.291 0.567 . . . . 0.0 111.829 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -142.75 143.17 32.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.016 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.437 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -52.91 149.77 11.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.113 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.57 ' HB3' ' N ' ' A' ' 1' ' ' MET . 8.8 Cg_exo -68.79 -9.88 27.49 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.701 2.267 . . . . 0.0 112.39 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.6 -18.53 13.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.204 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.19 91.34 1.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.665 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m 176.29 158.24 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.537 0.208 . . . . 0.0 110.655 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.459 ' CE1' HD23 ' A' ' 55' ' ' LEU . 9.8 t-160 -90.46 133.52 34.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.437 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 2.5 mt -122.28 -40.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.986 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.23 -161.38 20.6 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.928 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.26 -139.04 8.13 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.785 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -71.11 -70.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.602 0.239 . . . . 0.0 111.144 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -55.21 -50.83 68.39 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.198 0.523 . . . . 0.0 110.436 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -50.99 -43.71 60.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.231 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 ' CE2' ' A' ' 86' ' ' PHE . 6.1 tt -77.62 -29.1 51.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.312 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -52.25 -30.78 29.34 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.57 -35.56 79.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.5 t80 -61.79 -34.95 76.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.153 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.531 ' CE2' HD22 ' A' ' 82' ' ' LEU . 6.7 m-85 -87.22 -27.53 22.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.266 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.8 mttt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.922 -179.85 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.587 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 17.9 ttp . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.402 ' CD1' ' CD2' ' A' ' 24' ' ' LEU . 71.2 m-85 -76.77 153.83 34.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.09 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -113.0 119.58 38.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.777 -179.468 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.47 HG11 ' CE1' ' A' ' 33' ' ' PHE . 56.0 t -111.22 126.6 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.21 0.529 . . . . 0.0 111.865 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.629 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 22.7 m-85 -105.45 101.15 10.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.094 178.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.28 -137.46 2.24 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.498 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CE1' ' HE3' ' A' ' 37' ' ' MET . 46.8 m-85 -122.99 159.26 28.71 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -86.43 -70.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t 170.97 -37.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.743 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -79.09 -27.62 43.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.997 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.59 -42.14 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.854 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -153.32 154.62 34.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.9 157.91 32.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.776 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p 179.12 86.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -72.76 -34.95 48.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.285 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.02 -19.07 65.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.343 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 t -69.17 -62.41 1.39 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.83 0.348 . . . . 0.0 110.515 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -49.82 -36.34 26.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.741 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -62.28 -54.26 43.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.768 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.0 -45.98 85.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.258 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -50.0 -38.35 36.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.943 0.402 . . . . 0.0 110.299 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -68.52 -31.44 70.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.957 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.509 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 1.1 tt -56.52 -55.65 31.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.956 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' CD2' ' CD1' ' A' ' 2' ' ' PHE . 1.3 mt -60.28 -52.32 65.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.696 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.1 m -51.13 -41.37 60.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.621 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.19 -31.99 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.459 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.74 -9.8 57.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.107 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.49 51.41 0.12 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.941 0.4 . . . . 0.0 110.52 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -132.04 133.69 24.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.211 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.565 ' O ' ' HA ' ' A' ' 1' ' ' MET . 57.8 Cg_endo -81.7 161.57 19.02 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.547 2.165 . . . . 0.0 111.215 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 5.3 p90 -161.45 171.45 18.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 111.544 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -133.13 126.25 31.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.826 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.47 ' CE1' HG11 ' A' ' 4' ' ' VAL . 10.7 t80 -89.79 158.22 17.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.432 HG13 ' C ' ' A' ' 33' ' ' PHE . 24.1 mt -150.71 125.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.313 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -80.14 115.69 19.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.749 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.6 -20.3 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.071 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.9 ttp -124.22 85.76 54.89 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.146 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.94 -3.64 14.11 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.903 2.402 . . . . 0.0 112.429 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 37' ' ' MET . 9.2 tt0 -139.52 136.78 34.87 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.705 0.288 . . . . 0.0 110.732 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -64.27 -8.9 14.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.222 0.534 . . . . 0.0 112.131 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.47 -63.38 1.64 Allowed Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.93 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.79 146.79 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.645 0.259 . . . . 0.0 110.75 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -72.32 168.88 17.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 111.263 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.22 119.92 27.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.465 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -76.23 -19.7 58.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.099 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.8 -58.73 6.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.965 0.412 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -64.39 -40.59 96.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.095 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.4 mt -65.41 -32.34 57.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.564 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.23 -48.45 81.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.86 -37.44 82.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.376 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.629 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.5 tt -58.98 -57.67 12.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.751 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.522 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 77.0 mt -46.27 -43.75 15.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.803 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 m -70.95 -28.79 64.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' CD ' ' CD2' ' A' ' 69' ' ' PHE . 2.9 ttmm -65.19 -45.14 86.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.597 -179.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.522 ' CD1' ' HA ' ' A' ' 52' ' ' LEU . 1.5 mp -59.43 -63.98 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.98 0.419 . . . . 0.0 111.127 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.33 -113.54 0.31 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.134 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.41 29.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 111.029 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -121.37 -154.76 0.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.308 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 t -120.98 166.04 14.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.729 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -118.42 99.15 6.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 110.99 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mm -80.93 84.89 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.175 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.02 29.75 3.67 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.357 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.34 131.66 33.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 110.798 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -116.84 152.7 33.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.227 0.537 . . . . 0.0 111.635 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -117.14 158.57 44.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.449 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.5 Cg_endo -87.02 134.88 15.97 Favored 'Cis proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.197 -1.168 . . . . 0.0 112.762 0.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 1.9 tp60 -92.68 139.15 30.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.878 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.7 t -108.12 157.54 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.59 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.413 ' CD2' ' CD ' ' A' ' 54' ' ' LYS . 28.5 m-85 -144.15 141.32 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.66 148.4 26.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.587 ' HB3' ' N ' ' A' ' 1' ' ' MET . 12.8 Cg_exo -67.45 -14.04 41.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.902 2.401 . . . . 0.0 112.198 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.51 -21.54 14.73 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.148 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.78 88.54 0.83 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.674 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m 179.39 158.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.633 0.254 . . . . 0.0 110.743 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.421 ' CE1' HD21 ' A' ' 55' ' ' LEU . 8.4 t-160 -90.34 133.49 34.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.1 mt -116.97 -45.55 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.979 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.01 -152.17 16.87 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.026 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -95.68 -131.07 6.48 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.562 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.509 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -77.55 -70.15 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.653 0.227 . . . . 0.0 111.048 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -51.56 -50.76 59.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.366 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -55.96 -39.59 71.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.614 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.505 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.8 tt -78.42 -32.52 48.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.598 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.0 mmm-85 -51.48 -33.1 29.78 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.52 -35.0 78.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.156 178.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.8 t80 -63.54 -35.75 81.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.505 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -91.79 -9.88 41.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.559 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.0 mttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.972 179.975 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.561 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 9.4 ttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.95 0.405 . . . . 0.0 111.627 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.459 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 86.9 m-85 -62.47 155.7 24.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.641 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.765 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -128.22 121.41 29.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.116 -179.717 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.46 HG12 ' CE1' ' A' ' 33' ' ' PHE . 12.8 t -115.1 124.67 71.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.539 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 2.0 m-85 -103.99 104.38 14.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.2 -132.23 1.37 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.394 -178.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.069 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 93.9 m-85 -134.12 149.49 51.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.631 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 18.8 p-10 -156.47 -51.33 0.08 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.615 ' N ' ' HB3' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -52.84 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -177.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -47.98 81.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.442 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.481 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -86.65 22.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.601 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 1.069 ' CD2' ' HA ' ' A' ' 7' ' ' TYR 0.301 0.3 OUTLIER -149.0 77.74 1.38 Allowed 'General case' 0 N--CA 1.417 -2.103 0 C-N-CA 117.845 -1.542 . . . . 0.0 108.612 -171.98 . . . . . . . . 4 4 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -61.05 166.64 3.43 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.33 -1.759 . . . . 0.0 113.481 -177.522 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.626 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 31.5 p 169.96 111.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.342 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 13' ' ' LYS . 2.2 m -91.77 -37.33 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.706 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -75.15 -19.03 60.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.574 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.9 t -60.42 -51.76 68.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.783 0.325 . . . . 0.0 110.621 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.89 -31.8 7.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.551 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -78.19 -57.2 3.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.825 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.45 -45.36 80.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -57.33 -52.09 66.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.368 . . . . 0.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -55.12 -42.22 72.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.079 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.448 HD23 ' CD2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -57.51 -53.45 58.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.296 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 10.1 mt -57.96 -46.88 84.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.873 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.3 m -55.59 -36.98 67.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.131 0.491 . . . . 0.0 109.865 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.28 -30.04 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.559 179.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.503 ' HE3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -71.5 -12.14 61.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.105 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt 64.38 42.23 5.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.107 0.479 . . . . 0.0 110.169 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -122.75 129.04 25.17 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.146 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' A' ' 1' ' ' MET . 88.2 Cg_endo -77.21 140.05 19.39 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.274 1.983 . . . . 0.0 110.987 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 18.5 p90 -155.51 170.49 21.85 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.311 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.439 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 7.5 tt0 -136.57 134.56 37.59 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.193 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 8' ' ' ASP . 8.6 t80 -90.45 156.94 17.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.539 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 29.8 mt -133.29 120.07 37.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.582 0.706 . . . . 0.0 110.196 179.16 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.622 ' HB2' ' CE1' ' A' ' 12' ' ' HIS . 5.6 p-10 -99.62 118.13 35.49 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.568 -1.197 . . . . 0.0 112.718 -177.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.651 ' N ' ' CE1' ' A' ' 12' ' ' HIS . 20.1 pt -101.42 67.99 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 178.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.606 ' N ' ' HE1' ' A' ' 12' ' ' HIS . 2.3 mtm -168.15 85.26 0.73 Allowed Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 122.678 0.391 . . . . 0.0 111.283 177.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 59.5 Cg_endo -71.79 -12.93 29.22 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.04 1.827 . . . . 0.0 110.526 178.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -150.24 150.04 31.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.37 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.19 -6.9 4.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.343 0.592 . . . . 0.0 111.528 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.92 -56.76 3.42 Favored Glycine 0 C--N 1.313 -0.697 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.158 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.2 t -150.63 157.54 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.546 ' HD1' ' HG3' ' A' ' 37' ' ' MET . 1.8 m-85 -59.91 170.27 1.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.867 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.412 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -86.49 98.69 11.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.776 179.447 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -49.52 -28.06 5.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.158 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -61.47 -56.4 20.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.379 . . . . 0.0 110.467 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -61.49 -46.04 91.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.331 179.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.01 -44.06 77.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.372 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.39 84.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.218 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -42.5 99.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.451 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -54.24 -46.0 72.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.468 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.2 mt -56.22 -50.74 70.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.969 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.0 m -63.16 -33.51 75.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.441 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -63.61 -39.53 94.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.457 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 mt -60.02 -54.19 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.678 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.92 -112.82 0.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.125 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.8 ttt85 -150.49 33.0 0.63 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.034 0.445 . . . . 0.0 110.689 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -120.73 -146.87 0.38 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.501 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 t -120.18 170.3 9.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.805 0.336 . . . . 0.0 110.645 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -107.05 101.45 10.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.653 0.74 . . . . 0.0 110.709 179.633 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -80.31 86.52 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.479 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.55 29.87 75.92 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -43.74 153.39 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 p -123.45 168.53 12.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.162 0.506 . . . . 0.0 111.62 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.9 mmt -122.53 153.15 62.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.558 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.96 159.74 65.77 Favored 'Cis proline' 0 N--CA 1.462 -0.374 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.94 0.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.409 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 5.7 tp60 -112.75 109.73 19.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.119 179.178 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.765 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.2 t -90.63 164.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.781 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 85.4 m-85 -142.52 146.41 34.66 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.671 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -58.32 148.55 63.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.436 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.549 ' HB3' ' N ' ' A' ' 1' ' ' MET . 51.0 Cg_exo -57.76 -29.92 87.43 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.104 2.536 . . . . 0.0 112.264 179.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -89.83 -26.88 20.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.426 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.11 89.23 0.62 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.754 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 m -176.53 164.77 2.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.468 0.175 . . . . 0.0 110.589 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.409 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 10.7 t-160 -90.93 119.92 31.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.004 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 70' ' ' ALA . 32.2 mt -98.94 -49.3 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.667 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.28 -153.19 21.11 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.782 -179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.7 -138.02 9.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.541 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.21 -70.42 0.29 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.741 0.305 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.7 -49.33 76.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -51.27 -39.23 56.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.578 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.493 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -78.52 -31.93 47.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.371 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -52.43 -30.71 30.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.5 -35.84 78.07 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' LEU . 32.0 t80 -60.04 -36.87 78.23 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.197 178.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CE1' ' HE3' ' A' ' 27' ' ' LYS . 7.0 m-85 -89.17 -22.47 22.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.552 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.885 -179.877 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.866 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 23.0 tpp . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.604 -0.147 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 32' ' ' GLU . 97.2 m-85 -42.89 135.55 2.98 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.108 0.48 . . . . 0.0 110.53 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.26 124.09 50.32 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.622 -178.379 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.474 HG11 ' CE1' ' A' ' 33' ' ' PHE . 53.9 t -111.87 144.19 20.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.257 0.551 . . . . 0.0 111.4 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 7.9 m-85 -124.78 103.43 8.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.261 178.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.65 -141.28 3.08 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.248 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.493 ' CE1' ' HE1' ' A' ' 37' ' ' MET . 32.3 m-85 -124.15 160.74 27.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.733 0.301 . . . . 0.0 110.601 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -103.11 29.32 5.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.417 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.2 p 65.97 9.83 6.47 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.305 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -87.12 -54.95 4.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 111.97 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.498 ' CG2' ' HA ' ' A' ' 40' ' ' LYS . 3.6 mp -94.22 -25.38 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -146.52 134.87 21.85 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.81 -178.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -61.57 129.62 41.99 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.2 -178.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.1 m -159.01 89.29 0.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.259 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 16' ' ' TYR . 15.7 m -74.25 -37.84 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.406 ' N ' HG23 ' A' ' 15' ' ' VAL . 3.7 m-85 -55.89 -29.23 59.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 0.0 111.349 -179.048 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 t -65.03 -60.69 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.229 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -56.93 -36.07 69.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.966 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -66.27 -38.39 87.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.444 -179.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -72.62 -35.85 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.319 . . . . 0.0 110.946 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 9.9 tttt -60.2 -34.9 74.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.024 0.44 . . . . 0.0 109.867 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -39.65 81.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.959 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.49 -52.84 62.33 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.891 179.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.95 -37.36 74.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.227 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 m -60.72 -39.77 89.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -74.86 -33.11 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.894 178.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -75.77 -9.48 58.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.761 179.252 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 58.86 37.25 24.84 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.275 0.56 . . . . 0.0 110.392 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.464 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -120.65 104.95 41.72 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.708 -179.699 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.866 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 2.0 Cg_endo -45.23 168.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.682 2.255 . . . . 0.0 112.351 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.537 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 5.0 p90 -162.8 170.78 17.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.425 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 2' ' ' PHE . 2.1 tm-20 -137.86 122.94 19.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.454 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.474 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.3 t80 -89.33 159.66 17.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.997 0.427 . . . . 0.0 111.68 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.454 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 20.8 mt -145.41 120.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.095 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -82.8 131.17 35.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.728 -178.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.439 ' CD1' ' CE1' ' A' ' 7' ' ' TYR . 5.2 pt -100.33 -28.16 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.024 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.613 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.9 ttp -123.93 91.39 49.68 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.841 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.02 3.44 7.8 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.841 2.361 . . . . 0.0 112.962 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -139.52 146.89 40.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.791 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 6.8 tmtt? -71.42 -7.76 49.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.285 0.564 . . . . 0.0 111.692 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.93 -60.62 1.25 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.048 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 t -147.0 144.1 20.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 112.041 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.613 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -64.21 169.37 4.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.973 179.723 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -98.57 116.34 30.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -57.89 -24.05 55.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.584 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -55.4 -48.82 73.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.848 0.356 . . . . 0.0 110.99 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -76.5 -36.96 57.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.061 0.458 . . . . 0.0 110.216 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.0 mm -58.1 -50.43 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.692 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -44.15 96.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.437 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.56 -37.89 89.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.373 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 ' CD2' ' A' ' 5' ' ' TYR . 25.4 tp -61.09 -54.23 47.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.563 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.3 mt -50.7 -42.66 57.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.8 m -65.55 -35.13 79.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.192 179.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 2.8 tttp -64.47 -39.96 94.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.304 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.45 -45.34 91.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.526 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.05 -110.84 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.89 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -150.55 32.5 0.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.996 0.427 . . . . 0.0 110.621 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.89 -146.75 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.431 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -119.99 170.43 9.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.708 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.74 98.39 8.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.137 0.494 . . . . 0.0 110.562 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -81.08 86.53 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.15 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.19 29.23 72.15 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.272 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.7 tt -46.73 152.55 0.47 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.343 . . . . 0.0 111.347 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.6 p -130.28 166.01 21.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.173 0.511 . . . . 0.0 111.683 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.41 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 1.3 mpt? -125.33 154.96 72.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.629 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.6 Cg_endo -83.86 143.46 44.05 Favored 'Cis proline' 0 C--N 1.344 0.333 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.916 0.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.9 OUTLIER -103.25 128.28 50.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 179.089 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 5.9 t -100.99 160.5 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 112.14 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 97.2 m-85 -143.7 159.29 42.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.416 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.47 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -70.12 144.6 92.81 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.141 -179.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -37.78 -31.96 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.487 2.792 . . . . 0.0 112.446 179.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.82 36.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.118 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.25 -109.49 1.85 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.955 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -127.37 -173.95 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.121 0.486 . . . . 0.0 111.335 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.477 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 35.5 t-80 -70.71 137.33 49.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.116 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.8 mp -109.65 -31.36 2.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.706 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 75' ' ' HIS . . . 117.95 -156.62 15.56 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.205 179.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.64 -124.61 5.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.147 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.468 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -80.09 -70.46 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.618 0.209 . . . . 0.0 111.299 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -52.29 -47.97 65.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.125 0.488 . . . . 0.0 110.6 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -57.66 -45.04 86.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.679 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.46 HD23 ' CE2' ' A' ' 86' ' ' PHE . 3.9 tt -74.31 -32.6 62.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.448 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 87' ' ' LYS . 5.9 ttp85 -52.59 -33.1 44.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -65.01 -33.65 76.55 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.12 178.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LEU . 17.3 t80 -64.72 -34.22 77.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.483 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.485 ' CE1' ' HE3' ' A' ' 27' ' ' LYS . 7.5 m-85 -90.8 -71.03 0.65 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.558 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 83' ' ' ARG . 37.6 mttt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.912 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.538 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 55.6 ttm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.818 0.342 . . . . 0.0 111.449 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.47 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 46.6 m-85 -55.23 155.0 5.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.067 0.46 . . . . 0.0 111.016 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -124.56 119.29 28.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.033 -179.37 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.53 HG12 ' CE1' ' A' ' 33' ' ' PHE . 24.4 t -114.44 127.1 72.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.203 0.525 . . . . 0.0 112.067 179.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.28 104.58 13.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.103 177.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.17 -139.19 2.58 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.684 -179.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -121.71 160.52 24.35 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.908 0.385 . . . . 0.0 111.344 -179.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.79 -72.99 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.778 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t 172.97 -36.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.981 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -64.72 -44.96 88.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.229 -179.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.47 HG23 HD11 ' A' ' 11' ' ' ILE . 20.4 mm -90.16 -40.11 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.431 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -149.96 152.49 35.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.012 0.434 . . . . 0.0 111.15 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -80.66 169.84 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.895 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 p 173.88 117.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.06 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -87.05 -34.35 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -22.63 66.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.014 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.8 t -72.05 -64.51 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.796 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -50.18 -35.48 26.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 51.8 m-20 -72.13 -59.0 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.17 -31.3 63.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.859 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -61.11 -54.46 44.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.659 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -66.5 -24.65 66.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.025 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD13 ' CE1' ' A' ' 79' ' ' PHE . 1.3 tt -59.86 -58.18 9.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 110.501 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 5.5 mt -60.38 -42.76 96.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.795 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.5 m -60.96 -41.08 95.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.49 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.1 t -73.68 -26.74 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.032 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 1.5 tpmp? -68.46 -44.35 75.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.79 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.645 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 112.71 30.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.331 1.052 . . . . 0.0 110.997 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -125.74 141.86 40.45 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.857 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -80.35 143.43 15.54 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.531 2.154 . . . . 0.0 111.669 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.538 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 33.9 p90 -145.87 167.8 22.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.947 0.403 . . . . 0.0 111.973 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.66 126.13 26.82 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.53 ' CE1' HG12 ' A' ' 4' ' ' VAL . 24.7 t80 -89.94 155.73 18.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.23 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 mt -150.51 122.63 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.399 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -78.1 110.17 12.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.639 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 pt -62.87 -21.15 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.72 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.565 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.1 ttp -128.05 88.6 52.54 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.03 1.25 8.87 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.638 2.225 . . . . 0.0 112.569 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -139.46 139.29 36.99 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.513 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -66.94 -8.53 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.269 0.557 . . . . 0.0 111.895 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.3 -63.54 1.5 Allowed Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.429 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 t -145.9 143.78 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.717 0.294 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -65.6 168.2 7.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 111.235 -179.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.9 118.06 30.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.178 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -71.43 -14.05 62.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.96 -61.07 2.51 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -41.42 95.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.193 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.8 mt -64.53 -33.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.57 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.87 82.25 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.712 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.95 -38.11 84.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.349 179.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.425 HD11 ' CE1' ' A' ' 69' ' ' PHE . 5.5 tp -57.96 -52.3 66.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.538 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.8 mt -51.45 -44.41 62.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.101 0.477 . . . . 0.0 111.278 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 m -63.27 -35.59 80.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.484 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.49 -40.34 89.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.657 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.94 -67.73 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.642 179.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.19 -107.02 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.033 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -150.45 31.42 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.004 0.43 . . . . 0.0 110.704 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.91 -149.44 0.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.353 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -120.53 170.19 9.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.755 0.312 . . . . 0.0 110.855 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -89.82 99.04 12.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.253 0.549 . . . . 0.0 110.309 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.501 HD11 HG22 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -78.22 88.02 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.039 -179.76 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.3 29.89 31.15 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.685 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -46.57 156.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 110.999 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.8 p -105.62 147.87 27.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.101 0.477 . . . . 0.0 111.614 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.4 mmt -119.53 153.23 53.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.4 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HB2' HG11 ' A' ' 4' ' ' VAL . 2.8 Cg_exo -78.82 148.8 83.75 Favored 'Cis proline' 0 C--N 1.344 0.298 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.948 0.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.41 ' CG ' ' NE2' ' A' ' 75' ' ' HIS . 2.1 tp60 -96.0 129.58 43.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.819 178.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.6 t -107.79 157.04 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.055 0.455 . . . . 0.0 111.947 -179.053 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 40.9 m-85 -143.01 137.29 29.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.646 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.429 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -47.08 160.85 0.32 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.376 -178.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.466 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.3 Cg_exo -60.24 -30.54 91.43 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.175 2.583 . . . . 0.0 112.12 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -94.3 -19.73 20.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.188 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.85 88.72 1.3 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.597 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.52 126.74 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.802 0.334 . . . . 0.0 110.686 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.422 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 5.1 t-160 -62.47 114.06 3.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.158 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 70' ' ' ALA . 8.7 mt -104.67 -39.88 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.764 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.98 -153.93 21.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.571 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.1 -135.8 9.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.651 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 13.4 t80 -71.62 -70.87 0.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 111.129 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.99 -47.16 86.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.71 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -52.38 -41.25 62.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.633 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.484 HD23 ' CE2' ' A' ' 86' ' ' PHE . 4.9 tt -75.87 -35.25 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 87' ' ' LYS . 7.8 ttp180 -51.14 -30.0 15.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -71.46 -34.3 70.09 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.142 178.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 82' ' ' LEU . 53.6 t80 -62.89 -35.55 80.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.35 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.484 ' CE2' HD23 ' A' ' 82' ' ' LEU . 8.8 m-85 -89.1 -27.62 20.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.454 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 83' ' ' ARG . 21.0 mtpp . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.955 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.665 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 2.0 tpt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.391 0.138 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -40.07 119.78 1.07 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.749 0.785 . . . . 0.0 111.613 -177.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.35 126.51 35.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.295 -179.102 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.497 HG13 ' CE1' ' A' ' 33' ' ' PHE . 59.3 t -109.2 148.21 13.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.392 0.615 . . . . 0.0 111.186 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 46.6 m-85 -128.05 99.77 5.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.737 178.613 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.63 -137.21 2.24 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.727 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.78 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 59.0 m-85 -121.24 108.02 13.25 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.669 0.271 . . . . 0.0 111.373 -179.042 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.533 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -110.94 51.0 0.79 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.003 179.816 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.44 -169.8 1.13 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -87.17 8.72 22.63 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.327 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 37' ' ' MET . 3.7 pt -86.59 -14.0 10.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.459 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 11.5 t-80 -162.61 153.79 17.59 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.139 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HE2' HG23 ' A' ' 15' ' ' VAL . 5.5 ptmt -79.02 171.57 15.03 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.8 p -165.04 89.54 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.728 0.299 . . . . 0.0 111.069 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.446 HG23 ' HE2' ' A' ' 13' ' ' LYS . 1.9 m -91.49 -40.7 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.606 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.07 -23.27 64.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.654 -179.233 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.61 -47.03 80.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.23 -32.69 64.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -73.87 -55.65 5.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.682 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.19 -51.11 71.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 110.837 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -55.03 -47.16 75.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 179.69 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -61.62 -40.5 95.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.028 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.56 -53.48 57.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.999 179.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 10.3 mt -59.55 -44.54 93.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.411 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 m -57.67 -40.87 80.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.8 t -75.31 -33.42 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.483 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -75.59 -12.11 60.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.929 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.8 41.72 1.15 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.849 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.15 118.07 16.1 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.407 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 77.8 Cg_exo -52.31 -177.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.308 2.005 . . . . 0.0 111.565 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.419 ' CE2' ' HE3' ' A' ' 21' ' ' LYS . 5.0 p90 -164.92 170.84 14.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.921 0.391 . . . . 0.0 111.367 178.012 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.647 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 34.7 tt0 -141.66 121.0 13.12 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.028 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 10.7 t80 -92.32 165.86 12.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.115 0.483 . . . . 0.0 112.078 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.453 HD11 ' CE1' ' A' ' 5' ' ' TYR . 25.4 mt -150.65 128.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.184 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.11 125.92 32.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.8 -178.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.9 pt -100.78 -25.11 3.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.718 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.739 ' HE1' ' CD2' ' A' ' 12' ' ' HIS . 2.3 ttm -108.91 105.19 56.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.012 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 37.5 Cg_endo -66.11 -29.65 47.74 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 121.769 1.646 . . . . 0.0 110.244 178.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -146.15 155.94 43.07 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.212 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -6.57 6.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.33 0.586 . . . . 0.0 111.568 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.34 -55.36 2.91 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 115.11 -0.95 . . . . 0.0 114.009 -178.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 t -148.2 135.87 14.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.951 0.376 . . . . 0.0 111.754 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -59.83 168.72 1.66 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.875 179.785 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.42 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -89.05 129.72 35.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.483 -179.907 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.37 -35.16 79.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.855 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -66.68 -50.9 61.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -68.32 -41.32 80.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.858 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.416 HD11 ' O ' ' A' ' 44' ' ' ASP . 1.3 mp -66.62 -35.19 74.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.661 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.01 -57.95 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.307 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -55.93 -29.62 60.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.984 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 24.4 tp -61.44 -61.16 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.078 179.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.427 ' HA ' HD13 ' A' ' 55' ' ' LEU . 86.2 mt -46.28 -35.73 5.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.692 179.442 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 m -69.29 -34.26 74.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.831 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 7.5 mtpp -68.36 -43.49 77.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.818 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 52' ' ' LEU . 4.8 mp -58.6 -20.26 45.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.418 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.11 -29.45 7.57 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.765 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -89.88 -174.82 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -108.43 -31.8 7.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -109.85 169.96 8.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -112.87 99.94 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.57 82.75 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.162 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.59 23.77 55.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.646 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.78 140.77 58.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.699 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.3 p -131.95 170.69 14.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.107 0.479 . . . . 0.0 111.474 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -104.09 155.5 37.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.664 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.4 Cg_exo -82.14 135.58 29.17 Favored 'Cis proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.678 0.463 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -92.99 128.37 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.18 179.187 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.0 t -102.88 157.11 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.015 0.436 . . . . 0.0 111.669 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 78.3 m-85 -143.09 147.21 34.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.775 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -56.16 140.9 70.24 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.37 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.85 -31.99 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.005 2.47 . . . . 0.0 112.115 179.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.43 34.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.932 179.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.87 -108.1 2.01 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.998 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.9 t -133.96 175.44 9.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.266 0.555 . . . . 0.0 111.511 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.48 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 10.1 t-80 -59.32 129.26 41.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.019 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 70' ' ' ALA . 9.3 mt -102.09 -42.14 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.977 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.54 -153.3 20.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.757 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.09 -142.4 13.27 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.379 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -69.43 -70.62 0.27 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 110.811 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -58.79 -48.73 80.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.517 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.74 -42.54 62.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.451 179.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.547 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.6 tt -79.77 -28.73 40.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.028 179.471 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -51.38 -32.6 26.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.93 -35.25 80.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.6 t80 -63.14 -34.07 76.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.354 178.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.547 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.7 m-85 -93.09 -12.43 30.52 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.589 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.97 179.92 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.554 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 36.5 ttm . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.877 0.37 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.47 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 68.8 m-85 -58.62 163.98 2.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.833 -179.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.723 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -138.67 119.27 13.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.684 -179.305 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.537 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 24.0 t -108.54 147.91 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.239 0.542 . . . . 0.0 111.508 179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 27.9 m-85 -130.87 101.55 5.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.466 178.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.62 -136.5 2.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.57 -179.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -108.27 157.26 18.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.846 0.355 . . . . 0.0 111.304 -179.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 9' ' ' SER . 20.3 t0 -85.14 -4.66 59.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.979 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 86.28 -36.63 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.955 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.33 -33.79 61.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.691 0.281 . . . . 0.0 111.089 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 40' ' ' LYS . 1.5 mt -89.79 -32.14 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.337 -179.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -141.24 132.03 25.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 110.621 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 151.25 41.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.573 -179.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 168.96 91.04 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.836 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.2 m -57.43 -37.05 55.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.53 -23.43 50.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -65.05 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.499 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.06 -34.97 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -60.88 -46.97 88.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.896 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.425 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -60.54 -43.44 97.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.294 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -53.98 -36.89 63.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.004 0.431 . . . . 0.0 110.132 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -70.18 -28.54 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.204 179.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -57.42 -55.96 27.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.927 179.414 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' CD2' HD22 ' A' ' 82' ' ' LEU . 24.8 mt -64.2 -42.54 96.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.578 179.459 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.8 m -58.59 -34.35 71.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.205 179.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.0 t -76.8 -31.25 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.616 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HG3' ' CD1' ' A' ' 86' ' ' PHE . 15.0 mmtt -76.07 -19.59 58.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.195 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.76 60.38 0.11 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -139.76 142.45 31.27 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.953 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.415 ' O ' ' HA ' ' A' ' 1' ' ' MET . 87.4 Cg_endo -75.91 137.31 19.61 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.405 2.07 . . . . 0.0 111.405 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.554 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 20.0 p90 -151.91 170.33 20.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -138.38 129.43 27.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.545 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.537 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 49.0 t80 -89.94 160.02 16.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.054 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.434 HD13 ' CE1' ' A' ' 5' ' ' TYR . 15.3 mt -145.57 121.43 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.295 0.569 . . . . 0.0 110.274 179.29 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -91.27 121.36 32.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.157 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 pt -80.64 -4.4 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.057 179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.428 ' HE3' ' CE2' ' A' ' 43' ' ' PHE . 36.9 ttm -132.85 110.97 13.28 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.778 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 71.9 Cg_endo -76.91 -30.73 4.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.552 2.168 . . . . 0.0 112.474 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -139.69 155.33 47.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.639 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -64.54 -8.03 12.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.296 0.57 . . . . 0.0 111.524 179.966 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.41 -52.21 4.6 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 115.177 -0.919 . . . . 0.0 113.193 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 t -149.24 153.4 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.105 0.479 . . . . 0.0 112.235 -179.188 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.428 ' CE2' ' HE3' ' A' ' 37' ' ' MET . 62.4 m-85 -73.74 168.72 18.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.124 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.409 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -99.71 111.62 23.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.891 179.345 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -62.48 -26.57 68.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.747 0.308 . . . . 0.0 110.556 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.32 -56.05 19.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -36.68 81.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.302 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.5 mt -67.27 -38.18 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.35 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.44 -56.07 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.273 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.31 -28.89 56.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.429 HD13 ' CG ' ' A' ' 5' ' ' TYR . 26.0 tp -62.96 -60.85 2.9 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.212 179.519 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.4 mt -45.54 -39.42 7.43 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.207 0.527 . . . . 0.0 111.288 179.229 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.8 m -67.11 -36.12 81.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.001 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HG2' ' CD2' ' A' ' 69' ' ' PHE . 7.9 tttp -63.22 -50.28 70.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.333 179.383 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 5.0 mp -58.92 -55.05 40.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.68 -126.39 0.9 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.376 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -150.4 33.23 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.991 0.424 . . . . 0.0 110.861 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -120.74 -144.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 t -105.06 170.06 8.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.72 0.295 . . . . 0.0 110.624 179.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.69 98.31 11.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.299 0.571 . . . . 0.0 110.546 179.841 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.4 mt -80.37 86.41 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.07 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.23 30.31 75.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.039 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.5 tt -48.03 151.32 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 111.512 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 p -142.26 170.18 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.39 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -132.13 149.76 74.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.648 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -85.59 149.36 47.05 Favored 'Cis proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.758 0.354 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 8.1 mt-30 -114.44 133.99 55.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.451 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -105.88 168.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.302 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 78.8 m-85 -142.33 146.11 34.66 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.431 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -57.16 138.3 80.2 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.235 -178.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HB3' ' N ' ' A' ' 1' ' ' MET . 87.1 Cg_exo -46.17 -28.4 5.47 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.878 2.385 . . . . 0.0 111.902 178.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.91 33.55 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.91 179.578 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.92 -108.89 1.76 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.934 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.419 ' N ' ' HB1' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -145.36 179.36 7.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.29 0.566 . . . . 0.0 111.421 -179.537 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.41 ' CE1' ' OE1' ' A' ' 67' ' ' GLN . 16.3 t-160 -49.76 118.79 3.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.355 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 70' ' ' ALA . 6.7 mt -84.83 -47.51 17.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.891 0.376 . . . . 0.0 111.076 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.83 -152.36 18.02 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.493 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -93.37 -155.3 31.82 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.405 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.549 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -61.61 -67.76 0.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 O-C-N 122.83 -0.218 . . . . 0.0 110.859 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -48.39 -42.18 31.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.068 0.461 . . . . 0.0 110.541 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -67.37 -42.32 83.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.417 179.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.462 HD22 ' CD2' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -66.71 -45.83 77.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.316 179.726 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -51.13 -36.61 41.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -70.29 -34.95 73.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.233 178.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -66.54 -30.61 70.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.751 178.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CD2' HD23 ' A' ' 82' ' ' LEU . 24.8 m-85 -90.9 -66.72 0.9 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.69 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.2 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.577 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.3 ttm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.897 0.38 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.46 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 87.4 m-85 -64.4 156.34 29.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.011 0.434 . . . . 0.0 110.689 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.58 120.22 22.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.561 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.489 HG11 ' CE1' ' A' ' 33' ' ' PHE . 21.1 t -108.62 137.38 40.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.18 0.514 . . . . 0.0 111.755 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 2.5 m-85 -115.73 101.08 8.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.927 178.488 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.25 -138.19 2.39 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.286 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -126.22 157.11 39.09 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.647 0.261 . . . . 0.0 111.039 -179.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.01 -69.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.807 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 t 170.87 -39.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.813 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -76.77 -24.74 52.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.844 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.82 -43.62 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.153 0.501 . . . . 0.0 110.17 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -152.18 147.21 26.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.131 179.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.55 159.14 26.99 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.239 -179.382 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -177.06 106.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.585 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.92 -36.65 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.697 -179.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -62.87 -21.22 65.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.495 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.6 t -64.54 -52.84 55.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.955 0.407 . . . . 0.0 110.571 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -55.55 -32.46 63.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.323 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -72.34 -53.76 11.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.224 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.4 -48.6 74.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.982 0.42 . . . . 0.0 111.139 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -51.15 71.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -42.19 78.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.5 -54.67 44.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.394 179.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -55.38 -44.97 76.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.771 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.1 m -58.36 -34.62 70.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.133 0.492 . . . . 0.0 110.059 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.84 -30.18 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.734 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 2.1 mmtt -79.17 -14.38 59.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 66.31 60.81 0.61 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.999 0.428 . . . . 0.0 110.804 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -133.62 143.1 46.37 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 1' ' ' MET . 75.8 Cg_endo -80.17 132.86 9.55 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.606 2.204 . . . . 0.0 111.445 179.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.577 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 29.1 p90 -155.18 170.43 21.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.921 0.391 . . . . 0.0 112.012 -179.682 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -144.84 145.72 31.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.058 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.29 158.44 17.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.099 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 16.8 mt -142.28 117.66 5.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.213 179.352 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -81.33 119.44 23.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.54 -179.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.5 tt -85.86 -27.86 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.193 179.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 7.4 ttp -129.93 95.86 27.5 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 179.418 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -78.14 -5.06 14.88 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.563 2.175 . . . . 0.0 112.691 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -139.9 139.89 36.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.755 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.91 -8.63 23.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.237 0.542 . . . . 0.0 111.989 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.16 -61.68 1.8 Allowed Glycine 0 C--N 1.312 -0.787 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.228 179.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.52 133.01 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.735 0.302 . . . . 0.0 111.094 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.03 167.59 1.6 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.01 0.433 . . . . 0.0 111.29 -179.804 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.45 108.79 18.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.102 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -53.09 -25.89 14.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.163 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -55.83 -49.94 71.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.773 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -74.98 -34.45 62.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.125 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.0 mm -59.82 -49.92 82.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.775 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.55 -50.61 72.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.488 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.23 -41.05 98.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.353 179.44 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 tp -57.07 -49.61 75.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.75 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.76 -49.89 69.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.086 0.47 . . . . 0.0 111.153 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.4 m -60.98 -33.19 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.272 179.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -64.29 -41.36 96.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.354 179.505 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.84 -56.11 25.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.567 179.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.96 -109.03 0.27 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.953 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -150.65 30.89 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.414 . . . . 0.0 110.698 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -121.03 -148.84 0.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.377 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 t -120.62 170.32 9.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 0.0 110.687 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -98.09 98.85 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.041 0.448 . . . . 0.0 110.471 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -80.25 85.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.242 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.64 27.89 55.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.444 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -47.41 154.27 0.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.829 0.347 . . . . 0.0 111.01 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.3 p -113.84 157.94 21.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.089 0.471 . . . . 0.0 111.636 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -120.84 158.15 52.9 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.8 Cg_exo -82.18 148.58 69.11 Favored 'Cis proline' 0 C--N 1.343 0.253 0 C-N-CA 124.017 -1.243 . . . . 0.0 112.887 0.469 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -105.07 125.6 51.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.167 179.023 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -97.25 167.98 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.878 0.37 . . . . 0.0 111.607 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.485 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 75.7 m-85 -142.63 141.45 31.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.74 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.66 147.64 29.69 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.13 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.496 ' HB3' ' N ' ' A' ' 1' ' ' MET . 51.6 Cg_exo -54.57 -27.81 52.37 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.804 2.336 . . . . 0.0 111.813 179.099 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -97.69 -22.32 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.014 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.16 82.82 0.6 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.63 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.78 115.66 0.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.727 0.299 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -50.71 116.71 2.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.177 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.6 mt -88.82 -41.02 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.162 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.59 -150.09 17.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.633 -179.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.48 -140.12 9.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.399 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -75.84 -61.24 1.99 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.59 -42.72 67.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.24 -44.36 92.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.636 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -49.0 79.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.464 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 ttt-85 -52.34 -32.44 38.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -75.06 -32.34 61.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.162 178.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -67.22 -32.2 73.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.357 178.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' A' ' 27' ' ' LYS . 26.1 m-85 -93.34 -70.47 0.7 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.504 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.923 179.983 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.53 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 58.1 ttm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.99 0.424 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.486 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 93.0 m-85 -53.17 152.51 4.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.039 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -126.92 120.44 29.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.954 -179.15 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.459 HG13 ' CE1' ' A' ' 33' ' ' PHE . 27.3 t -111.01 138.03 40.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 0.0 111.438 179.467 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 2.8 m-85 -114.73 99.03 7.21 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.128 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.76 -138.36 2.48 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.237 -0.983 . . . . 0.0 112.561 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 17.6 m-85 -118.91 148.45 42.92 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.592 0.234 . . . . 0.0 110.674 -179.191 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.3 t0 -78.36 7.09 7.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.2 m 80.97 -15.78 0.71 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -85.93 -47.82 9.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 111.788 -179.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.0 mt -89.86 -15.34 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.971 -179.298 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.702 ' CD2' ' HE1' ' A' ' 37' ' ' MET . 12.1 t-80 -150.76 163.33 38.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.997 -178.23 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.06 157.84 23.98 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.062 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 176.84 108.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.92 0.39 . . . . 0.0 111.94 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.9 m -91.75 -28.97 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.391 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -71.44 -22.17 61.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.224 -178.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 p -67.26 -34.47 77.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.058 0.456 . . . . 0.0 110.45 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -56.27 12.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.59 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -49.77 72.1 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.392 -179.248 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.72 -45.19 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 111.038 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -64.74 -50.37 67.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.803 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -39.3 69.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.76 -54.28 48.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.451 179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 mt -56.89 -44.94 82.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.732 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.2 m -59.24 -39.53 83.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.097 0.475 . . . . 0.0 110.171 179.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.08 -32.63 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.66 179.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -76.56 -9.74 58.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.048 179.787 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.45 61.17 0.46 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.931 0.396 . . . . 0.0 110.778 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -140.76 138.73 18.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.175 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 1' ' ' MET . 52.4 Cg_endo -83.05 142.09 10.81 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.685 2.257 . . . . 0.0 111.499 179.249 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.53 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 49.7 p90 -153.1 170.27 20.9 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.66 140.64 35.01 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.094 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 4' ' ' VAL . 11.1 t80 -89.73 161.57 15.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.349 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.489 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 16.9 mt -147.4 120.65 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.198 179.459 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -95.71 131.21 42.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.536 -179.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -100.46 -24.54 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.912 179.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.702 ' HE1' ' CD2' ' A' ' 12' ' ' HIS . 21.9 ttm -114.5 82.0 7.35 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.755 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.53 7.81 4.79 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.715 2.276 . . . . 0.0 112.527 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -139.37 129.9 25.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.353 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -59.79 -8.28 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.183 0.516 . . . . 0.0 112.04 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.77 -71.52 1.04 Allowed Glycine 0 C--N 1.314 -0.657 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.374 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.07 133.95 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -67.69 165.65 16.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.011 0.434 . . . . 0.0 111.46 -179.637 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -81.28 124.89 29.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.346 -179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.28 -24.89 57.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.199 179.865 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.0 -51.35 68.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.85 0.357 . . . . 0.0 110.616 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -71.05 -39.23 72.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.119 179.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.29 -37.87 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.551 179.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.56 -49.68 70.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.49 -40.64 97.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.419 179.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.13 -51.19 70.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.707 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.6 mt -51.99 -46.64 64.95 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.132 0.492 . . . . 0.0 111.167 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -65.92 -32.97 74.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.105 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -63.43 -42.02 98.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.379 179.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.81 -69.85 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.074 179.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.0 -35.14 0.29 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.554 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -109.41 -166.48 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.333 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -109.48 -30.4 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -90.23 164.44 14.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.798 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.97 100.26 7.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.7 tp -78.96 83.92 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.091 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.99 25.63 56.9 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.571 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.26 137.05 42.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.939 0.399 . . . . 0.0 110.889 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.5 p -122.03 170.29 9.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 111.448 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.67 157.9 64.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.709 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.1 Cg_endo -85.25 149.81 50.29 Favored 'Cis proline' 0 N--CA 1.463 -0.304 0 C-N-CA 124.093 -1.211 . . . . 0.0 112.681 0.275 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -109.75 127.88 54.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.113 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -98.85 165.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.958 0.408 . . . . 0.0 111.672 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.514 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 84.5 m-85 -142.3 142.49 32.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.781 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.37 137.23 40.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.254 -178.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.451 ' HB3' ' N ' ' A' ' 1' ' ' MET . 98.5 Cg_exo -44.36 -29.89 3.37 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.08 2.52 . . . . 0.0 112.265 179.106 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.38 36.25 0.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.248 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.26 -109.29 1.12 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.837 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.9 p -135.86 176.11 8.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.021 0.438 . . . . 0.0 111.2 -179.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 41.8 t-80 -52.37 125.72 16.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.285 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 85' ' ' TYR . 19.0 mt -91.23 -45.3 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.41 ' HA2' ' CE1' ' A' ' 75' ' ' HIS . . . 132.0 -151.09 19.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.747 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.93 -136.72 7.83 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.61 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -77.17 -63.12 1.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 111.123 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -53.65 -45.68 70.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.902 0.382 . . . . 0.0 110.84 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -45.28 85.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.539 179.673 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.31 -47.81 83.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.702 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -52.38 -33.32 42.83 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.072 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.73 66.7 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.408 ' HB2' ' CG2' ' A' ' 76' ' ' ILE . 54.9 t80 -66.11 -33.94 76.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.404 178.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.525 ' CD1' ' HD2' ' A' ' 27' ' ' LYS . 18.7 m-85 -90.02 -26.95 20.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.428 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.194 -0.907 . . . . 0.0 110.857 -179.904 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.543 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 21.2 ttm . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.831 0.348 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.495 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 92.4 m-85 -60.04 148.57 35.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.621 -179.654 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -125.36 118.13 25.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 -179.378 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' A' ' 66' ' ' PRO . 70.7 t -108.82 144.6 16.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.179 0.514 . . . . 0.0 111.387 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.476 ' CZ ' HD13 ' A' ' 34' ' ' ILE . 6.8 m-85 -124.98 99.49 6.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.051 178.201 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.74 -149.14 5.7 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.891 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.463 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 63.3 m-85 -105.95 152.23 23.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.754 0.311 . . . . 0.0 111.273 -179.857 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.5 p30 -72.32 -63.12 1.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.576 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.4 p 160.2 -32.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.046 0.45 . . . . 0.0 110.849 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -85.13 -22.82 28.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.467 -179.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.448 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 9.6 mt -88.42 -38.7 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.603 0.239 . . . . 0.0 110.949 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -147.75 141.56 25.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 111.154 179.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 140.23 58.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.192 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 173.8 106.38 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.222 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 m -85.72 -25.65 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.399 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.27 -34.76 72.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.396 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -67.05 -42.73 84.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.71 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -24.83 68.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.971 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 87.9 m-20 -78.12 -53.59 7.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.234 -179.634 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -53.43 -45.2 69.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.968 0.413 . . . . 0.0 110.942 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -51.49 69.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.807 179.794 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -57.8 -39.26 77.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.669 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.417 HD21 ' CE2' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -56.63 -53.09 61.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.354 179.385 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.441 HD21 ' CD2' ' A' ' 2' ' ' PHE . 6.7 mt -56.33 -46.17 80.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.597 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -55.75 -36.62 67.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.053 0.454 . . . . 0.0 109.825 179.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.2 t -80.11 -30.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.491 179.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -13.49 60.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.046 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.26 59.85 0.51 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.99 0.424 . . . . 0.0 111.079 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -140.48 140.41 22.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.037 179.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' A' ' 1' ' ' MET . 71.7 Cg_endo -79.84 137.87 12.85 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.557 2.171 . . . . 0.0 111.376 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.543 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 13.2 p90 -154.89 170.28 22.06 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -138.8 129.87 26.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.972 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.457 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 1.2 t80 -92.62 122.34 34.94 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.901 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.476 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 7.7 mt -104.43 109.8 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.629 0.728 . . . . 0.0 110.469 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -81.6 118.93 23.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.253 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.422 ' HB ' ' CD1' ' A' ' 48' ' ' ILE . 20.3 pt -100.21 45.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.356 179.574 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.492 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.4 ttt -162.72 99.79 1.07 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.075 -179.659 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 56.3 Cg_endo -71.19 -33.14 11.91 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.265 1.976 . . . . 0.0 111.719 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.91 157.86 45.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.349 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 11' ' ' ILE . 4.8 mttt -64.96 -8.46 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.301 0.572 . . . . 0.0 111.453 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.68 -56.73 2.06 Favored Glycine 0 C--N 1.313 -0.721 0 CA-C-N 115.201 -0.908 . . . . 0.0 113.557 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.3 144.84 29.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 13.5 m-85 -71.08 170.65 12.43 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.153 179.438 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.415 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -95.15 115.84 27.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.753 179.151 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -56.72 -28.23 60.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.23 -52.87 62.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -70.78 -47.87 57.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.81 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 43' ' ' PHE . 1.8 mp -55.78 -48.71 77.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.62 96.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.521 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.78 -35.25 79.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.617 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 tp -58.71 -54.55 45.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.533 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.8 mt -53.56 -46.27 70.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.175 179.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 m -62.47 -32.1 72.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.386 179.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -69.67 -36.41 76.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.472 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.68 -61.16 2.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.555 179.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.5 -105.82 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.993 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -146.1 30.14 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.077 0.465 . . . . 0.0 110.547 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -120.91 -153.65 0.55 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.544 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 t -120.84 170.61 9.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.3 98.38 8.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.55 . . . . 0.0 110.282 179.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.0 mm -79.71 84.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.191 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.6 25.11 57.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.463 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.12 143.26 55.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.785 179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.4 p -121.69 153.21 38.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.277 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.0 mmt -102.65 153.97 37.81 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.495 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.464 ' HB2' HG12 ' A' ' 4' ' ' VAL . 3.2 Cg_exo -77.7 141.33 66.8 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.022 0.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' TYR . 35.5 mt-30 -99.31 122.4 42.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.488 179.223 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -96.5 165.76 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.897 0.38 . . . . 0.0 111.67 -179.483 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 72.2 m-85 -142.8 142.29 31.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.742 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -54.07 134.45 58.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.163 -178.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.521 ' HB3' ' N ' ' A' ' 1' ' ' MET . 98.0 Cg_exo -44.68 -29.41 3.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.912 2.408 . . . . 0.0 112.116 178.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -163.74 42.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.256 179.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.08 -107.93 0.7 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.741 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.58 176.13 8.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.154 0.502 . . . . 0.0 111.27 -179.646 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 68' ' ' VAL . 38.1 t-80 -52.51 123.2 10.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.178 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.5 mt -85.8 -44.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.09 -151.22 20.19 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 -179.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.51 -155.11 30.23 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.74 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.414 ' CE1' ' HA ' ' A' ' 20' ' ' ALA . 10.5 t80 -63.14 -70.58 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 110.835 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -57.53 -44.9 85.47 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.501 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.09 -31.62 31.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.379 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.5 HD22 ' CE2' ' A' ' 86' ' ' PHE . 3.6 tt -80.78 -34.98 33.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.269 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttp85 -52.16 -30.44 26.8 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -68.72 -35.22 76.86 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.514 -0.766 . . . . 0.0 108.974 178.067 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 28.2 t80 -62.54 -34.62 77.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.274 178.329 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.5 ' CE2' HD22 ' A' ' 82' ' ' LEU . 6.7 m-85 -87.61 -70.28 0.64 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.348 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.914 -179.939 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 58.5 ttm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.947 0.403 . . . . 0.0 111.469 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.494 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 64.2 m-85 -49.75 170.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.87 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -145.3 114.57 7.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.661 -179.341 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.478 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 61.7 t -107.63 143.16 18.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.296 0.569 . . . . 0.0 112.04 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 7.3 m-85 -121.71 105.64 10.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.623 177.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.47 -135.3 1.86 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.75 -179.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.436 ' HE1' ' HE1' ' A' ' 37' ' ' MET . 67.6 m-85 -110.45 150.49 28.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.88 0.371 . . . . 0.0 111.274 -179.33 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.32 6.94 46.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.229 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p 78.46 -8.86 1.6 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -85.2 -40.09 17.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.629 0.252 . . . . 0.0 111.301 -179.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.467 HG21 ' O ' ' A' ' 39' ' ' GLU . 2.4 mp -99.02 -38.25 6.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.847 0.356 . . . . 0.0 111.676 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 17.7 t60 -139.8 152.0 46.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.493 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 162.8 28.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.078 0.466 . . . . 0.0 112.067 -178.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -178.62 117.18 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.127 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 m -89.61 -34.59 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.992 0.425 . . . . 0.0 110.949 179.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -60.48 -23.25 64.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.333 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.52 -40.65 56.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.917 0.389 . . . . 0.0 110.42 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -63.88 -51.72 63.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.472 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 6.2 p30 -66.91 -49.0 66.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.163 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -53.5 -43.72 68.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.933 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -65.33 -58.44 5.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.796 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 ttm-85 -55.51 -40.19 71.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.523 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.97 -54.02 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.407 179.305 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 6.2 mt -56.29 -42.37 77.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.548 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -60.13 -36.5 77.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.86 179.255 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.67 -31.12 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.563 179.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -9.72 58.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.025 179.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm 67.89 60.82 0.43 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.148 0.499 . . . . 0.0 110.657 -179.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -146.44 132.55 9.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.978 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.4 Cg_endo -78.35 147.75 23.22 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.436 2.09 . . . . 0.0 111.134 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.525 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 12.7 p90 -157.33 170.9 21.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.607 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -140.74 135.02 31.12 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.983 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.478 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 28.4 t80 -89.47 164.26 14.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.221 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.459 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 11.0 mt -147.28 119.59 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.398 179.527 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -95.8 133.19 40.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.277 -179.332 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.437 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 2.0 pp -100.24 -13.96 8.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.219 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.436 ' HE1' ' HE1' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -122.65 75.55 45.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.464 179.967 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 77.8 Cg_endo -88.24 37.46 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.078 2.519 . . . . 0.0 112.926 -179.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.467 ' O ' HG21 ' A' ' 11' ' ' ILE . 38.6 mt-10 -139.0 170.74 15.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.486 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -61.52 -7.99 3.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.22 0.533 . . . . 0.0 112.046 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.29 55.37 0.02 OUTLIER Glycine 0 C--N 1.314 -0.669 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.758 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -150.31 118.93 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.23 0.538 . . . . 0.0 111.838 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.437 ' CZ ' HD13 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -64.89 137.25 57.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.358 178.901 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 36' ' ' ILE . 1.8 t70 -95.04 105.53 17.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.098 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.11 -21.52 32.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.663 -179.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.0 -51.27 70.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.677 0.275 . . . . 0.0 111.045 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.91 -41.15 64.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.386 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 44' ' ' ASP . 2.5 mp -59.83 -40.3 82.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.328 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.87 -48.52 71.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.235 179.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -39.28 93.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.439 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.402 HD22 ' NE2' ' A' ' 67' ' ' GLN . 28.2 tp -58.06 -50.65 72.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.613 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.6 mt -51.26 -45.08 61.94 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.145 0.498 . . . . 0.0 111.11 179.458 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.5 m -66.48 -31.16 71.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.134 179.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.81 -31.72 70.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.31 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.46 -70.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.87 179.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.02 -30.18 0.99 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.173 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -105.57 -174.97 2.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.691 0.282 . . . . 0.0 110.831 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -101.35 -30.65 11.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.102 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -104.43 166.05 10.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.998 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -117.26 100.32 7.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.688 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 pt -75.54 82.7 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.456 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.7 20.08 77.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.928 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.45 132.65 44.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 110.754 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.09 170.22 14.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.067 0.46 . . . . 0.0 111.429 -179.669 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.448 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -105.5 157.36 34.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.772 179.767 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.7 Cg_exo -76.82 152.77 95.74 Favored 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.977 -1.26 . . . . 0.0 112.98 0.467 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 5' ' ' TYR . 5.0 mt-30 -118.62 116.18 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.314 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -93.18 165.55 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.658 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 76.6 m-85 -143.2 148.15 36.02 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.697 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -58.22 144.73 76.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.182 -178.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.484 ' HB3' ' N ' ' A' ' 1' ' ' MET . 66.7 Cg_exo -54.62 -27.87 53.14 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.059 2.506 . . . . 0.0 112.434 179.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -90.78 -32.01 16.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.379 -179.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.37 80.89 0.17 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.798 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.74 164.09 21.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -90.54 118.42 29.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.144 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.3 mt -96.21 -46.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.031 0.443 . . . . 0.0 110.726 179.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.9 -147.9 17.56 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.022 -179.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.82 -161.9 36.74 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.207 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 19' ' ' ASN . 35.0 t80 -69.53 -49.59 52.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.405 179.734 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -55.76 -49.0 74.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.628 179.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -31.81 73.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.483 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.467 HD12 ' CD2' ' A' ' 86' ' ' PHE . 2.7 tm? -73.93 -42.54 60.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.653 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.6 ttt-85 -56.08 -43.92 78.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.678 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -61.84 -38.79 89.51 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.479 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -60.56 -40.28 91.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.89 177.795 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.467 ' CD2' HD12 ' A' ' 82' ' ' LEU . 3.9 m-30 -82.07 -10.12 59.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.141 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.152 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.612 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 34.6 ttm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.412 ' CD2' ' HD3' ' A' ' 71' ' ' PRO . 95.9 m-85 -78.11 143.9 36.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.461 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.72 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -104.94 118.9 37.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.444 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.682 HG22 HG22 ' A' ' 68' ' ' VAL . 5.9 t -101.66 117.32 46.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.083 0.468 . . . . 0.0 111.146 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.734 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.7 m-30 -92.6 98.76 11.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.616 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' C ' ' CD1' ' A' ' 7' ' ' TYR . . . -160.57 -140.21 2.84 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.747 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.691 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 5.4 m-85 -131.82 134.24 45.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 120.735 0.302 . . . . 0.0 111.539 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -128.39 62.36 1.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.102 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -172.78 -172.1 0.84 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.163 0.506 . . . . 0.0 111.845 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.13 2.18 47.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.885 HG21 ' O ' ' A' ' 39' ' ' GLU . 0.8 OUTLIER -87.37 -4.02 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.989 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.691 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 6.8 t60 -169.98 145.09 2.84 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.929 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.89 168.72 18.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.024 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -177.88 110.59 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.295 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 16' ' ' TYR . 27.7 m -90.58 -46.02 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.49 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.509 ' N ' HG23 ' A' ' 15' ' ' VAL . 24.2 m-85 -62.17 -22.27 65.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.032 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.0 t -63.07 -41.13 99.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.798 0.332 . . . . 0.0 111.038 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -62.0 -54.5 40.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.437 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 4.7 p30 -69.45 -51.66 34.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.398 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.82 -36.44 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.341 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -62.12 -57.83 10.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.472 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.768 ' O ' HG23 ' A' ' 26' ' ' VAL . 18.2 ttt180 -65.18 -23.79 67.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.817 HD12 ' CE1' ' A' ' 79' ' ' PHE . 5.5 tt -58.54 -58.7 7.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.085 0.469 . . . . 0.0 110.386 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.906 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 9.5 mt -63.23 -39.2 93.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.68 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.9 m -62.92 -39.51 94.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.436 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.0 t -65.78 -45.95 90.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.688 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -12.17 61.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.237 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.93 52.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.896 0.379 . . . . 0.0 111.274 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -136.74 138.17 25.55 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.752 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 1' ' ' MET . 63.1 Cg_endo -80.7 159.82 21.78 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.589 2.193 . . . . 0.0 111.775 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.61 ' CG ' HD12 ' A' ' 24' ' ' LEU . 30.3 p90 -161.63 170.75 19.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.842 0.353 . . . . 0.0 111.559 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.96 135.21 35.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.724 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 8.7 t80 -89.61 158.51 17.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.308 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.734 HD12 ' CE1' ' A' ' 5' ' ' TYR . 13.3 mt -147.69 121.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.212 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -89.61 127.34 35.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.297 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.655 HD11 ' OH ' ' A' ' 7' ' ' TYR . 5.0 pt -99.56 22.39 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.047 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.529 ' CE ' ' HE2' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -155.7 77.39 4.69 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.791 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.29 22.13 0.78 Allowed 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.825 2.35 . . . . 0.0 113.026 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.885 ' O ' HG21 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -147.74 157.65 43.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.587 0.232 . . . . 0.0 111.134 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.825 ' HA ' HG23 ' A' ' 11' ' ' ILE . 6.0 ptmt -47.4 -8.87 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' GLU . . . 176.21 46.69 0.06 OUTLIER Glycine 0 C--N 1.308 -0.988 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.553 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 t -150.13 120.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.516 . . . . 0.0 111.849 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.613 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -68.64 170.29 9.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.358 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.626 ' O ' HD13 ' A' ' 48' ' ' ILE . 6.3 t70 -95.1 105.77 17.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.372 . . . . 0.0 110.862 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -56.27 -29.18 60.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.88 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.46 -56.0 11.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 111.329 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HD3' HG21 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -69.66 -43.19 73.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.939 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.626 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.5 mp -52.01 -47.22 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.741 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.69 -54.81 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.16 -30.56 71.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.518 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.5 tt -59.22 -53.33 59.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.528 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 48' ' ' ILE . 14.2 mt -54.25 -50.44 67.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.041 0.448 . . . . 0.0 111.103 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.0 m -60.85 -36.59 79.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.367 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -66.47 -39.09 88.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.794 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.441 HD21 ' CD2' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -59.58 -52.5 65.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.096 0.474 . . . . 0.0 110.347 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.68 -114.42 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.89 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -150.48 30.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.102 0.477 . . . . 0.0 110.671 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -121.08 -143.62 0.34 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.467 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -119.55 170.34 9.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.734 0.302 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.65 98.11 8.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.253 0.549 . . . . 0.0 110.636 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 61' ' ' ILE . 6.4 tp -80.5 85.51 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.864 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.27 29.67 69.3 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.988 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.531 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.2 tm? -44.97 119.4 1.97 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.38 . . . . 0.0 111.172 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.2 p -110.09 170.27 8.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.251 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 154.01 61.01 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.939 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.1 Cg_endo -86.64 152.51 45.56 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 124.258 -1.143 . . . . 0.0 112.406 0.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -117.91 113.06 21.16 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -83.34 163.06 3.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.131 0.491 . . . . 0.0 111.902 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 50.9 m-85 -142.52 141.57 32.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.335 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.654 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.2 132.44 51.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.614 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HB3' ' N ' ' A' ' 1' ' ' MET . 33.7 Cg_exo -53.48 -21.88 19.82 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.56 2.173 . . . . 0.0 111.795 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -161.61 41.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.29 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.95 -110.72 0.63 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.998 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.515 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 37.1 m -137.85 178.62 6.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.136 0.493 . . . . 0.0 111.274 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 37.9 t-80 -55.75 132.36 49.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.116 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' HA ' ' A' ' 70' ' ' ALA . 9.4 mt -100.98 -42.65 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.05 -154.95 22.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.028 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.13 -141.39 10.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.843 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.817 ' CE1' HD12 ' A' ' 23' ' ' LEU . 26.5 t80 -72.42 -70.64 0.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.767 0.317 . . . . 0.0 111.332 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -56.93 -49.53 75.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 110.663 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -53.11 -37.64 61.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.706 HD21 ' CE1' ' A' ' 86' ' ' PHE . 5.4 tt -77.82 -34.49 51.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.212 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 -51.98 -31.37 29.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -68.8 -32.43 72.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.286 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 26.3 t80 -68.43 -29.99 68.77 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.589 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.906 ' CZ ' HD22 ' A' ' 24' ' ' LEU . 22.6 m-85 -92.33 -25.49 18.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.416 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.2 mttt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.793 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.545 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 34.2 ttp . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.902 0.382 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.464 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 65.0 m-85 -50.05 169.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.785 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -143.28 117.48 9.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.496 -178.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 68' ' ' VAL . 77.1 t -108.88 144.64 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.201 0.524 . . . . 0.0 111.535 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.759 ' CE1' HD12 ' A' ' 34' ' ' ILE . 10.9 m-85 -125.47 99.95 6.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.196 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.36 -137.46 2.22 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.257 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.08 159.34 20.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.738 0.304 . . . . 0.0 110.905 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -84.73 -73.7 0.42 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p 167.83 -33.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 110.638 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -85.12 -23.15 28.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.493 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.594 HG23 ' O ' ' A' ' 39' ' ' GLU . 4.1 mp -91.73 -44.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.222 0.534 . . . . 0.0 110.733 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -150.08 139.8 21.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.004 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.82 146.0 43.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.276 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.98 112.12 0.64 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.322 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 m -90.56 -30.74 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.451 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -65.02 -27.28 68.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.51 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.1 t -56.8 -53.86 52.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.352 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.16 -35.62 64.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.176 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -72.92 -58.96 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.989 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.12 -37.69 64.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.213 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -59.5 -54.27 48.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.691 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.85 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.4 tpp180 -66.33 -28.87 69.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.049 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.706 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.6 tt -54.57 -53.71 50.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.477 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.687 HD12 ' CG ' ' A' ' 31' ' ' PHE . 4.7 mt -65.18 -40.76 94.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.536 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 m -61.8 -34.02 75.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.329 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 22' ' ' ARG . 96.9 t -74.13 -28.51 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.01 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -83.45 -12.57 56.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.293 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.49 55.95 0.08 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -142.19 142.39 24.14 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.449 ' O ' ' HA ' ' A' ' 1' ' ' MET . 98.5 Cg_endo -79.09 148.54 21.73 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.485 2.123 . . . . 0.0 111.323 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.687 ' CG ' HD12 ' A' ' 24' ' ' LEU . 36.8 p90 -156.74 170.64 21.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' OE2' ' HE1' ' A' ' 1' ' ' MET . 1.4 tt0 -141.68 134.92 29.33 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.026 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.49 ' HE1' HG11 ' A' ' 4' ' ' VAL . 30.3 t80 -89.68 161.97 15.83 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.093 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.759 HD12 ' CE1' ' A' ' 5' ' ' TYR . 17.0 mt -147.22 121.4 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.602 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -99.45 131.77 45.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.938 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.672 HD12 ' HD1' ' A' ' 43' ' ' PHE . 1.1 pp -96.82 7.19 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.763 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.48 ' HE2' ' CE1' ' A' ' 43' ' ' PHE . 1.5 tpp -140.62 69.41 31.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.705 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 3.8 Cg_exo -80.96 43.65 1.59 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.296 2.664 . . . . 0.0 112.899 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.594 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -144.18 170.36 16.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.57 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.5 tptt -66.41 -7.69 20.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.199 0.523 . . . . 0.0 111.975 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.49 50.0 0.02 OUTLIER Glycine 0 C--N 1.313 -0.739 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.667 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -150.48 120.2 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.213 0.53 . . . . 0.0 111.818 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HD1' HD12 ' A' ' 36' ' ' ILE . 65.0 m-85 -65.61 136.61 56.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.157 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.588 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -97.83 113.76 25.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.831 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -63.37 -17.27 62.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.46 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -62.3 -57.29 11.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.862 0.363 . . . . 0.0 110.646 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -72.13 -39.29 68.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.206 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 43' ' ' PHE . 23.6 mt -60.48 -48.46 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.26 96.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.375 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.01 -37.63 88.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.323 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.449 HD13 ' CD2' ' A' ' 5' ' ' TYR . 26.7 tp -59.3 -51.9 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.6 -47.46 70.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.093 0.473 . . . . 0.0 111.192 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.0 m -62.63 -32.25 73.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.42 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 2.8 mmmt -67.71 -34.98 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.491 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.83 -39.15 84.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.466 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.5 -105.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.865 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -150.33 31.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.041 0.448 . . . . 0.0 110.636 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.01 -147.19 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.445 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 t -120.21 170.29 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 0.0 110.668 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.15 98.24 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 110.405 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mt -80.2 84.21 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.201 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.29 24.89 53.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.639 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.62 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -58.71 143.12 47.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 110.685 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.475 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 1.1 p -124.07 168.12 13.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 111.444 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.6 mtm -110.67 154.55 43.13 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.732 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.3 Cg_exo -79.27 140.65 58.2 Favored 'Cis proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.749 -1.355 . . . . 0.0 112.759 0.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.62 ' CD ' HD12 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -97.02 114.69 26.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.031 179.157 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 4' ' ' VAL . 6.5 t -95.71 160.27 2.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.996 0.427 . . . . 0.0 111.73 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 92.5 m-85 -142.44 153.44 43.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.723 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.956 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -61.62 147.35 88.74 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.271 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 1' ' ' MET . 64.2 Cg_exo -55.17 -23.89 38.65 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.293 2.662 . . . . 0.0 112.507 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -99.06 -29.0 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.397 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 132.26 93.83 0.58 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.756 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.85 159.85 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -90.2 125.55 35.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.017 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.956 HD11 ' HB2' ' A' ' 70' ' ' ALA . 3.1 mp -117.05 -27.28 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.488 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 120.14 -157.62 15.62 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.939 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.5 -140.65 11.56 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.675 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.706 ' CE1' HD12 ' A' ' 23' ' ' LEU . 24.4 t80 -65.96 -70.58 0.23 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.823 0.344 . . . . 0.0 111.145 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.19 -49.99 75.11 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.826 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.404 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 5.2 tt0 -51.09 -43.09 61.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.438 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.613 HD21 ' CD2' ' A' ' 86' ' ' PHE . 4.7 tt -74.76 -34.07 62.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.107 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.4 ttp180 -51.84 -28.62 16.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.14 -32.62 70.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.0 t80 -67.45 -32.02 72.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.67 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.613 ' CD2' HD21 ' A' ' 82' ' ' LEU . 10.2 m-85 -96.71 -70.61 0.71 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.651 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 83' ' ' ARG . 9.5 mmtp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.676 ' HG3' ' HA ' ' A' ' 31' ' ' PHE . 1.1 tpp . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.769 0.319 . . . . 0.0 111.687 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.492 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 65.8 m-85 -58.83 166.28 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.344 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -140.86 117.57 10.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.022 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.944 HG22 HG22 ' A' ' 68' ' ' VAL . 39.0 t -107.5 147.43 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.223 0.535 . . . . 0.0 111.48 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.715 ' CE1' HD12 ' A' ' 34' ' ' ILE . 14.8 m-85 -129.64 101.19 5.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.289 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.71 -138.67 2.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.174 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.649 ' HE2' ' HE3' ' A' ' 37' ' ' MET . 16.3 m-85 -116.03 158.56 22.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.619 0.247 . . . . 0.0 110.706 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -74.23 -69.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.689 0.28 . . . . 0.0 111.462 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 166.31 -38.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.038 0.447 . . . . 0.0 110.179 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -85.29 -22.82 28.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.623 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.615 HD12 ' N ' ' A' ' 11' ' ' ILE . 3.4 mp -89.65 -42.77 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.25 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.513 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 6.1 t60 -144.3 158.34 43.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.795 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 17.4 ptmt -80.6 144.96 31.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.963 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 p -174.3 117.75 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.307 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.14 -32.08 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -67.01 -24.61 66.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.42 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -65.79 -61.09 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 110.439 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -26.01 63.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.913 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 28.4 m-20 -78.66 -60.04 2.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.193 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.01 -45.97 71.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.172 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -58.19 -52.53 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.567 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.805 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.3 ttt85 -61.01 -40.76 94.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.576 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.77 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.1 tt -57.55 -53.82 53.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.416 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.77 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.6 mt -55.77 -46.72 77.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.732 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.1 m -56.77 -37.08 70.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.14 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' ARG . 43.4 t -77.83 -31.08 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.656 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -9.68 58.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.15 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt 68.13 53.36 0.63 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.947 0.403 . . . . 0.0 110.69 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -133.23 136.38 27.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.108 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 54.1 Cg_endo -81.29 137.14 10.41 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.547 2.165 . . . . 0.0 110.837 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.676 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 42.3 p90 -153.6 170.1 21.65 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.684 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -136.43 132.87 36.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.568 ' CE1' HG11 ' A' ' 4' ' ' VAL . 34.7 t80 -89.67 160.84 16.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.715 HD12 ' CE1' ' A' ' 5' ' ' TYR . 18.4 mt -146.63 121.14 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.323 0.582 . . . . 0.0 110.517 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -90.51 121.82 32.79 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.897 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 2.5 pt -91.45 -6.65 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.337 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.649 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 22.4 ttm -118.57 99.88 51.35 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.661 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.8 Cg_endo -76.16 -27.5 8.15 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.477 2.118 . . . . 0.0 111.768 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -140.28 150.14 43.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.217 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -64.38 -8.37 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.355 0.598 . . . . 0.0 111.801 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.51 -56.55 3.13 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.685 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.73 147.18 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.8 ' HB2' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -66.45 168.75 8.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.606 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.466 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 41.6 t0 -91.37 122.11 33.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -66.6 -26.5 67.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.886 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.02 -56.25 23.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.476 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -64.41 -44.24 91.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.136 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.8 HD11 ' HB2' ' A' ' 43' ' ' PHE . 42.9 mt -55.79 -42.95 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.392 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.74 -47.87 76.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.728 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.12 -36.56 82.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.335 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.926 ' O ' HD12 ' A' ' 55' ' ' LEU . 34.2 tp -63.05 -60.29 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.445 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.59 ' HA ' HD13 ' A' ' 55' ' ' LEU . 88.0 mt -44.91 -41.91 7.6 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.261 0.553 . . . . 0.0 111.747 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.9 m -69.03 -30.33 68.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.406 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 51' ' ' LEU . 4.4 tttp -69.05 -44.28 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.836 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.926 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -59.1 -67.09 0.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.381 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.77 -31.55 0.14 Allowed Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.901 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -135.69 -169.99 2.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.323 . . . . 0.0 110.919 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -103.63 20.18 18.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.231 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 t -120.09 165.68 14.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.826 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -128.98 100.69 5.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.008 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.5 mt -80.29 84.28 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.012 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.62 27.56 55.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.162 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.513 HD11 ' CD2' ' A' ' 55' ' ' LEU . 1.5 mm? -55.42 143.18 29.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.995 0.426 . . . . 0.0 111.238 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 152.58 45.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.3 mmt -108.75 148.92 38.76 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.727 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.3 Cg_exo -80.53 148.0 76.02 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 124.026 -1.239 . . . . 0.0 112.952 0.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 5' ' ' TYR . 6.7 tp60 -104.38 126.24 51.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.384 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.944 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -103.01 166.39 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.74 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 81.1 m-85 -142.53 153.03 43.22 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -65.11 149.71 96.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.264 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.675 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 40.9 Cg_exo -59.97 -25.76 80.48 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.026 2.484 . . . . 0.0 112.196 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.16 -25.95 17.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.246 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.4 91.11 0.84 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.658 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -179.17 161.21 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.791 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.419 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 10.5 t-160 -85.6 126.67 34.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 70' ' ' ALA . 18.6 mt -101.21 -45.42 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.033 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.39 -152.42 18.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.912 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.25 -146.38 12.0 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.859 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 19.3 t80 -72.27 -70.98 0.31 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.672 0.272 . . . . 0.0 111.327 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -55.84 -44.46 78.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.158 0.504 . . . . 0.0 110.508 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -52.54 -40.75 62.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.995 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.701 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.0 tt -73.63 -32.09 63.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.284 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.0 mmm-85 -51.81 -35.11 43.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.34 -34.57 78.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.3 t80 -61.82 -35.36 78.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.07 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.701 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.7 m-85 -91.51 -9.7 43.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.07 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.1 pttp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.964 179.831 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 8.2 ttm . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.1 144.54 38.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.097 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.68 118.81 37.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.333 -178.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.643 HG12 ' CE1' ' A' ' 33' ' ' PHE . 55.0 t -104.73 142.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.184 0.516 . . . . 0.0 111.042 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.875 ' CE1' HD12 ' A' ' 34' ' ' ILE . 9.8 m-85 -121.27 99.15 6.32 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.41 ' HA2' ' HG2' ' A' ' 65' ' ' MET . . . -159.08 -151.99 6.3 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.848 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.874 ' CE1' HD11 ' A' ' 36' ' ' ILE . 60.7 m-85 -102.74 125.12 49.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.754 0.311 . . . . 0.0 111.318 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.508 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 6.1 t0 -137.1 65.36 1.5 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.634 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.36 -171.62 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.144 0.497 . . . . 0.0 111.631 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.85 -2.61 58.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.96 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.16 -13.22 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.955 0.407 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.711 ' CG ' ' CD1' ' A' ' 7' ' ' TYR . 42.9 t-80 -165.59 141.02 5.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -80.78 174.97 11.09 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.11 92.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.932 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -79.28 -32.25 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.719 0.295 . . . . 0.0 111.445 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -63.91 -26.67 68.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.447 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -59.31 -42.08 90.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 110.329 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.39 -43.42 67.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.771 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -76.99 -55.21 5.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.846 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.57 -41.92 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.003 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -59.65 -53.74 54.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.589 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.786 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.2 ttt85 -64.76 -28.65 69.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.841 HD12 ' CE1' ' A' ' 79' ' ' PHE . 2.0 tt -60.05 -59.8 4.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.397 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.549 HD12 ' CG ' ' A' ' 31' ' ' PHE . 7.1 mt -58.52 -40.29 82.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.433 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.4 m -60.44 -38.06 82.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.878 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 22' ' ' ARG . 96.3 t -78.84 -30.28 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.627 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -70.13 -15.73 63.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.917 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 76.13 45.59 0.11 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.935 0.398 . . . . 0.0 111.0 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -144.01 137.62 14.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.023 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.603 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.6 Cg_endo -75.24 162.94 35.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.491 2.127 . . . . 0.0 111.117 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.549 ' CG ' HD12 ' A' ' 24' ' ' LEU . 53.9 p90 -161.72 171.03 18.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.458 ' OE2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -139.38 125.4 19.86 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.36 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.643 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.4 t80 -90.74 124.97 35.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.361 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.875 HD12 ' CE1' ' A' ' 5' ' ' TYR . 8.0 mt -106.48 114.22 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.477 0.656 . . . . 0.0 110.526 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -82.52 144.62 30.28 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.383 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.874 HD11 ' CE1' ' A' ' 7' ' ' TYR . 2.6 pt -100.89 -12.7 8.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.666 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 19.1 ttm -124.81 107.76 28.64 Favored Pre-proline 0 C--N 1.334 -0.089 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 44' ' ' ASP . 95.6 Cg_endo -79.96 -28.05 3.46 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.353 2.035 . . . . 0.0 110.927 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 37' ' ' MET . 0.4 OUTLIER -146.62 151.09 36.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.231 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -8.52 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.225 0.536 . . . . 0.0 111.99 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 -54.56 4.5 Favored Glycine 0 C--N 1.311 -0.86 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.126 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -150.87 134.16 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -56.99 170.14 0.46 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -87.1 106.19 17.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.658 0.266 . . . . 0.0 111.7 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.73 -27.48 59.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -59.03 -53.4 58.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.88 0.371 . . . . 0.0 110.581 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.729 ' HG2' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -70.01 -40.66 75.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.03 179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 44' ' ' ASP . 44.9 mm -58.13 -45.94 88.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.69 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.51 -56.58 11.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.296 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -60.62 -30.66 69.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.919 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -58.24 -53.26 60.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.572 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.6 mt -54.28 -46.58 72.76 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 111.204 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.8 m -63.86 -34.12 77.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.227 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HE3' ' CG ' ' A' ' 69' ' ' PHE . 2.0 mmmt -65.77 -36.93 84.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.438 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.33 -42.98 96.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.489 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.75 -107.31 0.31 Allowed Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.751 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -150.55 26.78 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.074 0.464 . . . . 0.0 110.834 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -121.67 -153.71 0.56 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.31 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -120.88 161.18 21.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.477 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.418 ' NE2' ' HG ' ' A' ' 63' ' ' LEU . 7.8 pt20 -115.04 98.75 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 110.785 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.559 ' H ' HD12 ' A' ' 61' ' ' ILE . 3.8 mp -81.63 87.72 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.557 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.07 33.37 5.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.412 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.754 HD13 ' N ' ' A' ' 64' ' ' THR . 2.1 tm? -44.56 130.71 6.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.759 0.314 . . . . 0.0 110.904 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.754 ' N ' HD13 ' A' ' 63' ' ' LEU . 4.6 m -112.33 148.3 34.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.082 0.467 . . . . 0.0 111.551 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.517 ' SD ' HD12 ' A' ' 63' ' ' LEU . 3.5 mpp? -119.65 155.72 54.33 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.791 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.8 Cg_exo -80.53 137.55 40.78 Favored 'Cis proline' 0 C--N 1.344 0.327 0 C-N-CA 123.861 -1.308 . . . . 0.0 112.858 0.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.5 tp60 -99.78 118.32 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.172 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.591 HG22 HG22 ' A' ' 4' ' ' VAL . 4.3 t -93.44 161.53 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.328 0.585 . . . . 0.0 112.145 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 86.2 m-85 -143.2 152.31 41.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.99 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.601 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -65.47 143.56 98.72 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.78 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HB3' ' N ' ' A' ' 1' ' ' MET . 21.8 Cg_exo -61.63 -17.48 54.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.354 2.036 . . . . 0.0 111.988 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -103.19 -25.91 13.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.862 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.48 86.21 0.49 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.697 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.433 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER 179.58 118.97 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 110.823 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.417 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 8.3 t-160 -55.53 131.79 47.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.3 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 70' ' ' ALA . 2.0 mp -116.76 -31.94 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 117.62 -161.13 13.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.718 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -90.31 -147.99 19.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.028 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.841 ' CE1' HD12 ' A' ' 23' ' ' LEU . 46.5 t80 -69.54 -53.84 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.347 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -57.82 -49.51 76.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.758 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -64.73 -36.08 83.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.734 HD12 HD13 ' A' ' 23' ' ' LEU . 1.4 tm? -66.02 -44.13 85.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.348 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.428 ' HG2' HD11 ' A' ' 23' ' ' LEU . 3.2 mmm-85 -54.42 -37.92 65.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.38 -37.17 74.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -62.07 -35.44 78.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.127 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.623 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.2 m-85 -86.52 -26.76 24.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.217 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.1 mttt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.86 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.566 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.3 ttp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.843 0.354 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.483 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 94.7 m-85 -59.26 160.83 6.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.669 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.9 mppp? -135.72 118.08 15.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.198 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.901 HG22 HG22 ' A' ' 68' ' ' VAL . 19.4 t -108.53 141.13 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.183 0.515 . . . . 0.0 111.926 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.846 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.6 m-85 -121.68 105.34 10.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.249 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.38 -139.0 2.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.392 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.42 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 38.7 m-85 -109.91 153.35 24.62 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.4 t70 -82.22 -2.63 53.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 2.3 p 81.82 -22.85 0.24 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.984 0.421 . . . . 0.0 110.921 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -75.71 -35.29 60.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.9 0.381 . . . . 0.0 111.124 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 11' ' ' ILE . 9.8 mm -104.6 -7.02 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -176.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -166.64 108.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -39.39 134.23 1.24 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.5 m -166.23 109.23 0.76 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.401 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 m -87.0 -29.71 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 110.732 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -58.12 -30.7 66.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.596 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.5 m -61.73 -55.0 34.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 110.059 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -53.56 -31.64 47.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.248 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.24 -59.68 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.19 -42.01 69.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.296 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -62.12 -57.79 10.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.471 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 26' ' ' VAL . 22.2 ttt180 -57.0 -39.12 74.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.238 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -57.02 -54.2 49.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.197 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.714 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.5 mt -57.32 -45.49 84.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.616 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.5 m -58.27 -36.06 72.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.079 0.466 . . . . 0.0 109.977 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 22' ' ' ARG . 53.1 t -79.82 -30.62 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.425 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -16.59 59.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.916 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt 72.53 57.32 0.14 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.93 0.395 . . . . 0.0 110.978 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -139.08 139.0 21.93 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.373 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.47 ' O ' ' HA ' ' A' ' 1' ' ' MET . 71.6 Cg_endo -80.14 140.12 13.82 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.56 2.174 . . . . 0.0 111.241 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 22.9 p90 -160.26 171.27 19.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.414 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 2.5 tt0 -142.06 137.84 31.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.962 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.618 ' CE1' HG11 ' A' ' 4' ' ' VAL . 39.6 t80 -89.41 159.74 17.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.833 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.846 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.3 mt -143.68 119.11 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.279 0.561 . . . . 0.0 110.456 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -80.66 135.94 36.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.394 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.608 HD13 ' SD ' ' A' ' 65' ' ' MET . 2.7 pt -97.01 -17.38 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.421 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.624 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 4.4 ttp -131.41 90.37 38.02 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.482 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 10.1 Cg_exo -71.17 -4.32 14.66 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.661 2.241 . . . . 0.0 113.207 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -139.65 144.11 37.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.068 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -68.09 -8.55 39.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.241 0.543 . . . . 0.0 111.945 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.91 -58.02 1.35 Allowed Glycine 0 C--N 1.313 -0.75 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.293 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.84 140.93 27.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -72.73 167.16 21.41 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.616 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 38' ' ' PRO . 30.6 p30 -91.37 103.46 16.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.382 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.9 -24.65 16.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.696 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -56.53 -50.16 72.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.922 0.391 . . . . 0.0 111.006 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -75.93 -32.06 59.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.459 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' A' ' 36' ' ' ILE . 37.0 mm -65.0 -47.25 88.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.004 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.98 -55.99 18.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.027 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -56.73 -31.97 65.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.608 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.882 ' O ' HD12 ' A' ' 55' ' ' LEU . 15.4 tp -61.34 -58.41 8.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.189 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.701 ' HA ' HD13 ' A' ' 55' ' ' LEU . 72.5 mt -44.04 -40.92 5.12 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.301 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.1 m -70.22 -35.64 74.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.301 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' LEU . 5.0 tttp -60.2 -41.86 93.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.679 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.882 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -58.64 -69.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.239 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.08 -35.08 0.31 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -102.8 -175.1 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.798 0.332 . . . . 0.0 111.009 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.73 -31.9 10.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.825 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -105.32 170.19 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.417 ' HB2' HD12 ' A' ' 63' ' ' LEU . 9.4 pt20 -122.72 101.51 7.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.757 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -80.06 85.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.309 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.92 27.25 70.99 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.579 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.709 HD22 ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -49.84 171.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 111.235 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.709 ' N ' HD22 ' A' ' 63' ' ' LEU . 6.9 p -143.29 156.67 44.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.1 0.476 . . . . 0.0 111.591 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.608 ' SD ' HD13 ' A' ' 36' ' ' ILE . 3.2 mtt -126.32 154.65 74.73 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.567 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HB2' HG13 ' A' ' 4' ' ' VAL . 7.5 Cg_exo -75.52 150.34 94.47 Favored 'Cis proline' 0 C--N 1.344 0.308 0 C-N-CA 124.008 -1.247 . . . . 0.0 112.77 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.667 ' OE1' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -102.58 123.15 45.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.495 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.901 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -97.03 166.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.343 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 81.6 m-85 -142.47 140.98 32.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.071 0.462 . . . . 0.0 110.895 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB3' ' N ' ' A' ' 74' ' ' SER . . . -53.4 134.98 52.39 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.411 -178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HB3' ' N ' ' A' ' 1' ' ' MET . 89.0 Cg_exo -45.92 -27.68 4.35 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.012 2.475 . . . . 0.0 112.074 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -165.43 38.8 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.153 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.56 -109.15 0.99 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.101 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.448 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 13.5 m -138.47 177.34 7.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.237 0.542 . . . . 0.0 111.335 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -53.06 122.3 9.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.096 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 70' ' ' ALA . 4.4 mt -83.83 -43.64 17.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.988 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.04 -149.84 17.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.526 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.6 -159.25 31.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.209 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -60.92 -57.85 10.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.767 0.318 . . . . 0.0 110.704 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -54.01 -43.95 70.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -57.16 -32.81 66.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.625 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.6 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -71.49 -47.47 55.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.655 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.28 -30.17 26.73 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -74.81 -33.65 62.25 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 82' ' ' LEU . 21.0 t80 -66.86 -32.43 73.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.392 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.6 ' HE2' HD21 ' A' ' 82' ' ' LEU . 7.1 m-85 -92.08 -70.31 0.7 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.336 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.87 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.671 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 12.4 tpp . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.429 0.157 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -39.85 120.92 1.2 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.511 0.672 . . . . 0.0 112.233 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -90.91 125.36 35.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.267 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.655 HG12 ' HE1' ' A' ' 33' ' ' PHE . 22.7 t -109.55 110.24 31.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.01 0.433 . . . . 0.0 111.107 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 16.4 m-85 -89.64 99.26 12.3 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.3 -141.07 3.02 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.031 -1.081 . . . . 0.0 112.723 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.823 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 30.4 m-85 -127.11 149.2 50.05 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.747 0.308 . . . . 0.0 111.261 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -102.23 22.02 13.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.7 9.63 7.44 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.445 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -85.87 -50.7 6.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.782 0.325 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.8 mm -103.0 -32.04 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.638 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -140.62 154.83 46.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.277 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 166.73 22.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 p 174.0 95.08 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.671 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 16' ' ' TYR . 34.2 m -69.7 -44.39 79.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.553 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.477 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -57.3 -29.37 63.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.233 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -56.74 11.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.02 -33.77 53.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.173 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 91.2 m-20 -69.92 -49.88 47.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.896 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.43 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -61.01 -32.59 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -60.61 -54.06 49.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.812 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -65.56 -25.52 67.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.603 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.5 tt -57.79 -55.23 37.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.324 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 31' ' ' PHE . 25.5 mt -63.17 -35.1 79.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.567 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.3 m -68.72 -41.64 78.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.177 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 22' ' ' ARG . 90.2 t -66.79 -31.99 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.523 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -84.65 -10.49 57.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.07 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 2.6 mtmt 68.54 53.36 0.56 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.969 0.414 . . . . 0.0 110.986 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.31 113.17 7.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.671 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 88.4 Cg_exo -45.72 174.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.643 2.229 . . . . 0.0 112.766 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.498 ' HB3' HD13 ' A' ' 24' ' ' LEU . 5.2 p90 -163.99 169.89 17.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.811 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.3 tm-20 -129.03 109.41 11.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.14 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.655 ' HE1' HG12 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -90.54 150.97 21.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.04 0.448 . . . . 0.0 111.461 -179.259 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.445 HG13 ' C ' ' A' ' 33' ' ' PHE . 30.2 mt -149.73 127.02 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.301 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -82.69 110.31 17.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.401 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.916 ' HB ' HD11 ' A' ' 48' ' ' ILE . 3.2 pt -73.46 -19.96 18.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.8 ttp -129.49 86.13 56.86 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.338 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.82 -3.05 13.34 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.663 2.242 . . . . 0.0 112.407 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 37' ' ' MET . 3.1 tt0 -139.89 136.46 33.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.43 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -7.86 12.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.222 0.534 . . . . 0.0 111.963 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.49 -63.48 1.56 Allowed Glycine 0 C--N 1.313 -0.747 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.409 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.14 140.47 26.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.66 0.267 . . . . 0.0 111.229 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -66.23 170.97 5.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.082 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.428 ' O ' HG12 ' A' ' 48' ' ' ILE . 1.3 t70 -83.2 95.23 8.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.958 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.39 -20.64 30.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.441 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.94 -60.62 3.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.022 0.439 . . . . 0.0 110.535 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -67.09 -40.3 86.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.302 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.916 HD11 ' HB ' ' A' ' 36' ' ' ILE . 34.3 mm -59.83 -37.68 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.779 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.52 -51.91 67.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.06 -32.48 64.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.256 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.3 tt -60.64 -53.35 58.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -50.95 -42.23 59.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.017 0.437 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.0 m -59.48 -45.62 91.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.707 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -61.96 -32.52 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.564 HD21 ' CD2' ' A' ' 51' ' ' LEU . 1.3 mt -60.75 -50.35 73.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.5 -19.24 2.43 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.119 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -148.14 -162.26 1.51 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 110.397 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -113.63 21.66 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.149 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -120.19 164.22 16.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.74 0.305 . . . . 0.0 110.965 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.4 102.59 6.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.729 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.9 pt -71.77 79.68 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.344 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.75 26.44 5.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.535 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 63' ' ' LEU . 1.5 tp -56.6 169.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.338 . . . . 0.0 111.154 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.9 p -150.84 158.8 44.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.459 ' HG2' HD13 ' A' ' 36' ' ' ILE . 4.1 mpp? -104.29 159.13 30.32 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.596 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.6 Cg_exo -80.01 145.69 73.0 Favored 'Cis proline' 0 C--N 1.344 0.31 0 C-N-CA 124.134 -1.194 . . . . 0.0 112.978 0.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.402 ' NE2' ' CD1' ' A' ' 63' ' ' LEU . 56.4 mm-40 -108.24 120.78 43.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.773 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -90.62 155.07 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.166 0.508 . . . . 0.0 111.927 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 75' ' ' HIS . 33.8 m-85 -143.16 137.76 29.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.635 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.584 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -47.88 156.46 0.71 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.717 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.24 -38.68 88.36 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.727 2.285 . . . . 0.0 112.037 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.47 -21.65 20.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.184 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.76 89.36 0.81 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.649 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -164.55 116.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.372 . . . . 0.0 110.624 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 2.1 t-160 -55.14 112.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.307 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.716 HG21 HD12 ' A' ' 82' ' ' LEU . 6.7 mt -98.53 -35.48 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.365 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.43 -151.92 20.07 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.233 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 82' ' ' LEU . . . -104.57 -141.05 10.74 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.118 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.603 ' CE1' HD12 ' A' ' 23' ' ' LEU . 13.0 t80 -73.63 -66.43 0.7 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 0.0 110.725 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -63.04 -42.68 99.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.948 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.43 -49.22 75.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.626 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.716 HD12 HG21 ' A' ' 76' ' ' ILE . 3.0 tt -74.43 -38.82 62.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.88 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -49.64 -27.61 4.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.958 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.75 -35.33 72.6 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.724 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.48 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -64.8 -37.32 87.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.05 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.587 ' CD2' HD21 ' A' ' 82' ' ' LEU . 14.8 m-85 -86.55 -20.28 28.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.583 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.992 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.632 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 38.2 ttm . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -79.35 147.45 32.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.239 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.18 120.53 42.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.221 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 68' ' ' VAL . 53.6 t -112.35 123.71 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.32 0.581 . . . . 0.0 111.996 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.1 m-85 -99.98 99.53 10.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.967 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.506 ' O ' HD13 ' A' ' 36' ' ' ILE . . . -158.07 -141.69 3.22 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.335 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.635 ' CE1' HD11 ' A' ' 36' ' ' ILE . 57.9 m-85 -121.7 159.02 27.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.0 111.402 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.59 -67.93 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 166.28 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.556 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.25 -27.74 47.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.816 HG21 ' O ' ' A' ' 37' ' ' MET . 4.2 mp -91.11 -37.04 8.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.261 0.553 . . . . 0.0 110.654 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -155.1 142.05 19.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.199 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.75 146.39 31.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.295 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.98 107.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.816 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 16' ' ' TYR . 31.4 m -71.74 -40.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.421 . . . . 0.0 110.577 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.407 ' N ' HG23 ' A' ' 15' ' ' VAL . 18.4 m-85 -51.82 -25.75 8.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.387 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -65.94 -62.85 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.125 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -57.01 -31.79 65.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.52 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -53.15 52.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.852 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.64 71.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.007 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -61.13 -35.75 77.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.083 0.468 . . . . 0.0 110.121 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.761 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.6 ttt180 -76.74 -27.62 55.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.604 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.819 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -57.35 -56.56 20.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.212 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.6 mt -63.04 -45.85 90.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.654 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 m -56.03 -35.44 66.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.366 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 22' ' ' ARG . 70.9 t -75.99 -29.54 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.682 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 1.5 mmtm -76.11 -12.91 60.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.226 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 76.16 38.7 0.31 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.03 0.443 . . . . 0.0 110.796 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -129.74 139.76 36.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.697 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 1' ' ' MET . 93.5 Cg_endo -77.74 160.98 30.93 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.471 2.114 . . . . 0.0 111.619 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -161.47 170.89 19.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.413 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -136.89 125.11 23.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.898 0.38 . . . . 0.0 110.792 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.454 ' HE1' HG11 ' A' ' 4' ' ' VAL . 13.0 t80 -89.84 156.96 18.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.162 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.432 HG13 ' C ' ' A' ' 33' ' ' PHE . 18.4 mt -150.43 123.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.275 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -86.12 110.58 19.65 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.534 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.678 ' HB ' HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -70.38 -14.19 17.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.311 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.816 ' O ' HG21 ' A' ' 11' ' ' ILE . 3.9 ttp -126.38 89.57 51.94 Favored Pre-proline 0 N--CA 1.455 -0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 110.931 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.48 0.07 10.32 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.57 2.18 . . . . 0.0 112.239 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 37' ' ' MET . 38.4 tt0 -140.02 136.25 33.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.603 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -63.93 -8.05 10.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.169 0.509 . . . . 0.0 112.114 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.89 -63.07 1.7 Allowed Glycine 0 C--N 1.313 -0.728 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.079 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -147.49 149.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.673 0.273 . . . . 0.0 111.142 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -69.14 171.27 8.58 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.873 0.368 . . . . 0.0 111.588 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -95.98 110.97 23.1 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.158 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -64.4 -23.19 67.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.808 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -58.62 -52.6 65.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 110.797 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.09 -44.64 68.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.248 0.547 . . . . 0.0 109.736 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.678 HD11 ' HB ' ' A' ' 36' ' ' ILE . 16.0 mm -54.91 -40.64 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.693 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.48 -51.4 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.645 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -32.35 64.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.228 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.603 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.7 tt -60.99 -50.13 74.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.193 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.489 HD21 ' HG3' ' A' ' 60' ' ' GLN . 85.5 mt -52.49 -43.49 65.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.565 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 m -54.5 -46.39 73.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.665 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' CB ' ' CE2' ' A' ' 69' ' ' PHE . 2.8 mtmm -63.31 -36.53 83.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.628 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mt -61.28 -52.66 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.723 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.6 -113.9 0.58 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.065 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -150.33 31.74 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.118 0.485 . . . . 0.0 110.509 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -121.01 -146.52 0.38 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.276 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -117.19 170.13 8.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.694 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.489 ' HG3' HD21 ' A' ' 52' ' ' LEU . 5.6 mt-30 -73.26 98.26 2.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.181 0.515 . . . . 0.0 110.455 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -79.9 79.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.148 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.68 21.71 71.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.472 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.551 HD11 ' OE1' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -57.79 131.69 51.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.962 0.41 . . . . 0.0 110.804 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 65' ' ' MET . 21.9 m -123.61 163.65 20.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.356 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.443 ' N ' HG22 ' A' ' 64' ' ' THR . 6.4 mtm -107.98 152.25 41.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.55 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.7 Cg_endo -83.0 137.9 32.8 Favored 'Cis proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.968 -1.263 . . . . 0.0 112.883 0.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.551 ' OE1' HD11 ' A' ' 63' ' ' LEU . 48.0 tp60 -96.29 138.59 33.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.861 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 77' ' ' GLY . 3.6 t -109.78 154.91 11.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.051 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.452 ' CE1' ' HG3' ' A' ' 67' ' ' GLN . 48.0 m-85 -143.39 143.21 31.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.547 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.56 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.58 155.21 14.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.264 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.632 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -72.47 -16.11 27.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.87 2.38 . . . . 0.0 112.097 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -104.72 -7.85 19.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.095 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.07 89.82 1.95 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.512 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -175.93 156.85 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.762 0.315 . . . . 0.0 111.093 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.453 ' CD2' ' NE2' ' A' ' 67' ' ' GLN . 7.4 t-160 -90.23 126.51 35.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.845 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 70' ' ' ALA . 16.7 mt -113.8 -45.82 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.257 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.633 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 124.22 -151.58 17.19 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.91 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -99.14 -129.43 6.55 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.439 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.819 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -80.88 -70.35 0.54 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.713 0.256 . . . . 0.0 110.69 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -52.17 -46.9 65.7 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.235 0.54 . . . . 0.0 110.221 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.434 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -58.88 -41.41 87.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.615 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.495 HD21 ' CD2' ' A' ' 86' ' ' PHE . 2.3 tt -74.54 -35.99 63.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.384 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.4 ttt180 -52.03 -32.84 35.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -34.42 74.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.291 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.436 ' CD2' HG23 ' A' ' 76' ' ' ILE . 43.3 t80 -65.95 -32.05 73.32 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.447 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.495 ' CD2' HD21 ' A' ' 82' ' ' LEU . 24.9 m-85 -97.84 -9.11 26.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.67 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 83' ' ' ARG . 3.5 mtpm? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.885 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.725 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.519 0.199 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 66.0 m-85 -39.78 110.06 0.13 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.985 0.898 . . . . 0.0 111.667 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.821 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -89.74 127.0 35.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.95 -1.477 . . . . 0.0 111.281 -179.041 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.689 HG12 ' HE1' ' A' ' 33' ' ' PHE . 25.3 t -106.43 112.25 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.01 0.433 . . . . 0.0 111.296 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 11.2 m-85 -89.79 99.01 12.1 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.27 -143.12 3.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.861 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 31.2 m-85 -117.68 143.46 46.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.84 0.352 . . . . 0.0 111.578 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.91 -76.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.522 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 170.32 -34.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 110.606 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -81.36 -27.94 34.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.46 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.895 HG21 ' O ' ' A' ' 37' ' ' MET . 3.0 mp -89.83 -45.24 15.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.353 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.537 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 5.0 t60 -143.93 159.62 42.25 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -80.24 149.91 30.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.539 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.4 p -157.27 93.52 1.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.149 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.5 m -82.01 -31.77 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.214 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -28.12 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.153 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 t -63.52 -45.3 91.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.038 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.76 -36.01 34.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.145 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.42 ' HB3' ' CE2' ' A' ' 79' ' ' PHE . 12.9 m120 -70.54 -56.88 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.669 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -57.31 -28.94 63.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.926 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -64.82 -44.3 90.29 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 26' ' ' VAL . 15.8 tpp85 -63.28 -36.13 82.66 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.87 HD21 HD23 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -59.05 -61.85 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.346 178.18 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -61.03 -53.39 57.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.93 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.5 m -52.63 -37.43 58.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.859 0.362 . . . . 0.0 111.235 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 22' ' ' ARG . 44.4 t -79.78 -17.81 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.778 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -89.0 -30.34 18.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.557 0.218 . . . . 0.0 111.527 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.32 67.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.54 HE22 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -150.15 129.9 6.6 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.536 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.725 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 75.8 Cg_exo -49.75 167.41 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.327 1.351 . . . . 0.0 110.706 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -165.15 160.48 18.71 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.792 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.729 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 19.2 mt-10 -124.78 122.3 37.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 111.054 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.689 ' HE1' HG12 ' A' ' 4' ' ' VAL . 1.5 t80 -103.93 143.15 33.24 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.045 0.45 . . . . 0.0 110.954 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 33' ' ' PHE . 18.1 mt -144.32 127.69 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.224 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.43 121.55 26.88 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.863 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.861 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.6 pt -77.56 -15.49 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.996 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.895 ' O ' HG21 ' A' ' 11' ' ' ILE . 33.0 ttm -125.01 79.53 65.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.769 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 60.4 Cg_endo -72.97 -5.34 17.04 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.753 2.302 . . . . 0.0 112.418 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.54 136.6 34.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.182 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -63.01 -8.84 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.183 0.515 . . . . 0.0 111.884 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.94 -61.19 2.16 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.542 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 43' ' ' PHE . 30.1 t -150.29 155.58 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 111.485 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -62.41 166.67 4.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.615 179.594 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 3.4 t70 -83.33 123.93 30.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.959 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 8.8 t0 -78.04 -27.98 48.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.232 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.22 -59.77 3.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 110.862 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -62.71 -46.55 87.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.489 HD11 ' HB ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -59.94 -31.07 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.635 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -62.99 -47.22 84.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -36.9 80.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.46 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.593 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.3 tt -58.4 -50.03 75.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.159 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -51.88 -45.12 64.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.353 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.4 m -57.3 -46.76 82.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.612 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -60.9 -39.0 87.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.679 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.89 -62.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.83 -116.58 0.47 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.967 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -150.58 26.87 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.941 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -121.58 -149.28 0.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.297 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 t -120.58 166.61 13.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.526 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.405 ' CB ' ' HB2' ' A' ' 63' ' ' LEU . 2.6 mt-30 -115.95 98.87 6.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.92 0.39 . . . . 0.0 110.808 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.7 tp -81.45 85.57 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.463 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.54 30.45 7.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.497 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.829 HD13 ' N ' ' A' ' 64' ' ' THR . 1.8 tm? -47.15 135.65 9.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.799 0.333 . . . . 0.0 110.785 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.829 ' N ' HD13 ' A' ' 63' ' ' LEU . 71.6 p -107.93 146.37 32.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.264 0.554 . . . . 0.0 111.854 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.408 ' SD ' HD12 ' A' ' 63' ' ' LEU . 3.9 mpp? -122.01 159.36 51.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.474 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_exo -78.96 151.87 88.28 Favored 'Cis proline' 0 C--N 1.343 0.258 0 C-N-CA 124.211 -1.162 . . . . 0.0 112.679 0.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.623 ' NE2' HD21 ' A' ' 63' ' ' LEU . 2.3 mt-30 -113.58 116.39 29.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.842 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.821 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -88.7 154.41 3.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.103 0.478 . . . . 0.0 112.158 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 2' ' ' PHE . 35.7 m-85 -142.61 139.16 31.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.015 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -57.14 144.22 70.18 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.048 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -34.88 -35.31 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.74 2.96 . . . . 0.0 112.685 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.43 33.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.198 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.54 -105.1 2.66 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.644 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 m -137.93 179.45 6.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.031 0.443 . . . . 0.0 110.869 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -63.76 125.08 23.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.941 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 1.015 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.6 mp -97.74 -28.4 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.524 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 120.89 -160.07 15.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.012 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.14 -131.77 7.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.587 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 9.6 t80 -76.49 -70.65 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.705 0.288 . . . . 0.0 111.032 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -57.4 -48.22 79.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.386 . . . . 0.0 110.648 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.441 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -54.53 -46.12 73.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.476 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.87 HD23 HD21 ' A' ' 23' ' ' LEU . 2.3 tt -66.94 -38.9 87.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.016 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.711 ' HG3' HD22 ' A' ' 23' ' ' LEU . 1.4 ttm180 -51.73 -29.94 20.5 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -72.19 -34.94 68.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.203 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 82' ' ' LEU . 59.2 t80 -64.76 -32.48 74.18 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.313 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.461 ' CE2' HD21 ' A' ' 82' ' ' LEU . 27.3 m-85 -95.77 -12.11 25.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.582 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.888 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.679 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 33.6 ttm . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -77.08 145.32 37.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.118 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.0 mptt -106.83 119.17 38.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.618 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.427 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 17.1 t -102.94 121.5 54.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.221 0.534 . . . . 0.0 111.122 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.781 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.6 m-30 -98.87 99.36 10.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.882 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.29 -135.65 1.86 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.972 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.656 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 57.1 m-85 -125.86 146.77 49.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.735 0.302 . . . . 0.0 111.076 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.445 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -137.52 51.86 1.91 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.967 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 t -167.88 -173.22 2.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.308 0.575 . . . . 0.0 112.011 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -86.58 4.65 39.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.757 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.637 HG23 ' HB2' ' A' ' 40' ' ' LYS . 10.6 mm -86.86 -13.44 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.539 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.656 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 2.3 t60 -163.08 122.68 2.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.664 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 168.68 7.98 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.54 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 174.7 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.662 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 16' ' ' TYR . 26.9 m -87.33 -41.88 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.702 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 15' ' ' VAL . 1.1 m-85 -60.89 -18.94 59.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.574 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.8 -58.43 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.4 . . . . 0.0 110.565 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -50.66 -40.9 54.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.049 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -64.1 -46.83 82.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.397 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -63.87 -49.91 70.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.381 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 31' ' ' PHE . 10.5 ttmt -50.47 -34.54 25.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.895 0.378 . . . . 0.0 110.586 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.815 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.9 tpt180 -66.74 -40.5 88.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.413 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.56 -55.62 32.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.235 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.83 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.4 mt -55.24 -45.17 76.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.61 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.7 m -57.3 -37.31 72.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.842 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.8 t -78.19 -34.21 18.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.505 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -17.96 62.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.852 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.47 53.2 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -140.03 136.13 16.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.195 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.614 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.6 Cg_endo -81.24 162.57 20.03 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.625 2.217 . . . . 0.0 110.761 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 6.4 p90 -161.34 171.1 18.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 111.981 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -136.2 134.16 37.88 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.568 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 10.9 t80 -89.69 158.74 17.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.534 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 5' ' ' TYR . 15.4 mt -148.31 121.96 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.385 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -86.05 133.34 33.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.052 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.558 HD11 ' OH ' ' A' ' 7' ' ' TYR . 20.8 pt -98.77 2.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.362 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.652 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -145.1 90.82 6.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.676 0.274 . . . . 0.0 110.434 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 44.8 Cg_endo -68.48 -26.42 34.4 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.698 2.265 . . . . 0.0 112.31 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -139.52 146.68 40.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.993 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.637 ' HB2' HG23 ' A' ' 11' ' ' ILE . 12.1 tttt -62.09 -8.8 5.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.295 0.569 . . . . 0.0 111.73 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.2 -53.47 6.13 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.522 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.7 t -151.36 146.87 15.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.419 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 46.6 m-85 -57.43 169.55 0.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.399 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -81.56 98.04 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.614 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 9.5 t0 -57.77 -21.05 39.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.31 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.13 -57.2 6.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.18 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 7.2 mmtp -72.3 -50.77 24.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.662 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.6 mp -49.91 -35.72 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -64.43 -61.39 2.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.037 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 2.4 pt-20 -63.33 -25.47 68.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.3 tt -57.27 -54.36 47.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.961 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.4 mt -55.81 -49.48 73.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.08 0.467 . . . . 0.0 110.917 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.8 m -60.13 -36.08 76.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.321 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -71.02 -36.01 72.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.959 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.467 HD21 ' CD2' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -59.46 -41.6 90.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.026 0.441 . . . . 0.0 110.501 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.31 -164.58 31.54 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.853 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -94.39 31.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -121.11 -150.81 0.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.247 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 t -120.87 170.3 9.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.734 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.4 98.46 11.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.127 0.489 . . . . 0.0 110.254 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.1 tp -80.28 86.9 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.497 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.54 29.89 61.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.512 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.72 134.86 4.13 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.813 0.339 . . . . 0.0 111.044 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.22 170.11 8.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.224 0.535 . . . . 0.0 111.793 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.4 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 15.8 mmt -124.9 154.81 70.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.572 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -80.64 145.12 69.36 Favored 'Cis proline' 0 C--N 1.343 0.284 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.73 0.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.468 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 0.7 OUTLIER -111.58 117.66 33.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.915 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.3 t -89.86 161.45 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.255 0.55 . . . . 0.0 111.878 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -142.51 143.91 32.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.407 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.684 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.42 131.57 76.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.447 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.679 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 32.3 Cg_exo -52.71 -24.02 22.0 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.63 2.22 . . . . 0.0 112.091 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.06 38.38 0.18 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.349 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.8 -109.29 0.78 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.705 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.535 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -140.8 -178.45 5.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.14 0.495 . . . . 0.0 111.142 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.468 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 17.2 t-80 -56.9 128.19 35.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.074 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.684 HD11 ' HA ' ' A' ' 70' ' ' ALA . 15.6 mt -100.21 -44.74 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.901 0.381 . . . . 0.0 110.777 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.45 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.13 -153.31 19.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.827 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -91.38 -138.85 8.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.119 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -75.43 -70.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.829 0.315 . . . . 0.0 110.642 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -47.36 -41.26 19.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.256 0.551 . . . . 0.0 110.323 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -39.58 94.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.412 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.709 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -75.03 -41.38 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.714 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -51.35 -33.48 29.79 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -68.6 -35.11 76.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.4 t80 -63.93 -34.12 77.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.562 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.709 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -88.9 -70.52 0.64 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.296 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.9 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.605 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.0 ttm . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.818 0.342 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.471 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 70.0 m-85 -63.22 157.02 23.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.03 0.443 . . . . 0.0 110.687 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.95 119.28 20.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.965 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.914 HG22 HG22 ' A' ' 68' ' ' VAL . 12.4 t -105.06 132.18 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.551 . . . . 0.0 112.038 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.4 m-85 -108.46 99.61 8.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.349 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.66 -141.55 3.16 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.327 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -118.74 151.68 37.56 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.845 0.355 . . . . 0.0 110.928 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.84 -75.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.072 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 t 170.99 -41.98 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.525 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -76.47 -26.3 55.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.862 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.614 HG21 ' O ' ' A' ' 37' ' ' MET . 4.1 mp -89.96 -41.3 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.978 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -149.76 149.56 30.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.049 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 143.27 48.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.54 102.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.002 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 m -87.02 -19.47 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.378 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -75.67 -20.35 58.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.595 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 p -71.18 -44.08 66.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.673 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.17 -41.45 99.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -59.67 -51.05 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.789 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 -28.82 69.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.035 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -43.29 99.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.288 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.911 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -69.65 -27.68 65.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.711 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.697 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -57.55 -57.14 13.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.414 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.1 mt -60.25 -40.01 88.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.658 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 m -60.5 -31.39 70.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.092 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 22' ' ' ARG . 92.9 t -73.76 -27.51 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.915 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -83.11 -17.64 42.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.322 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 74.09 55.57 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.939 0.4 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -137.26 145.17 48.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.764 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.451 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.1 Cg_endo -77.33 139.2 18.42 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.428 2.085 . . . . 0.0 111.587 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.605 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 14.6 p90 -153.12 170.5 20.35 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 3.8 tp10 -143.99 146.44 32.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.978 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.517 ' HE1' HG11 ' A' ' 4' ' ' VAL . 11.0 t80 -89.24 156.62 18.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.024 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.651 HD12 ' CE1' ' A' ' 5' ' ' TYR . 9.4 mt -143.3 118.58 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.242 0.544 . . . . 0.0 110.387 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -94.63 129.5 41.47 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.119 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.522 ' HB ' HD11 ' A' ' 48' ' ' ILE . 16.8 pt -86.81 -17.98 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.732 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.614 ' O ' HG21 ' A' ' 11' ' ' ILE . 2.7 ttp -122.61 92.56 48.99 Favored Pre-proline 0 N--CA 1.454 -0.243 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.3 -15.45 28.29 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.681 2.254 . . . . 0.0 112.722 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 37' ' ' MET . 2.9 pt-20 -139.64 142.9 36.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.838 0.352 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -65.58 -8.58 20.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.272 0.558 . . . . 0.0 111.851 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.94 -60.4 2.17 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.082 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 t -150.17 127.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.329 . . . . 0.0 110.837 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.56 170.43 1.05 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.446 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.11 96.56 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.124 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.77 -28.82 37.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.213 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -52.58 -44.62 66.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.927 0.394 . . . . 0.0 110.812 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -31.03 39.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.227 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' A' ' 36' ' ' ILE . 44.4 mm -63.31 -43.77 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.601 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.91 -55.76 11.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.078 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.58 -31.09 61.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.91 0.386 . . . . 0.0 110.389 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.929 ' O ' HD12 ' A' ' 55' ' ' LEU . 12.8 tp -59.22 -59.12 5.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.08 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HA ' HD13 ' A' ' 55' ' ' LEU . 71.1 mt -44.53 -44.08 8.43 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.303 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.9 m -69.68 -30.96 68.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.588 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 51' ' ' LEU . 5.1 tttp -65.39 -40.8 93.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.887 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.7 mp -59.34 -56.72 18.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.956 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.61 -110.5 0.27 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.165 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.33 31.32 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.04 0.448 . . . . 0.0 110.774 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -121.01 -148.53 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.288 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 t -120.34 170.26 9.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -92.01 98.8 11.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.201 0.525 . . . . 0.0 110.432 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.426 ' H ' HD12 ' A' ' 61' ' ' ILE . 3.4 mp -79.74 85.08 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.264 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.21 27.34 46.12 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.52 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -52.72 148.55 7.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.849 0.356 . . . . 0.0 110.993 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.1 p -121.68 170.15 10.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.146 0.498 . . . . 0.0 111.528 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.08 158.92 39.7 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.9 Cg_endo -85.81 151.44 49.84 Favored 'Cis proline' 0 N--CA 1.461 -0.406 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.898 0.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.59 HE21 ' HA ' ' A' ' 67' ' ' GLN . 2.2 mm-40 -111.71 117.9 34.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.223 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.914 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -91.28 166.31 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 0.0 111.837 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 64.1 m-85 -141.94 143.78 33.42 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.191 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.633 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -53.84 152.4 10.13 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.527 ' HB3' ' N ' ' A' ' 1' ' ' MET . 43.3 Cg_exo -59.3 -28.72 88.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.171 2.581 . . . . 0.0 112.54 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.85 -21.0 18.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.66 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.7 84.5 0.65 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.89 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.14 162.72 15.41 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -90.54 129.6 36.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.72 0.295 . . . . 0.0 110.971 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.654 HG21 HD12 ' A' ' 82' ' ' LEU . 1.4 mp -115.57 -43.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.789 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.458 ' HA2' HE22 ' A' ' 67' ' ' GLN . . . 119.14 -155.94 15.89 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.107 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -94.52 -134.1 7.33 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.535 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.697 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.71 -70.11 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.845 -0.209 . . . . 0.0 111.05 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -48.9 -44.63 40.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.176 0.512 . . . . 0.0 110.602 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -63.66 -44.77 92.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.885 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -69.88 -43.7 71.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.76 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 87' ' ' LYS . 6.2 ttp180 -51.56 -31.57 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -72.82 -32.63 65.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.333 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.47 ' CD2' HG12 ' A' ' 76' ' ' ILE . 54.0 t80 -68.6 -32.24 71.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.648 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.505 ' CD1' ' HG2' ' A' ' 27' ' ' LYS . 20.1 m-85 -96.61 -70.74 0.7 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.528 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.773 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.833 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 28.1 tpp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 110.502 -0.185 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.415 ' H ' ' HG3' ' A' ' 1' ' ' MET . 96.9 m-85 -43.13 137.57 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.805 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -115.48 120.51 39.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.978 -179.075 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.53 HG11 ' CE1' ' A' ' 33' ' ' PHE . 53.4 t -107.82 121.25 60.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.245 0.545 . . . . 0.0 111.845 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.57 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 20.0 m-85 -100.14 101.51 12.57 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.289 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 36' ' ' ILE . . . -162.24 -139.01 2.54 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.521 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.574 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 64.2 m-85 -118.31 159.98 22.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.974 0.416 . . . . 0.0 111.478 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -96.84 -73.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.03 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m 170.64 -42.08 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.307 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -69.88 -32.44 70.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.189 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.4 mm -100.18 -32.86 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 1.8 t-160 -157.33 122.14 4.44 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 148.5 51.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.98 118.89 1.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.297 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 m -84.78 -36.79 11.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.906 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.23 -29.23 69.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.252 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.7 t -56.27 -49.38 74.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.274 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -56.64 -34.57 67.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.342 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 38.4 m-80 -72.74 -51.21 20.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 111.021 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -55.06 -45.32 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.125 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -64.99 -40.74 95.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.323 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.8 mmt85 -62.54 -37.02 84.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.313 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.746 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -57.57 -56.86 16.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.073 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.746 ' N ' HD23 ' A' ' 23' ' ' LEU . 59.5 mt -62.76 -30.36 71.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.354 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.4 m -71.19 -36.43 71.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.201 0.524 . . . . 0.0 109.629 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 22' ' ' ARG . 94.5 t -75.78 -48.61 29.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.513 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.15 -19.9 62.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.788 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt 71.33 55.04 0.21 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.944 0.402 . . . . 0.0 110.634 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -139.9 122.68 10.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.833 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 5.0 Cg_endo -48.53 159.33 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.602 2.201 . . . . 0.0 112.732 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.599 ' HB3' HD13 ' A' ' 24' ' ' LEU . 35.0 p90 -163.44 170.73 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.884 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.8 tt0 -141.04 115.34 9.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.645 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.53 ' CE1' HG11 ' A' ' 4' ' ' VAL . 36.3 t80 -89.03 154.36 20.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.833 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.422 HG13 ' C ' ' A' ' 33' ' ' PHE . 10.3 mt -148.13 122.07 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.484 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -75.05 113.15 12.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.577 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.507 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.2 pp -64.7 -29.37 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.775 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.654 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.1 ttp -118.61 92.25 43.62 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.733 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HG3' ' HB2' ' A' ' 44' ' ' ASP . 88.0 Cg_endo -79.73 3.69 7.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.695 2.263 . . . . 0.0 112.957 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -139.2 144.16 38.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.488 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -66.89 -8.11 26.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.206 0.527 . . . . 0.0 111.574 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.69 -66.8 0.79 Allowed Glycine 0 C--N 1.315 -0.633 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.293 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.32 136.58 58.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 1.1 p90 -66.4 170.97 5.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.729 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.475 ' O ' HD13 ' A' ' 48' ' ' ILE . 7.5 t0 -77.85 124.58 28.16 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.244 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 1.4 t70 -80.07 -28.74 39.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.536 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -63.89 -56.72 13.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.328 . . . . 0.0 111.171 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -67.0 -38.15 85.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.475 HD13 ' O ' ' A' ' 44' ' ' ASP . 0.9 OUTLIER -71.57 -25.72 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.704 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -68.62 -48.55 63.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.972 0.415 . . . . 0.0 110.578 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.17 -34.71 76.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.233 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' CD2' HD21 ' A' ' 55' ' ' LEU . 3.5 tt -58.16 -50.79 72.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.397 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 52' ' ' LEU . 79.1 mt -54.15 -45.85 72.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.139 0.495 . . . . 0.0 111.404 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.9 m -61.2 -42.27 98.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.436 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -31.5 72.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.733 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.71 ' CD1' HD13 ' A' ' 63' ' ' LEU . 2.1 mt -62.43 -32.07 72.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.017 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.93 -26.57 8.76 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.234 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -124.11 -165.45 1.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.695 0.283 . . . . 0.0 110.647 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -103.82 -30.52 10.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.018 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -92.58 170.25 9.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -112.54 99.94 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.701 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.6 82.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.375 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.88 25.04 36.0 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.643 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.71 HD13 ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.11 155.7 16.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.923 0.392 . . . . 0.0 111.65 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -144.59 170.15 16.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.274 0.559 . . . . 0.0 112.058 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.418 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 4.2 mtt -115.82 154.94 48.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.568 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.6 Cg_exo -76.97 142.34 72.29 Favored 'Cis proline' 0 C--N 1.344 0.312 0 C-N-CA 123.846 -1.314 . . . . 0.0 112.644 0.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.4 ' CD ' HD21 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -102.68 116.91 33.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.938 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 82' ' ' LEU . 3.3 t -92.12 152.7 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.193 0.52 . . . . 0.0 111.62 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -143.57 139.88 29.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.564 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.698 ' HB1' ' HD2' ' A' ' 71' ' ' PRO . . . -55.27 165.17 1.15 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.684 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 19.6 Cg_endo -60.11 -24.61 77.42 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.777 2.318 . . . . 0.0 111.918 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.24 -26.06 19.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.268 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.65 -6.56 5.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.101 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.35 154.57 23.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.876 0.338 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -90.42 118.52 29.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.331 . . . . 0.0 110.962 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.535 HD11 ' HA ' ' A' ' 70' ' ' ALA . 28.2 mt -97.06 -48.46 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 134.41 -156.86 22.63 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.777 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.41 -141.45 10.91 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.839 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 25.8 t80 -67.79 -70.46 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 0.0 111.019 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.49 -47.42 84.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.088 0.471 . . . . 0.0 110.593 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -51.4 -37.18 46.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.645 ' CD1' HG11 ' A' ' 68' ' ' VAL . 4.3 tt -74.12 -35.99 64.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.18 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.18 -31.25 30.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.78 -31.8 71.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.495 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 14.1 t80 -71.05 -27.96 64.02 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.836 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 24' ' ' LEU . 29.7 m-85 -99.92 -13.45 19.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.088 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.04 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.674 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 18.7 tpp . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.412 0.149 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -39.7 127.59 2.0 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.667 0.746 . . . . 0.0 112.118 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -94.56 123.81 38.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.344 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 67' ' ' GLN . 24.6 t -111.96 114.64 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.379 . . . . 0.0 111.579 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 13.9 m-85 -93.27 99.9 12.36 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.19 -136.58 2.13 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.613 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -125.75 160.33 30.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.898 0.38 . . . . 0.0 111.895 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 9' ' ' SER . 5.3 m-20 -88.96 -68.12 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.645 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.7 OUTLIER 162.08 -29.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -76.61 -39.32 52.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.444 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 40' ' ' LYS . 7.5 mm -89.84 -46.25 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.582 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -140.66 149.79 42.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -77.38 161.46 28.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.735 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 p -176.89 98.18 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.221 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 m -77.76 -33.43 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.052 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -66.67 -28.12 68.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.051 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.6 t -62.66 -46.79 86.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 110.466 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -59.37 -31.08 68.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.051 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.25 -53.49 14.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.954 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.39 -49.06 70.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 110.943 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 1.5 ttmm -60.01 -50.02 75.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.627 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.794 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -60.11 -42.69 95.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.246 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.786 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -57.08 -54.13 50.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.05 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.786 ' N ' HD23 ' A' ' 23' ' ' LEU . 8.8 mt -56.84 -42.69 80.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.518 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -59.16 -38.13 78.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.68 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 22' ' ' ARG . 42.9 t -76.46 -34.09 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.48 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -9.83 58.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.866 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.13 51.69 1.62 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.002 0.429 . . . . 0.0 110.45 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -142.63 113.92 6.05 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.386 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.674 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 89.3 Cg_exo -49.25 178.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.386 2.057 . . . . 0.0 111.973 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 3.9 p90 -163.94 170.54 16.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.958 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 14.4 tp10 -134.44 112.38 10.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.471 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 7.0 t80 -89.1 155.96 19.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.292 0.567 . . . . 0.0 111.733 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG13 ' C ' ' A' ' 33' ' ' PHE . 45.3 mt -150.26 125.5 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.814 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -88.65 126.12 35.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.035 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.6 18.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.965 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -157.78 90.69 2.3 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.52 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 37.5 Cg_endo -66.07 -23.31 53.64 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.571 2.181 . . . . 0.0 112.021 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 37' ' ' MET . 2.7 mm-40 -139.56 143.93 37.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.148 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 11' ' ' ILE . 8.2 ttpt -64.33 -7.99 11.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.29 0.567 . . . . 0.0 111.866 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.72 -37.87 12.91 Favored Glycine 0 C--N 1.313 -0.731 0 CA-C-N 115.227 -0.897 . . . . 0.0 113.201 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -150.24 151.71 12.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.3 0.572 . . . . 0.0 112.157 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -75.27 169.01 18.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.313 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.621 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 t0 -94.88 103.36 15.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.753 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 5.5 t0 -69.7 -21.58 63.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.936 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -67.46 -57.19 6.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.108 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -69.95 -36.08 74.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.527 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 44' ' ' ASP . 21.4 mt -70.89 -26.37 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.412 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -68.01 -55.5 12.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.305 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.4 -36.06 73.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.828 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.587 HD13 ' CE2' ' A' ' 69' ' ' PHE . 6.7 tp -56.27 -50.42 71.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.528 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 52' ' ' LEU . 78.0 mt -53.36 -47.08 69.73 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.376 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.2 m -63.65 -39.39 94.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.425 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -59.22 -37.31 77.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.498 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' N ' HD23 ' A' ' 55' ' ' LEU . 1.2 mt -60.17 -56.43 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.552 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.58 -110.4 0.3 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.982 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -150.44 31.39 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.977 0.418 . . . . 0.0 110.68 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -120.96 -145.87 0.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.416 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.1 t -115.27 170.45 8.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.749 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 98.27 1.2 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.39 0.614 . . . . 0.0 110.452 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.04 84.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.254 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.93 26.45 58.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.432 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -56.04 132.54 50.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -126.03 153.47 44.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.274 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.82 155.55 36.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.636 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.7 Cg_exo -82.79 136.9 30.69 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 124.04 -1.233 . . . . 0.0 112.796 0.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.676 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -92.67 148.36 22.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.691 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -122.24 149.82 25.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.172 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CE2' HD13 ' A' ' 51' ' ' LEU . 53.1 m-85 -142.27 137.43 30.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.36 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -46.9 164.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.931 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 33.4 Cg_exo -59.99 -19.82 57.43 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.797 2.331 . . . . 0.0 112.071 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.84 -19.71 13.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.432 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.06 -19.38 3.9 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.09 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.418 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -56.69 109.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.876 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -54.65 134.74 47.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.447 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 70' ' ' ALA . 7.2 mt -115.9 -39.1 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.557 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 130.74 -153.69 20.37 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.702 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -94.24 -136.17 8.1 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.946 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -82.85 -55.02 4.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.578 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -57.31 -49.94 74.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.619 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -41.06 98.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.443 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.852 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -61.65 -53.53 54.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.62 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.607 ' N ' HD13 ' A' ' 82' ' ' LEU . 26.7 ttt180 -49.73 -39.2 36.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.87 0.367 . . . . 0.0 110.13 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -67.93 -37.95 82.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 82' ' ' LEU . 14.0 t80 -61.43 -34.5 75.52 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.576 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.852 ' CE2' HD21 ' A' ' 82' ' ' LEU . 12.1 m-85 -78.59 -62.44 1.69 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.003 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.711 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 34.2 ttp . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.743 0.306 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 84.7 m-85 -80.33 154.77 27.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.419 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -137.78 123.96 20.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.107 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 68' ' ' VAL . 53.9 t -108.04 141.59 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.222 0.534 . . . . 0.0 111.592 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.88 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.8 m-85 -123.35 100.54 6.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.41 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.44 -139.12 2.58 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.39 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.453 ' HH ' ' HE1' ' A' ' 43' ' ' PHE . 74.6 m-85 -110.58 160.05 17.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.776 0.322 . . . . 0.0 110.902 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -79.1 -78.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.703 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 t 166.43 -35.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.689 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.42 -22.6 28.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.196 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 40' ' ' LYS . 35.4 mm -91.79 -42.26 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -142.0 151.49 42.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.035 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -72.01 156.31 39.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.928 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 169.69 106.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.829 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -90.57 -32.15 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.377 . . . . 0.0 111.533 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.79 -31.73 71.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.649 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 p -62.23 -43.58 98.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -55.27 -33.38 63.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -73.76 -52.87 11.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.02 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.39 63.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.888 0.375 . . . . 0.0 111.029 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -60.9 -55.33 34.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.503 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.684 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.4 mtp180 -60.67 -29.32 69.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.733 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.717 HD11 ' HG2' ' A' ' 83' ' ' ARG . 3.4 tt -55.97 -53.55 55.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.592 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -69.07 -41.48 77.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 m -61.4 -37.13 82.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.082 0.468 . . . . 0.0 110.151 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 22' ' ' ARG . 75.4 t -77.63 -32.33 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.654 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -71.26 -15.78 62.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.218 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? 73.91 54.52 0.1 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 111.221 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -138.47 141.92 32.97 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.81 137.32 19.83 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.454 2.103 . . . . 0.0 111.623 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.711 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 4.6 p90 -154.56 168.48 26.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.073 0.463 . . . . 0.0 112.216 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -141.62 137.55 31.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.5 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.548 ' CE1' HG11 ' A' ' 4' ' ' VAL . 40.9 t80 -89.39 156.71 18.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.88 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.1 mt -142.15 117.38 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.349 0.595 . . . . 0.0 110.419 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -100.11 130.39 46.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.018 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.498 HG22 ' HB2' ' A' ' 47' ' ' LYS . 32.5 pt -97.6 28.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.024 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 39' ' ' GLU . 18.0 ttm -155.55 98.55 2.3 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.909 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 60.2 Cg_endo -71.32 -27.93 18.91 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.371 2.047 . . . . 0.0 112.098 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 37' ' ' MET . 4.0 mm-40 -139.68 156.01 47.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.994 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.465 ' N ' HG23 ' A' ' 11' ' ' ILE . 1.4 ttmp? -70.81 -7.74 47.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.269 0.557 . . . . 0.0 111.675 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.99 -25.29 8.5 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.487 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 t -142.74 127.01 15.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.289 0.566 . . . . 0.0 112.453 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.6 ' HB3' HD11 ' A' ' 48' ' ' ILE . 33.8 m-85 -71.83 164.11 26.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.215 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -93.08 94.66 8.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.194 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.92 -27.86 68.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.601 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.95 -54.15 48.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.695 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HB2' HG22 ' A' ' 36' ' ' ILE . 36.6 mmtt -69.84 -34.3 73.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.068 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 43' ' ' PHE . 43.8 mt -65.97 -39.66 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.39 -56.35 10.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.175 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.48 -35.43 72.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.835 0.35 . . . . 0.0 110.796 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.474 HD13 ' CD2' ' A' ' 5' ' ' TYR . 13.5 tp -56.92 -50.49 72.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.558 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.428 HD21 ' CG ' ' A' ' 60' ' ' GLN . 80.5 mt -53.39 -48.11 68.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.01 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.4 m -64.0 -35.38 80.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.031 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -38.19 90.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.131 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.11 -53.62 46.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.521 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.66 -109.95 0.33 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.045 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.63 30.83 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.942 0.401 . . . . 0.0 110.812 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -121.13 -149.2 0.42 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.463 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 t -120.49 170.47 9.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.583 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.428 ' CG ' HD21 ' A' ' 52' ' ' LEU . 10.2 mt-30 -82.6 98.2 8.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.188 0.518 . . . . 0.0 110.34 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 pt -80.36 84.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.28 25.6 57.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.499 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.48 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.0 OUTLIER -57.79 157.92 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 110.85 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 p -130.71 170.34 14.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 0.0 111.666 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -120.48 154.8 56.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.588 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HB2' HG13 ' A' ' 4' ' ' VAL . 6.3 Cg_exo -80.99 152.34 81.01 Favored 'Cis proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.908 -1.288 . . . . 0.0 112.803 0.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.48 ' CD ' HD12 ' A' ' 63' ' ' LEU . 10.0 mt-30 -109.08 113.01 25.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.181 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -90.79 166.34 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.409 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 70.1 m-85 -141.73 139.61 32.91 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.031 0.443 . . . . 0.0 110.628 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.688 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -61.42 156.77 50.13 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.496 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 1' ' ' MET . 51.9 Cg_exo -55.73 -31.75 81.39 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.15 2.567 . . . . 0.0 112.185 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -78.93 -35.54 43.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.22 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.6 41.27 0.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.821 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.7 m -120.65 169.12 10.68 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -90.16 117.56 29.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.776 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.688 HD11 ' HA ' ' A' ' 70' ' ' ALA . 27.9 mt -90.35 -49.37 13.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.986 0.422 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.43 -151.47 19.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.619 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.69 -149.28 25.46 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.595 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.693 ' CE1' HD12 ' A' ' 23' ' ' LEU . 18.2 t80 -64.75 -70.16 0.25 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.756 0.313 . . . . 0.0 110.775 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -56.55 -46.52 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.523 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.33 -35.81 68.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.272 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.545 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.4 tt -76.74 -37.03 56.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.287 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HG2' HD11 ' A' ' 23' ' ' LEU . 8.2 mtt180 -52.38 -31.6 34.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -70.66 -33.66 71.19 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.166 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CD2' HG23 ' A' ' 76' ' ' ILE . 40.1 t80 -67.13 -27.42 67.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.604 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.545 ' CE2' HD21 ' A' ' 82' ' ' LEU . 23.9 m-85 -99.29 -17.63 17.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.922 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.5 mttm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.809 -179.712 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.682 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 21.7 tpp . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.35 0.119 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -39.5 119.01 0.89 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.862 0.839 . . . . 0.0 112.069 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -89.38 126.5 35.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.296 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 68' ' ' VAL . 11.5 t -115.93 133.94 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.142 0.496 . . . . 0.0 111.463 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.806 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.5 m-85 -110.69 99.91 8.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -160.2 -137.26 2.18 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.855 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -125.05 141.8 51.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.792 0.33 . . . . 0.0 111.01 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -99.82 26.36 6.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 110.998 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.72 8.44 5.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.682 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -85.52 -49.67 7.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.578 HG23 ' HG3' ' A' ' 40' ' ' LYS . 39.4 mm -104.06 -32.57 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.293 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -141.14 140.26 34.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.835 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -81.26 174.78 11.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.504 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 173.74 109.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.349 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 m -71.82 -35.02 53.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.975 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.38 -29.67 70.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.132 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 t -60.93 -45.67 93.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.916 0.389 . . . . 0.0 110.656 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.39 -24.39 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.319 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 28.6 m-80 -79.96 -46.74 16.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.202 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.84 -53.1 61.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.787 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 13.1 ttpt -59.76 -44.66 93.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.495 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 26' ' ' VAL . 14.9 tpt180 -62.41 -42.6 99.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.414 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.9 tt -56.97 -53.49 57.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.135 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.1 mt -59.29 -43.96 92.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.538 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.6 m -59.34 -43.65 92.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.995 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.9 t -70.81 -38.73 73.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -74.16 -9.76 58.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.796 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' CE ' ' A' ' 28' ' ' LYS . 1.2 ttpt 64.3 59.9 0.99 Allowed 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 121.434 0.635 . . . . 0.0 110.221 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.27 108.83 4.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.088 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.682 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 92.6 Cg_exo -47.08 176.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.618 2.212 . . . . 0.0 112.299 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 4.2 p90 -164.06 170.65 16.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.3 tt0 -133.1 118.16 18.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.313 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.467 ' HE1' HG11 ' A' ' 4' ' ' VAL . 4.1 t80 -89.51 158.86 17.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.738 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.806 HD12 ' CE1' ' A' ' 5' ' ' TYR . 33.8 mt -146.33 122.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.62 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -83.65 123.18 29.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.183 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 pt -100.36 -26.93 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.52 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.8 ttp -121.24 93.49 48.8 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.504 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.4 Cg_endo -82.56 1.26 9.26 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.726 2.284 . . . . 0.0 112.264 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.562 ' C ' HG21 ' A' ' 11' ' ' ILE . 43.6 mt-10 -141.13 137.65 32.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.669 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HG3' HG23 ' A' ' 11' ' ' ILE . 17.1 mtmm -65.53 -8.37 19.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.234 0.54 . . . . 0.0 111.69 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.96 -68.46 1.14 Allowed Glycine 0 C--N 1.312 -0.753 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.104 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 t -134.58 135.48 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.795 0.331 . . . . 0.0 111.151 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -63.29 169.58 3.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.102 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.442 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 t0 -80.86 121.54 26.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.039 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -60.47 -22.4 63.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -64.84 -57.58 8.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.955 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -64.97 -47.2 78.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.716 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.72 -39.26 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.434 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.39 82.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.427 . . . . 0.0 110.418 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -67.13 -40.99 86.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.382 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.6 tp -57.51 -50.41 73.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 52' ' ' LEU . 80.3 mt -52.92 -45.93 67.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.084 0.469 . . . . 0.0 111.284 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.3 m -68.06 -33.16 74.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.283 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HE3' ' CD1' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -64.3 -39.27 93.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.399 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.5 mt -61.17 -66.77 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.967 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.67 -27.06 0.59 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.326 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.67 -175.27 2.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.722 0.296 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.51 -27.44 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.043 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -95.89 170.05 9.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -116.25 100.38 7.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.783 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mt -79.67 84.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.201 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.5 25.56 55.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.588 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -60.01 139.49 57.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.972 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.469 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 17.7 p -122.3 160.08 26.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.8 mtm -117.55 154.47 50.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.673 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.3 Cg_exo -79.52 155.41 89.41 Favored 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 124.105 -1.206 . . . . 0.0 112.74 0.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 64' ' ' THR . 52.4 mm-40 -109.85 125.9 53.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.045 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -97.97 159.82 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.991 0.424 . . . . 0.0 111.977 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 94.3 m-85 -142.9 148.16 36.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.588 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.646 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.16 141.3 69.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.31 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -40.69 -30.94 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.935 2.423 . . . . 0.0 112.168 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -167.86 34.08 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.142 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -125.1 -108.99 1.75 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.774 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.0 -179.6 5.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.464 ' CE1' ' OE1' ' A' ' 67' ' ' GLN . 86.4 t60 -64.39 134.35 54.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.118 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.646 HD11 ' HA ' ' A' ' 70' ' ' ALA . 8.0 mt -104.07 -41.27 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.651 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 137.19 -152.4 21.43 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.003 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.97 -131.05 7.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.502 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 32.6 t80 -76.07 -70.22 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.687 0.28 . . . . 0.0 111.131 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -54.47 -45.42 73.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.939 0.399 . . . . 0.0 110.954 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.468 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.9 OUTLIER -56.43 -45.84 80.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.605 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.723 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -64.46 -41.44 96.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.477 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -52.96 -33.8 52.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.54 -34.19 73.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.16 -33.3 75.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.49 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.723 ' HE2' HD21 ' A' ' 82' ' ' LEU . 21.1 m-85 -90.1 -69.8 0.7 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.471 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.961 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.603 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 2.8 ttt . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -75.1 146.46 41.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.728 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -108.42 118.03 35.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.297 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 68' ' ' VAL . 92.9 t -113.07 129.71 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.407 0.622 . . . . 0.0 112.196 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.616 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 21.9 m-85 -104.61 101.18 10.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.849 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.7 -142.18 3.32 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.516 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.4 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 57.8 m-85 -119.17 154.78 32.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.849 0.357 . . . . 0.0 111.422 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 9' ' ' SER . 22.0 p-10 -89.85 11.57 19.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.799 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER 80.0 -5.73 1.82 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.639 0.257 . . . . 0.0 111.527 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -86.48 -48.63 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' HG22 ' A' ' 11' ' ' ILE . 30.1 mm -94.11 -16.45 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -155.85 142.92 19.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -66.5 115.78 6.75 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.99 0.424 . . . . 0.0 111.761 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p -130.16 89.32 2.78 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.579 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.6 m -81.3 -32.05 11.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.441 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -65.8 -26.64 67.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.178 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.1 t -63.77 -51.91 62.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.408 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.12 -29.54 63.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.196 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -70.6 -57.66 4.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.879 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.23 -41.89 80.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -57.2 -51.19 70.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.812 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.781 ' O ' HG23 ' A' ' 26' ' ' VAL . 14.9 ttm-85 -60.31 -43.6 96.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.462 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.7 tt -58.87 -54.75 43.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.386 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.623 HD23 ' HZ ' ' A' ' 86' ' ' PHE . 5.4 mt -56.71 -46.34 81.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.682 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.6 m -55.83 -38.4 69.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.141 0.496 . . . . 0.0 110.031 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 22' ' ' ARG . 48.6 t -78.8 -31.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.548 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -73.08 -9.78 59.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.16 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 71.13 45.21 0.51 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.914 0.388 . . . . 0.0 110.957 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -132.44 130.48 21.86 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.593 ' O ' ' HA ' ' A' ' 1' ' ' MET . 44.3 Cg_endo -82.8 161.1 16.28 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.636 2.224 . . . . 0.0 111.191 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.474 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 5.1 p90 -161.31 171.2 18.75 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.916 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -132.45 121.19 23.0 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.536 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.636 ' HE1' HG12 ' A' ' 4' ' ' VAL . 1.1 t80 -89.82 150.87 22.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.763 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 mt -142.41 122.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.413 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -87.08 118.04 26.2 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.424 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.86 HD11 ' SD ' ' A' ' 65' ' ' MET . 34.0 pt -97.07 33.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.007 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 39' ' ' GLU . 42.9 ttm -160.59 82.59 2.11 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.57 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.01 -4.76 16.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.032 2.488 . . . . 0.0 112.875 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 37' ' ' MET . 1.8 mm-40 -139.21 155.64 47.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -71.12 -7.13 44.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.55 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.06 18.01 3.36 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.205 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 t -150.83 116.46 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 9.0 m-85 -72.31 170.22 14.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.676 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.556 ' C ' HD12 ' A' ' 48' ' ' ILE . 9.6 t0 -100.42 93.32 5.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 70.9 m-20 -64.03 -24.86 67.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.46 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.43 -58.7 5.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 36' ' ' ILE . 14.8 mmtm -69.16 -34.06 74.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.301 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.556 HD12 ' C ' ' A' ' 44' ' ' ASP . 49.1 mt -71.01 -32.69 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.639 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.34 -55.17 34.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -61.52 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.616 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 4.3 tt -59.54 -53.33 59.34 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.223 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.569 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.9 mt -52.88 -47.9 67.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.064 0.459 . . . . 0.0 110.959 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.4 m -53.39 -40.74 65.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.687 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 23.4 mtpp -70.11 -39.41 75.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.74 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -44.42 93.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.486 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.19 -137.03 5.07 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.897 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -122.85 30.34 6.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.123 0.487 . . . . 0.0 110.485 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.25 -156.72 0.69 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.211 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -121.17 170.57 9.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.632 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -79.47 98.14 6.69 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.286 0.565 . . . . 0.0 110.182 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -80.32 86.7 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.909 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.07 27.93 60.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.505 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -179.8 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.615 0.245 . . . . 0.0 110.684 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.4 p -150.36 159.72 44.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.154 0.502 . . . . 0.0 111.897 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.86 ' SD ' HD11 ' A' ' 36' ' ' ILE . 2.9 mtt -115.49 158.0 42.72 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.189 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.8 Cg_exo -79.7 145.48 73.56 Favored 'Cis proline' 0 C--N 1.345 0.347 0 C-N-CA 124.47 -1.054 . . . . 0.0 113.27 0.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -105.52 126.77 52.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.133 178.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 4' ' ' VAL . 5.7 t -96.99 159.02 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.99 0.424 . . . . 0.0 111.645 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.462 ' N ' HG12 ' A' ' 68' ' ' VAL . 32.0 m-85 -142.83 144.26 32.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.729 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.593 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -53.81 133.38 56.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.263 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 35.1 Cg_exo -55.05 -17.03 13.46 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.523 2.149 . . . . 0.0 112.312 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.73 39.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.386 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.86 -114.81 0.76 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.273 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.1 p -125.56 -173.02 2.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.142 0.496 . . . . 0.0 111.32 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 35.9 t-80 -66.35 145.18 56.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 70' ' ' ALA . 1.7 mp -120.04 -35.4 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.939 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 123.83 -156.55 18.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.093 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.27 -137.33 8.65 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.418 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.602 ' CE1' HD13 ' A' ' 23' ' ' LEU . 28.4 t80 -69.61 -70.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.723 0.297 . . . . 0.0 111.05 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -57.19 -48.98 77.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.964 0.412 . . . . 0.0 110.71 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -50.42 -36.66 34.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.359 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.589 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.4 tt -82.67 -29.85 29.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.232 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -51.63 -31.37 25.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -65.67 -34.73 78.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.112 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CD2' HG12 ' A' ' 76' ' ' ILE . 22.1 t80 -64.89 -33.22 75.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.542 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.623 ' HZ ' HD23 ' A' ' 24' ' ' LEU . 6.5 m-85 -86.49 -65.03 1.06 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.454 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.001 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.696 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 19.5 ttm . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.921 0.391 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 57.4 m-85 -82.43 151.39 26.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.764 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.1 mppp? -126.47 120.62 30.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.857 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.524 HG11 ' CE1' ' A' ' 33' ' ' PHE . 6.2 t -109.49 116.64 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.115 0.483 . . . . 0.0 111.848 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 21.8 m-85 -96.04 100.54 12.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.901 178.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.69 -137.96 2.32 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.352 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.678 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 3.1 m-85 -127.24 151.75 48.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -144.83 38.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.953 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.524 ' HB2' HG12 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -163.94 -162.82 0.73 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.108 0.48 . . . . 0.0 111.856 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -86.52 8.48 21.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.083 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.653 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -87.54 -8.13 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.678 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 6.6 t60 -170.17 144.07 2.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.329 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.607 ' HE2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -80.76 155.47 26.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.281 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 168.82 82.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.97 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.607 HG13 ' HE2' ' A' ' 13' ' ' LYS . 34.4 m -73.97 -41.23 52.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 15' ' ' VAL . 1.7 m-85 -59.57 -20.4 55.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.138 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 t -66.76 -60.23 2.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.778 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.74 -40.04 39.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 110.624 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -65.64 -43.99 87.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.576 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -67.41 -33.29 74.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -56.97 -44.39 82.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.813 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.0 ttp180 -70.94 -25.14 62.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.325 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.732 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -54.1 -57.29 11.64 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.241 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.62 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 13.8 mt -64.31 -41.41 96.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.52 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.2 m -60.39 -34.5 73.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.297 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 22' ' ' ARG . 67.2 t -72.24 -42.94 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.933 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -72.6 -19.75 61.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.209 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 2.7 tppt? 79.79 71.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 111.382 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -143.46 143.28 23.41 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.0 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.45 130.12 11.59 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.474 2.116 . . . . 0.0 111.968 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.696 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 6.1 p90 -151.54 166.96 29.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.89 0.376 . . . . 0.0 111.959 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -143.09 136.13 27.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.883 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CE1' HG11 ' A' ' 4' ' ' VAL . 13.1 t80 -89.75 159.79 16.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.224 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.701 HG21 ' HD2' ' A' ' 47' ' ' LYS . 23.5 mt -150.09 126.09 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.123 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 8' ' ' ASP . 68.6 m-80 -86.72 111.24 20.51 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.176 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.488 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 21.9 pt -75.22 -5.79 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.505 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.474 ' HE2' ' CE1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -135.33 69.77 68.35 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.448 179.548 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.48 -13.74 35.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.596 2.197 . . . . 0.0 112.135 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -139.16 135.79 34.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.352 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.86 -9.01 3.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.31 0.576 . . . . 0.0 111.429 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.06 -61.08 3.87 Favored Glycine 0 C--N 1.312 -0.767 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.352 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.4 t -151.95 157.0 5.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.476 ' N ' HG12 ' A' ' 42' ' ' VAL . 24.1 m-85 -58.83 170.3 0.84 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.902 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.742 ' O ' HD12 ' A' ' 48' ' ' ILE . 7.5 t70 -100.24 113.0 25.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.64 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.633 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 9.2 p30 -73.01 -18.79 61.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.07 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.45 -63.29 1.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 111.152 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.701 ' HD2' HG21 ' A' ' 34' ' ' ILE . 34.9 mmtt -64.17 -40.08 95.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.55 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.742 HD12 ' O ' ' A' ' 44' ' ' ASP . 34.9 mt -66.13 -28.53 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.654 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -64.23 -49.76 70.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.684 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -37.68 77.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.425 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.641 HD13 ' CE2' ' A' ' 69' ' ' PHE . 5.9 tp -57.3 -50.85 71.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.689 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -52.86 -45.94 67.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.516 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.7 m -62.99 -35.75 81.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.672 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -65.81 -38.59 89.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.788 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 51' ' ' LEU . 1.3 mt -59.6 -70.15 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.77 -106.95 0.2 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.144 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -150.35 32.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 111.045 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -120.97 -145.42 0.36 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.365 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.01 170.18 9.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.837 0.351 . . . . 0.0 110.712 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.1 98.43 1.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.4 0.619 . . . . 0.0 110.352 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.9 mt -79.67 85.5 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.346 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.21 28.23 54.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.489 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -46.58 123.51 5.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.393 . . . . 0.0 111.158 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 24.9 p -104.51 136.52 43.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.077 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.5 mmt -102.92 152.16 38.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.7 Cg_endo -83.56 144.64 49.42 Favored 'Cis proline' 0 C--N 1.346 0.405 0 C-N-CA 124.246 -1.148 . . . . 0.0 112.653 0.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 25.3 mm-40 -104.33 154.08 20.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -123.35 159.35 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.459 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.641 ' CE2' HD13 ' A' ' 51' ' ' LEU . 25.3 m-85 -142.3 132.7 25.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.932 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.571 ' N ' HD11 ' A' ' 76' ' ' ILE . . . -65.54 150.16 96.36 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.239 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.564 ' HB3' ' N ' ' A' ' 1' ' ' MET . 71.1 Cg_exo -45.73 -42.98 19.28 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.215 2.61 . . . . 0.0 112.746 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -29.03 64.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.98 79.64 0.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.467 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.9 127.57 3.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.939 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -58.54 108.94 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.613 HG23 ' CD2' ' A' ' 85' ' ' TYR . 4.0 mt -81.5 -41.79 19.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 125.48 -149.52 17.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.491 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -98.22 -132.42 7.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.32 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.732 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -83.02 -69.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.578 0.189 . . . . 0.0 110.877 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.7 -43.53 47.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.175 0.512 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -42.34 95.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.746 HD21 ' CE1' ' A' ' 86' ' ' PHE . 1.6 tt -71.77 -41.58 68.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.752 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -51.12 -35.24 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.85 -35.57 77.09 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.122 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.613 ' CD2' HG23 ' A' ' 76' ' ' ILE . 59.5 t80 -64.49 -32.36 73.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.588 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.746 ' CE1' HD21 ' A' ' 82' ' ' LEU . 27.7 m-85 -89.79 -27.1 20.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.058 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.701 179.701 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.8 ttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.897 0.379 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 68.9 m-85 -60.19 157.44 13.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.771 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.694 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -134.11 116.32 15.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.702 -179.53 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 68' ' ' VAL . 19.0 t -105.91 125.62 61.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.266 0.555 . . . . 0.0 111.829 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.768 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.0 m-30 -101.96 99.47 9.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.532 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.68 -138.02 2.33 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.413 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 22.6 m-85 -120.06 139.97 51.73 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 120.626 0.25 . . . . 0.0 110.502 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -92.97 22.28 5.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 4.5 m 65.74 5.73 3.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -81.89 -44.02 17.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.074 0.464 . . . . 0.0 110.521 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 11' ' ' ILE . 9.8 mm -124.95 1.5 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.263 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 4.9 t60 -157.04 131.19 8.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.538 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -80.99 159.57 24.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.348 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 176.75 123.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.118 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.0 m -83.13 -39.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.818 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -55.45 -28.85 56.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.728 0.299 . . . . 0.0 111.284 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.5 m -62.16 -53.84 49.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.55 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.26 -34.19 56.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.167 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -70.22 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.963 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.51 -31.95 48.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.288 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -60.69 -56.01 26.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.571 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.82 ' O ' HG23 ' A' ' 26' ' ' VAL . 12.1 ttt85 -64.65 -27.09 68.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.772 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.808 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.6 tt -57.31 -57.4 12.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.385 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.693 HD12 ' CG ' ' A' ' 31' ' ' PHE . 3.8 mt -59.85 -41.89 92.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.599 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -37.16 79.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.094 0.474 . . . . 0.0 110.063 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 22' ' ' ARG . 92.6 t -77.64 -25.36 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.867 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HE3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -77.71 -15.74 58.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? 70.34 42.28 0.93 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.066 0.46 . . . . 0.0 110.524 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -128.33 143.75 49.29 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.499 ' O ' ' HA ' ' A' ' 1' ' ' MET . 92.1 Cg_endo -77.01 136.96 16.96 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.389 2.06 . . . . 0.0 111.674 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.693 ' CG ' HD12 ' A' ' 24' ' ' LEU . 12.6 p90 -149.12 170.31 18.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.915 0.388 . . . . 0.0 112.008 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -147.75 141.21 25.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.196 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.471 ' HE1' HG11 ' A' ' 4' ' ' VAL . 8.3 t80 -89.71 162.87 15.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.043 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.768 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.9 mt -146.12 119.78 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.262 0.554 . . . . 0.0 110.417 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -82.08 125.23 30.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.346 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.45 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.9 pt -100.31 -12.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.171 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.536 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 21.7 ttm -123.07 79.04 51.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.767 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 17.9 Cg_exo -65.56 -22.1 58.91 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.283 1.989 . . . . 0.0 111.608 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -139.22 137.46 35.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.704 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.468 ' N ' HG21 ' A' ' 11' ' ' ILE . 19.7 tttt -61.35 -9.18 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.22 0.533 . . . . 0.0 112.245 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.31 -55.72 4.6 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.449 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 t -150.46 139.25 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.616 0.246 . . . . 0.0 111.559 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -58.76 170.33 0.82 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.045 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.482 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 12.6 p30 -88.89 109.49 20.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 111.875 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -58.06 -31.12 66.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.619 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -52.99 -42.35 65.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.786 0.327 . . . . 0.0 110.971 -179.478 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 53.0 mmtt -80.62 -39.15 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.254 0.55 . . . . 0.0 109.887 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 44' ' ' ASP . 43.9 mm -55.93 -46.01 80.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.722 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.68 -56.44 12.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.322 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 7.4 pt-20 -60.68 -28.78 68.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.583 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.11 -56.44 22.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.362 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.686 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.8 mt -52.35 -45.24 65.62 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.9 m -60.72 -38.81 86.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.278 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -65.27 -37.7 87.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.521 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -60.03 -20.17 56.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.935 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.27 -88.81 1.53 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.124 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -139.4 31.53 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.454 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' O ' HD12 ' A' ' 55' ' ' LEU . 5.2 t0 -121.61 110.55 16.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.376 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.4 t -78.25 142.06 38.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.452 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.9 pt20 -70.8 97.57 1.41 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.378 0.608 . . . . 0.0 111.036 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 61' ' ' ILE . 6.5 tp -80.88 79.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.481 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.76 24.37 69.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.101 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -54.48 159.91 1.92 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.858 0.361 . . . . 0.0 111.08 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 65' ' ' MET . 18.3 m -125.49 165.76 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.226 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.447 ' N ' HG22 ' A' ' 64' ' ' THR . 13.0 mmt -97.94 155.69 36.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.452 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.6 Cg_endo -86.34 149.81 42.92 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 124.211 -1.162 . . . . 0.0 113.106 0.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -108.71 112.61 25.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.918 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 4' ' ' VAL . 3.2 t -89.5 163.02 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.219 0.533 . . . . 0.0 112.183 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 44.9 m-85 -141.58 137.3 31.84 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.132 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.756 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -50.99 152.22 3.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.065 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.478 ' HB3' ' N ' ' A' ' 1' ' ' MET . 53.0 Cg_exo -54.87 -24.32 38.24 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.728 2.286 . . . . 0.0 112.028 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -101.63 -22.52 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.991 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.3 85.66 0.78 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.707 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.47 ' O ' HD12 ' A' ' 76' ' ' ILE . 1.4 m -165.79 126.68 1.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.736 0.303 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -61.28 117.72 5.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.794 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 70' ' ' ALA . 2.4 mp -110.11 -27.9 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.961 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 117.12 -155.46 16.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.901 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.06 -134.36 7.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.419 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.808 ' CE1' HD12 ' A' ' 23' ' ' LEU . 36.5 t80 -74.3 -67.12 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.625 0.25 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.81 -52.68 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -51.05 -41.85 60.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.402 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.737 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.6 tt -78.83 -29.03 44.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.129 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 87' ' ' LYS . 14.2 ttt85 -52.81 -30.66 34.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -67.77 -30.39 69.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' LEU . 24.0 t80 -68.64 -33.65 74.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.574 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.737 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.2 m-85 -95.51 -70.72 0.7 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.819 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' ARG . 1.3 mtpm? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.93 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 28.5 ttm . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.08 143.37 35.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.146 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.15 120.14 41.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.617 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.428 HG11 ' HE1' ' A' ' 33' ' ' PHE . 67.6 t -104.39 126.8 59.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.268 0.556 . . . . 0.0 111.727 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.716 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.8 m-30 -103.8 99.53 9.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.457 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.74 -141.05 3.04 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.33 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -116.61 160.63 20.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 120.675 0.274 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB2' HD13 ' A' ' 11' ' ' ILE . 6.1 m-20 -81.59 -78.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 t 170.49 -35.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.799 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -84.55 -22.94 29.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.38 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.599 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.3 mp -93.1 -39.01 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.74 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -155.93 145.0 20.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.272 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -68.39 158.26 33.99 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 p 175.38 113.9 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.815 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.6 m -90.29 -36.76 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.927 0.394 . . . . 0.0 111.1 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -62.25 -29.18 70.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.996 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 m -58.08 -48.04 81.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.028 0.442 . . . . 0.0 110.289 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -28.07 68.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.486 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.19 -57.22 4.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.765 0.317 . . . . 0.0 111.156 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.17 -26.16 37.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.319 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -68.53 -58.12 4.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 110.327 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.888 ' O ' HG23 ' A' ' 26' ' ' VAL . 13.1 mtt180 -63.17 -28.63 70.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.544 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.942 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -55.98 -56.53 19.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.197 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.633 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 1.5 mt -57.26 -40.01 76.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.58 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.4 m -60.06 -34.93 74.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.311 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 22' ' ' ARG . 22.1 t -62.41 -51.16 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.408 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' CE ' ' CE2' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -66.48 -16.74 64.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.375 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.82 42.82 0.19 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.141 0.496 . . . . 0.0 110.119 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -120.21 138.58 27.32 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.124 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.613 ' O ' ' HA ' ' A' ' 1' ' ' MET . 97.2 Cg_endo -74.31 158.24 44.94 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.013 1.809 . . . . 0.0 111.012 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.546 ' CG ' HD12 ' A' ' 24' ' ' LEU . 35.8 p90 -161.37 171.05 18.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.8 0.334 . . . . 0.0 111.668 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -141.57 130.83 23.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.512 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.428 ' HE1' HG11 ' A' ' 4' ' ' VAL . 21.0 t80 -89.14 159.56 17.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.955 0.407 . . . . 0.0 111.298 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.716 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.2 mt -146.85 120.11 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.552 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -91.66 112.48 24.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.543 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.82 HD11 ' CG1' ' A' ' 48' ' ' ILE . 6.6 tt -87.18 49.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.3 ttm -171.38 98.81 0.4 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.566 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 35.7 Cg_endo -65.1 -30.3 55.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.374 2.05 . . . . 0.0 112.288 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -143.01 158.71 43.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.419 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -71.0 -7.78 48.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.313 0.577 . . . . 0.0 111.498 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.61 -20.25 8.67 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.925 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 t -141.36 122.74 13.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.413 0.625 . . . . 0.0 112.5 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.746 ' HB3' HD11 ' A' ' 48' ' ' ILE . 31.6 m-85 -73.41 161.92 29.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.3 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.434 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 1.1 t70 -83.7 87.39 7.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.77 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -24.86 64.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.297 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -61.06 -55.86 27.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 110.713 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 6.4 mmtt -70.74 -43.55 68.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.112 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.82 ' CG1' HD11 ' A' ' 36' ' ' ILE . 63.0 mt -50.43 -38.22 15.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.672 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.47 -59.26 3.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 8.8 pt-20 -60.26 -30.03 69.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.159 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD2' HD21 ' A' ' 55' ' ' LEU . 1.9 tt -58.23 -50.14 74.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.146 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.1 mt -54.88 -48.4 73.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.097 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.9 m -66.18 -35.34 80.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.372 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -65.4 -37.14 86.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.829 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.503 HD21 ' CD2' ' A' ' 51' ' ' LEU . 1.2 mt -60.25 -67.34 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.85 -27.18 0.29 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.678 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.05 -165.5 1.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.898 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -91.56 -31.35 15.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.789 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -110.67 170.15 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 62' ' ' GLY . 11.7 pt20 -114.36 100.54 8.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.489 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -58.8 82.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.482 0.658 . . . . 0.0 111.598 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 60' ' ' GLN . . . 62.33 20.96 61.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.983 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.94 135.07 36.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.6 p -136.83 170.93 15.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.465 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.0 155.64 47.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.561 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -75.72 143.13 76.06 Favored 'Cis proline' 0 C--N 1.344 0.323 0 C-N-CA 123.8 -1.333 . . . . 0.0 112.83 0.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.493 ' HG2' ' HE1' ' A' ' 75' ' ' HIS . 1.7 mt-30 -111.97 113.76 26.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.879 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -87.91 161.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.111 0.482 . . . . 0.0 111.587 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 57.4 m-85 -143.08 139.04 30.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.345 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.704 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.53 132.52 54.43 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.294 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HB3' ' N ' ' A' ' 1' ' ' MET . 38.2 Cg_exo -54.87 -20.74 23.56 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.448 2.099 . . . . 0.0 111.911 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.57 39.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.279 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.48 -111.35 0.68 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.923 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.515 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 5.4 t -137.4 179.88 6.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.179 0.514 . . . . 0.0 111.273 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.493 ' HE1' ' HG2' ' A' ' 67' ' ' GLN . 86.8 t60 -56.34 126.9 28.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.025 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.704 HD11 ' HA ' ' A' ' 70' ' ' ALA . 11.0 mt -94.66 -42.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.78 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 134.22 -154.86 21.58 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.8 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 82' ' ' LEU . . . -93.62 -149.07 24.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.372 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.942 ' CE1' HD12 ' A' ' 23' ' ' LEU . 58.3 t80 -67.66 -59.14 3.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.757 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -62.09 -54.74 37.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.051 0.453 . . . . 0.0 110.818 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -52.02 -41.04 61.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.6 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.773 HD21 ' CE1' ' A' ' 86' ' ' PHE . 6.1 tt -79.69 -28.19 40.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.24 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 87' ' ' LYS . 2.2 mmm180 -52.28 -35.05 49.22 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -60.12 -32.59 71.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.2 t80 -68.4 -28.5 67.14 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.929 178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.773 ' CE1' HD21 ' A' ' 82' ' ' LEU . 15.7 m-85 -100.11 -70.86 0.72 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.833 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.567 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 56.2 ttp . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 81.0 m-85 -51.01 149.12 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.198 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 1.1 mptp? -117.23 116.99 28.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.219 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 68' ' ' VAL . 44.1 t -110.67 128.55 66.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.513 0.673 . . . . 0.0 112.577 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.583 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 22.0 m-85 -108.74 106.44 16.47 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.592 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.68 -137.26 2.29 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.831 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -123.94 134.11 53.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 122.449 0.3 . . . . 0.0 110.324 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -100.39 39.14 1.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 111.318 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 t 60.15 14.05 4.24 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.627 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -85.83 -53.29 5.21 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.901 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 37' ' ' MET . 18.6 mt -110.97 -15.26 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -160.67 148.42 15.99 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.07 159.28 33.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.62 119.07 1.0 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.433 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -90.38 -31.21 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.032 0.444 . . . . 0.0 111.125 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -62.7 -28.84 70.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.805 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 t -59.32 -47.07 86.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.049 0.452 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -62.52 -33.89 75.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.214 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 83.4 m-20 -74.61 -46.53 37.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.017 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -66.69 -40.52 88.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.92 0.39 . . . . 0.0 110.803 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -57.49 10.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.787 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.789 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -58.0 -40.12 79.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.387 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.733 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -59.15 -54.82 42.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.129 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.733 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.4 mt -55.97 -45.97 78.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.665 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -55.98 -38.01 69.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.157 0.504 . . . . 0.0 109.928 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.5 t -79.29 -29.71 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.497 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -75.25 -13.73 60.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.114 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm 68.56 46.31 1.01 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.0 0.429 . . . . 0.0 110.926 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -126.83 141.04 39.27 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.847 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.48 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.5 Cg_endo -82.06 140.38 11.21 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.514 2.143 . . . . 0.0 111.404 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 42.6 p90 -157.94 169.74 23.91 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.639 -0.424 . . . . 0.0 112.077 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.86 139.68 23.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.241 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.64 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.6 t80 -89.42 161.44 16.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.521 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.415 HG13 ' C ' ' A' ' 33' ' ' PHE . 12.1 mt -149.88 122.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 110.511 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -79.31 110.65 14.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.274 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.517 HG21 ' HB3' ' A' ' 5' ' ' TYR . 2.3 pt -86.01 -2.28 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.599 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.665 ' O ' HD12 ' A' ' 11' ' ' ILE . 38.5 ttm -119.41 107.22 41.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.87 -28.28 4.14 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.568 2.178 . . . . 0.0 111.546 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -139.95 152.77 46.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.665 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -65.6 -8.46 20.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.236 0.541 . . . . 0.0 112.048 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.41 -54.03 3.65 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.495 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.4 t -148.72 154.79 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.805 0.336 . . . . 0.0 111.378 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -77.45 170.39 16.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.96 114.42 25.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.687 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 35.1 m-20 -63.7 -15.62 58.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.412 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -62.7 -55.99 21.73 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.826 0.345 . . . . 0.0 110.839 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -70.09 -35.81 74.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' ' 43' ' ' PHE . 56.5 mt -70.43 -32.98 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.687 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.1 -57.42 12.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.64 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -63.17 -25.78 68.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.144 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.583 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 3.7 tt -60.36 -56.17 24.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.991 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.665 ' N ' HD23 ' A' ' 52' ' ' LEU . 2.1 mt -52.96 -45.17 67.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.065 0.46 . . . . 0.0 111.093 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 m -56.87 -49.02 76.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.379 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 11.3 mtpp -60.78 -36.28 78.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.404 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.78 -24.04 67.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.95 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.97 -132.65 11.38 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.925 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.56 31.24 2.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.102 0.477 . . . . 0.0 110.665 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.72 109.41 14.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.542 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 t -78.39 152.1 32.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.389 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -69.89 97.63 1.15 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.398 0.618 . . . . 0.0 110.898 -179.478 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.54 81.32 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.714 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.93 24.79 67.15 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.167 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -55.23 173.28 0.11 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.756 0.312 . . . . 0.0 110.778 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.8 p -133.16 169.05 17.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.193 0.52 . . . . 0.0 111.636 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.411 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 15.5 mmt -111.36 155.11 43.31 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.261 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.3 Cg_exo -84.33 143.01 40.18 Favored 'Cis proline' 0 N--CA 1.462 -0.341 0 C-N-CA 124.223 -1.157 . . . . 0.0 113.108 0.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -97.4 130.49 44.53 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.671 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 4' ' ' VAL . 4.1 t -99.77 160.56 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.02 0.438 . . . . 0.0 111.696 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.59 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 20.7 m-85 -141.55 138.1 32.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.527 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.572 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -44.82 138.51 4.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.502 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 90.6 Cg_exo -46.38 -25.73 3.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.917 2.411 . . . . 0.0 111.992 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.98 39.16 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.044 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.05 -112.37 1.09 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.366 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 t -127.18 -172.55 2.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.086 0.47 . . . . 0.0 111.495 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 83.0 t60 -67.21 145.83 54.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.087 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 70' ' ' ALA . 2.3 mp -123.04 -35.9 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.134 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.451 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.01 -156.44 20.72 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.774 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.73 -138.16 8.44 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.471 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 23' ' ' LEU . 31.5 t80 -71.85 -70.53 0.32 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.74 0.305 . . . . 0.0 110.773 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -56.43 -49.3 74.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.99 0.424 . . . . 0.0 110.48 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -36.34 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.291 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.634 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.9 tt -84.32 -29.77 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.023 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -51.7 -31.05 24.56 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.94 -34.42 78.08 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.219 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.459 ' CD2' HG12 ' A' ' 76' ' ' ILE . 15.4 t80 -65.27 -33.01 74.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.426 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.634 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.8 m-85 -87.95 -26.27 22.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.275 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 mttt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.9 -179.969 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.611 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 29.8 ttp . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -79.88 143.66 34.1 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.395 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.71 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -105.21 121.77 44.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.398 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 68' ' ' VAL . 38.6 t -103.38 126.58 57.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.82 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.577 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.6 m-30 -102.51 99.26 9.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.404 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.39 -138.33 2.46 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.503 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.769 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 93.0 m-85 -131.41 157.05 44.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.937 0.398 . . . . 0.0 111.543 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.588 ' O ' ' O ' ' A' ' 12' ' ' HIS . 32.6 p30 -80.25 -177.91 6.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.587 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -91.77 -13.7 31.11 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.698 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -85.67 -41.94 14.72 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mm -89.54 -45.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.588 ' O ' ' O ' ' A' ' 8' ' ' ASP . 20.8 t60 -139.64 115.51 10.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.68 0.752 . . . . 0.0 110.618 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.87 148.04 14.02 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.682 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 p -158.03 104.96 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 m -82.33 -33.37 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.723 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.97 -25.7 64.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.348 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.28 -48.78 80.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.626 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -55.29 -24.4 28.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.549 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 8.9 m-80 -74.68 -50.05 19.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.303 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.584 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -65.09 -40.79 95.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.791 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -61.41 -57.58 11.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.344 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.832 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -62.04 -33.8 75.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 0.0 109.709 179.245 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.78 HD13 ' N ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -57.55 -54.6 45.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.914 178.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.78 ' N ' HD13 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -58.49 -47.46 84.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.515 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -53.07 -39.99 63.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.116 0.484 . . . . 0.0 109.946 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 22' ' ' ARG . 60.7 t -72.98 -31.01 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.457 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HD3' ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -78.13 -9.81 59.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.043 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.35 37.25 1.2 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.051 0.453 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -123.51 133.13 24.37 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.015 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.611 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.9 Cg_endo -82.01 158.08 18.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.543 2.162 . . . . 0.0 111.227 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 9.1 p90 -161.72 171.57 17.67 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.767 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -136.86 137.42 39.66 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.463 ' HE1' HG11 ' A' ' 4' ' ' VAL . 10.9 t80 -89.36 158.42 17.79 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.196 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.577 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.1 mt -147.5 122.32 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.339 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -92.77 127.22 38.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.182 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.769 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 4.2 pt -89.53 -9.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.929 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.602 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 18.1 ttm -125.25 100.31 32.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.642 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.28 -22.99 28.94 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.647 2.232 . . . . 0.0 112.357 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -139.92 145.13 37.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -9.3 4.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.308 0.575 . . . . 0.0 111.78 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.91 -59.7 2.41 Favored Glycine 0 C--N 1.313 -0.708 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.741 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -146.85 134.69 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.685 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -69.49 170.64 10.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 48' ' ' ILE . 27.5 t70 -89.73 95.97 10.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.048 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -57.41 -18.68 19.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.104 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.47 -53.21 60.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -71.83 -36.29 70.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.362 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 44' ' ' ASP . 37.9 mm -53.16 -48.24 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.966 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.3 -53.14 57.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.627 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.49 -28.53 65.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.37 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.669 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.0 tt -58.23 -58.1 9.94 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.561 ' N ' HD23 ' A' ' 52' ' ' LEU . 4.1 mt -48.66 -48.14 40.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.307 0.575 . . . . 0.0 111.335 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.9 m -71.09 -22.06 62.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.192 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -73.09 -42.87 62.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.93 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.719 HD23 ' CE1' ' A' ' 75' ' ' HIS . 1.5 mp -59.33 -39.28 82.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.001 0.429 . . . . 0.0 110.886 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.94 -109.07 0.27 Allowed Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.057 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -150.5 32.53 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.241 0.544 . . . . 0.0 110.725 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -120.98 -152.09 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.385 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -120.98 170.6 9.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.863 0.363 . . . . 0.0 110.831 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -90.38 98.8 11.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.304 0.573 . . . . 0.0 110.476 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.6 mm -79.27 84.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.192 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.87 25.53 56.38 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.448 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.576 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.1 mm? -58.05 145.53 36.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 110.781 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.4 p -127.86 170.52 12.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.43 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.28 156.37 35.23 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.648 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.8 Cg_endo -85.19 145.12 40.18 Favored 'Cis proline' 0 N--CA 1.461 -0.419 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.834 0.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.576 ' CD ' HD12 ' A' ' 63' ' ' LEU . 3.3 mm-40 -107.68 113.35 26.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.743 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.8 t -87.25 161.36 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.291 0.567 . . . . 0.0 111.829 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.44 ' N ' HG12 ' A' ' 68' ' ' VAL . 55.8 m-85 -142.75 143.17 32.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.016 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.665 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -52.91 149.77 11.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.113 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' HB3' ' N ' ' A' ' 1' ' ' MET . 8.8 Cg_exo -68.79 -9.88 27.49 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.701 2.267 . . . . 0.0 112.39 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.6 -18.53 13.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.204 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.19 91.34 1.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.665 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m 176.29 158.24 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.537 0.208 . . . . 0.0 110.655 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.719 ' CE1' HD23 ' A' ' 55' ' ' LEU . 9.8 t-160 -90.46 133.52 34.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.665 HD12 ' N ' ' A' ' 70' ' ' ALA . 2.5 mt -122.28 -40.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.986 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 126.23 -161.38 20.6 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.928 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.26 -139.04 8.13 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.785 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -71.11 -70.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.602 0.239 . . . . 0.0 111.144 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -55.21 -50.83 68.39 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.198 0.523 . . . . 0.0 110.436 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -50.99 -43.71 60.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.231 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.618 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.1 tt -77.62 -29.1 51.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.312 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -52.25 -30.78 29.34 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.57 -35.56 79.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.5 t80 -61.79 -34.95 76.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.153 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.618 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -87.22 -27.53 22.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.266 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.8 mttt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.922 -179.85 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.637 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 17.9 ttp . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.402 ' CD1' ' CD2' ' A' ' 24' ' ' LEU . 71.2 m-85 -76.77 153.83 34.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.09 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -113.0 119.58 38.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.777 -179.468 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 68' ' ' VAL . 56.0 t -111.22 126.6 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.21 0.529 . . . . 0.0 111.865 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.643 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 22.7 m-85 -105.45 101.15 10.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.094 178.146 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.28 -137.46 2.24 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.498 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.612 ' CE1' HD11 ' A' ' 36' ' ' ILE . 46.8 m-85 -122.99 159.26 28.71 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -86.43 -70.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t 170.97 -37.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.743 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -79.09 -27.62 43.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.997 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.765 HG21 ' O ' ' A' ' 37' ' ' MET . 3.4 mp -89.59 -42.14 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.854 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -153.32 154.62 34.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.9 157.91 32.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.776 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p 179.12 86.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -72.76 -34.95 48.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.285 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.02 -19.07 65.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.343 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 t -69.17 -62.41 1.39 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.83 0.348 . . . . 0.0 110.515 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -49.82 -36.34 26.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.741 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -62.28 -54.26 43.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.768 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.0 -45.98 85.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.258 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -50.0 -38.35 36.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.943 0.402 . . . . 0.0 110.299 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.801 ' O ' HG23 ' A' ' 26' ' ' VAL . 11.8 tpt180 -68.52 -31.44 70.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.957 179.26 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.8 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.1 tt -56.52 -55.65 31.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.956 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.681 HD23 ' HZ ' ' A' ' 86' ' ' PHE . 1.3 mt -60.28 -52.32 65.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.696 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.1 m -51.13 -41.37 60.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.621 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 22' ' ' ARG . 74.9 t -66.19 -31.99 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.74 -9.8 57.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.107 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.49 51.41 0.12 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.941 0.4 . . . . 0.0 110.52 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -132.04 133.69 24.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.211 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.599 ' O ' ' HA ' ' A' ' 1' ' ' MET . 57.8 Cg_endo -81.7 161.57 19.02 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.547 2.165 . . . . 0.0 111.215 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 5.3 p90 -161.45 171.45 18.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 111.544 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -133.13 126.25 31.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.826 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.485 ' HE1' HG11 ' A' ' 4' ' ' VAL . 10.7 t80 -89.79 158.22 17.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.466 HD12 ' CE1' ' A' ' 5' ' ' TYR . 24.1 mt -150.71 125.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.313 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -80.14 115.69 19.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.749 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.612 HD11 ' CE1' ' A' ' 7' ' ' TYR . 2.3 pp -79.6 -20.3 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.071 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.765 ' O ' HG21 ' A' ' 11' ' ' ILE . 1.9 ttp -124.22 85.76 54.89 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.146 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.94 -3.64 14.11 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.903 2.402 . . . . 0.0 112.429 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 37' ' ' MET . 9.2 tt0 -139.52 136.78 34.87 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.705 0.288 . . . . 0.0 110.732 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -64.27 -8.9 14.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.222 0.534 . . . . 0.0 112.131 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.47 -63.38 1.64 Allowed Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.93 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.79 146.79 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.645 0.259 . . . . 0.0 110.75 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -72.32 168.88 17.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 111.263 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.669 ' O ' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -86.22 119.92 27.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.465 -179.506 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 4.9 t0 -76.23 -19.7 58.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.099 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.8 -58.73 6.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.965 0.412 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HD3' HG21 ' A' ' 34' ' ' ILE . 6.8 mmpt? -64.39 -40.59 96.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.095 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.669 HD12 ' O ' ' A' ' 44' ' ' ASP . 46.4 mt -65.41 -32.34 57.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.564 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -60.23 -48.45 81.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.786 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.86 -37.44 82.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.376 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.5 tt -58.98 -57.67 12.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.751 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.576 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 77.0 mt -46.27 -43.75 15.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.803 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 m -70.95 -28.79 64.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' CD ' ' CD2' ' A' ' 69' ' ' PHE . 2.9 ttmm -65.19 -45.14 86.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.597 -179.326 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.5 mp -59.43 -63.98 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.98 0.419 . . . . 0.0 111.127 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.33 -113.54 0.31 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.134 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.41 29.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 111.029 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -121.37 -154.76 0.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.308 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 t -120.98 166.04 14.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.729 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.63 ' CD ' HD23 ' A' ' 63' ' ' LEU . 20.9 mt-30 -118.42 99.15 6.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 110.99 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mm -80.93 84.89 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.175 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.02 29.75 3.67 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.357 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.63 HD23 ' CD ' ' A' ' 60' ' ' GLN . 3.1 tm? -52.34 131.66 33.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 110.798 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.629 ' N ' HD13 ' A' ' 63' ' ' LEU . 3.0 p -116.84 152.7 33.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.227 0.537 . . . . 0.0 111.635 -179.425 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -117.14 158.57 44.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.449 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.5 Cg_endo -87.02 134.88 15.97 Favored 'Cis proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.197 -1.168 . . . . 0.0 112.762 0.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.42 ' CG ' ' NE2' ' A' ' 75' ' ' HIS . 1.9 tp60 -92.68 139.15 30.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.878 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 77' ' ' GLY . 3.7 t -108.12 157.54 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.59 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.425 ' N ' HG12 ' A' ' 68' ' ' VAL . 28.5 m-85 -144.15 141.32 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.557 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.66 148.4 26.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.637 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 12.8 Cg_exo -67.45 -14.04 41.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.902 2.401 . . . . 0.0 112.198 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.51 -21.54 14.73 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.148 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.78 88.54 0.83 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.674 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m 179.39 158.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.633 0.254 . . . . 0.0 110.743 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.42 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 8.4 t-160 -90.34 133.49 34.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.557 HD11 ' HA ' ' A' ' 70' ' ' ALA . 17.1 mt -116.97 -45.55 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.979 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.622 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 122.01 -152.17 16.87 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.026 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -95.68 -131.07 6.48 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.562 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.8 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -77.55 -70.15 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.653 0.227 . . . . 0.0 111.048 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -51.56 -50.76 59.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.366 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -55.96 -39.59 71.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.614 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.7 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.8 tt -78.42 -32.52 48.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.598 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.0 mmm-85 -51.48 -33.1 29.78 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.52 -35.0 78.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.156 178.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.8 t80 -63.54 -35.75 81.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.7 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -91.79 -9.88 41.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.559 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.0 mttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.972 179.975 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.605 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 9.4 ttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.95 0.405 . . . . 0.0 111.627 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.475 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 86.9 m-85 -62.47 155.7 24.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.641 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.767 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -128.22 121.41 29.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.116 -179.717 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.066 HG22 HG22 ' A' ' 68' ' ' VAL . 12.8 t -115.1 124.67 71.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.893 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.0 m-85 -103.99 104.38 14.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.445 ' O ' ' HE1' ' A' ' 12' ' ' HIS . . . -167.2 -132.23 1.37 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.394 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.894 ' HA ' ' ND1' ' A' ' 12' ' ' HIS . 93.9 m-85 -134.12 149.49 51.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.645 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 18.8 p-10 -156.47 -51.33 0.08 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.641 ' N ' ' HB3' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -52.84 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -177.938 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -47.98 81.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.442 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.481 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -86.65 22.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.601 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.894 ' ND1' ' HA ' ' A' ' 7' ' ' TYR 0.301 2.0 t-80 -149.0 77.74 1.38 Allowed 'General case' 0 N--CA 1.417 -2.103 0 C-N-CA 117.845 -1.542 . . . . 0.0 108.612 -171.98 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.782 ' HE2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -61.05 166.64 3.43 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.33 -1.759 . . . . 0.0 113.481 -177.522 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 31.5 p 169.96 111.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.342 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.782 HG13 ' HE2' ' A' ' 13' ' ' LYS . 2.2 m -91.77 -37.33 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.706 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -75.15 -19.03 60.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.574 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.9 t -60.42 -51.76 68.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.783 0.325 . . . . 0.0 110.621 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.89 -31.8 7.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.551 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -78.19 -57.2 3.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.825 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -56.45 -45.36 80.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -57.33 -52.09 66.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.368 . . . . 0.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.788 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.1 mtm180 -55.12 -42.22 72.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.079 179.469 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.824 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -57.51 -53.45 58.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.296 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.824 ' N ' HD23 ' A' ' 23' ' ' LEU . 10.1 mt -57.96 -46.88 84.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.873 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.3 m -55.59 -36.98 67.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.131 0.491 . . . . 0.0 109.865 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.6 t -79.28 -30.04 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.559 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HE3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -71.5 -12.14 61.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.105 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt 64.38 42.23 5.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.107 0.479 . . . . 0.0 110.169 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -122.75 129.04 25.17 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.146 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' O ' ' HA ' ' A' ' 1' ' ' MET . 88.2 Cg_endo -77.21 140.05 19.39 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.274 1.983 . . . . 0.0 110.987 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.605 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 18.5 p90 -155.51 170.49 21.85 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.311 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.467 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 7.5 tt0 -136.57 134.56 37.59 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.193 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.629 ' CE2' ' HB3' ' A' ' 8' ' ' ASP . 8.6 t80 -90.45 156.94 17.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.893 HD12 ' CE1' ' A' ' 5' ' ' TYR . 29.8 mt -133.29 120.07 37.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.582 0.706 . . . . 0.0 110.196 179.16 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.503 ' HA ' ' CE1' ' A' ' 12' ' ' HIS . 5.6 p-10 -99.62 118.13 35.49 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.568 -1.197 . . . . 0.0 112.718 -177.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.849 HG22 ' HB2' ' A' ' 47' ' ' LYS . 20.1 pt -101.42 67.99 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 178.757 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.713 ' HE2' ' HE2' ' A' ' 7' ' ' TYR . 2.3 mtm -168.15 85.26 0.73 Allowed Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 122.678 0.391 . . . . 0.0 111.283 177.502 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 59.5 Cg_endo -71.79 -12.93 29.22 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.04 1.827 . . . . 0.0 110.526 178.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -150.24 150.04 31.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.37 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -63.19 -6.9 4.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.343 0.592 . . . . 0.0 111.528 179.605 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.92 -56.76 3.42 Favored Glycine 0 C--N 1.313 -0.697 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.158 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 43' ' ' PHE . 20.2 t -150.63 157.54 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.188 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.559 ' HD1' ' HG3' ' A' ' 37' ' ' MET . 1.8 m-85 -59.91 170.27 1.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.867 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.43 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -86.49 98.69 11.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.776 179.447 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -49.52 -28.06 5.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.158 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -61.47 -56.4 20.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.379 . . . . 0.0 110.467 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.849 ' HB2' HG22 ' A' ' 36' ' ' ILE . 7.8 mttt -61.49 -46.04 91.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.331 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.01 -44.06 77.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.372 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.39 84.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.218 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -42.5 99.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.451 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -54.24 -46.0 72.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.468 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.2 mt -56.22 -50.74 70.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.969 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.0 m -63.16 -33.51 75.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.441 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -63.61 -39.53 94.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.457 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 mt -60.02 -54.19 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.678 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.92 -112.82 0.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.125 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.8 ttt85 -150.49 33.0 0.63 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.034 0.445 . . . . 0.0 110.689 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -120.73 -146.87 0.38 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.501 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 t -120.18 170.3 9.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.805 0.336 . . . . 0.0 110.645 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -107.05 101.45 10.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.653 0.74 . . . . 0.0 110.709 179.633 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -80.31 86.52 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.479 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.55 29.87 75.92 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 60' ' ' GLN . 1.1 mm? -43.74 153.39 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 p -123.45 168.53 12.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.162 0.506 . . . . 0.0 111.62 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.9 mmt -122.53 153.15 62.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.558 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.9 Cg_endo -84.96 159.74 65.77 Favored 'Cis proline' 0 N--CA 1.462 -0.374 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.94 0.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.42 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 5.7 tp60 -112.75 109.73 19.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.119 179.178 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.066 HG22 HG22 ' A' ' 4' ' ' VAL . 3.2 t -90.63 164.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.781 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 85.4 m-85 -142.52 146.41 34.66 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.671 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.778 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -58.32 148.55 63.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.436 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 51.0 Cg_exo -57.76 -29.92 87.43 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.104 2.536 . . . . 0.0 112.264 179.208 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -89.83 -26.88 20.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.426 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.11 89.23 0.62 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.754 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 m -176.53 164.77 2.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.468 0.175 . . . . 0.0 110.589 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.42 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 10.7 t-160 -90.93 119.92 31.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.004 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.778 HD11 ' HA ' ' A' ' 70' ' ' ALA . 32.2 mt -98.94 -49.3 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.667 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.28 -153.19 21.11 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.782 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.7 -138.02 9.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.541 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.502 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 46.7 t80 -70.21 -70.42 0.29 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.741 0.305 . . . . 0.0 110.978 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.7 -49.33 76.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -51.27 -39.23 56.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.578 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.741 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -78.52 -31.93 47.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.371 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -52.43 -30.71 30.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.5 -35.84 78.07 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' LEU . 32.0 t80 -60.04 -36.87 78.23 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.197 178.186 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.741 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.0 m-85 -89.17 -22.47 22.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.552 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.885 -179.877 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.845 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 23.0 tpp . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.604 -0.147 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 32' ' ' GLU . 97.2 m-85 -42.89 135.55 2.98 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.108 0.48 . . . . 0.0 110.53 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.26 124.09 50.32 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.622 -178.379 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.986 HG22 HG22 ' A' ' 68' ' ' VAL . 53.9 t -111.87 144.19 20.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.257 0.551 . . . . 0.0 111.4 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.797 ' CE1' HD12 ' A' ' 34' ' ' ILE . 7.9 m-85 -124.78 103.43 8.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.261 178.595 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.65 -141.28 3.08 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.248 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 32.3 m-85 -124.15 160.74 27.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.733 0.301 . . . . 0.0 110.601 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -103.11 29.32 5.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.417 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.2 p 65.97 9.83 6.47 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.305 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -87.12 -54.95 4.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 111.97 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 37' ' ' MET . 3.6 mp -94.22 -25.38 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.403 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 13.8 t60 -146.52 134.87 21.85 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.81 -178.534 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -61.57 129.62 41.99 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.2 -178.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.1 m -159.01 89.29 0.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.259 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.25 -37.84 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -55.89 -29.23 59.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 0.0 111.349 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 t -65.03 -60.69 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.229 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -56.93 -36.07 69.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.966 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -66.27 -38.39 87.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.444 -179.58 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.579 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -72.62 -35.85 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.319 . . . . 0.0 110.946 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 9.9 tttt -60.2 -34.9 74.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.024 0.44 . . . . 0.0 109.867 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -68.53 -39.65 81.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.959 179.317 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.1 tt -55.49 -52.84 62.33 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.891 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.732 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.9 mt -57.95 -37.36 74.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.227 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 m -60.72 -39.77 89.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.596 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 22' ' ' ARG . 58.6 t -74.86 -33.11 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.894 178.643 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -75.77 -9.48 58.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.761 179.252 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 58.86 37.25 24.84 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.275 0.56 . . . . 0.0 110.392 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.489 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 2.4 mm-40 -120.65 104.95 41.72 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.708 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.845 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 2.0 Cg_endo -45.23 168.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.682 2.255 . . . . 0.0 112.351 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.568 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 5.0 p90 -162.8 170.78 17.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.425 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.1 tm-20 -137.86 122.94 19.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.454 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.502 ' HE1' HG11 ' A' ' 4' ' ' VAL . 7.3 t80 -89.33 159.66 17.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.997 0.427 . . . . 0.0 111.68 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.797 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.8 mt -145.41 120.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.095 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -82.8 131.17 35.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.728 -178.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.716 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 5.2 pt -100.33 -28.16 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.024 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.776 ' O ' HD13 ' A' ' 11' ' ' ILE . 5.9 ttp -123.93 91.39 49.68 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.841 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.403 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 84.2 Cg_endo -81.02 3.44 7.8 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.841 2.361 . . . . 0.0 112.962 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -139.52 146.89 40.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.791 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.724 ' HA ' HG23 ' A' ' 11' ' ' ILE . 6.8 tmtt? -71.42 -7.76 49.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.285 0.564 . . . . 0.0 111.692 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.93 -60.62 1.25 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.048 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 t -147.0 144.1 20.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 112.041 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -64.21 169.37 4.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.973 179.723 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 1.3 t0 -98.57 116.34 30.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -57.89 -24.05 55.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.584 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -55.4 -48.82 73.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.848 0.356 . . . . 0.0 110.99 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -76.5 -36.96 57.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.061 0.458 . . . . 0.0 110.216 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.0 mm -58.1 -50.43 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.692 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -44.15 96.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.437 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.56 -37.89 89.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.373 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.436 HD13 ' CD2' ' A' ' 5' ' ' TYR . 25.4 tp -61.09 -54.23 47.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.563 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.3 mt -50.7 -42.66 57.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.8 m -65.55 -35.13 79.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.192 179.213 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 2.8 tttp -64.47 -39.96 94.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.304 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.71 HD11 ' CD1' ' A' ' 63' ' ' LEU . 1.3 mt -59.45 -45.34 91.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.526 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.05 -110.84 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.89 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -150.55 32.5 0.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.996 0.427 . . . . 0.0 110.621 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.89 -146.75 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.431 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -119.99 170.43 9.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.708 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.74 98.39 8.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.137 0.494 . . . . 0.0 110.562 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -81.08 86.53 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.15 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.19 29.23 72.15 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.272 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.71 ' CD1' HD11 ' A' ' 55' ' ' LEU . 7.7 tt -46.73 152.55 0.47 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.343 . . . . 0.0 111.347 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.407 ' N ' HD23 ' A' ' 63' ' ' LEU . 35.6 p -130.28 166.01 21.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.173 0.511 . . . . 0.0 111.683 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.411 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 1.3 mpt? -125.33 154.96 72.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.629 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.6 Cg_endo -83.86 143.46 44.05 Favored 'Cis proline' 0 C--N 1.344 0.333 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.916 0.534 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.9 OUTLIER -103.25 128.28 50.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 179.089 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.986 HG22 HG22 ' A' ' 4' ' ' VAL . 5.9 t -100.99 160.5 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 112.14 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 97.2 m-85 -143.7 159.29 42.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.416 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -70.12 144.6 92.81 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.141 -179.341 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -37.78 -31.96 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.487 2.792 . . . . 0.0 112.446 179.182 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.82 36.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.118 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.25 -109.49 1.85 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.955 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -127.37 -173.95 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.121 0.486 . . . . 0.0 111.335 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.483 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 35.5 t-80 -70.71 137.33 49.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.116 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.8 mp -109.65 -31.36 2.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.706 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 75' ' ' HIS . . . 117.95 -156.62 15.56 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.205 179.397 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.64 -124.61 5.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.147 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -80.09 -70.46 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.618 0.209 . . . . 0.0 111.299 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -52.29 -47.97 65.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.125 0.488 . . . . 0.0 110.6 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -57.66 -45.04 86.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.679 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.733 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.9 tt -74.31 -32.6 62.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.448 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 87' ' ' LYS . 5.9 ttp85 -52.59 -33.1 44.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -65.01 -33.65 76.55 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.12 178.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LEU . 17.3 t80 -64.72 -34.22 77.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.483 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.733 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.5 m-85 -90.8 -71.03 0.65 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.558 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 83' ' ' ARG . 37.6 mttt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.912 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.574 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 55.6 ttm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.818 0.342 . . . . 0.0 111.449 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 46.6 m-85 -55.23 155.0 5.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.067 0.46 . . . . 0.0 111.016 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -124.56 119.29 28.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.033 -179.37 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.839 HG22 HG22 ' A' ' 68' ' ' VAL . 24.4 t -114.44 127.1 72.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.203 0.525 . . . . 0.0 112.067 179.468 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.463 ' CE1' HD12 ' A' ' 34' ' ' ILE . 24.9 m-85 -109.28 104.58 13.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.103 177.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.17 -139.19 2.58 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.684 -179.25 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.693 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 64.3 m-85 -121.71 160.52 24.35 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.908 0.385 . . . . 0.0 111.344 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.79 -72.99 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.778 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t 172.97 -36.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.981 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -64.72 -44.96 88.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.229 -179.555 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.4 mm -90.16 -40.11 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.431 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -149.96 152.49 35.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.012 0.434 . . . . 0.0 111.15 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -80.66 169.84 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.895 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 p 173.88 117.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.06 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -87.05 -34.35 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -22.63 66.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.014 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.8 t -72.05 -64.51 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.796 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -50.18 -35.48 26.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 51.8 m-20 -72.13 -59.0 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.17 -31.3 63.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.859 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -61.11 -54.46 44.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.659 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.728 ' O ' HG23 ' A' ' 26' ' ' VAL . 12.1 tpp180 -66.5 -24.65 66.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.025 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.555 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.3 tt -59.86 -58.18 9.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 110.501 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.644 HD12 ' CG ' ' A' ' 31' ' ' PHE . 5.5 mt -60.38 -42.76 96.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.795 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.5 m -60.96 -41.08 95.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.49 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 22' ' ' ARG . 71.1 t -73.68 -26.74 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.032 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.656 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 1.5 tpmp? -68.46 -44.35 75.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.79 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 112.71 30.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.331 1.052 . . . . 0.0 110.997 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -125.74 141.86 40.45 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.857 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.419 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.3 Cg_endo -80.35 143.43 15.54 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.531 2.154 . . . . 0.0 111.669 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.644 ' CG ' HD12 ' A' ' 24' ' ' LEU . 33.9 p90 -145.87 167.8 22.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.947 0.403 . . . . 0.0 111.973 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.66 126.13 26.82 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.579 ' CE1' HG11 ' A' ' 4' ' ' VAL . 24.7 t80 -89.94 155.73 18.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.23 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.62 HG21 ' HG2' ' A' ' 47' ' ' LYS . 10.1 mt -150.51 122.63 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.399 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -78.1 110.17 12.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.639 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.693 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.6 pt -62.87 -21.15 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.72 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.1 ttp -128.05 88.6 52.54 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.03 1.25 8.87 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.638 2.225 . . . . 0.0 112.569 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -139.46 139.29 36.99 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.513 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -66.94 -8.53 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.269 0.557 . . . . 0.0 111.895 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.3 -63.54 1.5 Allowed Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.429 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 t -145.9 143.78 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.717 0.294 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -65.6 168.2 7.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 111.235 -179.851 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.9 118.06 30.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.178 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 10.6 m-20 -71.43 -14.05 62.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.96 -61.07 2.51 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.62 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -64.77 -41.42 95.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.193 179.515 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.8 mt -64.53 -33.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.57 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -58.28 -47.87 82.25 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.712 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.95 -38.11 84.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.349 179.52 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.636 HD13 ' CE1' ' A' ' 69' ' ' PHE . 5.5 tp -57.96 -52.3 66.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.538 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.8 mt -51.45 -44.41 62.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.101 0.477 . . . . 0.0 111.278 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 m -63.27 -35.59 80.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.484 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.49 -40.34 89.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.657 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 51' ' ' LEU . 1.3 mt -59.94 -67.73 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.642 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.19 -107.02 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.033 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -150.45 31.42 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.004 0.43 . . . . 0.0 110.704 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.91 -149.44 0.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.353 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -120.53 170.19 9.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.755 0.312 . . . . 0.0 110.855 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -89.82 99.04 12.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.253 0.549 . . . . 0.0 110.309 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -78.22 88.02 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.039 -179.76 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.3 29.89 31.15 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.685 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.781 HD12 ' OE1' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -46.57 156.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 110.999 -179.961 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.8 p -105.62 147.87 27.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.101 0.477 . . . . 0.0 111.614 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.4 mmt -119.53 153.23 53.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.4 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HB2' HG13 ' A' ' 4' ' ' VAL . 2.8 Cg_exo -78.82 148.8 83.75 Favored 'Cis proline' 0 C--N 1.344 0.298 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.948 0.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.781 ' OE1' HD12 ' A' ' 63' ' ' LEU . 2.1 tp60 -96.0 129.58 43.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.819 178.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.839 HG22 HG22 ' A' ' 4' ' ' VAL . 3.6 t -107.79 157.04 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.055 0.455 . . . . 0.0 111.947 -179.053 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.636 ' CE1' HD13 ' A' ' 51' ' ' LEU . 40.9 m-85 -143.01 137.29 29.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.646 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' CA ' HD11 ' A' ' 76' ' ' ILE . . . -47.08 160.85 0.32 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.376 -178.639 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.3 Cg_exo -60.24 -30.54 91.43 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.175 2.583 . . . . 0.0 112.12 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -94.3 -19.73 20.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.188 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.85 88.72 1.3 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.597 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.52 126.74 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.802 0.334 . . . . 0.0 110.686 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.422 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 5.1 t-160 -62.47 114.06 3.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.158 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.516 HD11 ' CA ' ' A' ' 70' ' ' ALA . 8.7 mt -104.67 -39.88 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.764 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.98 -153.93 21.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.571 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.1 -135.8 9.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.651 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.555 ' CE1' HD12 ' A' ' 23' ' ' LEU . 13.4 t80 -71.62 -70.87 0.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 111.129 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.99 -47.16 86.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.71 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -52.38 -41.25 62.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.633 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.615 HD21 ' CE2' ' A' ' 86' ' ' PHE . 4.9 tt -75.87 -35.25 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 87' ' ' LYS . 7.8 ttp180 -51.14 -30.0 15.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -71.46 -34.3 70.09 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.142 178.231 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 82' ' ' LEU . 53.6 t80 -62.89 -35.55 80.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.35 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.615 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.8 m-85 -89.1 -27.62 20.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.454 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 83' ' ' ARG . 21.0 mtpp . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.955 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.677 ' HG2' ' C ' ' A' ' 30' ' ' PRO . 2.0 tpt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.391 0.138 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 89.0 m-85 -40.07 119.78 1.07 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.749 0.785 . . . . 0.0 111.613 -177.385 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.35 126.51 35.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.295 -179.102 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.551 HG11 ' CE1' ' A' ' 33' ' ' PHE . 59.3 t -109.2 148.21 13.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.392 0.615 . . . . 0.0 111.186 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.666 ' CE1' HD12 ' A' ' 34' ' ' ILE . 46.6 m-85 -128.05 99.77 5.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.737 178.613 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.63 -137.21 2.24 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.727 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.816 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 59.0 m-85 -121.24 108.02 13.25 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.669 0.271 . . . . 0.0 111.373 -179.042 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.524 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -110.94 51.0 0.79 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.003 179.816 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.44 -169.8 1.13 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -87.17 8.72 22.63 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.327 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 37' ' ' MET . 3.7 pt -86.59 -14.0 10.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.459 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 3.4 t60 -162.61 153.79 17.59 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.139 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -79.02 171.57 15.03 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.8 p -165.04 89.54 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.728 0.299 . . . . 0.0 111.069 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.9 m -91.49 -40.7 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.606 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.07 -23.27 64.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.654 -179.233 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.61 -47.03 80.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.23 -32.69 64.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -73.87 -55.65 5.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.682 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.19 -51.11 71.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 110.837 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -55.03 -47.16 75.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 179.69 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.801 ' O ' HG23 ' A' ' 26' ' ' VAL . 20.9 tpp180 -61.62 -40.5 95.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.028 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.584 ' C ' HD23 ' A' ' 23' ' ' LEU . 6.2 tt -56.56 -53.48 57.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.999 179.032 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.498 HD23 ' CZ ' ' A' ' 86' ' ' PHE . 10.3 mt -59.55 -44.54 93.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.411 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 m -57.67 -40.87 80.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 22' ' ' ARG . 50.8 t -75.31 -33.42 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.483 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' O ' ' NE2' ' A' ' 29' ' ' GLN . 1.9 mmtt -75.59 -12.11 60.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.929 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' O ' ' NE2' ' A' ' 29' ' ' GLN . 0.2 OUTLIER 69.8 41.72 1.15 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.849 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 28' ' ' LYS . 1.5 mp0 -132.15 118.07 16.1 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.407 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.677 ' C ' ' HG2' ' A' ' 1' ' ' MET . 77.8 Cg_exo -52.31 -177.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.308 2.005 . . . . 0.0 111.565 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE2' ' HE3' ' A' ' 21' ' ' LYS . 5.0 p90 -164.92 170.84 14.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.921 0.391 . . . . 0.0 111.367 178.012 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 34.7 tt0 -141.66 121.0 13.12 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.028 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.551 ' CE1' HG11 ' A' ' 4' ' ' VAL . 10.7 t80 -92.32 165.86 12.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.115 0.483 . . . . 0.0 112.078 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.666 HD12 ' CE1' ' A' ' 5' ' ' TYR . 25.4 mt -150.65 128.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.184 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.11 125.92 32.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.8 -178.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.414 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.9 pt -100.78 -25.11 3.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.718 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.795 ' HB3' HD12 ' A' ' 11' ' ' ILE . 2.3 ttm -108.91 105.19 56.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.012 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 37.5 Cg_endo -66.11 -29.65 47.74 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 121.769 1.646 . . . . 0.0 110.244 178.6 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -146.15 155.94 43.07 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.212 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -6.57 6.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.33 0.586 . . . . 0.0 111.568 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.34 -55.36 2.91 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 115.11 -0.95 . . . . 0.0 114.009 -178.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 t -148.2 135.87 14.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.951 0.376 . . . . 0.0 111.754 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -59.83 168.72 1.66 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.875 179.785 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.55 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -89.05 129.72 35.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.483 -179.907 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.37 -35.16 79.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.855 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -66.68 -50.9 61.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -68.32 -41.32 80.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.858 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.3 mp -66.62 -35.19 74.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.661 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.01 -57.95 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.307 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -55.93 -29.62 60.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.984 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.851 ' O ' HD12 ' A' ' 55' ' ' LEU . 24.4 tp -61.44 -61.16 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.078 179.449 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.617 ' HA ' HD13 ' A' ' 55' ' ' LEU . 86.2 mt -46.28 -35.73 5.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.692 179.442 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 m -69.29 -34.26 74.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.831 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 7.5 mtpp -68.36 -43.49 77.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.818 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.851 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -58.6 -20.26 45.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.418 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.11 -29.45 7.57 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.765 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -89.88 -174.82 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -108.43 -31.8 7.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -109.85 169.96 8.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -112.87 99.94 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -74.57 82.75 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.162 -179.913 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.59 23.77 55.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.646 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.477 HD12 ' NE2' ' A' ' 67' ' ' GLN . 1.1 mm? -64.78 140.77 58.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.3 p -131.95 170.69 14.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.107 0.479 . . . . 0.0 111.474 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -104.09 155.5 37.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.664 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.4 Cg_exo -82.14 135.58 29.17 Favored 'Cis proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.678 0.463 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.477 ' NE2' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.99 128.37 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.18 179.187 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.0 t -102.88 157.11 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.015 0.436 . . . . 0.0 111.669 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 78.3 m-85 -143.09 147.21 34.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.775 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.625 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.16 140.9 70.24 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.37 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.85 -31.99 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.005 2.47 . . . . 0.0 112.115 179.31 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.43 34.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.932 179.46 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.87 -108.1 2.01 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.998 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.9 t -133.96 175.44 9.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.266 0.555 . . . . 0.0 111.511 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -59.32 129.26 41.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.019 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.625 HD11 ' HA ' ' A' ' 70' ' ' ALA . 9.3 mt -102.09 -42.14 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.977 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.54 -153.3 20.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.757 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.09 -142.4 13.27 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.379 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -69.43 -70.62 0.27 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 110.811 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -58.79 -48.73 80.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.517 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.74 -42.54 62.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.451 179.597 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.75 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.6 tt -79.77 -28.73 40.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.028 179.471 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -51.38 -32.6 26.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.93 -35.25 80.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.162 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.6 t80 -63.14 -34.07 76.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.354 178.338 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.75 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.7 m-85 -93.09 -12.43 30.52 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.589 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.97 179.92 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.601 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 36.5 ttm . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.877 0.37 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 68.8 m-85 -58.62 163.98 2.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.833 -179.555 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.723 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -138.67 119.27 13.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.684 -179.305 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.943 HG22 HG22 ' A' ' 68' ' ' VAL . 24.0 t -108.54 147.91 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.239 0.542 . . . . 0.0 111.508 179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.697 ' CE1' HD12 ' A' ' 34' ' ' ILE . 27.9 m-85 -130.87 101.55 5.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.466 178.677 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.62 -136.5 2.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.57 -179.359 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -108.27 157.26 18.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.846 0.355 . . . . 0.0 111.304 -179.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 9' ' ' SER . 20.3 t0 -85.14 -4.66 59.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.979 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 86.28 -36.63 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.955 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -75.33 -33.79 61.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.691 0.281 . . . . 0.0 111.089 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 37' ' ' MET . 1.5 mt -89.79 -32.14 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.337 -179.779 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -141.24 132.03 25.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 110.621 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 151.25 41.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.573 -179.189 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 168.96 91.04 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.836 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.2 m -57.43 -37.05 55.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.53 -23.43 50.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -65.05 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.499 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.06 -34.97 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -60.88 -46.97 88.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.896 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -60.54 -43.44 97.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.294 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -53.98 -36.89 63.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.004 0.431 . . . . 0.0 110.132 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.768 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.3 tpp180 -70.18 -28.54 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.204 179.137 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.866 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -57.42 -55.96 27.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.927 179.414 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.646 HD21 HD21 ' A' ' 82' ' ' LEU . 24.8 mt -64.2 -42.54 96.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.578 179.459 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.8 m -58.59 -34.35 71.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.205 179.698 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 22' ' ' ARG . 72.0 t -76.8 -31.25 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.616 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HG3' ' CD1' ' A' ' 86' ' ' PHE . 15.0 mmtt -76.07 -19.59 58.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.195 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.76 60.38 0.11 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -139.76 142.45 31.27 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.953 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' HA ' ' A' ' 1' ' ' MET . 87.4 Cg_endo -75.91 137.31 19.61 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.405 2.07 . . . . 0.0 111.405 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.601 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 20.0 p90 -151.91 170.33 20.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -138.38 129.43 27.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.545 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.638 ' CE1' HG11 ' A' ' 4' ' ' VAL . 49.0 t80 -89.94 160.02 16.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.054 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.697 HD12 ' CE1' ' A' ' 5' ' ' TYR . 15.3 mt -145.57 121.43 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.295 0.569 . . . . 0.0 110.274 179.29 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -91.27 121.36 32.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.157 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.444 HD12 ' HD2' ' A' ' 43' ' ' PHE . 3.6 pt -80.64 -4.4 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.057 179.51 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.585 ' O ' HD12 ' A' ' 11' ' ' ILE . 36.9 ttm -132.85 110.97 13.28 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.778 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.42 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 71.9 Cg_endo -76.91 -30.73 4.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.552 2.168 . . . . 0.0 112.474 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 37' ' ' MET . 8.3 tp10 -139.69 155.33 47.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.639 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.455 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -64.54 -8.03 12.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.296 0.57 . . . . 0.0 111.524 179.966 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.41 -52.21 4.6 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 115.177 -0.919 . . . . 0.0 113.193 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 43' ' ' PHE . 22.9 t -149.24 153.4 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.105 0.479 . . . . 0.0 112.235 -179.188 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.74 ' HB3' HD11 ' A' ' 48' ' ' ILE . 62.4 m-85 -73.74 168.72 18.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.124 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.42 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -99.71 111.62 23.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.891 179.345 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -62.48 -26.57 68.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.747 0.308 . . . . 0.0 110.556 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.32 -56.05 19.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -36.68 81.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.302 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.74 HD11 ' HB3' ' A' ' 43' ' ' PHE . 34.5 mt -67.27 -38.18 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.35 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.44 -56.07 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.273 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.31 -28.89 56.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.866 ' O ' HD12 ' A' ' 55' ' ' LEU . 26.0 tp -62.96 -60.85 2.9 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.212 179.519 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.4 mt -45.54 -39.42 7.43 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.207 0.527 . . . . 0.0 111.288 179.229 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.8 m -67.11 -36.12 81.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.001 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HG2' ' CD2' ' A' ' 69' ' ' PHE . 7.9 tttp -63.22 -50.28 70.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.333 179.383 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 51' ' ' LEU . 5.0 mp -58.92 -55.05 40.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.68 -126.39 0.9 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.376 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -150.4 33.23 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.991 0.424 . . . . 0.0 110.861 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -120.74 -144.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 t -105.06 170.06 8.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.72 0.295 . . . . 0.0 110.624 179.705 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.69 98.31 11.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.299 0.571 . . . . 0.0 110.546 179.841 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.4 mt -80.37 86.41 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.07 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.23 30.31 75.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.039 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.444 HD11 HE22 ' A' ' 67' ' ' GLN . 7.5 tt -48.03 151.32 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 111.512 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 p -142.26 170.18 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.39 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -132.13 149.76 74.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.648 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -85.59 149.36 47.05 Favored 'Cis proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.758 0.354 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.444 HE22 HD11 ' A' ' 63' ' ' LEU . 8.1 mt-30 -114.44 133.99 55.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.451 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.943 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -105.88 168.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.302 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 78.8 m-85 -142.33 146.11 34.66 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -57.16 138.3 80.2 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.235 -178.828 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.472 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 87.1 Cg_exo -46.17 -28.4 5.47 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.878 2.385 . . . . 0.0 111.902 178.798 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.91 33.55 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.91 179.578 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.92 -108.89 1.76 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.934 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.431 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -145.36 179.36 7.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.29 0.566 . . . . 0.0 111.421 -179.537 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.41 ' CE1' ' OE1' ' A' ' 67' ' ' GLN . 16.3 t-160 -49.76 118.79 3.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.355 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.551 HG23 ' CD2' ' A' ' 85' ' ' TYR . 6.7 mt -84.83 -47.51 17.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.891 0.376 . . . . 0.0 111.076 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.83 -152.36 18.02 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.493 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -93.37 -155.3 31.82 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.405 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.866 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -61.61 -67.76 0.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 O-C-N 122.83 -0.218 . . . . 0.0 110.859 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -48.39 -42.18 31.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.068 0.461 . . . . 0.0 110.541 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -67.37 -42.32 83.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.417 179.604 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.646 HD21 HD21 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -66.71 -45.83 77.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.316 179.726 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -51.13 -36.61 41.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.653 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -70.29 -34.95 73.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.233 178.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.551 ' CD2' HG23 ' A' ' 76' ' ' ILE . 65.0 t80 -66.54 -30.61 70.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.751 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.601 ' CE2' HD21 ' A' ' 82' ' ' LEU . 24.8 m-85 -90.9 -66.72 0.9 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.69 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.2 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.617 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.3 ttm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.897 0.38 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.473 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 87.4 m-85 -64.4 156.34 29.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.011 0.434 . . . . 0.0 110.689 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.663 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.58 120.22 22.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.561 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 68' ' ' VAL . 21.1 t -108.62 137.38 40.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.18 0.514 . . . . 0.0 111.755 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.791 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.5 m-85 -115.73 101.08 8.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.927 178.488 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -160.25 -138.19 2.39 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.286 -179.277 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.409 ' CG ' ' HB3' ' A' ' 12' ' ' HIS . 41.7 m-85 -126.22 157.11 39.09 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.647 0.261 . . . . 0.0 111.039 -179.407 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.01 -69.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.807 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 t 170.87 -39.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.813 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -76.77 -24.74 52.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.844 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.667 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.0 mp -90.82 -43.62 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.153 0.501 . . . . 0.0 110.17 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.409 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 6.5 t-80 -152.18 147.21 26.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.131 179.318 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.55 159.14 26.99 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.239 -179.382 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -177.06 106.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.585 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.92 -36.65 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.697 -179.433 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -62.87 -21.22 65.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.495 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.6 t -64.54 -52.84 55.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.955 0.407 . . . . 0.0 110.571 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -55.55 -32.46 63.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.323 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -72.34 -53.76 11.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.224 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.4 -48.6 74.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.982 0.42 . . . . 0.0 111.139 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -51.15 71.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -56.78 -42.19 78.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.2 tt -57.5 -54.67 44.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.394 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.782 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.6 mt -55.38 -44.97 76.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.771 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.1 m -58.36 -34.62 70.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.133 0.492 . . . . 0.0 110.059 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 22' ' ' ARG . 48.0 t -79.84 -30.18 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.734 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.533 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 2.1 mmtt -79.17 -14.38 59.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 66.31 60.81 0.61 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.999 0.428 . . . . 0.0 110.804 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -133.62 143.1 46.37 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.466 ' O ' ' HA ' ' A' ' 1' ' ' MET . 75.8 Cg_endo -80.17 132.86 9.55 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.606 2.204 . . . . 0.0 111.445 179.209 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.617 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 29.1 p90 -155.18 170.43 21.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.921 0.391 . . . . 0.0 112.012 -179.682 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -144.84 145.72 31.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.058 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.494 ' CE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.29 158.44 17.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.099 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.791 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.8 mt -142.28 117.66 5.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.213 179.352 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -81.33 119.44 23.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.54 -179.053 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 6' ' ' GLY . 10.5 tt -85.86 -27.86 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.193 179.103 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 7.4 ttp -129.93 95.86 27.5 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 179.418 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -78.14 -5.06 14.88 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.563 2.175 . . . . 0.0 112.691 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -139.9 139.89 36.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.755 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.91 -8.63 23.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.237 0.542 . . . . 0.0 111.989 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.16 -61.68 1.8 Allowed Glycine 0 C--N 1.312 -0.787 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.228 179.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.52 133.01 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.735 0.302 . . . . 0.0 111.094 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.03 167.59 1.6 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.01 0.433 . . . . 0.0 111.29 -179.804 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.45 108.79 18.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.102 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -53.09 -25.89 14.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.163 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -55.83 -49.94 71.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.773 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -74.98 -34.45 62.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.125 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.459 ' CD1' HD11 ' A' ' 36' ' ' ILE . 30.0 mm -59.82 -49.92 82.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.775 179.628 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.55 -50.61 72.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.488 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.23 -41.05 98.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.353 179.44 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.501 HD22 ' HD2' ' A' ' 5' ' ' TYR . 6.2 tp -57.07 -49.61 75.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.75 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.76 -49.89 69.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.086 0.47 . . . . 0.0 111.153 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.4 m -60.98 -33.19 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.272 179.214 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -64.29 -41.36 96.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.354 179.505 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.5 mt -59.84 -56.11 25.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.567 179.392 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.96 -109.03 0.27 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.953 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -150.65 30.89 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.414 . . . . 0.0 110.698 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -121.03 -148.84 0.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.377 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 t -120.62 170.32 9.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 0.0 110.687 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -98.09 98.85 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.041 0.448 . . . . 0.0 110.471 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -80.25 85.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.242 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.64 27.89 55.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.444 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.534 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.1 mm? -47.41 154.27 0.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.829 0.347 . . . . 0.0 111.01 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.3 p -113.84 157.94 21.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.089 0.471 . . . . 0.0 111.636 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -120.84 158.15 52.9 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HB2' HG13 ' A' ' 4' ' ' VAL . 5.8 Cg_exo -82.18 148.58 69.11 Favored 'Cis proline' 0 C--N 1.343 0.253 0 C-N-CA 124.017 -1.243 . . . . 0.0 112.887 0.469 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.534 ' CD ' HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -105.07 125.6 51.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.167 179.023 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -97.25 167.98 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.878 0.37 . . . . 0.0 111.607 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.536 ' H ' HG12 ' A' ' 68' ' ' VAL . 75.7 m-85 -142.63 141.45 31.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.74 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB3' ' N ' ' A' ' 74' ' ' SER . . . -54.66 147.64 29.69 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.13 -178.918 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.497 ' HB3' ' N ' ' A' ' 1' ' ' MET . 51.6 Cg_exo -54.57 -27.81 52.37 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.804 2.336 . . . . 0.0 111.813 179.099 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -97.69 -22.32 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.014 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.16 82.82 0.6 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.63 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.497 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -168.78 115.66 0.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.727 0.299 . . . . 0.0 110.853 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -50.71 116.71 2.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.177 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.534 HG23 ' CD2' ' A' ' 85' ' ' TYR . 3.6 mt -88.82 -41.02 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.59 -150.09 17.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.633 -179.654 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.48 -140.12 9.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.399 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -75.84 -61.24 1.99 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.59 -42.72 67.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.24 -44.36 92.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.636 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.587 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -59.43 -49.0 79.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.464 179.831 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 ttt-85 -52.34 -32.44 38.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -75.06 -32.34 61.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.162 178.228 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.534 ' CD2' HG23 ' A' ' 76' ' ' ILE . 56.6 t80 -67.22 -32.2 73.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.357 178.473 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.587 ' HE2' HD21 ' A' ' 82' ' ' LEU . 26.1 m-85 -93.34 -70.47 0.7 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.504 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.923 179.983 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.565 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 58.1 ttm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.99 0.424 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.501 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 93.0 m-85 -53.17 152.51 4.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.039 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -126.92 120.44 29.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.954 -179.15 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.937 HG22 HG22 ' A' ' 68' ' ' VAL . 27.3 t -111.01 138.03 40.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 0.0 111.438 179.467 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.809 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.8 m-85 -114.73 99.03 7.21 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.128 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.76 -138.36 2.48 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.237 -0.983 . . . . 0.0 112.561 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.654 ' CE2' ' HE3' ' A' ' 37' ' ' MET . 17.6 m-85 -118.91 148.45 42.92 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.592 0.234 . . . . 0.0 110.674 -179.191 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.3 t0 -78.36 7.09 7.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.824 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.2 m 80.97 -15.78 0.71 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -85.93 -47.82 9.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 111.788 -179.61 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.86 -15.34 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.971 -179.298 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.479 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 3.5 t60 -150.76 163.33 38.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.997 -178.23 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.06 157.84 23.98 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.062 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 176.84 108.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.92 0.39 . . . . 0.0 111.94 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.9 m -91.75 -28.97 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.391 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -71.44 -22.17 61.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.224 -178.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 p -67.26 -34.47 77.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.058 0.456 . . . . 0.0 110.45 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -56.27 12.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.59 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -49.77 72.1 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.392 -179.248 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.72 -45.19 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 111.038 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -64.74 -50.37 67.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.803 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.749 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -55.18 -39.3 69.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 -179.94 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.679 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.5 tt -57.76 -54.28 48.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.451 179.762 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.8 mt -56.89 -44.94 82.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.2 m -59.24 -39.53 83.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.097 0.475 . . . . 0.0 110.171 179.486 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 22' ' ' ARG . 58.9 t -76.08 -32.63 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.66 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -76.56 -9.74 58.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.048 179.787 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 67.45 61.17 0.46 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.931 0.396 . . . . 0.0 110.778 -179.791 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -140.76 138.73 18.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.175 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' A' ' 1' ' ' MET . 52.4 Cg_endo -83.05 142.09 10.81 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.685 2.257 . . . . 0.0 111.499 179.249 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.565 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 49.7 p90 -153.1 170.27 20.9 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.66 140.64 35.01 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.094 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.464 ' CE1' HG11 ' A' ' 4' ' ' VAL . 11.1 t80 -89.73 161.57 15.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.349 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.809 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.9 mt -147.4 120.65 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.198 179.459 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -95.71 131.21 42.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.536 -179.178 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -100.46 -24.54 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.912 179.411 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.654 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 21.9 ttm -114.5 82.0 7.35 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.755 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.403 ' CG ' ' HB2' ' A' ' 44' ' ' ASP . 91.6 Cg_endo -81.53 7.81 4.79 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.715 2.276 . . . . 0.0 112.527 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -139.37 129.9 25.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.353 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -59.79 -8.28 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.183 0.516 . . . . 0.0 112.04 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.77 -71.52 1.04 Allowed Glycine 0 C--N 1.314 -0.657 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.374 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.07 133.95 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -67.69 165.65 16.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.011 0.434 . . . . 0.0 111.46 -179.637 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 28.5 t0 -81.28 124.89 29.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.346 -179.482 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.536 ' HA ' HD12 ' A' ' 48' ' ' ILE . 1.0 OUTLIER -75.28 -24.89 57.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.199 179.865 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.0 -51.35 68.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.85 0.357 . . . . 0.0 110.616 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -71.05 -39.23 72.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.119 179.169 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 45' ' ' ASP . 62.9 mt -58.29 -37.87 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.551 179.399 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.56 -49.68 70.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.49 -40.64 97.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.419 179.562 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.47 HD13 ' CD2' ' A' ' 5' ' ' TYR . 11.4 tp -58.13 -51.19 70.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.707 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.6 mt -51.99 -46.64 64.95 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.132 0.492 . . . . 0.0 111.167 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -65.92 -32.97 74.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.105 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -63.43 -42.02 98.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.379 179.492 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 mt -59.81 -69.85 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.074 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.0 -35.14 0.29 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.554 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -109.41 -166.48 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.333 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -109.48 -30.4 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -90.23 164.44 14.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.798 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -117.97 100.26 7.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.98 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.7 tp -78.96 83.92 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.091 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.99 25.63 56.9 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.571 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 1.6 mm? -54.26 137.05 42.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.939 0.399 . . . . 0.0 110.889 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.5 p -122.03 170.29 9.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 111.448 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.67 157.9 64.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.709 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HB2' HG13 ' A' ' 4' ' ' VAL . 2.1 Cg_endo -85.25 149.81 50.29 Favored 'Cis proline' 0 N--CA 1.463 -0.304 0 C-N-CA 124.093 -1.211 . . . . 0.0 112.681 0.275 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.576 ' HB3' ' HE1' ' A' ' 75' ' ' HIS . 22.2 mm-40 -109.75 127.88 54.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.113 179.046 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.937 HG22 HG22 ' A' ' 4' ' ' VAL . 2.7 t -98.85 165.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.958 0.408 . . . . 0.0 111.672 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.555 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 84.5 m-85 -142.3 142.49 32.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.781 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.817 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -52.37 137.23 40.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.254 -178.625 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.45 ' HB3' ' N ' ' A' ' 1' ' ' MET . 98.5 Cg_exo -44.36 -29.89 3.37 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.08 2.52 . . . . 0.0 112.265 179.106 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.38 36.25 0.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.248 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.26 -109.29 1.12 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.837 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.452 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 55.9 p -135.86 176.11 8.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.021 0.438 . . . . 0.0 111.2 -179.613 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.576 ' HE1' ' HB3' ' A' ' 67' ' ' GLN . 86.5 t60 -52.37 125.72 16.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.285 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.817 HD11 ' HA ' ' A' ' 70' ' ' ALA . 19.0 mt -91.23 -45.3 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.0 -151.09 19.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.747 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.93 -136.72 7.83 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.61 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -77.17 -63.12 1.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 111.123 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -53.65 -45.68 70.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.902 0.382 . . . . 0.0 110.84 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -45.28 85.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.539 179.673 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.708 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -59.31 -47.81 83.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.702 179.917 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -52.38 -33.32 42.83 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.072 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.73 66.7 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.338 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.473 ' CD1' HG23 ' A' ' 76' ' ' ILE . 54.9 t80 -66.11 -33.94 76.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.404 178.462 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.708 ' HE2' HD21 ' A' ' 82' ' ' LEU . 18.7 m-85 -90.02 -26.95 20.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.428 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.194 -0.907 . . . . 0.0 110.857 -179.904 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.585 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 21.2 ttm . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.831 0.348 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.51 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 92.4 m-85 -60.04 148.57 35.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.621 -179.654 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -125.36 118.13 25.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 -179.378 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.703 HG22 HG22 ' A' ' 68' ' ' VAL . 70.7 t -108.82 144.6 16.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.179 0.514 . . . . 0.0 111.387 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.878 ' CE1' HD12 ' A' ' 34' ' ' ILE . 6.8 m-85 -124.98 99.49 6.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.051 178.201 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.74 -149.14 5.7 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.891 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.423 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 63.3 m-85 -105.95 152.23 23.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.754 0.311 . . . . 0.0 111.273 -179.857 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.5 p30 -72.32 -63.12 1.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.576 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.4 p 160.2 -32.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.046 0.45 . . . . 0.0 110.849 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -85.13 -22.82 28.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.467 -179.35 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.453 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 9.6 mt -88.42 -38.7 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.603 0.239 . . . . 0.0 110.949 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -147.75 141.56 25.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 111.154 179.243 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 140.23 58.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.192 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 173.8 106.38 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.222 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 m -85.72 -25.65 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.399 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.27 -34.76 72.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.396 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -67.05 -42.73 84.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.71 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -24.83 68.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.971 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 87.9 m-20 -78.12 -53.59 7.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.234 -179.634 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 79' ' ' PHE . . . -53.43 -45.2 69.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.968 0.413 . . . . 0.0 110.942 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -51.49 69.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.807 179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.705 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.8 ttp180 -57.8 -39.26 77.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.669 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -56.63 -53.09 61.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.354 179.385 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.782 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.7 mt -56.33 -46.17 80.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.597 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -55.75 -36.62 67.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.053 0.454 . . . . 0.0 109.825 179.208 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 22' ' ' ARG . 43.2 t -80.11 -30.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.491 179.114 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HB3' ' NE2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -76.23 -13.49 60.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.046 179.61 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.26 59.85 0.51 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.99 0.424 . . . . 0.0 111.079 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.507 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -140.48 140.41 22.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.037 179.828 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.488 ' O ' ' HA ' ' A' ' 1' ' ' MET . 71.7 Cg_endo -79.84 137.87 12.85 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.557 2.171 . . . . 0.0 111.376 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.585 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 13.2 p90 -154.89 170.28 22.06 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -138.8 129.87 26.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.972 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.598 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.2 t80 -92.62 122.34 34.94 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.901 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.878 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.7 mt -104.43 109.8 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.629 0.728 . . . . 0.0 110.469 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -81.6 118.93 23.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.253 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.593 HG22 ' HB3' ' A' ' 47' ' ' LYS . 20.3 pt -100.21 45.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.356 179.574 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.508 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.4 ttt -162.72 99.79 1.07 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.075 -179.659 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 56.3 Cg_endo -71.19 -33.14 11.91 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.265 1.976 . . . . 0.0 111.719 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.91 157.86 45.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.349 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 11' ' ' ILE . 4.8 mttt -64.96 -8.46 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.301 0.572 . . . . 0.0 111.453 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.68 -56.73 2.06 Favored Glycine 0 C--N 1.313 -0.721 0 CA-C-N 115.201 -0.908 . . . . 0.0 113.557 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.3 144.84 29.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.629 ' HB3' HD11 ' A' ' 48' ' ' ILE . 13.5 m-85 -71.08 170.65 12.43 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.153 179.438 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.514 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -95.15 115.84 27.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.753 179.151 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -56.72 -28.23 60.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.23 -52.87 62.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HB3' HG22 ' A' ' 36' ' ' ILE . 27.3 mmtp -70.78 -47.87 57.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.81 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 43' ' ' PHE . 1.8 mp -55.78 -48.71 77.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.62 96.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.521 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.78 -35.25 79.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.617 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 tp -58.71 -54.55 45.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.533 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.414 ' N ' HD23 ' A' ' 52' ' ' LEU . 7.8 mt -53.56 -46.27 70.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.175 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 m -62.47 -32.1 72.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.386 179.309 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -69.67 -36.41 76.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.472 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.68 -61.16 2.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.555 179.434 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.5 -105.82 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.993 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -146.1 30.14 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.077 0.465 . . . . 0.0 110.547 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -120.91 -153.65 0.55 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.544 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 t -120.84 170.61 9.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.3 98.38 8.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.55 . . . . 0.0 110.282 179.627 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.0 mm -79.71 84.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.191 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.6 25.11 57.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.463 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.571 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -61.12 143.26 55.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.785 179.861 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.4 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 71.4 p -121.69 153.21 38.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.277 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.0 mmt -102.65 153.97 37.81 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.495 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.2 Cg_exo -77.7 141.33 66.8 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.022 0.526 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.571 ' CD ' HD12 ' A' ' 63' ' ' LEU . 35.5 mt-30 -99.31 122.4 42.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.488 179.223 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.703 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -96.5 165.76 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.897 0.38 . . . . 0.0 111.67 -179.483 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 72.2 m-85 -142.8 142.29 31.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.742 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.07 134.45 58.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.163 -178.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.536 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 98.0 Cg_exo -44.68 -29.41 3.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.912 2.408 . . . . 0.0 112.116 178.853 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -163.74 42.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.256 179.784 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.08 -107.93 0.7 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.741 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.47 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -137.58 176.13 8.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.154 0.502 . . . . 0.0 111.27 -179.646 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 68' ' ' VAL . 38.1 t-80 -52.51 123.2 10.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.178 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.636 HD11 ' HA ' ' A' ' 70' ' ' ALA . 13.5 mt -85.8 -44.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.09 -151.22 20.19 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 -179.433 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.51 -155.11 30.23 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.74 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 10.5 t80 -63.14 -70.58 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 110.835 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -57.53 -44.9 85.47 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.501 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.09 -31.62 31.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.379 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.72 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.6 tt -80.78 -34.98 33.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.269 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttp85 -52.16 -30.44 26.8 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.512 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -68.72 -35.22 76.86 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.514 -0.766 . . . . 0.0 108.974 178.067 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.459 ' CD2' HG23 ' A' ' 76' ' ' ILE . 28.2 t80 -62.54 -34.62 77.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.274 178.329 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.72 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -87.61 -70.28 0.64 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.348 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.914 -179.939 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.571 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 58.5 ttm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.947 0.403 . . . . 0.0 111.469 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.511 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 64.2 m-85 -49.75 170.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.87 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -145.3 114.57 7.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.661 -179.341 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.991 HG22 HG22 ' A' ' 68' ' ' VAL . 61.7 t -107.63 143.16 18.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.296 0.569 . . . . 0.0 112.04 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.827 ' CE1' HD12 ' A' ' 34' ' ' ILE . 7.3 m-85 -121.71 105.64 10.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.623 177.927 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.47 -135.3 1.86 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.75 -179.198 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.45 ' HE1' ' HE2' ' A' ' 37' ' ' MET . 67.6 m-85 -110.45 150.49 28.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.88 0.371 . . . . 0.0 111.274 -179.33 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.32 6.94 46.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.229 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p 78.46 -8.86 1.6 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -85.2 -40.09 17.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.629 0.252 . . . . 0.0 111.301 -179.614 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.657 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.4 mp -99.02 -38.25 6.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.847 0.356 . . . . 0.0 111.676 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.442 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 4.4 t-80 -139.8 152.0 46.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.493 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 162.8 28.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.078 0.466 . . . . 0.0 112.067 -178.746 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -178.62 117.18 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.127 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 m -89.61 -34.59 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.992 0.425 . . . . 0.0 110.949 179.72 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -60.48 -23.25 64.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.333 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.52 -40.65 56.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.917 0.389 . . . . 0.0 110.42 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -63.88 -51.72 63.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.472 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 6.2 p30 -66.91 -49.0 66.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.163 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.412 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -53.5 -43.72 68.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.933 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -65.33 -58.44 5.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.796 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.799 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.4 ttm-85 -55.51 -40.19 71.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.523 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.97 -54.02 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.407 179.305 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.803 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.2 mt -56.29 -42.37 77.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.548 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -60.13 -36.5 77.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.86 179.255 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 22' ' ' ARG . 40.1 t -79.67 -31.12 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.563 179.381 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -9.72 58.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.025 179.544 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm 67.89 60.82 0.43 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.148 0.499 . . . . 0.0 110.657 -179.611 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -146.44 132.55 9.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.978 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.4 Cg_endo -78.35 147.75 23.22 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.436 2.09 . . . . 0.0 111.134 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.571 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 12.7 p90 -157.33 170.9 21.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.607 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 1.7 tp10 -140.74 135.02 31.12 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.983 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.481 ' CE1' HG11 ' A' ' 4' ' ' VAL . 28.4 t80 -89.47 164.26 14.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.221 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.827 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.0 mt -147.28 119.59 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.398 179.527 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -95.8 133.19 40.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.277 -179.332 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 37' ' ' MET . 2.0 pp -100.24 -13.96 8.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.219 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.821 ' N ' HD12 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -122.65 75.55 45.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.464 179.967 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 77.8 Cg_endo -88.24 37.46 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.078 2.519 . . . . 0.0 112.926 -179.473 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -139.0 170.74 15.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.486 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -61.52 -7.99 3.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.22 0.533 . . . . 0.0 112.046 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.29 55.37 0.02 OUTLIER Glycine 0 C--N 1.314 -0.669 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.758 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -150.31 118.93 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.23 0.538 . . . . 0.0 111.838 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.89 137.25 57.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.358 178.901 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 1.8 t70 -95.04 105.53 17.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.098 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.11 -21.52 32.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.663 -179.715 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.0 -51.27 70.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.677 0.275 . . . . 0.0 111.045 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.739 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -72.91 -41.15 64.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.386 179.618 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 44' ' ' ASP . 2.5 mp -59.83 -40.3 82.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.328 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.87 -48.52 71.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.235 179.468 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -39.28 93.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.439 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.486 HD21 ' NE2' ' A' ' 67' ' ' GLN . 28.2 tp -58.06 -50.65 72.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.613 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 52' ' ' LEU . 78.6 mt -51.26 -45.08 61.94 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.145 0.498 . . . . 0.0 111.11 179.458 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.5 m -66.48 -31.16 71.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.134 179.157 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.81 -31.72 70.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.31 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.46 -70.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.87 179.482 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.02 -30.18 0.99 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.173 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -105.57 -174.97 2.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.691 0.282 . . . . 0.0 110.831 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -101.35 -30.65 11.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.102 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -104.43 166.05 10.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.998 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -117.26 100.32 7.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.688 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 pt -75.54 82.7 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.456 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.7 20.08 77.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.928 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.45 132.65 44.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 110.754 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 65' ' ' MET . 1.0 OUTLIER -131.09 170.22 14.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.067 0.46 . . . . 0.0 111.429 -179.669 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.485 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -105.5 157.36 34.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.772 179.767 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.7 Cg_exo -76.82 152.77 95.74 Favored 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.977 -1.26 . . . . 0.0 112.98 0.467 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.486 ' NE2' HD21 ' A' ' 51' ' ' LEU . 5.0 mt-30 -118.62 116.18 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.314 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.991 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -93.18 165.55 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.658 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 76.6 m-85 -143.2 148.15 36.02 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.697 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -58.22 144.73 76.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.182 -178.882 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.543 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 66.7 Cg_exo -54.62 -27.87 53.14 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.059 2.506 . . . . 0.0 112.434 179.351 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -90.78 -32.01 16.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.379 -179.516 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.37 80.89 0.17 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.798 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.74 164.09 21.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -90.54 118.42 29.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.144 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.665 HG21 HD23 ' A' ' 82' ' ' LEU . 21.3 mt -96.21 -46.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.031 0.443 . . . . 0.0 110.726 179.59 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.9 -147.9 17.56 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.022 -179.132 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.82 -161.9 36.74 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.207 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.551 ' HE1' HD13 ' A' ' 23' ' ' LEU . 35.0 t80 -69.53 -49.59 52.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.405 179.734 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -55.76 -49.0 74.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.628 179.633 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -31.81 73.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.483 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.763 HD11 ' CE2' ' A' ' 86' ' ' PHE . 2.7 tm? -73.93 -42.54 60.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.653 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.6 ttt-85 -56.08 -43.92 78.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.678 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG2' ' HD2' ' A' ' 87' ' ' LYS . 22.4 tt0 -61.84 -38.79 89.51 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.189 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.479 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -60.56 -40.28 91.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.89 177.795 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.763 ' CE2' HD11 ' A' ' 82' ' ' LEU . 3.9 m-30 -82.07 -10.12 59.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.141 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.404 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.152 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.612 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 34.6 ttm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.412 ' CD2' ' HD3' ' A' ' 71' ' ' PRO . 95.9 m-85 -78.11 143.9 36.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.461 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.72 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -104.94 118.9 37.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.444 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.682 HG22 HG22 ' A' ' 68' ' ' VAL . 5.9 t -101.66 117.32 46.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.083 0.468 . . . . 0.0 111.146 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.734 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.7 m-30 -92.6 98.76 11.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.616 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' C ' ' CD1' ' A' ' 7' ' ' TYR . . . -160.57 -140.21 2.84 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.747 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.691 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 5.4 m-85 -131.82 134.24 45.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 120.735 0.302 . . . . 0.0 111.539 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -128.39 62.36 1.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.102 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -172.78 -172.1 0.84 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.163 0.506 . . . . 0.0 111.845 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.13 2.18 47.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.885 HG21 ' O ' ' A' ' 39' ' ' GLU . 0.8 OUTLIER -87.37 -4.02 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.989 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.691 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 6.8 t60 -169.98 145.09 2.84 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.929 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.89 168.72 18.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.024 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -177.88 110.59 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.295 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 16' ' ' TYR . 27.7 m -90.58 -46.02 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.49 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.509 ' N ' HG23 ' A' ' 15' ' ' VAL . 24.2 m-85 -62.17 -22.27 65.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.032 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.0 t -63.07 -41.13 99.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.798 0.332 . . . . 0.0 111.038 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -62.0 -54.5 40.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.437 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 4.7 p30 -69.45 -51.66 34.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.398 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.82 -36.44 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.341 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -62.12 -57.83 10.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.472 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.768 ' O ' HG23 ' A' ' 26' ' ' VAL . 18.2 ttt180 -65.18 -23.79 67.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.817 HD12 ' CE1' ' A' ' 79' ' ' PHE . 5.5 tt -58.54 -58.7 7.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.085 0.469 . . . . 0.0 110.386 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.906 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 9.5 mt -63.23 -39.2 93.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.68 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.9 m -62.92 -39.51 94.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.436 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.0 t -65.78 -45.95 90.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.688 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -12.17 61.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.237 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.93 52.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.896 0.379 . . . . 0.0 111.274 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -136.74 138.17 25.55 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.752 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 1' ' ' MET . 63.1 Cg_endo -80.7 159.82 21.78 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.589 2.193 . . . . 0.0 111.775 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.61 ' CG ' HD12 ' A' ' 24' ' ' LEU . 30.3 p90 -161.63 170.75 19.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.842 0.353 . . . . 0.0 111.559 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.96 135.21 35.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.724 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 8.7 t80 -89.61 158.51 17.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.308 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.734 HD12 ' CE1' ' A' ' 5' ' ' TYR . 13.3 mt -147.69 121.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.212 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -89.61 127.34 35.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.297 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.655 HD11 ' OH ' ' A' ' 7' ' ' TYR . 5.0 pt -99.56 22.39 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.047 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.529 ' CE ' ' HE2' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -155.7 77.39 4.69 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.791 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.29 22.13 0.78 Allowed 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.825 2.35 . . . . 0.0 113.026 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.885 ' O ' HG21 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -147.74 157.65 43.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.587 0.232 . . . . 0.0 111.134 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.825 ' HA ' HG23 ' A' ' 11' ' ' ILE . 6.0 ptmt -47.4 -8.87 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' GLU . . . 176.21 46.69 0.06 OUTLIER Glycine 0 C--N 1.308 -0.988 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.553 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 t -150.13 120.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.516 . . . . 0.0 111.849 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.613 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -68.64 170.29 9.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.358 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.626 ' O ' HD13 ' A' ' 48' ' ' ILE . 6.3 t70 -95.1 105.77 17.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.372 . . . . 0.0 110.862 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -56.27 -29.18 60.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.88 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.46 -56.0 11.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 111.329 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HD3' HG21 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -69.66 -43.19 73.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.939 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.626 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.5 mp -52.01 -47.22 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.741 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.69 -54.81 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.16 -30.56 71.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.518 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.5 tt -59.22 -53.33 59.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.528 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 48' ' ' ILE . 14.2 mt -54.25 -50.44 67.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.041 0.448 . . . . 0.0 111.103 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.0 m -60.85 -36.59 79.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.367 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -66.47 -39.09 88.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.794 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.441 HD21 ' CD2' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -59.58 -52.5 65.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.096 0.474 . . . . 0.0 110.347 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.68 -114.42 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.89 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -150.48 30.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.102 0.477 . . . . 0.0 110.671 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -121.08 -143.62 0.34 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.467 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -119.55 170.34 9.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.734 0.302 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.65 98.11 8.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.253 0.549 . . . . 0.0 110.636 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 61' ' ' ILE . 6.4 tp -80.5 85.51 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.864 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.27 29.67 69.3 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.988 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.531 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.2 tm? -44.97 119.4 1.97 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.38 . . . . 0.0 111.172 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.2 p -110.09 170.27 8.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.251 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 154.01 61.01 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.939 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.1 Cg_endo -86.64 152.51 45.56 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 124.258 -1.143 . . . . 0.0 112.406 0.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -117.91 113.06 21.16 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -83.34 163.06 3.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.131 0.491 . . . . 0.0 111.902 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 50.9 m-85 -142.52 141.57 32.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.335 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.654 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.2 132.44 51.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.614 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HB3' ' N ' ' A' ' 1' ' ' MET . 33.7 Cg_exo -53.48 -21.88 19.82 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.56 2.173 . . . . 0.0 111.795 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -161.61 41.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.29 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.95 -110.72 0.63 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.998 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.515 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 37.1 m -137.85 178.62 6.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.136 0.493 . . . . 0.0 111.274 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 37.9 t-80 -55.75 132.36 49.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.116 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' HA ' ' A' ' 70' ' ' ALA . 9.4 mt -100.98 -42.65 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.05 -154.95 22.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.028 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.13 -141.39 10.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.843 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.817 ' CE1' HD12 ' A' ' 23' ' ' LEU . 26.5 t80 -72.42 -70.64 0.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.767 0.317 . . . . 0.0 111.332 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -56.93 -49.53 75.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 110.663 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -53.11 -37.64 61.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.706 HD21 ' CE1' ' A' ' 86' ' ' PHE . 5.4 tt -77.82 -34.49 51.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.212 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 -51.98 -31.37 29.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -68.8 -32.43 72.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.286 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 26.3 t80 -68.43 -29.99 68.77 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.589 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.906 ' CZ ' HD22 ' A' ' 24' ' ' LEU . 22.6 m-85 -92.33 -25.49 18.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.416 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.2 mttt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.793 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.545 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 34.2 ttp . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.902 0.382 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.464 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 65.0 m-85 -50.05 169.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.785 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -143.28 117.48 9.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.496 -178.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 68' ' ' VAL . 77.1 t -108.88 144.64 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.201 0.524 . . . . 0.0 111.535 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.759 ' CE1' HD12 ' A' ' 34' ' ' ILE . 10.9 m-85 -125.47 99.95 6.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.196 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.36 -137.46 2.22 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.257 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.08 159.34 20.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.738 0.304 . . . . 0.0 110.905 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -84.73 -73.7 0.42 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p 167.83 -33.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 110.638 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -85.12 -23.15 28.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.493 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.594 HG23 ' O ' ' A' ' 39' ' ' GLU . 4.1 mp -91.73 -44.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.222 0.534 . . . . 0.0 110.733 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -150.08 139.8 21.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.004 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.82 146.0 43.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.276 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.98 112.12 0.64 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.322 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 m -90.56 -30.74 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.451 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -65.02 -27.28 68.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.51 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.1 t -56.8 -53.86 52.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.352 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.16 -35.62 64.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.176 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -72.92 -58.96 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.989 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.12 -37.69 64.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.213 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -59.5 -54.27 48.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.691 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.85 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.4 tpp180 -66.33 -28.87 69.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.049 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.706 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.6 tt -54.57 -53.71 50.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.477 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.687 HD12 ' CG ' ' A' ' 31' ' ' PHE . 4.7 mt -65.18 -40.76 94.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.536 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 m -61.8 -34.02 75.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.329 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 22' ' ' ARG . 96.9 t -74.13 -28.51 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.01 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -83.45 -12.57 56.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.293 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.49 55.95 0.08 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -142.19 142.39 24.14 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.449 ' O ' ' HA ' ' A' ' 1' ' ' MET . 98.5 Cg_endo -79.09 148.54 21.73 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.485 2.123 . . . . 0.0 111.323 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.687 ' CG ' HD12 ' A' ' 24' ' ' LEU . 36.8 p90 -156.74 170.64 21.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' OE2' ' HE1' ' A' ' 1' ' ' MET . 1.4 tt0 -141.68 134.92 29.33 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.026 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.49 ' HE1' HG11 ' A' ' 4' ' ' VAL . 30.3 t80 -89.68 161.97 15.83 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.093 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.759 HD12 ' CE1' ' A' ' 5' ' ' TYR . 17.0 mt -147.22 121.4 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.602 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -99.45 131.77 45.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.938 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.672 HD12 ' HD1' ' A' ' 43' ' ' PHE . 1.1 pp -96.82 7.19 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.763 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.48 ' HE2' ' CE1' ' A' ' 43' ' ' PHE . 1.5 tpp -140.62 69.41 31.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.705 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 3.8 Cg_exo -80.96 43.65 1.59 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.296 2.664 . . . . 0.0 112.899 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.594 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -144.18 170.36 16.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.57 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.5 tptt -66.41 -7.69 20.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.199 0.523 . . . . 0.0 111.975 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.49 50.0 0.02 OUTLIER Glycine 0 C--N 1.313 -0.739 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.667 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -150.48 120.2 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.213 0.53 . . . . 0.0 111.818 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HD1' HD12 ' A' ' 36' ' ' ILE . 65.0 m-85 -65.61 136.61 56.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.157 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.588 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -97.83 113.76 25.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.831 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -63.37 -17.27 62.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.46 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -62.3 -57.29 11.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.862 0.363 . . . . 0.0 110.646 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -72.13 -39.29 68.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.206 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 43' ' ' PHE . 23.6 mt -60.48 -48.46 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.26 96.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.375 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.01 -37.63 88.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.323 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.449 HD13 ' CD2' ' A' ' 5' ' ' TYR . 26.7 tp -59.3 -51.9 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.6 -47.46 70.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.093 0.473 . . . . 0.0 111.192 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.0 m -62.63 -32.25 73.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.42 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 2.8 mmmt -67.71 -34.98 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.491 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.83 -39.15 84.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.466 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.5 -105.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.865 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -150.33 31.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.041 0.448 . . . . 0.0 110.636 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.01 -147.19 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.445 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 t -120.21 170.29 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 0.0 110.668 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.15 98.24 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 110.405 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mt -80.2 84.21 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.201 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.29 24.89 53.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.639 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.62 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -58.71 143.12 47.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 110.685 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.475 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 1.1 p -124.07 168.12 13.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 111.444 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.6 mtm -110.67 154.55 43.13 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.732 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.3 Cg_exo -79.27 140.65 58.2 Favored 'Cis proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.749 -1.355 . . . . 0.0 112.759 0.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.62 ' CD ' HD12 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -97.02 114.69 26.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.031 179.157 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 4' ' ' VAL . 6.5 t -95.71 160.27 2.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.996 0.427 . . . . 0.0 111.73 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 92.5 m-85 -142.44 153.44 43.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.723 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.956 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -61.62 147.35 88.74 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.271 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 1' ' ' MET . 64.2 Cg_exo -55.17 -23.89 38.65 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.293 2.662 . . . . 0.0 112.507 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -99.06 -29.0 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.397 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 132.26 93.83 0.58 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.756 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.85 159.85 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -90.2 125.55 35.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.017 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.956 HD11 ' HB2' ' A' ' 70' ' ' ALA . 3.1 mp -117.05 -27.28 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.488 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 120.14 -157.62 15.62 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.939 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.5 -140.65 11.56 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.675 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.706 ' CE1' HD12 ' A' ' 23' ' ' LEU . 24.4 t80 -65.96 -70.58 0.23 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.823 0.344 . . . . 0.0 111.145 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.19 -49.99 75.11 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.826 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.404 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 5.2 tt0 -51.09 -43.09 61.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.438 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.613 HD21 ' CD2' ' A' ' 86' ' ' PHE . 4.7 tt -74.76 -34.07 62.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.107 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.4 ttp180 -51.84 -28.62 16.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.14 -32.62 70.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.0 t80 -67.45 -32.02 72.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.67 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.613 ' CD2' HD21 ' A' ' 82' ' ' LEU . 10.2 m-85 -96.71 -70.61 0.71 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.651 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 83' ' ' ARG . 9.5 mmtp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.676 ' HG3' ' HA ' ' A' ' 31' ' ' PHE . 1.1 tpp . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.769 0.319 . . . . 0.0 111.687 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.492 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 65.8 m-85 -58.83 166.28 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.344 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -140.86 117.57 10.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.022 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.944 HG22 HG22 ' A' ' 68' ' ' VAL . 39.0 t -107.5 147.43 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.223 0.535 . . . . 0.0 111.48 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.715 ' CE1' HD12 ' A' ' 34' ' ' ILE . 14.8 m-85 -129.64 101.19 5.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.289 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.71 -138.67 2.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.174 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.649 ' HE2' ' HE3' ' A' ' 37' ' ' MET . 16.3 m-85 -116.03 158.56 22.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.619 0.247 . . . . 0.0 110.706 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -74.23 -69.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.689 0.28 . . . . 0.0 111.462 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 166.31 -38.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.038 0.447 . . . . 0.0 110.179 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -85.29 -22.82 28.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.623 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.615 HD12 ' N ' ' A' ' 11' ' ' ILE . 3.4 mp -89.65 -42.77 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.25 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.513 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 6.1 t60 -144.3 158.34 43.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.795 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 17.4 ptmt -80.6 144.96 31.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.963 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 p -174.3 117.75 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.307 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.14 -32.08 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -67.01 -24.61 66.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.42 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -65.79 -61.09 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 110.439 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -26.01 63.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.913 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 28.4 m-20 -78.66 -60.04 2.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.193 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.01 -45.97 71.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.172 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -58.19 -52.53 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.567 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.805 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.3 ttt85 -61.01 -40.76 94.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.576 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.77 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.1 tt -57.55 -53.82 53.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.416 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.77 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.6 mt -55.77 -46.72 77.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.732 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.1 m -56.77 -37.08 70.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.14 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' ARG . 43.4 t -77.83 -31.08 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.656 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -9.68 58.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.15 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt 68.13 53.36 0.63 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.947 0.403 . . . . 0.0 110.69 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -133.23 136.38 27.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.108 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 54.1 Cg_endo -81.29 137.14 10.41 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.547 2.165 . . . . 0.0 110.837 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.676 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 42.3 p90 -153.6 170.1 21.65 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.684 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -136.43 132.87 36.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.568 ' CE1' HG11 ' A' ' 4' ' ' VAL . 34.7 t80 -89.67 160.84 16.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.715 HD12 ' CE1' ' A' ' 5' ' ' TYR . 18.4 mt -146.63 121.14 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.323 0.582 . . . . 0.0 110.517 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -90.51 121.82 32.79 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.897 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 2.5 pt -91.45 -6.65 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.337 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.649 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 22.4 ttm -118.57 99.88 51.35 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.661 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.8 Cg_endo -76.16 -27.5 8.15 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.477 2.118 . . . . 0.0 111.768 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -140.28 150.14 43.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.217 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -64.38 -8.37 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.355 0.598 . . . . 0.0 111.801 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.51 -56.55 3.13 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.685 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.73 147.18 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.8 ' HB2' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -66.45 168.75 8.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.606 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.466 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 41.6 t0 -91.37 122.11 33.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -66.6 -26.5 67.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.886 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.02 -56.25 23.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.476 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -64.41 -44.24 91.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.136 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.8 HD11 ' HB2' ' A' ' 43' ' ' PHE . 42.9 mt -55.79 -42.95 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.392 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.74 -47.87 76.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.728 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.12 -36.56 82.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.335 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.926 ' O ' HD12 ' A' ' 55' ' ' LEU . 34.2 tp -63.05 -60.29 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.445 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.59 ' HA ' HD13 ' A' ' 55' ' ' LEU . 88.0 mt -44.91 -41.91 7.6 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.261 0.553 . . . . 0.0 111.747 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.9 m -69.03 -30.33 68.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.406 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 51' ' ' LEU . 4.4 tttp -69.05 -44.28 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.836 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.926 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -59.1 -67.09 0.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.381 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.77 -31.55 0.14 Allowed Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.901 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -135.69 -169.99 2.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.323 . . . . 0.0 110.919 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -103.63 20.18 18.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.231 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 t -120.09 165.68 14.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.826 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -128.98 100.69 5.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.008 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.5 mt -80.29 84.28 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.012 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.62 27.56 55.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.162 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD11 ' CD2' ' A' ' 55' ' ' LEU . 1.5 mm? -55.42 143.18 29.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.995 0.426 . . . . 0.0 111.238 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 152.58 45.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.3 mmt -108.75 148.92 38.76 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.727 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.3 Cg_exo -80.53 148.0 76.02 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 124.026 -1.239 . . . . 0.0 112.952 0.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 5' ' ' TYR . 6.7 tp60 -104.38 126.24 51.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.384 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.944 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -103.01 166.39 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.74 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 81.1 m-85 -142.53 153.03 43.22 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -65.11 149.71 96.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.264 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.675 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 40.9 Cg_exo -59.97 -25.76 80.48 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.026 2.484 . . . . 0.0 112.196 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.16 -25.95 17.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.246 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.4 91.11 0.84 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.658 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -179.17 161.21 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.791 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.419 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 10.5 t-160 -85.6 126.67 34.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 70' ' ' ALA . 18.6 mt -101.21 -45.42 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.033 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.39 -152.42 18.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.912 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.25 -146.38 12.0 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.859 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 19.3 t80 -72.27 -70.98 0.31 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.672 0.272 . . . . 0.0 111.327 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -55.84 -44.46 78.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.158 0.504 . . . . 0.0 110.508 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -52.54 -40.75 62.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.995 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.701 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.0 tt -73.63 -32.09 63.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.284 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.0 mmm-85 -51.81 -35.11 43.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.34 -34.57 78.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.3 t80 -61.82 -35.36 78.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.07 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.701 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.7 m-85 -91.51 -9.7 43.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.07 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.1 pttp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.964 179.831 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 8.2 ttm . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.1 144.54 38.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.097 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.68 118.81 37.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.333 -178.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.643 HG12 ' CE1' ' A' ' 33' ' ' PHE . 55.0 t -104.73 142.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.184 0.516 . . . . 0.0 111.042 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.875 ' CE1' HD12 ' A' ' 34' ' ' ILE . 9.8 m-85 -121.27 99.15 6.32 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' HA2' ' HG2' ' A' ' 65' ' ' MET . . . -159.08 -151.99 6.3 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.848 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.874 ' CE1' HD11 ' A' ' 36' ' ' ILE . 60.7 m-85 -102.74 125.12 49.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.754 0.311 . . . . 0.0 111.318 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.508 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 6.1 t0 -137.1 65.36 1.5 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.634 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.36 -171.62 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.144 0.497 . . . . 0.0 111.631 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.85 -2.61 58.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.96 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.16 -13.22 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.955 0.407 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.711 ' CG ' ' CD1' ' A' ' 7' ' ' TYR . 42.9 t-80 -165.59 141.02 5.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -80.78 174.97 11.09 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.11 92.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.932 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -79.28 -32.25 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.719 0.295 . . . . 0.0 111.445 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -63.91 -26.67 68.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.447 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -59.31 -42.08 90.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 110.329 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.39 -43.42 67.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.771 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -76.99 -55.21 5.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.846 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.57 -41.92 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.003 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -59.65 -53.74 54.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.589 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.786 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.2 ttt85 -64.76 -28.65 69.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.841 HD12 ' CE1' ' A' ' 79' ' ' PHE . 2.0 tt -60.05 -59.8 4.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.397 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.549 HD12 ' CG ' ' A' ' 31' ' ' PHE . 7.1 mt -58.52 -40.29 82.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.433 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.4 m -60.44 -38.06 82.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.878 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 22' ' ' ARG . 96.3 t -78.84 -30.28 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.627 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -70.13 -15.73 63.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.917 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 76.13 45.59 0.11 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.935 0.398 . . . . 0.0 111.0 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -144.01 137.62 14.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.023 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.603 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.6 Cg_endo -75.24 162.94 35.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.491 2.127 . . . . 0.0 111.117 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.549 ' CG ' HD12 ' A' ' 24' ' ' LEU . 53.9 p90 -161.72 171.03 18.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.458 ' OE2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -139.38 125.4 19.86 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.36 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.643 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.4 t80 -90.74 124.97 35.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.361 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.875 HD12 ' CE1' ' A' ' 5' ' ' TYR . 8.0 mt -106.48 114.22 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.477 0.656 . . . . 0.0 110.526 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -82.52 144.62 30.28 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.383 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.874 HD11 ' CE1' ' A' ' 7' ' ' TYR . 2.6 pt -100.89 -12.7 8.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.666 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 19.1 ttm -124.81 107.76 28.64 Favored Pre-proline 0 C--N 1.334 -0.089 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 44' ' ' ASP . 95.6 Cg_endo -79.96 -28.05 3.46 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.353 2.035 . . . . 0.0 110.927 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 37' ' ' MET . 0.4 OUTLIER -146.62 151.09 36.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.231 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -8.52 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.225 0.536 . . . . 0.0 111.99 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 -54.56 4.5 Favored Glycine 0 C--N 1.311 -0.86 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.126 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -150.87 134.16 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -56.99 170.14 0.46 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -87.1 106.19 17.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.658 0.266 . . . . 0.0 111.7 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.73 -27.48 59.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -59.03 -53.4 58.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.88 0.371 . . . . 0.0 110.581 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.729 ' HG2' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -70.01 -40.66 75.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.03 179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 44' ' ' ASP . 44.9 mm -58.13 -45.94 88.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.69 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.51 -56.58 11.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.296 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -60.62 -30.66 69.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.919 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -58.24 -53.26 60.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.572 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.6 mt -54.28 -46.58 72.76 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 111.204 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.8 m -63.86 -34.12 77.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.227 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HE3' ' CG ' ' A' ' 69' ' ' PHE . 2.0 mmmt -65.77 -36.93 84.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.438 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.33 -42.98 96.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.489 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.75 -107.31 0.31 Allowed Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.751 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -150.55 26.78 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.074 0.464 . . . . 0.0 110.834 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -121.67 -153.71 0.56 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.31 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -120.88 161.18 21.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.477 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.418 ' NE2' ' HG ' ' A' ' 63' ' ' LEU . 7.8 pt20 -115.04 98.75 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 110.785 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.559 ' H ' HD12 ' A' ' 61' ' ' ILE . 3.8 mp -81.63 87.72 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.557 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.07 33.37 5.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.412 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.754 HD13 ' N ' ' A' ' 64' ' ' THR . 2.1 tm? -44.56 130.71 6.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.759 0.314 . . . . 0.0 110.904 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.754 ' N ' HD13 ' A' ' 63' ' ' LEU . 4.6 m -112.33 148.3 34.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.082 0.467 . . . . 0.0 111.551 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.517 ' SD ' HD12 ' A' ' 63' ' ' LEU . 3.5 mpp? -119.65 155.72 54.33 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.791 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.8 Cg_exo -80.53 137.55 40.78 Favored 'Cis proline' 0 C--N 1.344 0.327 0 C-N-CA 123.861 -1.308 . . . . 0.0 112.858 0.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.5 tp60 -99.78 118.32 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.172 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.591 HG22 HG22 ' A' ' 4' ' ' VAL . 4.3 t -93.44 161.53 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.328 0.585 . . . . 0.0 112.145 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 86.2 m-85 -143.2 152.31 41.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.99 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.601 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -65.47 143.56 98.72 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.78 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HB3' ' N ' ' A' ' 1' ' ' MET . 21.8 Cg_exo -61.63 -17.48 54.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.354 2.036 . . . . 0.0 111.988 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -103.19 -25.91 13.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.862 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.48 86.21 0.49 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.697 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.433 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER 179.58 118.97 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 110.823 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.417 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 8.3 t-160 -55.53 131.79 47.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.3 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 70' ' ' ALA . 2.0 mp -116.76 -31.94 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 117.62 -161.13 13.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.718 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -90.31 -147.99 19.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.028 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.841 ' CE1' HD12 ' A' ' 23' ' ' LEU . 46.5 t80 -69.54 -53.84 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.347 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -57.82 -49.51 76.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.758 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -64.73 -36.08 83.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.734 HD12 HD13 ' A' ' 23' ' ' LEU . 1.4 tm? -66.02 -44.13 85.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.348 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.428 ' HG2' HD11 ' A' ' 23' ' ' LEU . 3.2 mmm-85 -54.42 -37.92 65.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.38 -37.17 74.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -62.07 -35.44 78.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.127 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.623 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.2 m-85 -86.52 -26.76 24.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.217 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.1 mttt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.86 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.566 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.3 ttp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.843 0.354 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.483 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 94.7 m-85 -59.26 160.83 6.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.669 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.9 mppp? -135.72 118.08 15.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.198 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.901 HG22 HG22 ' A' ' 68' ' ' VAL . 19.4 t -108.53 141.13 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.183 0.515 . . . . 0.0 111.926 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.846 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.6 m-85 -121.68 105.34 10.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.249 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.38 -139.0 2.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.392 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.42 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 38.7 m-85 -109.91 153.35 24.62 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.4 t70 -82.22 -2.63 53.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 2.3 p 81.82 -22.85 0.24 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.984 0.421 . . . . 0.0 110.921 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -75.71 -35.29 60.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.9 0.381 . . . . 0.0 111.124 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 11' ' ' ILE . 9.8 mm -104.6 -7.02 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -176.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -166.64 108.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -39.39 134.23 1.24 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.5 m -166.23 109.23 0.76 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.401 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 m -87.0 -29.71 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 110.732 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -58.12 -30.7 66.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.596 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.5 m -61.73 -55.0 34.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 110.059 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -53.56 -31.64 47.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.248 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.24 -59.68 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.19 -42.01 69.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.296 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -62.12 -57.79 10.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.471 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 26' ' ' VAL . 22.2 ttt180 -57.0 -39.12 74.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.238 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -57.02 -54.2 49.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.197 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.714 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.5 mt -57.32 -45.49 84.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.616 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.5 m -58.27 -36.06 72.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.079 0.466 . . . . 0.0 109.977 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 22' ' ' ARG . 53.1 t -79.82 -30.62 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.425 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -16.59 59.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.916 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt 72.53 57.32 0.14 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.93 0.395 . . . . 0.0 110.978 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -139.08 139.0 21.93 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.373 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.47 ' O ' ' HA ' ' A' ' 1' ' ' MET . 71.6 Cg_endo -80.14 140.12 13.82 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.56 2.174 . . . . 0.0 111.241 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 22.9 p90 -160.26 171.27 19.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.414 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 2.5 tt0 -142.06 137.84 31.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.962 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.618 ' CE1' HG11 ' A' ' 4' ' ' VAL . 39.6 t80 -89.41 159.74 17.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.833 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.846 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.3 mt -143.68 119.11 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.279 0.561 . . . . 0.0 110.456 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -80.66 135.94 36.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.394 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.608 HD13 ' SD ' ' A' ' 65' ' ' MET . 2.7 pt -97.01 -17.38 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.421 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.624 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 4.4 ttp -131.41 90.37 38.02 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.482 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 10.1 Cg_exo -71.17 -4.32 14.66 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.661 2.241 . . . . 0.0 113.207 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -139.65 144.11 37.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.068 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -68.09 -8.55 39.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.241 0.543 . . . . 0.0 111.945 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.91 -58.02 1.35 Allowed Glycine 0 C--N 1.313 -0.75 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.293 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.84 140.93 27.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -72.73 167.16 21.41 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.616 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 38' ' ' PRO . 30.6 p30 -91.37 103.46 16.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.382 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.9 -24.65 16.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.696 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -56.53 -50.16 72.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.922 0.391 . . . . 0.0 111.006 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -75.93 -32.06 59.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.459 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' A' ' 36' ' ' ILE . 37.0 mm -65.0 -47.25 88.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.004 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.98 -55.99 18.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.027 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -56.73 -31.97 65.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.608 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.882 ' O ' HD12 ' A' ' 55' ' ' LEU . 15.4 tp -61.34 -58.41 8.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.189 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.701 ' HA ' HD13 ' A' ' 55' ' ' LEU . 72.5 mt -44.04 -40.92 5.12 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.301 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.1 m -70.22 -35.64 74.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.301 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' LEU . 5.0 tttp -60.2 -41.86 93.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.679 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.882 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -58.64 -69.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.239 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.08 -35.08 0.31 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -102.8 -175.1 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.798 0.332 . . . . 0.0 111.009 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.73 -31.9 10.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.825 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -105.32 170.19 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.417 ' HB2' HD12 ' A' ' 63' ' ' LEU . 9.4 pt20 -122.72 101.51 7.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.757 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -80.06 85.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.309 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.92 27.25 70.99 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.579 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.709 HD22 ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -49.84 171.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 111.235 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.709 ' N ' HD22 ' A' ' 63' ' ' LEU . 6.9 p -143.29 156.67 44.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.1 0.476 . . . . 0.0 111.591 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.608 ' SD ' HD13 ' A' ' 36' ' ' ILE . 3.2 mtt -126.32 154.65 74.73 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.567 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HB2' HG13 ' A' ' 4' ' ' VAL . 7.5 Cg_exo -75.52 150.34 94.47 Favored 'Cis proline' 0 C--N 1.344 0.308 0 C-N-CA 124.008 -1.247 . . . . 0.0 112.77 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.667 ' OE1' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -102.58 123.15 45.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.495 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.901 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -97.03 166.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.343 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 81.6 m-85 -142.47 140.98 32.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.071 0.462 . . . . 0.0 110.895 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB3' ' N ' ' A' ' 74' ' ' SER . . . -53.4 134.98 52.39 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.411 -178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HB3' ' N ' ' A' ' 1' ' ' MET . 89.0 Cg_exo -45.92 -27.68 4.35 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.012 2.475 . . . . 0.0 112.074 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -165.43 38.8 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.153 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.56 -109.15 0.99 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.101 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.448 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 13.5 m -138.47 177.34 7.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.237 0.542 . . . . 0.0 111.335 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -53.06 122.3 9.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.096 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 70' ' ' ALA . 4.4 mt -83.83 -43.64 17.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.988 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.04 -149.84 17.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.526 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.6 -159.25 31.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.209 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -60.92 -57.85 10.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.767 0.318 . . . . 0.0 110.704 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -54.01 -43.95 70.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -57.16 -32.81 66.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.625 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.6 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -71.49 -47.47 55.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.655 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.28 -30.17 26.73 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -74.81 -33.65 62.25 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 82' ' ' LEU . 21.0 t80 -66.86 -32.43 73.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.392 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.6 ' HE2' HD21 ' A' ' 82' ' ' LEU . 7.1 m-85 -92.08 -70.31 0.7 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.336 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.87 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.671 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 12.4 tpp . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.429 0.157 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -39.85 120.92 1.2 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.511 0.672 . . . . 0.0 112.233 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -90.91 125.36 35.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.267 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.655 HG12 ' HE1' ' A' ' 33' ' ' PHE . 22.7 t -109.55 110.24 31.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.01 0.433 . . . . 0.0 111.107 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 16.4 m-85 -89.64 99.26 12.3 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.3 -141.07 3.02 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.031 -1.081 . . . . 0.0 112.723 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.823 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 30.4 m-85 -127.11 149.2 50.05 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.747 0.308 . . . . 0.0 111.261 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -102.23 22.02 13.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.7 9.63 7.44 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.445 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -85.87 -50.7 6.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.782 0.325 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.8 mm -103.0 -32.04 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.638 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -140.62 154.83 46.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.277 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 166.73 22.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 p 174.0 95.08 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.671 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 16' ' ' TYR . 34.2 m -69.7 -44.39 79.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.553 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.477 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -57.3 -29.37 63.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.233 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -56.74 11.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.02 -33.77 53.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.173 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 91.2 m-20 -69.92 -49.88 47.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.896 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.43 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -61.01 -32.59 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -60.61 -54.06 49.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.812 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -65.56 -25.52 67.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.603 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.5 tt -57.79 -55.23 37.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.324 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 31' ' ' PHE . 25.5 mt -63.17 -35.1 79.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.567 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.3 m -68.72 -41.64 78.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.177 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 22' ' ' ARG . 90.2 t -66.79 -31.99 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.523 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -84.65 -10.49 57.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.07 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 2.6 mtmt 68.54 53.36 0.56 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.969 0.414 . . . . 0.0 110.986 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.31 113.17 7.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.671 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 88.4 Cg_exo -45.72 174.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.643 2.229 . . . . 0.0 112.766 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.498 ' HB3' HD13 ' A' ' 24' ' ' LEU . 5.2 p90 -163.99 169.89 17.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.811 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.3 tm-20 -129.03 109.41 11.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.14 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.655 ' HE1' HG12 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -90.54 150.97 21.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.04 0.448 . . . . 0.0 111.461 -179.259 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.445 HG13 ' C ' ' A' ' 33' ' ' PHE . 30.2 mt -149.73 127.02 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.301 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -82.69 110.31 17.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.401 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.916 ' HB ' HD11 ' A' ' 48' ' ' ILE . 3.2 pt -73.46 -19.96 18.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.8 ttp -129.49 86.13 56.86 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.338 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.82 -3.05 13.34 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.663 2.242 . . . . 0.0 112.407 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 37' ' ' MET . 3.1 tt0 -139.89 136.46 33.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.43 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -7.86 12.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.222 0.534 . . . . 0.0 111.963 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.49 -63.48 1.56 Allowed Glycine 0 C--N 1.313 -0.747 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.409 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.14 140.47 26.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.66 0.267 . . . . 0.0 111.229 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -66.23 170.97 5.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.082 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.428 ' O ' HG12 ' A' ' 48' ' ' ILE . 1.3 t70 -83.2 95.23 8.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.958 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.39 -20.64 30.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.441 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.94 -60.62 3.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.022 0.439 . . . . 0.0 110.535 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -67.09 -40.3 86.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.302 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.916 HD11 ' HB ' ' A' ' 36' ' ' ILE . 34.3 mm -59.83 -37.68 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.779 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.52 -51.91 67.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.06 -32.48 64.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.256 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.3 tt -60.64 -53.35 58.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -50.95 -42.23 59.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.017 0.437 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.0 m -59.48 -45.62 91.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.707 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -61.96 -32.52 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.564 HD21 ' CD2' ' A' ' 51' ' ' LEU . 1.3 mt -60.75 -50.35 73.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.5 -19.24 2.43 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.119 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -148.14 -162.26 1.51 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 110.397 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -113.63 21.66 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.149 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -120.19 164.22 16.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.74 0.305 . . . . 0.0 110.965 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.4 102.59 6.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.729 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.9 pt -71.77 79.68 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.344 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.75 26.44 5.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.535 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 63' ' ' LEU . 1.5 tp -56.6 169.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.338 . . . . 0.0 111.154 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.9 p -150.84 158.8 44.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.459 ' HG2' HD13 ' A' ' 36' ' ' ILE . 4.1 mpp? -104.29 159.13 30.32 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.596 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.6 Cg_exo -80.01 145.69 73.0 Favored 'Cis proline' 0 C--N 1.344 0.31 0 C-N-CA 124.134 -1.194 . . . . 0.0 112.978 0.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.402 ' NE2' ' CD1' ' A' ' 63' ' ' LEU . 56.4 mm-40 -108.24 120.78 43.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.773 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -90.62 155.07 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.166 0.508 . . . . 0.0 111.927 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 75' ' ' HIS . 33.8 m-85 -143.16 137.76 29.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.635 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.584 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -47.88 156.46 0.71 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.717 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.24 -38.68 88.36 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.727 2.285 . . . . 0.0 112.037 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.47 -21.65 20.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.184 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.76 89.36 0.81 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.649 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -164.55 116.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.372 . . . . 0.0 110.624 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 2.1 t-160 -55.14 112.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.307 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.716 HG21 HD12 ' A' ' 82' ' ' LEU . 6.7 mt -98.53 -35.48 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.365 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.43 -151.92 20.07 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.233 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 82' ' ' LEU . . . -104.57 -141.05 10.74 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.118 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.603 ' CE1' HD12 ' A' ' 23' ' ' LEU . 13.0 t80 -73.63 -66.43 0.7 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 0.0 110.725 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -63.04 -42.68 99.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.948 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.43 -49.22 75.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.626 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.716 HD12 HG21 ' A' ' 76' ' ' ILE . 3.0 tt -74.43 -38.82 62.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.88 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -49.64 -27.61 4.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.958 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.75 -35.33 72.6 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.724 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.48 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -64.8 -37.32 87.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.05 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.587 ' CD2' HD21 ' A' ' 82' ' ' LEU . 14.8 m-85 -86.55 -20.28 28.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.583 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.992 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.632 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 38.2 ttm . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -79.35 147.45 32.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.239 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.18 120.53 42.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.221 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 68' ' ' VAL . 53.6 t -112.35 123.71 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.32 0.581 . . . . 0.0 111.996 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.1 m-85 -99.98 99.53 10.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.967 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.506 ' O ' HD13 ' A' ' 36' ' ' ILE . . . -158.07 -141.69 3.22 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.335 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.635 ' CE1' HD11 ' A' ' 36' ' ' ILE . 57.9 m-85 -121.7 159.02 27.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.0 111.402 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.59 -67.93 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 166.28 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.556 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.25 -27.74 47.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.816 HG21 ' O ' ' A' ' 37' ' ' MET . 4.2 mp -91.11 -37.04 8.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.261 0.553 . . . . 0.0 110.654 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -155.1 142.05 19.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.199 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.75 146.39 31.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.295 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.98 107.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.816 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 16' ' ' TYR . 31.4 m -71.74 -40.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.421 . . . . 0.0 110.577 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.407 ' N ' HG23 ' A' ' 15' ' ' VAL . 18.4 m-85 -51.82 -25.75 8.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.387 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -65.94 -62.85 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.125 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -57.01 -31.79 65.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.52 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -53.15 52.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.852 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.64 71.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.007 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -61.13 -35.75 77.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.083 0.468 . . . . 0.0 110.121 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.761 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.6 ttt180 -76.74 -27.62 55.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.604 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.819 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -57.35 -56.56 20.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.212 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.6 mt -63.04 -45.85 90.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.654 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 m -56.03 -35.44 66.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.366 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 22' ' ' ARG . 70.9 t -75.99 -29.54 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.682 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 1.5 mmtm -76.11 -12.91 60.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.226 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 76.16 38.7 0.31 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.03 0.443 . . . . 0.0 110.796 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -129.74 139.76 36.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.697 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 1' ' ' MET . 93.5 Cg_endo -77.74 160.98 30.93 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.471 2.114 . . . . 0.0 111.619 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -161.47 170.89 19.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.413 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -136.89 125.11 23.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.898 0.38 . . . . 0.0 110.792 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.454 ' HE1' HG11 ' A' ' 4' ' ' VAL . 13.0 t80 -89.84 156.96 18.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.162 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.432 HG13 ' C ' ' A' ' 33' ' ' PHE . 18.4 mt -150.43 123.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.275 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -86.12 110.58 19.65 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.534 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.678 ' HB ' HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -70.38 -14.19 17.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.311 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.816 ' O ' HG21 ' A' ' 11' ' ' ILE . 3.9 ttp -126.38 89.57 51.94 Favored Pre-proline 0 N--CA 1.455 -0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 110.931 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.48 0.07 10.32 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.57 2.18 . . . . 0.0 112.239 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 37' ' ' MET . 38.4 tt0 -140.02 136.25 33.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.603 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -63.93 -8.05 10.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.169 0.509 . . . . 0.0 112.114 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.89 -63.07 1.7 Allowed Glycine 0 C--N 1.313 -0.728 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.079 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -147.49 149.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.673 0.273 . . . . 0.0 111.142 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -69.14 171.27 8.58 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.873 0.368 . . . . 0.0 111.588 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -95.98 110.97 23.1 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.158 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -64.4 -23.19 67.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.808 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -58.62 -52.6 65.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 110.797 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.09 -44.64 68.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.248 0.547 . . . . 0.0 109.736 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.678 HD11 ' HB ' ' A' ' 36' ' ' ILE . 16.0 mm -54.91 -40.64 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.693 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.48 -51.4 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.645 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -32.35 64.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.228 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.603 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.7 tt -60.99 -50.13 74.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.193 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.489 HD21 ' HG3' ' A' ' 60' ' ' GLN . 85.5 mt -52.49 -43.49 65.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.565 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 m -54.5 -46.39 73.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.665 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' CB ' ' CE2' ' A' ' 69' ' ' PHE . 2.8 mtmm -63.31 -36.53 83.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.628 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mt -61.28 -52.66 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.723 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.6 -113.9 0.58 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.065 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -150.33 31.74 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.118 0.485 . . . . 0.0 110.509 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -121.01 -146.52 0.38 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.276 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -117.19 170.13 8.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.694 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.489 ' HG3' HD21 ' A' ' 52' ' ' LEU . 5.6 mt-30 -73.26 98.26 2.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.181 0.515 . . . . 0.0 110.455 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -79.9 79.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.148 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.68 21.71 71.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.472 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.551 HD11 ' OE1' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -57.79 131.69 51.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.962 0.41 . . . . 0.0 110.804 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 65' ' ' MET . 21.9 m -123.61 163.65 20.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.356 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.443 ' N ' HG22 ' A' ' 64' ' ' THR . 6.4 mtm -107.98 152.25 41.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.55 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.7 Cg_endo -83.0 137.9 32.8 Favored 'Cis proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.968 -1.263 . . . . 0.0 112.883 0.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.551 ' OE1' HD11 ' A' ' 63' ' ' LEU . 48.0 tp60 -96.29 138.59 33.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.861 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 77' ' ' GLY . 3.6 t -109.78 154.91 11.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.051 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.452 ' CE1' ' HG3' ' A' ' 67' ' ' GLN . 48.0 m-85 -143.39 143.21 31.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.547 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.56 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.58 155.21 14.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.264 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.632 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -72.47 -16.11 27.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.87 2.38 . . . . 0.0 112.097 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -104.72 -7.85 19.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.095 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.07 89.82 1.95 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.512 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -175.93 156.85 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.762 0.315 . . . . 0.0 111.093 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.453 ' CD2' ' NE2' ' A' ' 67' ' ' GLN . 7.4 t-160 -90.23 126.51 35.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.845 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 70' ' ' ALA . 16.7 mt -113.8 -45.82 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.257 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.633 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 124.22 -151.58 17.19 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.91 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -99.14 -129.43 6.55 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.439 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.819 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -80.88 -70.35 0.54 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.713 0.256 . . . . 0.0 110.69 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -52.17 -46.9 65.7 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.235 0.54 . . . . 0.0 110.221 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.434 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -58.88 -41.41 87.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.615 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.495 HD21 ' CD2' ' A' ' 86' ' ' PHE . 2.3 tt -74.54 -35.99 63.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.384 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.4 ttt180 -52.03 -32.84 35.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -34.42 74.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.291 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.436 ' CD2' HG23 ' A' ' 76' ' ' ILE . 43.3 t80 -65.95 -32.05 73.32 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.447 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.495 ' CD2' HD21 ' A' ' 82' ' ' LEU . 24.9 m-85 -97.84 -9.11 26.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.67 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 83' ' ' ARG . 3.5 mtpm? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.885 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.725 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.519 0.199 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 66.0 m-85 -39.78 110.06 0.13 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.985 0.898 . . . . 0.0 111.667 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.821 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -89.74 127.0 35.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.95 -1.477 . . . . 0.0 111.281 -179.041 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.689 HG12 ' HE1' ' A' ' 33' ' ' PHE . 25.3 t -106.43 112.25 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.01 0.433 . . . . 0.0 111.296 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 11.2 m-85 -89.79 99.01 12.1 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.27 -143.12 3.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.861 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 31.2 m-85 -117.68 143.46 46.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.84 0.352 . . . . 0.0 111.578 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.91 -76.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.522 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 170.32 -34.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 110.606 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -81.36 -27.94 34.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.46 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.895 HG21 ' O ' ' A' ' 37' ' ' MET . 3.0 mp -89.83 -45.24 15.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.353 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.537 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 5.0 t60 -143.93 159.62 42.25 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -80.24 149.91 30.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.539 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.4 p -157.27 93.52 1.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.149 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.5 m -82.01 -31.77 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.214 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -28.12 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.153 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 t -63.52 -45.3 91.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.038 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.76 -36.01 34.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.145 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.42 ' HB3' ' CE2' ' A' ' 79' ' ' PHE . 12.9 m120 -70.54 -56.88 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.669 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -57.31 -28.94 63.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.926 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -64.82 -44.3 90.29 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 26' ' ' VAL . 15.8 tpp85 -63.28 -36.13 82.66 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.87 HD21 HD23 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -59.05 -61.85 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.346 178.18 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -61.03 -53.39 57.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.93 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.5 m -52.63 -37.43 58.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.859 0.362 . . . . 0.0 111.235 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 22' ' ' ARG . 44.4 t -79.78 -17.81 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.778 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -89.0 -30.34 18.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.557 0.218 . . . . 0.0 111.527 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.32 67.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.54 HE22 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -150.15 129.9 6.6 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.536 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.725 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 75.8 Cg_exo -49.75 167.41 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.327 1.351 . . . . 0.0 110.706 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -165.15 160.48 18.71 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.792 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.729 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 19.2 mt-10 -124.78 122.3 37.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 111.054 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.689 ' HE1' HG12 ' A' ' 4' ' ' VAL . 1.5 t80 -103.93 143.15 33.24 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.045 0.45 . . . . 0.0 110.954 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 33' ' ' PHE . 18.1 mt -144.32 127.69 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.224 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.43 121.55 26.88 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.863 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.861 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.6 pt -77.56 -15.49 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.996 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.895 ' O ' HG21 ' A' ' 11' ' ' ILE . 33.0 ttm -125.01 79.53 65.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.769 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 60.4 Cg_endo -72.97 -5.34 17.04 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.753 2.302 . . . . 0.0 112.418 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.54 136.6 34.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.182 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -63.01 -8.84 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.183 0.515 . . . . 0.0 111.884 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.94 -61.19 2.16 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.542 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 43' ' ' PHE . 30.1 t -150.29 155.58 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 111.485 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -62.41 166.67 4.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.615 179.594 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 3.4 t70 -83.33 123.93 30.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.959 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 8.8 t0 -78.04 -27.98 48.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.232 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.22 -59.77 3.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 110.862 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -62.71 -46.55 87.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.489 HD11 ' HB ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -59.94 -31.07 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.635 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -62.99 -47.22 84.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -36.9 80.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.46 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.593 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.3 tt -58.4 -50.03 75.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.159 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -51.88 -45.12 64.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.353 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.4 m -57.3 -46.76 82.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.612 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -60.9 -39.0 87.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.679 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.89 -62.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.83 -116.58 0.47 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.967 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -150.58 26.87 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.941 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -121.58 -149.28 0.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.297 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 t -120.58 166.61 13.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.526 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.405 ' CB ' ' HB2' ' A' ' 63' ' ' LEU . 2.6 mt-30 -115.95 98.87 6.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.92 0.39 . . . . 0.0 110.808 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.7 tp -81.45 85.57 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.463 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.54 30.45 7.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.497 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.829 HD13 ' N ' ' A' ' 64' ' ' THR . 1.8 tm? -47.15 135.65 9.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.799 0.333 . . . . 0.0 110.785 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.829 ' N ' HD13 ' A' ' 63' ' ' LEU . 71.6 p -107.93 146.37 32.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.264 0.554 . . . . 0.0 111.854 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.408 ' SD ' HD12 ' A' ' 63' ' ' LEU . 3.9 mpp? -122.01 159.36 51.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.474 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_exo -78.96 151.87 88.28 Favored 'Cis proline' 0 C--N 1.343 0.258 0 C-N-CA 124.211 -1.162 . . . . 0.0 112.679 0.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.623 ' NE2' HD21 ' A' ' 63' ' ' LEU . 2.3 mt-30 -113.58 116.39 29.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.842 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.821 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -88.7 154.41 3.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.103 0.478 . . . . 0.0 112.158 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 2' ' ' PHE . 35.7 m-85 -142.61 139.16 31.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.015 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -57.14 144.22 70.18 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.048 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -34.88 -35.31 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.74 2.96 . . . . 0.0 112.685 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.43 33.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.198 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.54 -105.1 2.66 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.644 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 m -137.93 179.45 6.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.031 0.443 . . . . 0.0 110.869 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -63.76 125.08 23.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.941 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.015 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.6 mp -97.74 -28.4 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.524 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 120.89 -160.07 15.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.012 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.14 -131.77 7.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.587 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 9.6 t80 -76.49 -70.65 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.705 0.288 . . . . 0.0 111.032 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -57.4 -48.22 79.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.386 . . . . 0.0 110.648 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.441 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -54.53 -46.12 73.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.476 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.87 HD23 HD21 ' A' ' 23' ' ' LEU . 2.3 tt -66.94 -38.9 87.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.016 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.711 ' HG3' HD22 ' A' ' 23' ' ' LEU . 1.4 ttm180 -51.73 -29.94 20.5 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -72.19 -34.94 68.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.203 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 82' ' ' LEU . 59.2 t80 -64.76 -32.48 74.18 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.313 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.461 ' CE2' HD21 ' A' ' 82' ' ' LEU . 27.3 m-85 -95.77 -12.11 25.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.582 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.888 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.679 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 33.6 ttm . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -77.08 145.32 37.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.118 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.0 mptt -106.83 119.17 38.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.618 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.427 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 17.1 t -102.94 121.5 54.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.221 0.534 . . . . 0.0 111.122 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.781 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.6 m-30 -98.87 99.36 10.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.882 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.29 -135.65 1.86 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.972 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.656 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 57.1 m-85 -125.86 146.77 49.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.735 0.302 . . . . 0.0 111.076 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -137.52 51.86 1.91 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.967 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 t -167.88 -173.22 2.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.308 0.575 . . . . 0.0 112.011 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -86.58 4.65 39.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.757 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.637 HG23 ' HB2' ' A' ' 40' ' ' LYS . 10.6 mm -86.86 -13.44 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.539 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.656 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 2.3 t60 -163.08 122.68 2.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.664 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 168.68 7.98 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.54 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 174.7 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.662 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 16' ' ' TYR . 26.9 m -87.33 -41.88 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.702 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 15' ' ' VAL . 1.1 m-85 -60.89 -18.94 59.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.574 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.8 -58.43 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.4 . . . . 0.0 110.565 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -50.66 -40.9 54.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.049 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -64.1 -46.83 82.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.397 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -63.87 -49.91 70.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.381 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 31' ' ' PHE . 10.5 ttmt -50.47 -34.54 25.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.895 0.378 . . . . 0.0 110.586 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.815 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.9 tpt180 -66.74 -40.5 88.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.413 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.56 -55.62 32.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.235 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.83 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.4 mt -55.24 -45.17 76.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.61 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.7 m -57.3 -37.31 72.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.842 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.8 t -78.19 -34.21 18.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.505 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -17.96 62.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.852 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.47 53.2 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -140.03 136.13 16.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.195 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.614 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.6 Cg_endo -81.24 162.57 20.03 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.625 2.217 . . . . 0.0 110.761 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 6.4 p90 -161.34 171.1 18.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 111.981 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -136.2 134.16 37.88 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.568 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 10.9 t80 -89.69 158.74 17.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.534 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 5' ' ' TYR . 15.4 mt -148.31 121.96 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.385 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -86.05 133.34 33.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.052 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.558 HD11 ' OH ' ' A' ' 7' ' ' TYR . 20.8 pt -98.77 2.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.362 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.652 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -145.1 90.82 6.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.676 0.274 . . . . 0.0 110.434 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 44.8 Cg_endo -68.48 -26.42 34.4 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.698 2.265 . . . . 0.0 112.31 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -139.52 146.68 40.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.993 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.637 ' HB2' HG23 ' A' ' 11' ' ' ILE . 12.1 tttt -62.09 -8.8 5.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.295 0.569 . . . . 0.0 111.73 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.2 -53.47 6.13 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.522 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.7 t -151.36 146.87 15.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.419 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 46.6 m-85 -57.43 169.55 0.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.399 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -81.56 98.04 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.614 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 9.5 t0 -57.77 -21.05 39.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.31 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.13 -57.2 6.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.18 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 7.2 mmtp -72.3 -50.77 24.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.662 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.6 mp -49.91 -35.72 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -64.43 -61.39 2.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.037 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 2.4 pt-20 -63.33 -25.47 68.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.3 tt -57.27 -54.36 47.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.961 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.4 mt -55.81 -49.48 73.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.08 0.467 . . . . 0.0 110.917 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.8 m -60.13 -36.08 76.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.321 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -71.02 -36.01 72.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.959 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.467 HD21 ' CD2' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -59.46 -41.6 90.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.026 0.441 . . . . 0.0 110.501 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.31 -164.58 31.54 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.853 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -94.39 31.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -121.11 -150.81 0.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.247 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 t -120.87 170.3 9.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.734 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.4 98.46 11.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.127 0.489 . . . . 0.0 110.254 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.1 tp -80.28 86.9 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.497 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.54 29.89 61.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.512 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.72 134.86 4.13 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.813 0.339 . . . . 0.0 111.044 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.22 170.11 8.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.224 0.535 . . . . 0.0 111.793 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.4 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 15.8 mmt -124.9 154.81 70.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.572 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -80.64 145.12 69.36 Favored 'Cis proline' 0 C--N 1.343 0.284 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.73 0.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.468 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 0.7 OUTLIER -111.58 117.66 33.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.915 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.3 t -89.86 161.45 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.255 0.55 . . . . 0.0 111.878 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -142.51 143.91 32.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.407 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.684 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.42 131.57 76.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.447 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.679 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 32.3 Cg_exo -52.71 -24.02 22.0 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.63 2.22 . . . . 0.0 112.091 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.06 38.38 0.18 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.349 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.8 -109.29 0.78 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.705 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.535 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -140.8 -178.45 5.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.14 0.495 . . . . 0.0 111.142 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.468 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 17.2 t-80 -56.9 128.19 35.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.074 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.684 HD11 ' HA ' ' A' ' 70' ' ' ALA . 15.6 mt -100.21 -44.74 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.901 0.381 . . . . 0.0 110.777 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.45 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.13 -153.31 19.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.827 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -91.38 -138.85 8.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.119 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -75.43 -70.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.829 0.315 . . . . 0.0 110.642 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -47.36 -41.26 19.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.256 0.551 . . . . 0.0 110.323 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -39.58 94.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.412 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.709 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -75.03 -41.38 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.714 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -51.35 -33.48 29.79 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -68.6 -35.11 76.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.4 t80 -63.93 -34.12 77.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.562 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.709 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -88.9 -70.52 0.64 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.296 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.9 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.605 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.0 ttm . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.818 0.342 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.471 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 70.0 m-85 -63.22 157.02 23.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.03 0.443 . . . . 0.0 110.687 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.95 119.28 20.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.965 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.914 HG22 HG22 ' A' ' 68' ' ' VAL . 12.4 t -105.06 132.18 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.551 . . . . 0.0 112.038 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.4 m-85 -108.46 99.61 8.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.349 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.66 -141.55 3.16 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.327 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -118.74 151.68 37.56 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.845 0.355 . . . . 0.0 110.928 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.84 -75.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.072 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 t 170.99 -41.98 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.525 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -76.47 -26.3 55.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.862 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.614 HG21 ' O ' ' A' ' 37' ' ' MET . 4.1 mp -89.96 -41.3 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.978 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -149.76 149.56 30.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.049 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 143.27 48.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.54 102.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.002 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 m -87.02 -19.47 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.378 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -75.67 -20.35 58.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.595 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 p -71.18 -44.08 66.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.673 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.17 -41.45 99.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -59.67 -51.05 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.789 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 -28.82 69.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.035 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -43.29 99.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.288 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.911 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -69.65 -27.68 65.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.711 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.697 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -57.55 -57.14 13.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.414 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.1 mt -60.25 -40.01 88.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.658 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 m -60.5 -31.39 70.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.092 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 22' ' ' ARG . 92.9 t -73.76 -27.51 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.915 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -83.11 -17.64 42.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.322 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 74.09 55.57 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.939 0.4 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -137.26 145.17 48.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.764 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.1 Cg_endo -77.33 139.2 18.42 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.428 2.085 . . . . 0.0 111.587 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.605 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 14.6 p90 -153.12 170.5 20.35 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 3.8 tp10 -143.99 146.44 32.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.978 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.517 ' HE1' HG11 ' A' ' 4' ' ' VAL . 11.0 t80 -89.24 156.62 18.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.024 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.651 HD12 ' CE1' ' A' ' 5' ' ' TYR . 9.4 mt -143.3 118.58 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.242 0.544 . . . . 0.0 110.387 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -94.63 129.5 41.47 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.119 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.522 ' HB ' HD11 ' A' ' 48' ' ' ILE . 16.8 pt -86.81 -17.98 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.732 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.614 ' O ' HG21 ' A' ' 11' ' ' ILE . 2.7 ttp -122.61 92.56 48.99 Favored Pre-proline 0 N--CA 1.454 -0.243 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.3 -15.45 28.29 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.681 2.254 . . . . 0.0 112.722 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 37' ' ' MET . 2.9 pt-20 -139.64 142.9 36.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.838 0.352 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -65.58 -8.58 20.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.272 0.558 . . . . 0.0 111.851 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.94 -60.4 2.17 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.082 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 t -150.17 127.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.329 . . . . 0.0 110.837 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.56 170.43 1.05 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.446 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.11 96.56 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.124 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.77 -28.82 37.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.213 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -52.58 -44.62 66.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.927 0.394 . . . . 0.0 110.812 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -31.03 39.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.227 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' A' ' 36' ' ' ILE . 44.4 mm -63.31 -43.77 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.601 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.91 -55.76 11.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.078 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.58 -31.09 61.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.91 0.386 . . . . 0.0 110.389 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.929 ' O ' HD12 ' A' ' 55' ' ' LEU . 12.8 tp -59.22 -59.12 5.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.08 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HA ' HD13 ' A' ' 55' ' ' LEU . 71.1 mt -44.53 -44.08 8.43 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.303 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.9 m -69.68 -30.96 68.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.588 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 51' ' ' LEU . 5.1 tttp -65.39 -40.8 93.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.887 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.7 mp -59.34 -56.72 18.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.956 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.61 -110.5 0.27 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.165 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.33 31.32 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.04 0.448 . . . . 0.0 110.774 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -121.01 -148.53 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.288 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 t -120.34 170.26 9.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -92.01 98.8 11.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.201 0.525 . . . . 0.0 110.432 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.426 ' H ' HD12 ' A' ' 61' ' ' ILE . 3.4 mp -79.74 85.08 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.264 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.21 27.34 46.12 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.52 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -52.72 148.55 7.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.849 0.356 . . . . 0.0 110.993 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.1 p -121.68 170.15 10.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.146 0.498 . . . . 0.0 111.528 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.08 158.92 39.7 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.9 Cg_endo -85.81 151.44 49.84 Favored 'Cis proline' 0 N--CA 1.461 -0.406 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.898 0.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.59 HE21 ' HA ' ' A' ' 67' ' ' GLN . 2.2 mm-40 -111.71 117.9 34.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.223 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.914 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -91.28 166.31 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 0.0 111.837 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 64.1 m-85 -141.94 143.78 33.42 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.191 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.633 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -53.84 152.4 10.13 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.527 ' HB3' ' N ' ' A' ' 1' ' ' MET . 43.3 Cg_exo -59.3 -28.72 88.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.171 2.581 . . . . 0.0 112.54 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.85 -21.0 18.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.66 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.7 84.5 0.65 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.89 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.14 162.72 15.41 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -90.54 129.6 36.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.72 0.295 . . . . 0.0 110.971 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.654 HG21 HD12 ' A' ' 82' ' ' LEU . 1.4 mp -115.57 -43.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.789 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.458 ' HA2' HE22 ' A' ' 67' ' ' GLN . . . 119.14 -155.94 15.89 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.107 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -94.52 -134.1 7.33 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.535 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.697 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.71 -70.11 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.845 -0.209 . . . . 0.0 111.05 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -48.9 -44.63 40.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.176 0.512 . . . . 0.0 110.602 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -63.66 -44.77 92.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.885 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -69.88 -43.7 71.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.76 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 87' ' ' LYS . 6.2 ttp180 -51.56 -31.57 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -72.82 -32.63 65.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.333 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.47 ' CD2' HG12 ' A' ' 76' ' ' ILE . 54.0 t80 -68.6 -32.24 71.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.648 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.505 ' CD1' ' HG2' ' A' ' 27' ' ' LYS . 20.1 m-85 -96.61 -70.74 0.7 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.528 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.773 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.833 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 28.1 tpp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 110.502 -0.185 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.415 ' H ' ' HG3' ' A' ' 1' ' ' MET . 96.9 m-85 -43.13 137.57 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.805 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -115.48 120.51 39.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.978 -179.075 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.53 HG11 ' CE1' ' A' ' 33' ' ' PHE . 53.4 t -107.82 121.25 60.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.245 0.545 . . . . 0.0 111.845 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.57 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 20.0 m-85 -100.14 101.51 12.57 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.289 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 36' ' ' ILE . . . -162.24 -139.01 2.54 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.521 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.574 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 64.2 m-85 -118.31 159.98 22.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.974 0.416 . . . . 0.0 111.478 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -96.84 -73.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.03 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m 170.64 -42.08 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.307 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -69.88 -32.44 70.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.189 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.4 mm -100.18 -32.86 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 1.8 t-160 -157.33 122.14 4.44 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 148.5 51.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.98 118.89 1.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.297 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 m -84.78 -36.79 11.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.906 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.23 -29.23 69.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.252 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.7 t -56.27 -49.38 74.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.274 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -56.64 -34.57 67.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.342 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 38.4 m-80 -72.74 -51.21 20.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 111.021 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -55.06 -45.32 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.125 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -64.99 -40.74 95.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.323 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.8 mmt85 -62.54 -37.02 84.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.313 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.746 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -57.57 -56.86 16.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.073 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.746 ' N ' HD23 ' A' ' 23' ' ' LEU . 59.5 mt -62.76 -30.36 71.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.354 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.4 m -71.19 -36.43 71.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.201 0.524 . . . . 0.0 109.629 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 22' ' ' ARG . 94.5 t -75.78 -48.61 29.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.513 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.15 -19.9 62.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.788 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt 71.33 55.04 0.21 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.944 0.402 . . . . 0.0 110.634 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -139.9 122.68 10.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.833 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 5.0 Cg_endo -48.53 159.33 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.602 2.201 . . . . 0.0 112.732 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.599 ' HB3' HD13 ' A' ' 24' ' ' LEU . 35.0 p90 -163.44 170.73 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.884 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.8 tt0 -141.04 115.34 9.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.645 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.53 ' CE1' HG11 ' A' ' 4' ' ' VAL . 36.3 t80 -89.03 154.36 20.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.833 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.422 HG13 ' C ' ' A' ' 33' ' ' PHE . 10.3 mt -148.13 122.07 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.484 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -75.05 113.15 12.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.577 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.507 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.2 pp -64.7 -29.37 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.775 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.654 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.1 ttp -118.61 92.25 43.62 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.733 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HG3' ' HB2' ' A' ' 44' ' ' ASP . 88.0 Cg_endo -79.73 3.69 7.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.695 2.263 . . . . 0.0 112.957 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -139.2 144.16 38.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.488 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -66.89 -8.11 26.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.206 0.527 . . . . 0.0 111.574 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.69 -66.8 0.79 Allowed Glycine 0 C--N 1.315 -0.633 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.293 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.32 136.58 58.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 1.1 p90 -66.4 170.97 5.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.729 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.475 ' O ' HD13 ' A' ' 48' ' ' ILE . 7.5 t0 -77.85 124.58 28.16 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.244 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 1.4 t70 -80.07 -28.74 39.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.536 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -63.89 -56.72 13.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.328 . . . . 0.0 111.171 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -67.0 -38.15 85.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.475 HD13 ' O ' ' A' ' 44' ' ' ASP . 0.9 OUTLIER -71.57 -25.72 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.704 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -68.62 -48.55 63.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.972 0.415 . . . . 0.0 110.578 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.17 -34.71 76.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.233 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' CD2' HD21 ' A' ' 55' ' ' LEU . 3.5 tt -58.16 -50.79 72.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.397 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 52' ' ' LEU . 79.1 mt -54.15 -45.85 72.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.139 0.495 . . . . 0.0 111.404 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.9 m -61.2 -42.27 98.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.436 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -31.5 72.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.733 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.71 ' CD1' HD13 ' A' ' 63' ' ' LEU . 2.1 mt -62.43 -32.07 72.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.017 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.93 -26.57 8.76 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.234 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -124.11 -165.45 1.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.695 0.283 . . . . 0.0 110.647 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -103.82 -30.52 10.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.018 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -92.58 170.25 9.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -112.54 99.94 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.701 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.6 82.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.375 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.88 25.04 36.0 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.643 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.71 HD13 ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.11 155.7 16.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.923 0.392 . . . . 0.0 111.65 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -144.59 170.15 16.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.274 0.559 . . . . 0.0 112.058 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.418 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 4.2 mtt -115.82 154.94 48.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.568 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.6 Cg_exo -76.97 142.34 72.29 Favored 'Cis proline' 0 C--N 1.344 0.312 0 C-N-CA 123.846 -1.314 . . . . 0.0 112.644 0.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.4 ' CD ' HD21 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -102.68 116.91 33.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.938 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 82' ' ' LEU . 3.3 t -92.12 152.7 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.193 0.52 . . . . 0.0 111.62 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -143.57 139.88 29.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.564 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.698 ' HB1' ' HD2' ' A' ' 71' ' ' PRO . . . -55.27 165.17 1.15 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.684 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 19.6 Cg_endo -60.11 -24.61 77.42 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.777 2.318 . . . . 0.0 111.918 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.24 -26.06 19.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.268 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.65 -6.56 5.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.101 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.35 154.57 23.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.876 0.338 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -90.42 118.52 29.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.331 . . . . 0.0 110.962 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.535 HD11 ' HA ' ' A' ' 70' ' ' ALA . 28.2 mt -97.06 -48.46 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 134.41 -156.86 22.63 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.777 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.41 -141.45 10.91 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.839 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 25.8 t80 -67.79 -70.46 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 0.0 111.019 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.49 -47.42 84.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.088 0.471 . . . . 0.0 110.593 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -51.4 -37.18 46.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.645 ' CD1' HG11 ' A' ' 68' ' ' VAL . 4.3 tt -74.12 -35.99 64.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.18 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.18 -31.25 30.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.78 -31.8 71.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.495 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 14.1 t80 -71.05 -27.96 64.02 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.836 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 24' ' ' LEU . 29.7 m-85 -99.92 -13.45 19.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.088 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.04 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.674 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 18.7 tpp . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.412 0.149 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -39.7 127.59 2.0 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.667 0.746 . . . . 0.0 112.118 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -94.56 123.81 38.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.344 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 67' ' ' GLN . 24.6 t -111.96 114.64 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.379 . . . . 0.0 111.579 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 13.9 m-85 -93.27 99.9 12.36 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.19 -136.58 2.13 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.613 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -125.75 160.33 30.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.898 0.38 . . . . 0.0 111.895 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 9' ' ' SER . 5.3 m-20 -88.96 -68.12 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.645 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.7 OUTLIER 162.08 -29.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -76.61 -39.32 52.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.444 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 40' ' ' LYS . 7.5 mm -89.84 -46.25 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.582 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -140.66 149.79 42.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -77.38 161.46 28.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.735 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 p -176.89 98.18 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.221 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 m -77.76 -33.43 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.052 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -66.67 -28.12 68.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.051 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.6 t -62.66 -46.79 86.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 110.466 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -59.37 -31.08 68.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.051 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.25 -53.49 14.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.954 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.39 -49.06 70.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 110.943 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 1.5 ttmm -60.01 -50.02 75.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.627 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.794 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -60.11 -42.69 95.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.246 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.786 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -57.08 -54.13 50.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.05 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.786 ' N ' HD23 ' A' ' 23' ' ' LEU . 8.8 mt -56.84 -42.69 80.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.518 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -59.16 -38.13 78.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.68 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 22' ' ' ARG . 42.9 t -76.46 -34.09 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.48 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -9.83 58.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.866 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.13 51.69 1.62 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.002 0.429 . . . . 0.0 110.45 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -142.63 113.92 6.05 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.386 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.674 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 89.3 Cg_exo -49.25 178.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.386 2.057 . . . . 0.0 111.973 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 3.9 p90 -163.94 170.54 16.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.958 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 14.4 tp10 -134.44 112.38 10.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.471 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 7.0 t80 -89.1 155.96 19.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.292 0.567 . . . . 0.0 111.733 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG13 ' C ' ' A' ' 33' ' ' PHE . 45.3 mt -150.26 125.5 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.814 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -88.65 126.12 35.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.035 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.6 18.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.965 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -157.78 90.69 2.3 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.52 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 37.5 Cg_endo -66.07 -23.31 53.64 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.571 2.181 . . . . 0.0 112.021 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 37' ' ' MET . 2.7 mm-40 -139.56 143.93 37.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.148 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 11' ' ' ILE . 8.2 ttpt -64.33 -7.99 11.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.29 0.567 . . . . 0.0 111.866 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.72 -37.87 12.91 Favored Glycine 0 C--N 1.313 -0.731 0 CA-C-N 115.227 -0.897 . . . . 0.0 113.201 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -150.24 151.71 12.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.3 0.572 . . . . 0.0 112.157 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -75.27 169.01 18.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.313 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.621 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 t0 -94.88 103.36 15.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.753 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 5.5 t0 -69.7 -21.58 63.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.936 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -67.46 -57.19 6.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.108 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -69.95 -36.08 74.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.527 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 44' ' ' ASP . 21.4 mt -70.89 -26.37 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.412 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -68.01 -55.5 12.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.305 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.4 -36.06 73.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.828 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.587 HD13 ' CE2' ' A' ' 69' ' ' PHE . 6.7 tp -56.27 -50.42 71.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.528 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 52' ' ' LEU . 78.0 mt -53.36 -47.08 69.73 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.376 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.2 m -63.65 -39.39 94.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.425 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -59.22 -37.31 77.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.498 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' N ' HD23 ' A' ' 55' ' ' LEU . 1.2 mt -60.17 -56.43 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.552 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.58 -110.4 0.3 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.982 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -150.44 31.39 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.977 0.418 . . . . 0.0 110.68 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -120.96 -145.87 0.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.416 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.1 t -115.27 170.45 8.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.749 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 98.27 1.2 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.39 0.614 . . . . 0.0 110.452 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.04 84.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.254 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.93 26.45 58.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.432 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -56.04 132.54 50.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -126.03 153.47 44.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.274 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.82 155.55 36.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.636 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.7 Cg_exo -82.79 136.9 30.69 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 124.04 -1.233 . . . . 0.0 112.796 0.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.676 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -92.67 148.36 22.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.691 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -122.24 149.82 25.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.172 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CE2' HD13 ' A' ' 51' ' ' LEU . 53.1 m-85 -142.27 137.43 30.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.36 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -46.9 164.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.931 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 33.4 Cg_exo -59.99 -19.82 57.43 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.797 2.331 . . . . 0.0 112.071 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.84 -19.71 13.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.432 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.06 -19.38 3.9 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.09 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.418 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -56.69 109.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.876 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -54.65 134.74 47.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.447 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 70' ' ' ALA . 7.2 mt -115.9 -39.1 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.557 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 130.74 -153.69 20.37 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.702 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -94.24 -136.17 8.1 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.946 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -82.85 -55.02 4.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.578 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -57.31 -49.94 74.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.619 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -41.06 98.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.443 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.852 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -61.65 -53.53 54.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.62 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.607 ' N ' HD13 ' A' ' 82' ' ' LEU . 26.7 ttt180 -49.73 -39.2 36.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.87 0.367 . . . . 0.0 110.13 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -67.93 -37.95 82.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 82' ' ' LEU . 14.0 t80 -61.43 -34.5 75.52 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.576 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.852 ' CE2' HD21 ' A' ' 82' ' ' LEU . 12.1 m-85 -78.59 -62.44 1.69 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.003 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.711 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 34.2 ttp . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.743 0.306 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 84.7 m-85 -80.33 154.77 27.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.419 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -137.78 123.96 20.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.107 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 68' ' ' VAL . 53.9 t -108.04 141.59 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.222 0.534 . . . . 0.0 111.592 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.88 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.8 m-85 -123.35 100.54 6.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.41 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.44 -139.12 2.58 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.39 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.453 ' HH ' ' HE1' ' A' ' 43' ' ' PHE . 74.6 m-85 -110.58 160.05 17.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.776 0.322 . . . . 0.0 110.902 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -79.1 -78.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.703 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 t 166.43 -35.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.689 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.42 -22.6 28.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.196 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 40' ' ' LYS . 35.4 mm -91.79 -42.26 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -142.0 151.49 42.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.035 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -72.01 156.31 39.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.928 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 169.69 106.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.829 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -90.57 -32.15 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.377 . . . . 0.0 111.533 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.79 -31.73 71.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.649 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 p -62.23 -43.58 98.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -55.27 -33.38 63.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -73.76 -52.87 11.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.02 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.39 63.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.888 0.375 . . . . 0.0 111.029 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -60.9 -55.33 34.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.503 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.684 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.4 mtp180 -60.67 -29.32 69.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.733 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.717 HD11 ' HG2' ' A' ' 83' ' ' ARG . 3.4 tt -55.97 -53.55 55.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.592 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -69.07 -41.48 77.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 m -61.4 -37.13 82.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.082 0.468 . . . . 0.0 110.151 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 22' ' ' ARG . 75.4 t -77.63 -32.33 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.654 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -71.26 -15.78 62.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.218 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? 73.91 54.52 0.1 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 111.221 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -138.47 141.92 32.97 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.81 137.32 19.83 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.454 2.103 . . . . 0.0 111.623 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.711 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 4.6 p90 -154.56 168.48 26.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.073 0.463 . . . . 0.0 112.216 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -141.62 137.55 31.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.5 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.548 ' CE1' HG11 ' A' ' 4' ' ' VAL . 40.9 t80 -89.39 156.71 18.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.88 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.1 mt -142.15 117.38 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.349 0.595 . . . . 0.0 110.419 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -100.11 130.39 46.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.018 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.498 HG22 ' HB2' ' A' ' 47' ' ' LYS . 32.5 pt -97.6 28.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.024 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 39' ' ' GLU . 18.0 ttm -155.55 98.55 2.3 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.909 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 60.2 Cg_endo -71.32 -27.93 18.91 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.371 2.047 . . . . 0.0 112.098 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 37' ' ' MET . 4.0 mm-40 -139.68 156.01 47.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.994 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.465 ' N ' HG23 ' A' ' 11' ' ' ILE . 1.4 ttmp? -70.81 -7.74 47.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.269 0.557 . . . . 0.0 111.675 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.99 -25.29 8.5 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.487 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 t -142.74 127.01 15.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.289 0.566 . . . . 0.0 112.453 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.6 ' HB3' HD11 ' A' ' 48' ' ' ILE . 33.8 m-85 -71.83 164.11 26.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.215 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -93.08 94.66 8.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.194 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.92 -27.86 68.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.601 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.95 -54.15 48.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.695 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HB2' HG22 ' A' ' 36' ' ' ILE . 36.6 mmtt -69.84 -34.3 73.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.068 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 43' ' ' PHE . 43.8 mt -65.97 -39.66 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.39 -56.35 10.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.175 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.48 -35.43 72.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.835 0.35 . . . . 0.0 110.796 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.474 HD13 ' CD2' ' A' ' 5' ' ' TYR . 13.5 tp -56.92 -50.49 72.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.558 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.428 HD21 ' CG ' ' A' ' 60' ' ' GLN . 80.5 mt -53.39 -48.11 68.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.01 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.4 m -64.0 -35.38 80.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.031 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -38.19 90.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.131 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.11 -53.62 46.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.521 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.66 -109.95 0.33 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.045 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.63 30.83 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.942 0.401 . . . . 0.0 110.812 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -121.13 -149.2 0.42 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.463 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 t -120.49 170.47 9.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.583 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.428 ' CG ' HD21 ' A' ' 52' ' ' LEU . 10.2 mt-30 -82.6 98.2 8.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.188 0.518 . . . . 0.0 110.34 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 pt -80.36 84.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.28 25.6 57.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.499 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.48 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.0 OUTLIER -57.79 157.92 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 110.85 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 p -130.71 170.34 14.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 0.0 111.666 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -120.48 154.8 56.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.588 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HB2' HG13 ' A' ' 4' ' ' VAL . 6.3 Cg_exo -80.99 152.34 81.01 Favored 'Cis proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.908 -1.288 . . . . 0.0 112.803 0.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.48 ' CD ' HD12 ' A' ' 63' ' ' LEU . 10.0 mt-30 -109.08 113.01 25.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.181 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -90.79 166.34 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.409 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 70.1 m-85 -141.73 139.61 32.91 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.031 0.443 . . . . 0.0 110.628 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.688 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -61.42 156.77 50.13 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.496 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 1' ' ' MET . 51.9 Cg_exo -55.73 -31.75 81.39 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.15 2.567 . . . . 0.0 112.185 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -78.93 -35.54 43.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.22 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.6 41.27 0.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.821 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.7 m -120.65 169.12 10.68 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -90.16 117.56 29.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.776 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.688 HD11 ' HA ' ' A' ' 70' ' ' ALA . 27.9 mt -90.35 -49.37 13.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.986 0.422 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.43 -151.47 19.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.619 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.69 -149.28 25.46 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.595 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.693 ' CE1' HD12 ' A' ' 23' ' ' LEU . 18.2 t80 -64.75 -70.16 0.25 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.756 0.313 . . . . 0.0 110.775 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -56.55 -46.52 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.523 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.33 -35.81 68.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.272 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.545 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.4 tt -76.74 -37.03 56.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.287 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HG2' HD11 ' A' ' 23' ' ' LEU . 8.2 mtt180 -52.38 -31.6 34.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -70.66 -33.66 71.19 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.166 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CD2' HG23 ' A' ' 76' ' ' ILE . 40.1 t80 -67.13 -27.42 67.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.604 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.545 ' CE2' HD21 ' A' ' 82' ' ' LEU . 23.9 m-85 -99.29 -17.63 17.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.922 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.5 mttm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.809 -179.712 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.682 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 21.7 tpp . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.35 0.119 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -39.5 119.01 0.89 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.862 0.839 . . . . 0.0 112.069 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -89.38 126.5 35.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.296 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 68' ' ' VAL . 11.5 t -115.93 133.94 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.142 0.496 . . . . 0.0 111.463 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.806 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.5 m-85 -110.69 99.91 8.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -160.2 -137.26 2.18 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.855 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -125.05 141.8 51.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.792 0.33 . . . . 0.0 111.01 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -99.82 26.36 6.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 110.998 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.72 8.44 5.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.682 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -85.52 -49.67 7.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.578 HG23 ' HG3' ' A' ' 40' ' ' LYS . 39.4 mm -104.06 -32.57 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.293 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -141.14 140.26 34.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.835 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -81.26 174.78 11.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.504 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 173.74 109.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.349 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 m -71.82 -35.02 53.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.975 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.38 -29.67 70.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.132 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 t -60.93 -45.67 93.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.916 0.389 . . . . 0.0 110.656 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.39 -24.39 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.319 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 28.6 m-80 -79.96 -46.74 16.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.202 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.84 -53.1 61.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.787 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 13.1 ttpt -59.76 -44.66 93.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.495 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 26' ' ' VAL . 14.9 tpt180 -62.41 -42.6 99.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.414 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.9 tt -56.97 -53.49 57.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.135 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.1 mt -59.29 -43.96 92.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.538 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.6 m -59.34 -43.65 92.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.995 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.9 t -70.81 -38.73 73.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -74.16 -9.76 58.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.796 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' CE ' ' A' ' 28' ' ' LYS . 1.2 ttpt 64.3 59.9 0.99 Allowed 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 121.434 0.635 . . . . 0.0 110.221 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.27 108.83 4.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.088 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.682 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 92.6 Cg_exo -47.08 176.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.618 2.212 . . . . 0.0 112.299 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 4.2 p90 -164.06 170.65 16.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.3 tt0 -133.1 118.16 18.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.313 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.467 ' HE1' HG11 ' A' ' 4' ' ' VAL . 4.1 t80 -89.51 158.86 17.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.738 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.806 HD12 ' CE1' ' A' ' 5' ' ' TYR . 33.8 mt -146.33 122.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.62 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -83.65 123.18 29.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.183 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 pt -100.36 -26.93 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.52 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.8 ttp -121.24 93.49 48.8 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.504 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.4 Cg_endo -82.56 1.26 9.26 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.726 2.284 . . . . 0.0 112.264 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.562 ' C ' HG21 ' A' ' 11' ' ' ILE . 43.6 mt-10 -141.13 137.65 32.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.669 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HG3' HG23 ' A' ' 11' ' ' ILE . 17.1 mtmm -65.53 -8.37 19.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.234 0.54 . . . . 0.0 111.69 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.96 -68.46 1.14 Allowed Glycine 0 C--N 1.312 -0.753 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.104 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 t -134.58 135.48 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.795 0.331 . . . . 0.0 111.151 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -63.29 169.58 3.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.102 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 t0 -80.86 121.54 26.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.039 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -60.47 -22.4 63.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -64.84 -57.58 8.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.955 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -64.97 -47.2 78.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.716 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.72 -39.26 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.434 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.39 82.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.427 . . . . 0.0 110.418 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -67.13 -40.99 86.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.382 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.6 tp -57.51 -50.41 73.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 52' ' ' LEU . 80.3 mt -52.92 -45.93 67.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.084 0.469 . . . . 0.0 111.284 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.3 m -68.06 -33.16 74.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.283 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HE3' ' CD1' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -64.3 -39.27 93.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.399 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.5 mt -61.17 -66.77 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.967 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.67 -27.06 0.59 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.326 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.67 -175.27 2.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.722 0.296 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.51 -27.44 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.043 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -95.89 170.05 9.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -116.25 100.38 7.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.783 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mt -79.67 84.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.201 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.5 25.56 55.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.588 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -60.01 139.49 57.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.972 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.469 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 17.7 p -122.3 160.08 26.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.8 mtm -117.55 154.47 50.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.673 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.3 Cg_exo -79.52 155.41 89.41 Favored 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 124.105 -1.206 . . . . 0.0 112.74 0.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 64' ' ' THR . 52.4 mm-40 -109.85 125.9 53.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.045 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -97.97 159.82 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.991 0.424 . . . . 0.0 111.977 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 94.3 m-85 -142.9 148.16 36.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.588 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.646 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.16 141.3 69.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.31 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -40.69 -30.94 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.935 2.423 . . . . 0.0 112.168 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -167.86 34.08 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.142 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -125.1 -108.99 1.75 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.774 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.0 -179.6 5.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.464 ' CE1' ' OE1' ' A' ' 67' ' ' GLN . 86.4 t60 -64.39 134.35 54.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.118 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.646 HD11 ' HA ' ' A' ' 70' ' ' ALA . 8.0 mt -104.07 -41.27 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.651 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 137.19 -152.4 21.43 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.003 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.97 -131.05 7.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.502 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 32.6 t80 -76.07 -70.22 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.687 0.28 . . . . 0.0 111.131 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -54.47 -45.42 73.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.939 0.399 . . . . 0.0 110.954 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.468 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.9 OUTLIER -56.43 -45.84 80.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.605 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.723 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -64.46 -41.44 96.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.477 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -52.96 -33.8 52.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.54 -34.19 73.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.16 -33.3 75.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.49 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.723 ' HE2' HD21 ' A' ' 82' ' ' LEU . 21.1 m-85 -90.1 -69.8 0.7 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.471 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.961 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.603 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 2.8 ttt . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -75.1 146.46 41.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.728 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -108.42 118.03 35.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.297 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 68' ' ' VAL . 92.9 t -113.07 129.71 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.407 0.622 . . . . 0.0 112.196 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.616 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 21.9 m-85 -104.61 101.18 10.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.849 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.7 -142.18 3.32 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.516 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.4 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 57.8 m-85 -119.17 154.78 32.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.849 0.357 . . . . 0.0 111.422 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 9' ' ' SER . 22.0 p-10 -89.85 11.57 19.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.799 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER 80.0 -5.73 1.82 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.639 0.257 . . . . 0.0 111.527 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -86.48 -48.63 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' HG22 ' A' ' 11' ' ' ILE . 30.1 mm -94.11 -16.45 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -155.85 142.92 19.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -66.5 115.78 6.75 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.99 0.424 . . . . 0.0 111.761 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p -130.16 89.32 2.78 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.579 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.6 m -81.3 -32.05 11.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.441 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -65.8 -26.64 67.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.178 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.1 t -63.77 -51.91 62.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.408 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.12 -29.54 63.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.196 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -70.6 -57.66 4.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.879 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.23 -41.89 80.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -57.2 -51.19 70.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.812 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.781 ' O ' HG23 ' A' ' 26' ' ' VAL . 14.9 ttm-85 -60.31 -43.6 96.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.462 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.7 tt -58.87 -54.75 43.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.386 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.623 HD23 ' HZ ' ' A' ' 86' ' ' PHE . 5.4 mt -56.71 -46.34 81.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.682 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.6 m -55.83 -38.4 69.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.141 0.496 . . . . 0.0 110.031 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 22' ' ' ARG . 48.6 t -78.8 -31.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.548 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -73.08 -9.78 59.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.16 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 71.13 45.21 0.51 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.914 0.388 . . . . 0.0 110.957 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -132.44 130.48 21.86 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.593 ' O ' ' HA ' ' A' ' 1' ' ' MET . 44.3 Cg_endo -82.8 161.1 16.28 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.636 2.224 . . . . 0.0 111.191 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.474 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 5.1 p90 -161.31 171.2 18.75 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.916 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -132.45 121.19 23.0 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.536 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.636 ' HE1' HG12 ' A' ' 4' ' ' VAL . 1.1 t80 -89.82 150.87 22.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.763 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 mt -142.41 122.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.413 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -87.08 118.04 26.2 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.424 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.86 HD11 ' SD ' ' A' ' 65' ' ' MET . 34.0 pt -97.07 33.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.007 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 39' ' ' GLU . 42.9 ttm -160.59 82.59 2.11 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.57 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.01 -4.76 16.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.032 2.488 . . . . 0.0 112.875 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 37' ' ' MET . 1.8 mm-40 -139.21 155.64 47.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -71.12 -7.13 44.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.55 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.06 18.01 3.36 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.205 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 t -150.83 116.46 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 9.0 m-85 -72.31 170.22 14.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.676 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.556 ' C ' HD12 ' A' ' 48' ' ' ILE . 9.6 t0 -100.42 93.32 5.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 70.9 m-20 -64.03 -24.86 67.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.46 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.43 -58.7 5.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 36' ' ' ILE . 14.8 mmtm -69.16 -34.06 74.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.301 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.556 HD12 ' C ' ' A' ' 44' ' ' ASP . 49.1 mt -71.01 -32.69 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.639 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.34 -55.17 34.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -61.52 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.616 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 4.3 tt -59.54 -53.33 59.34 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.223 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.569 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.9 mt -52.88 -47.9 67.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.064 0.459 . . . . 0.0 110.959 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.4 m -53.39 -40.74 65.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.687 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 23.4 mtpp -70.11 -39.41 75.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.74 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -44.42 93.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.486 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.19 -137.03 5.07 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.897 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -122.85 30.34 6.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.123 0.487 . . . . 0.0 110.485 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.25 -156.72 0.69 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.211 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -121.17 170.57 9.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.632 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -79.47 98.14 6.69 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.286 0.565 . . . . 0.0 110.182 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -80.32 86.7 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.909 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.07 27.93 60.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.505 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -179.8 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.615 0.245 . . . . 0.0 110.684 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.4 p -150.36 159.72 44.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.154 0.502 . . . . 0.0 111.897 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.86 ' SD ' HD11 ' A' ' 36' ' ' ILE . 2.9 mtt -115.49 158.0 42.72 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.189 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.8 Cg_exo -79.7 145.48 73.56 Favored 'Cis proline' 0 C--N 1.345 0.347 0 C-N-CA 124.47 -1.054 . . . . 0.0 113.27 0.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -105.52 126.77 52.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.133 178.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 4' ' ' VAL . 5.7 t -96.99 159.02 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.99 0.424 . . . . 0.0 111.645 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.462 ' N ' HG12 ' A' ' 68' ' ' VAL . 32.0 m-85 -142.83 144.26 32.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.729 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.593 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -53.81 133.38 56.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.263 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 35.1 Cg_exo -55.05 -17.03 13.46 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.523 2.149 . . . . 0.0 112.312 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.73 39.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.386 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.86 -114.81 0.76 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.273 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.1 p -125.56 -173.02 2.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.142 0.496 . . . . 0.0 111.32 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 35.9 t-80 -66.35 145.18 56.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 70' ' ' ALA . 1.7 mp -120.04 -35.4 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.939 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 123.83 -156.55 18.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.093 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.27 -137.33 8.65 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.418 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.602 ' CE1' HD13 ' A' ' 23' ' ' LEU . 28.4 t80 -69.61 -70.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.723 0.297 . . . . 0.0 111.05 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -57.19 -48.98 77.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.964 0.412 . . . . 0.0 110.71 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -50.42 -36.66 34.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.359 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.589 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.4 tt -82.67 -29.85 29.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.232 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -51.63 -31.37 25.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -65.67 -34.73 78.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.112 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CD2' HG12 ' A' ' 76' ' ' ILE . 22.1 t80 -64.89 -33.22 75.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.542 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.623 ' HZ ' HD23 ' A' ' 24' ' ' LEU . 6.5 m-85 -86.49 -65.03 1.06 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.454 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.001 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.696 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 19.5 ttm . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.921 0.391 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 57.4 m-85 -82.43 151.39 26.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.764 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.1 mppp? -126.47 120.62 30.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.857 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.524 HG11 ' CE1' ' A' ' 33' ' ' PHE . 6.2 t -109.49 116.64 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.115 0.483 . . . . 0.0 111.848 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 21.8 m-85 -96.04 100.54 12.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.901 178.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.69 -137.96 2.32 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.352 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.678 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 3.1 m-85 -127.24 151.75 48.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -144.83 38.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.953 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.524 ' HB2' HG12 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -163.94 -162.82 0.73 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.108 0.48 . . . . 0.0 111.856 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -86.52 8.48 21.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.083 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.653 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -87.54 -8.13 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.678 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 6.6 t60 -170.17 144.07 2.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.329 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.607 ' HE2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -80.76 155.47 26.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.281 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 168.82 82.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.97 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.607 HG13 ' HE2' ' A' ' 13' ' ' LYS . 34.4 m -73.97 -41.23 52.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 15' ' ' VAL . 1.7 m-85 -59.57 -20.4 55.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.138 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 t -66.76 -60.23 2.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.778 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.74 -40.04 39.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 110.624 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -65.64 -43.99 87.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.576 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -67.41 -33.29 74.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -56.97 -44.39 82.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.813 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.0 ttp180 -70.94 -25.14 62.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.325 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.732 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -54.1 -57.29 11.64 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.241 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.62 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 13.8 mt -64.31 -41.41 96.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.52 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.2 m -60.39 -34.5 73.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.297 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 22' ' ' ARG . 67.2 t -72.24 -42.94 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.933 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -72.6 -19.75 61.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.209 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 2.7 tppt? 79.79 71.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 111.382 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -143.46 143.28 23.41 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.0 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.45 130.12 11.59 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.474 2.116 . . . . 0.0 111.968 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.696 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 6.1 p90 -151.54 166.96 29.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.89 0.376 . . . . 0.0 111.959 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -143.09 136.13 27.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.883 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CE1' HG11 ' A' ' 4' ' ' VAL . 13.1 t80 -89.75 159.79 16.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.224 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.701 HG21 ' HD2' ' A' ' 47' ' ' LYS . 23.5 mt -150.09 126.09 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.123 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 8' ' ' ASP . 68.6 m-80 -86.72 111.24 20.51 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.176 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.488 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 21.9 pt -75.22 -5.79 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.505 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.474 ' HE2' ' CE1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -135.33 69.77 68.35 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.448 179.548 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.48 -13.74 35.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.596 2.197 . . . . 0.0 112.135 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -139.16 135.79 34.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.352 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.86 -9.01 3.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.31 0.576 . . . . 0.0 111.429 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.06 -61.08 3.87 Favored Glycine 0 C--N 1.312 -0.767 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.352 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.4 t -151.95 157.0 5.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.476 ' N ' HG12 ' A' ' 42' ' ' VAL . 24.1 m-85 -58.83 170.3 0.84 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.902 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.742 ' O ' HD12 ' A' ' 48' ' ' ILE . 7.5 t70 -100.24 113.0 25.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.64 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.633 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 9.2 p30 -73.01 -18.79 61.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.07 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.45 -63.29 1.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 111.152 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.701 ' HD2' HG21 ' A' ' 34' ' ' ILE . 34.9 mmtt -64.17 -40.08 95.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.55 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.742 HD12 ' O ' ' A' ' 44' ' ' ASP . 34.9 mt -66.13 -28.53 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.654 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -64.23 -49.76 70.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.684 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -37.68 77.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.425 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.641 HD13 ' CE2' ' A' ' 69' ' ' PHE . 5.9 tp -57.3 -50.85 71.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.689 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -52.86 -45.94 67.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.516 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.7 m -62.99 -35.75 81.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.672 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -65.81 -38.59 89.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.788 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 51' ' ' LEU . 1.3 mt -59.6 -70.15 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.77 -106.95 0.2 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.144 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -150.35 32.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 111.045 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -120.97 -145.42 0.36 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.365 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.01 170.18 9.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.837 0.351 . . . . 0.0 110.712 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.1 98.43 1.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.4 0.619 . . . . 0.0 110.352 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.9 mt -79.67 85.5 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.346 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.21 28.23 54.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.489 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -46.58 123.51 5.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.393 . . . . 0.0 111.158 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 24.9 p -104.51 136.52 43.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.077 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.5 mmt -102.92 152.16 38.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.7 Cg_endo -83.56 144.64 49.42 Favored 'Cis proline' 0 C--N 1.346 0.405 0 C-N-CA 124.246 -1.148 . . . . 0.0 112.653 0.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 25.3 mm-40 -104.33 154.08 20.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -123.35 159.35 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.459 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.641 ' CE2' HD13 ' A' ' 51' ' ' LEU . 25.3 m-85 -142.3 132.7 25.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.932 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.571 ' N ' HD11 ' A' ' 76' ' ' ILE . . . -65.54 150.16 96.36 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.239 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.564 ' HB3' ' N ' ' A' ' 1' ' ' MET . 71.1 Cg_exo -45.73 -42.98 19.28 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.215 2.61 . . . . 0.0 112.746 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -29.03 64.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.98 79.64 0.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.467 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.9 127.57 3.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.939 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -58.54 108.94 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.613 HG23 ' CD2' ' A' ' 85' ' ' TYR . 4.0 mt -81.5 -41.79 19.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 125.48 -149.52 17.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.491 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -98.22 -132.42 7.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.32 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.732 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -83.02 -69.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.578 0.189 . . . . 0.0 110.877 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.7 -43.53 47.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.175 0.512 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -42.34 95.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.746 HD21 ' CE1' ' A' ' 86' ' ' PHE . 1.6 tt -71.77 -41.58 68.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.752 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -51.12 -35.24 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.85 -35.57 77.09 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.122 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.613 ' CD2' HG23 ' A' ' 76' ' ' ILE . 59.5 t80 -64.49 -32.36 73.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.588 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.746 ' CE1' HD21 ' A' ' 82' ' ' LEU . 27.7 m-85 -89.79 -27.1 20.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.058 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.701 179.701 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.8 ttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.897 0.379 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 68.9 m-85 -60.19 157.44 13.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.771 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.694 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -134.11 116.32 15.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.702 -179.53 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 68' ' ' VAL . 19.0 t -105.91 125.62 61.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.266 0.555 . . . . 0.0 111.829 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.768 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.0 m-30 -101.96 99.47 9.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.532 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.68 -138.02 2.33 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.413 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 22.6 m-85 -120.06 139.97 51.73 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 120.626 0.25 . . . . 0.0 110.502 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -92.97 22.28 5.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 4.5 m 65.74 5.73 3.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -81.89 -44.02 17.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.074 0.464 . . . . 0.0 110.521 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 11' ' ' ILE . 9.8 mm -124.95 1.5 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.263 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 4.9 t60 -157.04 131.19 8.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.538 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -80.99 159.57 24.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.348 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 176.75 123.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.118 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.0 m -83.13 -39.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.818 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -55.45 -28.85 56.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.728 0.299 . . . . 0.0 111.284 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.5 m -62.16 -53.84 49.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.55 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.26 -34.19 56.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.167 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -70.22 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.963 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.51 -31.95 48.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.288 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -60.69 -56.01 26.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.571 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.82 ' O ' HG23 ' A' ' 26' ' ' VAL . 12.1 ttt85 -64.65 -27.09 68.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.772 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.808 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.6 tt -57.31 -57.4 12.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.385 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.693 HD12 ' CG ' ' A' ' 31' ' ' PHE . 3.8 mt -59.85 -41.89 92.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.599 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -37.16 79.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.094 0.474 . . . . 0.0 110.063 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 22' ' ' ARG . 92.6 t -77.64 -25.36 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.867 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HE3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -77.71 -15.74 58.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? 70.34 42.28 0.93 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.066 0.46 . . . . 0.0 110.524 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -128.33 143.75 49.29 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.499 ' O ' ' HA ' ' A' ' 1' ' ' MET . 92.1 Cg_endo -77.01 136.96 16.96 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.389 2.06 . . . . 0.0 111.674 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.693 ' CG ' HD12 ' A' ' 24' ' ' LEU . 12.6 p90 -149.12 170.31 18.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.915 0.388 . . . . 0.0 112.008 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -147.75 141.21 25.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.196 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.471 ' HE1' HG11 ' A' ' 4' ' ' VAL . 8.3 t80 -89.71 162.87 15.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.043 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.768 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.9 mt -146.12 119.78 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.262 0.554 . . . . 0.0 110.417 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -82.08 125.23 30.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.346 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.45 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.9 pt -100.31 -12.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.171 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.536 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 21.7 ttm -123.07 79.04 51.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.767 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 17.9 Cg_exo -65.56 -22.1 58.91 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.283 1.989 . . . . 0.0 111.608 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -139.22 137.46 35.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.704 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.468 ' N ' HG21 ' A' ' 11' ' ' ILE . 19.7 tttt -61.35 -9.18 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.22 0.533 . . . . 0.0 112.245 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.31 -55.72 4.6 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.449 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 t -150.46 139.25 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.616 0.246 . . . . 0.0 111.559 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -58.76 170.33 0.82 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.045 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.482 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 12.6 p30 -88.89 109.49 20.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 111.875 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -58.06 -31.12 66.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.619 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -52.99 -42.35 65.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.786 0.327 . . . . 0.0 110.971 -179.478 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 53.0 mmtt -80.62 -39.15 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.254 0.55 . . . . 0.0 109.887 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 44' ' ' ASP . 43.9 mm -55.93 -46.01 80.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.722 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.68 -56.44 12.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.322 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 7.4 pt-20 -60.68 -28.78 68.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.583 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.11 -56.44 22.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.362 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.686 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.8 mt -52.35 -45.24 65.62 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.9 m -60.72 -38.81 86.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.278 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -65.27 -37.7 87.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.521 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -60.03 -20.17 56.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.935 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.27 -88.81 1.53 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.124 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -139.4 31.53 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.454 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' O ' HD12 ' A' ' 55' ' ' LEU . 5.2 t0 -121.61 110.55 16.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.376 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.4 t -78.25 142.06 38.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.452 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.9 pt20 -70.8 97.57 1.41 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.378 0.608 . . . . 0.0 111.036 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 61' ' ' ILE . 6.5 tp -80.88 79.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.481 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.76 24.37 69.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.101 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -54.48 159.91 1.92 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.858 0.361 . . . . 0.0 111.08 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 65' ' ' MET . 18.3 m -125.49 165.76 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.226 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.447 ' N ' HG22 ' A' ' 64' ' ' THR . 13.0 mmt -97.94 155.69 36.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.452 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.6 Cg_endo -86.34 149.81 42.92 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 124.211 -1.162 . . . . 0.0 113.106 0.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -108.71 112.61 25.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.918 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 4' ' ' VAL . 3.2 t -89.5 163.02 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.219 0.533 . . . . 0.0 112.183 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 44.9 m-85 -141.58 137.3 31.84 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.132 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.756 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -50.99 152.22 3.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.065 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.478 ' HB3' ' N ' ' A' ' 1' ' ' MET . 53.0 Cg_exo -54.87 -24.32 38.24 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.728 2.286 . . . . 0.0 112.028 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -101.63 -22.52 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.991 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.3 85.66 0.78 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.707 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.47 ' O ' HD12 ' A' ' 76' ' ' ILE . 1.4 m -165.79 126.68 1.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.736 0.303 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -61.28 117.72 5.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.794 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 70' ' ' ALA . 2.4 mp -110.11 -27.9 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.961 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 117.12 -155.46 16.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.901 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.06 -134.36 7.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.419 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.808 ' CE1' HD12 ' A' ' 23' ' ' LEU . 36.5 t80 -74.3 -67.12 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.625 0.25 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.81 -52.68 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -51.05 -41.85 60.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.402 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.737 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.6 tt -78.83 -29.03 44.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.129 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 87' ' ' LYS . 14.2 ttt85 -52.81 -30.66 34.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -67.77 -30.39 69.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' LEU . 24.0 t80 -68.64 -33.65 74.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.574 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.737 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.2 m-85 -95.51 -70.72 0.7 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.819 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' ARG . 1.3 mtpm? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.93 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 28.5 ttm . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.08 143.37 35.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.146 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.15 120.14 41.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.617 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.428 HG11 ' HE1' ' A' ' 33' ' ' PHE . 67.6 t -104.39 126.8 59.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.268 0.556 . . . . 0.0 111.727 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.716 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.8 m-30 -103.8 99.53 9.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.457 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.74 -141.05 3.04 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.33 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -116.61 160.63 20.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 120.675 0.274 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB2' HD13 ' A' ' 11' ' ' ILE . 6.1 m-20 -81.59 -78.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 t 170.49 -35.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.799 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -84.55 -22.94 29.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.38 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.599 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.3 mp -93.1 -39.01 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.74 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -155.93 145.0 20.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.272 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -68.39 158.26 33.99 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 p 175.38 113.9 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.815 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.6 m -90.29 -36.76 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.927 0.394 . . . . 0.0 111.1 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -62.25 -29.18 70.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.996 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 m -58.08 -48.04 81.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.028 0.442 . . . . 0.0 110.289 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -28.07 68.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.486 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.19 -57.22 4.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.765 0.317 . . . . 0.0 111.156 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.17 -26.16 37.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.319 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -68.53 -58.12 4.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 110.327 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.888 ' O ' HG23 ' A' ' 26' ' ' VAL . 13.1 mtt180 -63.17 -28.63 70.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.544 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.942 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -55.98 -56.53 19.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.197 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.633 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 1.5 mt -57.26 -40.01 76.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.58 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.4 m -60.06 -34.93 74.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.311 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 22' ' ' ARG . 22.1 t -62.41 -51.16 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.408 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' CE ' ' CE2' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -66.48 -16.74 64.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.375 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.82 42.82 0.19 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.141 0.496 . . . . 0.0 110.119 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -120.21 138.58 27.32 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.124 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.613 ' O ' ' HA ' ' A' ' 1' ' ' MET . 97.2 Cg_endo -74.31 158.24 44.94 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.013 1.809 . . . . 0.0 111.012 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.546 ' CG ' HD12 ' A' ' 24' ' ' LEU . 35.8 p90 -161.37 171.05 18.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.8 0.334 . . . . 0.0 111.668 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -141.57 130.83 23.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.512 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.428 ' HE1' HG11 ' A' ' 4' ' ' VAL . 21.0 t80 -89.14 159.56 17.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.955 0.407 . . . . 0.0 111.298 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.716 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.2 mt -146.85 120.11 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.552 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -91.66 112.48 24.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.543 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.82 HD11 ' CG1' ' A' ' 48' ' ' ILE . 6.6 tt -87.18 49.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.3 ttm -171.38 98.81 0.4 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.566 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 35.7 Cg_endo -65.1 -30.3 55.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.374 2.05 . . . . 0.0 112.288 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -143.01 158.71 43.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.419 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -71.0 -7.78 48.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.313 0.577 . . . . 0.0 111.498 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.61 -20.25 8.67 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.925 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 t -141.36 122.74 13.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.413 0.625 . . . . 0.0 112.5 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.746 ' HB3' HD11 ' A' ' 48' ' ' ILE . 31.6 m-85 -73.41 161.92 29.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.3 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.434 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 1.1 t70 -83.7 87.39 7.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.77 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -24.86 64.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.297 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -61.06 -55.86 27.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 110.713 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 6.4 mmtt -70.74 -43.55 68.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.112 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.82 ' CG1' HD11 ' A' ' 36' ' ' ILE . 63.0 mt -50.43 -38.22 15.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.672 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.47 -59.26 3.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 8.8 pt-20 -60.26 -30.03 69.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.159 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD2' HD21 ' A' ' 55' ' ' LEU . 1.9 tt -58.23 -50.14 74.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.146 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.1 mt -54.88 -48.4 73.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.097 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.9 m -66.18 -35.34 80.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.372 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -65.4 -37.14 86.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.829 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.503 HD21 ' CD2' ' A' ' 51' ' ' LEU . 1.2 mt -60.25 -67.34 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.85 -27.18 0.29 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.678 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.05 -165.5 1.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.898 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -91.56 -31.35 15.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.789 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -110.67 170.15 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 62' ' ' GLY . 11.7 pt20 -114.36 100.54 8.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.489 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -58.8 82.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.482 0.658 . . . . 0.0 111.598 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 60' ' ' GLN . . . 62.33 20.96 61.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.983 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.94 135.07 36.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.6 p -136.83 170.93 15.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.465 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.0 155.64 47.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.561 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -75.72 143.13 76.06 Favored 'Cis proline' 0 C--N 1.344 0.323 0 C-N-CA 123.8 -1.333 . . . . 0.0 112.83 0.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.493 ' HG2' ' HE1' ' A' ' 75' ' ' HIS . 1.7 mt-30 -111.97 113.76 26.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.879 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -87.91 161.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.111 0.482 . . . . 0.0 111.587 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 57.4 m-85 -143.08 139.04 30.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.345 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.704 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.53 132.52 54.43 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.294 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HB3' ' N ' ' A' ' 1' ' ' MET . 38.2 Cg_exo -54.87 -20.74 23.56 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.448 2.099 . . . . 0.0 111.911 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.57 39.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.279 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.48 -111.35 0.68 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.923 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.515 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 5.4 t -137.4 179.88 6.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.179 0.514 . . . . 0.0 111.273 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.493 ' HE1' ' HG2' ' A' ' 67' ' ' GLN . 86.8 t60 -56.34 126.9 28.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.025 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.704 HD11 ' HA ' ' A' ' 70' ' ' ALA . 11.0 mt -94.66 -42.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.78 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 134.22 -154.86 21.58 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.8 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 82' ' ' LEU . . . -93.62 -149.07 24.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.372 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.942 ' CE1' HD12 ' A' ' 23' ' ' LEU . 58.3 t80 -67.66 -59.14 3.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.757 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -62.09 -54.74 37.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.051 0.453 . . . . 0.0 110.818 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -52.02 -41.04 61.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.6 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.773 HD21 ' CE1' ' A' ' 86' ' ' PHE . 6.1 tt -79.69 -28.19 40.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.24 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 87' ' ' LYS . 2.2 mmm180 -52.28 -35.05 49.22 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -60.12 -32.59 71.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.2 t80 -68.4 -28.5 67.14 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.929 178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.773 ' CE1' HD21 ' A' ' 82' ' ' LEU . 15.7 m-85 -100.11 -70.86 0.72 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.833 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.567 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 56.2 ttp . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 81.0 m-85 -51.01 149.12 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.198 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 1.1 mptp? -117.23 116.99 28.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.219 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 68' ' ' VAL . 44.1 t -110.67 128.55 66.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.513 0.673 . . . . 0.0 112.577 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.583 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 22.0 m-85 -108.74 106.44 16.47 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.592 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.68 -137.26 2.29 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.831 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -123.94 134.11 53.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 122.449 0.3 . . . . 0.0 110.324 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -100.39 39.14 1.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 111.318 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 t 60.15 14.05 4.24 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.627 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -85.83 -53.29 5.21 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.901 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 37' ' ' MET . 18.6 mt -110.97 -15.26 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -160.67 148.42 15.99 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.07 159.28 33.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.62 119.07 1.0 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.433 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -90.38 -31.21 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.032 0.444 . . . . 0.0 111.125 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -62.7 -28.84 70.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.805 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 t -59.32 -47.07 86.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.049 0.452 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -62.52 -33.89 75.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.214 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 83.4 m-20 -74.61 -46.53 37.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.017 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -66.69 -40.52 88.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.92 0.39 . . . . 0.0 110.803 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -57.49 10.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.787 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.789 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -58.0 -40.12 79.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.387 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.733 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -59.15 -54.82 42.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.129 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.733 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.4 mt -55.97 -45.97 78.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.665 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -55.98 -38.01 69.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.157 0.504 . . . . 0.0 109.928 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.5 t -79.29 -29.71 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.497 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -75.25 -13.73 60.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.114 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm 68.56 46.31 1.01 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.0 0.429 . . . . 0.0 110.926 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -126.83 141.04 39.27 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.847 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.48 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.5 Cg_endo -82.06 140.38 11.21 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.514 2.143 . . . . 0.0 111.404 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 42.6 p90 -157.94 169.74 23.91 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.639 -0.424 . . . . 0.0 112.077 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.86 139.68 23.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.241 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.64 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.6 t80 -89.42 161.44 16.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.521 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.415 HG13 ' C ' ' A' ' 33' ' ' PHE . 12.1 mt -149.88 122.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 110.511 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -79.31 110.65 14.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.274 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.517 HG21 ' HB3' ' A' ' 5' ' ' TYR . 2.3 pt -86.01 -2.28 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.599 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.665 ' O ' HD12 ' A' ' 11' ' ' ILE . 38.5 ttm -119.41 107.22 41.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.87 -28.28 4.14 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.568 2.178 . . . . 0.0 111.546 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -139.95 152.77 46.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.665 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -65.6 -8.46 20.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.236 0.541 . . . . 0.0 112.048 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.41 -54.03 3.65 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.495 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.4 t -148.72 154.79 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.805 0.336 . . . . 0.0 111.378 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -77.45 170.39 16.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.96 114.42 25.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.687 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 35.1 m-20 -63.7 -15.62 58.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.412 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -62.7 -55.99 21.73 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.826 0.345 . . . . 0.0 110.839 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -70.09 -35.81 74.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' ' 43' ' ' PHE . 56.5 mt -70.43 -32.98 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.687 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.1 -57.42 12.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.64 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -63.17 -25.78 68.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.144 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.583 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 3.7 tt -60.36 -56.17 24.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.991 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.665 ' N ' HD23 ' A' ' 52' ' ' LEU . 2.1 mt -52.96 -45.17 67.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.065 0.46 . . . . 0.0 111.093 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 m -56.87 -49.02 76.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.379 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 11.3 mtpp -60.78 -36.28 78.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.404 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.78 -24.04 67.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.95 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.97 -132.65 11.38 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.925 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.56 31.24 2.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.102 0.477 . . . . 0.0 110.665 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.72 109.41 14.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.542 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 t -78.39 152.1 32.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.389 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -69.89 97.63 1.15 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.398 0.618 . . . . 0.0 110.898 -179.478 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.54 81.32 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.714 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.93 24.79 67.15 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.167 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -55.23 173.28 0.11 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.756 0.312 . . . . 0.0 110.778 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.8 p -133.16 169.05 17.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.193 0.52 . . . . 0.0 111.636 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.411 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 15.5 mmt -111.36 155.11 43.31 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.261 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.3 Cg_exo -84.33 143.01 40.18 Favored 'Cis proline' 0 N--CA 1.462 -0.341 0 C-N-CA 124.223 -1.157 . . . . 0.0 113.108 0.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -97.4 130.49 44.53 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.671 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 4' ' ' VAL . 4.1 t -99.77 160.56 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.02 0.438 . . . . 0.0 111.696 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.59 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 20.7 m-85 -141.55 138.1 32.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.527 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.572 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -44.82 138.51 4.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.502 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 90.6 Cg_exo -46.38 -25.73 3.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.917 2.411 . . . . 0.0 111.992 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.98 39.16 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.044 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.05 -112.37 1.09 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.366 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 t -127.18 -172.55 2.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.086 0.47 . . . . 0.0 111.495 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 83.0 t60 -67.21 145.83 54.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.087 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 70' ' ' ALA . 2.3 mp -123.04 -35.9 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.134 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.451 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.01 -156.44 20.72 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.774 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.73 -138.16 8.44 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.471 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 23' ' ' LEU . 31.5 t80 -71.85 -70.53 0.32 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.74 0.305 . . . . 0.0 110.773 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -56.43 -49.3 74.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.99 0.424 . . . . 0.0 110.48 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -36.34 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.291 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.634 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.9 tt -84.32 -29.77 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.023 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -51.7 -31.05 24.56 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.94 -34.42 78.08 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.219 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.459 ' CD2' HG12 ' A' ' 76' ' ' ILE . 15.4 t80 -65.27 -33.01 74.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.426 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.634 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.8 m-85 -87.95 -26.27 22.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.275 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 mttt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.9 -179.969 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.611 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 29.8 ttp . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -79.88 143.66 34.1 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.395 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.71 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -105.21 121.77 44.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.398 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 68' ' ' VAL . 38.6 t -103.38 126.58 57.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.82 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.577 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.6 m-30 -102.51 99.26 9.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.404 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.39 -138.33 2.46 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.503 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.769 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 93.0 m-85 -131.41 157.05 44.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.937 0.398 . . . . 0.0 111.543 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.588 ' O ' ' O ' ' A' ' 12' ' ' HIS . 32.6 p30 -80.25 -177.91 6.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.587 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -91.77 -13.7 31.11 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.698 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -85.67 -41.94 14.72 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mm -89.54 -45.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.588 ' O ' ' O ' ' A' ' 8' ' ' ASP . 20.8 t60 -139.64 115.51 10.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.68 0.752 . . . . 0.0 110.618 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.87 148.04 14.02 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.682 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 p -158.03 104.96 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 m -82.33 -33.37 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.723 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.97 -25.7 64.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.348 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.28 -48.78 80.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.626 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -55.29 -24.4 28.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.549 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 8.9 m-80 -74.68 -50.05 19.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.303 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.584 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -65.09 -40.79 95.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.791 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -61.41 -57.58 11.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.344 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.832 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -62.04 -33.8 75.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 0.0 109.709 179.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.78 HD13 ' N ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -57.55 -54.6 45.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.914 178.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.78 ' N ' HD13 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -58.49 -47.46 84.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.515 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -53.07 -39.99 63.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.116 0.484 . . . . 0.0 109.946 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 22' ' ' ARG . 60.7 t -72.98 -31.01 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.457 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HD3' ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -78.13 -9.81 59.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.043 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.35 37.25 1.2 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.051 0.453 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -123.51 133.13 24.37 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.015 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.611 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.9 Cg_endo -82.01 158.08 18.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.543 2.162 . . . . 0.0 111.227 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 9.1 p90 -161.72 171.57 17.67 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.767 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -136.86 137.42 39.66 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.463 ' HE1' HG11 ' A' ' 4' ' ' VAL . 10.9 t80 -89.36 158.42 17.79 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.196 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.577 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.1 mt -147.5 122.32 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.339 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -92.77 127.22 38.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.182 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.769 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 4.2 pt -89.53 -9.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.929 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.602 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 18.1 ttm -125.25 100.31 32.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.642 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.28 -22.99 28.94 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.647 2.232 . . . . 0.0 112.357 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -139.92 145.13 37.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -9.3 4.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.308 0.575 . . . . 0.0 111.78 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.91 -59.7 2.41 Favored Glycine 0 C--N 1.313 -0.708 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.741 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -146.85 134.69 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.685 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -69.49 170.64 10.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 48' ' ' ILE . 27.5 t70 -89.73 95.97 10.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.048 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -57.41 -18.68 19.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.104 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.47 -53.21 60.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -71.83 -36.29 70.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.362 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 44' ' ' ASP . 37.9 mm -53.16 -48.24 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.966 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.3 -53.14 57.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.627 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.49 -28.53 65.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.37 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.669 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.0 tt -58.23 -58.1 9.94 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.561 ' N ' HD23 ' A' ' 52' ' ' LEU . 4.1 mt -48.66 -48.14 40.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.307 0.575 . . . . 0.0 111.335 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.9 m -71.09 -22.06 62.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.192 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -73.09 -42.87 62.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.93 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.719 HD23 ' CE1' ' A' ' 75' ' ' HIS . 1.5 mp -59.33 -39.28 82.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.001 0.429 . . . . 0.0 110.886 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.94 -109.07 0.27 Allowed Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.057 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -150.5 32.53 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.241 0.544 . . . . 0.0 110.725 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -120.98 -152.09 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.385 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -120.98 170.6 9.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.863 0.363 . . . . 0.0 110.831 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -90.38 98.8 11.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.304 0.573 . . . . 0.0 110.476 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.6 mm -79.27 84.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.192 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.87 25.53 56.38 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.448 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.576 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.1 mm? -58.05 145.53 36.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 110.781 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.4 p -127.86 170.52 12.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.43 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.28 156.37 35.23 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.648 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.8 Cg_endo -85.19 145.12 40.18 Favored 'Cis proline' 0 N--CA 1.461 -0.419 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.834 0.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.576 ' CD ' HD12 ' A' ' 63' ' ' LEU . 3.3 mm-40 -107.68 113.35 26.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.743 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.8 t -87.25 161.36 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.291 0.567 . . . . 0.0 111.829 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.44 ' N ' HG12 ' A' ' 68' ' ' VAL . 55.8 m-85 -142.75 143.17 32.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.016 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.665 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -52.91 149.77 11.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.113 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' HB3' ' N ' ' A' ' 1' ' ' MET . 8.8 Cg_exo -68.79 -9.88 27.49 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.701 2.267 . . . . 0.0 112.39 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.6 -18.53 13.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.204 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.19 91.34 1.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.665 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m 176.29 158.24 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.537 0.208 . . . . 0.0 110.655 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.719 ' CE1' HD23 ' A' ' 55' ' ' LEU . 9.8 t-160 -90.46 133.52 34.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.665 HD12 ' N ' ' A' ' 70' ' ' ALA . 2.5 mt -122.28 -40.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.986 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 126.23 -161.38 20.6 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.928 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.26 -139.04 8.13 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.785 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -71.11 -70.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.602 0.239 . . . . 0.0 111.144 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -55.21 -50.83 68.39 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.198 0.523 . . . . 0.0 110.436 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -50.99 -43.71 60.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.231 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.618 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.1 tt -77.62 -29.1 51.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.312 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -52.25 -30.78 29.34 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.57 -35.56 79.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.5 t80 -61.79 -34.95 76.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.153 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.618 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -87.22 -27.53 22.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.266 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.8 mttt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.922 -179.85 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.637 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 17.9 ttp . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.402 ' CD1' ' CD2' ' A' ' 24' ' ' LEU . 71.2 m-85 -76.77 153.83 34.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.09 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -113.0 119.58 38.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.777 -179.468 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 68' ' ' VAL . 56.0 t -111.22 126.6 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.21 0.529 . . . . 0.0 111.865 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.643 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 22.7 m-85 -105.45 101.15 10.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.094 178.146 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.28 -137.46 2.24 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.498 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.612 ' CE1' HD11 ' A' ' 36' ' ' ILE . 46.8 m-85 -122.99 159.26 28.71 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -86.43 -70.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t 170.97 -37.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.743 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -79.09 -27.62 43.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.997 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.765 HG21 ' O ' ' A' ' 37' ' ' MET . 3.4 mp -89.59 -42.14 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.854 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -153.32 154.62 34.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.9 157.91 32.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.776 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p 179.12 86.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -72.76 -34.95 48.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.285 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.02 -19.07 65.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.343 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 t -69.17 -62.41 1.39 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.83 0.348 . . . . 0.0 110.515 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -49.82 -36.34 26.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.741 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -62.28 -54.26 43.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.768 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.0 -45.98 85.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.258 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -50.0 -38.35 36.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.943 0.402 . . . . 0.0 110.299 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.801 ' O ' HG23 ' A' ' 26' ' ' VAL . 11.8 tpt180 -68.52 -31.44 70.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.957 179.26 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.8 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.1 tt -56.52 -55.65 31.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.956 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.681 HD23 ' HZ ' ' A' ' 86' ' ' PHE . 1.3 mt -60.28 -52.32 65.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.696 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.1 m -51.13 -41.37 60.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.621 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 22' ' ' ARG . 74.9 t -66.19 -31.99 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.74 -9.8 57.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.107 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.49 51.41 0.12 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.941 0.4 . . . . 0.0 110.52 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -132.04 133.69 24.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.211 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.599 ' O ' ' HA ' ' A' ' 1' ' ' MET . 57.8 Cg_endo -81.7 161.57 19.02 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.547 2.165 . . . . 0.0 111.215 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 5.3 p90 -161.45 171.45 18.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 111.544 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -133.13 126.25 31.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.826 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.485 ' HE1' HG11 ' A' ' 4' ' ' VAL . 10.7 t80 -89.79 158.22 17.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.466 HD12 ' CE1' ' A' ' 5' ' ' TYR . 24.1 mt -150.71 125.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.313 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -80.14 115.69 19.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.749 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.612 HD11 ' CE1' ' A' ' 7' ' ' TYR . 2.3 pp -79.6 -20.3 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.071 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.765 ' O ' HG21 ' A' ' 11' ' ' ILE . 1.9 ttp -124.22 85.76 54.89 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.146 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.94 -3.64 14.11 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.903 2.402 . . . . 0.0 112.429 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 37' ' ' MET . 9.2 tt0 -139.52 136.78 34.87 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.705 0.288 . . . . 0.0 110.732 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -64.27 -8.9 14.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.222 0.534 . . . . 0.0 112.131 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.47 -63.38 1.64 Allowed Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.93 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.79 146.79 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.645 0.259 . . . . 0.0 110.75 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -72.32 168.88 17.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 111.263 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.669 ' O ' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -86.22 119.92 27.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.465 -179.506 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 4.9 t0 -76.23 -19.7 58.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.099 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.8 -58.73 6.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.965 0.412 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HD3' HG21 ' A' ' 34' ' ' ILE . 6.8 mmpt? -64.39 -40.59 96.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.095 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.669 HD12 ' O ' ' A' ' 44' ' ' ASP . 46.4 mt -65.41 -32.34 57.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.564 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -60.23 -48.45 81.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.786 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.86 -37.44 82.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.376 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.5 tt -58.98 -57.67 12.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.751 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.576 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 77.0 mt -46.27 -43.75 15.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.803 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 m -70.95 -28.79 64.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' CD ' ' CD2' ' A' ' 69' ' ' PHE . 2.9 ttmm -65.19 -45.14 86.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.597 -179.326 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.5 mp -59.43 -63.98 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.98 0.419 . . . . 0.0 111.127 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.33 -113.54 0.31 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.134 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.41 29.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 111.029 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -121.37 -154.76 0.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.308 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 t -120.98 166.04 14.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.729 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.63 ' CD ' HD23 ' A' ' 63' ' ' LEU . 20.9 mt-30 -118.42 99.15 6.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 110.99 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mm -80.93 84.89 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.175 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.02 29.75 3.67 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.357 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.63 HD23 ' CD ' ' A' ' 60' ' ' GLN . 3.1 tm? -52.34 131.66 33.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 110.798 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.629 ' N ' HD13 ' A' ' 63' ' ' LEU . 3.0 p -116.84 152.7 33.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.227 0.537 . . . . 0.0 111.635 -179.425 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -117.14 158.57 44.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.449 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.5 Cg_endo -87.02 134.88 15.97 Favored 'Cis proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.197 -1.168 . . . . 0.0 112.762 0.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.42 ' CG ' ' NE2' ' A' ' 75' ' ' HIS . 1.9 tp60 -92.68 139.15 30.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.878 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 77' ' ' GLY . 3.7 t -108.12 157.54 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.59 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.425 ' N ' HG12 ' A' ' 68' ' ' VAL . 28.5 m-85 -144.15 141.32 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.557 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.66 148.4 26.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.637 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 12.8 Cg_exo -67.45 -14.04 41.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.902 2.401 . . . . 0.0 112.198 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.51 -21.54 14.73 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.148 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.78 88.54 0.83 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.674 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m 179.39 158.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.633 0.254 . . . . 0.0 110.743 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.42 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 8.4 t-160 -90.34 133.49 34.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.557 HD11 ' HA ' ' A' ' 70' ' ' ALA . 17.1 mt -116.97 -45.55 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.979 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.622 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 122.01 -152.17 16.87 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.026 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -95.68 -131.07 6.48 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.562 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.8 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -77.55 -70.15 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.653 0.227 . . . . 0.0 111.048 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -51.56 -50.76 59.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.366 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -55.96 -39.59 71.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.614 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.7 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.8 tt -78.42 -32.52 48.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.598 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.0 mmm-85 -51.48 -33.1 29.78 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.52 -35.0 78.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.156 178.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.8 t80 -63.54 -35.75 81.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.7 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -91.79 -9.88 41.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.559 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.0 mttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.972 179.975 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.605 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 9.4 ttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.95 0.405 . . . . 0.0 111.627 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.475 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 86.9 m-85 -62.47 155.7 24.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.641 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.767 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -128.22 121.41 29.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.116 -179.717 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.066 HG22 HG22 ' A' ' 68' ' ' VAL . 12.8 t -115.1 124.67 71.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.893 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.0 m-85 -103.99 104.38 14.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.445 ' O ' ' HE1' ' A' ' 12' ' ' HIS . . . -167.2 -132.23 1.37 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.394 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.894 ' HA ' ' ND1' ' A' ' 12' ' ' HIS . 93.9 m-85 -134.12 149.49 51.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.645 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 18.8 p-10 -156.47 -51.33 0.08 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.641 ' N ' ' HB3' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -52.84 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -177.938 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -47.98 81.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.442 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.481 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -86.65 22.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.601 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.894 ' ND1' ' HA ' ' A' ' 7' ' ' TYR 0.301 2.0 t-80 -149.0 77.74 1.38 Allowed 'General case' 0 N--CA 1.417 -2.103 0 C-N-CA 117.845 -1.542 . . . . 0.0 108.612 -171.98 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.782 ' HE2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -61.05 166.64 3.43 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.33 -1.759 . . . . 0.0 113.481 -177.522 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 31.5 p 169.96 111.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.342 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.782 HG13 ' HE2' ' A' ' 13' ' ' LYS . 2.2 m -91.77 -37.33 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.706 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -75.15 -19.03 60.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.574 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.9 t -60.42 -51.76 68.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.783 0.325 . . . . 0.0 110.621 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.89 -31.8 7.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.551 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -78.19 -57.2 3.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.825 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -56.45 -45.36 80.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -57.33 -52.09 66.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.368 . . . . 0.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.788 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.1 mtm180 -55.12 -42.22 72.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.079 179.469 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.824 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -57.51 -53.45 58.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.296 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.824 ' N ' HD23 ' A' ' 23' ' ' LEU . 10.1 mt -57.96 -46.88 84.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.873 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.3 m -55.59 -36.98 67.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.131 0.491 . . . . 0.0 109.865 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.6 t -79.28 -30.04 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.559 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HE3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -71.5 -12.14 61.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.105 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt 64.38 42.23 5.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.107 0.479 . . . . 0.0 110.169 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -122.75 129.04 25.17 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.146 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' O ' ' HA ' ' A' ' 1' ' ' MET . 88.2 Cg_endo -77.21 140.05 19.39 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.274 1.983 . . . . 0.0 110.987 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.605 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 18.5 p90 -155.51 170.49 21.85 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.311 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.467 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 7.5 tt0 -136.57 134.56 37.59 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.193 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.629 ' CE2' ' HB3' ' A' ' 8' ' ' ASP . 8.6 t80 -90.45 156.94 17.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.893 HD12 ' CE1' ' A' ' 5' ' ' TYR . 29.8 mt -133.29 120.07 37.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.582 0.706 . . . . 0.0 110.196 179.16 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.503 ' HA ' ' CE1' ' A' ' 12' ' ' HIS . 5.6 p-10 -99.62 118.13 35.49 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.568 -1.197 . . . . 0.0 112.718 -177.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.849 HG22 ' HB2' ' A' ' 47' ' ' LYS . 20.1 pt -101.42 67.99 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 178.757 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.713 ' HE2' ' HE2' ' A' ' 7' ' ' TYR . 2.3 mtm -168.15 85.26 0.73 Allowed Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 122.678 0.391 . . . . 0.0 111.283 177.502 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 59.5 Cg_endo -71.79 -12.93 29.22 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.04 1.827 . . . . 0.0 110.526 178.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -150.24 150.04 31.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.37 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -63.19 -6.9 4.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.343 0.592 . . . . 0.0 111.528 179.605 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.92 -56.76 3.42 Favored Glycine 0 C--N 1.313 -0.697 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.158 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 43' ' ' PHE . 20.2 t -150.63 157.54 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.188 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.559 ' HD1' ' HG3' ' A' ' 37' ' ' MET . 1.8 m-85 -59.91 170.27 1.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.867 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.43 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -86.49 98.69 11.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.776 179.447 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -49.52 -28.06 5.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.158 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -61.47 -56.4 20.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.379 . . . . 0.0 110.467 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.849 ' HB2' HG22 ' A' ' 36' ' ' ILE . 7.8 mttt -61.49 -46.04 91.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.331 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.01 -44.06 77.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.372 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.39 84.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.218 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -42.5 99.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.451 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -54.24 -46.0 72.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.468 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.2 mt -56.22 -50.74 70.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.969 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.0 m -63.16 -33.51 75.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.441 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -63.61 -39.53 94.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.457 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 mt -60.02 -54.19 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.678 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.92 -112.82 0.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.125 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.8 ttt85 -150.49 33.0 0.63 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.034 0.445 . . . . 0.0 110.689 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -120.73 -146.87 0.38 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.501 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 t -120.18 170.3 9.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.805 0.336 . . . . 0.0 110.645 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -107.05 101.45 10.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.653 0.74 . . . . 0.0 110.709 179.633 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -80.31 86.52 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.479 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.55 29.87 75.92 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 60' ' ' GLN . 1.1 mm? -43.74 153.39 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 p -123.45 168.53 12.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.162 0.506 . . . . 0.0 111.62 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.9 mmt -122.53 153.15 62.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.558 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.9 Cg_endo -84.96 159.74 65.77 Favored 'Cis proline' 0 N--CA 1.462 -0.374 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.94 0.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.42 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 5.7 tp60 -112.75 109.73 19.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.119 179.178 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.066 HG22 HG22 ' A' ' 4' ' ' VAL . 3.2 t -90.63 164.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.781 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 85.4 m-85 -142.52 146.41 34.66 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.671 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.778 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -58.32 148.55 63.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.436 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 51.0 Cg_exo -57.76 -29.92 87.43 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.104 2.536 . . . . 0.0 112.264 179.208 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -89.83 -26.88 20.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.426 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.11 89.23 0.62 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.754 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 m -176.53 164.77 2.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.468 0.175 . . . . 0.0 110.589 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.42 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 10.7 t-160 -90.93 119.92 31.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.004 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.778 HD11 ' HA ' ' A' ' 70' ' ' ALA . 32.2 mt -98.94 -49.3 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.667 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.28 -153.19 21.11 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.782 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.7 -138.02 9.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.541 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.502 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 46.7 t80 -70.21 -70.42 0.29 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.741 0.305 . . . . 0.0 110.978 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.7 -49.33 76.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -51.27 -39.23 56.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.578 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.741 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -78.52 -31.93 47.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.371 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -52.43 -30.71 30.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.5 -35.84 78.07 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' LEU . 32.0 t80 -60.04 -36.87 78.23 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.197 178.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.741 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.0 m-85 -89.17 -22.47 22.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.552 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.885 -179.877 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.845 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 23.0 tpp . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.604 -0.147 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 32' ' ' GLU . 97.2 m-85 -42.89 135.55 2.98 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.108 0.48 . . . . 0.0 110.53 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.26 124.09 50.32 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.622 -178.379 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.986 HG22 HG22 ' A' ' 68' ' ' VAL . 53.9 t -111.87 144.19 20.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.257 0.551 . . . . 0.0 111.4 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.797 ' CE1' HD12 ' A' ' 34' ' ' ILE . 7.9 m-85 -124.78 103.43 8.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.261 178.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.65 -141.28 3.08 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.248 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 32.3 m-85 -124.15 160.74 27.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.733 0.301 . . . . 0.0 110.601 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -103.11 29.32 5.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.417 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.2 p 65.97 9.83 6.47 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.305 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -87.12 -54.95 4.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 111.97 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 37' ' ' MET . 3.6 mp -94.22 -25.38 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.403 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 13.8 t60 -146.52 134.87 21.85 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.81 -178.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -61.57 129.62 41.99 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.2 -178.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.1 m -159.01 89.29 0.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.259 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.25 -37.84 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -55.89 -29.23 59.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 0.0 111.349 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 t -65.03 -60.69 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.229 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -56.93 -36.07 69.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.966 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -66.27 -38.39 87.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.444 -179.58 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.579 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -72.62 -35.85 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.319 . . . . 0.0 110.946 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 9.9 tttt -60.2 -34.9 74.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.024 0.44 . . . . 0.0 109.867 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -68.53 -39.65 81.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.959 179.317 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.1 tt -55.49 -52.84 62.33 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.891 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.732 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.9 mt -57.95 -37.36 74.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.227 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 m -60.72 -39.77 89.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.596 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 22' ' ' ARG . 58.6 t -74.86 -33.11 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.894 178.643 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -75.77 -9.48 58.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.761 179.252 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 58.86 37.25 24.84 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.275 0.56 . . . . 0.0 110.392 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.489 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 2.4 mm-40 -120.65 104.95 41.72 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.708 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.845 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 2.0 Cg_endo -45.23 168.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.682 2.255 . . . . 0.0 112.351 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.568 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 5.0 p90 -162.8 170.78 17.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.425 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.1 tm-20 -137.86 122.94 19.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.454 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.502 ' HE1' HG11 ' A' ' 4' ' ' VAL . 7.3 t80 -89.33 159.66 17.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.997 0.427 . . . . 0.0 111.68 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.797 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.8 mt -145.41 120.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.095 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -82.8 131.17 35.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.728 -178.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.716 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 5.2 pt -100.33 -28.16 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.024 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.776 ' O ' HD13 ' A' ' 11' ' ' ILE . 5.9 ttp -123.93 91.39 49.68 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.841 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.403 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 84.2 Cg_endo -81.02 3.44 7.8 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.841 2.361 . . . . 0.0 112.962 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -139.52 146.89 40.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.791 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.724 ' HA ' HG23 ' A' ' 11' ' ' ILE . 6.8 tmtt? -71.42 -7.76 49.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.285 0.564 . . . . 0.0 111.692 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.93 -60.62 1.25 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.048 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 t -147.0 144.1 20.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 112.041 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -64.21 169.37 4.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.973 179.723 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 1.3 t0 -98.57 116.34 30.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -57.89 -24.05 55.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.584 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -55.4 -48.82 73.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.848 0.356 . . . . 0.0 110.99 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -76.5 -36.96 57.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.061 0.458 . . . . 0.0 110.216 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.0 mm -58.1 -50.43 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.692 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -44.15 96.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.437 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.56 -37.89 89.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.373 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.436 HD13 ' CD2' ' A' ' 5' ' ' TYR . 25.4 tp -61.09 -54.23 47.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.563 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.3 mt -50.7 -42.66 57.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.8 m -65.55 -35.13 79.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.192 179.213 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 2.8 tttp -64.47 -39.96 94.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.304 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.71 HD11 ' CD1' ' A' ' 63' ' ' LEU . 1.3 mt -59.45 -45.34 91.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.526 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.05 -110.84 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.89 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -150.55 32.5 0.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.996 0.427 . . . . 0.0 110.621 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.89 -146.75 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.431 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -119.99 170.43 9.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.708 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.74 98.39 8.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.137 0.494 . . . . 0.0 110.562 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -81.08 86.53 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.15 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.19 29.23 72.15 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.272 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.71 ' CD1' HD11 ' A' ' 55' ' ' LEU . 7.7 tt -46.73 152.55 0.47 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.343 . . . . 0.0 111.347 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.407 ' N ' HD23 ' A' ' 63' ' ' LEU . 35.6 p -130.28 166.01 21.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.173 0.511 . . . . 0.0 111.683 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.411 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 1.3 mpt? -125.33 154.96 72.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.629 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.6 Cg_endo -83.86 143.46 44.05 Favored 'Cis proline' 0 C--N 1.344 0.333 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.916 0.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.9 OUTLIER -103.25 128.28 50.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 179.089 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.986 HG22 HG22 ' A' ' 4' ' ' VAL . 5.9 t -100.99 160.5 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 112.14 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 97.2 m-85 -143.7 159.29 42.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.416 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -70.12 144.6 92.81 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.141 -179.341 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -37.78 -31.96 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.487 2.792 . . . . 0.0 112.446 179.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.82 36.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.118 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.25 -109.49 1.85 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.955 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -127.37 -173.95 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.121 0.486 . . . . 0.0 111.335 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.483 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 35.5 t-80 -70.71 137.33 49.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.116 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.8 mp -109.65 -31.36 2.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.706 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 75' ' ' HIS . . . 117.95 -156.62 15.56 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.205 179.397 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.64 -124.61 5.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.147 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -80.09 -70.46 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.618 0.209 . . . . 0.0 111.299 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -52.29 -47.97 65.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.125 0.488 . . . . 0.0 110.6 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -57.66 -45.04 86.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.679 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.733 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.9 tt -74.31 -32.6 62.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.448 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 87' ' ' LYS . 5.9 ttp85 -52.59 -33.1 44.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -65.01 -33.65 76.55 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.12 178.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LEU . 17.3 t80 -64.72 -34.22 77.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.483 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.733 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.5 m-85 -90.8 -71.03 0.65 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.558 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 83' ' ' ARG . 37.6 mttt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.912 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.574 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 55.6 ttm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.818 0.342 . . . . 0.0 111.449 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 46.6 m-85 -55.23 155.0 5.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.067 0.46 . . . . 0.0 111.016 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -124.56 119.29 28.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.033 -179.37 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.839 HG22 HG22 ' A' ' 68' ' ' VAL . 24.4 t -114.44 127.1 72.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.203 0.525 . . . . 0.0 112.067 179.468 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.463 ' CE1' HD12 ' A' ' 34' ' ' ILE . 24.9 m-85 -109.28 104.58 13.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.103 177.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.17 -139.19 2.58 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.684 -179.25 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.693 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 64.3 m-85 -121.71 160.52 24.35 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.908 0.385 . . . . 0.0 111.344 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.79 -72.99 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.778 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t 172.97 -36.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.981 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -64.72 -44.96 88.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.229 -179.555 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.4 mm -90.16 -40.11 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.431 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -149.96 152.49 35.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.012 0.434 . . . . 0.0 111.15 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -80.66 169.84 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.895 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 p 173.88 117.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.06 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -87.05 -34.35 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -22.63 66.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.014 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.8 t -72.05 -64.51 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.796 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -50.18 -35.48 26.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 51.8 m-20 -72.13 -59.0 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.17 -31.3 63.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.859 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -61.11 -54.46 44.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.659 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.728 ' O ' HG23 ' A' ' 26' ' ' VAL . 12.1 tpp180 -66.5 -24.65 66.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.025 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.555 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.3 tt -59.86 -58.18 9.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 110.501 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.644 HD12 ' CG ' ' A' ' 31' ' ' PHE . 5.5 mt -60.38 -42.76 96.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.795 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.5 m -60.96 -41.08 95.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.49 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 22' ' ' ARG . 71.1 t -73.68 -26.74 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.032 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.656 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 1.5 tpmp? -68.46 -44.35 75.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.79 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 112.71 30.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.331 1.052 . . . . 0.0 110.997 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -125.74 141.86 40.45 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.857 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.419 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.3 Cg_endo -80.35 143.43 15.54 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.531 2.154 . . . . 0.0 111.669 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.644 ' CG ' HD12 ' A' ' 24' ' ' LEU . 33.9 p90 -145.87 167.8 22.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.947 0.403 . . . . 0.0 111.973 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.66 126.13 26.82 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.579 ' CE1' HG11 ' A' ' 4' ' ' VAL . 24.7 t80 -89.94 155.73 18.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.23 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.62 HG21 ' HG2' ' A' ' 47' ' ' LYS . 10.1 mt -150.51 122.63 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.399 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -78.1 110.17 12.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.639 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.693 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.6 pt -62.87 -21.15 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.72 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.1 ttp -128.05 88.6 52.54 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.03 1.25 8.87 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.638 2.225 . . . . 0.0 112.569 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -139.46 139.29 36.99 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.513 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -66.94 -8.53 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.269 0.557 . . . . 0.0 111.895 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.3 -63.54 1.5 Allowed Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.429 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 t -145.9 143.78 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.717 0.294 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -65.6 168.2 7.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 111.235 -179.851 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.9 118.06 30.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.178 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 10.6 m-20 -71.43 -14.05 62.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.96 -61.07 2.51 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.62 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -64.77 -41.42 95.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.193 179.515 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.8 mt -64.53 -33.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.57 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -58.28 -47.87 82.25 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.712 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.95 -38.11 84.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.349 179.52 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.636 HD13 ' CE1' ' A' ' 69' ' ' PHE . 5.5 tp -57.96 -52.3 66.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.538 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.8 mt -51.45 -44.41 62.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.101 0.477 . . . . 0.0 111.278 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 m -63.27 -35.59 80.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.484 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.49 -40.34 89.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.657 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 51' ' ' LEU . 1.3 mt -59.94 -67.73 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.642 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.19 -107.02 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.033 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -150.45 31.42 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.004 0.43 . . . . 0.0 110.704 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.91 -149.44 0.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.353 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -120.53 170.19 9.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.755 0.312 . . . . 0.0 110.855 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -89.82 99.04 12.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.253 0.549 . . . . 0.0 110.309 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -78.22 88.02 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.039 -179.76 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.3 29.89 31.15 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.685 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.781 HD12 ' OE1' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -46.57 156.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 110.999 -179.961 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.8 p -105.62 147.87 27.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.101 0.477 . . . . 0.0 111.614 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.4 mmt -119.53 153.23 53.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.4 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HB2' HG13 ' A' ' 4' ' ' VAL . 2.8 Cg_exo -78.82 148.8 83.75 Favored 'Cis proline' 0 C--N 1.344 0.298 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.948 0.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.781 ' OE1' HD12 ' A' ' 63' ' ' LEU . 2.1 tp60 -96.0 129.58 43.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.819 178.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.839 HG22 HG22 ' A' ' 4' ' ' VAL . 3.6 t -107.79 157.04 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.055 0.455 . . . . 0.0 111.947 -179.053 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.636 ' CE1' HD13 ' A' ' 51' ' ' LEU . 40.9 m-85 -143.01 137.29 29.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.646 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' CA ' HD11 ' A' ' 76' ' ' ILE . . . -47.08 160.85 0.32 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.376 -178.639 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.3 Cg_exo -60.24 -30.54 91.43 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.175 2.583 . . . . 0.0 112.12 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -94.3 -19.73 20.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.188 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.85 88.72 1.3 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.597 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.52 126.74 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.802 0.334 . . . . 0.0 110.686 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.422 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 5.1 t-160 -62.47 114.06 3.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.158 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.516 HD11 ' CA ' ' A' ' 70' ' ' ALA . 8.7 mt -104.67 -39.88 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.764 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.98 -153.93 21.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.571 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.1 -135.8 9.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.651 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.555 ' CE1' HD12 ' A' ' 23' ' ' LEU . 13.4 t80 -71.62 -70.87 0.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 111.129 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.99 -47.16 86.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.71 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -52.38 -41.25 62.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.633 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.615 HD21 ' CE2' ' A' ' 86' ' ' PHE . 4.9 tt -75.87 -35.25 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 87' ' ' LYS . 7.8 ttp180 -51.14 -30.0 15.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -71.46 -34.3 70.09 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.142 178.231 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 82' ' ' LEU . 53.6 t80 -62.89 -35.55 80.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.35 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.615 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.8 m-85 -89.1 -27.62 20.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.454 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 83' ' ' ARG . 21.0 mtpp . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.955 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.677 ' HG2' ' C ' ' A' ' 30' ' ' PRO . 2.0 tpt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.391 0.138 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 89.0 m-85 -40.07 119.78 1.07 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.749 0.785 . . . . 0.0 111.613 -177.385 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.35 126.51 35.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.295 -179.102 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.551 HG11 ' CE1' ' A' ' 33' ' ' PHE . 59.3 t -109.2 148.21 13.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.392 0.615 . . . . 0.0 111.186 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.666 ' CE1' HD12 ' A' ' 34' ' ' ILE . 46.6 m-85 -128.05 99.77 5.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.737 178.613 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.63 -137.21 2.24 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.727 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.816 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 59.0 m-85 -121.24 108.02 13.25 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.669 0.271 . . . . 0.0 111.373 -179.042 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.524 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -110.94 51.0 0.79 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.003 179.816 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.44 -169.8 1.13 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -87.17 8.72 22.63 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.327 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 37' ' ' MET . 3.7 pt -86.59 -14.0 10.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.459 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 3.4 t60 -162.61 153.79 17.59 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.139 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -79.02 171.57 15.03 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.8 p -165.04 89.54 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.728 0.299 . . . . 0.0 111.069 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.9 m -91.49 -40.7 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.606 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.07 -23.27 64.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.654 -179.233 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.61 -47.03 80.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.23 -32.69 64.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -73.87 -55.65 5.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.682 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.19 -51.11 71.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 110.837 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -55.03 -47.16 75.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 179.69 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.801 ' O ' HG23 ' A' ' 26' ' ' VAL . 20.9 tpp180 -61.62 -40.5 95.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.028 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' C ' HD23 ' A' ' 23' ' ' LEU . 6.2 tt -56.56 -53.48 57.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.999 179.032 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.498 HD23 ' CZ ' ' A' ' 86' ' ' PHE . 10.3 mt -59.55 -44.54 93.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.411 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 m -57.67 -40.87 80.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 22' ' ' ARG . 50.8 t -75.31 -33.42 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.483 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' O ' ' NE2' ' A' ' 29' ' ' GLN . 1.9 mmtt -75.59 -12.11 60.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.929 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' O ' ' NE2' ' A' ' 29' ' ' GLN . 0.2 OUTLIER 69.8 41.72 1.15 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.849 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 28' ' ' LYS . 1.5 mp0 -132.15 118.07 16.1 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.407 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.677 ' C ' ' HG2' ' A' ' 1' ' ' MET . 77.8 Cg_exo -52.31 -177.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.308 2.005 . . . . 0.0 111.565 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE2' ' HE3' ' A' ' 21' ' ' LYS . 5.0 p90 -164.92 170.84 14.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.921 0.391 . . . . 0.0 111.367 178.012 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 34.7 tt0 -141.66 121.0 13.12 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.028 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.551 ' CE1' HG11 ' A' ' 4' ' ' VAL . 10.7 t80 -92.32 165.86 12.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.115 0.483 . . . . 0.0 112.078 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.666 HD12 ' CE1' ' A' ' 5' ' ' TYR . 25.4 mt -150.65 128.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.184 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.11 125.92 32.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.8 -178.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.414 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.9 pt -100.78 -25.11 3.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.718 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.795 ' HB3' HD12 ' A' ' 11' ' ' ILE . 2.3 ttm -108.91 105.19 56.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.012 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 37.5 Cg_endo -66.11 -29.65 47.74 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 121.769 1.646 . . . . 0.0 110.244 178.6 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -146.15 155.94 43.07 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.212 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -6.57 6.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.33 0.586 . . . . 0.0 111.568 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.34 -55.36 2.91 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 115.11 -0.95 . . . . 0.0 114.009 -178.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 t -148.2 135.87 14.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.951 0.376 . . . . 0.0 111.754 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -59.83 168.72 1.66 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.875 179.785 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.55 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -89.05 129.72 35.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.483 -179.907 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.37 -35.16 79.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.855 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -66.68 -50.9 61.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -68.32 -41.32 80.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.858 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.3 mp -66.62 -35.19 74.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.661 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.01 -57.95 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.307 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -55.93 -29.62 60.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.984 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.851 ' O ' HD12 ' A' ' 55' ' ' LEU . 24.4 tp -61.44 -61.16 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.078 179.449 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.617 ' HA ' HD13 ' A' ' 55' ' ' LEU . 86.2 mt -46.28 -35.73 5.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.692 179.442 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 m -69.29 -34.26 74.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.831 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 7.5 mtpp -68.36 -43.49 77.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.818 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.851 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -58.6 -20.26 45.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.418 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.11 -29.45 7.57 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.765 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -89.88 -174.82 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -108.43 -31.8 7.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -109.85 169.96 8.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -112.87 99.94 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -74.57 82.75 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.162 -179.913 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.59 23.77 55.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.646 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.477 HD12 ' NE2' ' A' ' 67' ' ' GLN . 1.1 mm? -64.78 140.77 58.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.3 p -131.95 170.69 14.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.107 0.479 . . . . 0.0 111.474 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -104.09 155.5 37.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.664 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.4 Cg_exo -82.14 135.58 29.17 Favored 'Cis proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.678 0.463 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.477 ' NE2' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.99 128.37 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.18 179.187 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.0 t -102.88 157.11 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.015 0.436 . . . . 0.0 111.669 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 78.3 m-85 -143.09 147.21 34.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.775 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.625 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.16 140.9 70.24 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.37 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.85 -31.99 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.005 2.47 . . . . 0.0 112.115 179.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.43 34.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.932 179.46 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.87 -108.1 2.01 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.998 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.9 t -133.96 175.44 9.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.266 0.555 . . . . 0.0 111.511 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -59.32 129.26 41.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.019 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.625 HD11 ' HA ' ' A' ' 70' ' ' ALA . 9.3 mt -102.09 -42.14 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.977 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.54 -153.3 20.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.757 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.09 -142.4 13.27 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.379 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -69.43 -70.62 0.27 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 110.811 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -58.79 -48.73 80.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.517 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.74 -42.54 62.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.451 179.597 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.75 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.6 tt -79.77 -28.73 40.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.028 179.471 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -51.38 -32.6 26.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.93 -35.25 80.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.162 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.6 t80 -63.14 -34.07 76.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.354 178.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.75 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.7 m-85 -93.09 -12.43 30.52 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.589 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.97 179.92 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.601 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 36.5 ttm . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.877 0.37 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 68.8 m-85 -58.62 163.98 2.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.833 -179.555 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.723 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -138.67 119.27 13.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.684 -179.305 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.943 HG22 HG22 ' A' ' 68' ' ' VAL . 24.0 t -108.54 147.91 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.239 0.542 . . . . 0.0 111.508 179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.697 ' CE1' HD12 ' A' ' 34' ' ' ILE . 27.9 m-85 -130.87 101.55 5.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.466 178.677 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.62 -136.5 2.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.57 -179.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -108.27 157.26 18.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.846 0.355 . . . . 0.0 111.304 -179.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 9' ' ' SER . 20.3 t0 -85.14 -4.66 59.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.979 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 86.28 -36.63 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.955 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -75.33 -33.79 61.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.691 0.281 . . . . 0.0 111.089 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 37' ' ' MET . 1.5 mt -89.79 -32.14 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.337 -179.779 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -141.24 132.03 25.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 110.621 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 151.25 41.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.573 -179.189 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 168.96 91.04 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.836 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.2 m -57.43 -37.05 55.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.53 -23.43 50.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -65.05 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.499 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.06 -34.97 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -60.88 -46.97 88.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.896 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -60.54 -43.44 97.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.294 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -53.98 -36.89 63.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.004 0.431 . . . . 0.0 110.132 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.768 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.3 tpp180 -70.18 -28.54 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.204 179.137 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.866 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -57.42 -55.96 27.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.927 179.414 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.646 HD21 HD21 ' A' ' 82' ' ' LEU . 24.8 mt -64.2 -42.54 96.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.578 179.459 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.8 m -58.59 -34.35 71.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.205 179.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 22' ' ' ARG . 72.0 t -76.8 -31.25 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.616 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HG3' ' CD1' ' A' ' 86' ' ' PHE . 15.0 mmtt -76.07 -19.59 58.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.195 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.76 60.38 0.11 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -139.76 142.45 31.27 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.953 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' HA ' ' A' ' 1' ' ' MET . 87.4 Cg_endo -75.91 137.31 19.61 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.405 2.07 . . . . 0.0 111.405 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.601 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 20.0 p90 -151.91 170.33 20.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -138.38 129.43 27.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.545 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.638 ' CE1' HG11 ' A' ' 4' ' ' VAL . 49.0 t80 -89.94 160.02 16.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.054 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.697 HD12 ' CE1' ' A' ' 5' ' ' TYR . 15.3 mt -145.57 121.43 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.295 0.569 . . . . 0.0 110.274 179.29 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -91.27 121.36 32.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.157 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.444 HD12 ' HD2' ' A' ' 43' ' ' PHE . 3.6 pt -80.64 -4.4 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.057 179.51 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.585 ' O ' HD12 ' A' ' 11' ' ' ILE . 36.9 ttm -132.85 110.97 13.28 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.778 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.42 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 71.9 Cg_endo -76.91 -30.73 4.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.552 2.168 . . . . 0.0 112.474 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 37' ' ' MET . 8.3 tp10 -139.69 155.33 47.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.639 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -64.54 -8.03 12.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.296 0.57 . . . . 0.0 111.524 179.966 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.41 -52.21 4.6 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 115.177 -0.919 . . . . 0.0 113.193 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 43' ' ' PHE . 22.9 t -149.24 153.4 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.105 0.479 . . . . 0.0 112.235 -179.188 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.74 ' HB3' HD11 ' A' ' 48' ' ' ILE . 62.4 m-85 -73.74 168.72 18.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.124 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.42 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -99.71 111.62 23.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.891 179.345 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -62.48 -26.57 68.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.747 0.308 . . . . 0.0 110.556 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.32 -56.05 19.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -36.68 81.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.302 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.74 HD11 ' HB3' ' A' ' 43' ' ' PHE . 34.5 mt -67.27 -38.18 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.35 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.44 -56.07 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.273 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.31 -28.89 56.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.866 ' O ' HD12 ' A' ' 55' ' ' LEU . 26.0 tp -62.96 -60.85 2.9 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.212 179.519 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.4 mt -45.54 -39.42 7.43 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.207 0.527 . . . . 0.0 111.288 179.229 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.8 m -67.11 -36.12 81.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.001 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HG2' ' CD2' ' A' ' 69' ' ' PHE . 7.9 tttp -63.22 -50.28 70.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.333 179.383 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 51' ' ' LEU . 5.0 mp -58.92 -55.05 40.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.68 -126.39 0.9 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.376 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -150.4 33.23 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.991 0.424 . . . . 0.0 110.861 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -120.74 -144.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 t -105.06 170.06 8.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.72 0.295 . . . . 0.0 110.624 179.705 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.69 98.31 11.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.299 0.571 . . . . 0.0 110.546 179.841 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.4 mt -80.37 86.41 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.07 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.23 30.31 75.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.039 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.444 HD11 HE22 ' A' ' 67' ' ' GLN . 7.5 tt -48.03 151.32 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 111.512 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 p -142.26 170.18 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.39 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -132.13 149.76 74.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.648 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -85.59 149.36 47.05 Favored 'Cis proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.758 0.354 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.444 HE22 HD11 ' A' ' 63' ' ' LEU . 8.1 mt-30 -114.44 133.99 55.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.451 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.943 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -105.88 168.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.302 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 78.8 m-85 -142.33 146.11 34.66 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -57.16 138.3 80.2 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.235 -178.828 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.472 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 87.1 Cg_exo -46.17 -28.4 5.47 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.878 2.385 . . . . 0.0 111.902 178.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.91 33.55 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.91 179.578 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.92 -108.89 1.76 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.934 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.431 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -145.36 179.36 7.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.29 0.566 . . . . 0.0 111.421 -179.537 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.41 ' CE1' ' OE1' ' A' ' 67' ' ' GLN . 16.3 t-160 -49.76 118.79 3.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.355 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.551 HG23 ' CD2' ' A' ' 85' ' ' TYR . 6.7 mt -84.83 -47.51 17.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.891 0.376 . . . . 0.0 111.076 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.83 -152.36 18.02 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.493 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -93.37 -155.3 31.82 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.405 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.866 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -61.61 -67.76 0.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 O-C-N 122.83 -0.218 . . . . 0.0 110.859 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -48.39 -42.18 31.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.068 0.461 . . . . 0.0 110.541 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -67.37 -42.32 83.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.417 179.604 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.646 HD21 HD21 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -66.71 -45.83 77.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.316 179.726 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -51.13 -36.61 41.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.653 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -70.29 -34.95 73.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.233 178.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.551 ' CD2' HG23 ' A' ' 76' ' ' ILE . 65.0 t80 -66.54 -30.61 70.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.751 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.601 ' CE2' HD21 ' A' ' 82' ' ' LEU . 24.8 m-85 -90.9 -66.72 0.9 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.69 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.2 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.617 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.3 ttm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.897 0.38 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.473 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 87.4 m-85 -64.4 156.34 29.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.011 0.434 . . . . 0.0 110.689 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.663 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.58 120.22 22.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.561 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 68' ' ' VAL . 21.1 t -108.62 137.38 40.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.18 0.514 . . . . 0.0 111.755 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.791 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.5 m-85 -115.73 101.08 8.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.927 178.488 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -160.25 -138.19 2.39 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.286 -179.277 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.409 ' CG ' ' HB3' ' A' ' 12' ' ' HIS . 41.7 m-85 -126.22 157.11 39.09 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.647 0.261 . . . . 0.0 111.039 -179.407 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.01 -69.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.807 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 t 170.87 -39.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.813 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -76.77 -24.74 52.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.844 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.667 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.0 mp -90.82 -43.62 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.153 0.501 . . . . 0.0 110.17 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.409 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 6.5 t-80 -152.18 147.21 26.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.131 179.318 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.55 159.14 26.99 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.239 -179.382 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -177.06 106.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.585 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.92 -36.65 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.697 -179.433 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -62.87 -21.22 65.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.495 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.6 t -64.54 -52.84 55.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.955 0.407 . . . . 0.0 110.571 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -55.55 -32.46 63.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.323 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -72.34 -53.76 11.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.224 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.4 -48.6 74.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.982 0.42 . . . . 0.0 111.139 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -51.15 71.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -56.78 -42.19 78.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.2 tt -57.5 -54.67 44.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.394 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.782 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.6 mt -55.38 -44.97 76.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.771 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.1 m -58.36 -34.62 70.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.133 0.492 . . . . 0.0 110.059 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 22' ' ' ARG . 48.0 t -79.84 -30.18 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.734 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.533 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 2.1 mmtt -79.17 -14.38 59.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 66.31 60.81 0.61 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.999 0.428 . . . . 0.0 110.804 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -133.62 143.1 46.37 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' O ' ' HA ' ' A' ' 1' ' ' MET . 75.8 Cg_endo -80.17 132.86 9.55 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.606 2.204 . . . . 0.0 111.445 179.209 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.617 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 29.1 p90 -155.18 170.43 21.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.921 0.391 . . . . 0.0 112.012 -179.682 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -144.84 145.72 31.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.058 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.494 ' CE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.29 158.44 17.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.099 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.791 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.8 mt -142.28 117.66 5.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.213 179.352 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -81.33 119.44 23.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.54 -179.053 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 6' ' ' GLY . 10.5 tt -85.86 -27.86 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.193 179.103 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 7.4 ttp -129.93 95.86 27.5 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 179.418 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -78.14 -5.06 14.88 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.563 2.175 . . . . 0.0 112.691 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -139.9 139.89 36.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.755 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.91 -8.63 23.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.237 0.542 . . . . 0.0 111.989 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.16 -61.68 1.8 Allowed Glycine 0 C--N 1.312 -0.787 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.228 179.614 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.52 133.01 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.735 0.302 . . . . 0.0 111.094 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.03 167.59 1.6 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.01 0.433 . . . . 0.0 111.29 -179.804 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.45 108.79 18.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.102 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -53.09 -25.89 14.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.163 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -55.83 -49.94 71.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.773 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -74.98 -34.45 62.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.125 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.459 ' CD1' HD11 ' A' ' 36' ' ' ILE . 30.0 mm -59.82 -49.92 82.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.775 179.628 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.55 -50.61 72.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.488 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.23 -41.05 98.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.353 179.44 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.501 HD22 ' HD2' ' A' ' 5' ' ' TYR . 6.2 tp -57.07 -49.61 75.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.75 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.76 -49.89 69.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.086 0.47 . . . . 0.0 111.153 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.4 m -60.98 -33.19 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.272 179.214 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -64.29 -41.36 96.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.354 179.505 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.5 mt -59.84 -56.11 25.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.567 179.392 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.96 -109.03 0.27 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.953 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -150.65 30.89 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.414 . . . . 0.0 110.698 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -121.03 -148.84 0.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.377 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 t -120.62 170.32 9.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 0.0 110.687 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -98.09 98.85 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.041 0.448 . . . . 0.0 110.471 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -80.25 85.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.242 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.64 27.89 55.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.444 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.534 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.1 mm? -47.41 154.27 0.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.829 0.347 . . . . 0.0 111.01 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.3 p -113.84 157.94 21.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.089 0.471 . . . . 0.0 111.636 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -120.84 158.15 52.9 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HB2' HG13 ' A' ' 4' ' ' VAL . 5.8 Cg_exo -82.18 148.58 69.11 Favored 'Cis proline' 0 C--N 1.343 0.253 0 C-N-CA 124.017 -1.243 . . . . 0.0 112.887 0.469 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.534 ' CD ' HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -105.07 125.6 51.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.167 179.023 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -97.25 167.98 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.878 0.37 . . . . 0.0 111.607 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.536 ' H ' HG12 ' A' ' 68' ' ' VAL . 75.7 m-85 -142.63 141.45 31.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.74 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB3' ' N ' ' A' ' 74' ' ' SER . . . -54.66 147.64 29.69 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.13 -178.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.497 ' HB3' ' N ' ' A' ' 1' ' ' MET . 51.6 Cg_exo -54.57 -27.81 52.37 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.804 2.336 . . . . 0.0 111.813 179.099 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -97.69 -22.32 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.014 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.16 82.82 0.6 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.63 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.497 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -168.78 115.66 0.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.727 0.299 . . . . 0.0 110.853 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -50.71 116.71 2.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.177 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.534 HG23 ' CD2' ' A' ' 85' ' ' TYR . 3.6 mt -88.82 -41.02 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.59 -150.09 17.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.633 -179.654 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.48 -140.12 9.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.399 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -75.84 -61.24 1.99 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.59 -42.72 67.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.24 -44.36 92.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.636 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.587 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -59.43 -49.0 79.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.464 179.831 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 ttt-85 -52.34 -32.44 38.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -75.06 -32.34 61.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.162 178.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.534 ' CD2' HG23 ' A' ' 76' ' ' ILE . 56.6 t80 -67.22 -32.2 73.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.357 178.473 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.587 ' HE2' HD21 ' A' ' 82' ' ' LEU . 26.1 m-85 -93.34 -70.47 0.7 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.504 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.923 179.983 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.565 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 58.1 ttm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.99 0.424 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.501 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 93.0 m-85 -53.17 152.51 4.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.039 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -126.92 120.44 29.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.954 -179.15 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.937 HG22 HG22 ' A' ' 68' ' ' VAL . 27.3 t -111.01 138.03 40.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 0.0 111.438 179.467 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.809 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.8 m-85 -114.73 99.03 7.21 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.128 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.76 -138.36 2.48 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.237 -0.983 . . . . 0.0 112.561 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.654 ' CE2' ' HE3' ' A' ' 37' ' ' MET . 17.6 m-85 -118.91 148.45 42.92 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.592 0.234 . . . . 0.0 110.674 -179.191 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.3 t0 -78.36 7.09 7.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.824 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.2 m 80.97 -15.78 0.71 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -85.93 -47.82 9.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 111.788 -179.61 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.86 -15.34 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.971 -179.298 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.479 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 3.5 t60 -150.76 163.33 38.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.997 -178.23 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.06 157.84 23.98 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.062 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 176.84 108.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.92 0.39 . . . . 0.0 111.94 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.9 m -91.75 -28.97 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.391 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -71.44 -22.17 61.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.224 -178.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 p -67.26 -34.47 77.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.058 0.456 . . . . 0.0 110.45 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -56.27 12.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.59 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -49.77 72.1 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.392 -179.248 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.72 -45.19 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 111.038 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -64.74 -50.37 67.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.803 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.749 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -55.18 -39.3 69.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 -179.94 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.679 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.5 tt -57.76 -54.28 48.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.451 179.762 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.8 mt -56.89 -44.94 82.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.2 m -59.24 -39.53 83.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.097 0.475 . . . . 0.0 110.171 179.486 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 22' ' ' ARG . 58.9 t -76.08 -32.63 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.66 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -76.56 -9.74 58.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.048 179.787 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 67.45 61.17 0.46 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.931 0.396 . . . . 0.0 110.778 -179.791 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -140.76 138.73 18.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.175 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' A' ' 1' ' ' MET . 52.4 Cg_endo -83.05 142.09 10.81 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.685 2.257 . . . . 0.0 111.499 179.249 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.565 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 49.7 p90 -153.1 170.27 20.9 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.66 140.64 35.01 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.094 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.464 ' CE1' HG11 ' A' ' 4' ' ' VAL . 11.1 t80 -89.73 161.57 15.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.349 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.809 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.9 mt -147.4 120.65 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.198 179.459 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -95.71 131.21 42.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.536 -179.178 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -100.46 -24.54 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.912 179.411 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.654 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 21.9 ttm -114.5 82.0 7.35 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.755 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.403 ' CG ' ' HB2' ' A' ' 44' ' ' ASP . 91.6 Cg_endo -81.53 7.81 4.79 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.715 2.276 . . . . 0.0 112.527 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -139.37 129.9 25.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.353 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -59.79 -8.28 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.183 0.516 . . . . 0.0 112.04 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.77 -71.52 1.04 Allowed Glycine 0 C--N 1.314 -0.657 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.374 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.07 133.95 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -67.69 165.65 16.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.011 0.434 . . . . 0.0 111.46 -179.637 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 28.5 t0 -81.28 124.89 29.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.346 -179.482 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.536 ' HA ' HD12 ' A' ' 48' ' ' ILE . 1.0 OUTLIER -75.28 -24.89 57.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.199 179.865 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.0 -51.35 68.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.85 0.357 . . . . 0.0 110.616 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -71.05 -39.23 72.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.119 179.169 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 45' ' ' ASP . 62.9 mt -58.29 -37.87 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.551 179.399 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.56 -49.68 70.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.49 -40.64 97.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.419 179.562 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.47 HD13 ' CD2' ' A' ' 5' ' ' TYR . 11.4 tp -58.13 -51.19 70.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.707 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.6 mt -51.99 -46.64 64.95 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.132 0.492 . . . . 0.0 111.167 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -65.92 -32.97 74.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.105 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -63.43 -42.02 98.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.379 179.492 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 mt -59.81 -69.85 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.074 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.0 -35.14 0.29 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.554 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -109.41 -166.48 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.333 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -109.48 -30.4 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -90.23 164.44 14.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.798 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -117.97 100.26 7.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.98 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.7 tp -78.96 83.92 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.091 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.99 25.63 56.9 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.571 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 1.6 mm? -54.26 137.05 42.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.939 0.399 . . . . 0.0 110.889 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.5 p -122.03 170.29 9.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 111.448 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.67 157.9 64.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.709 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HB2' HG13 ' A' ' 4' ' ' VAL . 2.1 Cg_endo -85.25 149.81 50.29 Favored 'Cis proline' 0 N--CA 1.463 -0.304 0 C-N-CA 124.093 -1.211 . . . . 0.0 112.681 0.275 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.576 ' HB3' ' HE1' ' A' ' 75' ' ' HIS . 22.2 mm-40 -109.75 127.88 54.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.113 179.046 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.937 HG22 HG22 ' A' ' 4' ' ' VAL . 2.7 t -98.85 165.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.958 0.408 . . . . 0.0 111.672 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.555 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 84.5 m-85 -142.3 142.49 32.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.781 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.817 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -52.37 137.23 40.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.254 -178.625 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.45 ' HB3' ' N ' ' A' ' 1' ' ' MET . 98.5 Cg_exo -44.36 -29.89 3.37 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.08 2.52 . . . . 0.0 112.265 179.106 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.38 36.25 0.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.248 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.26 -109.29 1.12 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.837 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.452 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 55.9 p -135.86 176.11 8.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.021 0.438 . . . . 0.0 111.2 -179.613 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.576 ' HE1' ' HB3' ' A' ' 67' ' ' GLN . 86.5 t60 -52.37 125.72 16.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.285 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.817 HD11 ' HA ' ' A' ' 70' ' ' ALA . 19.0 mt -91.23 -45.3 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.0 -151.09 19.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.747 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.93 -136.72 7.83 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.61 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -77.17 -63.12 1.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 111.123 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -53.65 -45.68 70.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.902 0.382 . . . . 0.0 110.84 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -45.28 85.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.539 179.673 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.708 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -59.31 -47.81 83.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.702 179.917 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -52.38 -33.32 42.83 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.072 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.73 66.7 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.338 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.473 ' CD1' HG23 ' A' ' 76' ' ' ILE . 54.9 t80 -66.11 -33.94 76.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.404 178.462 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.708 ' HE2' HD21 ' A' ' 82' ' ' LEU . 18.7 m-85 -90.02 -26.95 20.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.428 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.194 -0.907 . . . . 0.0 110.857 -179.904 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.585 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 21.2 ttm . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.831 0.348 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.51 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 92.4 m-85 -60.04 148.57 35.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.621 -179.654 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -125.36 118.13 25.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 -179.378 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.703 HG22 HG22 ' A' ' 68' ' ' VAL . 70.7 t -108.82 144.6 16.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.179 0.514 . . . . 0.0 111.387 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.878 ' CE1' HD12 ' A' ' 34' ' ' ILE . 6.8 m-85 -124.98 99.49 6.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.051 178.201 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.74 -149.14 5.7 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.891 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.423 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 63.3 m-85 -105.95 152.23 23.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.754 0.311 . . . . 0.0 111.273 -179.857 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.5 p30 -72.32 -63.12 1.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.576 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.4 p 160.2 -32.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.046 0.45 . . . . 0.0 110.849 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -85.13 -22.82 28.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.467 -179.35 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.453 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 9.6 mt -88.42 -38.7 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.603 0.239 . . . . 0.0 110.949 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -147.75 141.56 25.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 111.154 179.243 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 140.23 58.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.192 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 173.8 106.38 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.222 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 m -85.72 -25.65 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.399 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.27 -34.76 72.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.396 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -67.05 -42.73 84.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.71 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -24.83 68.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.971 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 87.9 m-20 -78.12 -53.59 7.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.234 -179.634 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 79' ' ' PHE . . . -53.43 -45.2 69.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.968 0.413 . . . . 0.0 110.942 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -51.49 69.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.807 179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.705 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.8 ttp180 -57.8 -39.26 77.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.669 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -56.63 -53.09 61.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.354 179.385 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.782 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.7 mt -56.33 -46.17 80.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.597 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -55.75 -36.62 67.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.053 0.454 . . . . 0.0 109.825 179.208 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 22' ' ' ARG . 43.2 t -80.11 -30.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.491 179.114 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HB3' ' NE2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -76.23 -13.49 60.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.046 179.61 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.26 59.85 0.51 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.99 0.424 . . . . 0.0 111.079 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.507 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -140.48 140.41 22.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.037 179.828 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.488 ' O ' ' HA ' ' A' ' 1' ' ' MET . 71.7 Cg_endo -79.84 137.87 12.85 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.557 2.171 . . . . 0.0 111.376 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.585 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 13.2 p90 -154.89 170.28 22.06 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -138.8 129.87 26.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.972 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.598 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.2 t80 -92.62 122.34 34.94 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.901 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.878 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.7 mt -104.43 109.8 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.629 0.728 . . . . 0.0 110.469 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -81.6 118.93 23.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.253 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.593 HG22 ' HB3' ' A' ' 47' ' ' LYS . 20.3 pt -100.21 45.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.356 179.574 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.508 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.4 ttt -162.72 99.79 1.07 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.075 -179.659 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 56.3 Cg_endo -71.19 -33.14 11.91 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.265 1.976 . . . . 0.0 111.719 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.91 157.86 45.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.349 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 11' ' ' ILE . 4.8 mttt -64.96 -8.46 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.301 0.572 . . . . 0.0 111.453 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.68 -56.73 2.06 Favored Glycine 0 C--N 1.313 -0.721 0 CA-C-N 115.201 -0.908 . . . . 0.0 113.557 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.3 144.84 29.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.629 ' HB3' HD11 ' A' ' 48' ' ' ILE . 13.5 m-85 -71.08 170.65 12.43 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.153 179.438 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -95.15 115.84 27.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.753 179.151 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -56.72 -28.23 60.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.23 -52.87 62.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HB3' HG22 ' A' ' 36' ' ' ILE . 27.3 mmtp -70.78 -47.87 57.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.81 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 43' ' ' PHE . 1.8 mp -55.78 -48.71 77.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.62 96.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.521 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.78 -35.25 79.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.617 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 tp -58.71 -54.55 45.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.533 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.414 ' N ' HD23 ' A' ' 52' ' ' LEU . 7.8 mt -53.56 -46.27 70.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.175 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 m -62.47 -32.1 72.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.386 179.309 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -69.67 -36.41 76.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.472 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.68 -61.16 2.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.555 179.434 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.5 -105.82 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.993 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -146.1 30.14 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.077 0.465 . . . . 0.0 110.547 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -120.91 -153.65 0.55 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.544 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 t -120.84 170.61 9.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.3 98.38 8.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.55 . . . . 0.0 110.282 179.627 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.0 mm -79.71 84.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.191 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.6 25.11 57.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.463 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.571 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -61.12 143.26 55.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.785 179.861 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.4 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 71.4 p -121.69 153.21 38.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.277 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.0 mmt -102.65 153.97 37.81 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.495 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.2 Cg_exo -77.7 141.33 66.8 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.022 0.526 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.571 ' CD ' HD12 ' A' ' 63' ' ' LEU . 35.5 mt-30 -99.31 122.4 42.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.488 179.223 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.703 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -96.5 165.76 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.897 0.38 . . . . 0.0 111.67 -179.483 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 72.2 m-85 -142.8 142.29 31.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.742 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.07 134.45 58.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.163 -178.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.536 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 98.0 Cg_exo -44.68 -29.41 3.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.912 2.408 . . . . 0.0 112.116 178.853 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -163.74 42.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.256 179.784 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.08 -107.93 0.7 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.741 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.47 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -137.58 176.13 8.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.154 0.502 . . . . 0.0 111.27 -179.646 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 68' ' ' VAL . 38.1 t-80 -52.51 123.2 10.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.178 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.636 HD11 ' HA ' ' A' ' 70' ' ' ALA . 13.5 mt -85.8 -44.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.09 -151.22 20.19 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 -179.433 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.51 -155.11 30.23 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.74 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 10.5 t80 -63.14 -70.58 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 110.835 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -57.53 -44.9 85.47 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.501 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.09 -31.62 31.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.379 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.72 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.6 tt -80.78 -34.98 33.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.269 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttp85 -52.16 -30.44 26.8 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.512 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -68.72 -35.22 76.86 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.514 -0.766 . . . . 0.0 108.974 178.067 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.459 ' CD2' HG23 ' A' ' 76' ' ' ILE . 28.2 t80 -62.54 -34.62 77.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.274 178.329 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.72 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -87.61 -70.28 0.64 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.348 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.914 -179.939 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.571 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 58.5 ttm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.947 0.403 . . . . 0.0 111.469 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.511 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 64.2 m-85 -49.75 170.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.87 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -145.3 114.57 7.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.661 -179.341 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.991 HG22 HG22 ' A' ' 68' ' ' VAL . 61.7 t -107.63 143.16 18.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.296 0.569 . . . . 0.0 112.04 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.827 ' CE1' HD12 ' A' ' 34' ' ' ILE . 7.3 m-85 -121.71 105.64 10.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.623 177.927 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.47 -135.3 1.86 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.75 -179.198 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.45 ' HE1' ' HE2' ' A' ' 37' ' ' MET . 67.6 m-85 -110.45 150.49 28.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.88 0.371 . . . . 0.0 111.274 -179.33 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.32 6.94 46.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.229 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p 78.46 -8.86 1.6 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -85.2 -40.09 17.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.629 0.252 . . . . 0.0 111.301 -179.614 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.657 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.4 mp -99.02 -38.25 6.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.847 0.356 . . . . 0.0 111.676 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.442 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 4.4 t-80 -139.8 152.0 46.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.493 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 162.8 28.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.078 0.466 . . . . 0.0 112.067 -178.746 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -178.62 117.18 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.127 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 m -89.61 -34.59 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.992 0.425 . . . . 0.0 110.949 179.72 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -60.48 -23.25 64.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.333 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.52 -40.65 56.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.917 0.389 . . . . 0.0 110.42 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -63.88 -51.72 63.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.472 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 6.2 p30 -66.91 -49.0 66.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.163 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -53.5 -43.72 68.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.933 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -65.33 -58.44 5.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.796 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.799 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.4 ttm-85 -55.51 -40.19 71.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.523 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.97 -54.02 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.407 179.305 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.803 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.2 mt -56.29 -42.37 77.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.548 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -60.13 -36.5 77.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.86 179.255 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 22' ' ' ARG . 40.1 t -79.67 -31.12 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.563 179.381 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -9.72 58.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.025 179.544 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm 67.89 60.82 0.43 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.148 0.499 . . . . 0.0 110.657 -179.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -146.44 132.55 9.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.978 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.4 Cg_endo -78.35 147.75 23.22 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.436 2.09 . . . . 0.0 111.134 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.571 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 12.7 p90 -157.33 170.9 21.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.607 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 1.7 tp10 -140.74 135.02 31.12 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.983 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.481 ' CE1' HG11 ' A' ' 4' ' ' VAL . 28.4 t80 -89.47 164.26 14.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.221 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.827 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.0 mt -147.28 119.59 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.398 179.527 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -95.8 133.19 40.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.277 -179.332 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 37' ' ' MET . 2.0 pp -100.24 -13.96 8.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.219 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.821 ' N ' HD12 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -122.65 75.55 45.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.464 179.967 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 77.8 Cg_endo -88.24 37.46 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.078 2.519 . . . . 0.0 112.926 -179.473 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -139.0 170.74 15.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.486 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -61.52 -7.99 3.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.22 0.533 . . . . 0.0 112.046 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.29 55.37 0.02 OUTLIER Glycine 0 C--N 1.314 -0.669 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.758 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -150.31 118.93 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.23 0.538 . . . . 0.0 111.838 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.89 137.25 57.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.358 178.901 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 1.8 t70 -95.04 105.53 17.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.098 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.11 -21.52 32.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.663 -179.715 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.0 -51.27 70.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.677 0.275 . . . . 0.0 111.045 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.739 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -72.91 -41.15 64.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.386 179.618 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 44' ' ' ASP . 2.5 mp -59.83 -40.3 82.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.328 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.87 -48.52 71.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.235 179.468 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -39.28 93.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.439 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.486 HD21 ' NE2' ' A' ' 67' ' ' GLN . 28.2 tp -58.06 -50.65 72.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.613 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 52' ' ' LEU . 78.6 mt -51.26 -45.08 61.94 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.145 0.498 . . . . 0.0 111.11 179.458 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.5 m -66.48 -31.16 71.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.134 179.157 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.81 -31.72 70.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.31 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.46 -70.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.87 179.482 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.02 -30.18 0.99 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.173 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -105.57 -174.97 2.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.691 0.282 . . . . 0.0 110.831 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -101.35 -30.65 11.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.102 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -104.43 166.05 10.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.998 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -117.26 100.32 7.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.688 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 pt -75.54 82.7 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.456 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.7 20.08 77.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.928 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.45 132.65 44.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 110.754 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 65' ' ' MET . 1.0 OUTLIER -131.09 170.22 14.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.067 0.46 . . . . 0.0 111.429 -179.669 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.485 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -105.5 157.36 34.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.772 179.767 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.7 Cg_exo -76.82 152.77 95.74 Favored 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.977 -1.26 . . . . 0.0 112.98 0.467 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.486 ' NE2' HD21 ' A' ' 51' ' ' LEU . 5.0 mt-30 -118.62 116.18 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.314 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.991 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -93.18 165.55 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.658 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 76.6 m-85 -143.2 148.15 36.02 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.697 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -58.22 144.73 76.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.182 -178.882 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.543 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 66.7 Cg_exo -54.62 -27.87 53.14 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.059 2.506 . . . . 0.0 112.434 179.351 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -90.78 -32.01 16.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.379 -179.516 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.37 80.89 0.17 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.798 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.74 164.09 21.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -90.54 118.42 29.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.144 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.665 HG21 HD23 ' A' ' 82' ' ' LEU . 21.3 mt -96.21 -46.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.031 0.443 . . . . 0.0 110.726 179.59 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.9 -147.9 17.56 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.022 -179.132 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.82 -161.9 36.74 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.207 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.551 ' HE1' HD13 ' A' ' 23' ' ' LEU . 35.0 t80 -69.53 -49.59 52.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.405 179.734 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -55.76 -49.0 74.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.628 179.633 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -31.81 73.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.483 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.763 HD11 ' CE2' ' A' ' 86' ' ' PHE . 2.7 tm? -73.93 -42.54 60.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.653 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.6 ttt-85 -56.08 -43.92 78.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.678 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG2' ' HD2' ' A' ' 87' ' ' LYS . 22.4 tt0 -61.84 -38.79 89.51 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.189 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.479 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -60.56 -40.28 91.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.89 177.795 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.763 ' CE2' HD11 ' A' ' 82' ' ' LEU . 3.9 m-30 -82.07 -10.12 59.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.141 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.404 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.152 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.612 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 34.6 ttm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.412 ' CD2' ' HD3' ' A' ' 71' ' ' PRO . 95.9 m-85 -78.11 143.9 36.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.461 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.72 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -104.94 118.9 37.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.444 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.682 HG22 HG22 ' A' ' 68' ' ' VAL . 5.9 t -101.66 117.32 46.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.083 0.468 . . . . 0.0 111.146 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.734 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.7 m-30 -92.6 98.76 11.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.616 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' C ' ' CD1' ' A' ' 7' ' ' TYR . . . -160.57 -140.21 2.84 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.747 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.697 ' HE2' ' HE3' ' A' ' 37' ' ' MET . 5.4 m-85 -131.82 134.24 45.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 120.735 0.302 . . . . 0.0 111.539 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -128.39 62.36 1.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.102 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -172.78 -172.1 0.84 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.163 0.506 . . . . 0.0 111.845 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.13 2.18 47.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.885 HG21 ' O ' ' A' ' 39' ' ' GLU . 0.8 OUTLIER -87.37 -4.02 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.989 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.691 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 11.1 t-80 -169.98 145.09 2.84 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.929 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.89 168.72 18.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.024 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -177.88 110.59 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.295 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 16' ' ' TYR . 27.7 m -90.58 -46.02 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.49 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.509 ' N ' HG23 ' A' ' 15' ' ' VAL . 24.2 m-85 -62.17 -22.27 65.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.032 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.0 t -63.07 -41.13 99.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.798 0.332 . . . . 0.0 111.038 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -62.0 -54.5 40.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.437 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 4.7 p30 -69.45 -51.66 34.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.398 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.82 -36.44 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.341 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -62.12 -57.83 10.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.472 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.768 ' O ' HG23 ' A' ' 26' ' ' VAL . 18.2 ttt180 -65.18 -23.79 67.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.817 HD12 ' CE1' ' A' ' 79' ' ' PHE . 5.5 tt -58.54 -58.7 7.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.085 0.469 . . . . 0.0 110.386 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.906 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 9.5 mt -63.23 -39.2 93.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.68 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.9 m -62.92 -39.51 94.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.436 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.0 t -65.78 -45.95 90.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.688 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -12.17 61.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.237 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.93 52.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.896 0.379 . . . . 0.0 111.274 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -136.74 138.17 25.55 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.752 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 1' ' ' MET . 63.1 Cg_endo -80.7 159.82 21.78 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.589 2.193 . . . . 0.0 111.775 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.61 ' CG ' HD12 ' A' ' 24' ' ' LEU . 30.3 p90 -161.63 170.75 19.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.842 0.353 . . . . 0.0 111.559 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.96 135.21 35.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.724 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 8.7 t80 -89.61 158.51 17.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.308 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.734 HD12 ' CE1' ' A' ' 5' ' ' TYR . 13.3 mt -147.69 121.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.212 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -89.61 127.34 35.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.297 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.655 HD11 ' OH ' ' A' ' 7' ' ' TYR . 5.0 pt -99.56 22.39 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.047 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.697 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -155.7 77.39 4.69 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.791 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.29 22.13 0.78 Allowed 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.825 2.35 . . . . 0.0 113.026 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.885 ' O ' HG21 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -147.74 157.65 43.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.587 0.232 . . . . 0.0 111.134 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.825 ' HA ' HG23 ' A' ' 11' ' ' ILE . 6.0 ptmt -47.4 -8.87 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' GLU . . . 176.21 46.69 0.06 OUTLIER Glycine 0 C--N 1.308 -0.988 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.553 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 t -150.13 120.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.516 . . . . 0.0 111.849 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.613 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -68.64 170.29 9.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.358 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.626 ' O ' HD13 ' A' ' 48' ' ' ILE . 6.3 t70 -95.1 105.77 17.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.372 . . . . 0.0 110.862 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -56.27 -29.18 60.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.88 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.46 -56.0 11.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 111.329 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HD3' HG21 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -69.66 -43.19 73.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.939 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.626 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.5 mp -52.01 -47.22 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.741 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.69 -54.81 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.16 -30.56 71.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.518 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.5 tt -59.22 -53.33 59.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.528 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 48' ' ' ILE . 14.2 mt -54.25 -50.44 67.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.041 0.448 . . . . 0.0 111.103 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.0 m -60.85 -36.59 79.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.367 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -66.47 -39.09 88.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.794 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.441 HD21 ' CD2' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -59.58 -52.5 65.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.096 0.474 . . . . 0.0 110.347 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.68 -114.42 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.89 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -150.48 30.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.102 0.477 . . . . 0.0 110.671 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -121.08 -143.62 0.34 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.467 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -119.55 170.34 9.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.734 0.302 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.65 98.11 8.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.253 0.549 . . . . 0.0 110.636 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 61' ' ' ILE . 6.4 tp -80.5 85.51 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.864 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.27 29.67 69.3 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.988 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.531 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.2 tm? -44.97 119.4 1.97 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.38 . . . . 0.0 111.172 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.2 p -110.09 170.27 8.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.251 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 154.01 61.01 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.939 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.1 Cg_endo -86.64 152.51 45.56 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 124.258 -1.143 . . . . 0.0 112.406 0.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -117.91 113.06 21.16 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -83.34 163.06 3.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.131 0.491 . . . . 0.0 111.902 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 50.9 m-85 -142.52 141.57 32.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.335 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.654 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.2 132.44 51.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.614 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HB3' ' N ' ' A' ' 1' ' ' MET . 33.7 Cg_exo -53.48 -21.88 19.82 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.56 2.173 . . . . 0.0 111.795 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -161.61 41.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.29 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.95 -110.72 0.63 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.998 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.515 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 37.1 m -137.85 178.62 6.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.136 0.493 . . . . 0.0 111.274 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 37.9 t-80 -55.75 132.36 49.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.116 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' HA ' ' A' ' 70' ' ' ALA . 9.4 mt -100.98 -42.65 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.05 -154.95 22.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.028 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.13 -141.39 10.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.843 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.817 ' CE1' HD12 ' A' ' 23' ' ' LEU . 26.5 t80 -72.42 -70.64 0.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.767 0.317 . . . . 0.0 111.332 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -56.93 -49.53 75.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 110.663 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -53.11 -37.64 61.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.706 HD21 ' CE1' ' A' ' 86' ' ' PHE . 5.4 tt -77.82 -34.49 51.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.212 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 -51.98 -31.37 29.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -68.8 -32.43 72.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.286 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 26.3 t80 -68.43 -29.99 68.77 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.589 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.906 ' CZ ' HD22 ' A' ' 24' ' ' LEU . 22.6 m-85 -92.33 -25.49 18.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.416 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.2 mttt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.793 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.545 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 34.2 ttp . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.902 0.382 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.464 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 65.0 m-85 -50.05 169.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.785 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -143.28 117.48 9.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.496 -178.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 68' ' ' VAL . 77.1 t -108.88 144.64 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.201 0.524 . . . . 0.0 111.535 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.759 ' CE1' HD12 ' A' ' 34' ' ' ILE . 10.9 m-85 -125.47 99.95 6.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.196 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.36 -137.46 2.22 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.257 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.08 159.34 20.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.738 0.304 . . . . 0.0 110.905 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -84.73 -73.7 0.42 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p 167.83 -33.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 110.638 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -85.12 -23.15 28.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.493 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.594 HG23 ' O ' ' A' ' 39' ' ' GLU . 4.1 mp -91.73 -44.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.222 0.534 . . . . 0.0 110.733 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -150.08 139.8 21.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.004 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.82 146.0 43.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.276 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.98 112.12 0.64 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.322 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 m -90.56 -30.74 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.451 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -65.02 -27.28 68.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.51 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.1 t -56.8 -53.86 52.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.352 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.16 -35.62 64.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.176 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -72.92 -58.96 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.989 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.12 -37.69 64.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.213 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -59.5 -54.27 48.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.691 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.85 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.4 tpp180 -66.33 -28.87 69.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.049 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.706 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.6 tt -54.57 -53.71 50.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.477 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.687 HD12 ' CG ' ' A' ' 31' ' ' PHE . 4.7 mt -65.18 -40.76 94.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.536 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 m -61.8 -34.02 75.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.329 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 22' ' ' ARG . 96.9 t -74.13 -28.51 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.01 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -83.45 -12.57 56.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.293 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.49 55.95 0.08 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -142.19 142.39 24.14 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.449 ' O ' ' HA ' ' A' ' 1' ' ' MET . 98.5 Cg_endo -79.09 148.54 21.73 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.485 2.123 . . . . 0.0 111.323 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.687 ' CG ' HD12 ' A' ' 24' ' ' LEU . 36.8 p90 -156.74 170.64 21.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' OE2' ' HE1' ' A' ' 1' ' ' MET . 1.4 tt0 -141.68 134.92 29.33 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.026 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.49 ' HE1' HG11 ' A' ' 4' ' ' VAL . 30.3 t80 -89.68 161.97 15.83 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.093 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.759 HD12 ' CE1' ' A' ' 5' ' ' TYR . 17.0 mt -147.22 121.4 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.602 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -99.45 131.77 45.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.938 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.672 HD12 ' HD1' ' A' ' 43' ' ' PHE . 1.1 pp -96.82 7.19 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.763 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.48 ' HE2' ' CE1' ' A' ' 43' ' ' PHE . 1.5 tpp -140.62 69.41 31.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.705 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 3.8 Cg_exo -80.96 43.65 1.59 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.296 2.664 . . . . 0.0 112.899 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.594 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -144.18 170.36 16.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.57 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.5 tptt -66.41 -7.69 20.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.199 0.523 . . . . 0.0 111.975 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.49 50.0 0.02 OUTLIER Glycine 0 C--N 1.313 -0.739 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.667 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -150.48 120.2 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.213 0.53 . . . . 0.0 111.818 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HD1' HD12 ' A' ' 36' ' ' ILE . 65.0 m-85 -65.61 136.61 56.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.157 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.588 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -97.83 113.76 25.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.831 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -63.37 -17.27 62.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.46 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -62.3 -57.29 11.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.862 0.363 . . . . 0.0 110.646 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -72.13 -39.29 68.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.206 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 43' ' ' PHE . 23.6 mt -60.48 -48.46 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.26 96.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.375 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.01 -37.63 88.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.323 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.449 HD13 ' CD2' ' A' ' 5' ' ' TYR . 26.7 tp -59.3 -51.9 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.6 -47.46 70.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.093 0.473 . . . . 0.0 111.192 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.0 m -62.63 -32.25 73.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.42 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 2.8 mmmt -67.71 -34.98 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.491 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.83 -39.15 84.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.466 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.5 -105.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.865 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -150.33 31.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.041 0.448 . . . . 0.0 110.636 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.01 -147.19 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.445 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 t -120.21 170.29 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 0.0 110.668 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.15 98.24 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 110.405 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mt -80.2 84.21 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.201 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.29 24.89 53.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.639 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.62 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -58.71 143.12 47.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 110.685 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -124.07 168.12 13.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 111.444 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.6 mtm -110.67 154.55 43.13 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.732 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.3 Cg_exo -79.27 140.65 58.2 Favored 'Cis proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.749 -1.355 . . . . 0.0 112.759 0.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.62 ' CD ' HD12 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -97.02 114.69 26.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.031 179.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 4' ' ' VAL . 6.5 t -95.71 160.27 2.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.996 0.427 . . . . 0.0 111.73 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 92.5 m-85 -142.44 153.44 43.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.723 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.956 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -61.62 147.35 88.74 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.271 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 1' ' ' MET . 64.2 Cg_exo -55.17 -23.89 38.65 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.293 2.662 . . . . 0.0 112.507 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -99.06 -29.0 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.397 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 132.26 93.83 0.58 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.756 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.85 159.85 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -90.2 125.55 35.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.017 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.956 HD11 ' HB2' ' A' ' 70' ' ' ALA . 3.1 mp -117.05 -27.28 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.488 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 120.14 -157.62 15.62 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.939 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.5 -140.65 11.56 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.675 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.706 ' CE1' HD12 ' A' ' 23' ' ' LEU . 24.4 t80 -65.96 -70.58 0.23 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.823 0.344 . . . . 0.0 111.145 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.19 -49.99 75.11 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.826 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.404 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 5.2 tt0 -51.09 -43.09 61.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.438 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.613 HD21 ' CD2' ' A' ' 86' ' ' PHE . 4.7 tt -74.76 -34.07 62.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.107 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.4 ttp180 -51.84 -28.62 16.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.14 -32.62 70.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.0 t80 -67.45 -32.02 72.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.67 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.613 ' CD2' HD21 ' A' ' 82' ' ' LEU . 10.2 m-85 -96.71 -70.61 0.71 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.651 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 83' ' ' ARG . 9.5 mmtp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.676 ' HG3' ' HA ' ' A' ' 31' ' ' PHE . 1.1 tpp . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.769 0.319 . . . . 0.0 111.687 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.492 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 65.8 m-85 -58.83 166.28 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.344 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -140.86 117.57 10.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.022 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.944 HG22 HG22 ' A' ' 68' ' ' VAL . 39.0 t -107.5 147.43 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.223 0.535 . . . . 0.0 111.48 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.715 ' CE1' HD12 ' A' ' 34' ' ' ILE . 14.8 m-85 -129.64 101.19 5.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.289 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.71 -138.67 2.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.174 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.649 ' HE2' ' HE3' ' A' ' 37' ' ' MET . 16.3 m-85 -116.03 158.56 22.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.619 0.247 . . . . 0.0 110.706 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -74.23 -69.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.689 0.28 . . . . 0.0 111.462 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 166.31 -38.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.038 0.447 . . . . 0.0 110.179 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -85.29 -22.82 28.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.623 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.615 HD12 ' N ' ' A' ' 11' ' ' ILE . 3.4 mp -89.65 -42.77 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.25 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.513 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 12.2 t-80 -144.3 158.34 43.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.795 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 17.4 ptmt -80.6 144.96 31.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.963 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 p -174.3 117.75 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.307 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.14 -32.08 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -67.01 -24.61 66.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.42 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -65.79 -61.09 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 110.439 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -26.01 63.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.913 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 28.4 m-20 -78.66 -60.04 2.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.193 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.01 -45.97 71.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.172 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -58.19 -52.53 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.567 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.805 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.3 ttt85 -61.01 -40.76 94.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.576 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.77 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.1 tt -57.55 -53.82 53.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.416 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.77 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.6 mt -55.77 -46.72 77.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.732 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.1 m -56.77 -37.08 70.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.14 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' ARG . 43.4 t -77.83 -31.08 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.656 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -9.68 58.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.15 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt 68.13 53.36 0.63 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.947 0.403 . . . . 0.0 110.69 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -133.23 136.38 27.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.108 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 54.1 Cg_endo -81.29 137.14 10.41 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.547 2.165 . . . . 0.0 110.837 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.676 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 42.3 p90 -153.6 170.1 21.65 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.684 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -136.43 132.87 36.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.568 ' CE1' HG11 ' A' ' 4' ' ' VAL . 34.7 t80 -89.67 160.84 16.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.715 HD12 ' CE1' ' A' ' 5' ' ' TYR . 18.4 mt -146.63 121.14 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.323 0.582 . . . . 0.0 110.517 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -90.51 121.82 32.79 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.897 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 2.5 pt -91.45 -6.65 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.337 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.649 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 22.4 ttm -118.57 99.88 51.35 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.661 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.8 Cg_endo -76.16 -27.5 8.15 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.477 2.118 . . . . 0.0 111.768 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -140.28 150.14 43.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.217 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -64.38 -8.37 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.355 0.598 . . . . 0.0 111.801 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.51 -56.55 3.13 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.685 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.73 147.18 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.8 ' HB2' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -66.45 168.75 8.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.606 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.466 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 41.6 t0 -91.37 122.11 33.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -66.6 -26.5 67.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.886 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.02 -56.25 23.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.476 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -64.41 -44.24 91.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.136 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.8 HD11 ' HB2' ' A' ' 43' ' ' PHE . 42.9 mt -55.79 -42.95 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.392 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.74 -47.87 76.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.728 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.12 -36.56 82.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.335 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.926 ' O ' HD12 ' A' ' 55' ' ' LEU . 34.2 tp -63.05 -60.29 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.445 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.59 ' HA ' HD13 ' A' ' 55' ' ' LEU . 88.0 mt -44.91 -41.91 7.6 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.261 0.553 . . . . 0.0 111.747 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.9 m -69.03 -30.33 68.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.406 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 51' ' ' LEU . 4.4 tttp -69.05 -44.28 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.836 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.926 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -59.1 -67.09 0.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.381 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.77 -31.55 0.14 Allowed Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.901 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -135.69 -169.99 2.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.323 . . . . 0.0 110.919 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -103.63 20.18 18.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.231 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 t -120.09 165.68 14.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.826 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -128.98 100.69 5.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.008 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.5 mt -80.29 84.28 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.012 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.62 27.56 55.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.162 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.513 HD11 ' CD2' ' A' ' 55' ' ' LEU . 1.5 mm? -55.42 143.18 29.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.995 0.426 . . . . 0.0 111.238 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 152.58 45.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.3 mmt -108.75 148.92 38.76 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.727 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.3 Cg_exo -80.53 148.0 76.02 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 124.026 -1.239 . . . . 0.0 112.952 0.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 5' ' ' TYR . 6.7 tp60 -104.38 126.24 51.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.384 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.944 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -103.01 166.39 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.74 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 81.1 m-85 -142.53 153.03 43.22 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -65.11 149.71 96.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.264 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.675 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 40.9 Cg_exo -59.97 -25.76 80.48 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.026 2.484 . . . . 0.0 112.196 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.16 -25.95 17.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.246 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.4 91.11 0.84 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.658 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -179.17 161.21 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.791 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.419 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 10.5 t-160 -85.6 126.67 34.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 70' ' ' ALA . 18.6 mt -101.21 -45.42 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.033 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.39 -152.42 18.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.912 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.25 -146.38 12.0 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.859 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 19.3 t80 -72.27 -70.98 0.31 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.672 0.272 . . . . 0.0 111.327 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -55.84 -44.46 78.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.158 0.504 . . . . 0.0 110.508 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -52.54 -40.75 62.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.995 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.701 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.0 tt -73.63 -32.09 63.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.284 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.0 mmm-85 -51.81 -35.11 43.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.34 -34.57 78.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.3 t80 -61.82 -35.36 78.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.07 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.701 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.7 m-85 -91.51 -9.7 43.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.07 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.1 pttp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.964 179.831 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 8.2 ttm . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.1 144.54 38.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.097 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.68 118.81 37.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.333 -178.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.643 HG12 ' CE1' ' A' ' 33' ' ' PHE . 55.0 t -104.73 142.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.184 0.516 . . . . 0.0 111.042 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.875 ' CE1' HD12 ' A' ' 34' ' ' ILE . 9.8 m-85 -121.27 99.15 6.32 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.41 ' HA2' ' HG2' ' A' ' 65' ' ' MET . . . -159.08 -151.99 6.3 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.848 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.874 ' CE1' HD11 ' A' ' 36' ' ' ILE . 60.7 m-85 -102.74 125.12 49.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.754 0.311 . . . . 0.0 111.318 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.508 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 6.1 t0 -137.1 65.36 1.5 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.634 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.36 -171.62 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.144 0.497 . . . . 0.0 111.631 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.85 -2.61 58.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.96 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.16 -13.22 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.955 0.407 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.711 ' CG ' ' CD1' ' A' ' 7' ' ' TYR . 42.9 t-80 -165.59 141.02 5.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -80.78 174.97 11.09 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.11 92.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.932 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -79.28 -32.25 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.719 0.295 . . . . 0.0 111.445 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -63.91 -26.67 68.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.447 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -59.31 -42.08 90.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 110.329 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.39 -43.42 67.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.771 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -76.99 -55.21 5.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.846 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.57 -41.92 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.003 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -59.65 -53.74 54.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.589 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.786 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.2 ttt85 -64.76 -28.65 69.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.841 HD12 ' CE1' ' A' ' 79' ' ' PHE . 2.0 tt -60.05 -59.8 4.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.397 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.549 HD12 ' CG ' ' A' ' 31' ' ' PHE . 7.1 mt -58.52 -40.29 82.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.433 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.4 m -60.44 -38.06 82.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.878 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 22' ' ' ARG . 96.3 t -78.84 -30.28 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.627 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -70.13 -15.73 63.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.917 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 76.13 45.59 0.11 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.935 0.398 . . . . 0.0 111.0 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -144.01 137.62 14.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.023 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.603 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.6 Cg_endo -75.24 162.94 35.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.491 2.127 . . . . 0.0 111.117 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.549 ' CG ' HD12 ' A' ' 24' ' ' LEU . 53.9 p90 -161.72 171.03 18.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.458 ' OE2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -139.38 125.4 19.86 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.36 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.643 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.4 t80 -90.74 124.97 35.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.361 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.875 HD12 ' CE1' ' A' ' 5' ' ' TYR . 8.0 mt -106.48 114.22 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.477 0.656 . . . . 0.0 110.526 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -82.52 144.62 30.28 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.383 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.874 HD11 ' CE1' ' A' ' 7' ' ' TYR . 2.6 pt -100.89 -12.7 8.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.666 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 19.1 ttm -124.81 107.76 28.64 Favored Pre-proline 0 C--N 1.334 -0.089 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 44' ' ' ASP . 95.6 Cg_endo -79.96 -28.05 3.46 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.353 2.035 . . . . 0.0 110.927 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 37' ' ' MET . 0.4 OUTLIER -146.62 151.09 36.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.231 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -8.52 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.225 0.536 . . . . 0.0 111.99 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 -54.56 4.5 Favored Glycine 0 C--N 1.311 -0.86 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.126 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -150.87 134.16 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -56.99 170.14 0.46 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -87.1 106.19 17.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.658 0.266 . . . . 0.0 111.7 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.73 -27.48 59.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -59.03 -53.4 58.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.88 0.371 . . . . 0.0 110.581 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.729 ' HG2' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -70.01 -40.66 75.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.03 179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 44' ' ' ASP . 44.9 mm -58.13 -45.94 88.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.69 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.51 -56.58 11.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.296 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -60.62 -30.66 69.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.919 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -58.24 -53.26 60.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.572 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.6 mt -54.28 -46.58 72.76 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 111.204 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.8 m -63.86 -34.12 77.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.227 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HE3' ' CG ' ' A' ' 69' ' ' PHE . 2.0 mmmt -65.77 -36.93 84.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.438 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.33 -42.98 96.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.489 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.75 -107.31 0.31 Allowed Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.751 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -150.55 26.78 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.074 0.464 . . . . 0.0 110.834 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -121.67 -153.71 0.56 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.31 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -120.88 161.18 21.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.477 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.418 ' NE2' ' HG ' ' A' ' 63' ' ' LEU . 7.8 pt20 -115.04 98.75 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 110.785 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.559 ' H ' HD12 ' A' ' 61' ' ' ILE . 3.8 mp -81.63 87.72 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.557 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.07 33.37 5.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.412 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.754 HD13 ' N ' ' A' ' 64' ' ' THR . 2.1 tm? -44.56 130.71 6.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.759 0.314 . . . . 0.0 110.904 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.754 ' N ' HD13 ' A' ' 63' ' ' LEU . 4.6 m -112.33 148.3 34.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.082 0.467 . . . . 0.0 111.551 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.517 ' SD ' HD12 ' A' ' 63' ' ' LEU . 3.5 mpp? -119.65 155.72 54.33 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.791 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.8 Cg_exo -80.53 137.55 40.78 Favored 'Cis proline' 0 C--N 1.344 0.327 0 C-N-CA 123.861 -1.308 . . . . 0.0 112.858 0.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.5 tp60 -99.78 118.32 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.172 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.591 HG22 HG22 ' A' ' 4' ' ' VAL . 4.3 t -93.44 161.53 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.328 0.585 . . . . 0.0 112.145 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 86.2 m-85 -143.2 152.31 41.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.99 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.601 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -65.47 143.56 98.72 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.78 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HB3' ' N ' ' A' ' 1' ' ' MET . 21.8 Cg_exo -61.63 -17.48 54.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.354 2.036 . . . . 0.0 111.988 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -103.19 -25.91 13.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.862 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.48 86.21 0.49 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.697 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.433 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER 179.58 118.97 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 110.823 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.417 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 8.3 t-160 -55.53 131.79 47.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.3 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 70' ' ' ALA . 2.0 mp -116.76 -31.94 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 117.62 -161.13 13.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.718 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -90.31 -147.99 19.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.028 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.841 ' CE1' HD12 ' A' ' 23' ' ' LEU . 46.5 t80 -69.54 -53.84 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.347 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -57.82 -49.51 76.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.758 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -64.73 -36.08 83.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.734 HD12 HD13 ' A' ' 23' ' ' LEU . 1.4 tm? -66.02 -44.13 85.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.348 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.428 ' HG2' HD11 ' A' ' 23' ' ' LEU . 3.2 mmm-85 -54.42 -37.92 65.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.38 -37.17 74.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -62.07 -35.44 78.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.127 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.623 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.2 m-85 -86.52 -26.76 24.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.217 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.1 mttt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.86 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.566 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.3 ttp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.843 0.354 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.483 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 94.7 m-85 -59.26 160.83 6.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.669 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.9 mppp? -135.72 118.08 15.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.198 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.901 HG22 HG22 ' A' ' 68' ' ' VAL . 19.4 t -108.53 141.13 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.183 0.515 . . . . 0.0 111.926 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.846 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.6 m-85 -121.68 105.34 10.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.249 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.38 -139.0 2.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.392 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.42 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 38.7 m-85 -109.91 153.35 24.62 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.4 t70 -82.22 -2.63 53.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 2.3 p 81.82 -22.85 0.24 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.984 0.421 . . . . 0.0 110.921 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -75.71 -35.29 60.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.9 0.381 . . . . 0.0 111.124 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 11' ' ' ILE . 9.8 mm -104.6 -7.02 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -176.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.518 ' HD2' ' HE3' ' A' ' 37' ' ' MET . 1.3 t-80 -166.64 108.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -176.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -39.39 134.23 1.24 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.5 m -166.23 109.23 0.76 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.401 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 m -87.0 -29.71 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 110.732 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -58.12 -30.7 66.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.596 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.5 m -61.73 -55.0 34.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 110.059 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -53.56 -31.64 47.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.248 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.24 -59.68 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.19 -42.01 69.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.296 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -62.12 -57.79 10.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.471 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 26' ' ' VAL . 22.2 ttt180 -57.0 -39.12 74.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.238 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -57.02 -54.2 49.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.197 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.714 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.5 mt -57.32 -45.49 84.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.616 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.5 m -58.27 -36.06 72.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.079 0.466 . . . . 0.0 109.977 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 22' ' ' ARG . 53.1 t -79.82 -30.62 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.425 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -16.59 59.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.916 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt 72.53 57.32 0.14 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.93 0.395 . . . . 0.0 110.978 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -139.08 139.0 21.93 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.373 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.47 ' O ' ' HA ' ' A' ' 1' ' ' MET . 71.6 Cg_endo -80.14 140.12 13.82 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.56 2.174 . . . . 0.0 111.241 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 22.9 p90 -160.26 171.27 19.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.414 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 2.5 tt0 -142.06 137.84 31.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.962 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.618 ' CE1' HG11 ' A' ' 4' ' ' VAL . 39.6 t80 -89.41 159.74 17.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.833 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.846 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.3 mt -143.68 119.11 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.279 0.561 . . . . 0.0 110.456 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -80.66 135.94 36.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.394 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.608 HD13 ' SD ' ' A' ' 65' ' ' MET . 2.7 pt -97.01 -17.38 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.421 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.624 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 4.4 ttp -131.41 90.37 38.02 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.482 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 10.1 Cg_exo -71.17 -4.32 14.66 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.661 2.241 . . . . 0.0 113.207 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -139.65 144.11 37.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.068 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -68.09 -8.55 39.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.241 0.543 . . . . 0.0 111.945 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.91 -58.02 1.35 Allowed Glycine 0 C--N 1.313 -0.75 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.293 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.84 140.93 27.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -72.73 167.16 21.41 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.616 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 38' ' ' PRO . 30.6 p30 -91.37 103.46 16.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.382 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.9 -24.65 16.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.696 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -56.53 -50.16 72.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.922 0.391 . . . . 0.0 111.006 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -75.93 -32.06 59.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.459 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' A' ' 36' ' ' ILE . 37.0 mm -65.0 -47.25 88.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.004 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.98 -55.99 18.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.027 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -56.73 -31.97 65.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.608 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.882 ' O ' HD12 ' A' ' 55' ' ' LEU . 15.4 tp -61.34 -58.41 8.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.189 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.701 ' HA ' HD13 ' A' ' 55' ' ' LEU . 72.5 mt -44.04 -40.92 5.12 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.301 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.1 m -70.22 -35.64 74.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.301 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' LEU . 5.0 tttp -60.2 -41.86 93.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.679 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.882 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -58.64 -69.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.239 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.08 -35.08 0.31 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -102.8 -175.1 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.798 0.332 . . . . 0.0 111.009 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.73 -31.9 10.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.825 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -105.32 170.19 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.417 ' HB2' HD12 ' A' ' 63' ' ' LEU . 9.4 pt20 -122.72 101.51 7.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.757 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -80.06 85.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.309 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.92 27.25 70.99 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.579 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.709 HD22 ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -49.84 171.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 111.235 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.709 ' N ' HD22 ' A' ' 63' ' ' LEU . 6.9 p -143.29 156.67 44.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.1 0.476 . . . . 0.0 111.591 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.608 ' SD ' HD13 ' A' ' 36' ' ' ILE . 3.2 mtt -126.32 154.65 74.73 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.567 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HB2' HG13 ' A' ' 4' ' ' VAL . 7.5 Cg_exo -75.52 150.34 94.47 Favored 'Cis proline' 0 C--N 1.344 0.308 0 C-N-CA 124.008 -1.247 . . . . 0.0 112.77 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.667 ' OE1' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -102.58 123.15 45.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.495 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.901 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -97.03 166.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.343 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 81.6 m-85 -142.47 140.98 32.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.071 0.462 . . . . 0.0 110.895 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB3' ' N ' ' A' ' 74' ' ' SER . . . -53.4 134.98 52.39 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.411 -178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HB3' ' N ' ' A' ' 1' ' ' MET . 89.0 Cg_exo -45.92 -27.68 4.35 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.012 2.475 . . . . 0.0 112.074 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -165.43 38.8 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.153 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.56 -109.15 0.99 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.101 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.448 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 13.5 m -138.47 177.34 7.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.237 0.542 . . . . 0.0 111.335 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -53.06 122.3 9.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.096 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 70' ' ' ALA . 4.4 mt -83.83 -43.64 17.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.988 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.04 -149.84 17.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.526 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.6 -159.25 31.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.209 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -60.92 -57.85 10.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.767 0.318 . . . . 0.0 110.704 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -54.01 -43.95 70.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -57.16 -32.81 66.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.625 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.6 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -71.49 -47.47 55.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.655 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.28 -30.17 26.73 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -74.81 -33.65 62.25 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 82' ' ' LEU . 21.0 t80 -66.86 -32.43 73.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.392 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.6 ' HE2' HD21 ' A' ' 82' ' ' LEU . 7.1 m-85 -92.08 -70.31 0.7 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.336 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.87 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.671 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 12.4 tpp . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.429 0.157 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -39.85 120.92 1.2 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.511 0.672 . . . . 0.0 112.233 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -90.91 125.36 35.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.267 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.655 HG12 ' HE1' ' A' ' 33' ' ' PHE . 22.7 t -109.55 110.24 31.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.01 0.433 . . . . 0.0 111.107 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 16.4 m-85 -89.64 99.26 12.3 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.3 -141.07 3.02 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.031 -1.081 . . . . 0.0 112.723 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.823 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 30.4 m-85 -127.11 149.2 50.05 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.747 0.308 . . . . 0.0 111.261 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -102.23 22.02 13.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.7 9.63 7.44 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.445 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -85.87 -50.7 6.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.782 0.325 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.8 mm -103.0 -32.04 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.638 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -140.62 154.83 46.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.277 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 166.73 22.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 p 174.0 95.08 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.671 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 16' ' ' TYR . 34.2 m -69.7 -44.39 79.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.553 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.477 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -57.3 -29.37 63.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.233 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -56.74 11.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.02 -33.77 53.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.173 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 91.2 m-20 -69.92 -49.88 47.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.896 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.43 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -61.01 -32.59 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -60.61 -54.06 49.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.812 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -65.56 -25.52 67.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.603 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.5 tt -57.79 -55.23 37.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.324 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 31' ' ' PHE . 25.5 mt -63.17 -35.1 79.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.567 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.3 m -68.72 -41.64 78.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.177 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 22' ' ' ARG . 90.2 t -66.79 -31.99 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.523 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -84.65 -10.49 57.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.07 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 2.6 mtmt 68.54 53.36 0.56 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.969 0.414 . . . . 0.0 110.986 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.31 113.17 7.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.671 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 88.4 Cg_exo -45.72 174.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.643 2.229 . . . . 0.0 112.766 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.498 ' HB3' HD13 ' A' ' 24' ' ' LEU . 5.2 p90 -163.99 169.89 17.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.811 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.3 tm-20 -129.03 109.41 11.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.14 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.655 ' HE1' HG12 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -90.54 150.97 21.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.04 0.448 . . . . 0.0 111.461 -179.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.445 HG13 ' C ' ' A' ' 33' ' ' PHE . 30.2 mt -149.73 127.02 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.301 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -82.69 110.31 17.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.401 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.916 ' HB ' HD11 ' A' ' 48' ' ' ILE . 3.2 pt -73.46 -19.96 18.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.8 ttp -129.49 86.13 56.86 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.338 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.82 -3.05 13.34 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.663 2.242 . . . . 0.0 112.407 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 37' ' ' MET . 3.1 tt0 -139.89 136.46 33.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.43 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -7.86 12.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.222 0.534 . . . . 0.0 111.963 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.49 -63.48 1.56 Allowed Glycine 0 C--N 1.313 -0.747 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.409 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.14 140.47 26.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.66 0.267 . . . . 0.0 111.229 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -66.23 170.97 5.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.082 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.428 ' O ' HG12 ' A' ' 48' ' ' ILE . 1.3 t70 -83.2 95.23 8.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.958 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.39 -20.64 30.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.441 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.94 -60.62 3.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.022 0.439 . . . . 0.0 110.535 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -67.09 -40.3 86.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.302 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.916 HD11 ' HB ' ' A' ' 36' ' ' ILE . 34.3 mm -59.83 -37.68 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.779 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.52 -51.91 67.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.06 -32.48 64.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.256 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.3 tt -60.64 -53.35 58.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -50.95 -42.23 59.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.017 0.437 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.0 m -59.48 -45.62 91.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.707 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -61.96 -32.52 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.564 HD21 ' CD2' ' A' ' 51' ' ' LEU . 1.3 mt -60.75 -50.35 73.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.5 -19.24 2.43 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.119 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -148.14 -162.26 1.51 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 110.397 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -113.63 21.66 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.149 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -120.19 164.22 16.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.74 0.305 . . . . 0.0 110.965 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.4 102.59 6.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.729 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.9 pt -71.77 79.68 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.344 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.75 26.44 5.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.535 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 63' ' ' LEU . 1.5 tp -56.6 169.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.338 . . . . 0.0 111.154 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.9 p -150.84 158.8 44.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.459 ' HG2' HD13 ' A' ' 36' ' ' ILE . 4.1 mpp? -104.29 159.13 30.32 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.596 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.6 Cg_exo -80.01 145.69 73.0 Favored 'Cis proline' 0 C--N 1.344 0.31 0 C-N-CA 124.134 -1.194 . . . . 0.0 112.978 0.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.402 ' NE2' ' CD1' ' A' ' 63' ' ' LEU . 56.4 mm-40 -108.24 120.78 43.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.773 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -90.62 155.07 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.166 0.508 . . . . 0.0 111.927 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 75' ' ' HIS . 33.8 m-85 -143.16 137.76 29.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.635 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.584 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -47.88 156.46 0.71 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.717 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.24 -38.68 88.36 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.727 2.285 . . . . 0.0 112.037 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.47 -21.65 20.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.184 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.76 89.36 0.81 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.649 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -164.55 116.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.372 . . . . 0.0 110.624 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 2.1 t-160 -55.14 112.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.307 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.716 HG21 HD12 ' A' ' 82' ' ' LEU . 6.7 mt -98.53 -35.48 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.365 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.43 -151.92 20.07 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.233 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 82' ' ' LEU . . . -104.57 -141.05 10.74 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.118 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.603 ' CE1' HD12 ' A' ' 23' ' ' LEU . 13.0 t80 -73.63 -66.43 0.7 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 0.0 110.725 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -63.04 -42.68 99.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.948 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.43 -49.22 75.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.626 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.716 HD12 HG21 ' A' ' 76' ' ' ILE . 3.0 tt -74.43 -38.82 62.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.88 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -49.64 -27.61 4.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.958 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.75 -35.33 72.6 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.724 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.48 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -64.8 -37.32 87.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.587 ' CD2' HD21 ' A' ' 82' ' ' LEU . 14.8 m-85 -86.55 -20.28 28.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.583 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.992 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.632 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 38.2 ttm . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -79.35 147.45 32.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.239 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.18 120.53 42.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.221 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 68' ' ' VAL . 53.6 t -112.35 123.71 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.32 0.581 . . . . 0.0 111.996 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.1 m-85 -99.98 99.53 10.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.967 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.506 ' O ' HD13 ' A' ' 36' ' ' ILE . . . -158.07 -141.69 3.22 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.335 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.635 ' CE1' HD11 ' A' ' 36' ' ' ILE . 57.9 m-85 -121.7 159.02 27.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.0 111.402 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.59 -67.93 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 166.28 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.556 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.25 -27.74 47.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.816 HG21 ' O ' ' A' ' 37' ' ' MET . 4.2 mp -91.11 -37.04 8.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.261 0.553 . . . . 0.0 110.654 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -155.1 142.05 19.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.199 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.75 146.39 31.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.295 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.98 107.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.816 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 16' ' ' TYR . 31.4 m -71.74 -40.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.421 . . . . 0.0 110.577 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.407 ' N ' HG23 ' A' ' 15' ' ' VAL . 18.4 m-85 -51.82 -25.75 8.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.387 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -65.94 -62.85 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.125 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -57.01 -31.79 65.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.52 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -53.15 52.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.852 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.64 71.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.007 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -61.13 -35.75 77.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.083 0.468 . . . . 0.0 110.121 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.761 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.6 ttt180 -76.74 -27.62 55.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.604 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.819 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -57.35 -56.56 20.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.212 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.6 mt -63.04 -45.85 90.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.654 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 m -56.03 -35.44 66.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.366 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 22' ' ' ARG . 70.9 t -75.99 -29.54 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.682 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 1.5 mmtm -76.11 -12.91 60.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.226 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 76.16 38.7 0.31 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.03 0.443 . . . . 0.0 110.796 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -129.74 139.76 36.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.697 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 1' ' ' MET . 93.5 Cg_endo -77.74 160.98 30.93 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.471 2.114 . . . . 0.0 111.619 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -161.47 170.89 19.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.413 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -136.89 125.11 23.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.898 0.38 . . . . 0.0 110.792 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.454 ' HE1' HG11 ' A' ' 4' ' ' VAL . 13.0 t80 -89.84 156.96 18.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.162 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.432 HG13 ' C ' ' A' ' 33' ' ' PHE . 18.4 mt -150.43 123.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.275 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -86.12 110.58 19.65 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.534 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.678 ' HB ' HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -70.38 -14.19 17.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.311 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.816 ' O ' HG21 ' A' ' 11' ' ' ILE . 3.9 ttp -126.38 89.57 51.94 Favored Pre-proline 0 N--CA 1.455 -0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 110.931 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.48 0.07 10.32 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.57 2.18 . . . . 0.0 112.239 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 37' ' ' MET . 38.4 tt0 -140.02 136.25 33.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.603 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -63.93 -8.05 10.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.169 0.509 . . . . 0.0 112.114 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.89 -63.07 1.7 Allowed Glycine 0 C--N 1.313 -0.728 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.079 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -147.49 149.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.673 0.273 . . . . 0.0 111.142 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -69.14 171.27 8.58 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.873 0.368 . . . . 0.0 111.588 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -95.98 110.97 23.1 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.158 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -64.4 -23.19 67.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.808 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -58.62 -52.6 65.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 110.797 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.09 -44.64 68.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.248 0.547 . . . . 0.0 109.736 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.678 HD11 ' HB ' ' A' ' 36' ' ' ILE . 16.0 mm -54.91 -40.64 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.693 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.48 -51.4 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.645 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -32.35 64.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.228 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.603 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.7 tt -60.99 -50.13 74.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.193 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.489 HD21 ' HG3' ' A' ' 60' ' ' GLN . 85.5 mt -52.49 -43.49 65.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.565 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 m -54.5 -46.39 73.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.665 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' CB ' ' CE2' ' A' ' 69' ' ' PHE . 2.8 mtmm -63.31 -36.53 83.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.628 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mt -61.28 -52.66 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.723 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.6 -113.9 0.58 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.065 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -150.33 31.74 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.118 0.485 . . . . 0.0 110.509 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -121.01 -146.52 0.38 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.276 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -117.19 170.13 8.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.694 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.489 ' HG3' HD21 ' A' ' 52' ' ' LEU . 5.6 mt-30 -73.26 98.26 2.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.181 0.515 . . . . 0.0 110.455 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -79.9 79.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.148 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.68 21.71 71.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.472 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.551 HD11 ' OE1' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -57.79 131.69 51.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.962 0.41 . . . . 0.0 110.804 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 65' ' ' MET . 21.9 m -123.61 163.65 20.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.356 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.443 ' N ' HG22 ' A' ' 64' ' ' THR . 6.4 mtm -107.98 152.25 41.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.55 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.7 Cg_endo -83.0 137.9 32.8 Favored 'Cis proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.968 -1.263 . . . . 0.0 112.883 0.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.551 ' OE1' HD11 ' A' ' 63' ' ' LEU . 48.0 tp60 -96.29 138.59 33.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.861 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 77' ' ' GLY . 3.6 t -109.78 154.91 11.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.051 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.452 ' CE1' ' HG3' ' A' ' 67' ' ' GLN . 48.0 m-85 -143.39 143.21 31.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.547 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.56 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.58 155.21 14.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.264 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.632 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -72.47 -16.11 27.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.87 2.38 . . . . 0.0 112.097 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -104.72 -7.85 19.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.095 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.07 89.82 1.95 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.512 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -175.93 156.85 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.762 0.315 . . . . 0.0 111.093 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.453 ' CD2' ' NE2' ' A' ' 67' ' ' GLN . 7.4 t-160 -90.23 126.51 35.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.845 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 70' ' ' ALA . 16.7 mt -113.8 -45.82 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.257 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.633 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 124.22 -151.58 17.19 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.91 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -99.14 -129.43 6.55 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.439 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.819 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -80.88 -70.35 0.54 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.713 0.256 . . . . 0.0 110.69 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -52.17 -46.9 65.7 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.235 0.54 . . . . 0.0 110.221 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.434 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -58.88 -41.41 87.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.615 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.495 HD21 ' CD2' ' A' ' 86' ' ' PHE . 2.3 tt -74.54 -35.99 63.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.384 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.4 ttt180 -52.03 -32.84 35.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -34.42 74.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.291 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.436 ' CD2' HG23 ' A' ' 76' ' ' ILE . 43.3 t80 -65.95 -32.05 73.32 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.447 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.495 ' CD2' HD21 ' A' ' 82' ' ' LEU . 24.9 m-85 -97.84 -9.11 26.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.67 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 83' ' ' ARG . 3.5 mtpm? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.885 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.725 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.519 0.199 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 66.0 m-85 -39.78 110.06 0.13 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.985 0.898 . . . . 0.0 111.667 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.821 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -89.74 127.0 35.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.95 -1.477 . . . . 0.0 111.281 -179.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.689 HG12 ' HE1' ' A' ' 33' ' ' PHE . 25.3 t -106.43 112.25 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.01 0.433 . . . . 0.0 111.296 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 11.2 m-85 -89.79 99.01 12.1 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.27 -143.12 3.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.861 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 31.2 m-85 -117.68 143.46 46.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.84 0.352 . . . . 0.0 111.578 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.91 -76.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.522 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 170.32 -34.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 110.606 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -81.36 -27.94 34.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.46 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.895 HG21 ' O ' ' A' ' 37' ' ' MET . 3.0 mp -89.83 -45.24 15.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.353 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.605 ' CD2' ' HE3' ' A' ' 37' ' ' MET . 18.7 t-80 -143.93 159.62 42.25 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -80.24 149.91 30.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.539 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.4 p -157.27 93.52 1.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.149 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.5 m -82.01 -31.77 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.214 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -28.12 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.153 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 t -63.52 -45.3 91.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.038 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.76 -36.01 34.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.145 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.42 ' HB3' ' CE2' ' A' ' 79' ' ' PHE . 20.4 m-80 -70.54 -56.88 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.669 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -57.31 -28.94 63.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.926 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -64.82 -44.3 90.29 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 26' ' ' VAL . 15.8 tpp85 -63.28 -36.13 82.66 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.87 HD21 HD23 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -59.05 -61.85 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.346 178.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -61.03 -53.39 57.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.93 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.5 m -52.63 -37.43 58.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.859 0.362 . . . . 0.0 111.235 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 22' ' ' ARG . 44.4 t -79.78 -17.81 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.778 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -89.0 -30.34 18.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.557 0.218 . . . . 0.0 111.527 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.32 67.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.54 HE22 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -150.15 129.9 6.6 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.536 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.725 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 75.8 Cg_exo -49.75 167.41 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.327 1.351 . . . . 0.0 110.706 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -165.15 160.48 18.71 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.792 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.729 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 19.2 mt-10 -124.78 122.3 37.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 111.054 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.689 ' HE1' HG12 ' A' ' 4' ' ' VAL . 1.5 t80 -103.93 143.15 33.24 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.045 0.45 . . . . 0.0 110.954 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 33' ' ' PHE . 18.1 mt -144.32 127.69 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.224 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -82.43 121.55 26.88 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.863 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.861 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.6 pt -77.56 -15.49 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.996 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.895 ' O ' HG21 ' A' ' 11' ' ' ILE . 33.0 ttm -125.01 79.53 65.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.769 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 60.4 Cg_endo -72.97 -5.34 17.04 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.753 2.302 . . . . 0.0 112.418 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.54 136.6 34.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.182 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -63.01 -8.84 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.183 0.515 . . . . 0.0 111.884 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.94 -61.19 2.16 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.542 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 43' ' ' PHE . 30.1 t -150.29 155.58 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 111.485 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -62.41 166.67 4.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.615 179.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 3.4 t70 -83.33 123.93 30.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.959 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 8.8 t0 -78.04 -27.98 48.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.232 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.22 -59.77 3.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 110.862 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -62.71 -46.55 87.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.489 HD11 ' HB ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -59.94 -31.07 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.635 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -62.99 -47.22 84.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -36.9 80.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.46 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.593 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.3 tt -58.4 -50.03 75.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.159 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -51.88 -45.12 64.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.353 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.4 m -57.3 -46.76 82.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.612 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -60.9 -39.0 87.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.679 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.89 -62.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.83 -116.58 0.47 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.967 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -150.58 26.87 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.941 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -121.58 -149.28 0.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.297 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 t -120.58 166.61 13.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.526 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.405 ' CB ' ' HB2' ' A' ' 63' ' ' LEU . 2.6 mt-30 -115.95 98.87 6.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.92 0.39 . . . . 0.0 110.808 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.7 tp -81.45 85.57 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.463 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.54 30.45 7.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.497 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.829 HD13 ' N ' ' A' ' 64' ' ' THR . 1.8 tm? -47.15 135.65 9.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.799 0.333 . . . . 0.0 110.785 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.829 ' N ' HD13 ' A' ' 63' ' ' LEU . 71.6 p -107.93 146.37 32.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.264 0.554 . . . . 0.0 111.854 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.408 ' SD ' HD12 ' A' ' 63' ' ' LEU . 3.9 mpp? -122.01 159.36 51.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.474 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_exo -78.96 151.87 88.28 Favored 'Cis proline' 0 C--N 1.343 0.258 0 C-N-CA 124.211 -1.162 . . . . 0.0 112.679 0.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.623 ' NE2' HD21 ' A' ' 63' ' ' LEU . 2.3 mt-30 -113.58 116.39 29.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.842 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.821 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -88.7 154.41 3.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.103 0.478 . . . . 0.0 112.158 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 2' ' ' PHE . 35.7 m-85 -142.61 139.16 31.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.015 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -57.14 144.22 70.18 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.048 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -34.88 -35.31 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.74 2.96 . . . . 0.0 112.685 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.43 33.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.198 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.54 -105.1 2.66 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.644 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 m -137.93 179.45 6.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.031 0.443 . . . . 0.0 110.869 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -63.76 125.08 23.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.941 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 1.015 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.6 mp -97.74 -28.4 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.524 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 120.89 -160.07 15.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.012 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.14 -131.77 7.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.587 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 9.6 t80 -76.49 -70.65 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.705 0.288 . . . . 0.0 111.032 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -57.4 -48.22 79.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.386 . . . . 0.0 110.648 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.441 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -54.53 -46.12 73.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.476 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.87 HD23 HD21 ' A' ' 23' ' ' LEU . 2.3 tt -66.94 -38.9 87.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.016 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.711 ' HG3' HD22 ' A' ' 23' ' ' LEU . 1.4 ttm180 -51.73 -29.94 20.5 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -72.19 -34.94 68.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.203 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 82' ' ' LEU . 59.2 t80 -64.76 -32.48 74.18 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.313 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.461 ' CE2' HD21 ' A' ' 82' ' ' LEU . 27.3 m-85 -95.77 -12.11 25.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.582 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.888 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.679 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 33.6 ttm . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -77.08 145.32 37.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.118 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.0 mptt -106.83 119.17 38.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.618 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.427 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 17.1 t -102.94 121.5 54.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.221 0.534 . . . . 0.0 111.122 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.781 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.6 m-30 -98.87 99.36 10.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.882 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.29 -135.65 1.86 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.972 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.853 ' HE2' ' HE3' ' A' ' 37' ' ' MET . 57.1 m-85 -125.86 146.77 49.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.735 0.302 . . . . 0.0 111.076 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.445 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -137.52 51.86 1.91 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.967 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 t -167.88 -173.22 2.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.308 0.575 . . . . 0.0 112.011 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -86.58 4.65 39.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.757 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.637 HG23 ' HB2' ' A' ' 40' ' ' LYS . 10.6 mm -86.86 -13.44 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.539 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.656 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 9.6 t-80 -163.08 122.68 2.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.664 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 168.68 7.98 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.54 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 174.7 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.662 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 16' ' ' TYR . 26.9 m -87.33 -41.88 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.702 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 15' ' ' VAL . 1.1 m-85 -60.89 -18.94 59.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.574 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.8 -58.43 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.4 . . . . 0.0 110.565 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -50.66 -40.9 54.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.049 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -64.1 -46.83 82.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.397 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -63.87 -49.91 70.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.381 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 31' ' ' PHE . 10.5 ttmt -50.47 -34.54 25.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.895 0.378 . . . . 0.0 110.586 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.815 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.9 tpt180 -66.74 -40.5 88.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.413 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.56 -55.62 32.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.235 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.83 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.4 mt -55.24 -45.17 76.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.61 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.7 m -57.3 -37.31 72.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.842 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.8 t -78.19 -34.21 18.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.505 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -17.96 62.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.852 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.47 53.2 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -140.03 136.13 16.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.195 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.614 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.6 Cg_endo -81.24 162.57 20.03 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.625 2.217 . . . . 0.0 110.761 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 6.4 p90 -161.34 171.1 18.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 111.981 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -136.2 134.16 37.88 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.568 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 10.9 t80 -89.69 158.74 17.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.534 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 5' ' ' TYR . 15.4 mt -148.31 121.96 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.385 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -86.05 133.34 33.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.052 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.558 HD11 ' OH ' ' A' ' 7' ' ' TYR . 20.8 pt -98.77 2.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.362 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.853 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -145.1 90.82 6.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.676 0.274 . . . . 0.0 110.434 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 44.8 Cg_endo -68.48 -26.42 34.4 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.698 2.265 . . . . 0.0 112.31 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -139.52 146.68 40.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.993 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.637 ' HB2' HG23 ' A' ' 11' ' ' ILE . 12.1 tttt -62.09 -8.8 5.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.295 0.569 . . . . 0.0 111.73 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.2 -53.47 6.13 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.522 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.7 t -151.36 146.87 15.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.419 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 46.6 m-85 -57.43 169.55 0.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.399 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -81.56 98.04 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.614 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 9.5 t0 -57.77 -21.05 39.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.31 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.13 -57.2 6.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.18 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 7.2 mmtp -72.3 -50.77 24.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.662 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.6 mp -49.91 -35.72 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -64.43 -61.39 2.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.037 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 2.4 pt-20 -63.33 -25.47 68.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.3 tt -57.27 -54.36 47.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.961 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.4 mt -55.81 -49.48 73.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.08 0.467 . . . . 0.0 110.917 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.8 m -60.13 -36.08 76.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.321 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -71.02 -36.01 72.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.959 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.467 HD21 ' CD2' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -59.46 -41.6 90.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.026 0.441 . . . . 0.0 110.501 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.31 -164.58 31.54 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.853 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -94.39 31.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -121.11 -150.81 0.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.247 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 t -120.87 170.3 9.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.734 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.4 98.46 11.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.127 0.489 . . . . 0.0 110.254 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.1 tp -80.28 86.9 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.497 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.54 29.89 61.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.512 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.72 134.86 4.13 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.813 0.339 . . . . 0.0 111.044 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.22 170.11 8.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.224 0.535 . . . . 0.0 111.793 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.4 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 15.8 mmt -124.9 154.81 70.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.572 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -80.64 145.12 69.36 Favored 'Cis proline' 0 C--N 1.343 0.284 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.73 0.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.468 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 0.7 OUTLIER -111.58 117.66 33.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.915 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.3 t -89.86 161.45 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.255 0.55 . . . . 0.0 111.878 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -142.51 143.91 32.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.407 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.684 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.42 131.57 76.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.447 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.679 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 32.3 Cg_exo -52.71 -24.02 22.0 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.63 2.22 . . . . 0.0 112.091 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.06 38.38 0.18 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.349 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.8 -109.29 0.78 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.705 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.535 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -140.8 -178.45 5.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.14 0.495 . . . . 0.0 111.142 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.468 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 17.2 t-80 -56.9 128.19 35.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.074 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.684 HD11 ' HA ' ' A' ' 70' ' ' ALA . 15.6 mt -100.21 -44.74 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.901 0.381 . . . . 0.0 110.777 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.45 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.13 -153.31 19.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.827 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -91.38 -138.85 8.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.119 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -75.43 -70.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.829 0.315 . . . . 0.0 110.642 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -47.36 -41.26 19.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.256 0.551 . . . . 0.0 110.323 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -39.58 94.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.412 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.709 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -75.03 -41.38 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.714 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -51.35 -33.48 29.79 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -68.6 -35.11 76.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.4 t80 -63.93 -34.12 77.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.562 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.709 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -88.9 -70.52 0.64 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.296 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.9 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.605 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.0 ttm . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.818 0.342 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.471 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 70.0 m-85 -63.22 157.02 23.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.03 0.443 . . . . 0.0 110.687 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.95 119.28 20.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.965 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.914 HG22 HG22 ' A' ' 68' ' ' VAL . 12.4 t -105.06 132.18 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.551 . . . . 0.0 112.038 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.4 m-85 -108.46 99.61 8.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.349 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.66 -141.55 3.16 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.327 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -118.74 151.68 37.56 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.845 0.355 . . . . 0.0 110.928 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.84 -75.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.072 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 t 170.99 -41.98 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.525 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -76.47 -26.3 55.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.862 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.614 HG21 ' O ' ' A' ' 37' ' ' MET . 4.1 mp -89.96 -41.3 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.978 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -149.76 149.56 30.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.049 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 143.27 48.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.54 102.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.002 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 m -87.02 -19.47 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.378 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -75.67 -20.35 58.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.595 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 p -71.18 -44.08 66.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.673 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.17 -41.45 99.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -59.67 -51.05 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.789 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 -28.82 69.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.035 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -43.29 99.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.288 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.911 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -69.65 -27.68 65.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.711 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.697 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -57.55 -57.14 13.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.414 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.1 mt -60.25 -40.01 88.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.658 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 m -60.5 -31.39 70.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.092 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 22' ' ' ARG . 92.9 t -73.76 -27.51 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.915 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -83.11 -17.64 42.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.322 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 74.09 55.57 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.939 0.4 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -137.26 145.17 48.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.764 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.451 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.1 Cg_endo -77.33 139.2 18.42 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.428 2.085 . . . . 0.0 111.587 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.605 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 14.6 p90 -153.12 170.5 20.35 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 3.8 tp10 -143.99 146.44 32.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.978 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.517 ' HE1' HG11 ' A' ' 4' ' ' VAL . 11.0 t80 -89.24 156.62 18.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.024 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.651 HD12 ' CE1' ' A' ' 5' ' ' TYR . 9.4 mt -143.3 118.58 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.242 0.544 . . . . 0.0 110.387 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -94.63 129.5 41.47 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.119 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.522 ' HB ' HD11 ' A' ' 48' ' ' ILE . 16.8 pt -86.81 -17.98 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.732 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.614 ' O ' HG21 ' A' ' 11' ' ' ILE . 2.7 ttp -122.61 92.56 48.99 Favored Pre-proline 0 N--CA 1.454 -0.243 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.3 -15.45 28.29 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.681 2.254 . . . . 0.0 112.722 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 37' ' ' MET . 2.9 pt-20 -139.64 142.9 36.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.838 0.352 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -65.58 -8.58 20.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.272 0.558 . . . . 0.0 111.851 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.94 -60.4 2.17 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.082 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 t -150.17 127.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.329 . . . . 0.0 110.837 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.56 170.43 1.05 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.446 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.11 96.56 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.124 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.77 -28.82 37.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.213 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -52.58 -44.62 66.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.927 0.394 . . . . 0.0 110.812 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -31.03 39.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.227 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' A' ' 36' ' ' ILE . 44.4 mm -63.31 -43.77 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.601 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.91 -55.76 11.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.078 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.58 -31.09 61.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.91 0.386 . . . . 0.0 110.389 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.929 ' O ' HD12 ' A' ' 55' ' ' LEU . 12.8 tp -59.22 -59.12 5.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.08 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HA ' HD13 ' A' ' 55' ' ' LEU . 71.1 mt -44.53 -44.08 8.43 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.303 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.9 m -69.68 -30.96 68.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.588 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 51' ' ' LEU . 5.1 tttp -65.39 -40.8 93.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.887 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.7 mp -59.34 -56.72 18.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.956 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.61 -110.5 0.27 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.165 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.33 31.32 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.04 0.448 . . . . 0.0 110.774 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -121.01 -148.53 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.288 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 t -120.34 170.26 9.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -92.01 98.8 11.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.201 0.525 . . . . 0.0 110.432 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.426 ' H ' HD12 ' A' ' 61' ' ' ILE . 3.4 mp -79.74 85.08 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.264 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.21 27.34 46.12 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.52 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.438 HD12 ' NE2' ' A' ' 67' ' ' GLN . 1.4 mm? -52.72 148.55 7.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.849 0.356 . . . . 0.0 110.993 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.1 p -121.68 170.15 10.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.146 0.498 . . . . 0.0 111.528 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.08 158.92 39.7 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.9 Cg_endo -85.81 151.44 49.84 Favored 'Cis proline' 0 N--CA 1.461 -0.406 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.898 0.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.438 ' NE2' HD12 ' A' ' 63' ' ' LEU . 12.0 mm100 -111.71 117.9 34.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.223 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.914 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -91.28 166.31 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 0.0 111.837 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 64.1 m-85 -141.94 143.78 33.42 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.191 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.633 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -53.84 152.4 10.13 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.527 ' HB3' ' N ' ' A' ' 1' ' ' MET . 43.3 Cg_exo -59.3 -28.72 88.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.171 2.581 . . . . 0.0 112.54 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.85 -21.0 18.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.66 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.7 84.5 0.65 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.89 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.14 162.72 15.41 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -90.54 129.6 36.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.72 0.295 . . . . 0.0 110.971 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.654 HG21 HD12 ' A' ' 82' ' ' LEU . 1.4 mp -115.57 -43.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.789 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 119.14 -155.94 15.89 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.107 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -94.52 -134.1 7.33 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.535 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.697 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.71 -70.11 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.845 -0.209 . . . . 0.0 111.05 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -48.9 -44.63 40.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.176 0.512 . . . . 0.0 110.602 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -63.66 -44.77 92.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.885 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -69.88 -43.7 71.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.76 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 87' ' ' LYS . 6.2 ttp180 -51.56 -31.57 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -72.82 -32.63 65.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.333 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.47 ' CD2' HG12 ' A' ' 76' ' ' ILE . 54.0 t80 -68.6 -32.24 71.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.648 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.505 ' CD1' ' HG2' ' A' ' 27' ' ' LYS . 20.1 m-85 -96.61 -70.74 0.7 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.528 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.773 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.833 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 28.1 tpp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 110.502 -0.185 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.415 ' H ' ' HG3' ' A' ' 1' ' ' MET . 96.9 m-85 -43.13 137.57 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.805 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -115.48 120.51 39.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.978 -179.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.53 HG11 ' CE1' ' A' ' 33' ' ' PHE . 53.4 t -107.82 121.25 60.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.245 0.545 . . . . 0.0 111.845 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.57 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 20.0 m-85 -100.14 101.51 12.57 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.289 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 36' ' ' ILE . . . -162.24 -139.01 2.54 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.521 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.637 ' CE1' ' CD2' ' A' ' 12' ' ' HIS . 64.2 m-85 -118.31 159.98 22.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.974 0.416 . . . . 0.0 111.478 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -96.84 -73.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.03 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m 170.64 -42.08 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.307 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -69.88 -32.44 70.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.189 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.4 mm -100.18 -32.86 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.935 ' HD2' ' HE2' ' A' ' 37' ' ' MET . 1.4 t-80 -157.33 122.14 4.44 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 148.5 51.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.98 118.89 1.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.297 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 m -84.78 -36.79 11.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.906 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.23 -29.23 69.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.252 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.7 t -56.27 -49.38 74.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.274 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -56.64 -34.57 67.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.342 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 38.4 m-80 -72.74 -51.21 20.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 111.021 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -55.06 -45.32 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.125 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -64.99 -40.74 95.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.323 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.8 mmt85 -62.54 -37.02 84.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.313 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.746 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -57.57 -56.86 16.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.073 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.746 ' N ' HD23 ' A' ' 23' ' ' LEU . 59.5 mt -62.76 -30.36 71.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.354 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.4 m -71.19 -36.43 71.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.201 0.524 . . . . 0.0 109.629 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 22' ' ' ARG . 94.5 t -75.78 -48.61 29.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.513 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.15 -19.9 62.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.788 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt 71.33 55.04 0.21 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.944 0.402 . . . . 0.0 110.634 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -139.9 122.68 10.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.833 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 5.0 Cg_endo -48.53 159.33 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.602 2.201 . . . . 0.0 112.732 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.599 ' HB3' HD13 ' A' ' 24' ' ' LEU . 35.0 p90 -163.44 170.73 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.884 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.8 tt0 -141.04 115.34 9.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.645 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.53 ' CE1' HG11 ' A' ' 4' ' ' VAL . 36.3 t80 -89.03 154.36 20.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.833 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.422 HG13 ' C ' ' A' ' 33' ' ' PHE . 10.3 mt -148.13 122.07 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.484 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -75.05 113.15 12.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.577 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.507 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.2 pp -64.7 -29.37 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.775 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.935 ' HE2' ' HD2' ' A' ' 12' ' ' HIS . 2.1 ttp -118.61 92.25 43.62 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.733 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HG3' ' HB2' ' A' ' 44' ' ' ASP . 88.0 Cg_endo -79.73 3.69 7.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.695 2.263 . . . . 0.0 112.957 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -139.2 144.16 38.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.488 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -66.89 -8.11 26.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.206 0.527 . . . . 0.0 111.574 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.69 -66.8 0.79 Allowed Glycine 0 C--N 1.315 -0.633 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.293 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.32 136.58 58.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 1.1 p90 -66.4 170.97 5.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.729 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.475 ' O ' HD13 ' A' ' 48' ' ' ILE . 7.5 t0 -77.85 124.58 28.16 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.244 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 1.4 t70 -80.07 -28.74 39.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.536 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -63.89 -56.72 13.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.328 . . . . 0.0 111.171 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -67.0 -38.15 85.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.475 HD13 ' O ' ' A' ' 44' ' ' ASP . 0.9 OUTLIER -71.57 -25.72 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.704 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -68.62 -48.55 63.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.972 0.415 . . . . 0.0 110.578 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.17 -34.71 76.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.233 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' CD2' HD21 ' A' ' 55' ' ' LEU . 3.5 tt -58.16 -50.79 72.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.397 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 52' ' ' LEU . 79.1 mt -54.15 -45.85 72.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.139 0.495 . . . . 0.0 111.404 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.9 m -61.2 -42.27 98.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.436 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -31.5 72.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.733 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.71 ' CD1' HD13 ' A' ' 63' ' ' LEU . 2.1 mt -62.43 -32.07 72.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.017 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.93 -26.57 8.76 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.234 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -124.11 -165.45 1.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.695 0.283 . . . . 0.0 110.647 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -103.82 -30.52 10.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.018 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -92.58 170.25 9.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -112.54 99.94 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.701 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.6 82.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.375 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.88 25.04 36.0 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.643 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.71 HD13 ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.11 155.7 16.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.923 0.392 . . . . 0.0 111.65 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -144.59 170.15 16.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.274 0.559 . . . . 0.0 112.058 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.418 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 4.2 mtt -115.82 154.94 48.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.568 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.6 Cg_exo -76.97 142.34 72.29 Favored 'Cis proline' 0 C--N 1.344 0.312 0 C-N-CA 123.846 -1.314 . . . . 0.0 112.644 0.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.4 ' CD ' HD21 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -102.68 116.91 33.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.938 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 82' ' ' LEU . 3.3 t -92.12 152.7 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.193 0.52 . . . . 0.0 111.62 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -143.57 139.88 29.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.564 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.698 ' HB1' ' HD2' ' A' ' 71' ' ' PRO . . . -55.27 165.17 1.15 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.684 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 19.6 Cg_endo -60.11 -24.61 77.42 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.777 2.318 . . . . 0.0 111.918 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.24 -26.06 19.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.268 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.65 -6.56 5.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.101 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.35 154.57 23.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.876 0.338 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -90.42 118.52 29.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.331 . . . . 0.0 110.962 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.535 HD11 ' HA ' ' A' ' 70' ' ' ALA . 28.2 mt -97.06 -48.46 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 134.41 -156.86 22.63 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.777 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.41 -141.45 10.91 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.839 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 25.8 t80 -67.79 -70.46 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 0.0 111.019 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.49 -47.42 84.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.088 0.471 . . . . 0.0 110.593 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -51.4 -37.18 46.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.645 ' CD1' HG11 ' A' ' 68' ' ' VAL . 4.3 tt -74.12 -35.99 64.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.18 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.18 -31.25 30.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.78 -31.8 71.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.495 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 14.1 t80 -71.05 -27.96 64.02 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.836 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 24' ' ' LEU . 29.7 m-85 -99.92 -13.45 19.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.088 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.04 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.674 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 18.7 tpp . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.412 0.149 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -39.7 127.59 2.0 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.667 0.746 . . . . 0.0 112.118 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -94.56 123.81 38.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.344 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 67' ' ' GLN . 24.6 t -111.96 114.64 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.379 . . . . 0.0 111.579 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 13.9 m-85 -93.27 99.9 12.36 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.19 -136.58 2.13 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.613 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -125.75 160.33 30.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.898 0.38 . . . . 0.0 111.895 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 9' ' ' SER . 5.3 m-20 -88.96 -68.12 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.645 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.7 OUTLIER 162.08 -29.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -76.61 -39.32 52.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.444 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 40' ' ' LYS . 7.5 mm -89.84 -46.25 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.582 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -140.66 149.79 42.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -77.38 161.46 28.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.735 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 p -176.89 98.18 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.221 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 m -77.76 -33.43 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.052 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -66.67 -28.12 68.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.051 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.6 t -62.66 -46.79 86.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 110.466 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -59.37 -31.08 68.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.051 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.25 -53.49 14.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.954 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.39 -49.06 70.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 110.943 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 1.5 ttmm -60.01 -50.02 75.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.627 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.794 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -60.11 -42.69 95.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.246 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.786 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -57.08 -54.13 50.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.05 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.786 ' N ' HD23 ' A' ' 23' ' ' LEU . 8.8 mt -56.84 -42.69 80.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.518 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -59.16 -38.13 78.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.68 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 22' ' ' ARG . 42.9 t -76.46 -34.09 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.48 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -9.83 58.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.866 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.13 51.69 1.62 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.002 0.429 . . . . 0.0 110.45 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -142.63 113.92 6.05 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.386 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.674 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 89.3 Cg_exo -49.25 178.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.386 2.057 . . . . 0.0 111.973 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 3.9 p90 -163.94 170.54 16.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.958 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 14.4 tp10 -134.44 112.38 10.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.471 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 7.0 t80 -89.1 155.96 19.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.292 0.567 . . . . 0.0 111.733 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG13 ' C ' ' A' ' 33' ' ' PHE . 45.3 mt -150.26 125.5 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.814 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -88.65 126.12 35.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.035 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.6 18.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.965 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -157.78 90.69 2.3 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.52 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 37.5 Cg_endo -66.07 -23.31 53.64 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.571 2.181 . . . . 0.0 112.021 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 37' ' ' MET . 2.7 mm-40 -139.56 143.93 37.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.148 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 11' ' ' ILE . 8.2 ttpt -64.33 -7.99 11.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.29 0.567 . . . . 0.0 111.866 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.72 -37.87 12.91 Favored Glycine 0 C--N 1.313 -0.731 0 CA-C-N 115.227 -0.897 . . . . 0.0 113.201 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -150.24 151.71 12.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.3 0.572 . . . . 0.0 112.157 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -75.27 169.01 18.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.313 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.621 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 t0 -94.88 103.36 15.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.753 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 5.5 t0 -69.7 -21.58 63.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.936 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -67.46 -57.19 6.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.108 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -69.95 -36.08 74.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.527 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 44' ' ' ASP . 21.4 mt -70.89 -26.37 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.412 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -68.01 -55.5 12.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.305 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.4 -36.06 73.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.828 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.587 HD13 ' CE2' ' A' ' 69' ' ' PHE . 6.7 tp -56.27 -50.42 71.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.528 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 52' ' ' LEU . 78.0 mt -53.36 -47.08 69.73 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.376 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.2 m -63.65 -39.39 94.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.425 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -59.22 -37.31 77.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.498 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' N ' HD23 ' A' ' 55' ' ' LEU . 1.2 mt -60.17 -56.43 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.552 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.58 -110.4 0.3 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.982 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -150.44 31.39 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.977 0.418 . . . . 0.0 110.68 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -120.96 -145.87 0.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.416 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.1 t -115.27 170.45 8.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.749 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 98.27 1.2 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.39 0.614 . . . . 0.0 110.452 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.04 84.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.254 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.93 26.45 58.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.432 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.433 HD11 HE21 ' A' ' 67' ' ' GLN . 1.4 mm? -56.04 132.54 50.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -126.03 153.47 44.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.274 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.82 155.55 36.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.636 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.7 Cg_exo -82.79 136.9 30.69 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 124.04 -1.233 . . . . 0.0 112.796 0.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 3.4 mm100 -92.67 148.36 22.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -122.24 149.82 25.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.172 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CE2' HD13 ' A' ' 51' ' ' LEU . 53.1 m-85 -142.27 137.43 30.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.36 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -46.9 164.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.931 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 33.4 Cg_exo -59.99 -19.82 57.43 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.797 2.331 . . . . 0.0 112.071 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.84 -19.71 13.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.432 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.06 -19.38 3.9 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.09 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.418 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -56.69 109.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.876 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -54.65 134.74 47.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.447 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 70' ' ' ALA . 7.2 mt -115.9 -39.1 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.557 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 130.74 -153.69 20.37 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.702 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -94.24 -136.17 8.1 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.946 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -82.85 -55.02 4.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.578 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -57.31 -49.94 74.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.619 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -41.06 98.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.443 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.852 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -61.65 -53.53 54.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.62 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.607 ' N ' HD13 ' A' ' 82' ' ' LEU . 26.7 ttt180 -49.73 -39.2 36.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.87 0.367 . . . . 0.0 110.13 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -67.93 -37.95 82.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 82' ' ' LEU . 14.0 t80 -61.43 -34.5 75.52 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.576 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.852 ' CE2' HD21 ' A' ' 82' ' ' LEU . 12.1 m-85 -78.59 -62.44 1.69 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.003 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.711 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 34.2 ttp . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.743 0.306 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 84.7 m-85 -80.33 154.77 27.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.419 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -137.78 123.96 20.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.107 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 68' ' ' VAL . 53.9 t -108.04 141.59 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.222 0.534 . . . . 0.0 111.592 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.88 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.8 m-85 -123.35 100.54 6.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.41 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.44 -139.12 2.58 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.39 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.453 ' HH ' ' HE1' ' A' ' 43' ' ' PHE . 74.6 m-85 -110.58 160.05 17.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.776 0.322 . . . . 0.0 110.902 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -79.1 -78.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.703 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 t 166.43 -35.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.689 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.42 -22.6 28.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.196 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 40' ' ' LYS . 35.4 mm -91.79 -42.26 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -142.0 151.49 42.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.035 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -72.01 156.31 39.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.928 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 169.69 106.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.829 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -90.57 -32.15 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.377 . . . . 0.0 111.533 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.79 -31.73 71.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.649 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 p -62.23 -43.58 98.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -55.27 -33.38 63.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -73.76 -52.87 11.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.02 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.39 63.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.888 0.375 . . . . 0.0 111.029 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -60.9 -55.33 34.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.503 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.684 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.4 mtp180 -60.67 -29.32 69.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.733 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.717 HD11 ' HG2' ' A' ' 83' ' ' ARG . 3.4 tt -55.97 -53.55 55.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.592 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -69.07 -41.48 77.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 m -61.4 -37.13 82.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.082 0.468 . . . . 0.0 110.151 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 22' ' ' ARG . 75.4 t -77.63 -32.33 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.654 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -71.26 -15.78 62.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.218 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? 73.91 54.52 0.1 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 111.221 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -138.47 141.92 32.97 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.81 137.32 19.83 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.454 2.103 . . . . 0.0 111.623 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.711 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 4.6 p90 -154.56 168.48 26.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.073 0.463 . . . . 0.0 112.216 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -141.62 137.55 31.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.5 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.548 ' CE1' HG11 ' A' ' 4' ' ' VAL . 40.9 t80 -89.39 156.71 18.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.88 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.1 mt -142.15 117.38 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.349 0.595 . . . . 0.0 110.419 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -100.11 130.39 46.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.018 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.498 HG22 ' HB2' ' A' ' 47' ' ' LYS . 32.5 pt -97.6 28.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.024 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 39' ' ' GLU . 18.0 ttm -155.55 98.55 2.3 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.909 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 60.2 Cg_endo -71.32 -27.93 18.91 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.371 2.047 . . . . 0.0 112.098 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 37' ' ' MET . 4.0 mm-40 -139.68 156.01 47.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.994 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.465 ' N ' HG23 ' A' ' 11' ' ' ILE . 1.4 ttmp? -70.81 -7.74 47.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.269 0.557 . . . . 0.0 111.675 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.99 -25.29 8.5 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.487 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 t -142.74 127.01 15.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.289 0.566 . . . . 0.0 112.453 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.6 ' HB3' HD11 ' A' ' 48' ' ' ILE . 33.8 m-85 -71.83 164.11 26.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.215 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -93.08 94.66 8.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.194 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.92 -27.86 68.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.601 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.95 -54.15 48.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.695 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HB2' HG22 ' A' ' 36' ' ' ILE . 36.6 mmtt -69.84 -34.3 73.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.068 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 43' ' ' PHE . 43.8 mt -65.97 -39.66 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.39 -56.35 10.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.175 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.48 -35.43 72.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.835 0.35 . . . . 0.0 110.796 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.474 HD13 ' CD2' ' A' ' 5' ' ' TYR . 13.5 tp -56.92 -50.49 72.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.558 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.428 HD21 ' CG ' ' A' ' 60' ' ' GLN . 80.5 mt -53.39 -48.11 68.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.01 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.4 m -64.0 -35.38 80.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.031 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -38.19 90.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.131 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.11 -53.62 46.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.521 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.66 -109.95 0.33 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.045 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.63 30.83 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.942 0.401 . . . . 0.0 110.812 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -121.13 -149.2 0.42 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.463 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 t -120.49 170.47 9.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.583 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.428 ' CG ' HD21 ' A' ' 52' ' ' LEU . 10.2 mt-30 -82.6 98.2 8.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.188 0.518 . . . . 0.0 110.34 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 pt -80.36 84.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.28 25.6 57.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.499 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.48 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.0 OUTLIER -57.79 157.92 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 110.85 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 p -130.71 170.34 14.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 0.0 111.666 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -120.48 154.8 56.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.588 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HB2' HG13 ' A' ' 4' ' ' VAL . 6.3 Cg_exo -80.99 152.34 81.01 Favored 'Cis proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.908 -1.288 . . . . 0.0 112.803 0.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.48 ' CD ' HD12 ' A' ' 63' ' ' LEU . 10.0 mt-30 -109.08 113.01 25.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.181 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -90.79 166.34 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.409 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 70.1 m-85 -141.73 139.61 32.91 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.031 0.443 . . . . 0.0 110.628 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.688 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -61.42 156.77 50.13 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.496 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 1' ' ' MET . 51.9 Cg_exo -55.73 -31.75 81.39 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.15 2.567 . . . . 0.0 112.185 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -78.93 -35.54 43.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.22 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.6 41.27 0.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.821 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.7 m -120.65 169.12 10.68 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -90.16 117.56 29.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.776 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.688 HD11 ' HA ' ' A' ' 70' ' ' ALA . 27.9 mt -90.35 -49.37 13.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.986 0.422 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.43 -151.47 19.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.619 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.69 -149.28 25.46 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.595 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.693 ' CE1' HD12 ' A' ' 23' ' ' LEU . 18.2 t80 -64.75 -70.16 0.25 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.756 0.313 . . . . 0.0 110.775 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -56.55 -46.52 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.523 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.33 -35.81 68.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.272 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.545 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.4 tt -76.74 -37.03 56.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.287 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HG2' HD11 ' A' ' 23' ' ' LEU . 8.2 mtt180 -52.38 -31.6 34.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -70.66 -33.66 71.19 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.166 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CD2' HG23 ' A' ' 76' ' ' ILE . 40.1 t80 -67.13 -27.42 67.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.604 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.545 ' CE2' HD21 ' A' ' 82' ' ' LEU . 23.9 m-85 -99.29 -17.63 17.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.922 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.5 mttm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.809 -179.712 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.682 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 21.7 tpp . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.35 0.119 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -39.5 119.01 0.89 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.862 0.839 . . . . 0.0 112.069 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -89.38 126.5 35.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.296 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 68' ' ' VAL . 11.5 t -115.93 133.94 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.142 0.496 . . . . 0.0 111.463 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.806 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.5 m-85 -110.69 99.91 8.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -160.2 -137.26 2.18 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.855 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -125.05 141.8 51.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.792 0.33 . . . . 0.0 111.01 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -99.82 26.36 6.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 110.998 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.72 8.44 5.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.682 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -85.52 -49.67 7.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.578 HG23 ' HG3' ' A' ' 40' ' ' LYS . 39.4 mm -104.06 -32.57 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.293 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -141.14 140.26 34.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.835 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -81.26 174.78 11.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.504 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 173.74 109.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.349 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 m -71.82 -35.02 53.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.975 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.38 -29.67 70.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.132 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 t -60.93 -45.67 93.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.916 0.389 . . . . 0.0 110.656 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.39 -24.39 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.319 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 28.6 m-80 -79.96 -46.74 16.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.202 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.84 -53.1 61.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.787 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 13.1 ttpt -59.76 -44.66 93.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.495 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 26' ' ' VAL . 14.9 tpt180 -62.41 -42.6 99.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.414 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.9 tt -56.97 -53.49 57.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.135 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.1 mt -59.29 -43.96 92.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.538 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.6 m -59.34 -43.65 92.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.995 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.9 t -70.81 -38.73 73.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -74.16 -9.76 58.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.796 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' CE ' ' A' ' 28' ' ' LYS . 1.2 ttpt 64.3 59.9 0.99 Allowed 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 121.434 0.635 . . . . 0.0 110.221 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.27 108.83 4.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.088 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.682 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 92.6 Cg_exo -47.08 176.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.618 2.212 . . . . 0.0 112.299 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 4.2 p90 -164.06 170.65 16.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.3 tt0 -133.1 118.16 18.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.313 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.467 ' HE1' HG11 ' A' ' 4' ' ' VAL . 4.1 t80 -89.51 158.86 17.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.738 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.806 HD12 ' CE1' ' A' ' 5' ' ' TYR . 33.8 mt -146.33 122.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.62 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -83.65 123.18 29.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.183 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 pt -100.36 -26.93 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.52 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.8 ttp -121.24 93.49 48.8 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.504 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.4 Cg_endo -82.56 1.26 9.26 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.726 2.284 . . . . 0.0 112.264 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.562 ' C ' HG21 ' A' ' 11' ' ' ILE . 43.6 mt-10 -141.13 137.65 32.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.669 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HG3' HG23 ' A' ' 11' ' ' ILE . 17.1 mtmm -65.53 -8.37 19.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.234 0.54 . . . . 0.0 111.69 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.96 -68.46 1.14 Allowed Glycine 0 C--N 1.312 -0.753 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.104 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 t -134.58 135.48 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.795 0.331 . . . . 0.0 111.151 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -63.29 169.58 3.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.102 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.442 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 t0 -80.86 121.54 26.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.039 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -60.47 -22.4 63.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -64.84 -57.58 8.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.955 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -64.97 -47.2 78.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.716 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.72 -39.26 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.434 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.39 82.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.427 . . . . 0.0 110.418 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -67.13 -40.99 86.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.382 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.6 tp -57.51 -50.41 73.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 52' ' ' LEU . 80.3 mt -52.92 -45.93 67.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.084 0.469 . . . . 0.0 111.284 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.3 m -68.06 -33.16 74.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.283 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HE3' ' CD1' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -64.3 -39.27 93.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.399 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.5 mt -61.17 -66.77 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.967 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.67 -27.06 0.59 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.326 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.67 -175.27 2.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.722 0.296 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.51 -27.44 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.043 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -95.89 170.05 9.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -116.25 100.38 7.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.783 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mt -79.67 84.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.201 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.5 25.56 55.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.588 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -60.01 139.49 57.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.972 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.7 p -122.3 160.08 26.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.8 mtm -117.55 154.47 50.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.673 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.3 Cg_exo -79.52 155.41 89.41 Favored 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 124.105 -1.206 . . . . 0.0 112.74 0.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.419 ' NE2' ' NE2' ' A' ' 75' ' ' HIS . 14.6 mm100 -109.85 125.9 53.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.045 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -97.97 159.82 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.991 0.424 . . . . 0.0 111.977 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 94.3 m-85 -142.9 148.16 36.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.588 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.646 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.16 141.3 69.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.31 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -40.69 -30.94 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.935 2.423 . . . . 0.0 112.168 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -167.86 34.08 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.142 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -125.1 -108.99 1.75 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.774 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.0 -179.6 5.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.447 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 47.0 t-80 -64.39 134.35 54.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.118 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.646 HD11 ' HA ' ' A' ' 70' ' ' ALA . 8.0 mt -104.07 -41.27 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.651 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 137.19 -152.4 21.43 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.003 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.97 -131.05 7.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.502 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 32.6 t80 -76.07 -70.22 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.687 0.28 . . . . 0.0 111.131 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -54.47 -45.42 73.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.939 0.399 . . . . 0.0 110.954 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.468 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.9 OUTLIER -56.43 -45.84 80.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.605 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.723 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -64.46 -41.44 96.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.477 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -52.96 -33.8 52.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.54 -34.19 73.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.16 -33.3 75.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.49 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.723 ' HE2' HD21 ' A' ' 82' ' ' LEU . 21.1 m-85 -90.1 -69.8 0.7 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.471 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.961 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.603 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 2.8 ttt . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -75.1 146.46 41.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.728 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -108.42 118.03 35.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.297 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 68' ' ' VAL . 92.9 t -113.07 129.71 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.407 0.622 . . . . 0.0 112.196 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.616 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 21.9 m-85 -104.61 101.18 10.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.849 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.7 -142.18 3.32 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.516 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.4 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 57.8 m-85 -119.17 154.78 32.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.849 0.357 . . . . 0.0 111.422 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 9' ' ' SER . 22.0 p-10 -89.85 11.57 19.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.799 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER 80.0 -5.73 1.82 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.639 0.257 . . . . 0.0 111.527 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -86.48 -48.63 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' HG22 ' A' ' 11' ' ' ILE . 30.1 mm -94.11 -16.45 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -155.85 142.92 19.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -66.5 115.78 6.75 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.99 0.424 . . . . 0.0 111.761 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p -130.16 89.32 2.78 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.579 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.6 m -81.3 -32.05 11.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.441 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -65.8 -26.64 67.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.178 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.1 t -63.77 -51.91 62.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.408 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.12 -29.54 63.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.196 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -70.6 -57.66 4.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.879 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.23 -41.89 80.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -57.2 -51.19 70.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.812 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.781 ' O ' HG23 ' A' ' 26' ' ' VAL . 14.9 ttm-85 -60.31 -43.6 96.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.462 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.7 tt -58.87 -54.75 43.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.386 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.623 HD23 ' HZ ' ' A' ' 86' ' ' PHE . 5.4 mt -56.71 -46.34 81.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.682 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.6 m -55.83 -38.4 69.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.141 0.496 . . . . 0.0 110.031 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 22' ' ' ARG . 48.6 t -78.8 -31.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.548 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -73.08 -9.78 59.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.16 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 71.13 45.21 0.51 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.914 0.388 . . . . 0.0 110.957 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -132.44 130.48 21.86 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.593 ' O ' ' HA ' ' A' ' 1' ' ' MET . 44.3 Cg_endo -82.8 161.1 16.28 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.636 2.224 . . . . 0.0 111.191 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.474 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 5.1 p90 -161.31 171.2 18.75 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.916 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -132.45 121.19 23.0 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.536 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.636 ' HE1' HG12 ' A' ' 4' ' ' VAL . 1.1 t80 -89.82 150.87 22.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.763 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 mt -142.41 122.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.413 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -87.08 118.04 26.2 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.424 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.86 HD11 ' SD ' ' A' ' 65' ' ' MET . 34.0 pt -97.07 33.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.007 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 39' ' ' GLU . 42.9 ttm -160.59 82.59 2.11 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.57 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.01 -4.76 16.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.032 2.488 . . . . 0.0 112.875 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 37' ' ' MET . 1.8 mm-40 -139.21 155.64 47.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -71.12 -7.13 44.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.06 18.01 3.36 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.205 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 t -150.83 116.46 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 9.0 m-85 -72.31 170.22 14.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.676 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.556 ' C ' HD12 ' A' ' 48' ' ' ILE . 9.6 t0 -100.42 93.32 5.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 70.9 m-20 -64.03 -24.86 67.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.46 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.43 -58.7 5.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 36' ' ' ILE . 14.8 mmtm -69.16 -34.06 74.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.301 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.556 HD12 ' C ' ' A' ' 44' ' ' ASP . 49.1 mt -71.01 -32.69 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.639 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.34 -55.17 34.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -61.52 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.616 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 4.3 tt -59.54 -53.33 59.34 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.223 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.569 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.9 mt -52.88 -47.9 67.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.064 0.459 . . . . 0.0 110.959 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.4 m -53.39 -40.74 65.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.687 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 23.4 mtpp -70.11 -39.41 75.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.74 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -44.42 93.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.486 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.19 -137.03 5.07 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.897 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -122.85 30.34 6.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.123 0.487 . . . . 0.0 110.485 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.25 -156.72 0.69 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.211 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -121.17 170.57 9.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.632 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -79.47 98.14 6.69 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.286 0.565 . . . . 0.0 110.182 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -80.32 86.7 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.909 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.07 27.93 60.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.505 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -179.8 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.615 0.245 . . . . 0.0 110.684 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.4 p -150.36 159.72 44.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.154 0.502 . . . . 0.0 111.897 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.86 ' SD ' HD11 ' A' ' 36' ' ' ILE . 2.9 mtt -115.49 158.0 42.72 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.189 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.8 Cg_exo -79.7 145.48 73.56 Favored 'Cis proline' 0 C--N 1.345 0.347 0 C-N-CA 124.47 -1.054 . . . . 0.0 113.27 0.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -105.52 126.77 52.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.133 178.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 4' ' ' VAL . 5.7 t -96.99 159.02 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.99 0.424 . . . . 0.0 111.645 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.462 ' N ' HG12 ' A' ' 68' ' ' VAL . 32.0 m-85 -142.83 144.26 32.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.729 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.593 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -53.81 133.38 56.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.263 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 35.1 Cg_exo -55.05 -17.03 13.46 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.523 2.149 . . . . 0.0 112.312 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.73 39.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.386 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.86 -114.81 0.76 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.273 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.1 p -125.56 -173.02 2.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.142 0.496 . . . . 0.0 111.32 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 35.9 t-80 -66.35 145.18 56.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 70' ' ' ALA . 1.7 mp -120.04 -35.4 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.939 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 123.83 -156.55 18.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.093 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.27 -137.33 8.65 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.418 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.602 ' CE1' HD13 ' A' ' 23' ' ' LEU . 28.4 t80 -69.61 -70.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.723 0.297 . . . . 0.0 111.05 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -57.19 -48.98 77.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.964 0.412 . . . . 0.0 110.71 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -50.42 -36.66 34.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.359 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.589 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.4 tt -82.67 -29.85 29.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.232 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -51.63 -31.37 25.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -65.67 -34.73 78.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.112 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CD2' HG12 ' A' ' 76' ' ' ILE . 22.1 t80 -64.89 -33.22 75.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.542 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.623 ' HZ ' HD23 ' A' ' 24' ' ' LEU . 6.5 m-85 -86.49 -65.03 1.06 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.454 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.001 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.696 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 19.5 ttm . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.921 0.391 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 57.4 m-85 -82.43 151.39 26.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.764 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.1 mppp? -126.47 120.62 30.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.857 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.524 HG11 ' CE1' ' A' ' 33' ' ' PHE . 6.2 t -109.49 116.64 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.115 0.483 . . . . 0.0 111.848 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 21.8 m-85 -96.04 100.54 12.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.901 178.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.69 -137.96 2.32 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.352 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.678 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 3.1 m-85 -127.24 151.75 48.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -144.83 38.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.953 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.524 ' HB2' HG12 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -163.94 -162.82 0.73 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.108 0.48 . . . . 0.0 111.856 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -86.52 8.48 21.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.083 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.653 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -87.54 -8.13 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.678 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 20.6 t-80 -170.17 144.07 2.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.329 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.607 ' HE2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -80.76 155.47 26.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.281 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 168.82 82.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.97 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.607 HG13 ' HE2' ' A' ' 13' ' ' LYS . 34.4 m -73.97 -41.23 52.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 15' ' ' VAL . 1.7 m-85 -59.57 -20.4 55.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.138 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 t -66.76 -60.23 2.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.778 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.74 -40.04 39.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 110.624 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -65.64 -43.99 87.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.576 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -67.41 -33.29 74.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -56.97 -44.39 82.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.813 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.0 ttp180 -70.94 -25.14 62.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.325 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.732 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -54.1 -57.29 11.64 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.241 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.62 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 13.8 mt -64.31 -41.41 96.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.52 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.2 m -60.39 -34.5 73.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.297 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 22' ' ' ARG . 67.2 t -72.24 -42.94 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.933 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -72.6 -19.75 61.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.209 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 2.7 tppt? 79.79 71.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 111.382 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -143.46 143.28 23.41 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.0 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.45 130.12 11.59 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.474 2.116 . . . . 0.0 111.968 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.696 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 6.1 p90 -151.54 166.96 29.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.89 0.376 . . . . 0.0 111.959 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -143.09 136.13 27.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.883 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CE1' HG11 ' A' ' 4' ' ' VAL . 13.1 t80 -89.75 159.79 16.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.224 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.701 HG21 ' HD2' ' A' ' 47' ' ' LYS . 23.5 mt -150.09 126.09 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.123 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 8' ' ' ASP . 68.6 m-80 -86.72 111.24 20.51 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.176 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.488 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 21.9 pt -75.22 -5.79 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.505 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.484 ' HE2' ' CE1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -135.33 69.77 68.35 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.448 179.548 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.48 -13.74 35.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.596 2.197 . . . . 0.0 112.135 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -139.16 135.79 34.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.352 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.86 -9.01 3.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.31 0.576 . . . . 0.0 111.429 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.06 -61.08 3.87 Favored Glycine 0 C--N 1.312 -0.767 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.352 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.4 t -151.95 157.0 5.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CE1' ' HE2' ' A' ' 37' ' ' MET . 24.1 m-85 -58.83 170.3 0.84 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.902 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.742 ' O ' HD12 ' A' ' 48' ' ' ILE . 7.5 t70 -100.24 113.0 25.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.64 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.633 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 9.2 p30 -73.01 -18.79 61.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.07 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.45 -63.29 1.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 111.152 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.701 ' HD2' HG21 ' A' ' 34' ' ' ILE . 34.9 mmtt -64.17 -40.08 95.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.55 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.742 HD12 ' O ' ' A' ' 44' ' ' ASP . 34.9 mt -66.13 -28.53 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.654 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -64.23 -49.76 70.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.684 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -37.68 77.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.425 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.641 HD13 ' CE2' ' A' ' 69' ' ' PHE . 5.9 tp -57.3 -50.85 71.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.689 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -52.86 -45.94 67.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.516 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.7 m -62.99 -35.75 81.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.672 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -65.81 -38.59 89.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.788 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 51' ' ' LEU . 1.3 mt -59.6 -70.15 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.77 -106.95 0.2 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.144 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -150.35 32.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 111.045 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -120.97 -145.42 0.36 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.365 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.01 170.18 9.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.837 0.351 . . . . 0.0 110.712 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.1 98.43 1.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.4 0.619 . . . . 0.0 110.352 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.9 mt -79.67 85.5 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.346 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.21 28.23 54.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.489 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -46.58 123.51 5.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.393 . . . . 0.0 111.158 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 24.9 p -104.51 136.52 43.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.077 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.5 mmt -102.92 152.16 38.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.7 Cg_endo -83.56 144.64 49.42 Favored 'Cis proline' 0 C--N 1.346 0.405 0 C-N-CA 124.246 -1.148 . . . . 0.0 112.653 0.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 25.3 mm-40 -104.33 154.08 20.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -123.35 159.35 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.459 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.641 ' CE2' HD13 ' A' ' 51' ' ' LEU . 25.3 m-85 -142.3 132.7 25.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.932 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.571 ' N ' HD11 ' A' ' 76' ' ' ILE . . . -65.54 150.16 96.36 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.239 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.564 ' HB3' ' N ' ' A' ' 1' ' ' MET . 71.1 Cg_exo -45.73 -42.98 19.28 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.215 2.61 . . . . 0.0 112.746 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -29.03 64.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.98 79.64 0.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.467 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.9 127.57 3.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.939 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -58.54 108.94 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.613 HG23 ' CD2' ' A' ' 85' ' ' TYR . 4.0 mt -81.5 -41.79 19.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 125.48 -149.52 17.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.491 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -98.22 -132.42 7.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.32 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.732 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -83.02 -69.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.578 0.189 . . . . 0.0 110.877 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.7 -43.53 47.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.175 0.512 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -42.34 95.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.746 HD21 ' CE1' ' A' ' 86' ' ' PHE . 1.6 tt -71.77 -41.58 68.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.752 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -51.12 -35.24 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.85 -35.57 77.09 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.122 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.613 ' CD2' HG23 ' A' ' 76' ' ' ILE . 59.5 t80 -64.49 -32.36 73.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.588 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.746 ' CE1' HD21 ' A' ' 82' ' ' LEU . 27.7 m-85 -89.79 -27.1 20.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.058 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.701 179.701 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.8 ttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.897 0.379 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 68.9 m-85 -60.19 157.44 13.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.771 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.694 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -134.11 116.32 15.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.702 -179.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 68' ' ' VAL . 19.0 t -105.91 125.62 61.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.266 0.555 . . . . 0.0 111.829 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.768 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.0 m-30 -101.96 99.47 9.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.532 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.68 -138.02 2.33 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.413 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.718 ' HE2' ' HE3' ' A' ' 37' ' ' MET . 22.6 m-85 -120.06 139.97 51.73 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 120.626 0.25 . . . . 0.0 110.502 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -92.97 22.28 5.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 4.5 m 65.74 5.73 3.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -81.89 -44.02 17.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.074 0.464 . . . . 0.0 110.521 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 11' ' ' ILE . 9.8 mm -124.95 1.5 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.263 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 13.3 t-80 -157.04 131.19 8.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.538 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -80.99 159.57 24.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.348 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 176.75 123.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.118 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.0 m -83.13 -39.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.818 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -55.45 -28.85 56.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.728 0.299 . . . . 0.0 111.284 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.5 m -62.16 -53.84 49.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.55 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.26 -34.19 56.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.167 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -70.22 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.963 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.51 -31.95 48.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.288 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -60.69 -56.01 26.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.571 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.82 ' O ' HG23 ' A' ' 26' ' ' VAL . 12.1 ttt85 -64.65 -27.09 68.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.772 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.808 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.6 tt -57.31 -57.4 12.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.385 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.693 HD12 ' CG ' ' A' ' 31' ' ' PHE . 3.8 mt -59.85 -41.89 92.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.599 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -37.16 79.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.094 0.474 . . . . 0.0 110.063 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 22' ' ' ARG . 92.6 t -77.64 -25.36 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.867 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HE3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -77.71 -15.74 58.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? 70.34 42.28 0.93 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.066 0.46 . . . . 0.0 110.524 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -128.33 143.75 49.29 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.499 ' O ' ' HA ' ' A' ' 1' ' ' MET . 92.1 Cg_endo -77.01 136.96 16.96 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.389 2.06 . . . . 0.0 111.674 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.693 ' CG ' HD12 ' A' ' 24' ' ' LEU . 12.6 p90 -149.12 170.31 18.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.915 0.388 . . . . 0.0 112.008 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -147.75 141.21 25.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.196 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.471 ' HE1' HG11 ' A' ' 4' ' ' VAL . 8.3 t80 -89.71 162.87 15.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.043 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.768 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.9 mt -146.12 119.78 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.262 0.554 . . . . 0.0 110.417 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -82.08 125.23 30.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.346 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.45 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.9 pt -100.31 -12.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.171 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.718 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 21.7 ttm -123.07 79.04 51.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.767 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 17.9 Cg_exo -65.56 -22.1 58.91 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.283 1.989 . . . . 0.0 111.608 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -139.22 137.46 35.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.704 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.468 ' N ' HG21 ' A' ' 11' ' ' ILE . 19.7 tttt -61.35 -9.18 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.22 0.533 . . . . 0.0 112.245 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.31 -55.72 4.6 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.449 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 t -150.46 139.25 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.616 0.246 . . . . 0.0 111.559 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -58.76 170.33 0.82 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.045 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.482 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 12.6 p30 -88.89 109.49 20.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 111.875 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -58.06 -31.12 66.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.619 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -52.99 -42.35 65.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.786 0.327 . . . . 0.0 110.971 -179.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 53.0 mmtt -80.62 -39.15 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.254 0.55 . . . . 0.0 109.887 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 44' ' ' ASP . 43.9 mm -55.93 -46.01 80.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.722 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.68 -56.44 12.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.322 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 7.4 pt-20 -60.68 -28.78 68.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.583 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.11 -56.44 22.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.362 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.686 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.8 mt -52.35 -45.24 65.62 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.9 m -60.72 -38.81 86.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.278 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -65.27 -37.7 87.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.521 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -60.03 -20.17 56.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.935 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.27 -88.81 1.53 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.124 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -139.4 31.53 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.454 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' O ' HD12 ' A' ' 55' ' ' LEU . 5.2 t0 -121.61 110.55 16.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.376 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.4 t -78.25 142.06 38.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.452 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.9 pt20 -70.8 97.57 1.41 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.378 0.608 . . . . 0.0 111.036 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 61' ' ' ILE . 6.5 tp -80.88 79.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.481 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.76 24.37 69.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.101 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -54.48 159.91 1.92 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.858 0.361 . . . . 0.0 111.08 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 65' ' ' MET . 18.3 m -125.49 165.76 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.226 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.447 ' N ' HG22 ' A' ' 64' ' ' THR . 13.0 mmt -97.94 155.69 36.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.452 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.6 Cg_endo -86.34 149.81 42.92 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 124.211 -1.162 . . . . 0.0 113.106 0.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -108.71 112.61 25.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.918 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 4' ' ' VAL . 3.2 t -89.5 163.02 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.219 0.533 . . . . 0.0 112.183 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 44.9 m-85 -141.58 137.3 31.84 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.132 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.756 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -50.99 152.22 3.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.065 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.478 ' HB3' ' N ' ' A' ' 1' ' ' MET . 53.0 Cg_exo -54.87 -24.32 38.24 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.728 2.286 . . . . 0.0 112.028 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -101.63 -22.52 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.991 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.3 85.66 0.78 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.707 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.47 ' O ' HD12 ' A' ' 76' ' ' ILE . 1.4 m -165.79 126.68 1.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.736 0.303 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -61.28 117.72 5.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.794 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 70' ' ' ALA . 2.4 mp -110.11 -27.9 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.961 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 117.12 -155.46 16.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.901 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.06 -134.36 7.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.419 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.808 ' CE1' HD12 ' A' ' 23' ' ' LEU . 36.5 t80 -74.3 -67.12 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.625 0.25 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.81 -52.68 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -51.05 -41.85 60.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.402 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.737 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.6 tt -78.83 -29.03 44.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.129 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 87' ' ' LYS . 14.2 ttt85 -52.81 -30.66 34.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -67.77 -30.39 69.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' LEU . 24.0 t80 -68.64 -33.65 74.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.574 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.737 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.2 m-85 -95.51 -70.72 0.7 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.819 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' ARG . 1.3 mtpm? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.93 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 28.5 ttm . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.08 143.37 35.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.146 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.15 120.14 41.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.617 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.428 HG11 ' HE1' ' A' ' 33' ' ' PHE . 67.6 t -104.39 126.8 59.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.268 0.556 . . . . 0.0 111.727 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.716 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.8 m-30 -103.8 99.53 9.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.457 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.74 -141.05 3.04 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.33 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -116.61 160.63 20.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 120.675 0.274 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB2' HD13 ' A' ' 11' ' ' ILE . 6.1 m-20 -81.59 -78.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 t 170.49 -35.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.799 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -84.55 -22.94 29.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.38 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.599 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.3 mp -93.1 -39.01 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.74 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -155.93 145.0 20.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.272 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -68.39 158.26 33.99 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 p 175.38 113.9 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.815 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.6 m -90.29 -36.76 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.927 0.394 . . . . 0.0 111.1 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -62.25 -29.18 70.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.996 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 m -58.08 -48.04 81.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.028 0.442 . . . . 0.0 110.289 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -28.07 68.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.486 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.19 -57.22 4.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.765 0.317 . . . . 0.0 111.156 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.17 -26.16 37.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.319 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -68.53 -58.12 4.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 110.327 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.888 ' O ' HG23 ' A' ' 26' ' ' VAL . 13.1 mtt180 -63.17 -28.63 70.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.544 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.942 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -55.98 -56.53 19.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.197 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.633 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 1.5 mt -57.26 -40.01 76.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.58 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.4 m -60.06 -34.93 74.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.311 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 22' ' ' ARG . 22.1 t -62.41 -51.16 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.408 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' CE ' ' CE2' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -66.48 -16.74 64.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.375 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.82 42.82 0.19 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.141 0.496 . . . . 0.0 110.119 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -120.21 138.58 27.32 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.124 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.613 ' O ' ' HA ' ' A' ' 1' ' ' MET . 97.2 Cg_endo -74.31 158.24 44.94 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.013 1.809 . . . . 0.0 111.012 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.546 ' CG ' HD12 ' A' ' 24' ' ' LEU . 35.8 p90 -161.37 171.05 18.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.8 0.334 . . . . 0.0 111.668 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -141.57 130.83 23.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.512 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.428 ' HE1' HG11 ' A' ' 4' ' ' VAL . 21.0 t80 -89.14 159.56 17.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.955 0.407 . . . . 0.0 111.298 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.716 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.2 mt -146.85 120.11 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.552 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -91.66 112.48 24.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.543 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.82 HD11 ' CG1' ' A' ' 48' ' ' ILE . 6.6 tt -87.18 49.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.3 ttm -171.38 98.81 0.4 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.566 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 35.7 Cg_endo -65.1 -30.3 55.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.374 2.05 . . . . 0.0 112.288 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -143.01 158.71 43.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.419 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -71.0 -7.78 48.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.313 0.577 . . . . 0.0 111.498 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.61 -20.25 8.67 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.925 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 t -141.36 122.74 13.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.413 0.625 . . . . 0.0 112.5 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.746 ' HB3' HD11 ' A' ' 48' ' ' ILE . 31.6 m-85 -73.41 161.92 29.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.3 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.434 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 1.1 t70 -83.7 87.39 7.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.77 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -24.86 64.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.297 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -61.06 -55.86 27.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 110.713 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 6.4 mmtt -70.74 -43.55 68.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.112 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.82 ' CG1' HD11 ' A' ' 36' ' ' ILE . 63.0 mt -50.43 -38.22 15.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.672 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.47 -59.26 3.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 8.8 pt-20 -60.26 -30.03 69.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.159 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD2' HD21 ' A' ' 55' ' ' LEU . 1.9 tt -58.23 -50.14 74.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.146 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.1 mt -54.88 -48.4 73.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.097 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.9 m -66.18 -35.34 80.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.372 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -65.4 -37.14 86.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.829 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.503 HD21 ' CD2' ' A' ' 51' ' ' LEU . 1.2 mt -60.25 -67.34 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.85 -27.18 0.29 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.678 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.05 -165.5 1.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.898 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -91.56 -31.35 15.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.789 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -110.67 170.15 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 62' ' ' GLY . 9.9 pt20 -114.36 100.54 8.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.489 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -58.8 82.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.482 0.658 . . . . 0.0 111.598 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 60' ' ' GLN . . . 62.33 20.96 61.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.983 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.94 135.07 36.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.6 p -136.83 170.93 15.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.465 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.0 155.64 47.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.561 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -75.72 143.13 76.06 Favored 'Cis proline' 0 C--N 1.344 0.323 0 C-N-CA 123.8 -1.333 . . . . 0.0 112.83 0.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 1.7 mt-30 -111.97 113.76 26.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.879 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -87.91 161.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.111 0.482 . . . . 0.0 111.587 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 57.4 m-85 -143.08 139.04 30.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.345 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.704 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.53 132.52 54.43 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.294 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HB3' ' N ' ' A' ' 1' ' ' MET . 38.2 Cg_exo -54.87 -20.74 23.56 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.448 2.099 . . . . 0.0 111.911 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.57 39.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.279 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.48 -111.35 0.68 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.923 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.515 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 5.4 t -137.4 179.88 6.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.179 0.514 . . . . 0.0 111.273 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 41.0 t-80 -56.34 126.9 28.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.025 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.704 HD11 ' HA ' ' A' ' 70' ' ' ALA . 11.0 mt -94.66 -42.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.78 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 134.22 -154.86 21.58 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.8 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 82' ' ' LEU . . . -93.62 -149.07 24.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.372 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.942 ' CE1' HD12 ' A' ' 23' ' ' LEU . 58.3 t80 -67.66 -59.14 3.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.757 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -62.09 -54.74 37.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.051 0.453 . . . . 0.0 110.818 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -52.02 -41.04 61.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.6 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.773 HD21 ' CE1' ' A' ' 86' ' ' PHE . 6.1 tt -79.69 -28.19 40.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.24 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 87' ' ' LYS . 2.2 mmm180 -52.28 -35.05 49.22 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -60.12 -32.59 71.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.2 t80 -68.4 -28.5 67.14 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.929 178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.773 ' CE1' HD21 ' A' ' 82' ' ' LEU . 15.7 m-85 -100.11 -70.86 0.72 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.833 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.567 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 56.2 ttp . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 81.0 m-85 -51.01 149.12 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.198 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 1.1 mptp? -117.23 116.99 28.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.219 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 68' ' ' VAL . 44.1 t -110.67 128.55 66.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.513 0.673 . . . . 0.0 112.577 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.583 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 22.0 m-85 -108.74 106.44 16.47 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.592 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.68 -137.26 2.29 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.831 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -123.94 134.11 53.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 122.449 0.3 . . . . 0.0 110.324 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -100.39 39.14 1.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 111.318 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 t 60.15 14.05 4.24 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.627 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -85.83 -53.29 5.21 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.901 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 37' ' ' MET . 18.6 mt -110.97 -15.26 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -160.67 148.42 15.99 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.07 159.28 33.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.62 119.07 1.0 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.433 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -90.38 -31.21 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.032 0.444 . . . . 0.0 111.125 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -62.7 -28.84 70.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.805 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 t -59.32 -47.07 86.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.049 0.452 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -62.52 -33.89 75.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.214 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 83.4 m-20 -74.61 -46.53 37.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.017 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -66.69 -40.52 88.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.92 0.39 . . . . 0.0 110.803 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -57.49 10.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.787 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.789 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -58.0 -40.12 79.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.387 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.733 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -59.15 -54.82 42.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.129 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.733 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.4 mt -55.97 -45.97 78.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.665 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -55.98 -38.01 69.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.157 0.504 . . . . 0.0 109.928 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.5 t -79.29 -29.71 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.497 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -75.25 -13.73 60.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.114 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm 68.56 46.31 1.01 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.0 0.429 . . . . 0.0 110.926 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -126.83 141.04 39.27 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.847 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.48 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.5 Cg_endo -82.06 140.38 11.21 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.514 2.143 . . . . 0.0 111.404 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 42.6 p90 -157.94 169.74 23.91 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.639 -0.424 . . . . 0.0 112.077 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.86 139.68 23.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.241 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.64 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.6 t80 -89.42 161.44 16.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.521 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.415 HG13 ' C ' ' A' ' 33' ' ' PHE . 12.1 mt -149.88 122.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 110.511 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -79.31 110.65 14.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.274 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.517 HG21 ' HB3' ' A' ' 5' ' ' TYR . 2.3 pt -86.01 -2.28 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.599 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.665 ' O ' HD12 ' A' ' 11' ' ' ILE . 38.5 ttm -119.41 107.22 41.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.87 -28.28 4.14 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.568 2.178 . . . . 0.0 111.546 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -139.95 152.77 46.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.665 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -65.6 -8.46 20.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.236 0.541 . . . . 0.0 112.048 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.41 -54.03 3.65 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.495 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.4 t -148.72 154.79 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.805 0.336 . . . . 0.0 111.378 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -77.45 170.39 16.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.96 114.42 25.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.687 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 35.1 m-20 -63.7 -15.62 58.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.412 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -62.7 -55.99 21.73 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.826 0.345 . . . . 0.0 110.839 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -70.09 -35.81 74.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' ' 43' ' ' PHE . 56.5 mt -70.43 -32.98 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.687 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.1 -57.42 12.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.64 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -63.17 -25.78 68.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.144 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.583 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 3.7 tt -60.36 -56.17 24.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.991 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.665 ' N ' HD23 ' A' ' 52' ' ' LEU . 2.1 mt -52.96 -45.17 67.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.065 0.46 . . . . 0.0 111.093 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 m -56.87 -49.02 76.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.379 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 11.3 mtpp -60.78 -36.28 78.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.404 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.78 -24.04 67.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.95 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.97 -132.65 11.38 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.925 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.56 31.24 2.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.102 0.477 . . . . 0.0 110.665 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.72 109.41 14.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.542 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 t -78.39 152.1 32.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.389 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -69.89 97.63 1.15 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.398 0.618 . . . . 0.0 110.898 -179.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.54 81.32 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.714 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.93 24.79 67.15 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.167 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -55.23 173.28 0.11 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.756 0.312 . . . . 0.0 110.778 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.8 p -133.16 169.05 17.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.193 0.52 . . . . 0.0 111.636 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.411 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 15.5 mmt -111.36 155.11 43.31 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.261 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.3 Cg_exo -84.33 143.01 40.18 Favored 'Cis proline' 0 N--CA 1.462 -0.341 0 C-N-CA 124.223 -1.157 . . . . 0.0 113.108 0.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -97.4 130.49 44.53 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.671 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 4' ' ' VAL . 4.1 t -99.77 160.56 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.02 0.438 . . . . 0.0 111.696 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.59 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 20.7 m-85 -141.55 138.1 32.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.527 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.572 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -44.82 138.51 4.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.502 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 90.6 Cg_exo -46.38 -25.73 3.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.917 2.411 . . . . 0.0 111.992 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.98 39.16 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.044 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.05 -112.37 1.09 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.366 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 t -127.18 -172.55 2.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.086 0.47 . . . . 0.0 111.495 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 28.5 t-80 -67.21 145.83 54.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.087 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 70' ' ' ALA . 2.3 mp -123.04 -35.9 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.134 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.451 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.01 -156.44 20.72 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.774 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.73 -138.16 8.44 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.471 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 23' ' ' LEU . 31.5 t80 -71.85 -70.53 0.32 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.74 0.305 . . . . 0.0 110.773 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -56.43 -49.3 74.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.99 0.424 . . . . 0.0 110.48 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -36.34 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.291 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.634 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.9 tt -84.32 -29.77 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.023 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -51.7 -31.05 24.56 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.94 -34.42 78.08 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.219 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.459 ' CD2' HG12 ' A' ' 76' ' ' ILE . 15.4 t80 -65.27 -33.01 74.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.426 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.634 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.8 m-85 -87.95 -26.27 22.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.275 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 mttt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.9 -179.969 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.611 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 29.8 ttp . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -79.88 143.66 34.1 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.395 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.71 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -105.21 121.77 44.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.398 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 68' ' ' VAL . 38.6 t -103.38 126.58 57.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.82 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.577 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.6 m-30 -102.51 99.26 9.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.404 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.39 -138.33 2.46 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.503 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.769 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 93.0 m-85 -131.41 157.05 44.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.937 0.398 . . . . 0.0 111.543 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.588 ' O ' ' O ' ' A' ' 12' ' ' HIS . 32.6 p30 -80.25 -177.91 6.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.587 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -91.77 -13.7 31.11 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.698 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -85.67 -41.94 14.72 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mm -89.54 -45.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.588 ' O ' ' O ' ' A' ' 8' ' ' ASP . 20.8 t60 -139.64 115.51 10.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.68 0.752 . . . . 0.0 110.618 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.87 148.04 14.02 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.682 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 p -158.03 104.96 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 m -82.33 -33.37 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.723 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.97 -25.7 64.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.348 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.28 -48.78 80.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.626 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -55.29 -24.4 28.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.549 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 8.9 m-80 -74.68 -50.05 19.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.303 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.584 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -65.09 -40.79 95.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.791 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -61.41 -57.58 11.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.344 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.832 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -62.04 -33.8 75.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 0.0 109.709 179.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.78 HD13 ' N ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -57.55 -54.6 45.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.914 178.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.78 ' N ' HD13 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -58.49 -47.46 84.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.515 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -53.07 -39.99 63.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.116 0.484 . . . . 0.0 109.946 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 22' ' ' ARG . 60.7 t -72.98 -31.01 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.457 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HD3' ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -78.13 -9.81 59.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.043 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.35 37.25 1.2 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.051 0.453 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -123.51 133.13 24.37 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.015 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.611 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.9 Cg_endo -82.01 158.08 18.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.543 2.162 . . . . 0.0 111.227 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 9.1 p90 -161.72 171.57 17.67 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.767 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -136.86 137.42 39.66 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.463 ' HE1' HG11 ' A' ' 4' ' ' VAL . 10.9 t80 -89.36 158.42 17.79 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.196 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.577 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.1 mt -147.5 122.32 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.339 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -92.77 127.22 38.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.182 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.769 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 4.2 pt -89.53 -9.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.929 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.602 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 18.1 ttm -125.25 100.31 32.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.642 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.28 -22.99 28.94 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.647 2.232 . . . . 0.0 112.357 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -139.92 145.13 37.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -9.3 4.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.308 0.575 . . . . 0.0 111.78 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.91 -59.7 2.41 Favored Glycine 0 C--N 1.313 -0.708 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.741 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -146.85 134.69 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.685 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -69.49 170.64 10.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 48' ' ' ILE . 27.5 t70 -89.73 95.97 10.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.048 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -57.41 -18.68 19.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.104 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.47 -53.21 60.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -71.83 -36.29 70.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.362 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 44' ' ' ASP . 37.9 mm -53.16 -48.24 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.966 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.3 -53.14 57.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.627 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.49 -28.53 65.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.37 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.669 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.0 tt -58.23 -58.1 9.94 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.561 ' N ' HD23 ' A' ' 52' ' ' LEU . 4.1 mt -48.66 -48.14 40.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.307 0.575 . . . . 0.0 111.335 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.9 m -71.09 -22.06 62.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.192 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -73.09 -42.87 62.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.93 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.719 HD23 ' CE1' ' A' ' 75' ' ' HIS . 1.5 mp -59.33 -39.28 82.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.001 0.429 . . . . 0.0 110.886 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.94 -109.07 0.27 Allowed Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.057 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -150.5 32.53 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.241 0.544 . . . . 0.0 110.725 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -120.98 -152.09 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.385 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -120.98 170.6 9.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.863 0.363 . . . . 0.0 110.831 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -90.38 98.8 11.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.304 0.573 . . . . 0.0 110.476 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.6 mm -79.27 84.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.192 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.87 25.53 56.38 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.448 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.576 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.1 mm? -58.05 145.53 36.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 110.781 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.4 p -127.86 170.52 12.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.43 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.28 156.37 35.23 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.648 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.8 Cg_endo -85.19 145.12 40.18 Favored 'Cis proline' 0 N--CA 1.461 -0.419 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.834 0.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.576 ' CD ' HD12 ' A' ' 63' ' ' LEU . 3.3 mm-40 -107.68 113.35 26.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.743 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.8 t -87.25 161.36 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.291 0.567 . . . . 0.0 111.829 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.44 ' N ' HG12 ' A' ' 68' ' ' VAL . 55.8 m-85 -142.75 143.17 32.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.016 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.665 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -52.91 149.77 11.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.113 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' HB3' ' N ' ' A' ' 1' ' ' MET . 8.8 Cg_exo -68.79 -9.88 27.49 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.701 2.267 . . . . 0.0 112.39 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.6 -18.53 13.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.204 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.19 91.34 1.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.665 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m 176.29 158.24 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.537 0.208 . . . . 0.0 110.655 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.719 ' CE1' HD23 ' A' ' 55' ' ' LEU . 9.8 t-160 -90.46 133.52 34.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.665 HD12 ' N ' ' A' ' 70' ' ' ALA . 2.5 mt -122.28 -40.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.986 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 126.23 -161.38 20.6 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.928 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.26 -139.04 8.13 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.785 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -71.11 -70.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.602 0.239 . . . . 0.0 111.144 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -55.21 -50.83 68.39 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.198 0.523 . . . . 0.0 110.436 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -50.99 -43.71 60.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.231 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.618 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.1 tt -77.62 -29.1 51.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.312 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -52.25 -30.78 29.34 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.57 -35.56 79.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.5 t80 -61.79 -34.95 76.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.153 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.618 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -87.22 -27.53 22.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.266 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.8 mttt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.922 -179.85 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.637 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 17.9 ttp . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.402 ' CD1' ' CD2' ' A' ' 24' ' ' LEU . 71.2 m-85 -76.77 153.83 34.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.09 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -113.0 119.58 38.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.777 -179.468 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 68' ' ' VAL . 56.0 t -111.22 126.6 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.21 0.529 . . . . 0.0 111.865 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.643 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 22.7 m-85 -105.45 101.15 10.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.094 178.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.28 -137.46 2.24 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.498 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.612 ' CE1' HD11 ' A' ' 36' ' ' ILE . 46.8 m-85 -122.99 159.26 28.71 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -86.43 -70.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t 170.97 -37.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.743 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -79.09 -27.62 43.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.997 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.765 HG21 ' O ' ' A' ' 37' ' ' MET . 3.4 mp -89.59 -42.14 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.854 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -153.32 154.62 34.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.9 157.91 32.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.776 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p 179.12 86.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -72.76 -34.95 48.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.285 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.02 -19.07 65.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.343 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 t -69.17 -62.41 1.39 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.83 0.348 . . . . 0.0 110.515 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -49.82 -36.34 26.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.741 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -62.28 -54.26 43.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.768 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.0 -45.98 85.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.258 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -50.0 -38.35 36.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.943 0.402 . . . . 0.0 110.299 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.801 ' O ' HG23 ' A' ' 26' ' ' VAL . 11.8 tpt180 -68.52 -31.44 70.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.957 179.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.8 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.1 tt -56.52 -55.65 31.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.956 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.681 HD23 ' HZ ' ' A' ' 86' ' ' PHE . 1.3 mt -60.28 -52.32 65.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.696 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.1 m -51.13 -41.37 60.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.621 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 22' ' ' ARG . 74.9 t -66.19 -31.99 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.74 -9.8 57.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.107 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.49 51.41 0.12 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.941 0.4 . . . . 0.0 110.52 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.401 ' NE2' ' HD2' ' A' ' 30' ' ' PRO . 15.0 mm100 -132.04 133.69 24.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.211 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.599 ' O ' ' HA ' ' A' ' 1' ' ' MET . 57.8 Cg_endo -81.7 161.57 19.02 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.547 2.165 . . . . 0.0 111.215 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 5.3 p90 -161.45 171.45 18.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 111.544 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -133.13 126.25 31.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.826 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.485 ' HE1' HG11 ' A' ' 4' ' ' VAL . 10.7 t80 -89.79 158.22 17.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.466 HD12 ' CE1' ' A' ' 5' ' ' TYR . 24.1 mt -150.71 125.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.313 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -80.14 115.69 19.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.749 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.612 HD11 ' CE1' ' A' ' 7' ' ' TYR . 2.3 pp -79.6 -20.3 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.071 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.765 ' O ' HG21 ' A' ' 11' ' ' ILE . 1.9 ttp -124.22 85.76 54.89 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.146 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.94 -3.64 14.11 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.903 2.402 . . . . 0.0 112.429 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 37' ' ' MET . 9.2 tt0 -139.52 136.78 34.87 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.705 0.288 . . . . 0.0 110.732 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -64.27 -8.9 14.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.222 0.534 . . . . 0.0 112.131 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.47 -63.38 1.64 Allowed Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.93 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.79 146.79 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.645 0.259 . . . . 0.0 110.75 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -72.32 168.88 17.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 111.263 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.669 ' O ' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -86.22 119.92 27.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.465 -179.506 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 4.9 t0 -76.23 -19.7 58.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.099 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.8 -58.73 6.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.965 0.412 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HD3' HG21 ' A' ' 34' ' ' ILE . 6.8 mmpt? -64.39 -40.59 96.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.095 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.669 HD12 ' O ' ' A' ' 44' ' ' ASP . 46.4 mt -65.41 -32.34 57.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.564 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -60.23 -48.45 81.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.786 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.86 -37.44 82.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.376 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.5 tt -58.98 -57.67 12.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.751 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.576 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 77.0 mt -46.27 -43.75 15.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.803 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 m -70.95 -28.79 64.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' CD ' ' CD2' ' A' ' 69' ' ' PHE . 2.9 ttmm -65.19 -45.14 86.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.597 -179.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.5 mp -59.43 -63.98 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.98 0.419 . . . . 0.0 111.127 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.33 -113.54 0.31 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.134 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.41 29.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 111.029 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -121.37 -154.76 0.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.308 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 t -120.98 166.04 14.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.729 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.63 ' CD ' HD23 ' A' ' 63' ' ' LEU . 20.9 mt-30 -118.42 99.15 6.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 110.99 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mm -80.93 84.89 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.175 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.02 29.75 3.67 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.357 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.63 HD23 ' CD ' ' A' ' 60' ' ' GLN . 3.1 tm? -52.34 131.66 33.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 110.798 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.629 ' N ' HD13 ' A' ' 63' ' ' LEU . 3.0 p -116.84 152.7 33.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.227 0.537 . . . . 0.0 111.635 -179.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -117.14 158.57 44.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.449 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.5 Cg_endo -87.02 134.88 15.97 Favored 'Cis proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.197 -1.168 . . . . 0.0 112.762 0.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.42 ' CG ' ' NE2' ' A' ' 75' ' ' HIS . 1.9 tp60 -92.68 139.15 30.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.878 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 77' ' ' GLY . 3.7 t -108.12 157.54 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.59 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.425 ' N ' HG12 ' A' ' 68' ' ' VAL . 28.5 m-85 -144.15 141.32 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.557 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.66 148.4 26.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.637 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 12.8 Cg_exo -67.45 -14.04 41.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.902 2.401 . . . . 0.0 112.198 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.51 -21.54 14.73 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.148 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.78 88.54 0.83 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.674 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m 179.39 158.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.633 0.254 . . . . 0.0 110.743 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.42 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 8.4 t-160 -90.34 133.49 34.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.557 HD11 ' HA ' ' A' ' 70' ' ' ALA . 17.1 mt -116.97 -45.55 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.979 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.622 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 122.01 -152.17 16.87 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.026 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -95.68 -131.07 6.48 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.562 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.8 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -77.55 -70.15 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.653 0.227 . . . . 0.0 111.048 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -51.56 -50.76 59.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.366 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -55.96 -39.59 71.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.614 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.7 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.8 tt -78.42 -32.52 48.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.598 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.0 mmm-85 -51.48 -33.1 29.78 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.52 -35.0 78.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.156 178.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.8 t80 -63.54 -35.75 81.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.7 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -91.79 -9.88 41.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.559 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.0 mttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.972 179.975 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.605 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 9.4 ttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.95 0.405 . . . . 0.0 111.627 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.475 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 86.9 m-85 -62.47 155.7 24.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.641 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.767 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -128.22 121.41 29.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.116 -179.717 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.066 HG22 HG22 ' A' ' 68' ' ' VAL . 12.8 t -115.1 124.67 71.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.893 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.0 m-85 -103.99 104.38 14.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.2 -132.23 1.37 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.394 -178.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 1.094 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 93.9 m-85 -134.12 149.49 51.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.645 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 18.8 p-10 -156.47 -51.33 0.08 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.641 ' N ' ' HB3' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -52.84 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -177.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -47.98 81.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.442 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.481 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -86.65 22.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.601 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 1.094 ' CD2' ' HA ' ' A' ' 7' ' ' TYR 0.301 0.3 OUTLIER -149.0 77.74 1.38 Allowed 'General case' 0 N--CA 1.417 -2.103 0 C-N-CA 117.845 -1.542 . . . . 0.0 108.612 -171.98 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.782 ' HE2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -61.05 166.64 3.43 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.33 -1.759 . . . . 0.0 113.481 -177.522 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 31.5 p 169.96 111.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.342 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.782 HG13 ' HE2' ' A' ' 13' ' ' LYS . 2.2 m -91.77 -37.33 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.706 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -75.15 -19.03 60.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.574 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.9 t -60.42 -51.76 68.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.783 0.325 . . . . 0.0 110.621 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.89 -31.8 7.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.551 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -78.19 -57.2 3.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.825 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -56.45 -45.36 80.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -57.33 -52.09 66.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.368 . . . . 0.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.788 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.1 mtm180 -55.12 -42.22 72.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.079 179.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.824 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -57.51 -53.45 58.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.296 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.824 ' N ' HD23 ' A' ' 23' ' ' LEU . 10.1 mt -57.96 -46.88 84.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.873 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.3 m -55.59 -36.98 67.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.131 0.491 . . . . 0.0 109.865 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.6 t -79.28 -30.04 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.559 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HE3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -71.5 -12.14 61.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.105 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt 64.38 42.23 5.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.107 0.479 . . . . 0.0 110.169 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -122.75 129.04 25.17 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.146 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' O ' ' HA ' ' A' ' 1' ' ' MET . 88.2 Cg_endo -77.21 140.05 19.39 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.274 1.983 . . . . 0.0 110.987 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.605 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 18.5 p90 -155.51 170.49 21.85 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.311 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.467 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 7.5 tt0 -136.57 134.56 37.59 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.193 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.629 ' CE2' ' HB3' ' A' ' 8' ' ' ASP . 8.6 t80 -90.45 156.94 17.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.893 HD12 ' CE1' ' A' ' 5' ' ' TYR . 29.8 mt -133.29 120.07 37.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.582 0.706 . . . . 0.0 110.196 179.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.632 ' HB2' ' CE1' ' A' ' 12' ' ' HIS . 5.6 p-10 -99.62 118.13 35.49 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.568 -1.197 . . . . 0.0 112.718 -177.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.849 HG22 ' HB2' ' A' ' 47' ' ' LYS . 20.1 pt -101.42 67.99 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 178.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.713 ' HE2' ' HE2' ' A' ' 7' ' ' TYR . 2.3 mtm -168.15 85.26 0.73 Allowed Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 122.678 0.391 . . . . 0.0 111.283 177.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 59.5 Cg_endo -71.79 -12.93 29.22 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.04 1.827 . . . . 0.0 110.526 178.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -150.24 150.04 31.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.37 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -63.19 -6.9 4.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.343 0.592 . . . . 0.0 111.528 179.605 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.92 -56.76 3.42 Favored Glycine 0 C--N 1.313 -0.697 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.158 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 43' ' ' PHE . 20.2 t -150.63 157.54 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.559 ' HD1' ' HG3' ' A' ' 37' ' ' MET . 1.8 m-85 -59.91 170.27 1.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.867 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.43 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -86.49 98.69 11.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.776 179.447 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -49.52 -28.06 5.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.158 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -61.47 -56.4 20.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.379 . . . . 0.0 110.467 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.849 ' HB2' HG22 ' A' ' 36' ' ' ILE . 7.8 mttt -61.49 -46.04 91.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.331 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.01 -44.06 77.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.372 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.39 84.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.218 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -42.5 99.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.451 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -54.24 -46.0 72.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.468 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.2 mt -56.22 -50.74 70.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.969 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.0 m -63.16 -33.51 75.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.441 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -63.61 -39.53 94.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.457 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 mt -60.02 -54.19 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.678 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.92 -112.82 0.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.125 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.8 ttt85 -150.49 33.0 0.63 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.034 0.445 . . . . 0.0 110.689 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -120.73 -146.87 0.38 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.501 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 t -120.18 170.3 9.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.805 0.336 . . . . 0.0 110.645 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -107.05 101.45 10.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.653 0.74 . . . . 0.0 110.709 179.633 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -80.31 86.52 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.479 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.55 29.87 75.92 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 60' ' ' GLN . 1.1 mm? -43.74 153.39 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 p -123.45 168.53 12.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.162 0.506 . . . . 0.0 111.62 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.9 mmt -122.53 153.15 62.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.558 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.9 Cg_endo -84.96 159.74 65.77 Favored 'Cis proline' 0 N--CA 1.462 -0.374 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.94 0.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.42 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 5.7 tp60 -112.75 109.73 19.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.119 179.178 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.066 HG22 HG22 ' A' ' 4' ' ' VAL . 3.2 t -90.63 164.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.781 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 85.4 m-85 -142.52 146.41 34.66 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.671 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.778 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -58.32 148.55 63.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.436 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 51.0 Cg_exo -57.76 -29.92 87.43 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.104 2.536 . . . . 0.0 112.264 179.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -89.83 -26.88 20.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.426 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.11 89.23 0.62 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.754 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 m -176.53 164.77 2.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.468 0.175 . . . . 0.0 110.589 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.42 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 10.7 t-160 -90.93 119.92 31.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.004 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.778 HD11 ' HA ' ' A' ' 70' ' ' ALA . 32.2 mt -98.94 -49.3 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.667 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.28 -153.19 21.11 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.782 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.7 -138.02 9.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.541 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.502 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 46.7 t80 -70.21 -70.42 0.29 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.741 0.305 . . . . 0.0 110.978 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.7 -49.33 76.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -51.27 -39.23 56.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.578 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.741 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -78.52 -31.93 47.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.371 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -52.43 -30.71 30.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.5 -35.84 78.07 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' LEU . 32.0 t80 -60.04 -36.87 78.23 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.197 178.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.741 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.0 m-85 -89.17 -22.47 22.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.552 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.885 -179.877 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.845 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 23.0 tpp . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.604 -0.147 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 32' ' ' GLU . 97.2 m-85 -42.89 135.55 2.98 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.108 0.48 . . . . 0.0 110.53 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.26 124.09 50.32 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.622 -178.379 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.986 HG22 HG22 ' A' ' 68' ' ' VAL . 53.9 t -111.87 144.19 20.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.257 0.551 . . . . 0.0 111.4 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.797 ' CE1' HD12 ' A' ' 34' ' ' ILE . 7.9 m-85 -124.78 103.43 8.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.261 178.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.65 -141.28 3.08 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.248 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 32.3 m-85 -124.15 160.74 27.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.733 0.301 . . . . 0.0 110.601 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -103.11 29.32 5.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.417 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.2 p 65.97 9.83 6.47 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.305 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -87.12 -54.95 4.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 111.97 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 37' ' ' MET . 3.6 mp -94.22 -25.38 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.403 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 13.8 t60 -146.52 134.87 21.85 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.81 -178.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -61.57 129.62 41.99 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.2 -178.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.1 m -159.01 89.29 0.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.259 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.25 -37.84 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -55.89 -29.23 59.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 0.0 111.349 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 t -65.03 -60.69 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.229 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -56.93 -36.07 69.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.966 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -66.27 -38.39 87.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.444 -179.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.579 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -72.62 -35.85 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.319 . . . . 0.0 110.946 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 9.9 tttt -60.2 -34.9 74.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.024 0.44 . . . . 0.0 109.867 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -68.53 -39.65 81.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.959 179.317 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.1 tt -55.49 -52.84 62.33 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.891 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.732 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.9 mt -57.95 -37.36 74.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.227 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 m -60.72 -39.77 89.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 22' ' ' ARG . 58.6 t -74.86 -33.11 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.894 178.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -75.77 -9.48 58.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.761 179.252 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 58.86 37.25 24.84 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.275 0.56 . . . . 0.0 110.392 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.489 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -120.65 104.95 41.72 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.708 -179.699 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.845 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 2.0 Cg_endo -45.23 168.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.682 2.255 . . . . 0.0 112.351 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.568 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 5.0 p90 -162.8 170.78 17.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.425 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.1 tm-20 -137.86 122.94 19.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.454 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.502 ' HE1' HG11 ' A' ' 4' ' ' VAL . 7.3 t80 -89.33 159.66 17.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.997 0.427 . . . . 0.0 111.68 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.797 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.8 mt -145.41 120.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.095 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -82.8 131.17 35.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.728 -178.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.716 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 5.2 pt -100.33 -28.16 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.024 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.776 ' O ' HD13 ' A' ' 11' ' ' ILE . 5.9 ttp -123.93 91.39 49.68 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.841 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.403 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 84.2 Cg_endo -81.02 3.44 7.8 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.841 2.361 . . . . 0.0 112.962 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -139.52 146.89 40.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.791 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.724 ' HA ' HG23 ' A' ' 11' ' ' ILE . 6.8 tmtt? -71.42 -7.76 49.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.285 0.564 . . . . 0.0 111.692 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.93 -60.62 1.25 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.048 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 t -147.0 144.1 20.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 112.041 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -64.21 169.37 4.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.973 179.723 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 1.3 t0 -98.57 116.34 30.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -57.89 -24.05 55.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.584 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -55.4 -48.82 73.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.848 0.356 . . . . 0.0 110.99 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -76.5 -36.96 57.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.061 0.458 . . . . 0.0 110.216 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.0 mm -58.1 -50.43 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.692 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -44.15 96.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.437 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.56 -37.89 89.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.373 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.436 HD13 ' CD2' ' A' ' 5' ' ' TYR . 25.4 tp -61.09 -54.23 47.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.563 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.3 mt -50.7 -42.66 57.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.8 m -65.55 -35.13 79.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.192 179.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 2.8 tttp -64.47 -39.96 94.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.304 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.71 HD11 ' CD1' ' A' ' 63' ' ' LEU . 1.3 mt -59.45 -45.34 91.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.526 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.05 -110.84 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.89 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -150.55 32.5 0.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.996 0.427 . . . . 0.0 110.621 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.89 -146.75 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.431 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -119.99 170.43 9.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.708 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.74 98.39 8.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.137 0.494 . . . . 0.0 110.562 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -81.08 86.53 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.15 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.19 29.23 72.15 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.272 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.71 ' CD1' HD11 ' A' ' 55' ' ' LEU . 7.7 tt -46.73 152.55 0.47 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.343 . . . . 0.0 111.347 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.407 ' N ' HD23 ' A' ' 63' ' ' LEU . 35.6 p -130.28 166.01 21.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.173 0.511 . . . . 0.0 111.683 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.411 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 1.3 mpt? -125.33 154.96 72.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.629 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.6 Cg_endo -83.86 143.46 44.05 Favored 'Cis proline' 0 C--N 1.344 0.333 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.916 0.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.9 OUTLIER -103.25 128.28 50.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 179.089 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.986 HG22 HG22 ' A' ' 4' ' ' VAL . 5.9 t -100.99 160.5 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 112.14 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 97.2 m-85 -143.7 159.29 42.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.416 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -70.12 144.6 92.81 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.141 -179.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -37.78 -31.96 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.487 2.792 . . . . 0.0 112.446 179.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.82 36.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.118 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.25 -109.49 1.85 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.955 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -127.37 -173.95 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.121 0.486 . . . . 0.0 111.335 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.483 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 35.5 t-80 -70.71 137.33 49.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.116 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.8 mp -109.65 -31.36 2.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.706 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 75' ' ' HIS . . . 117.95 -156.62 15.56 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.205 179.397 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.64 -124.61 5.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.147 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -80.09 -70.46 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.618 0.209 . . . . 0.0 111.299 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -52.29 -47.97 65.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.125 0.488 . . . . 0.0 110.6 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -57.66 -45.04 86.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.679 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.733 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.9 tt -74.31 -32.6 62.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.448 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 87' ' ' LYS . 5.9 ttp85 -52.59 -33.1 44.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -65.01 -33.65 76.55 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.12 178.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LEU . 17.3 t80 -64.72 -34.22 77.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.483 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.733 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.5 m-85 -90.8 -71.03 0.65 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.558 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 83' ' ' ARG . 37.6 mttt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.912 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.574 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 55.6 ttm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.818 0.342 . . . . 0.0 111.449 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 46.6 m-85 -55.23 155.0 5.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.067 0.46 . . . . 0.0 111.016 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -124.56 119.29 28.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.033 -179.37 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.839 HG22 HG22 ' A' ' 68' ' ' VAL . 24.4 t -114.44 127.1 72.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.203 0.525 . . . . 0.0 112.067 179.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.463 ' CE1' HD12 ' A' ' 34' ' ' ILE . 24.9 m-85 -109.28 104.58 13.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.103 177.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.17 -139.19 2.58 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.684 -179.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.693 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 64.3 m-85 -121.71 160.52 24.35 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.908 0.385 . . . . 0.0 111.344 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.79 -72.99 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.778 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t 172.97 -36.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.981 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -64.72 -44.96 88.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.229 -179.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.4 mm -90.16 -40.11 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.431 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -149.96 152.49 35.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.012 0.434 . . . . 0.0 111.15 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -80.66 169.84 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.895 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 p 173.88 117.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.06 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -87.05 -34.35 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -22.63 66.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.014 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.8 t -72.05 -64.51 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.796 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -50.18 -35.48 26.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 51.8 m-20 -72.13 -59.0 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.17 -31.3 63.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.859 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -61.11 -54.46 44.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.659 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.728 ' O ' HG23 ' A' ' 26' ' ' VAL . 12.1 tpp180 -66.5 -24.65 66.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.025 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.555 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.3 tt -59.86 -58.18 9.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 110.501 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.644 HD12 ' CG ' ' A' ' 31' ' ' PHE . 5.5 mt -60.38 -42.76 96.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.795 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.5 m -60.96 -41.08 95.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.49 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 22' ' ' ARG . 71.1 t -73.68 -26.74 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.032 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.656 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 1.5 tpmp? -68.46 -44.35 75.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.79 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 112.71 30.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.331 1.052 . . . . 0.0 110.997 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -125.74 141.86 40.45 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.857 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.419 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.3 Cg_endo -80.35 143.43 15.54 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.531 2.154 . . . . 0.0 111.669 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.644 ' CG ' HD12 ' A' ' 24' ' ' LEU . 33.9 p90 -145.87 167.8 22.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.947 0.403 . . . . 0.0 111.973 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.66 126.13 26.82 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.579 ' CE1' HG11 ' A' ' 4' ' ' VAL . 24.7 t80 -89.94 155.73 18.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.23 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.62 HG21 ' HG2' ' A' ' 47' ' ' LYS . 10.1 mt -150.51 122.63 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.399 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -78.1 110.17 12.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.639 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.693 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.6 pt -62.87 -21.15 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.72 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.1 ttp -128.05 88.6 52.54 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.03 1.25 8.87 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.638 2.225 . . . . 0.0 112.569 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -139.46 139.29 36.99 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.513 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -66.94 -8.53 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.269 0.557 . . . . 0.0 111.895 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.3 -63.54 1.5 Allowed Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.429 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 t -145.9 143.78 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.717 0.294 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -65.6 168.2 7.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 111.235 -179.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.9 118.06 30.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.178 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 10.6 m-20 -71.43 -14.05 62.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.96 -61.07 2.51 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.62 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -64.77 -41.42 95.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.193 179.515 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.8 mt -64.53 -33.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.57 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -58.28 -47.87 82.25 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.712 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.95 -38.11 84.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.349 179.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.636 HD13 ' CE1' ' A' ' 69' ' ' PHE . 5.5 tp -57.96 -52.3 66.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.538 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.8 mt -51.45 -44.41 62.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.101 0.477 . . . . 0.0 111.278 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 m -63.27 -35.59 80.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.484 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.49 -40.34 89.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.657 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 51' ' ' LEU . 1.3 mt -59.94 -67.73 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.642 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.19 -107.02 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.033 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -150.45 31.42 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.004 0.43 . . . . 0.0 110.704 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.91 -149.44 0.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.353 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -120.53 170.19 9.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.755 0.312 . . . . 0.0 110.855 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -89.82 99.04 12.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.253 0.549 . . . . 0.0 110.309 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -78.22 88.02 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.039 -179.76 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.3 29.89 31.15 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.685 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.781 HD12 ' OE1' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -46.57 156.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 110.999 -179.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.8 p -105.62 147.87 27.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.101 0.477 . . . . 0.0 111.614 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.4 mmt -119.53 153.23 53.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.4 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HB2' HG13 ' A' ' 4' ' ' VAL . 2.8 Cg_exo -78.82 148.8 83.75 Favored 'Cis proline' 0 C--N 1.344 0.298 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.948 0.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.781 ' OE1' HD12 ' A' ' 63' ' ' LEU . 2.1 tp60 -96.0 129.58 43.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.819 178.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.839 HG22 HG22 ' A' ' 4' ' ' VAL . 3.6 t -107.79 157.04 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.055 0.455 . . . . 0.0 111.947 -179.053 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.636 ' CE1' HD13 ' A' ' 51' ' ' LEU . 40.9 m-85 -143.01 137.29 29.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.646 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' CA ' HD11 ' A' ' 76' ' ' ILE . . . -47.08 160.85 0.32 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.376 -178.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.3 Cg_exo -60.24 -30.54 91.43 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.175 2.583 . . . . 0.0 112.12 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -94.3 -19.73 20.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.188 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.85 88.72 1.3 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.597 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.52 126.74 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.802 0.334 . . . . 0.0 110.686 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.422 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 5.1 t-160 -62.47 114.06 3.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.158 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.516 HD11 ' CA ' ' A' ' 70' ' ' ALA . 8.7 mt -104.67 -39.88 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.764 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.98 -153.93 21.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.571 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.1 -135.8 9.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.651 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.555 ' CE1' HD12 ' A' ' 23' ' ' LEU . 13.4 t80 -71.62 -70.87 0.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 111.129 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.99 -47.16 86.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.71 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -52.38 -41.25 62.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.633 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.615 HD21 ' CE2' ' A' ' 86' ' ' PHE . 4.9 tt -75.87 -35.25 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 87' ' ' LYS . 7.8 ttp180 -51.14 -30.0 15.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -71.46 -34.3 70.09 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.142 178.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 82' ' ' LEU . 53.6 t80 -62.89 -35.55 80.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.615 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.8 m-85 -89.1 -27.62 20.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.454 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 83' ' ' ARG . 21.0 mtpp . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.955 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.677 ' HG2' ' C ' ' A' ' 30' ' ' PRO . 2.0 tpt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.391 0.138 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 89.0 m-85 -40.07 119.78 1.07 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.749 0.785 . . . . 0.0 111.613 -177.385 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.35 126.51 35.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.295 -179.102 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.551 HG11 ' CE1' ' A' ' 33' ' ' PHE . 59.3 t -109.2 148.21 13.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.392 0.615 . . . . 0.0 111.186 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.666 ' CE1' HD12 ' A' ' 34' ' ' ILE . 46.6 m-85 -128.05 99.77 5.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.737 178.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.63 -137.21 2.24 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.727 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.816 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 59.0 m-85 -121.24 108.02 13.25 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.669 0.271 . . . . 0.0 111.373 -179.042 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.524 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -110.94 51.0 0.79 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.003 179.816 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.44 -169.8 1.13 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -87.17 8.72 22.63 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.327 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 37' ' ' MET . 3.7 pt -86.59 -14.0 10.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.459 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 11.5 t-80 -162.61 153.79 17.59 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.139 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -79.02 171.57 15.03 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.8 p -165.04 89.54 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.728 0.299 . . . . 0.0 111.069 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.9 m -91.49 -40.7 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.606 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.07 -23.27 64.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.654 -179.233 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.61 -47.03 80.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.23 -32.69 64.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -73.87 -55.65 5.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.682 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.19 -51.11 71.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 110.837 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -55.03 -47.16 75.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 179.69 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.801 ' O ' HG23 ' A' ' 26' ' ' VAL . 20.9 tpp180 -61.62 -40.5 95.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.028 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.584 ' C ' HD23 ' A' ' 23' ' ' LEU . 6.2 tt -56.56 -53.48 57.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.999 179.032 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.498 HD23 ' CZ ' ' A' ' 86' ' ' PHE . 10.3 mt -59.55 -44.54 93.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.411 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 m -57.67 -40.87 80.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 22' ' ' ARG . 50.8 t -75.31 -33.42 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.483 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -75.59 -12.11 60.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.929 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.8 41.72 1.15 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.849 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.15 118.07 16.1 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.407 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.677 ' C ' ' HG2' ' A' ' 1' ' ' MET . 77.8 Cg_exo -52.31 -177.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.308 2.005 . . . . 0.0 111.565 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE2' ' HE3' ' A' ' 21' ' ' LYS . 5.0 p90 -164.92 170.84 14.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.921 0.391 . . . . 0.0 111.367 178.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 34.7 tt0 -141.66 121.0 13.12 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.028 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.551 ' CE1' HG11 ' A' ' 4' ' ' VAL . 10.7 t80 -92.32 165.86 12.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.115 0.483 . . . . 0.0 112.078 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.666 HD12 ' CE1' ' A' ' 5' ' ' TYR . 25.4 mt -150.65 128.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.184 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.11 125.92 32.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.8 -178.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.414 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.9 pt -100.78 -25.11 3.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.718 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.8 ' HE1' ' CD2' ' A' ' 12' ' ' HIS . 2.3 ttm -108.91 105.19 56.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.012 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 37.5 Cg_endo -66.11 -29.65 47.74 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 121.769 1.646 . . . . 0.0 110.244 178.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -146.15 155.94 43.07 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.212 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -6.57 6.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.33 0.586 . . . . 0.0 111.568 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.34 -55.36 2.91 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 115.11 -0.95 . . . . 0.0 114.009 -178.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 t -148.2 135.87 14.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.951 0.376 . . . . 0.0 111.754 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -59.83 168.72 1.66 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.875 179.785 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.55 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -89.05 129.72 35.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.483 -179.907 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.37 -35.16 79.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.855 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -66.68 -50.9 61.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -68.32 -41.32 80.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.858 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.3 mp -66.62 -35.19 74.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.661 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.01 -57.95 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.307 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -55.93 -29.62 60.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.984 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.851 ' O ' HD12 ' A' ' 55' ' ' LEU . 24.4 tp -61.44 -61.16 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.078 179.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.617 ' HA ' HD13 ' A' ' 55' ' ' LEU . 86.2 mt -46.28 -35.73 5.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.692 179.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 m -69.29 -34.26 74.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.831 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 7.5 mtpp -68.36 -43.49 77.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.818 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.851 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -58.6 -20.26 45.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.418 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.11 -29.45 7.57 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.765 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -89.88 -174.82 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -108.43 -31.8 7.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -109.85 169.96 8.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -112.87 99.94 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -74.57 82.75 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.162 -179.913 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.59 23.77 55.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.646 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.477 HD12 ' NE2' ' A' ' 67' ' ' GLN . 1.1 mm? -64.78 140.77 58.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.3 p -131.95 170.69 14.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.107 0.479 . . . . 0.0 111.474 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -104.09 155.5 37.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.664 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.4 Cg_exo -82.14 135.58 29.17 Favored 'Cis proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.678 0.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.477 ' NE2' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.99 128.37 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.18 179.187 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.0 t -102.88 157.11 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.015 0.436 . . . . 0.0 111.669 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 78.3 m-85 -143.09 147.21 34.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.775 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.625 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.16 140.9 70.24 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.37 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.85 -31.99 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.005 2.47 . . . . 0.0 112.115 179.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.43 34.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.932 179.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.87 -108.1 2.01 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.998 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.9 t -133.96 175.44 9.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.266 0.555 . . . . 0.0 111.511 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.48 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 10.1 t-80 -59.32 129.26 41.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.019 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.625 HD11 ' HA ' ' A' ' 70' ' ' ALA . 9.3 mt -102.09 -42.14 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.977 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.54 -153.3 20.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.757 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.09 -142.4 13.27 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.379 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -69.43 -70.62 0.27 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 110.811 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -58.79 -48.73 80.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.517 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.74 -42.54 62.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.451 179.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.75 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.6 tt -79.77 -28.73 40.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.028 179.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -51.38 -32.6 26.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.93 -35.25 80.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.6 t80 -63.14 -34.07 76.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.354 178.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.75 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.7 m-85 -93.09 -12.43 30.52 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.589 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.97 179.92 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.601 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 36.5 ttm . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.877 0.37 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 68.8 m-85 -58.62 163.98 2.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.833 -179.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.723 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -138.67 119.27 13.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.684 -179.305 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.943 HG22 HG22 ' A' ' 68' ' ' VAL . 24.0 t -108.54 147.91 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.239 0.542 . . . . 0.0 111.508 179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.697 ' CE1' HD12 ' A' ' 34' ' ' ILE . 27.9 m-85 -130.87 101.55 5.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.466 178.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.62 -136.5 2.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.57 -179.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -108.27 157.26 18.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.846 0.355 . . . . 0.0 111.304 -179.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 9' ' ' SER . 20.3 t0 -85.14 -4.66 59.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.979 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 86.28 -36.63 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.955 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.33 -33.79 61.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.691 0.281 . . . . 0.0 111.089 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 37' ' ' MET . 1.5 mt -89.79 -32.14 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.337 -179.779 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -141.24 132.03 25.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 110.621 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 151.25 41.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.573 -179.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 168.96 91.04 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.836 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.2 m -57.43 -37.05 55.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.53 -23.43 50.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -65.05 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.499 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.06 -34.97 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -60.88 -46.97 88.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.896 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -60.54 -43.44 97.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.294 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -53.98 -36.89 63.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.004 0.431 . . . . 0.0 110.132 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.768 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.3 tpp180 -70.18 -28.54 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.204 179.137 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.866 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -57.42 -55.96 27.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.927 179.414 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.646 HD21 HD21 ' A' ' 82' ' ' LEU . 24.8 mt -64.2 -42.54 96.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.578 179.459 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.8 m -58.59 -34.35 71.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.205 179.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 22' ' ' ARG . 72.0 t -76.8 -31.25 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.616 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HG3' ' CD1' ' A' ' 86' ' ' PHE . 15.0 mmtt -76.07 -19.59 58.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.195 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.76 60.38 0.11 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.403 ' NE2' ' HD2' ' A' ' 30' ' ' PRO . 24.2 mm100 -139.76 142.45 31.27 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.953 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' HA ' ' A' ' 1' ' ' MET . 87.4 Cg_endo -75.91 137.31 19.61 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.405 2.07 . . . . 0.0 111.405 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.601 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 20.0 p90 -151.91 170.33 20.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -138.38 129.43 27.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.545 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.638 ' CE1' HG11 ' A' ' 4' ' ' VAL . 49.0 t80 -89.94 160.02 16.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.054 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.697 HD12 ' CE1' ' A' ' 5' ' ' TYR . 15.3 mt -145.57 121.43 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.295 0.569 . . . . 0.0 110.274 179.29 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -91.27 121.36 32.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.157 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.444 HD12 ' HD2' ' A' ' 43' ' ' PHE . 3.6 pt -80.64 -4.4 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.057 179.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.585 ' O ' HD12 ' A' ' 11' ' ' ILE . 36.9 ttm -132.85 110.97 13.28 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.778 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.42 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 71.9 Cg_endo -76.91 -30.73 4.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.552 2.168 . . . . 0.0 112.474 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 37' ' ' MET . 8.3 tp10 -139.69 155.33 47.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.639 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.455 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -64.54 -8.03 12.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.296 0.57 . . . . 0.0 111.524 179.966 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.41 -52.21 4.6 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 115.177 -0.919 . . . . 0.0 113.193 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 43' ' ' PHE . 22.9 t -149.24 153.4 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.105 0.479 . . . . 0.0 112.235 -179.188 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.74 ' HB3' HD11 ' A' ' 48' ' ' ILE . 62.4 m-85 -73.74 168.72 18.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.124 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.42 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -99.71 111.62 23.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.891 179.345 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -62.48 -26.57 68.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.747 0.308 . . . . 0.0 110.556 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.32 -56.05 19.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -36.68 81.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.302 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.74 HD11 ' HB3' ' A' ' 43' ' ' PHE . 34.5 mt -67.27 -38.18 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.35 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.44 -56.07 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.273 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.31 -28.89 56.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.866 ' O ' HD12 ' A' ' 55' ' ' LEU . 26.0 tp -62.96 -60.85 2.9 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.212 179.519 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.4 mt -45.54 -39.42 7.43 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.207 0.527 . . . . 0.0 111.288 179.229 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.8 m -67.11 -36.12 81.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.001 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HG2' ' CD2' ' A' ' 69' ' ' PHE . 7.9 tttp -63.22 -50.28 70.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.333 179.383 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 51' ' ' LEU . 5.0 mp -58.92 -55.05 40.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.68 -126.39 0.9 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.376 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -150.4 33.23 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.991 0.424 . . . . 0.0 110.861 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -120.74 -144.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 t -105.06 170.06 8.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.72 0.295 . . . . 0.0 110.624 179.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.69 98.31 11.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.299 0.571 . . . . 0.0 110.546 179.841 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.4 mt -80.37 86.41 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.07 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.23 30.31 75.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.039 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.444 HD11 HE22 ' A' ' 67' ' ' GLN . 7.5 tt -48.03 151.32 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 111.512 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 p -142.26 170.18 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.39 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -132.13 149.76 74.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.648 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -85.59 149.36 47.05 Favored 'Cis proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.758 0.354 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.444 HE22 HD11 ' A' ' 63' ' ' LEU . 8.1 mt-30 -114.44 133.99 55.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.451 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.943 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -105.88 168.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.302 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 78.8 m-85 -142.33 146.11 34.66 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -57.16 138.3 80.2 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.235 -178.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.472 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 87.1 Cg_exo -46.17 -28.4 5.47 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.878 2.385 . . . . 0.0 111.902 178.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.91 33.55 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.91 179.578 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.92 -108.89 1.76 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.934 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.431 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -145.36 179.36 7.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.29 0.566 . . . . 0.0 111.421 -179.537 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.41 ' CE1' ' OE1' ' A' ' 67' ' ' GLN . 16.3 t-160 -49.76 118.79 3.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.355 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.551 HG23 ' CD2' ' A' ' 85' ' ' TYR . 6.7 mt -84.83 -47.51 17.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.891 0.376 . . . . 0.0 111.076 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.83 -152.36 18.02 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.493 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -93.37 -155.3 31.82 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.405 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.866 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -61.61 -67.76 0.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 O-C-N 122.83 -0.218 . . . . 0.0 110.859 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -48.39 -42.18 31.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.068 0.461 . . . . 0.0 110.541 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -67.37 -42.32 83.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.417 179.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.646 HD21 HD21 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -66.71 -45.83 77.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.316 179.726 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -51.13 -36.61 41.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -70.29 -34.95 73.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.233 178.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.551 ' CD2' HG23 ' A' ' 76' ' ' ILE . 65.0 t80 -66.54 -30.61 70.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.751 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.601 ' CE2' HD21 ' A' ' 82' ' ' LEU . 24.8 m-85 -90.9 -66.72 0.9 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.69 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.2 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.617 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.3 ttm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.897 0.38 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.473 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 87.4 m-85 -64.4 156.34 29.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.011 0.434 . . . . 0.0 110.689 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.663 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.58 120.22 22.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.561 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 68' ' ' VAL . 21.1 t -108.62 137.38 40.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.18 0.514 . . . . 0.0 111.755 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.791 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.5 m-85 -115.73 101.08 8.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.927 178.488 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -160.25 -138.19 2.39 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.286 -179.277 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.409 ' CG ' ' HB3' ' A' ' 12' ' ' HIS . 41.7 m-85 -126.22 157.11 39.09 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.647 0.261 . . . . 0.0 111.039 -179.407 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.01 -69.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.807 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 t 170.87 -39.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.813 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -76.77 -24.74 52.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.844 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.667 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.0 mp -90.82 -43.62 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.153 0.501 . . . . 0.0 110.17 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.409 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 32.7 t60 -152.18 147.21 26.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.131 179.318 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.55 159.14 26.99 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.239 -179.382 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -177.06 106.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.585 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.92 -36.65 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.697 -179.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -62.87 -21.22 65.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.495 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.6 t -64.54 -52.84 55.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.955 0.407 . . . . 0.0 110.571 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -55.55 -32.46 63.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.323 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -72.34 -53.76 11.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.224 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.4 -48.6 74.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.982 0.42 . . . . 0.0 111.139 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -51.15 71.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -56.78 -42.19 78.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.2 tt -57.5 -54.67 44.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.394 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.782 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.6 mt -55.38 -44.97 76.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.771 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.1 m -58.36 -34.62 70.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.133 0.492 . . . . 0.0 110.059 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 22' ' ' ARG . 48.0 t -79.84 -30.18 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.734 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.533 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 2.1 mmtt -79.17 -14.38 59.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 66.31 60.81 0.61 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.999 0.428 . . . . 0.0 110.804 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -133.62 143.1 46.37 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.466 ' O ' ' HA ' ' A' ' 1' ' ' MET . 75.8 Cg_endo -80.17 132.86 9.55 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.606 2.204 . . . . 0.0 111.445 179.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.617 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 29.1 p90 -155.18 170.43 21.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.921 0.391 . . . . 0.0 112.012 -179.682 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -144.84 145.72 31.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.058 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.494 ' CE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.29 158.44 17.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.099 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.791 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.8 mt -142.28 117.66 5.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.213 179.352 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -81.33 119.44 23.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.54 -179.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 6' ' ' GLY . 10.5 tt -85.86 -27.86 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.193 179.103 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 7.4 ttp -129.93 95.86 27.5 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 179.418 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -78.14 -5.06 14.88 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.563 2.175 . . . . 0.0 112.691 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -139.9 139.89 36.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.755 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.91 -8.63 23.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.237 0.542 . . . . 0.0 111.989 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.16 -61.68 1.8 Allowed Glycine 0 C--N 1.312 -0.787 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.228 179.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.52 133.01 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.735 0.302 . . . . 0.0 111.094 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.03 167.59 1.6 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.01 0.433 . . . . 0.0 111.29 -179.804 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.45 108.79 18.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.102 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -53.09 -25.89 14.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.163 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -55.83 -49.94 71.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.773 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -74.98 -34.45 62.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.125 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.459 ' CD1' HD11 ' A' ' 36' ' ' ILE . 30.0 mm -59.82 -49.92 82.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.775 179.628 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.55 -50.61 72.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.488 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.23 -41.05 98.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.353 179.44 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.501 HD22 ' HD2' ' A' ' 5' ' ' TYR . 6.2 tp -57.07 -49.61 75.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.75 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.76 -49.89 69.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.086 0.47 . . . . 0.0 111.153 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.4 m -60.98 -33.19 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.272 179.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -64.29 -41.36 96.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.354 179.505 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.5 mt -59.84 -56.11 25.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.567 179.392 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.96 -109.03 0.27 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.953 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -150.65 30.89 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.414 . . . . 0.0 110.698 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -121.03 -148.84 0.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.377 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 t -120.62 170.32 9.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 0.0 110.687 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -98.09 98.85 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.041 0.448 . . . . 0.0 110.471 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -80.25 85.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.242 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.64 27.89 55.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.444 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.534 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.1 mm? -47.41 154.27 0.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.829 0.347 . . . . 0.0 111.01 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.3 p -113.84 157.94 21.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.089 0.471 . . . . 0.0 111.636 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -120.84 158.15 52.9 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HB2' HG13 ' A' ' 4' ' ' VAL . 5.8 Cg_exo -82.18 148.58 69.11 Favored 'Cis proline' 0 C--N 1.343 0.253 0 C-N-CA 124.017 -1.243 . . . . 0.0 112.887 0.469 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.534 ' CD ' HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -105.07 125.6 51.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.167 179.023 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -97.25 167.98 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.878 0.37 . . . . 0.0 111.607 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.536 ' H ' HG12 ' A' ' 68' ' ' VAL . 75.7 m-85 -142.63 141.45 31.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.74 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB3' ' N ' ' A' ' 74' ' ' SER . . . -54.66 147.64 29.69 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.13 -178.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.497 ' HB3' ' N ' ' A' ' 1' ' ' MET . 51.6 Cg_exo -54.57 -27.81 52.37 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.804 2.336 . . . . 0.0 111.813 179.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -97.69 -22.32 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.014 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.16 82.82 0.6 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.63 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.497 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -168.78 115.66 0.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.727 0.299 . . . . 0.0 110.853 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -50.71 116.71 2.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.177 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.534 HG23 ' CD2' ' A' ' 85' ' ' TYR . 3.6 mt -88.82 -41.02 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.59 -150.09 17.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.633 -179.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.48 -140.12 9.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.399 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -75.84 -61.24 1.99 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.59 -42.72 67.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.24 -44.36 92.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.636 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.587 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -59.43 -49.0 79.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.464 179.831 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 ttt-85 -52.34 -32.44 38.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -75.06 -32.34 61.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.162 178.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.534 ' CD2' HG23 ' A' ' 76' ' ' ILE . 56.6 t80 -67.22 -32.2 73.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.357 178.473 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.587 ' HE2' HD21 ' A' ' 82' ' ' LEU . 26.1 m-85 -93.34 -70.47 0.7 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.504 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.923 179.983 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.565 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 58.1 ttm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.99 0.424 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.501 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 93.0 m-85 -53.17 152.51 4.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.039 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -126.92 120.44 29.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.954 -179.15 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.937 HG22 HG22 ' A' ' 68' ' ' VAL . 27.3 t -111.01 138.03 40.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 0.0 111.438 179.467 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.809 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.8 m-85 -114.73 99.03 7.21 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.128 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.76 -138.36 2.48 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.237 -0.983 . . . . 0.0 112.561 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.735 ' CE2' ' HE3' ' A' ' 37' ' ' MET . 17.6 m-85 -118.91 148.45 42.92 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.592 0.234 . . . . 0.0 110.674 -179.191 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.3 t0 -78.36 7.09 7.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.2 m 80.97 -15.78 0.71 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -85.93 -47.82 9.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 111.788 -179.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.86 -15.34 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.971 -179.298 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.479 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 12.1 t-80 -150.76 163.33 38.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.997 -178.23 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.06 157.84 23.98 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.062 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 176.84 108.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.92 0.39 . . . . 0.0 111.94 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.9 m -91.75 -28.97 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.391 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -71.44 -22.17 61.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.224 -178.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 p -67.26 -34.47 77.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.058 0.456 . . . . 0.0 110.45 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -56.27 12.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.59 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -49.77 72.1 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.392 -179.248 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.72 -45.19 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 111.038 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -64.74 -50.37 67.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.803 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.749 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -55.18 -39.3 69.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 -179.94 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.679 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.5 tt -57.76 -54.28 48.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.451 179.762 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.8 mt -56.89 -44.94 82.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.2 m -59.24 -39.53 83.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.097 0.475 . . . . 0.0 110.171 179.486 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 22' ' ' ARG . 58.9 t -76.08 -32.63 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.66 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -76.56 -9.74 58.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.048 179.787 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 67.45 61.17 0.46 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.931 0.396 . . . . 0.0 110.778 -179.791 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -140.76 138.73 18.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.175 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' A' ' 1' ' ' MET . 52.4 Cg_endo -83.05 142.09 10.81 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.685 2.257 . . . . 0.0 111.499 179.249 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.565 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 49.7 p90 -153.1 170.27 20.9 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.66 140.64 35.01 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.094 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.464 ' CE1' HG11 ' A' ' 4' ' ' VAL . 11.1 t80 -89.73 161.57 15.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.349 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.809 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.9 mt -147.4 120.65 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.198 179.459 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -95.71 131.21 42.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.536 -179.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -100.46 -24.54 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.912 179.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.735 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 21.9 ttm -114.5 82.0 7.35 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.755 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.403 ' CG ' ' HB2' ' A' ' 44' ' ' ASP . 91.6 Cg_endo -81.53 7.81 4.79 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.715 2.276 . . . . 0.0 112.527 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -139.37 129.9 25.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.353 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -59.79 -8.28 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.183 0.516 . . . . 0.0 112.04 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.77 -71.52 1.04 Allowed Glycine 0 C--N 1.314 -0.657 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.374 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.07 133.95 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -67.69 165.65 16.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.011 0.434 . . . . 0.0 111.46 -179.637 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 28.5 t0 -81.28 124.89 29.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.346 -179.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.536 ' HA ' HD12 ' A' ' 48' ' ' ILE . 1.0 OUTLIER -75.28 -24.89 57.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.199 179.865 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.0 -51.35 68.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.85 0.357 . . . . 0.0 110.616 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -71.05 -39.23 72.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.119 179.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 45' ' ' ASP . 62.9 mt -58.29 -37.87 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.551 179.399 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.56 -49.68 70.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.49 -40.64 97.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.419 179.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.47 HD13 ' CD2' ' A' ' 5' ' ' TYR . 11.4 tp -58.13 -51.19 70.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.707 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.6 mt -51.99 -46.64 64.95 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.132 0.492 . . . . 0.0 111.167 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -65.92 -32.97 74.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.105 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -63.43 -42.02 98.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.379 179.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 mt -59.81 -69.85 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.074 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.0 -35.14 0.29 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.554 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -109.41 -166.48 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.333 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -109.48 -30.4 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -90.23 164.44 14.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.798 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -117.97 100.26 7.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.7 tp -78.96 83.92 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.091 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.99 25.63 56.9 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.571 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 1.6 mm? -54.26 137.05 42.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.939 0.399 . . . . 0.0 110.889 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.5 p -122.03 170.29 9.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 111.448 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.67 157.9 64.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.709 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HB2' HG13 ' A' ' 4' ' ' VAL . 2.1 Cg_endo -85.25 149.81 50.29 Favored 'Cis proline' 0 N--CA 1.463 -0.304 0 C-N-CA 124.093 -1.211 . . . . 0.0 112.681 0.275 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -109.75 127.88 54.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.113 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.937 HG22 HG22 ' A' ' 4' ' ' VAL . 2.7 t -98.85 165.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.958 0.408 . . . . 0.0 111.672 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.555 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 84.5 m-85 -142.3 142.49 32.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.781 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.817 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -52.37 137.23 40.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.254 -178.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.45 ' HB3' ' N ' ' A' ' 1' ' ' MET . 98.5 Cg_exo -44.36 -29.89 3.37 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.08 2.52 . . . . 0.0 112.265 179.106 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.38 36.25 0.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.248 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.26 -109.29 1.12 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.837 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.452 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 55.9 p -135.86 176.11 8.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.021 0.438 . . . . 0.0 111.2 -179.613 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.417 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 41.8 t-80 -52.37 125.72 16.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.285 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.817 HD11 ' HA ' ' A' ' 70' ' ' ALA . 19.0 mt -91.23 -45.3 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.417 ' HA2' ' CE1' ' A' ' 75' ' ' HIS . . . 132.0 -151.09 19.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.747 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.93 -136.72 7.83 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.61 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -77.17 -63.12 1.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 111.123 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -53.65 -45.68 70.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.902 0.382 . . . . 0.0 110.84 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -45.28 85.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.539 179.673 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.708 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -59.31 -47.81 83.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.702 179.917 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -52.38 -33.32 42.83 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.072 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.73 66.7 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.338 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.473 ' CD1' HG23 ' A' ' 76' ' ' ILE . 54.9 t80 -66.11 -33.94 76.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.404 178.462 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.708 ' HE2' HD21 ' A' ' 82' ' ' LEU . 18.7 m-85 -90.02 -26.95 20.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.428 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.194 -0.907 . . . . 0.0 110.857 -179.904 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.585 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 21.2 ttm . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.831 0.348 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.51 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 92.4 m-85 -60.04 148.57 35.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.621 -179.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -125.36 118.13 25.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 -179.378 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.703 HG22 HG22 ' A' ' 68' ' ' VAL . 70.7 t -108.82 144.6 16.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.179 0.514 . . . . 0.0 111.387 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.878 ' CE1' HD12 ' A' ' 34' ' ' ILE . 6.8 m-85 -124.98 99.49 6.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.051 178.201 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.74 -149.14 5.7 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.891 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.423 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 63.3 m-85 -105.95 152.23 23.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.754 0.311 . . . . 0.0 111.273 -179.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.5 p30 -72.32 -63.12 1.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.576 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.4 p 160.2 -32.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.046 0.45 . . . . 0.0 110.849 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -85.13 -22.82 28.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.467 -179.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.453 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 9.6 mt -88.42 -38.7 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.603 0.239 . . . . 0.0 110.949 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -147.75 141.56 25.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 111.154 179.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 140.23 58.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.192 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 173.8 106.38 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.222 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 m -85.72 -25.65 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.399 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.27 -34.76 72.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.396 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -67.05 -42.73 84.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.71 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -24.83 68.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.971 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 87.9 m-20 -78.12 -53.59 7.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.234 -179.634 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 79' ' ' PHE . . . -53.43 -45.2 69.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.968 0.413 . . . . 0.0 110.942 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -51.49 69.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.807 179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.705 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.8 ttp180 -57.8 -39.26 77.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.669 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -56.63 -53.09 61.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.354 179.385 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.782 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.7 mt -56.33 -46.17 80.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.597 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -55.75 -36.62 67.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.053 0.454 . . . . 0.0 109.825 179.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 22' ' ' ARG . 43.2 t -80.11 -30.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.491 179.114 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -13.49 60.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.046 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.26 59.85 0.51 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.99 0.424 . . . . 0.0 111.079 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -140.48 140.41 22.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.037 179.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.488 ' O ' ' HA ' ' A' ' 1' ' ' MET . 71.7 Cg_endo -79.84 137.87 12.85 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.557 2.171 . . . . 0.0 111.376 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.585 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 13.2 p90 -154.89 170.28 22.06 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -138.8 129.87 26.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.972 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.598 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.2 t80 -92.62 122.34 34.94 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.901 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.878 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.7 mt -104.43 109.8 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.629 0.728 . . . . 0.0 110.469 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -81.6 118.93 23.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.253 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.593 HG22 ' HB3' ' A' ' 47' ' ' LYS . 20.3 pt -100.21 45.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.356 179.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.508 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.4 ttt -162.72 99.79 1.07 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.075 -179.659 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 56.3 Cg_endo -71.19 -33.14 11.91 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.265 1.976 . . . . 0.0 111.719 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.91 157.86 45.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.349 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 11' ' ' ILE . 4.8 mttt -64.96 -8.46 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.301 0.572 . . . . 0.0 111.453 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.68 -56.73 2.06 Favored Glycine 0 C--N 1.313 -0.721 0 CA-C-N 115.201 -0.908 . . . . 0.0 113.557 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.3 144.84 29.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.629 ' HB3' HD11 ' A' ' 48' ' ' ILE . 13.5 m-85 -71.08 170.65 12.43 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.153 179.438 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.514 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -95.15 115.84 27.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.753 179.151 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -56.72 -28.23 60.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.23 -52.87 62.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HB3' HG22 ' A' ' 36' ' ' ILE . 27.3 mmtp -70.78 -47.87 57.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.81 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 43' ' ' PHE . 1.8 mp -55.78 -48.71 77.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.62 96.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.521 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.78 -35.25 79.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.617 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 tp -58.71 -54.55 45.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.533 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.414 ' N ' HD23 ' A' ' 52' ' ' LEU . 7.8 mt -53.56 -46.27 70.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.175 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 m -62.47 -32.1 72.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.386 179.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -69.67 -36.41 76.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.472 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.68 -61.16 2.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.555 179.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.5 -105.82 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.993 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -146.1 30.14 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.077 0.465 . . . . 0.0 110.547 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -120.91 -153.65 0.55 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.544 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 t -120.84 170.61 9.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.3 98.38 8.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.55 . . . . 0.0 110.282 179.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.0 mm -79.71 84.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.191 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.6 25.11 57.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.463 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.571 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -61.12 143.26 55.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.785 179.861 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.4 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 71.4 p -121.69 153.21 38.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.277 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.0 mmt -102.65 153.97 37.81 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.495 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.2 Cg_exo -77.7 141.33 66.8 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.022 0.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.571 ' CD ' HD12 ' A' ' 63' ' ' LEU . 35.5 mt-30 -99.31 122.4 42.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.488 179.223 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.703 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -96.5 165.76 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.897 0.38 . . . . 0.0 111.67 -179.483 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 72.2 m-85 -142.8 142.29 31.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.742 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.07 134.45 58.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.163 -178.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.536 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 98.0 Cg_exo -44.68 -29.41 3.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.912 2.408 . . . . 0.0 112.116 178.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -163.74 42.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.256 179.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.08 -107.93 0.7 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.741 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.47 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -137.58 176.13 8.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.154 0.502 . . . . 0.0 111.27 -179.646 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 68' ' ' VAL . 38.1 t-80 -52.51 123.2 10.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.178 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.636 HD11 ' HA ' ' A' ' 70' ' ' ALA . 13.5 mt -85.8 -44.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.09 -151.22 20.19 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 -179.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.51 -155.11 30.23 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.74 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 10.5 t80 -63.14 -70.58 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 110.835 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -57.53 -44.9 85.47 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.501 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.09 -31.62 31.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.379 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.72 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.6 tt -80.78 -34.98 33.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.269 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttp85 -52.16 -30.44 26.8 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -68.72 -35.22 76.86 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.514 -0.766 . . . . 0.0 108.974 178.067 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.459 ' CD2' HG23 ' A' ' 76' ' ' ILE . 28.2 t80 -62.54 -34.62 77.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.274 178.329 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.72 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -87.61 -70.28 0.64 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.348 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.914 -179.939 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.571 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 58.5 ttm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.947 0.403 . . . . 0.0 111.469 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.511 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 64.2 m-85 -49.75 170.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.87 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -145.3 114.57 7.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.661 -179.341 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.991 HG22 HG22 ' A' ' 68' ' ' VAL . 61.7 t -107.63 143.16 18.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.296 0.569 . . . . 0.0 112.04 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.827 ' CE1' HD12 ' A' ' 34' ' ' ILE . 7.3 m-85 -121.71 105.64 10.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.623 177.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.47 -135.3 1.86 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.75 -179.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.45 ' HE1' ' HE2' ' A' ' 37' ' ' MET . 67.6 m-85 -110.45 150.49 28.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.88 0.371 . . . . 0.0 111.274 -179.33 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.32 6.94 46.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.229 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p 78.46 -8.86 1.6 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -85.2 -40.09 17.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.629 0.252 . . . . 0.0 111.301 -179.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.657 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.4 mp -99.02 -38.25 6.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.847 0.356 . . . . 0.0 111.676 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.442 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 17.7 t60 -139.8 152.0 46.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.493 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 162.8 28.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.078 0.466 . . . . 0.0 112.067 -178.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -178.62 117.18 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.127 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 m -89.61 -34.59 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.992 0.425 . . . . 0.0 110.949 179.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -60.48 -23.25 64.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.333 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.52 -40.65 56.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.917 0.389 . . . . 0.0 110.42 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -63.88 -51.72 63.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.472 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 6.2 p30 -66.91 -49.0 66.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.163 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.412 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -53.5 -43.72 68.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.933 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -65.33 -58.44 5.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.796 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.799 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.4 ttm-85 -55.51 -40.19 71.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.523 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.97 -54.02 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.407 179.305 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.803 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.2 mt -56.29 -42.37 77.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.548 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -60.13 -36.5 77.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.86 179.255 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 22' ' ' ARG . 40.1 t -79.67 -31.12 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.563 179.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -9.72 58.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.025 179.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm 67.89 60.82 0.43 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.148 0.499 . . . . 0.0 110.657 -179.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -146.44 132.55 9.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.978 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.4 Cg_endo -78.35 147.75 23.22 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.436 2.09 . . . . 0.0 111.134 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.571 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 12.7 p90 -157.33 170.9 21.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.607 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 1.7 tp10 -140.74 135.02 31.12 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.983 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.481 ' CE1' HG11 ' A' ' 4' ' ' VAL . 28.4 t80 -89.47 164.26 14.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.221 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.827 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.0 mt -147.28 119.59 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.398 179.527 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -95.8 133.19 40.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.277 -179.332 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 37' ' ' MET . 2.0 pp -100.24 -13.96 8.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.219 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.821 ' N ' HD12 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -122.65 75.55 45.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.464 179.967 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 77.8 Cg_endo -88.24 37.46 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.078 2.519 . . . . 0.0 112.926 -179.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -139.0 170.74 15.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.486 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -61.52 -7.99 3.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.22 0.533 . . . . 0.0 112.046 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.29 55.37 0.02 OUTLIER Glycine 0 C--N 1.314 -0.669 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.758 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -150.31 118.93 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.23 0.538 . . . . 0.0 111.838 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.89 137.25 57.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.358 178.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 1.8 t70 -95.04 105.53 17.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.098 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.11 -21.52 32.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.663 -179.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.0 -51.27 70.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.677 0.275 . . . . 0.0 111.045 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.739 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -72.91 -41.15 64.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.386 179.618 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 44' ' ' ASP . 2.5 mp -59.83 -40.3 82.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.328 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.87 -48.52 71.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.235 179.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -39.28 93.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.439 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.486 HD21 ' NE2' ' A' ' 67' ' ' GLN . 28.2 tp -58.06 -50.65 72.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.613 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 52' ' ' LEU . 78.6 mt -51.26 -45.08 61.94 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.145 0.498 . . . . 0.0 111.11 179.458 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.5 m -66.48 -31.16 71.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.134 179.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.81 -31.72 70.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.31 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.46 -70.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.87 179.482 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.02 -30.18 0.99 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.173 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -105.57 -174.97 2.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.691 0.282 . . . . 0.0 110.831 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -101.35 -30.65 11.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.102 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -104.43 166.05 10.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.998 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -117.26 100.32 7.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.688 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 pt -75.54 82.7 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.456 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.7 20.08 77.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.928 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.45 132.65 44.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 110.754 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 65' ' ' MET . 1.0 OUTLIER -131.09 170.22 14.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.067 0.46 . . . . 0.0 111.429 -179.669 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.485 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -105.5 157.36 34.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.772 179.767 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.7 Cg_exo -76.82 152.77 95.74 Favored 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.977 -1.26 . . . . 0.0 112.98 0.467 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.486 ' NE2' HD21 ' A' ' 51' ' ' LEU . 5.0 mt-30 -118.62 116.18 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.314 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.991 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -93.18 165.55 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.658 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 76.6 m-85 -143.2 148.15 36.02 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.697 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -58.22 144.73 76.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.182 -178.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.543 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 66.7 Cg_exo -54.62 -27.87 53.14 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.059 2.506 . . . . 0.0 112.434 179.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -90.78 -32.01 16.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.379 -179.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.37 80.89 0.17 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.798 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.74 164.09 21.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -90.54 118.42 29.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.144 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.665 HG21 HD23 ' A' ' 82' ' ' LEU . 21.3 mt -96.21 -46.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.031 0.443 . . . . 0.0 110.726 179.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.9 -147.9 17.56 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.022 -179.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.82 -161.9 36.74 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.207 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.551 ' HE1' HD13 ' A' ' 23' ' ' LEU . 35.0 t80 -69.53 -49.59 52.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.405 179.734 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -55.76 -49.0 74.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.628 179.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -31.81 73.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.483 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.763 HD11 ' CE2' ' A' ' 86' ' ' PHE . 2.7 tm? -73.93 -42.54 60.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.653 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.6 ttt-85 -56.08 -43.92 78.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.678 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG2' ' HD2' ' A' ' 87' ' ' LYS . 22.4 tt0 -61.84 -38.79 89.51 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.189 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.479 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -60.56 -40.28 91.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.89 177.795 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.763 ' CE2' HD11 ' A' ' 82' ' ' LEU . 3.9 m-30 -82.07 -10.12 59.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.141 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.404 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.152 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.612 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 34.6 ttm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.412 ' CD2' ' HD3' ' A' ' 71' ' ' PRO . 95.9 m-85 -78.11 143.9 36.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.461 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.72 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -104.94 118.9 37.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.444 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.682 HG22 HG22 ' A' ' 68' ' ' VAL . 5.9 t -101.66 117.32 46.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.083 0.468 . . . . 0.0 111.146 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.734 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.7 m-30 -92.6 98.76 11.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.616 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' C ' ' CD1' ' A' ' 7' ' ' TYR . . . -160.57 -140.21 2.84 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.747 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.697 ' HE2' ' HE3' ' A' ' 37' ' ' MET . 5.4 m-85 -131.82 134.24 45.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 120.735 0.302 . . . . 0.0 111.539 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -128.39 62.36 1.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.102 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -172.78 -172.1 0.84 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.163 0.506 . . . . 0.0 111.845 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.13 2.18 47.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.885 HG21 ' O ' ' A' ' 39' ' ' GLU . 0.8 OUTLIER -87.37 -4.02 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.989 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.691 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 11.1 t-80 -169.98 145.09 2.84 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.929 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.89 168.72 18.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.024 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -177.88 110.59 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.295 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 16' ' ' TYR . 27.7 m -90.58 -46.02 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.49 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.509 ' N ' HG23 ' A' ' 15' ' ' VAL . 24.2 m-85 -62.17 -22.27 65.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.032 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.0 t -63.07 -41.13 99.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.798 0.332 . . . . 0.0 111.038 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -62.0 -54.5 40.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.437 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 4.7 p30 -69.45 -51.66 34.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.398 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.82 -36.44 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.341 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -62.12 -57.83 10.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.472 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.768 ' O ' HG23 ' A' ' 26' ' ' VAL . 18.2 ttt180 -65.18 -23.79 67.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.817 HD12 ' CE1' ' A' ' 79' ' ' PHE . 5.5 tt -58.54 -58.7 7.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.085 0.469 . . . . 0.0 110.386 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.906 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 9.5 mt -63.23 -39.2 93.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.68 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.9 m -62.92 -39.51 94.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.436 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.0 t -65.78 -45.95 90.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.688 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -12.17 61.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.237 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.93 52.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.896 0.379 . . . . 0.0 111.274 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -136.74 138.17 25.55 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.752 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 1' ' ' MET . 63.1 Cg_endo -80.7 159.82 21.78 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.589 2.193 . . . . 0.0 111.775 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.61 ' CG ' HD12 ' A' ' 24' ' ' LEU . 30.3 p90 -161.63 170.75 19.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.842 0.353 . . . . 0.0 111.559 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.96 135.21 35.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.724 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 8.7 t80 -89.61 158.51 17.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.308 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.734 HD12 ' CE1' ' A' ' 5' ' ' TYR . 13.3 mt -147.69 121.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.212 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -89.61 127.34 35.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.297 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.655 HD11 ' OH ' ' A' ' 7' ' ' TYR . 5.0 pt -99.56 22.39 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.047 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.697 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -155.7 77.39 4.69 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.791 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.29 22.13 0.78 Allowed 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.825 2.35 . . . . 0.0 113.026 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.885 ' O ' HG21 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -147.74 157.65 43.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.587 0.232 . . . . 0.0 111.134 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.825 ' HA ' HG23 ' A' ' 11' ' ' ILE . 6.0 ptmt -47.4 -8.87 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' GLU . . . 176.21 46.69 0.06 OUTLIER Glycine 0 C--N 1.308 -0.988 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.553 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 t -150.13 120.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.516 . . . . 0.0 111.849 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.613 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -68.64 170.29 9.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.358 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.626 ' O ' HD13 ' A' ' 48' ' ' ILE . 6.3 t70 -95.1 105.77 17.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.372 . . . . 0.0 110.862 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -56.27 -29.18 60.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.88 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.46 -56.0 11.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 111.329 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HD3' HG21 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -69.66 -43.19 73.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.939 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.626 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.5 mp -52.01 -47.22 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.741 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.69 -54.81 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.16 -30.56 71.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.518 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.5 tt -59.22 -53.33 59.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.528 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 48' ' ' ILE . 14.2 mt -54.25 -50.44 67.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.041 0.448 . . . . 0.0 111.103 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.0 m -60.85 -36.59 79.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.367 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -66.47 -39.09 88.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.794 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.441 HD21 ' CD2' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -59.58 -52.5 65.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.096 0.474 . . . . 0.0 110.347 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.68 -114.42 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.89 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -150.48 30.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.102 0.477 . . . . 0.0 110.671 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -121.08 -143.62 0.34 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.467 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -119.55 170.34 9.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.734 0.302 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.65 98.11 8.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.253 0.549 . . . . 0.0 110.636 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 61' ' ' ILE . 6.4 tp -80.5 85.51 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.864 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.27 29.67 69.3 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.988 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.531 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.2 tm? -44.97 119.4 1.97 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.38 . . . . 0.0 111.172 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.2 p -110.09 170.27 8.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.251 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 154.01 61.01 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.939 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.1 Cg_endo -86.64 152.51 45.56 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 124.258 -1.143 . . . . 0.0 112.406 0.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -117.91 113.06 21.16 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -83.34 163.06 3.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.131 0.491 . . . . 0.0 111.902 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 50.9 m-85 -142.52 141.57 32.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.335 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.654 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.2 132.44 51.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.614 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HB3' ' N ' ' A' ' 1' ' ' MET . 33.7 Cg_exo -53.48 -21.88 19.82 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.56 2.173 . . . . 0.0 111.795 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -161.61 41.14 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.29 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.95 -110.72 0.63 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.998 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.515 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 37.1 m -137.85 178.62 6.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.136 0.493 . . . . 0.0 111.274 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 37.9 t-80 -55.75 132.36 49.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.116 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' HA ' ' A' ' 70' ' ' ALA . 9.4 mt -100.98 -42.65 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.05 -154.95 22.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.028 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.13 -141.39 10.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.843 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.817 ' CE1' HD12 ' A' ' 23' ' ' LEU . 26.5 t80 -72.42 -70.64 0.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.767 0.317 . . . . 0.0 111.332 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -56.93 -49.53 75.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 110.663 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -53.11 -37.64 61.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.512 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.706 HD21 ' CE1' ' A' ' 86' ' ' PHE . 5.4 tt -77.82 -34.49 51.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.212 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 -51.98 -31.37 29.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -68.8 -32.43 72.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.286 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 26.3 t80 -68.43 -29.99 68.77 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.589 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.906 ' CZ ' HD22 ' A' ' 24' ' ' LEU . 22.6 m-85 -92.33 -25.49 18.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.416 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.2 mttt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.793 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.545 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 34.2 ttp . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.902 0.382 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.464 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 65.0 m-85 -50.05 169.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.785 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -143.28 117.48 9.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.496 -178.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 68' ' ' VAL . 77.1 t -108.88 144.64 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.201 0.524 . . . . 0.0 111.535 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.759 ' CE1' HD12 ' A' ' 34' ' ' ILE . 10.9 m-85 -125.47 99.95 6.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.196 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.36 -137.46 2.22 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.257 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.08 159.34 20.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.738 0.304 . . . . 0.0 110.905 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -84.73 -73.7 0.42 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p 167.83 -33.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 110.638 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -85.12 -23.15 28.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.493 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.594 HG23 ' O ' ' A' ' 39' ' ' GLU . 4.1 mp -91.73 -44.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.222 0.534 . . . . 0.0 110.733 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -150.08 139.8 21.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.004 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.82 146.0 43.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.276 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.98 112.12 0.64 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.322 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 m -90.56 -30.74 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.451 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -65.02 -27.28 68.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.51 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.1 t -56.8 -53.86 52.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.352 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.16 -35.62 64.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.176 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -72.92 -58.96 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.989 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.12 -37.69 64.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.213 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -59.5 -54.27 48.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.691 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.85 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.4 tpp180 -66.33 -28.87 69.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.049 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.706 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.6 tt -54.57 -53.71 50.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.477 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.687 HD12 ' CG ' ' A' ' 31' ' ' PHE . 4.7 mt -65.18 -40.76 94.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.536 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 m -61.8 -34.02 75.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.329 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 22' ' ' ARG . 96.9 t -74.13 -28.51 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.01 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -83.45 -12.57 56.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.293 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.49 55.95 0.08 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 111.14 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -142.19 142.39 24.14 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.449 ' O ' ' HA ' ' A' ' 1' ' ' MET . 98.5 Cg_endo -79.09 148.54 21.73 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.485 2.123 . . . . 0.0 111.323 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.687 ' CG ' HD12 ' A' ' 24' ' ' LEU . 36.8 p90 -156.74 170.64 21.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' OE2' ' HE1' ' A' ' 1' ' ' MET . 1.4 tt0 -141.68 134.92 29.33 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.026 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.49 ' HE1' HG11 ' A' ' 4' ' ' VAL . 30.3 t80 -89.68 161.97 15.83 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.093 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.759 HD12 ' CE1' ' A' ' 5' ' ' TYR . 17.0 mt -147.22 121.4 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.602 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -99.45 131.77 45.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.938 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.672 HD12 ' HD1' ' A' ' 43' ' ' PHE . 1.1 pp -96.82 7.19 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.763 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.48 ' HE2' ' CE1' ' A' ' 43' ' ' PHE . 1.5 tpp -140.62 69.41 31.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.705 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 3.8 Cg_exo -80.96 43.65 1.59 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.296 2.664 . . . . 0.0 112.899 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.594 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -144.18 170.36 16.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.57 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.5 tptt -66.41 -7.69 20.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.199 0.523 . . . . 0.0 111.975 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.49 50.0 0.02 OUTLIER Glycine 0 C--N 1.313 -0.739 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.667 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -150.48 120.2 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.213 0.53 . . . . 0.0 111.818 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HD1' HD12 ' A' ' 36' ' ' ILE . 65.0 m-85 -65.61 136.61 56.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.157 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.588 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -97.83 113.76 25.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.831 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -63.37 -17.27 62.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.46 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -62.3 -57.29 11.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.862 0.363 . . . . 0.0 110.646 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -72.13 -39.29 68.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.206 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 43' ' ' PHE . 23.6 mt -60.48 -48.46 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.26 96.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.375 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.01 -37.63 88.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.323 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.449 HD13 ' CD2' ' A' ' 5' ' ' TYR . 26.7 tp -59.3 -51.9 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.6 -47.46 70.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.093 0.473 . . . . 0.0 111.192 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.0 m -62.63 -32.25 73.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.42 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 2.8 mmmt -67.71 -34.98 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.491 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.83 -39.15 84.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.466 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.5 -105.85 0.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.865 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -150.33 31.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.041 0.448 . . . . 0.0 110.636 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.01 -147.19 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.445 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 t -120.21 170.29 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 0.0 110.668 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.15 98.24 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 110.405 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mt -80.2 84.21 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.201 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.29 24.89 53.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.639 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.62 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -58.71 143.12 47.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 110.685 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -124.07 168.12 13.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 111.444 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.6 mtm -110.67 154.55 43.13 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.732 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.3 Cg_exo -79.27 140.65 58.2 Favored 'Cis proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.749 -1.355 . . . . 0.0 112.759 0.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.62 ' CD ' HD12 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -97.02 114.69 26.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.031 179.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.891 HG22 HG22 ' A' ' 4' ' ' VAL . 6.5 t -95.71 160.27 2.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.996 0.427 . . . . 0.0 111.73 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 92.5 m-85 -142.44 153.44 43.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.723 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.956 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -61.62 147.35 88.74 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.271 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 1' ' ' MET . 64.2 Cg_exo -55.17 -23.89 38.65 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.293 2.662 . . . . 0.0 112.507 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -99.06 -29.0 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.397 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 132.26 93.83 0.58 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.756 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.85 159.85 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -90.2 125.55 35.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.017 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.956 HD11 ' HB2' ' A' ' 70' ' ' ALA . 3.1 mp -117.05 -27.28 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.488 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 120.14 -157.62 15.62 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.939 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.5 -140.65 11.56 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.675 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.706 ' CE1' HD12 ' A' ' 23' ' ' LEU . 24.4 t80 -65.96 -70.58 0.23 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.823 0.344 . . . . 0.0 111.145 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.19 -49.99 75.11 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.826 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.404 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 5.2 tt0 -51.09 -43.09 61.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.438 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.613 HD21 ' CD2' ' A' ' 86' ' ' PHE . 4.7 tt -74.76 -34.07 62.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.107 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.4 ttp180 -51.84 -28.62 16.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.14 -32.62 70.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.0 t80 -67.45 -32.02 72.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.67 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.613 ' CD2' HD21 ' A' ' 82' ' ' LEU . 10.2 m-85 -96.71 -70.61 0.71 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.651 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 83' ' ' ARG . 9.5 mmtp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.676 ' HG3' ' HA ' ' A' ' 31' ' ' PHE . 1.1 tpp . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.769 0.319 . . . . 0.0 111.687 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.492 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 65.8 m-85 -58.83 166.28 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.344 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -140.86 117.57 10.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.022 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.944 HG22 HG22 ' A' ' 68' ' ' VAL . 39.0 t -107.5 147.43 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.223 0.535 . . . . 0.0 111.48 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.715 ' CE1' HD12 ' A' ' 34' ' ' ILE . 14.8 m-85 -129.64 101.19 5.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.289 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.71 -138.67 2.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.174 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.649 ' HE2' ' HE3' ' A' ' 37' ' ' MET . 16.3 m-85 -116.03 158.56 22.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.619 0.247 . . . . 0.0 110.706 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -74.23 -69.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.689 0.28 . . . . 0.0 111.462 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 166.31 -38.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.038 0.447 . . . . 0.0 110.179 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -85.29 -22.82 28.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.623 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.615 HD12 ' N ' ' A' ' 11' ' ' ILE . 3.4 mp -89.65 -42.77 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.25 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.513 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 12.2 t-80 -144.3 158.34 43.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.795 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 17.4 ptmt -80.6 144.96 31.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.963 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 p -174.3 117.75 0.22 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.307 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.14 -32.08 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -67.01 -24.61 66.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.42 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -65.79 -61.09 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.398 . . . . 0.0 110.439 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -26.01 63.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.913 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 28.4 m-20 -78.66 -60.04 2.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.193 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.01 -45.97 71.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.172 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -58.19 -52.53 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.567 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.805 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.3 ttt85 -61.01 -40.76 94.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.576 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.77 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.1 tt -57.55 -53.82 53.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.416 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.77 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.6 mt -55.77 -46.72 77.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.732 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.1 m -56.77 -37.08 70.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.14 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' ARG . 43.4 t -77.83 -31.08 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.656 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -9.68 58.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.15 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt 68.13 53.36 0.63 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.947 0.403 . . . . 0.0 110.69 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -133.23 136.38 27.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.108 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 54.1 Cg_endo -81.29 137.14 10.41 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.547 2.165 . . . . 0.0 110.837 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.676 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 42.3 p90 -153.6 170.1 21.65 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.684 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -136.43 132.87 36.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.568 ' CE1' HG11 ' A' ' 4' ' ' VAL . 34.7 t80 -89.67 160.84 16.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.715 HD12 ' CE1' ' A' ' 5' ' ' TYR . 18.4 mt -146.63 121.14 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.323 0.582 . . . . 0.0 110.517 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -90.51 121.82 32.79 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.897 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 2.5 pt -91.45 -6.65 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.337 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.649 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 22.4 ttm -118.57 99.88 51.35 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.661 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.8 Cg_endo -76.16 -27.5 8.15 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.477 2.118 . . . . 0.0 111.768 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -140.28 150.14 43.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.217 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -64.38 -8.37 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.355 0.598 . . . . 0.0 111.801 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.51 -56.55 3.13 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.685 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.73 147.18 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.8 ' HB2' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -66.45 168.75 8.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.606 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.466 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 41.6 t0 -91.37 122.11 33.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -66.6 -26.5 67.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.886 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.02 -56.25 23.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.476 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -64.41 -44.24 91.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.136 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.8 HD11 ' HB2' ' A' ' 43' ' ' PHE . 42.9 mt -55.79 -42.95 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.392 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.74 -47.87 76.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.728 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.12 -36.56 82.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.335 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.926 ' O ' HD12 ' A' ' 55' ' ' LEU . 34.2 tp -63.05 -60.29 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.445 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.59 ' HA ' HD13 ' A' ' 55' ' ' LEU . 88.0 mt -44.91 -41.91 7.6 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.261 0.553 . . . . 0.0 111.747 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.9 m -69.03 -30.33 68.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.406 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 51' ' ' LEU . 4.4 tttp -69.05 -44.28 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.836 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.926 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -59.1 -67.09 0.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.381 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.77 -31.55 0.14 Allowed Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.901 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -135.69 -169.99 2.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.323 . . . . 0.0 110.919 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -103.63 20.18 18.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.231 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 t -120.09 165.68 14.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.826 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -128.98 100.69 5.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.008 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.5 mt -80.29 84.28 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.012 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.62 27.56 55.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.162 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD11 ' CD2' ' A' ' 55' ' ' LEU . 1.5 mm? -55.42 143.18 29.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.995 0.426 . . . . 0.0 111.238 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 152.58 45.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.3 mmt -108.75 148.92 38.76 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.727 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.3 Cg_exo -80.53 148.0 76.02 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 124.026 -1.239 . . . . 0.0 112.952 0.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 5' ' ' TYR . 6.7 tp60 -104.38 126.24 51.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.384 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.944 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -103.01 166.39 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.74 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 81.1 m-85 -142.53 153.03 43.22 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -65.11 149.71 96.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.264 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.675 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 40.9 Cg_exo -59.97 -25.76 80.48 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.026 2.484 . . . . 0.0 112.196 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.16 -25.95 17.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.246 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.4 91.11 0.84 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.658 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -179.17 161.21 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.791 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.419 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 10.5 t-160 -85.6 126.67 34.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 70' ' ' ALA . 18.6 mt -101.21 -45.42 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.033 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.39 -152.42 18.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.912 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.25 -146.38 12.0 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.859 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 19.3 t80 -72.27 -70.98 0.31 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.672 0.272 . . . . 0.0 111.327 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -55.84 -44.46 78.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.158 0.504 . . . . 0.0 110.508 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -52.54 -40.75 62.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.995 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.701 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.0 tt -73.63 -32.09 63.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.284 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.0 mmm-85 -51.81 -35.11 43.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.34 -34.57 78.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.3 t80 -61.82 -35.36 78.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.07 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.701 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.7 m-85 -91.51 -9.7 43.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.07 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.1 pttp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.964 179.831 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 8.2 ttm . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.1 144.54 38.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.097 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.68 118.81 37.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.333 -178.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.643 HG12 ' CE1' ' A' ' 33' ' ' PHE . 55.0 t -104.73 142.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.184 0.516 . . . . 0.0 111.042 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.875 ' CE1' HD12 ' A' ' 34' ' ' ILE . 9.8 m-85 -121.27 99.15 6.32 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' HA2' ' HG2' ' A' ' 65' ' ' MET . . . -159.08 -151.99 6.3 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.848 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.874 ' CE1' HD11 ' A' ' 36' ' ' ILE . 60.7 m-85 -102.74 125.12 49.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.754 0.311 . . . . 0.0 111.318 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.508 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 6.1 t0 -137.1 65.36 1.5 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.634 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.36 -171.62 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.144 0.497 . . . . 0.0 111.631 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.85 -2.61 58.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.96 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.16 -13.22 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.955 0.407 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.711 ' CG ' ' CD1' ' A' ' 7' ' ' TYR . 42.9 t-80 -165.59 141.02 5.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -80.78 174.97 11.09 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.11 92.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.932 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -79.28 -32.25 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.719 0.295 . . . . 0.0 111.445 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -63.91 -26.67 68.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.447 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -59.31 -42.08 90.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 110.329 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.39 -43.42 67.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.771 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -76.99 -55.21 5.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.846 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.57 -41.92 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.003 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -59.65 -53.74 54.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.589 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.786 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.2 ttt85 -64.76 -28.65 69.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.841 HD12 ' CE1' ' A' ' 79' ' ' PHE . 2.0 tt -60.05 -59.8 4.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.397 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.549 HD12 ' CG ' ' A' ' 31' ' ' PHE . 7.1 mt -58.52 -40.29 82.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.433 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.4 m -60.44 -38.06 82.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.878 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 22' ' ' ARG . 96.3 t -78.84 -30.28 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.627 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -70.13 -15.73 63.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.917 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 76.13 45.59 0.11 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.935 0.398 . . . . 0.0 111.0 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -144.01 137.62 14.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.023 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.603 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.6 Cg_endo -75.24 162.94 35.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.491 2.127 . . . . 0.0 111.117 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.549 ' CG ' HD12 ' A' ' 24' ' ' LEU . 53.9 p90 -161.72 171.03 18.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.458 ' OE2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -139.38 125.4 19.86 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.36 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.643 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.4 t80 -90.74 124.97 35.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.361 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.875 HD12 ' CE1' ' A' ' 5' ' ' TYR . 8.0 mt -106.48 114.22 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.477 0.656 . . . . 0.0 110.526 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -82.52 144.62 30.28 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.383 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.874 HD11 ' CE1' ' A' ' 7' ' ' TYR . 2.6 pt -100.89 -12.7 8.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.666 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 19.1 ttm -124.81 107.76 28.64 Favored Pre-proline 0 C--N 1.334 -0.089 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 44' ' ' ASP . 95.6 Cg_endo -79.96 -28.05 3.46 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.353 2.035 . . . . 0.0 110.927 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 37' ' ' MET . 0.4 OUTLIER -146.62 151.09 36.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.231 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -8.52 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.225 0.536 . . . . 0.0 111.99 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 -54.56 4.5 Favored Glycine 0 C--N 1.311 -0.86 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.126 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -150.87 134.16 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -56.99 170.14 0.46 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.473 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -87.1 106.19 17.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.658 0.266 . . . . 0.0 111.7 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.73 -27.48 59.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -59.03 -53.4 58.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.88 0.371 . . . . 0.0 110.581 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.729 ' HG2' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -70.01 -40.66 75.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.03 179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 44' ' ' ASP . 44.9 mm -58.13 -45.94 88.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.69 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.51 -56.58 11.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.296 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -60.62 -30.66 69.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.919 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -58.24 -53.26 60.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.572 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.6 mt -54.28 -46.58 72.76 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 111.204 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.8 m -63.86 -34.12 77.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.227 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HE3' ' CG ' ' A' ' 69' ' ' PHE . 2.0 mmmt -65.77 -36.93 84.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.438 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.33 -42.98 96.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.489 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.75 -107.31 0.31 Allowed Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.751 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -150.55 26.78 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.074 0.464 . . . . 0.0 110.834 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -121.67 -153.71 0.56 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.31 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -120.88 161.18 21.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.477 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.418 ' NE2' ' HG ' ' A' ' 63' ' ' LEU . 7.8 pt20 -115.04 98.75 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 110.785 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.559 ' H ' HD12 ' A' ' 61' ' ' ILE . 3.8 mp -81.63 87.72 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.557 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.07 33.37 5.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.412 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.754 HD13 ' N ' ' A' ' 64' ' ' THR . 2.1 tm? -44.56 130.71 6.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.759 0.314 . . . . 0.0 110.904 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.754 ' N ' HD13 ' A' ' 63' ' ' LEU . 4.6 m -112.33 148.3 34.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.082 0.467 . . . . 0.0 111.551 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.517 ' SD ' HD12 ' A' ' 63' ' ' LEU . 3.5 mpp? -119.65 155.72 54.33 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.791 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.8 Cg_exo -80.53 137.55 40.78 Favored 'Cis proline' 0 C--N 1.344 0.327 0 C-N-CA 123.861 -1.308 . . . . 0.0 112.858 0.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.5 tp60 -99.78 118.32 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.172 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.591 HG22 HG22 ' A' ' 4' ' ' VAL . 4.3 t -93.44 161.53 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.328 0.585 . . . . 0.0 112.145 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 86.2 m-85 -143.2 152.31 41.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.99 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.601 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -65.47 143.56 98.72 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.78 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HB3' ' N ' ' A' ' 1' ' ' MET . 21.8 Cg_exo -61.63 -17.48 54.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.354 2.036 . . . . 0.0 111.988 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -103.19 -25.91 13.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.862 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.48 86.21 0.49 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.697 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.433 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER 179.58 118.97 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 110.823 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.417 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 8.3 t-160 -55.53 131.79 47.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.3 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 70' ' ' ALA . 2.0 mp -116.76 -31.94 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 117.62 -161.13 13.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.718 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -90.31 -147.99 19.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.028 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.841 ' CE1' HD12 ' A' ' 23' ' ' LEU . 46.5 t80 -69.54 -53.84 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.347 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -57.82 -49.51 76.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.758 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -64.73 -36.08 83.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.734 HD12 HD13 ' A' ' 23' ' ' LEU . 1.4 tm? -66.02 -44.13 85.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.348 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.428 ' HG2' HD11 ' A' ' 23' ' ' LEU . 3.2 mmm-85 -54.42 -37.92 65.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.38 -37.17 74.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -62.07 -35.44 78.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.127 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.623 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.2 m-85 -86.52 -26.76 24.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.217 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.1 mttt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.86 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.566 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.3 ttp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.843 0.354 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.483 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 94.7 m-85 -59.26 160.83 6.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.669 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.9 mppp? -135.72 118.08 15.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.198 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.901 HG22 HG22 ' A' ' 68' ' ' VAL . 19.4 t -108.53 141.13 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.183 0.515 . . . . 0.0 111.926 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.846 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.6 m-85 -121.68 105.34 10.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.249 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.38 -139.0 2.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.392 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.42 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 38.7 m-85 -109.91 153.35 24.62 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.4 t70 -82.22 -2.63 53.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 2.3 p 81.82 -22.85 0.24 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.984 0.421 . . . . 0.0 110.921 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -75.71 -35.29 60.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.9 0.381 . . . . 0.0 111.124 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 11' ' ' ILE . 9.8 mm -104.6 -7.02 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -176.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.518 ' HD2' ' HE3' ' A' ' 37' ' ' MET . 1.3 t-80 -166.64 108.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -176.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -39.39 134.23 1.24 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.5 m -166.23 109.23 0.76 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.401 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 m -87.0 -29.71 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 110.732 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -58.12 -30.7 66.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.596 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.5 m -61.73 -55.0 34.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 110.059 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -53.56 -31.64 47.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.248 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.24 -59.68 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.19 -42.01 69.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.296 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER -62.12 -57.79 10.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.471 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 26' ' ' VAL . 22.2 ttt180 -57.0 -39.12 74.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.238 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -57.02 -54.2 49.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.197 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.714 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.5 mt -57.32 -45.49 84.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.616 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.5 m -58.27 -36.06 72.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.079 0.466 . . . . 0.0 109.977 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 22' ' ' ARG . 53.1 t -79.82 -30.62 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.425 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -16.59 59.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.916 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt 72.53 57.32 0.14 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.93 0.395 . . . . 0.0 110.978 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -139.08 139.0 21.93 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.373 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.47 ' O ' ' HA ' ' A' ' 1' ' ' MET . 71.6 Cg_endo -80.14 140.12 13.82 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.56 2.174 . . . . 0.0 111.241 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 22.9 p90 -160.26 171.27 19.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.414 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 2.5 tt0 -142.06 137.84 31.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.962 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.618 ' CE1' HG11 ' A' ' 4' ' ' VAL . 39.6 t80 -89.41 159.74 17.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.833 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.846 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.3 mt -143.68 119.11 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.279 0.561 . . . . 0.0 110.456 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -80.66 135.94 36.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.394 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.608 HD13 ' SD ' ' A' ' 65' ' ' MET . 2.7 pt -97.01 -17.38 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.421 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.624 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 4.4 ttp -131.41 90.37 38.02 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.482 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 10.1 Cg_exo -71.17 -4.32 14.66 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.661 2.241 . . . . 0.0 113.207 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -139.65 144.11 37.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.068 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -68.09 -8.55 39.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.241 0.543 . . . . 0.0 111.945 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.91 -58.02 1.35 Allowed Glycine 0 C--N 1.313 -0.75 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.293 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.84 140.93 27.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -72.73 167.16 21.41 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.616 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 38' ' ' PRO . 30.6 p30 -91.37 103.46 16.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.382 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.9 -24.65 16.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.696 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -56.53 -50.16 72.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.922 0.391 . . . . 0.0 111.006 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -75.93 -32.06 59.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.459 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' A' ' 36' ' ' ILE . 37.0 mm -65.0 -47.25 88.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.004 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.98 -55.99 18.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.027 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -56.73 -31.97 65.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.608 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.882 ' O ' HD12 ' A' ' 55' ' ' LEU . 15.4 tp -61.34 -58.41 8.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.189 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.701 ' HA ' HD13 ' A' ' 55' ' ' LEU . 72.5 mt -44.04 -40.92 5.12 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.301 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.1 m -70.22 -35.64 74.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.301 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' LEU . 5.0 tttp -60.2 -41.86 93.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.679 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.882 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -58.64 -69.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.239 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.08 -35.08 0.31 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -102.8 -175.1 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.798 0.332 . . . . 0.0 111.009 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.73 -31.9 10.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.825 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -105.32 170.19 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.417 ' HB2' HD12 ' A' ' 63' ' ' LEU . 9.4 pt20 -122.72 101.51 7.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.757 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -80.06 85.92 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.309 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.92 27.25 70.99 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.579 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.709 HD22 ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -49.84 171.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 111.235 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.709 ' N ' HD22 ' A' ' 63' ' ' LEU . 6.9 p -143.29 156.67 44.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.1 0.476 . . . . 0.0 111.591 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.608 ' SD ' HD13 ' A' ' 36' ' ' ILE . 3.2 mtt -126.32 154.65 74.73 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.567 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HB2' HG13 ' A' ' 4' ' ' VAL . 7.5 Cg_exo -75.52 150.34 94.47 Favored 'Cis proline' 0 C--N 1.344 0.308 0 C-N-CA 124.008 -1.247 . . . . 0.0 112.77 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.667 ' OE1' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -102.58 123.15 45.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.495 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.901 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -97.03 166.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.343 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 81.6 m-85 -142.47 140.98 32.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.071 0.462 . . . . 0.0 110.895 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB3' ' N ' ' A' ' 74' ' ' SER . . . -53.4 134.98 52.39 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.411 -178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HB3' ' N ' ' A' ' 1' ' ' MET . 89.0 Cg_exo -45.92 -27.68 4.35 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.012 2.475 . . . . 0.0 112.074 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -165.43 38.8 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.153 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.56 -109.15 0.99 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.101 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.448 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 13.5 m -138.47 177.34 7.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.237 0.542 . . . . 0.0 111.335 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -53.06 122.3 9.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.096 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 70' ' ' ALA . 4.4 mt -83.83 -43.64 17.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.988 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.04 -149.84 17.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.526 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.6 -159.25 31.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.209 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -60.92 -57.85 10.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.767 0.318 . . . . 0.0 110.704 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -54.01 -43.95 70.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -57.16 -32.81 66.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.625 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.6 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -71.49 -47.47 55.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.655 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.28 -30.17 26.73 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -74.81 -33.65 62.25 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 82' ' ' LEU . 21.0 t80 -66.86 -32.43 73.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.392 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.6 ' HE2' HD21 ' A' ' 82' ' ' LEU . 7.1 m-85 -92.08 -70.31 0.7 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.336 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.87 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.671 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 12.4 tpp . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.429 0.157 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -39.85 120.92 1.2 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.511 0.672 . . . . 0.0 112.233 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -90.91 125.36 35.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.267 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.655 HG12 ' HE1' ' A' ' 33' ' ' PHE . 22.7 t -109.55 110.24 31.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.01 0.433 . . . . 0.0 111.107 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 16.4 m-85 -89.64 99.26 12.3 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.3 -141.07 3.02 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.031 -1.081 . . . . 0.0 112.723 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.823 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 30.4 m-85 -127.11 149.2 50.05 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.747 0.308 . . . . 0.0 111.261 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -102.23 22.02 13.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.7 9.63 7.44 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.445 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -85.87 -50.7 6.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.782 0.325 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.8 mm -103.0 -32.04 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.638 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -140.62 154.83 46.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.277 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 166.73 22.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.134 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 p 174.0 95.08 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.671 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 16' ' ' TYR . 34.2 m -69.7 -44.39 79.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.553 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.477 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -57.3 -29.37 63.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.233 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -64.67 -56.74 11.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.02 -33.77 53.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.173 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 91.2 m-20 -69.92 -49.88 47.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.896 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.43 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -61.01 -32.59 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -60.61 -54.06 49.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.812 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -65.56 -25.52 67.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.603 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.5 tt -57.79 -55.23 37.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.324 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 31' ' ' PHE . 25.5 mt -63.17 -35.1 79.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.567 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.3 m -68.72 -41.64 78.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.177 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 22' ' ' ARG . 90.2 t -66.79 -31.99 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.523 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -84.65 -10.49 57.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.07 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 2.6 mtmt 68.54 53.36 0.56 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.969 0.414 . . . . 0.0 110.986 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.31 113.17 7.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.671 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 88.4 Cg_exo -45.72 174.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.643 2.229 . . . . 0.0 112.766 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.498 ' HB3' HD13 ' A' ' 24' ' ' LEU . 5.2 p90 -163.99 169.89 17.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.811 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.3 tm-20 -129.03 109.41 11.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.14 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.655 ' HE1' HG12 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -90.54 150.97 21.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.04 0.448 . . . . 0.0 111.461 -179.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.445 HG13 ' C ' ' A' ' 33' ' ' PHE . 30.2 mt -149.73 127.02 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.301 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -82.69 110.31 17.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.401 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.916 ' HB ' HD11 ' A' ' 48' ' ' ILE . 3.2 pt -73.46 -19.96 18.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.8 ttp -129.49 86.13 56.86 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.338 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.82 -3.05 13.34 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.663 2.242 . . . . 0.0 112.407 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 37' ' ' MET . 3.1 tt0 -139.89 136.46 33.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.43 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -7.86 12.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.222 0.534 . . . . 0.0 111.963 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.49 -63.48 1.56 Allowed Glycine 0 C--N 1.313 -0.747 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.409 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.14 140.47 26.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.66 0.267 . . . . 0.0 111.229 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -66.23 170.97 5.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.082 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.428 ' O ' HG12 ' A' ' 48' ' ' ILE . 1.3 t70 -83.2 95.23 8.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.958 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.39 -20.64 30.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.441 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.94 -60.62 3.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.022 0.439 . . . . 0.0 110.535 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -67.09 -40.3 86.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.302 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.916 HD11 ' HB ' ' A' ' 36' ' ' ILE . 34.3 mm -59.83 -37.68 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.779 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.52 -51.91 67.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.06 -32.48 64.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.256 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.3 tt -60.64 -53.35 58.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -50.95 -42.23 59.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.017 0.437 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.0 m -59.48 -45.62 91.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.707 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -61.96 -32.52 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.564 HD21 ' CD2' ' A' ' 51' ' ' LEU . 1.3 mt -60.75 -50.35 73.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.5 -19.24 2.43 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.119 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -148.14 -162.26 1.51 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 110.397 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -113.63 21.66 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.149 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -120.19 164.22 16.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.74 0.305 . . . . 0.0 110.965 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.4 102.59 6.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.729 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.9 pt -71.77 79.68 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.344 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 48.75 26.44 5.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.535 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 63' ' ' LEU . 1.5 tp -56.6 169.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.338 . . . . 0.0 111.154 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.9 p -150.84 158.8 44.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.459 ' HG2' HD13 ' A' ' 36' ' ' ILE . 4.1 mpp? -104.29 159.13 30.32 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.596 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.6 Cg_exo -80.01 145.69 73.0 Favored 'Cis proline' 0 C--N 1.344 0.31 0 C-N-CA 124.134 -1.194 . . . . 0.0 112.978 0.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.402 ' NE2' ' CD1' ' A' ' 63' ' ' LEU . 56.4 mm-40 -108.24 120.78 43.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.773 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -90.62 155.07 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.166 0.508 . . . . 0.0 111.927 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 75' ' ' HIS . 33.8 m-85 -143.16 137.76 29.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.635 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.584 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -47.88 156.46 0.71 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.717 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.24 -38.68 88.36 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.727 2.285 . . . . 0.0 112.037 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.47 -21.65 20.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.184 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.76 89.36 0.81 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.649 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -164.55 116.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.372 . . . . 0.0 110.624 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 2.1 t-160 -55.14 112.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.307 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.716 HG21 HD12 ' A' ' 82' ' ' LEU . 6.7 mt -98.53 -35.48 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.365 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 132.43 -151.92 20.07 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.233 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 82' ' ' LEU . . . -104.57 -141.05 10.74 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.118 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.603 ' CE1' HD12 ' A' ' 23' ' ' LEU . 13.0 t80 -73.63 -66.43 0.7 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 0.0 110.725 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -63.04 -42.68 99.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.948 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.43 -49.22 75.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.626 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.716 HD12 HG21 ' A' ' 76' ' ' ILE . 3.0 tt -74.43 -38.82 62.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.88 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -49.64 -27.61 4.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.958 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.75 -35.33 72.6 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.724 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.48 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -64.8 -37.32 87.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.587 ' CD2' HD21 ' A' ' 82' ' ' LEU . 14.8 m-85 -86.55 -20.28 28.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.583 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.992 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.632 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 38.2 ttm . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -79.35 147.45 32.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.239 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.18 120.53 42.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.221 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 68' ' ' VAL . 53.6 t -112.35 123.71 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.32 0.581 . . . . 0.0 111.996 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.1 m-85 -99.98 99.53 10.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.967 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.506 ' O ' HD13 ' A' ' 36' ' ' ILE . . . -158.07 -141.69 3.22 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.335 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.635 ' CE1' HD11 ' A' ' 36' ' ' ILE . 57.9 m-85 -121.7 159.02 27.45 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.0 111.402 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.59 -67.93 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 166.28 -37.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.556 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.25 -27.74 47.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.816 HG21 ' O ' ' A' ' 37' ' ' MET . 4.2 mp -91.11 -37.04 8.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.261 0.553 . . . . 0.0 110.654 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -155.1 142.05 19.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.199 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.75 146.39 31.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.295 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.98 107.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.816 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 16' ' ' TYR . 31.4 m -71.74 -40.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.985 0.421 . . . . 0.0 110.577 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.407 ' N ' HG23 ' A' ' 15' ' ' VAL . 18.4 m-85 -51.82 -25.75 8.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.387 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.5 t -65.94 -62.85 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.125 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -57.01 -31.79 65.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.52 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -53.15 52.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.852 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.64 71.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.007 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -61.13 -35.75 77.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.083 0.468 . . . . 0.0 110.121 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.761 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.6 ttt180 -76.74 -27.62 55.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.604 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.819 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -57.35 -56.56 20.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.212 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.6 mt -63.04 -45.85 90.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.654 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 m -56.03 -35.44 66.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.366 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 22' ' ' ARG . 70.9 t -75.99 -29.54 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.682 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 1.5 mmtm -76.11 -12.91 60.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.226 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 76.16 38.7 0.31 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.03 0.443 . . . . 0.0 110.796 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -129.74 139.76 36.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.697 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 1' ' ' MET . 93.5 Cg_endo -77.74 160.98 30.93 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.471 2.114 . . . . 0.0 111.619 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -161.47 170.89 19.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.413 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -136.89 125.11 23.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.898 0.38 . . . . 0.0 110.792 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.454 ' HE1' HG11 ' A' ' 4' ' ' VAL . 13.0 t80 -89.84 156.96 18.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.162 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.432 HG13 ' C ' ' A' ' 33' ' ' PHE . 18.4 mt -150.43 123.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.275 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -86.12 110.58 19.65 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.534 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.678 ' HB ' HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -70.38 -14.19 17.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.311 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.816 ' O ' HG21 ' A' ' 11' ' ' ILE . 3.9 ttp -126.38 89.57 51.94 Favored Pre-proline 0 N--CA 1.455 -0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 110.931 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.48 0.07 10.32 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.57 2.18 . . . . 0.0 112.239 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 37' ' ' MET . 38.4 tt0 -140.02 136.25 33.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.603 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -63.93 -8.05 10.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.169 0.509 . . . . 0.0 112.114 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.89 -63.07 1.7 Allowed Glycine 0 C--N 1.313 -0.728 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.079 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -147.49 149.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.673 0.273 . . . . 0.0 111.142 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -69.14 171.27 8.58 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.873 0.368 . . . . 0.0 111.588 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -95.98 110.97 23.1 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.158 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -64.4 -23.19 67.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.808 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -58.62 -52.6 65.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.807 0.337 . . . . 0.0 110.797 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.09 -44.64 68.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.248 0.547 . . . . 0.0 109.736 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.678 HD11 ' HB ' ' A' ' 36' ' ' ILE . 16.0 mm -54.91 -40.64 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.693 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.48 -51.4 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.645 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -32.35 64.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.228 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.603 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.7 tt -60.99 -50.13 74.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.193 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.489 HD21 ' HG3' ' A' ' 60' ' ' GLN . 85.5 mt -52.49 -43.49 65.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.565 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 m -54.5 -46.39 73.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.665 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' CB ' ' CE2' ' A' ' 69' ' ' PHE . 2.8 mtmm -63.31 -36.53 83.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.628 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mt -61.28 -52.66 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.723 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.6 -113.9 0.58 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.065 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -150.33 31.74 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.118 0.485 . . . . 0.0 110.509 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -121.01 -146.52 0.38 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.276 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.1 t -117.19 170.13 8.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.694 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.489 ' HG3' HD21 ' A' ' 52' ' ' LEU . 5.6 mt-30 -73.26 98.26 2.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.181 0.515 . . . . 0.0 110.455 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -79.9 79.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.148 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.68 21.71 71.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.472 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.551 HD11 ' OE1' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -57.79 131.69 51.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.962 0.41 . . . . 0.0 110.804 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 65' ' ' MET . 21.9 m -123.61 163.65 20.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.356 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.443 ' N ' HG22 ' A' ' 64' ' ' THR . 6.4 mtm -107.98 152.25 41.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.55 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.7 Cg_endo -83.0 137.9 32.8 Favored 'Cis proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.968 -1.263 . . . . 0.0 112.883 0.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.551 ' OE1' HD11 ' A' ' 63' ' ' LEU . 48.0 tp60 -96.29 138.59 33.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.861 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 77' ' ' GLY . 3.6 t -109.78 154.91 11.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.051 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.452 ' CE1' ' HG3' ' A' ' 67' ' ' GLN . 48.0 m-85 -143.39 143.21 31.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.547 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.56 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.58 155.21 14.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.264 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.632 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -72.47 -16.11 27.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.87 2.38 . . . . 0.0 112.097 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -104.72 -7.85 19.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.095 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.07 89.82 1.95 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.512 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -175.93 156.85 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.762 0.315 . . . . 0.0 111.093 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.453 ' CD2' ' NE2' ' A' ' 67' ' ' GLN . 7.4 t-160 -90.23 126.51 35.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.845 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 70' ' ' ALA . 16.7 mt -113.8 -45.82 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.257 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.633 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 124.22 -151.58 17.19 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.91 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -99.14 -129.43 6.55 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.439 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.819 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -80.88 -70.35 0.54 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.713 0.256 . . . . 0.0 110.69 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -52.17 -46.9 65.7 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.235 0.54 . . . . 0.0 110.221 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.434 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -58.88 -41.41 87.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.615 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.495 HD21 ' CD2' ' A' ' 86' ' ' PHE . 2.3 tt -74.54 -35.99 63.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.384 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.4 ttt180 -52.03 -32.84 35.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -34.42 74.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.291 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.436 ' CD2' HG23 ' A' ' 76' ' ' ILE . 43.3 t80 -65.95 -32.05 73.32 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.447 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.495 ' CD2' HD21 ' A' ' 82' ' ' LEU . 24.9 m-85 -97.84 -9.11 26.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.67 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 83' ' ' ARG . 3.5 mtpm? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.885 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.725 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.519 0.199 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 66.0 m-85 -39.78 110.06 0.13 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.985 0.898 . . . . 0.0 111.667 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.821 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -89.74 127.0 35.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.95 -1.477 . . . . 0.0 111.281 -179.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.689 HG12 ' HE1' ' A' ' 33' ' ' PHE . 25.3 t -106.43 112.25 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.01 0.433 . . . . 0.0 111.296 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 11.2 m-85 -89.79 99.01 12.1 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.27 -143.12 3.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.861 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 31.2 m-85 -117.68 143.46 46.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.84 0.352 . . . . 0.0 111.578 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.91 -76.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.522 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 170.32 -34.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 110.606 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -81.36 -27.94 34.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.46 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.895 HG21 ' O ' ' A' ' 37' ' ' MET . 3.0 mp -89.83 -45.24 15.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.353 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.605 ' CD2' ' HE3' ' A' ' 37' ' ' MET . 18.7 t-80 -143.93 159.62 42.25 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -80.24 149.91 30.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.539 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.4 p -157.27 93.52 1.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.149 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.5 m -82.01 -31.77 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.214 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.36 -28.12 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.153 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 t -63.52 -45.3 91.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.038 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.76 -36.01 34.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.145 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.42 ' HB3' ' CE2' ' A' ' 79' ' ' PHE . 20.4 m-80 -70.54 -56.88 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.669 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -57.31 -28.94 63.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.926 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -64.82 -44.3 90.29 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 26' ' ' VAL . 15.8 tpp85 -63.28 -36.13 82.66 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.87 HD21 HD23 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -59.05 -61.85 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.346 178.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -61.03 -53.39 57.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.93 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.5 m -52.63 -37.43 58.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.859 0.362 . . . . 0.0 111.235 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 22' ' ' ARG . 44.4 t -79.78 -17.81 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.778 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.4 OUTLIER -89.0 -30.34 18.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.557 0.218 . . . . 0.0 111.527 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.32 67.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.54 HE22 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -150.15 129.9 6.6 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.536 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.725 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 75.8 Cg_exo -49.75 167.41 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.327 1.351 . . . . 0.0 110.706 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -165.15 160.48 18.71 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.792 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.729 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 19.2 mt-10 -124.78 122.3 37.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 111.054 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.689 ' HE1' HG12 ' A' ' 4' ' ' VAL . 1.5 t80 -103.93 143.15 33.24 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.045 0.45 . . . . 0.0 110.954 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 33' ' ' PHE . 18.1 mt -144.32 127.69 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.224 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -82.43 121.55 26.88 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.863 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.861 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.6 pt -77.56 -15.49 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.996 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.895 ' O ' HG21 ' A' ' 11' ' ' ILE . 33.0 ttm -125.01 79.53 65.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.769 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 60.4 Cg_endo -72.97 -5.34 17.04 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.753 2.302 . . . . 0.0 112.418 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.54 136.6 34.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.182 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -63.01 -8.84 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.183 0.515 . . . . 0.0 111.884 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.94 -61.19 2.16 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.542 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 43' ' ' PHE . 30.1 t -150.29 155.58 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 111.485 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -62.41 166.67 4.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.615 179.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 3.4 t70 -83.33 123.93 30.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.959 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 8.8 t0 -78.04 -27.98 48.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.232 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.22 -59.77 3.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 110.862 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -62.71 -46.55 87.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.489 HD11 ' HB ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -59.94 -31.07 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.635 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -62.99 -47.22 84.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -36.9 80.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.46 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.593 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.3 tt -58.4 -50.03 75.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.159 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -51.88 -45.12 64.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.353 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.4 m -57.3 -46.76 82.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.612 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -60.9 -39.0 87.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.679 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.89 -62.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.83 -116.58 0.47 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.967 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -150.58 26.87 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.941 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -121.58 -149.28 0.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.297 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 t -120.58 166.61 13.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.526 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.405 ' CB ' ' HB2' ' A' ' 63' ' ' LEU . 2.6 mt-30 -115.95 98.87 6.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.92 0.39 . . . . 0.0 110.808 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.7 tp -81.45 85.57 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.463 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.54 30.45 7.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.497 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.829 HD13 ' N ' ' A' ' 64' ' ' THR . 1.8 tm? -47.15 135.65 9.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.799 0.333 . . . . 0.0 110.785 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.829 ' N ' HD13 ' A' ' 63' ' ' LEU . 71.6 p -107.93 146.37 32.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.264 0.554 . . . . 0.0 111.854 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.408 ' SD ' HD12 ' A' ' 63' ' ' LEU . 3.9 mpp? -122.01 159.36 51.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.474 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_exo -78.96 151.87 88.28 Favored 'Cis proline' 0 C--N 1.343 0.258 0 C-N-CA 124.211 -1.162 . . . . 0.0 112.679 0.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.623 ' NE2' HD21 ' A' ' 63' ' ' LEU . 2.3 mt-30 -113.58 116.39 29.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.842 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.821 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -88.7 154.41 3.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.103 0.478 . . . . 0.0 112.158 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 2' ' ' PHE . 35.7 m-85 -142.61 139.16 31.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.015 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -57.14 144.22 70.18 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.048 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -34.88 -35.31 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.74 2.96 . . . . 0.0 112.685 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.43 33.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.198 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.54 -105.1 2.66 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.644 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 m -137.93 179.45 6.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.031 0.443 . . . . 0.0 110.869 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -63.76 125.08 23.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.941 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.015 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.6 mp -97.74 -28.4 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.524 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 120.89 -160.07 15.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.012 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.14 -131.77 7.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.587 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 9.6 t80 -76.49 -70.65 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.705 0.288 . . . . 0.0 111.032 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -57.4 -48.22 79.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.386 . . . . 0.0 110.648 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.441 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -54.53 -46.12 73.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.476 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.87 HD23 HD21 ' A' ' 23' ' ' LEU . 2.3 tt -66.94 -38.9 87.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.016 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.711 ' HG3' HD22 ' A' ' 23' ' ' LEU . 1.4 ttm180 -51.73 -29.94 20.5 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -72.19 -34.94 68.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.203 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 82' ' ' LEU . 59.2 t80 -64.76 -32.48 74.18 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.313 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.461 ' CE2' HD21 ' A' ' 82' ' ' LEU . 27.3 m-85 -95.77 -12.11 25.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.582 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.888 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.679 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 33.6 ttm . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -77.08 145.32 37.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.118 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.0 mptt -106.83 119.17 38.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.618 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.427 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 17.1 t -102.94 121.5 54.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.221 0.534 . . . . 0.0 111.122 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.781 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.6 m-30 -98.87 99.36 10.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.882 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.29 -135.65 1.86 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.972 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.853 ' HE2' ' HE3' ' A' ' 37' ' ' MET . 57.1 m-85 -125.86 146.77 49.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.735 0.302 . . . . 0.0 111.076 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -137.52 51.86 1.91 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.967 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 t -167.88 -173.22 2.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.308 0.575 . . . . 0.0 112.011 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -86.58 4.65 39.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.757 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.637 HG23 ' HB2' ' A' ' 40' ' ' LYS . 10.6 mm -86.86 -13.44 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.539 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.656 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 9.6 t-80 -163.08 122.68 2.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.664 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 168.68 7.98 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.54 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 174.7 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.662 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 16' ' ' TYR . 26.9 m -87.33 -41.88 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.702 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 15' ' ' VAL . 1.1 m-85 -60.89 -18.94 59.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.574 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.8 -58.43 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.4 . . . . 0.0 110.565 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -50.66 -40.9 54.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.049 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -64.1 -46.83 82.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.397 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -63.87 -49.91 70.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.381 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 31' ' ' PHE . 10.5 ttmt -50.47 -34.54 25.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.895 0.378 . . . . 0.0 110.586 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.815 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.9 tpt180 -66.74 -40.5 88.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.413 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.56 -55.62 32.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.235 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.83 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.4 mt -55.24 -45.17 76.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.61 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.7 m -57.3 -37.31 72.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.842 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.8 t -78.19 -34.21 18.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.505 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -17.96 62.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.852 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.47 53.2 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -140.03 136.13 16.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.195 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.614 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.6 Cg_endo -81.24 162.57 20.03 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.625 2.217 . . . . 0.0 110.761 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 6.4 p90 -161.34 171.1 18.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 111.981 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -136.2 134.16 37.88 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.568 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 10.9 t80 -89.69 158.74 17.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.534 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 5' ' ' TYR . 15.4 mt -148.31 121.96 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.385 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -86.05 133.34 33.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.052 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.558 HD11 ' OH ' ' A' ' 7' ' ' TYR . 20.8 pt -98.77 2.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.362 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.853 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -145.1 90.82 6.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.676 0.274 . . . . 0.0 110.434 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 44.8 Cg_endo -68.48 -26.42 34.4 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.698 2.265 . . . . 0.0 112.31 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -139.52 146.68 40.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.993 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.637 ' HB2' HG23 ' A' ' 11' ' ' ILE . 12.1 tttt -62.09 -8.8 5.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.295 0.569 . . . . 0.0 111.73 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.2 -53.47 6.13 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.522 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.7 t -151.36 146.87 15.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.419 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 46.6 m-85 -57.43 169.55 0.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.399 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -81.56 98.04 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.614 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 9.5 t0 -57.77 -21.05 39.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.31 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.13 -57.2 6.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.18 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 7.2 mmtp -72.3 -50.77 24.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.662 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.6 mp -49.91 -35.72 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -64.43 -61.39 2.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.037 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 2.4 pt-20 -63.33 -25.47 68.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.3 tt -57.27 -54.36 47.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.961 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.4 mt -55.81 -49.48 73.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.08 0.467 . . . . 0.0 110.917 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.8 m -60.13 -36.08 76.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.321 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -71.02 -36.01 72.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.959 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.467 HD21 ' CD2' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -59.46 -41.6 90.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.026 0.441 . . . . 0.0 110.501 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.31 -164.58 31.54 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.853 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -94.39 31.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -121.11 -150.81 0.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.247 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 t -120.87 170.3 9.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.734 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.4 98.46 11.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.127 0.489 . . . . 0.0 110.254 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.1 tp -80.28 86.9 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.497 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.54 29.89 61.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.512 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.72 134.86 4.13 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.813 0.339 . . . . 0.0 111.044 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.22 170.11 8.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.224 0.535 . . . . 0.0 111.793 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.4 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 15.8 mmt -124.9 154.81 70.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.572 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -80.64 145.12 69.36 Favored 'Cis proline' 0 C--N 1.343 0.284 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.73 0.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.468 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 0.7 OUTLIER -111.58 117.66 33.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.915 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.3 t -89.86 161.45 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.255 0.55 . . . . 0.0 111.878 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -142.51 143.91 32.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.407 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.684 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.42 131.57 76.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.447 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.679 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 32.3 Cg_exo -52.71 -24.02 22.0 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.63 2.22 . . . . 0.0 112.091 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.06 38.38 0.18 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.349 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.8 -109.29 0.78 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.705 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.535 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -140.8 -178.45 5.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.14 0.495 . . . . 0.0 111.142 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.468 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 17.2 t-80 -56.9 128.19 35.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.074 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.684 HD11 ' HA ' ' A' ' 70' ' ' ALA . 15.6 mt -100.21 -44.74 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.901 0.381 . . . . 0.0 110.777 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.45 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.13 -153.31 19.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.827 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -91.38 -138.85 8.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.119 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -75.43 -70.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.829 0.315 . . . . 0.0 110.642 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -47.36 -41.26 19.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.256 0.551 . . . . 0.0 110.323 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -39.58 94.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.412 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.709 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -75.03 -41.38 59.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.714 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -51.35 -33.48 29.79 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -68.6 -35.11 76.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.4 t80 -63.93 -34.12 77.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.562 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.709 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -88.9 -70.52 0.64 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.296 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.9 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.605 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.0 ttm . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.818 0.342 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.471 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 70.0 m-85 -63.22 157.02 23.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.03 0.443 . . . . 0.0 110.687 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.95 119.28 20.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.965 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.914 HG22 HG22 ' A' ' 68' ' ' VAL . 12.4 t -105.06 132.18 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.551 . . . . 0.0 112.038 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.4 m-85 -108.46 99.61 8.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.349 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.66 -141.55 3.16 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.327 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -118.74 151.68 37.56 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.845 0.355 . . . . 0.0 110.928 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.84 -75.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.072 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 t 170.99 -41.98 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.525 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -76.47 -26.3 55.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.862 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.614 HG21 ' O ' ' A' ' 37' ' ' MET . 4.1 mp -89.96 -41.3 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.978 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -149.76 149.56 30.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.049 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 143.27 48.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.54 102.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.002 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 m -87.02 -19.47 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.378 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -75.67 -20.35 58.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.595 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 p -71.18 -44.08 66.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.673 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.17 -41.45 99.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -59.67 -51.05 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.789 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 -28.82 69.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.035 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -43.29 99.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.288 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.911 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -69.65 -27.68 65.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.711 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.697 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -57.55 -57.14 13.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.414 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.1 mt -60.25 -40.01 88.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.658 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 m -60.5 -31.39 70.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.092 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 22' ' ' ARG . 92.9 t -73.76 -27.51 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.915 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -83.11 -17.64 42.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.322 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 74.09 55.57 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.939 0.4 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -137.26 145.17 48.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.764 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.1 Cg_endo -77.33 139.2 18.42 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.428 2.085 . . . . 0.0 111.587 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.605 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 14.6 p90 -153.12 170.5 20.35 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 3.8 tp10 -143.99 146.44 32.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.978 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.517 ' HE1' HG11 ' A' ' 4' ' ' VAL . 11.0 t80 -89.24 156.62 18.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.024 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.651 HD12 ' CE1' ' A' ' 5' ' ' TYR . 9.4 mt -143.3 118.58 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.242 0.544 . . . . 0.0 110.387 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -94.63 129.5 41.47 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.119 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.522 ' HB ' HD11 ' A' ' 48' ' ' ILE . 16.8 pt -86.81 -17.98 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.732 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.614 ' O ' HG21 ' A' ' 11' ' ' ILE . 2.7 ttp -122.61 92.56 48.99 Favored Pre-proline 0 N--CA 1.454 -0.243 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.3 -15.45 28.29 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.681 2.254 . . . . 0.0 112.722 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 37' ' ' MET . 2.9 pt-20 -139.64 142.9 36.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.838 0.352 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -65.58 -8.58 20.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.272 0.558 . . . . 0.0 111.851 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.94 -60.4 2.17 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.082 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 t -150.17 127.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.329 . . . . 0.0 110.837 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.56 170.43 1.05 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.446 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.11 96.56 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.124 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.77 -28.82 37.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.213 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -52.58 -44.62 66.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.927 0.394 . . . . 0.0 110.812 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -31.03 39.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.227 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' A' ' 36' ' ' ILE . 44.4 mm -63.31 -43.77 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.601 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.91 -55.76 11.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.078 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.58 -31.09 61.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.91 0.386 . . . . 0.0 110.389 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.929 ' O ' HD12 ' A' ' 55' ' ' LEU . 12.8 tp -59.22 -59.12 5.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.08 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HA ' HD13 ' A' ' 55' ' ' LEU . 71.1 mt -44.53 -44.08 8.43 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.303 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.9 m -69.68 -30.96 68.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.588 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 51' ' ' LEU . 5.1 tttp -65.39 -40.8 93.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.887 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.7 mp -59.34 -56.72 18.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.956 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.61 -110.5 0.27 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.165 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.33 31.32 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.04 0.448 . . . . 0.0 110.774 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -121.01 -148.53 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.288 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 t -120.34 170.26 9.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -92.01 98.8 11.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.201 0.525 . . . . 0.0 110.432 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.426 ' H ' HD12 ' A' ' 61' ' ' ILE . 3.4 mp -79.74 85.08 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.264 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.21 27.34 46.12 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.52 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD12 ' NE2' ' A' ' 67' ' ' GLN . 1.4 mm? -52.72 148.55 7.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.849 0.356 . . . . 0.0 110.993 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.1 p -121.68 170.15 10.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.146 0.498 . . . . 0.0 111.528 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.08 158.92 39.7 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.9 Cg_endo -85.81 151.44 49.84 Favored 'Cis proline' 0 N--CA 1.461 -0.406 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.898 0.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.438 ' NE2' HD12 ' A' ' 63' ' ' LEU . 12.0 mm100 -111.71 117.9 34.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.223 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.914 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -91.28 166.31 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 0.0 111.837 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 64.1 m-85 -141.94 143.78 33.42 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.191 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.633 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -53.84 152.4 10.13 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.527 ' HB3' ' N ' ' A' ' 1' ' ' MET . 43.3 Cg_exo -59.3 -28.72 88.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.171 2.581 . . . . 0.0 112.54 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.85 -21.0 18.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.66 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.7 84.5 0.65 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.89 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.14 162.72 15.41 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -90.54 129.6 36.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.72 0.295 . . . . 0.0 110.971 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.654 HG21 HD12 ' A' ' 82' ' ' LEU . 1.4 mp -115.57 -43.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.789 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 119.14 -155.94 15.89 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.107 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -94.52 -134.1 7.33 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.535 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.697 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.71 -70.11 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.845 -0.209 . . . . 0.0 111.05 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -48.9 -44.63 40.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.176 0.512 . . . . 0.0 110.602 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -63.66 -44.77 92.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.885 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -69.88 -43.7 71.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.76 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 87' ' ' LYS . 6.2 ttp180 -51.56 -31.57 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -72.82 -32.63 65.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.333 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.47 ' CD2' HG12 ' A' ' 76' ' ' ILE . 54.0 t80 -68.6 -32.24 71.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.648 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.505 ' CD1' ' HG2' ' A' ' 27' ' ' LYS . 20.1 m-85 -96.61 -70.74 0.7 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.528 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.773 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.833 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 28.1 tpp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 110.502 -0.185 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.415 ' H ' ' HG3' ' A' ' 1' ' ' MET . 96.9 m-85 -43.13 137.57 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.805 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -115.48 120.51 39.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.978 -179.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.53 HG11 ' CE1' ' A' ' 33' ' ' PHE . 53.4 t -107.82 121.25 60.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.245 0.545 . . . . 0.0 111.845 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.57 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 20.0 m-85 -100.14 101.51 12.57 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.289 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 36' ' ' ILE . . . -162.24 -139.01 2.54 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.521 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.637 ' CE1' ' CD2' ' A' ' 12' ' ' HIS . 64.2 m-85 -118.31 159.98 22.45 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.974 0.416 . . . . 0.0 111.478 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -96.84 -73.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.03 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m 170.64 -42.08 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.307 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -69.88 -32.44 70.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.189 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.4 mm -100.18 -32.86 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.935 ' HD2' ' HE2' ' A' ' 37' ' ' MET . 1.4 t-80 -157.33 122.14 4.44 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 148.5 51.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.98 118.89 1.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.297 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 m -84.78 -36.79 11.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.906 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.23 -29.23 69.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.252 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.7 t -56.27 -49.38 74.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.274 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -56.64 -34.57 67.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.342 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 38.4 m-80 -72.74 -51.21 20.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 111.021 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -55.06 -45.32 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.125 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -64.99 -40.74 95.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.323 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.8 mmt85 -62.54 -37.02 84.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.313 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.746 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -57.57 -56.86 16.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.073 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.746 ' N ' HD23 ' A' ' 23' ' ' LEU . 59.5 mt -62.76 -30.36 71.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.354 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.4 m -71.19 -36.43 71.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.201 0.524 . . . . 0.0 109.629 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 22' ' ' ARG . 94.5 t -75.78 -48.61 29.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.513 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.15 -19.9 62.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.788 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt 71.33 55.04 0.21 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.944 0.402 . . . . 0.0 110.634 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -139.9 122.68 10.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.833 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 5.0 Cg_endo -48.53 159.33 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.602 2.201 . . . . 0.0 112.732 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.599 ' HB3' HD13 ' A' ' 24' ' ' LEU . 35.0 p90 -163.44 170.73 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.884 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.8 tt0 -141.04 115.34 9.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.645 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.53 ' CE1' HG11 ' A' ' 4' ' ' VAL . 36.3 t80 -89.03 154.36 20.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.833 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.422 HG13 ' C ' ' A' ' 33' ' ' PHE . 10.3 mt -148.13 122.07 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.484 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -75.05 113.15 12.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.577 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.507 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.2 pp -64.7 -29.37 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.775 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.935 ' HE2' ' HD2' ' A' ' 12' ' ' HIS . 2.1 ttp -118.61 92.25 43.62 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.733 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HG3' ' HB2' ' A' ' 44' ' ' ASP . 88.0 Cg_endo -79.73 3.69 7.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.695 2.263 . . . . 0.0 112.957 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -139.2 144.16 38.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.488 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -66.89 -8.11 26.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.206 0.527 . . . . 0.0 111.574 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.69 -66.8 0.79 Allowed Glycine 0 C--N 1.315 -0.633 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.293 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.32 136.58 58.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 1.1 p90 -66.4 170.97 5.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.729 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.475 ' O ' HD13 ' A' ' 48' ' ' ILE . 7.5 t0 -77.85 124.58 28.16 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.244 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 1.4 t70 -80.07 -28.74 39.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.536 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -63.89 -56.72 13.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.328 . . . . 0.0 111.171 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -67.0 -38.15 85.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.475 HD13 ' O ' ' A' ' 44' ' ' ASP . 0.9 OUTLIER -71.57 -25.72 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.704 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -68.62 -48.55 63.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.972 0.415 . . . . 0.0 110.578 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.17 -34.71 76.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.233 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' CD2' HD21 ' A' ' 55' ' ' LEU . 3.5 tt -58.16 -50.79 72.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.397 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 52' ' ' LEU . 79.1 mt -54.15 -45.85 72.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.139 0.495 . . . . 0.0 111.404 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.9 m -61.2 -42.27 98.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.436 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -31.5 72.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.733 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.71 ' CD1' HD13 ' A' ' 63' ' ' LEU . 2.1 mt -62.43 -32.07 72.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.017 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.93 -26.57 8.76 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.234 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -124.11 -165.45 1.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.695 0.283 . . . . 0.0 110.647 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -103.82 -30.52 10.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.018 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -92.58 170.25 9.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -112.54 99.94 8.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.701 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.6 82.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.375 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.88 25.04 36.0 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.643 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.71 HD13 ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.11 155.7 16.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.923 0.392 . . . . 0.0 111.65 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -144.59 170.15 16.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.274 0.559 . . . . 0.0 112.058 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.418 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 4.2 mtt -115.82 154.94 48.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.568 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.6 Cg_exo -76.97 142.34 72.29 Favored 'Cis proline' 0 C--N 1.344 0.312 0 C-N-CA 123.846 -1.314 . . . . 0.0 112.644 0.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.4 ' CD ' HD21 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -102.68 116.91 33.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.938 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 82' ' ' LEU . 3.3 t -92.12 152.7 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.193 0.52 . . . . 0.0 111.62 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -143.57 139.88 29.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.564 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.698 ' HB1' ' HD2' ' A' ' 71' ' ' PRO . . . -55.27 165.17 1.15 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.684 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 19.6 Cg_endo -60.11 -24.61 77.42 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.777 2.318 . . . . 0.0 111.918 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.24 -26.06 19.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.268 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.65 -6.56 5.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.101 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.35 154.57 23.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.876 0.338 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -90.42 118.52 29.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.331 . . . . 0.0 110.962 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.535 HD11 ' HA ' ' A' ' 70' ' ' ALA . 28.2 mt -97.06 -48.46 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 134.41 -156.86 22.63 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.777 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.41 -141.45 10.91 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.839 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 25.8 t80 -67.79 -70.46 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 0.0 111.019 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.49 -47.42 84.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.088 0.471 . . . . 0.0 110.593 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -51.4 -37.18 46.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.645 ' CD1' HG11 ' A' ' 68' ' ' VAL . 4.3 tt -74.12 -35.99 64.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.18 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.18 -31.25 30.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.78 -31.8 71.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.495 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . 14.1 t80 -71.05 -27.96 64.02 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.836 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 24' ' ' LEU . 29.7 m-85 -99.92 -13.45 19.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.088 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.04 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.674 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 18.7 tpp . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.412 0.149 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -39.7 127.59 2.0 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.667 0.746 . . . . 0.0 112.118 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -94.56 123.81 38.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.344 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 67' ' ' GLN . 24.6 t -111.96 114.64 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.379 . . . . 0.0 111.579 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 13.9 m-85 -93.27 99.9 12.36 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.19 -136.58 2.13 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.613 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -125.75 160.33 30.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.898 0.38 . . . . 0.0 111.895 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 9' ' ' SER . 5.3 m-20 -88.96 -68.12 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.645 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.7 OUTLIER 162.08 -29.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -76.61 -39.32 52.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.444 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 40' ' ' LYS . 7.5 mm -89.84 -46.25 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.582 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -140.66 149.79 42.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -77.38 161.46 28.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.735 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 p -176.89 98.18 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.221 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 m -77.76 -33.43 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.052 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -66.67 -28.12 68.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.051 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.6 t -62.66 -46.79 86.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 110.466 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -59.37 -31.08 68.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.051 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.25 -53.49 14.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.954 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.39 -49.06 70.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 110.943 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 1.5 ttmm -60.01 -50.02 75.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.627 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.794 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -60.11 -42.69 95.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.246 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.786 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -57.08 -54.13 50.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.05 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.786 ' N ' HD23 ' A' ' 23' ' ' LEU . 8.8 mt -56.84 -42.69 80.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.518 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -59.16 -38.13 78.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.68 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 22' ' ' ARG . 42.9 t -76.46 -34.09 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.48 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -9.83 58.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.866 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.13 51.69 1.62 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.002 0.429 . . . . 0.0 110.45 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -142.63 113.92 6.05 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.386 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.674 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 89.3 Cg_exo -49.25 178.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.386 2.057 . . . . 0.0 111.973 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 3.9 p90 -163.94 170.54 16.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.958 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 14.4 tp10 -134.44 112.38 10.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.471 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 7.0 t80 -89.1 155.96 19.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.292 0.567 . . . . 0.0 111.733 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG13 ' C ' ' A' ' 33' ' ' PHE . 45.3 mt -150.26 125.5 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.814 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -88.65 126.12 35.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.035 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.6 18.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.965 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -157.78 90.69 2.3 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.52 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 37.5 Cg_endo -66.07 -23.31 53.64 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.571 2.181 . . . . 0.0 112.021 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 37' ' ' MET . 2.7 mm-40 -139.56 143.93 37.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.148 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 11' ' ' ILE . 8.2 ttpt -64.33 -7.99 11.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.29 0.567 . . . . 0.0 111.866 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.72 -37.87 12.91 Favored Glycine 0 C--N 1.313 -0.731 0 CA-C-N 115.227 -0.897 . . . . 0.0 113.201 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -150.24 151.71 12.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.3 0.572 . . . . 0.0 112.157 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -75.27 169.01 18.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.313 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.621 ' O ' HD12 ' A' ' 48' ' ' ILE . 2.8 t0 -94.88 103.36 15.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.753 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 5.5 t0 -69.7 -21.58 63.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.936 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -67.46 -57.19 6.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.108 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -69.95 -36.08 74.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.527 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 44' ' ' ASP . 21.4 mt -70.89 -26.37 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.412 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -68.01 -55.5 12.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.305 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.4 -36.06 73.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.828 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.587 HD13 ' CE2' ' A' ' 69' ' ' PHE . 6.7 tp -56.27 -50.42 71.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.528 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 52' ' ' LEU . 78.0 mt -53.36 -47.08 69.73 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.376 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.2 m -63.65 -39.39 94.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.425 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -59.22 -37.31 77.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.498 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' N ' HD23 ' A' ' 55' ' ' LEU . 1.2 mt -60.17 -56.43 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.552 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.58 -110.4 0.3 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.982 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -150.44 31.39 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.977 0.418 . . . . 0.0 110.68 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -120.96 -145.87 0.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.416 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.1 t -115.27 170.45 8.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.749 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 98.27 1.2 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.39 0.614 . . . . 0.0 110.452 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.04 84.84 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.254 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.93 26.45 58.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.432 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.433 HD11 HE21 ' A' ' 67' ' ' GLN . 1.4 mm? -56.04 132.54 50.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -126.03 153.47 44.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.274 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.82 155.55 36.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.636 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.7 Cg_exo -82.79 136.9 30.69 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 124.04 -1.233 . . . . 0.0 112.796 0.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 3.4 mm100 -92.67 148.36 22.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -122.24 149.82 25.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.172 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CE2' HD13 ' A' ' 51' ' ' LEU . 53.1 m-85 -142.27 137.43 30.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.36 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -46.9 164.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.931 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 33.4 Cg_exo -59.99 -19.82 57.43 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.797 2.331 . . . . 0.0 112.071 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.84 -19.71 13.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.432 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.06 -19.38 3.9 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.09 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.418 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -56.69 109.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.876 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -54.65 134.74 47.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.447 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 70' ' ' ALA . 7.2 mt -115.9 -39.1 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.557 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 130.74 -153.69 20.37 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.702 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -94.24 -136.17 8.1 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.946 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -82.85 -55.02 4.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.578 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -57.31 -49.94 74.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.619 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -41.06 98.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.443 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.852 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -61.65 -53.53 54.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.62 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.607 ' N ' HD13 ' A' ' 82' ' ' LEU . 26.7 ttt180 -49.73 -39.2 36.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.87 0.367 . . . . 0.0 110.13 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -67.93 -37.95 82.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 82' ' ' LEU . 14.0 t80 -61.43 -34.5 75.52 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.576 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.852 ' CE2' HD21 ' A' ' 82' ' ' LEU . 12.1 m-85 -78.59 -62.44 1.69 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.003 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.711 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 34.2 ttp . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.743 0.306 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 84.7 m-85 -80.33 154.77 27.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.419 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -137.78 123.96 20.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.107 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 68' ' ' VAL . 53.9 t -108.04 141.59 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.222 0.534 . . . . 0.0 111.592 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.88 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.8 m-85 -123.35 100.54 6.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.41 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.44 -139.12 2.58 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.39 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.453 ' HH ' ' HE1' ' A' ' 43' ' ' PHE . 74.6 m-85 -110.58 160.05 17.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.776 0.322 . . . . 0.0 110.902 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -79.1 -78.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.703 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 t 166.43 -35.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.689 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.42 -22.6 28.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.196 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 40' ' ' LYS . 35.4 mm -91.79 -42.26 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -142.0 151.49 42.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.035 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -72.01 156.31 39.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.928 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 169.69 106.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.829 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -90.57 -32.15 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.377 . . . . 0.0 111.533 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.79 -31.73 71.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.649 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 p -62.23 -43.58 98.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -55.27 -33.38 63.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -73.76 -52.87 11.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.02 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.39 63.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.888 0.375 . . . . 0.0 111.029 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -60.9 -55.33 34.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.503 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.684 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.4 mtp180 -60.67 -29.32 69.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.733 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.717 HD11 ' HG2' ' A' ' 83' ' ' ARG . 3.4 tt -55.97 -53.55 55.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.592 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -69.07 -41.48 77.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 m -61.4 -37.13 82.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.082 0.468 . . . . 0.0 110.151 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 22' ' ' ARG . 75.4 t -77.63 -32.33 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.654 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -71.26 -15.78 62.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.218 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? 73.91 54.52 0.1 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 111.221 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -138.47 141.92 32.97 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.81 137.32 19.83 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.454 2.103 . . . . 0.0 111.623 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.711 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 4.6 p90 -154.56 168.48 26.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.073 0.463 . . . . 0.0 112.216 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -141.62 137.55 31.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.5 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.548 ' CE1' HG11 ' A' ' 4' ' ' VAL . 40.9 t80 -89.39 156.71 18.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.88 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.1 mt -142.15 117.38 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.349 0.595 . . . . 0.0 110.419 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -100.11 130.39 46.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.018 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.498 HG22 ' HB2' ' A' ' 47' ' ' LYS . 32.5 pt -97.6 28.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.024 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 39' ' ' GLU . 18.0 ttm -155.55 98.55 2.3 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.909 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 60.2 Cg_endo -71.32 -27.93 18.91 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.371 2.047 . . . . 0.0 112.098 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 37' ' ' MET . 4.0 mm-40 -139.68 156.01 47.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.994 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.465 ' N ' HG23 ' A' ' 11' ' ' ILE . 1.4 ttmp? -70.81 -7.74 47.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.269 0.557 . . . . 0.0 111.675 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.99 -25.29 8.5 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.487 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 t -142.74 127.01 15.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.289 0.566 . . . . 0.0 112.453 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.6 ' HB3' HD11 ' A' ' 48' ' ' ILE . 33.8 m-85 -71.83 164.11 26.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.215 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -93.08 94.66 8.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.194 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.92 -27.86 68.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.601 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -60.95 -54.15 48.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.695 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HB2' HG22 ' A' ' 36' ' ' ILE . 36.6 mmtt -69.84 -34.3 73.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.068 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 43' ' ' PHE . 43.8 mt -65.97 -39.66 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.39 -56.35 10.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.175 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.48 -35.43 72.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.835 0.35 . . . . 0.0 110.796 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.474 HD13 ' CD2' ' A' ' 5' ' ' TYR . 13.5 tp -56.92 -50.49 72.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.558 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.428 HD21 ' CG ' ' A' ' 60' ' ' GLN . 80.5 mt -53.39 -48.11 68.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.01 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.4 m -64.0 -35.38 80.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.031 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -38.19 90.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.131 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.11 -53.62 46.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.521 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.66 -109.95 0.33 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.045 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.63 30.83 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.942 0.401 . . . . 0.0 110.812 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -121.13 -149.2 0.42 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.463 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 t -120.49 170.47 9.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.583 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.428 ' CG ' HD21 ' A' ' 52' ' ' LEU . 10.2 mt-30 -82.6 98.2 8.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.188 0.518 . . . . 0.0 110.34 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 pt -80.36 84.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.28 25.6 57.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.499 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.48 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.0 OUTLIER -57.79 157.92 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 110.85 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 p -130.71 170.34 14.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 0.0 111.666 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -120.48 154.8 56.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.588 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HB2' HG13 ' A' ' 4' ' ' VAL . 6.3 Cg_exo -80.99 152.34 81.01 Favored 'Cis proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.908 -1.288 . . . . 0.0 112.803 0.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.48 ' CD ' HD12 ' A' ' 63' ' ' LEU . 10.0 mt-30 -109.08 113.01 25.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.181 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -90.79 166.34 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.409 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 70.1 m-85 -141.73 139.61 32.91 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.031 0.443 . . . . 0.0 110.628 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.688 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -61.42 156.77 50.13 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.496 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 1' ' ' MET . 51.9 Cg_exo -55.73 -31.75 81.39 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.15 2.567 . . . . 0.0 112.185 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -78.93 -35.54 43.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.22 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.6 41.27 0.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.821 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.7 m -120.65 169.12 10.68 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -90.16 117.56 29.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.776 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.688 HD11 ' HA ' ' A' ' 70' ' ' ALA . 27.9 mt -90.35 -49.37 13.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.986 0.422 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.43 -151.47 19.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.619 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.69 -149.28 25.46 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.595 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.693 ' CE1' HD12 ' A' ' 23' ' ' LEU . 18.2 t80 -64.75 -70.16 0.25 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.756 0.313 . . . . 0.0 110.775 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -56.55 -46.52 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.523 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.33 -35.81 68.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.272 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.545 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.4 tt -76.74 -37.03 56.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.287 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HG2' HD11 ' A' ' 23' ' ' LEU . 8.2 mtt180 -52.38 -31.6 34.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -70.66 -33.66 71.19 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.166 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CD2' HG23 ' A' ' 76' ' ' ILE . 40.1 t80 -67.13 -27.42 67.31 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.604 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.545 ' CE2' HD21 ' A' ' 82' ' ' LEU . 23.9 m-85 -99.29 -17.63 17.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.922 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.5 mttm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.809 -179.712 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.682 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 21.7 tpp . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.35 0.119 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -39.5 119.01 0.89 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.862 0.839 . . . . 0.0 112.069 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -89.38 126.5 35.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.296 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 68' ' ' VAL . 11.5 t -115.93 133.94 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.142 0.496 . . . . 0.0 111.463 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.806 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.5 m-85 -110.69 99.91 8.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -160.2 -137.26 2.18 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.855 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -125.05 141.8 51.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.792 0.33 . . . . 0.0 111.01 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -99.82 26.36 6.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 110.998 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.72 8.44 5.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.682 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -85.52 -49.67 7.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.578 HG23 ' HG3' ' A' ' 40' ' ' LYS . 39.4 mm -104.06 -32.57 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.293 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -141.14 140.26 34.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.835 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -81.26 174.78 11.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.504 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 173.74 109.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.349 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 m -71.82 -35.02 53.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.975 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.38 -29.67 70.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.132 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 t -60.93 -45.67 93.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.916 0.389 . . . . 0.0 110.656 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.39 -24.39 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.319 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 28.6 m-80 -79.96 -46.74 16.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.202 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.84 -53.1 61.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.787 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 13.1 ttpt -59.76 -44.66 93.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.495 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 26' ' ' VAL . 14.9 tpt180 -62.41 -42.6 99.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.414 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.9 tt -56.97 -53.49 57.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.135 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.1 mt -59.29 -43.96 92.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.538 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.6 m -59.34 -43.65 92.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.995 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.9 t -70.81 -38.73 73.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -74.16 -9.76 58.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.796 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' CE ' ' A' ' 28' ' ' LYS . 1.2 ttpt 64.3 59.9 0.99 Allowed 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 121.434 0.635 . . . . 0.0 110.221 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.27 108.83 4.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.088 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.682 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 92.6 Cg_exo -47.08 176.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.618 2.212 . . . . 0.0 112.299 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 4.2 p90 -164.06 170.65 16.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.3 tt0 -133.1 118.16 18.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.313 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.467 ' HE1' HG11 ' A' ' 4' ' ' VAL . 4.1 t80 -89.51 158.86 17.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.738 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.806 HD12 ' CE1' ' A' ' 5' ' ' TYR . 33.8 mt -146.33 122.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.62 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -83.65 123.18 29.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.183 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 pt -100.36 -26.93 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.52 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.8 ttp -121.24 93.49 48.8 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.504 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.4 Cg_endo -82.56 1.26 9.26 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.726 2.284 . . . . 0.0 112.264 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.562 ' C ' HG21 ' A' ' 11' ' ' ILE . 43.6 mt-10 -141.13 137.65 32.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.669 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HG3' HG23 ' A' ' 11' ' ' ILE . 17.1 mtmm -65.53 -8.37 19.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.234 0.54 . . . . 0.0 111.69 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.96 -68.46 1.14 Allowed Glycine 0 C--N 1.312 -0.753 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.104 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 t -134.58 135.48 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.795 0.331 . . . . 0.0 111.151 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -63.29 169.58 3.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.102 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 t0 -80.86 121.54 26.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.039 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -60.47 -22.4 63.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -64.84 -57.58 8.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.955 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -64.97 -47.2 78.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.716 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.72 -39.26 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.434 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.39 82.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.427 . . . . 0.0 110.418 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -67.13 -40.99 86.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.382 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.6 tp -57.51 -50.41 73.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 52' ' ' LEU . 80.3 mt -52.92 -45.93 67.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.084 0.469 . . . . 0.0 111.284 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.3 m -68.06 -33.16 74.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.283 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HE3' ' CD1' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -64.3 -39.27 93.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.399 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.5 mt -61.17 -66.77 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.967 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.67 -27.06 0.59 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.326 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.67 -175.27 2.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.722 0.296 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.51 -27.44 13.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.043 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -95.89 170.05 9.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -116.25 100.38 7.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.783 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mt -79.67 84.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.201 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.5 25.56 55.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.588 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -60.01 139.49 57.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.972 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.7 p -122.3 160.08 26.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.8 mtm -117.55 154.47 50.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.673 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.3 Cg_exo -79.52 155.41 89.41 Favored 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 124.105 -1.206 . . . . 0.0 112.74 0.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.419 ' NE2' ' NE2' ' A' ' 75' ' ' HIS . 14.6 mm100 -109.85 125.9 53.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.045 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -97.97 159.82 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.991 0.424 . . . . 0.0 111.977 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 94.3 m-85 -142.9 148.16 36.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.588 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.646 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.16 141.3 69.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.31 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -40.69 -30.94 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.935 2.423 . . . . 0.0 112.168 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -167.86 34.08 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.142 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -125.1 -108.99 1.75 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.774 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.0 -179.6 5.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.447 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 47.0 t-80 -64.39 134.35 54.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.118 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.646 HD11 ' HA ' ' A' ' 70' ' ' ALA . 8.0 mt -104.07 -41.27 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.651 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 137.19 -152.4 21.43 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.003 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.97 -131.05 7.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.502 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 32.6 t80 -76.07 -70.22 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.687 0.28 . . . . 0.0 111.131 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -54.47 -45.42 73.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.939 0.399 . . . . 0.0 110.954 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.468 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.9 OUTLIER -56.43 -45.84 80.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.605 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.723 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -64.46 -41.44 96.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.477 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -52.96 -33.8 52.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.54 -34.19 73.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.16 -33.3 75.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.49 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.723 ' HE2' HD21 ' A' ' 82' ' ' LEU . 21.1 m-85 -90.1 -69.8 0.7 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.471 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.961 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.603 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 2.8 ttt . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -75.1 146.46 41.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.728 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -108.42 118.03 35.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.297 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 68' ' ' VAL . 92.9 t -113.07 129.71 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.407 0.622 . . . . 0.0 112.196 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.616 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 21.9 m-85 -104.61 101.18 10.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.849 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.7 -142.18 3.32 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.516 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.4 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 57.8 m-85 -119.17 154.78 32.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.849 0.357 . . . . 0.0 111.422 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 9' ' ' SER . 22.0 p-10 -89.85 11.57 19.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.799 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER 80.0 -5.73 1.82 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.639 0.257 . . . . 0.0 111.527 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -86.48 -48.63 8.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' HG22 ' A' ' 11' ' ' ILE . 30.1 mm -94.11 -16.45 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -155.85 142.92 19.1 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -66.5 115.78 6.75 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.99 0.424 . . . . 0.0 111.761 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p -130.16 89.32 2.78 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.579 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.6 m -81.3 -32.05 11.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.441 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -65.8 -26.64 67.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.178 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.1 t -63.77 -51.91 62.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.408 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.12 -29.54 63.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.196 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -70.6 -57.66 4.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.879 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.23 -41.89 80.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -57.2 -51.19 70.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.812 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.781 ' O ' HG23 ' A' ' 26' ' ' VAL . 14.9 ttm-85 -60.31 -43.6 96.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.462 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.7 tt -58.87 -54.75 43.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.386 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.623 HD23 ' HZ ' ' A' ' 86' ' ' PHE . 5.4 mt -56.71 -46.34 81.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.682 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.6 m -55.83 -38.4 69.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.141 0.496 . . . . 0.0 110.031 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 22' ' ' ARG . 48.6 t -78.8 -31.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.548 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -73.08 -9.78 59.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.16 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 71.13 45.21 0.51 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.914 0.388 . . . . 0.0 110.957 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -132.44 130.48 21.86 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.593 ' O ' ' HA ' ' A' ' 1' ' ' MET . 44.3 Cg_endo -82.8 161.1 16.28 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.636 2.224 . . . . 0.0 111.191 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.474 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 5.1 p90 -161.31 171.2 18.75 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.916 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -132.45 121.19 23.0 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.536 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.636 ' HE1' HG12 ' A' ' 4' ' ' VAL . 1.1 t80 -89.82 150.87 22.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.763 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 mt -142.41 122.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.413 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -87.08 118.04 26.2 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.424 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.86 HD11 ' SD ' ' A' ' 65' ' ' MET . 34.0 pt -97.07 33.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.007 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 39' ' ' GLU . 42.9 ttm -160.59 82.59 2.11 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.57 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.01 -4.76 16.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.032 2.488 . . . . 0.0 112.875 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 37' ' ' MET . 1.8 mm-40 -139.21 155.64 47.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -71.12 -7.13 44.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.06 18.01 3.36 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.205 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 t -150.83 116.46 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 9.0 m-85 -72.31 170.22 14.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.676 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.556 ' C ' HD12 ' A' ' 48' ' ' ILE . 9.6 t0 -100.42 93.32 5.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 70.9 m-20 -64.03 -24.86 67.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.46 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.43 -58.7 5.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 36' ' ' ILE . 14.8 mmtm -69.16 -34.06 74.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.301 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.556 HD12 ' C ' ' A' ' 44' ' ' ASP . 49.1 mt -71.01 -32.69 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.639 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.34 -55.17 34.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -61.52 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.616 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 4.3 tt -59.54 -53.33 59.34 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.223 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.569 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.9 mt -52.88 -47.9 67.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.064 0.459 . . . . 0.0 110.959 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.4 m -53.39 -40.74 65.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.687 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 23.4 mtpp -70.11 -39.41 75.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.74 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -44.42 93.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.486 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.19 -137.03 5.07 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.897 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -122.85 30.34 6.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.123 0.487 . . . . 0.0 110.485 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.25 -156.72 0.69 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.211 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -121.17 170.57 9.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.632 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -79.47 98.14 6.69 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.286 0.565 . . . . 0.0 110.182 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -80.32 86.7 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.909 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.07 27.93 60.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.505 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -179.8 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.615 0.245 . . . . 0.0 110.684 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.4 p -150.36 159.72 44.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.154 0.502 . . . . 0.0 111.897 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.86 ' SD ' HD11 ' A' ' 36' ' ' ILE . 2.9 mtt -115.49 158.0 42.72 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.189 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.8 Cg_exo -79.7 145.48 73.56 Favored 'Cis proline' 0 C--N 1.345 0.347 0 C-N-CA 124.47 -1.054 . . . . 0.0 113.27 0.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -105.52 126.77 52.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.133 178.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 4' ' ' VAL . 5.7 t -96.99 159.02 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.99 0.424 . . . . 0.0 111.645 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.462 ' N ' HG12 ' A' ' 68' ' ' VAL . 32.0 m-85 -142.83 144.26 32.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.729 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.593 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -53.81 133.38 56.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.263 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 35.1 Cg_exo -55.05 -17.03 13.46 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.523 2.149 . . . . 0.0 112.312 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.73 39.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.386 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.86 -114.81 0.76 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.273 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.1 p -125.56 -173.02 2.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.142 0.496 . . . . 0.0 111.32 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 35.9 t-80 -66.35 145.18 56.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 70' ' ' ALA . 1.7 mp -120.04 -35.4 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.939 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 123.83 -156.55 18.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.093 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.27 -137.33 8.65 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.418 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.602 ' CE1' HD13 ' A' ' 23' ' ' LEU . 28.4 t80 -69.61 -70.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.723 0.297 . . . . 0.0 111.05 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -57.19 -48.98 77.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.964 0.412 . . . . 0.0 110.71 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -50.42 -36.66 34.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.359 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.589 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.4 tt -82.67 -29.85 29.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.232 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -51.63 -31.37 25.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -65.67 -34.73 78.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.112 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CD2' HG12 ' A' ' 76' ' ' ILE . 22.1 t80 -64.89 -33.22 75.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.542 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.623 ' HZ ' HD23 ' A' ' 24' ' ' LEU . 6.5 m-85 -86.49 -65.03 1.06 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.454 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.001 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.696 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 19.5 ttm . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.921 0.391 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 57.4 m-85 -82.43 151.39 26.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.764 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.1 mppp? -126.47 120.62 30.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.857 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.524 HG11 ' CE1' ' A' ' 33' ' ' PHE . 6.2 t -109.49 116.64 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.115 0.483 . . . . 0.0 111.848 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 21.8 m-85 -96.04 100.54 12.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.901 178.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.69 -137.96 2.32 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.352 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.678 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 3.1 m-85 -127.24 151.75 48.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -144.83 38.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.953 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.524 ' HB2' HG12 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -163.94 -162.82 0.73 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.108 0.48 . . . . 0.0 111.856 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -86.52 8.48 21.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.083 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.653 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -87.54 -8.13 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.678 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 20.6 t-80 -170.17 144.07 2.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.329 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.607 ' HE2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -80.76 155.47 26.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.281 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 168.82 82.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.97 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.607 HG13 ' HE2' ' A' ' 13' ' ' LYS . 34.4 m -73.97 -41.23 52.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 15' ' ' VAL . 1.7 m-85 -59.57 -20.4 55.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.138 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 t -66.76 -60.23 2.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.778 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.74 -40.04 39.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 110.624 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -65.64 -43.99 87.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.576 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -67.41 -33.29 74.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -56.97 -44.39 82.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.813 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.0 ttp180 -70.94 -25.14 62.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.325 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.732 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -54.1 -57.29 11.64 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.241 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.62 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 13.8 mt -64.31 -41.41 96.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.52 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.2 m -60.39 -34.5 73.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.297 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 22' ' ' ARG . 67.2 t -72.24 -42.94 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.933 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -72.6 -19.75 61.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.209 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 2.7 tppt? 79.79 71.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 111.382 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -143.46 143.28 23.41 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.0 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.45 130.12 11.59 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.474 2.116 . . . . 0.0 111.968 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.696 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 6.1 p90 -151.54 166.96 29.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.89 0.376 . . . . 0.0 111.959 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -143.09 136.13 27.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.883 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CE1' HG11 ' A' ' 4' ' ' VAL . 13.1 t80 -89.75 159.79 16.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.224 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.701 HG21 ' HD2' ' A' ' 47' ' ' LYS . 23.5 mt -150.09 126.09 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.123 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 8' ' ' ASP . 68.6 m-80 -86.72 111.24 20.51 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.176 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.488 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 21.9 pt -75.22 -5.79 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.505 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.484 ' HE2' ' CE1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -135.33 69.77 68.35 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.448 179.548 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.48 -13.74 35.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.596 2.197 . . . . 0.0 112.135 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -139.16 135.79 34.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.352 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.86 -9.01 3.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.31 0.576 . . . . 0.0 111.429 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.06 -61.08 3.87 Favored Glycine 0 C--N 1.312 -0.767 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.352 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.4 t -151.95 157.0 5.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CE1' ' HE2' ' A' ' 37' ' ' MET . 24.1 m-85 -58.83 170.3 0.84 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.902 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.742 ' O ' HD12 ' A' ' 48' ' ' ILE . 7.5 t70 -100.24 113.0 25.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.64 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.633 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 9.2 p30 -73.01 -18.79 61.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.07 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.45 -63.29 1.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 111.152 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.701 ' HD2' HG21 ' A' ' 34' ' ' ILE . 34.9 mmtt -64.17 -40.08 95.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.55 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.742 HD12 ' O ' ' A' ' 44' ' ' ASP . 34.9 mt -66.13 -28.53 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.654 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -64.23 -49.76 70.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.684 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -37.68 77.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.425 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.641 HD13 ' CE2' ' A' ' 69' ' ' PHE . 5.9 tp -57.3 -50.85 71.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.689 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -52.86 -45.94 67.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.516 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.7 m -62.99 -35.75 81.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.672 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -65.81 -38.59 89.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.788 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 51' ' ' LEU . 1.3 mt -59.6 -70.15 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.77 -106.95 0.2 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.144 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -150.35 32.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 111.045 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -120.97 -145.42 0.36 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.365 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.01 170.18 9.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.837 0.351 . . . . 0.0 110.712 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.1 98.43 1.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.4 0.619 . . . . 0.0 110.352 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.9 mt -79.67 85.5 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.346 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.21 28.23 54.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.489 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -46.58 123.51 5.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.924 0.393 . . . . 0.0 111.158 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 24.9 p -104.51 136.52 43.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.077 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.5 mmt -102.92 152.16 38.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.7 Cg_endo -83.56 144.64 49.42 Favored 'Cis proline' 0 C--N 1.346 0.405 0 C-N-CA 124.246 -1.148 . . . . 0.0 112.653 0.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 25.3 mm-40 -104.33 154.08 20.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -123.35 159.35 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.459 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.641 ' CE2' HD13 ' A' ' 51' ' ' LEU . 25.3 m-85 -142.3 132.7 25.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.932 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.571 ' N ' HD11 ' A' ' 76' ' ' ILE . . . -65.54 150.16 96.36 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.239 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.564 ' HB3' ' N ' ' A' ' 1' ' ' MET . 71.1 Cg_exo -45.73 -42.98 19.28 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.215 2.61 . . . . 0.0 112.746 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.66 -29.03 64.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.98 79.64 0.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.467 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.9 127.57 3.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.939 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -58.54 108.94 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.613 HG23 ' CD2' ' A' ' 85' ' ' TYR . 4.0 mt -81.5 -41.79 19.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 125.48 -149.52 17.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.491 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -98.22 -132.42 7.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.32 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.732 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -83.02 -69.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.578 0.189 . . . . 0.0 110.877 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.7 -43.53 47.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.175 0.512 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -42.34 95.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.746 HD21 ' CE1' ' A' ' 86' ' ' PHE . 1.6 tt -71.77 -41.58 68.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.752 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -51.12 -35.24 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.85 -35.57 77.09 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.122 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.613 ' CD2' HG23 ' A' ' 76' ' ' ILE . 59.5 t80 -64.49 -32.36 73.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.588 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.746 ' CE1' HD21 ' A' ' 82' ' ' LEU . 27.7 m-85 -89.79 -27.1 20.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.058 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.701 179.701 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.8 ttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.897 0.379 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 68.9 m-85 -60.19 157.44 13.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.771 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.694 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -134.11 116.32 15.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.702 -179.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 68' ' ' VAL . 19.0 t -105.91 125.62 61.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.266 0.555 . . . . 0.0 111.829 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.768 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.0 m-30 -101.96 99.47 9.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.532 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.68 -138.02 2.33 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.413 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.718 ' HE2' ' HE3' ' A' ' 37' ' ' MET . 22.6 m-85 -120.06 139.97 51.73 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 120.626 0.25 . . . . 0.0 110.502 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -92.97 22.28 5.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 4.5 m 65.74 5.73 3.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -81.89 -44.02 17.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.074 0.464 . . . . 0.0 110.521 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 11' ' ' ILE . 9.8 mm -124.95 1.5 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.263 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 13.3 t-80 -157.04 131.19 8.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.538 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -80.99 159.57 24.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.348 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 176.75 123.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.118 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.0 m -83.13 -39.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.818 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -55.45 -28.85 56.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.728 0.299 . . . . 0.0 111.284 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.5 m -62.16 -53.84 49.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.55 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.26 -34.19 56.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.167 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -70.22 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.963 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.51 -31.95 48.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.288 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -60.69 -56.01 26.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.571 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.82 ' O ' HG23 ' A' ' 26' ' ' VAL . 12.1 ttt85 -64.65 -27.09 68.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.772 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.808 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.6 tt -57.31 -57.4 12.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.385 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.693 HD12 ' CG ' ' A' ' 31' ' ' PHE . 3.8 mt -59.85 -41.89 92.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.599 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -37.16 79.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.094 0.474 . . . . 0.0 110.063 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 22' ' ' ARG . 92.6 t -77.64 -25.36 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.867 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HE3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -77.71 -15.74 58.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? 70.34 42.28 0.93 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.066 0.46 . . . . 0.0 110.524 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -128.33 143.75 49.29 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.499 ' O ' ' HA ' ' A' ' 1' ' ' MET . 92.1 Cg_endo -77.01 136.96 16.96 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.389 2.06 . . . . 0.0 111.674 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.693 ' CG ' HD12 ' A' ' 24' ' ' LEU . 12.6 p90 -149.12 170.31 18.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.915 0.388 . . . . 0.0 112.008 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -147.75 141.21 25.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.196 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.471 ' HE1' HG11 ' A' ' 4' ' ' VAL . 8.3 t80 -89.71 162.87 15.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.043 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.768 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.9 mt -146.12 119.78 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.262 0.554 . . . . 0.0 110.417 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -82.08 125.23 30.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.346 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.45 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.9 pt -100.31 -12.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.171 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.718 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 21.7 ttm -123.07 79.04 51.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.767 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HG2' ' HB3' ' A' ' 44' ' ' ASP . 17.9 Cg_exo -65.56 -22.1 58.91 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.283 1.989 . . . . 0.0 111.608 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -139.22 137.46 35.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.704 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.468 ' N ' HG21 ' A' ' 11' ' ' ILE . 19.7 tttt -61.35 -9.18 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.22 0.533 . . . . 0.0 112.245 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.31 -55.72 4.6 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.449 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 t -150.46 139.25 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.616 0.246 . . . . 0.0 111.559 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -58.76 170.33 0.82 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.045 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.482 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 12.6 p30 -88.89 109.49 20.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 111.875 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -58.06 -31.12 66.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.619 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -52.99 -42.35 65.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.786 0.327 . . . . 0.0 110.971 -179.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 53.0 mmtt -80.62 -39.15 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.254 0.55 . . . . 0.0 109.887 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 44' ' ' ASP . 43.9 mm -55.93 -46.01 80.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.722 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.68 -56.44 12.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.322 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 7.4 pt-20 -60.68 -28.78 68.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.583 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.11 -56.44 22.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.362 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.686 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.8 mt -52.35 -45.24 65.62 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.9 m -60.72 -38.81 86.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.278 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -65.27 -37.7 87.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.521 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -60.03 -20.17 56.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.935 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.27 -88.81 1.53 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.124 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -139.4 31.53 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.454 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' O ' HD12 ' A' ' 55' ' ' LEU . 5.2 t0 -121.61 110.55 16.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.376 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.4 t -78.25 142.06 38.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.452 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 1.9 pt20 -70.8 97.57 1.41 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.378 0.608 . . . . 0.0 111.036 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 61' ' ' ILE . 6.5 tp -80.88 79.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.481 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.76 24.37 69.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.101 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -54.48 159.91 1.92 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.858 0.361 . . . . 0.0 111.08 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 65' ' ' MET . 18.3 m -125.49 165.76 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.226 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.447 ' N ' HG22 ' A' ' 64' ' ' THR . 13.0 mmt -97.94 155.69 36.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.452 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.6 Cg_endo -86.34 149.81 42.92 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 124.211 -1.162 . . . . 0.0 113.106 0.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -108.71 112.61 25.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.918 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 4' ' ' VAL . 3.2 t -89.5 163.02 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.219 0.533 . . . . 0.0 112.183 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 44.9 m-85 -141.58 137.3 31.84 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.132 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.756 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -50.99 152.22 3.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.065 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.478 ' HB3' ' N ' ' A' ' 1' ' ' MET . 53.0 Cg_exo -54.87 -24.32 38.24 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.728 2.286 . . . . 0.0 112.028 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -101.63 -22.52 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.991 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.3 85.66 0.78 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.707 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.47 ' O ' HD12 ' A' ' 76' ' ' ILE . 1.4 m -165.79 126.68 1.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.736 0.303 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -61.28 117.72 5.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.794 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 70' ' ' ALA . 2.4 mp -110.11 -27.9 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.961 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 117.12 -155.46 16.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.901 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.06 -134.36 7.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.419 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.808 ' CE1' HD12 ' A' ' 23' ' ' LEU . 36.5 t80 -74.3 -67.12 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.625 0.25 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.81 -52.68 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 110.759 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -51.05 -41.85 60.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.402 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.737 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.6 tt -78.83 -29.03 44.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.129 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 87' ' ' LYS . 14.2 ttt85 -52.81 -30.66 34.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -67.77 -30.39 69.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' LEU . 24.0 t80 -68.64 -33.65 74.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.574 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.737 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.2 m-85 -95.51 -70.72 0.7 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.819 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' ARG . 1.3 mtpm? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.93 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 28.5 ttm . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.08 143.37 35.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.146 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.15 120.14 41.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.617 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.428 HG11 ' HE1' ' A' ' 33' ' ' PHE . 67.6 t -104.39 126.8 59.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.268 0.556 . . . . 0.0 111.727 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.716 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.8 m-30 -103.8 99.53 9.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.457 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.74 -141.05 3.04 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.33 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -116.61 160.63 20.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 120.675 0.274 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB2' HD13 ' A' ' 11' ' ' ILE . 6.1 m-20 -81.59 -78.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 t 170.49 -35.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.799 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -84.55 -22.94 29.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.38 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.599 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.3 mp -93.1 -39.01 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.74 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -155.93 145.0 20.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.272 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -68.39 158.26 33.99 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 p 175.38 113.9 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.815 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.6 m -90.29 -36.76 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.927 0.394 . . . . 0.0 111.1 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -62.25 -29.18 70.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.996 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 m -58.08 -48.04 81.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.028 0.442 . . . . 0.0 110.289 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -28.07 68.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.486 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.19 -57.22 4.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.765 0.317 . . . . 0.0 111.156 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.17 -26.16 37.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.319 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -68.53 -58.12 4.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 110.327 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.888 ' O ' HG23 ' A' ' 26' ' ' VAL . 13.1 mtt180 -63.17 -28.63 70.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.544 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.942 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -55.98 -56.53 19.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.197 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.633 HD22 ' CZ ' ' A' ' 86' ' ' PHE . 1.5 mt -57.26 -40.01 76.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.58 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.4 m -60.06 -34.93 74.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.311 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 22' ' ' ARG . 22.1 t -62.41 -51.16 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.408 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' CE ' ' CE2' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -66.48 -16.74 64.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.375 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.82 42.82 0.19 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.141 0.496 . . . . 0.0 110.119 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -120.21 138.58 27.32 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.124 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.613 ' O ' ' HA ' ' A' ' 1' ' ' MET . 97.2 Cg_endo -74.31 158.24 44.94 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.013 1.809 . . . . 0.0 111.012 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.546 ' CG ' HD12 ' A' ' 24' ' ' LEU . 35.8 p90 -161.37 171.05 18.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.8 0.334 . . . . 0.0 111.668 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -141.57 130.83 23.52 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.512 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.428 ' HE1' HG11 ' A' ' 4' ' ' VAL . 21.0 t80 -89.14 159.56 17.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.955 0.407 . . . . 0.0 111.298 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.716 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.2 mt -146.85 120.11 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.552 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -91.66 112.48 24.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.543 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.82 HD11 ' CG1' ' A' ' 48' ' ' ILE . 6.6 tt -87.18 49.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.3 ttm -171.38 98.81 0.4 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.566 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 35.7 Cg_endo -65.1 -30.3 55.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.374 2.05 . . . . 0.0 112.288 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -143.01 158.71 43.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.419 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -71.0 -7.78 48.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.313 0.577 . . . . 0.0 111.498 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.61 -20.25 8.67 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.925 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 t -141.36 122.74 13.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.413 0.625 . . . . 0.0 112.5 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.746 ' HB3' HD11 ' A' ' 48' ' ' ILE . 31.6 m-85 -73.41 161.92 29.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.3 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.434 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 1.1 t70 -83.7 87.39 7.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.77 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -24.86 64.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.297 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -61.06 -55.86 27.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 110.713 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 6.4 mmtt -70.74 -43.55 68.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.112 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.82 ' CG1' HD11 ' A' ' 36' ' ' ILE . 63.0 mt -50.43 -38.22 15.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.672 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.47 -59.26 3.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 8.8 pt-20 -60.26 -30.03 69.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.159 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD2' HD21 ' A' ' 55' ' ' LEU . 1.9 tt -58.23 -50.14 74.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.146 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.1 mt -54.88 -48.4 73.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.097 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.9 m -66.18 -35.34 80.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.372 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -65.4 -37.14 86.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.829 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.503 HD21 ' CD2' ' A' ' 51' ' ' LEU . 1.2 mt -60.25 -67.34 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.85 -27.18 0.29 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.678 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.05 -165.5 1.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.898 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -91.56 -31.35 15.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.789 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -110.67 170.15 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 62' ' ' GLY . 9.9 pt20 -114.36 100.54 8.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.489 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -58.8 82.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.482 0.658 . . . . 0.0 111.598 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 60' ' ' GLN . . . 62.33 20.96 61.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.983 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.94 135.07 36.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.6 p -136.83 170.93 15.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.465 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.0 155.64 47.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.561 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -75.72 143.13 76.06 Favored 'Cis proline' 0 C--N 1.344 0.323 0 C-N-CA 123.8 -1.333 . . . . 0.0 112.83 0.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 1.7 mt-30 -111.97 113.76 26.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.879 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -87.91 161.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.111 0.482 . . . . 0.0 111.587 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 57.4 m-85 -143.08 139.04 30.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.345 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.704 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.53 132.52 54.43 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.294 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HB3' ' N ' ' A' ' 1' ' ' MET . 38.2 Cg_exo -54.87 -20.74 23.56 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.448 2.099 . . . . 0.0 111.911 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.57 39.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.279 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.48 -111.35 0.68 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.923 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.515 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 5.4 t -137.4 179.88 6.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.179 0.514 . . . . 0.0 111.273 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 41.0 t-80 -56.34 126.9 28.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.025 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.704 HD11 ' HA ' ' A' ' 70' ' ' ALA . 11.0 mt -94.66 -42.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.78 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 134.22 -154.86 21.58 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.8 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 82' ' ' LEU . . . -93.62 -149.07 24.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.372 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.942 ' CE1' HD12 ' A' ' 23' ' ' LEU . 58.3 t80 -67.66 -59.14 3.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.757 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -62.09 -54.74 37.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.051 0.453 . . . . 0.0 110.818 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -52.02 -41.04 61.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.6 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.773 HD21 ' CE1' ' A' ' 86' ' ' PHE . 6.1 tt -79.69 -28.19 40.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.24 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 87' ' ' LYS . 2.2 mmm180 -52.28 -35.05 49.22 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -60.12 -32.59 71.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.2 t80 -68.4 -28.5 67.14 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.929 178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.773 ' CE1' HD21 ' A' ' 82' ' ' LEU . 15.7 m-85 -100.11 -70.86 0.72 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.833 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.567 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 56.2 ttp . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 81.0 m-85 -51.01 149.12 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.198 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 1.1 mptp? -117.23 116.99 28.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.219 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 68' ' ' VAL . 44.1 t -110.67 128.55 66.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.513 0.673 . . . . 0.0 112.577 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.583 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 22.0 m-85 -108.74 106.44 16.47 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.592 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.68 -137.26 2.29 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.831 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -123.94 134.11 53.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 122.449 0.3 . . . . 0.0 110.324 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -100.39 39.14 1.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 111.318 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 t 60.15 14.05 4.24 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.627 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -85.83 -53.29 5.21 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.901 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 37' ' ' MET . 18.6 mt -110.97 -15.26 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -160.67 148.42 15.99 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.07 159.28 33.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.62 119.07 1.0 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.433 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -90.38 -31.21 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.032 0.444 . . . . 0.0 111.125 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -62.7 -28.84 70.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.805 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 t -59.32 -47.07 86.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.049 0.452 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -62.52 -33.89 75.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.214 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 83.4 m-20 -74.61 -46.53 37.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.017 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -66.69 -40.52 88.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.92 0.39 . . . . 0.0 110.803 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -57.49 10.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.787 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.789 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -58.0 -40.12 79.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.387 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.733 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -59.15 -54.82 42.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.129 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.733 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.4 mt -55.97 -45.97 78.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.665 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 m -55.98 -38.01 69.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.157 0.504 . . . . 0.0 109.928 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.5 t -79.29 -29.71 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.497 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -75.25 -13.73 60.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.114 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm 68.56 46.31 1.01 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.0 0.429 . . . . 0.0 110.926 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -126.83 141.04 39.27 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.847 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.48 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.5 Cg_endo -82.06 140.38 11.21 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.514 2.143 . . . . 0.0 111.404 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 42.6 p90 -157.94 169.74 23.91 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.639 -0.424 . . . . 0.0 112.077 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.86 139.68 23.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.241 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.64 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.6 t80 -89.42 161.44 16.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.521 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.415 HG13 ' C ' ' A' ' 33' ' ' PHE . 12.1 mt -149.88 122.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 110.511 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -79.31 110.65 14.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.274 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.517 HG21 ' HB3' ' A' ' 5' ' ' TYR . 2.3 pt -86.01 -2.28 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.599 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.665 ' O ' HD12 ' A' ' 11' ' ' ILE . 38.5 ttm -119.41 107.22 41.42 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.87 -28.28 4.14 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.568 2.178 . . . . 0.0 111.546 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -139.95 152.77 46.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.665 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -65.6 -8.46 20.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.236 0.541 . . . . 0.0 112.048 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.41 -54.03 3.65 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.495 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.4 t -148.72 154.79 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.805 0.336 . . . . 0.0 111.378 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -77.45 170.39 16.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.96 114.42 25.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.687 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 35.1 m-20 -63.7 -15.62 58.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.412 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -62.7 -55.99 21.73 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.826 0.345 . . . . 0.0 110.839 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -70.09 -35.81 74.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' ' 43' ' ' PHE . 56.5 mt -70.43 -32.98 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.687 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.1 -57.42 12.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.64 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -63.17 -25.78 68.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.144 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.583 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 3.7 tt -60.36 -56.17 24.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.991 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.665 ' N ' HD23 ' A' ' 52' ' ' LEU . 2.1 mt -52.96 -45.17 67.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.065 0.46 . . . . 0.0 111.093 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 m -56.87 -49.02 76.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.379 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HE3' ' CD2' ' A' ' 69' ' ' PHE . 11.3 mtpp -60.78 -36.28 78.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.404 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.78 -24.04 67.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.95 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.97 -132.65 11.38 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.925 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.56 31.24 2.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.102 0.477 . . . . 0.0 110.665 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.72 109.41 14.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.542 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 t -78.39 152.1 32.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.389 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -69.89 97.63 1.15 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.398 0.618 . . . . 0.0 110.898 -179.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.54 81.32 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.714 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.93 24.79 67.15 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.167 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -55.23 173.28 0.11 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.756 0.312 . . . . 0.0 110.778 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.8 p -133.16 169.05 17.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.193 0.52 . . . . 0.0 111.636 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.411 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 15.5 mmt -111.36 155.11 43.31 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.261 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.3 Cg_exo -84.33 143.01 40.18 Favored 'Cis proline' 0 N--CA 1.462 -0.341 0 C-N-CA 124.223 -1.157 . . . . 0.0 113.108 0.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -97.4 130.49 44.53 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.671 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 4' ' ' VAL . 4.1 t -99.77 160.56 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.02 0.438 . . . . 0.0 111.696 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.59 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 20.7 m-85 -141.55 138.1 32.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.527 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.572 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -44.82 138.51 4.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.502 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 90.6 Cg_exo -46.38 -25.73 3.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.917 2.411 . . . . 0.0 111.992 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.98 39.16 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.044 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.05 -112.37 1.09 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.366 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 t -127.18 -172.55 2.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.086 0.47 . . . . 0.0 111.495 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 28.5 t-80 -67.21 145.83 54.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.087 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 70' ' ' ALA . 2.3 mp -123.04 -35.9 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.134 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.451 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.01 -156.44 20.72 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.774 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.73 -138.16 8.44 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.471 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 23' ' ' LEU . 31.5 t80 -71.85 -70.53 0.32 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.74 0.305 . . . . 0.0 110.773 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -56.43 -49.3 74.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.99 0.424 . . . . 0.0 110.48 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -36.34 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.291 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.634 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.9 tt -84.32 -29.77 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.023 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -51.7 -31.05 24.56 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.94 -34.42 78.08 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.219 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.459 ' CD2' HG12 ' A' ' 76' ' ' ILE . 15.4 t80 -65.27 -33.01 74.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.426 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.634 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.8 m-85 -87.95 -26.27 22.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.275 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 mttt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.9 -179.969 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.611 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 29.8 ttp . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -79.88 143.66 34.1 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.395 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.71 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -105.21 121.77 44.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.398 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 68' ' ' VAL . 38.6 t -103.38 126.58 57.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.82 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.577 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.6 m-30 -102.51 99.26 9.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.404 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.39 -138.33 2.46 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.503 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.769 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 93.0 m-85 -131.41 157.05 44.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.937 0.398 . . . . 0.0 111.543 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.588 ' O ' ' O ' ' A' ' 12' ' ' HIS . 32.6 p30 -80.25 -177.91 6.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.587 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -91.77 -13.7 31.11 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.698 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -85.67 -41.94 14.72 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mm -89.54 -45.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.588 ' O ' ' O ' ' A' ' 8' ' ' ASP . 20.8 t60 -139.64 115.51 10.21 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.68 0.752 . . . . 0.0 110.618 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.87 148.04 14.02 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.682 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 p -158.03 104.96 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 m -82.33 -33.37 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.723 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.97 -25.7 64.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.348 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.28 -48.78 80.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.626 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -55.29 -24.4 28.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.549 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 8.9 m-80 -74.68 -50.05 19.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.303 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.584 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -65.09 -40.79 95.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.791 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -61.41 -57.58 11.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.344 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.832 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -62.04 -33.8 75.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 0.0 109.709 179.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.78 HD13 ' N ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -57.55 -54.6 45.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.914 178.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.78 ' N ' HD13 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -58.49 -47.46 84.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.515 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -53.07 -39.99 63.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.116 0.484 . . . . 0.0 109.946 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 22' ' ' ARG . 60.7 t -72.98 -31.01 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.457 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HD3' ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -78.13 -9.81 59.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.043 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.35 37.25 1.2 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.051 0.453 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -123.51 133.13 24.37 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.015 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.611 ' O ' ' HA ' ' A' ' 1' ' ' MET . 59.9 Cg_endo -82.01 158.08 18.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.543 2.162 . . . . 0.0 111.227 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 9.1 p90 -161.72 171.57 17.67 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.767 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -136.86 137.42 39.66 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.463 ' HE1' HG11 ' A' ' 4' ' ' VAL . 10.9 t80 -89.36 158.42 17.79 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.196 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.577 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.1 mt -147.5 122.32 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.339 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -92.77 127.22 38.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.182 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.769 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 4.2 pt -89.53 -9.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.929 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.602 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 18.1 ttm -125.25 100.31 32.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.642 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.28 -22.99 28.94 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.647 2.232 . . . . 0.0 112.357 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -139.92 145.13 37.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -9.3 4.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.308 0.575 . . . . 0.0 111.78 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.91 -59.7 2.41 Favored Glycine 0 C--N 1.313 -0.708 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.741 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -146.85 134.69 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.685 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -69.49 170.64 10.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 48' ' ' ILE . 27.5 t70 -89.73 95.97 10.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.048 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -57.41 -18.68 19.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.104 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.47 -53.21 60.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -71.83 -36.29 70.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.362 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 44' ' ' ASP . 37.9 mm -53.16 -48.24 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.966 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.3 -53.14 57.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.627 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.49 -28.53 65.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.37 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.669 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.0 tt -58.23 -58.1 9.94 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.561 ' N ' HD23 ' A' ' 52' ' ' LEU . 4.1 mt -48.66 -48.14 40.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.307 0.575 . . . . 0.0 111.335 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.9 m -71.09 -22.06 62.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.192 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -73.09 -42.87 62.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.93 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.719 HD23 ' CE1' ' A' ' 75' ' ' HIS . 1.5 mp -59.33 -39.28 82.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.001 0.429 . . . . 0.0 110.886 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.94 -109.07 0.27 Allowed Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.057 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -150.5 32.53 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.241 0.544 . . . . 0.0 110.725 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -120.98 -152.09 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.385 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -120.98 170.6 9.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.863 0.363 . . . . 0.0 110.831 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -90.38 98.8 11.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.304 0.573 . . . . 0.0 110.476 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.6 mm -79.27 84.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.192 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.87 25.53 56.38 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.448 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.576 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.1 mm? -58.05 145.53 36.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 110.781 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.4 p -127.86 170.52 12.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.43 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.28 156.37 35.23 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.648 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.8 Cg_endo -85.19 145.12 40.18 Favored 'Cis proline' 0 N--CA 1.461 -0.419 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.834 0.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.576 ' CD ' HD12 ' A' ' 63' ' ' LEU . 3.3 mm-40 -107.68 113.35 26.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.743 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.8 t -87.25 161.36 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.291 0.567 . . . . 0.0 111.829 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.44 ' N ' HG12 ' A' ' 68' ' ' VAL . 55.8 m-85 -142.75 143.17 32.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.016 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.665 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -52.91 149.77 11.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.113 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' HB3' ' N ' ' A' ' 1' ' ' MET . 8.8 Cg_exo -68.79 -9.88 27.49 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.701 2.267 . . . . 0.0 112.39 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.6 -18.53 13.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.204 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.19 91.34 1.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.665 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m 176.29 158.24 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.537 0.208 . . . . 0.0 110.655 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.719 ' CE1' HD23 ' A' ' 55' ' ' LEU . 9.8 t-160 -90.46 133.52 34.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.665 HD12 ' N ' ' A' ' 70' ' ' ALA . 2.5 mt -122.28 -40.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.986 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 126.23 -161.38 20.6 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.928 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.26 -139.04 8.13 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.785 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -71.11 -70.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.602 0.239 . . . . 0.0 111.144 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -55.21 -50.83 68.39 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.198 0.523 . . . . 0.0 110.436 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -50.99 -43.71 60.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.231 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.618 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.1 tt -77.62 -29.1 51.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.312 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -52.25 -30.78 29.34 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.57 -35.56 79.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.5 t80 -61.79 -34.95 76.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.153 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.618 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -87.22 -27.53 22.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.266 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.8 mttt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.922 -179.85 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.637 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 17.9 ttp . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.402 ' CD1' ' CD2' ' A' ' 24' ' ' LEU . 71.2 m-85 -76.77 153.83 34.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.09 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -113.0 119.58 38.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.777 -179.468 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 68' ' ' VAL . 56.0 t -111.22 126.6 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.21 0.529 . . . . 0.0 111.865 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.643 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 22.7 m-85 -105.45 101.15 10.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.094 178.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.28 -137.46 2.24 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.498 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.612 ' CE1' HD11 ' A' ' 36' ' ' ILE . 46.8 m-85 -122.99 159.26 28.71 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -86.43 -70.39 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t 170.97 -37.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.743 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -79.09 -27.62 43.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.997 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.765 HG21 ' O ' ' A' ' 37' ' ' MET . 3.4 mp -89.59 -42.14 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.854 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -153.32 154.62 34.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.9 157.91 32.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.776 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p 179.12 86.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -72.76 -34.95 48.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.285 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.02 -19.07 65.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.343 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 t -69.17 -62.41 1.39 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.83 0.348 . . . . 0.0 110.515 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -49.82 -36.34 26.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.741 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -62.28 -54.26 43.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.768 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.0 -45.98 85.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.258 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -50.0 -38.35 36.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.943 0.402 . . . . 0.0 110.299 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.801 ' O ' HG23 ' A' ' 26' ' ' VAL . 11.8 tpt180 -68.52 -31.44 70.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.957 179.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.8 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.1 tt -56.52 -55.65 31.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.956 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.681 HD23 ' HZ ' ' A' ' 86' ' ' PHE . 1.3 mt -60.28 -52.32 65.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.696 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.1 m -51.13 -41.37 60.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.621 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 22' ' ' ARG . 74.9 t -66.19 -31.99 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.74 -9.8 57.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.107 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.49 51.41 0.12 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.941 0.4 . . . . 0.0 110.52 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.401 ' NE2' ' HD2' ' A' ' 30' ' ' PRO . 15.0 mm100 -132.04 133.69 24.25 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.211 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.599 ' O ' ' HA ' ' A' ' 1' ' ' MET . 57.8 Cg_endo -81.7 161.57 19.02 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.547 2.165 . . . . 0.0 111.215 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 5.3 p90 -161.45 171.45 18.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 111.544 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -133.13 126.25 31.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.826 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.485 ' HE1' HG11 ' A' ' 4' ' ' VAL . 10.7 t80 -89.79 158.22 17.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.466 HD12 ' CE1' ' A' ' 5' ' ' TYR . 24.1 mt -150.71 125.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.313 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -80.14 115.69 19.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.749 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.612 HD11 ' CE1' ' A' ' 7' ' ' TYR . 2.3 pp -79.6 -20.3 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.071 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.765 ' O ' HG21 ' A' ' 11' ' ' ILE . 1.9 ttp -124.22 85.76 54.89 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.146 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.94 -3.64 14.11 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.903 2.402 . . . . 0.0 112.429 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 37' ' ' MET . 9.2 tt0 -139.52 136.78 34.87 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.705 0.288 . . . . 0.0 110.732 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -64.27 -8.9 14.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.222 0.534 . . . . 0.0 112.131 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.47 -63.38 1.64 Allowed Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.93 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.79 146.79 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.645 0.259 . . . . 0.0 110.75 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -72.32 168.88 17.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 111.263 -179.879 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.669 ' O ' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -86.22 119.92 27.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.465 -179.506 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 4.9 t0 -76.23 -19.7 58.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.099 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.8 -58.73 6.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.965 0.412 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HD3' HG21 ' A' ' 34' ' ' ILE . 6.8 mmpt? -64.39 -40.59 96.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.095 179.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.669 HD12 ' O ' ' A' ' 44' ' ' ASP . 46.4 mt -65.41 -32.34 57.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.564 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -60.23 -48.45 81.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.786 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.86 -37.44 82.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.376 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.5 tt -58.98 -57.67 12.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.751 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.576 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 77.0 mt -46.27 -43.75 15.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.803 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 m -70.95 -28.79 64.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' CD ' ' CD2' ' A' ' 69' ' ' PHE . 2.9 ttmm -65.19 -45.14 86.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.597 -179.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.5 mp -59.43 -63.98 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.98 0.419 . . . . 0.0 111.127 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.33 -113.54 0.31 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.134 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.41 29.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 111.029 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -121.37 -154.76 0.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.308 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 t -120.98 166.04 14.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.729 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.63 ' CD ' HD23 ' A' ' 63' ' ' LEU . 20.9 mt-30 -118.42 99.15 6.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 110.99 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mm -80.93 84.89 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.175 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.02 29.75 3.67 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.357 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.63 HD23 ' CD ' ' A' ' 60' ' ' GLN . 3.1 tm? -52.34 131.66 33.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 110.798 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.629 ' N ' HD13 ' A' ' 63' ' ' LEU . 3.0 p -116.84 152.7 33.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.227 0.537 . . . . 0.0 111.635 -179.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -117.14 158.57 44.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.449 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.5 Cg_endo -87.02 134.88 15.97 Favored 'Cis proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.197 -1.168 . . . . 0.0 112.762 0.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.42 ' CG ' ' NE2' ' A' ' 75' ' ' HIS . 1.9 tp60 -92.68 139.15 30.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.878 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 77' ' ' GLY . 3.7 t -108.12 157.54 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.59 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.425 ' N ' HG12 ' A' ' 68' ' ' VAL . 28.5 m-85 -144.15 141.32 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.557 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.66 148.4 26.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.637 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 12.8 Cg_exo -67.45 -14.04 41.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.902 2.401 . . . . 0.0 112.198 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.51 -21.54 14.73 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.148 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.78 88.54 0.83 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.674 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m 179.39 158.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.633 0.254 . . . . 0.0 110.743 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.42 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 8.4 t-160 -90.34 133.49 34.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.557 HD11 ' HA ' ' A' ' 70' ' ' ALA . 17.1 mt -116.97 -45.55 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.979 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.622 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 122.01 -152.17 16.87 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.026 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -95.68 -131.07 6.48 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.562 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.8 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -77.55 -70.15 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.653 0.227 . . . . 0.0 111.048 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -51.56 -50.76 59.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.366 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -55.96 -39.59 71.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.614 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.7 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.8 tt -78.42 -32.52 48.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.598 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.0 mmm-85 -51.48 -33.1 29.78 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.52 -35.0 78.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.156 178.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' LEU . 31.8 t80 -63.54 -35.75 81.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.7 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -91.79 -9.88 41.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.559 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.0 mttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.972 179.975 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.605 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 9.4 ttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.95 0.405 . . . . 0.0 111.627 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.475 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 86.9 m-85 -62.47 155.7 24.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.641 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.767 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -128.22 121.41 29.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.116 -179.717 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.066 HG22 HG22 ' A' ' 68' ' ' VAL . 12.8 t -115.1 124.67 71.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.893 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.0 m-85 -103.99 104.38 14.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.2 -132.23 1.37 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.394 -178.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 1.094 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 93.9 m-85 -134.12 149.49 51.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.645 ' HA ' ' SG ' ' A' ' 14' ' ' CYS . 18.8 p-10 -156.47 -51.33 0.08 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.641 ' N ' ' HB3' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -52.84 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -177.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -47.98 81.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.442 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.481 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -86.65 22.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.601 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 1.094 ' CD2' ' HA ' ' A' ' 7' ' ' TYR 0.301 0.3 OUTLIER -149.0 77.74 1.38 Allowed 'General case' 0 N--CA 1.417 -2.103 0 C-N-CA 117.845 -1.542 . . . . 0.0 108.612 -171.98 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.782 ' HE2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -61.05 166.64 3.43 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.33 -1.759 . . . . 0.0 113.481 -177.522 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 31.5 p 169.96 111.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.342 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.782 HG13 ' HE2' ' A' ' 13' ' ' LYS . 2.2 m -91.77 -37.33 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.706 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -75.15 -19.03 60.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.574 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.9 t -60.42 -51.76 68.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.783 0.325 . . . . 0.0 110.621 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.89 -31.8 7.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.551 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -78.19 -57.2 3.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.825 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -56.45 -45.36 80.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -57.33 -52.09 66.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.368 . . . . 0.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.788 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.1 mtm180 -55.12 -42.22 72.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.079 179.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.824 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -57.51 -53.45 58.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.296 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.824 ' N ' HD23 ' A' ' 23' ' ' LEU . 10.1 mt -57.96 -46.88 84.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.873 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.3 m -55.59 -36.98 67.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.131 0.491 . . . . 0.0 109.865 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.6 t -79.28 -30.04 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.559 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HE3' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -71.5 -12.14 61.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.105 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt 64.38 42.23 5.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.107 0.479 . . . . 0.0 110.169 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -122.75 129.04 25.17 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.146 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' O ' ' HA ' ' A' ' 1' ' ' MET . 88.2 Cg_endo -77.21 140.05 19.39 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.274 1.983 . . . . 0.0 110.987 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.605 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 18.5 p90 -155.51 170.49 21.85 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.311 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.467 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 7.5 tt0 -136.57 134.56 37.59 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.193 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.629 ' CE2' ' HB3' ' A' ' 8' ' ' ASP . 8.6 t80 -90.45 156.94 17.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.893 HD12 ' CE1' ' A' ' 5' ' ' TYR . 29.8 mt -133.29 120.07 37.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.582 0.706 . . . . 0.0 110.196 179.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.632 ' HB2' ' CE1' ' A' ' 12' ' ' HIS . 5.6 p-10 -99.62 118.13 35.49 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.568 -1.197 . . . . 0.0 112.718 -177.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.849 HG22 ' HB2' ' A' ' 47' ' ' LYS . 20.1 pt -101.42 67.99 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 178.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.713 ' HE2' ' HE2' ' A' ' 7' ' ' TYR . 2.3 mtm -168.15 85.26 0.73 Allowed Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 122.678 0.391 . . . . 0.0 111.283 177.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 59.5 Cg_endo -71.79 -12.93 29.22 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.04 1.827 . . . . 0.0 110.526 178.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -150.24 150.04 31.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.37 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -63.19 -6.9 4.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.343 0.592 . . . . 0.0 111.528 179.605 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.92 -56.76 3.42 Favored Glycine 0 C--N 1.313 -0.697 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.158 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 43' ' ' PHE . 20.2 t -150.63 157.54 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.559 ' HD1' ' HG3' ' A' ' 37' ' ' MET . 1.8 m-85 -59.91 170.27 1.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.867 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.43 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -86.49 98.69 11.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.776 179.447 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -49.52 -28.06 5.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.158 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -61.47 -56.4 20.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.379 . . . . 0.0 110.467 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.849 ' HB2' HG22 ' A' ' 36' ' ' ILE . 7.8 mttt -61.49 -46.04 91.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.331 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.01 -44.06 77.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.372 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.39 84.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.218 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -42.5 99.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.451 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -54.24 -46.0 72.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.468 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.2 mt -56.22 -50.74 70.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.969 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.0 m -63.16 -33.51 75.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.441 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -63.61 -39.53 94.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.457 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 mt -60.02 -54.19 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.678 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.92 -112.82 0.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.125 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.8 ttt85 -150.49 33.0 0.63 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.034 0.445 . . . . 0.0 110.689 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -120.73 -146.87 0.38 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.501 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 t -120.18 170.3 9.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.805 0.336 . . . . 0.0 110.645 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -107.05 101.45 10.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.653 0.74 . . . . 0.0 110.709 179.633 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -80.31 86.52 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.479 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.55 29.87 75.92 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 60' ' ' GLN . 1.1 mm? -43.74 153.39 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 p -123.45 168.53 12.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.162 0.506 . . . . 0.0 111.62 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.9 mmt -122.53 153.15 62.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.558 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.9 Cg_endo -84.96 159.74 65.77 Favored 'Cis proline' 0 N--CA 1.462 -0.374 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.94 0.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.42 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 5.7 tp60 -112.75 109.73 19.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.119 179.178 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.066 HG22 HG22 ' A' ' 4' ' ' VAL . 3.2 t -90.63 164.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.781 -179.101 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 85.4 m-85 -142.52 146.41 34.66 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.671 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.778 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -58.32 148.55 63.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.436 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 51.0 Cg_exo -57.76 -29.92 87.43 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.104 2.536 . . . . 0.0 112.264 179.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -89.83 -26.88 20.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.426 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.11 89.23 0.62 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.754 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 m -176.53 164.77 2.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.468 0.175 . . . . 0.0 110.589 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.42 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 10.7 t-160 -90.93 119.92 31.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.004 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.778 HD11 ' HA ' ' A' ' 70' ' ' ALA . 32.2 mt -98.94 -49.3 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.667 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.28 -153.19 21.11 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.782 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.7 -138.02 9.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.541 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.502 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 46.7 t80 -70.21 -70.42 0.29 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.741 0.305 . . . . 0.0 110.978 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.7 -49.33 76.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -51.27 -39.23 56.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.578 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.741 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -78.52 -31.93 47.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.371 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -52.43 -30.71 30.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.5 -35.84 78.07 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' LEU . 32.0 t80 -60.04 -36.87 78.23 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.197 178.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.741 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.0 m-85 -89.17 -22.47 22.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.552 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.885 -179.877 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.845 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 23.0 tpp . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.604 -0.147 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 32' ' ' GLU . 97.2 m-85 -42.89 135.55 2.98 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.108 0.48 . . . . 0.0 110.53 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.26 124.09 50.32 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.622 -178.379 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.986 HG22 HG22 ' A' ' 68' ' ' VAL . 53.9 t -111.87 144.19 20.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.257 0.551 . . . . 0.0 111.4 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.797 ' CE1' HD12 ' A' ' 34' ' ' ILE . 7.9 m-85 -124.78 103.43 8.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.261 178.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.65 -141.28 3.08 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.248 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 32.3 m-85 -124.15 160.74 27.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.733 0.301 . . . . 0.0 110.601 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -103.11 29.32 5.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.417 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.2 p 65.97 9.83 6.47 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.305 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -87.12 -54.95 4.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 111.97 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 37' ' ' MET . 3.6 mp -94.22 -25.38 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.403 ' HB3' ' CD2' ' A' ' 7' ' ' TYR . 13.8 t60 -146.52 134.87 21.85 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.81 -178.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -61.57 129.62 41.99 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.2 -178.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.1 m -159.01 89.29 0.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.259 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.25 -37.84 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -55.89 -29.23 59.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 0.0 111.349 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 t -65.03 -60.69 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.229 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -56.93 -36.07 69.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.966 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -66.27 -38.39 87.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.444 -179.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.579 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -72.62 -35.85 67.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.319 . . . . 0.0 110.946 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 9.9 tttt -60.2 -34.9 74.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.024 0.44 . . . . 0.0 109.867 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -68.53 -39.65 81.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.959 179.317 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.1 tt -55.49 -52.84 62.33 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.891 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.732 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.9 mt -57.95 -37.36 74.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.227 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 m -60.72 -39.77 89.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 22' ' ' ARG . 58.6 t -74.86 -33.11 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.894 178.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -75.77 -9.48 58.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.761 179.252 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 58.86 37.25 24.84 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.275 0.56 . . . . 0.0 110.392 -179.086 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.489 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -120.65 104.95 41.72 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.708 -179.699 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.845 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 2.0 Cg_endo -45.23 168.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.682 2.255 . . . . 0.0 112.351 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.568 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 5.0 p90 -162.8 170.78 17.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.425 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.1 tm-20 -137.86 122.94 19.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.454 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.502 ' HE1' HG11 ' A' ' 4' ' ' VAL . 7.3 t80 -89.33 159.66 17.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.997 0.427 . . . . 0.0 111.68 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.797 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.8 mt -145.41 120.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.095 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -82.8 131.17 35.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.728 -178.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.716 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 5.2 pt -100.33 -28.16 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.024 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.776 ' O ' HD13 ' A' ' 11' ' ' ILE . 5.9 ttp -123.93 91.39 49.68 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.841 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.403 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 84.2 Cg_endo -81.02 3.44 7.8 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.841 2.361 . . . . 0.0 112.962 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -139.52 146.89 40.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.791 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.724 ' HA ' HG23 ' A' ' 11' ' ' ILE . 6.8 tmtt? -71.42 -7.76 49.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.285 0.564 . . . . 0.0 111.692 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.93 -60.62 1.25 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.048 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 t -147.0 144.1 20.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 112.041 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -64.21 169.37 4.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.973 179.723 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 1.3 t0 -98.57 116.34 30.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -57.89 -24.05 55.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.584 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -55.4 -48.82 73.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.848 0.356 . . . . 0.0 110.99 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -76.5 -36.96 57.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.061 0.458 . . . . 0.0 110.216 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.0 mm -58.1 -50.43 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.692 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.57 -44.15 96.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.437 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.56 -37.89 89.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.373 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.436 HD13 ' CD2' ' A' ' 5' ' ' TYR . 25.4 tp -61.09 -54.23 47.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.563 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.3 mt -50.7 -42.66 57.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.8 m -65.55 -35.13 79.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.192 179.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 2.8 tttp -64.47 -39.96 94.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.304 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.71 HD11 ' CD1' ' A' ' 63' ' ' LEU . 1.3 mt -59.45 -45.34 91.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.526 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.05 -110.84 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.89 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -150.55 32.5 0.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.996 0.427 . . . . 0.0 110.621 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.89 -146.75 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.431 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -119.99 170.43 9.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.708 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.74 98.39 8.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.137 0.494 . . . . 0.0 110.562 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -81.08 86.53 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.15 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.19 29.23 72.15 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.272 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.71 ' CD1' HD11 ' A' ' 55' ' ' LEU . 7.7 tt -46.73 152.55 0.47 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.343 . . . . 0.0 111.347 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.407 ' N ' HD23 ' A' ' 63' ' ' LEU . 35.6 p -130.28 166.01 21.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.173 0.511 . . . . 0.0 111.683 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.411 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 1.3 mpt? -125.33 154.96 72.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.629 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.6 Cg_endo -83.86 143.46 44.05 Favored 'Cis proline' 0 C--N 1.344 0.333 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.916 0.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 0.9 OUTLIER -103.25 128.28 50.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 179.089 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.986 HG22 HG22 ' A' ' 4' ' ' VAL . 5.9 t -100.99 160.5 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 112.14 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 97.2 m-85 -143.7 159.29 42.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.416 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -70.12 144.6 92.81 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.141 -179.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -37.78 -31.96 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.487 2.792 . . . . 0.0 112.446 179.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.82 36.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.118 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.25 -109.49 1.85 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.955 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -127.37 -173.95 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.121 0.486 . . . . 0.0 111.335 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.483 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 35.5 t-80 -70.71 137.33 49.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.116 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.8 mp -109.65 -31.36 2.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.706 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 75' ' ' HIS . . . 117.95 -156.62 15.56 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.205 179.397 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.64 -124.61 5.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.147 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -80.09 -70.46 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.618 0.209 . . . . 0.0 111.299 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -52.29 -47.97 65.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.125 0.488 . . . . 0.0 110.6 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -57.66 -45.04 86.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.679 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.733 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.9 tt -74.31 -32.6 62.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.448 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 87' ' ' LYS . 5.9 ttp85 -52.59 -33.1 44.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -65.01 -33.65 76.55 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.12 178.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LEU . 17.3 t80 -64.72 -34.22 77.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.483 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.733 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.5 m-85 -90.8 -71.03 0.65 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.558 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 83' ' ' ARG . 37.6 mttt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.912 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.574 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 55.6 ttm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.818 0.342 . . . . 0.0 111.449 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 46.6 m-85 -55.23 155.0 5.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.067 0.46 . . . . 0.0 111.016 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -124.56 119.29 28.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.033 -179.37 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.839 HG22 HG22 ' A' ' 68' ' ' VAL . 24.4 t -114.44 127.1 72.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.203 0.525 . . . . 0.0 112.067 179.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.463 ' CE1' HD12 ' A' ' 34' ' ' ILE . 24.9 m-85 -109.28 104.58 13.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.103 177.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.17 -139.19 2.58 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.684 -179.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.693 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 64.3 m-85 -121.71 160.52 24.35 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 120.908 0.385 . . . . 0.0 111.344 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.79 -72.99 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.778 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t 172.97 -36.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.981 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -64.72 -44.96 88.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.229 -179.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.4 mm -90.16 -40.11 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.431 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -149.96 152.49 35.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.012 0.434 . . . . 0.0 111.15 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -80.66 169.84 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.895 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 p 173.88 117.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.06 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -87.05 -34.35 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -22.63 66.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.014 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.8 t -72.05 -64.51 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.796 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -50.18 -35.48 26.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 51.8 m-20 -72.13 -59.0 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.17 -31.3 63.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.859 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -61.11 -54.46 44.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.659 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.728 ' O ' HG23 ' A' ' 26' ' ' VAL . 12.1 tpp180 -66.5 -24.65 66.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.025 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.555 HD12 ' CE1' ' A' ' 79' ' ' PHE . 1.3 tt -59.86 -58.18 9.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 110.501 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.644 HD12 ' CG ' ' A' ' 31' ' ' PHE . 5.5 mt -60.38 -42.76 96.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.795 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.5 m -60.96 -41.08 95.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.49 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 22' ' ' ARG . 71.1 t -73.68 -26.74 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.032 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.656 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 1.5 tpmp? -68.46 -44.35 75.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.79 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 112.71 30.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.331 1.052 . . . . 0.0 110.997 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -125.74 141.86 40.45 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.857 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.419 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.3 Cg_endo -80.35 143.43 15.54 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.531 2.154 . . . . 0.0 111.669 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.644 ' CG ' HD12 ' A' ' 24' ' ' LEU . 33.9 p90 -145.87 167.8 22.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.947 0.403 . . . . 0.0 111.973 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.66 126.13 26.82 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.579 ' CE1' HG11 ' A' ' 4' ' ' VAL . 24.7 t80 -89.94 155.73 18.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.23 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.62 HG21 ' HG2' ' A' ' 47' ' ' LYS . 10.1 mt -150.51 122.63 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.399 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -78.1 110.17 12.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.639 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.693 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.6 pt -62.87 -21.15 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.72 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.1 ttp -128.05 88.6 52.54 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.03 1.25 8.87 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.638 2.225 . . . . 0.0 112.569 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -139.46 139.29 36.99 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.513 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -66.94 -8.53 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.269 0.557 . . . . 0.0 111.895 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.3 -63.54 1.5 Allowed Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.429 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 t -145.9 143.78 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.717 0.294 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -65.6 168.2 7.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 111.235 -179.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.9 118.06 30.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.178 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 10.6 m-20 -71.43 -14.05 62.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.96 -61.07 2.51 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.62 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -64.77 -41.42 95.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.193 179.515 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.8 mt -64.53 -33.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.57 179.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -58.28 -47.87 82.25 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.712 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.95 -38.11 84.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.349 179.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.636 HD13 ' CE1' ' A' ' 69' ' ' PHE . 5.5 tp -57.96 -52.3 66.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.538 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.8 mt -51.45 -44.41 62.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.101 0.477 . . . . 0.0 111.278 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 m -63.27 -35.59 80.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.484 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.49 -40.34 89.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.657 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 51' ' ' LEU . 1.3 mt -59.94 -67.73 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.642 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.19 -107.02 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.033 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -150.45 31.42 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.004 0.43 . . . . 0.0 110.704 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.91 -149.44 0.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.353 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -120.53 170.19 9.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.755 0.312 . . . . 0.0 110.855 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -89.82 99.04 12.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.253 0.549 . . . . 0.0 110.309 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -78.22 88.02 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.039 -179.76 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 52.3 29.89 31.15 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.685 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.781 HD12 ' OE1' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -46.57 156.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 110.999 -179.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.8 p -105.62 147.87 27.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.101 0.477 . . . . 0.0 111.614 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.4 mmt -119.53 153.23 53.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.4 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HB2' HG13 ' A' ' 4' ' ' VAL . 2.8 Cg_exo -78.82 148.8 83.75 Favored 'Cis proline' 0 C--N 1.344 0.298 0 C-N-CA 124.122 -1.199 . . . . 0.0 112.948 0.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.781 ' OE1' HD12 ' A' ' 63' ' ' LEU . 2.1 tp60 -96.0 129.58 43.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.819 178.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.839 HG22 HG22 ' A' ' 4' ' ' VAL . 3.6 t -107.79 157.04 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.055 0.455 . . . . 0.0 111.947 -179.053 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.636 ' CE1' HD13 ' A' ' 51' ' ' LEU . 40.9 m-85 -143.01 137.29 29.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.646 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' CA ' HD11 ' A' ' 76' ' ' ILE . . . -47.08 160.85 0.32 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.376 -178.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.3 Cg_exo -60.24 -30.54 91.43 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.175 2.583 . . . . 0.0 112.12 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -94.3 -19.73 20.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.188 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.85 88.72 1.3 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.597 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.52 126.74 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.802 0.334 . . . . 0.0 110.686 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.422 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 5.1 t-160 -62.47 114.06 3.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.158 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.516 HD11 ' CA ' ' A' ' 70' ' ' ALA . 8.7 mt -104.67 -39.88 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.764 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.98 -153.93 21.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.571 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.1 -135.8 9.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.651 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.555 ' CE1' HD12 ' A' ' 23' ' ' LEU . 13.4 t80 -71.62 -70.87 0.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 111.129 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.99 -47.16 86.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.71 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -52.38 -41.25 62.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.633 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.615 HD21 ' CE2' ' A' ' 86' ' ' PHE . 4.9 tt -75.87 -35.25 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 87' ' ' LYS . 7.8 ttp180 -51.14 -30.0 15.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -71.46 -34.3 70.09 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.142 178.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 82' ' ' LEU . 53.6 t80 -62.89 -35.55 80.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.615 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.8 m-85 -89.1 -27.62 20.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.454 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 83' ' ' ARG . 21.0 mtpp . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.955 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.677 ' HG2' ' C ' ' A' ' 30' ' ' PRO . 2.0 tpt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.391 0.138 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 89.0 m-85 -40.07 119.78 1.07 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.749 0.785 . . . . 0.0 111.613 -177.385 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.35 126.51 35.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.295 -179.102 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.551 HG11 ' CE1' ' A' ' 33' ' ' PHE . 59.3 t -109.2 148.21 13.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.392 0.615 . . . . 0.0 111.186 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.666 ' CE1' HD12 ' A' ' 34' ' ' ILE . 46.6 m-85 -128.05 99.77 5.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.737 178.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.63 -137.21 2.24 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.727 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.816 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 59.0 m-85 -121.24 108.02 13.25 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.669 0.271 . . . . 0.0 111.373 -179.042 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.524 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -110.94 51.0 0.79 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.003 179.816 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.44 -169.8 1.13 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -87.17 8.72 22.63 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.327 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 37' ' ' MET . 3.7 pt -86.59 -14.0 10.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.459 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 11.5 t-80 -162.61 153.79 17.59 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.139 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -79.02 171.57 15.03 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.8 p -165.04 89.54 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.728 0.299 . . . . 0.0 111.069 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.9 m -91.49 -40.7 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.606 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.07 -23.27 64.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.654 -179.233 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.61 -47.03 80.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.23 -32.69 64.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -73.87 -55.65 5.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.682 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.19 -51.11 71.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 110.837 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -55.03 -47.16 75.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 179.69 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.801 ' O ' HG23 ' A' ' 26' ' ' VAL . 20.9 tpp180 -61.62 -40.5 95.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.028 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' C ' HD23 ' A' ' 23' ' ' LEU . 6.2 tt -56.56 -53.48 57.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.999 179.032 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.498 HD23 ' CZ ' ' A' ' 86' ' ' PHE . 10.3 mt -59.55 -44.54 93.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.411 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 m -57.67 -40.87 80.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 22' ' ' ARG . 50.8 t -75.31 -33.42 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.483 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -75.59 -12.11 60.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.929 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.8 41.72 1.15 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.849 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.15 118.07 16.1 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.407 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.677 ' C ' ' HG2' ' A' ' 1' ' ' MET . 77.8 Cg_exo -52.31 -177.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.308 2.005 . . . . 0.0 111.565 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE2' ' HE3' ' A' ' 21' ' ' LYS . 5.0 p90 -164.92 170.84 14.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.921 0.391 . . . . 0.0 111.367 178.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 34.7 tt0 -141.66 121.0 13.12 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.028 179.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.551 ' CE1' HG11 ' A' ' 4' ' ' VAL . 10.7 t80 -92.32 165.86 12.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.115 0.483 . . . . 0.0 112.078 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.666 HD12 ' CE1' ' A' ' 5' ' ' TYR . 25.4 mt -150.65 128.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.184 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.11 125.92 32.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.8 -178.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.414 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.9 pt -100.78 -25.11 3.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.718 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.8 ' HE1' ' CD2' ' A' ' 12' ' ' HIS . 2.3 ttm -108.91 105.19 56.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.012 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 37.5 Cg_endo -66.11 -29.65 47.74 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 121.769 1.646 . . . . 0.0 110.244 178.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -146.15 155.94 43.07 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.212 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -6.57 6.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.33 0.586 . . . . 0.0 111.568 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.34 -55.36 2.91 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 115.11 -0.95 . . . . 0.0 114.009 -178.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 t -148.2 135.87 14.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.951 0.376 . . . . 0.0 111.754 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -59.83 168.72 1.66 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.875 179.785 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.55 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -89.05 129.72 35.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.483 -179.907 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.37 -35.16 79.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.855 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -66.68 -50.9 61.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -68.32 -41.32 80.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.858 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.3 mp -66.62 -35.19 74.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.661 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.01 -57.95 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.307 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -55.93 -29.62 60.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.984 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.851 ' O ' HD12 ' A' ' 55' ' ' LEU . 24.4 tp -61.44 -61.16 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.078 179.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.617 ' HA ' HD13 ' A' ' 55' ' ' LEU . 86.2 mt -46.28 -35.73 5.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.692 179.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 m -69.29 -34.26 74.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.831 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 7.5 mtpp -68.36 -43.49 77.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.818 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.851 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.8 mp -58.6 -20.26 45.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.418 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.11 -29.45 7.57 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.765 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -89.88 -174.82 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -108.43 -31.8 7.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -109.85 169.96 8.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -112.87 99.94 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -74.57 82.75 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.162 -179.913 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.59 23.77 55.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.646 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.477 HD12 ' NE2' ' A' ' 67' ' ' GLN . 1.1 mm? -64.78 140.77 58.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.3 p -131.95 170.69 14.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.107 0.479 . . . . 0.0 111.474 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -104.09 155.5 37.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.664 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.4 Cg_exo -82.14 135.58 29.17 Favored 'Cis proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.678 0.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.477 ' NE2' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.99 128.37 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.18 179.187 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.0 t -102.88 157.11 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.015 0.436 . . . . 0.0 111.669 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 78.3 m-85 -143.09 147.21 34.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.775 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.625 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -56.16 140.9 70.24 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.37 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.85 -31.99 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.005 2.47 . . . . 0.0 112.115 179.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.43 34.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.932 179.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.87 -108.1 2.01 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.998 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.9 t -133.96 175.44 9.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.266 0.555 . . . . 0.0 111.511 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.48 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 10.1 t-80 -59.32 129.26 41.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.019 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.625 HD11 ' HA ' ' A' ' 70' ' ' ALA . 9.3 mt -102.09 -42.14 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.977 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.54 -153.3 20.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.757 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.09 -142.4 13.27 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.379 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -69.43 -70.62 0.27 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 110.811 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -58.79 -48.73 80.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.517 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.74 -42.54 62.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.451 179.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.75 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.6 tt -79.77 -28.73 40.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.028 179.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -51.38 -32.6 26.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.93 -35.25 80.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.6 t80 -63.14 -34.07 76.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.354 178.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.75 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.7 m-85 -93.09 -12.43 30.52 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.589 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.97 179.92 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.601 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 36.5 ttm . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.877 0.37 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 68.8 m-85 -58.62 163.98 2.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.833 -179.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.723 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -138.67 119.27 13.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.684 -179.305 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.943 HG22 HG22 ' A' ' 68' ' ' VAL . 24.0 t -108.54 147.91 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.239 0.542 . . . . 0.0 111.508 179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.697 ' CE1' HD12 ' A' ' 34' ' ' ILE . 27.9 m-85 -130.87 101.55 5.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.466 178.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.62 -136.5 2.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.57 -179.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -108.27 157.26 18.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.846 0.355 . . . . 0.0 111.304 -179.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 9' ' ' SER . 20.3 t0 -85.14 -4.66 59.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.979 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 86.28 -36.63 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.955 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.33 -33.79 61.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.691 0.281 . . . . 0.0 111.089 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 37' ' ' MET . 1.5 mt -89.79 -32.14 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.337 -179.779 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -141.24 132.03 25.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 110.621 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 151.25 41.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.573 -179.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 168.96 91.04 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.836 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.2 m -57.43 -37.05 55.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.53 -23.43 50.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -65.05 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.499 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.06 -34.97 23.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -60.88 -46.97 88.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.896 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -60.54 -43.44 97.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.294 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -53.98 -36.89 63.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.004 0.431 . . . . 0.0 110.132 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.768 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.3 tpp180 -70.18 -28.54 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.204 179.137 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.866 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -57.42 -55.96 27.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.927 179.414 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.646 HD21 HD21 ' A' ' 82' ' ' LEU . 24.8 mt -64.2 -42.54 96.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.578 179.459 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.8 m -58.59 -34.35 71.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.205 179.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 22' ' ' ARG . 72.0 t -76.8 -31.25 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.616 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HG3' ' CD1' ' A' ' 86' ' ' PHE . 15.0 mmtt -76.07 -19.59 58.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.195 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.76 60.38 0.11 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.403 ' NE2' ' HD2' ' A' ' 30' ' ' PRO . 24.2 mm100 -139.76 142.45 31.27 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.953 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' HA ' ' A' ' 1' ' ' MET . 87.4 Cg_endo -75.91 137.31 19.61 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.405 2.07 . . . . 0.0 111.405 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.601 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 20.0 p90 -151.91 170.33 20.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -138.38 129.43 27.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.545 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.638 ' CE1' HG11 ' A' ' 4' ' ' VAL . 49.0 t80 -89.94 160.02 16.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.054 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.697 HD12 ' CE1' ' A' ' 5' ' ' TYR . 15.3 mt -145.57 121.43 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.295 0.569 . . . . 0.0 110.274 179.29 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -91.27 121.36 32.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.157 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.444 HD12 ' HD2' ' A' ' 43' ' ' PHE . 3.6 pt -80.64 -4.4 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.057 179.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.585 ' O ' HD12 ' A' ' 11' ' ' ILE . 36.9 ttm -132.85 110.97 13.28 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.778 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.42 ' HD3' ' CB ' ' A' ' 44' ' ' ASP . 71.9 Cg_endo -76.91 -30.73 4.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.552 2.168 . . . . 0.0 112.474 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 37' ' ' MET . 8.3 tp10 -139.69 155.33 47.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.639 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -64.54 -8.03 12.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.296 0.57 . . . . 0.0 111.524 179.966 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.41 -52.21 4.6 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 115.177 -0.919 . . . . 0.0 113.193 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 43' ' ' PHE . 22.9 t -149.24 153.4 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.105 0.479 . . . . 0.0 112.235 -179.188 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.74 ' HB3' HD11 ' A' ' 48' ' ' ILE . 62.4 m-85 -73.74 168.72 18.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.124 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.42 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -99.71 111.62 23.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.891 179.345 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -62.48 -26.57 68.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.747 0.308 . . . . 0.0 110.556 179.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.32 -56.05 19.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -36.68 81.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.302 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.74 HD11 ' HB3' ' A' ' 43' ' ' PHE . 34.5 mt -67.27 -38.18 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.35 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.44 -56.07 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.273 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.31 -28.89 56.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.866 ' O ' HD12 ' A' ' 55' ' ' LEU . 26.0 tp -62.96 -60.85 2.9 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.212 179.519 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.4 mt -45.54 -39.42 7.43 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.207 0.527 . . . . 0.0 111.288 179.229 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.8 m -67.11 -36.12 81.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.001 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HG2' ' CD2' ' A' ' 69' ' ' PHE . 7.9 tttp -63.22 -50.28 70.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.333 179.383 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 51' ' ' LEU . 5.0 mp -58.92 -55.05 40.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.68 -126.39 0.9 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.376 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -150.4 33.23 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.991 0.424 . . . . 0.0 110.861 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -120.74 -144.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 t -105.06 170.06 8.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.72 0.295 . . . . 0.0 110.624 179.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.69 98.31 11.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.299 0.571 . . . . 0.0 110.546 179.841 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.4 mt -80.37 86.41 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.07 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.23 30.31 75.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.039 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.444 HD11 HE22 ' A' ' 67' ' ' GLN . 7.5 tt -48.03 151.32 0.98 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 111.512 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 p -142.26 170.18 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.39 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -132.13 149.76 74.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.648 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -85.59 149.36 47.05 Favored 'Cis proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.758 0.354 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.444 HE22 HD11 ' A' ' 63' ' ' LEU . 8.1 mt-30 -114.44 133.99 55.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.451 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.943 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -105.88 168.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.302 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 78.8 m-85 -142.33 146.11 34.66 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -57.16 138.3 80.2 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.235 -178.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.472 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 87.1 Cg_exo -46.17 -28.4 5.47 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.878 2.385 . . . . 0.0 111.902 178.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.91 33.55 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.91 179.578 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.92 -108.89 1.76 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.934 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.431 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -145.36 179.36 7.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.29 0.566 . . . . 0.0 111.421 -179.537 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.41 ' CE1' ' OE1' ' A' ' 67' ' ' GLN . 16.3 t-160 -49.76 118.79 3.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.355 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.551 HG23 ' CD2' ' A' ' 85' ' ' TYR . 6.7 mt -84.83 -47.51 17.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.891 0.376 . . . . 0.0 111.076 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.83 -152.36 18.02 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.493 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -93.37 -155.3 31.82 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.405 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.866 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -61.61 -67.76 0.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 O-C-N 122.83 -0.218 . . . . 0.0 110.859 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -48.39 -42.18 31.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.068 0.461 . . . . 0.0 110.541 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -67.37 -42.32 83.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.417 179.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.646 HD21 HD21 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -66.71 -45.83 77.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.316 179.726 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -51.13 -36.61 41.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -70.29 -34.95 73.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.233 178.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.551 ' CD2' HG23 ' A' ' 76' ' ' ILE . 65.0 t80 -66.54 -30.61 70.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.751 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.601 ' CE2' HD21 ' A' ' 82' ' ' LEU . 24.8 m-85 -90.9 -66.72 0.9 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.69 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.2 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.617 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.3 ttm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.897 0.38 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.473 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 87.4 m-85 -64.4 156.34 29.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.011 0.434 . . . . 0.0 110.689 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.663 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.58 120.22 22.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.561 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 68' ' ' VAL . 21.1 t -108.62 137.38 40.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.18 0.514 . . . . 0.0 111.755 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.791 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.5 m-85 -115.73 101.08 8.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.927 178.488 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -160.25 -138.19 2.39 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.286 -179.277 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.409 ' CG ' ' HB3' ' A' ' 12' ' ' HIS . 41.7 m-85 -126.22 157.11 39.09 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.647 0.261 . . . . 0.0 111.039 -179.407 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.01 -69.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.807 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.1 t 170.87 -39.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.813 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -76.77 -24.74 52.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.844 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.667 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.0 mp -90.82 -43.62 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.153 0.501 . . . . 0.0 110.17 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.409 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 32.7 t60 -152.18 147.21 26.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.131 179.318 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.55 159.14 26.99 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.239 -179.382 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -177.06 106.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.585 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.92 -36.65 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.697 -179.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -62.87 -21.22 65.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.495 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.6 t -64.54 -52.84 55.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.955 0.407 . . . . 0.0 110.571 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -55.55 -32.46 63.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.323 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -72.34 -53.76 11.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.224 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.4 -48.6 74.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.982 0.42 . . . . 0.0 111.139 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -51.15 71.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -56.78 -42.19 78.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.2 tt -57.5 -54.67 44.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.394 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.782 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.6 mt -55.38 -44.97 76.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.771 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.1 m -58.36 -34.62 70.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.133 0.492 . . . . 0.0 110.059 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 22' ' ' ARG . 48.0 t -79.84 -30.18 13.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.734 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.533 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 2.1 mmtt -79.17 -14.38 59.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 66.31 60.81 0.61 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.999 0.428 . . . . 0.0 110.804 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -133.62 143.1 46.37 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' O ' ' HA ' ' A' ' 1' ' ' MET . 75.8 Cg_endo -80.17 132.86 9.55 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.606 2.204 . . . . 0.0 111.445 179.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.617 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 29.1 p90 -155.18 170.43 21.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.921 0.391 . . . . 0.0 112.012 -179.682 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -144.84 145.72 31.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.058 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.494 ' CE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.29 158.44 17.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.099 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.791 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.8 mt -142.28 117.66 5.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.213 179.352 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -81.33 119.44 23.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.54 -179.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 6' ' ' GLY . 10.5 tt -85.86 -27.86 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.193 179.103 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 7.4 ttp -129.93 95.86 27.5 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 179.418 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -78.14 -5.06 14.88 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.563 2.175 . . . . 0.0 112.691 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -139.9 139.89 36.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.755 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.91 -8.63 23.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.237 0.542 . . . . 0.0 111.989 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.16 -61.68 1.8 Allowed Glycine 0 C--N 1.312 -0.787 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.228 179.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.52 133.01 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.735 0.302 . . . . 0.0 111.094 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.03 167.59 1.6 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.01 0.433 . . . . 0.0 111.29 -179.804 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.45 108.79 18.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.102 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -53.09 -25.89 14.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.163 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -55.83 -49.94 71.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.773 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -74.98 -34.45 62.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.125 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.459 ' CD1' HD11 ' A' ' 36' ' ' ILE . 30.0 mm -59.82 -49.92 82.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.775 179.628 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.55 -50.61 72.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.488 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.23 -41.05 98.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.353 179.44 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.501 HD22 ' HD2' ' A' ' 5' ' ' TYR . 6.2 tp -57.07 -49.61 75.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.75 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.76 -49.89 69.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.086 0.47 . . . . 0.0 111.153 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.4 m -60.98 -33.19 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.272 179.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -64.29 -41.36 96.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.354 179.505 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.5 mt -59.84 -56.11 25.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.567 179.392 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.96 -109.03 0.27 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.953 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -150.65 30.89 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.414 . . . . 0.0 110.698 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -121.03 -148.84 0.42 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.377 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 t -120.62 170.32 9.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 0.0 110.687 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -98.09 98.85 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.041 0.448 . . . . 0.0 110.471 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -80.25 85.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.242 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.64 27.89 55.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.444 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.534 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.1 mm? -47.41 154.27 0.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.829 0.347 . . . . 0.0 111.01 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.3 p -113.84 157.94 21.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.089 0.471 . . . . 0.0 111.636 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -120.84 158.15 52.9 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HB2' HG13 ' A' ' 4' ' ' VAL . 5.8 Cg_exo -82.18 148.58 69.11 Favored 'Cis proline' 0 C--N 1.343 0.253 0 C-N-CA 124.017 -1.243 . . . . 0.0 112.887 0.469 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.534 ' CD ' HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -105.07 125.6 51.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.167 179.023 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -97.25 167.98 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.878 0.37 . . . . 0.0 111.607 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.536 ' H ' HG12 ' A' ' 68' ' ' VAL . 75.7 m-85 -142.63 141.45 31.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.74 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB3' ' N ' ' A' ' 74' ' ' SER . . . -54.66 147.64 29.69 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.13 -178.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.497 ' HB3' ' N ' ' A' ' 1' ' ' MET . 51.6 Cg_exo -54.57 -27.81 52.37 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.804 2.336 . . . . 0.0 111.813 179.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -97.69 -22.32 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.014 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.16 82.82 0.6 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.63 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.497 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -168.78 115.66 0.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.727 0.299 . . . . 0.0 110.853 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -50.71 116.71 2.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.177 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.534 HG23 ' CD2' ' A' ' 85' ' ' TYR . 3.6 mt -88.82 -41.02 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.59 -150.09 17.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.633 -179.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.48 -140.12 9.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.399 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -75.84 -61.24 1.99 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.59 -42.72 67.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.24 -44.36 92.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.636 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.587 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -59.43 -49.0 79.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.464 179.831 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 ttt-85 -52.34 -32.44 38.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -75.06 -32.34 61.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.162 178.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.534 ' CD2' HG23 ' A' ' 76' ' ' ILE . 56.6 t80 -67.22 -32.2 73.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.357 178.473 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.587 ' HE2' HD21 ' A' ' 82' ' ' LEU . 26.1 m-85 -93.34 -70.47 0.7 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.504 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.923 179.983 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.565 ' HG3' ' CA ' ' A' ' 31' ' ' PHE . 58.1 ttm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.99 0.424 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.501 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 93.0 m-85 -53.17 152.51 4.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.039 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -126.92 120.44 29.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.954 -179.15 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.937 HG22 HG22 ' A' ' 68' ' ' VAL . 27.3 t -111.01 138.03 40.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 0.0 111.438 179.467 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.809 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.8 m-85 -114.73 99.03 7.21 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.128 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.76 -138.36 2.48 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.237 -0.983 . . . . 0.0 112.561 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.735 ' CE2' ' HE3' ' A' ' 37' ' ' MET . 17.6 m-85 -118.91 148.45 42.92 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.592 0.234 . . . . 0.0 110.674 -179.191 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.3 t0 -78.36 7.09 7.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.2 m 80.97 -15.78 0.71 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -85.93 -47.82 9.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 111.788 -179.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.86 -15.34 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.971 -179.298 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.479 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 12.1 t-80 -150.76 163.33 38.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.997 -178.23 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.06 157.84 23.98 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.062 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 176.84 108.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.92 0.39 . . . . 0.0 111.94 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.9 m -91.75 -28.97 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.391 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -71.44 -22.17 61.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.224 -178.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 p -67.26 -34.47 77.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.058 0.456 . . . . 0.0 110.45 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -56.27 12.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.59 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -49.77 72.1 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.392 -179.248 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.72 -45.19 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 111.038 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -64.74 -50.37 67.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.803 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.749 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -55.18 -39.3 69.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 -179.94 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.679 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.5 tt -57.76 -54.28 48.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.451 179.762 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.8 mt -56.89 -44.94 82.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.2 m -59.24 -39.53 83.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.097 0.475 . . . . 0.0 110.171 179.486 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 22' ' ' ARG . 58.9 t -76.08 -32.63 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.66 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -76.56 -9.74 58.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.048 179.787 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 67.45 61.17 0.46 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.931 0.396 . . . . 0.0 110.778 -179.791 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -140.76 138.73 18.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.175 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' A' ' 1' ' ' MET . 52.4 Cg_endo -83.05 142.09 10.81 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.685 2.257 . . . . 0.0 111.499 179.249 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.565 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 49.7 p90 -153.1 170.27 20.9 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.66 140.64 35.01 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.094 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.464 ' CE1' HG11 ' A' ' 4' ' ' VAL . 11.1 t80 -89.73 161.57 15.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.349 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.809 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.9 mt -147.4 120.65 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.198 179.459 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -95.71 131.21 42.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.536 -179.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -100.46 -24.54 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.912 179.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.735 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 21.9 ttm -114.5 82.0 7.35 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.755 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.403 ' CG ' ' HB2' ' A' ' 44' ' ' ASP . 91.6 Cg_endo -81.53 7.81 4.79 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.715 2.276 . . . . 0.0 112.527 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -139.37 129.9 25.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.353 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -59.79 -8.28 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.183 0.516 . . . . 0.0 112.04 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.77 -71.52 1.04 Allowed Glycine 0 C--N 1.314 -0.657 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.374 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.07 133.95 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -67.69 165.65 16.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.011 0.434 . . . . 0.0 111.46 -179.637 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 28.5 t0 -81.28 124.89 29.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.346 -179.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.536 ' HA ' HD12 ' A' ' 48' ' ' ILE . 1.0 OUTLIER -75.28 -24.89 57.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.199 179.865 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.0 -51.35 68.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.85 0.357 . . . . 0.0 110.616 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -71.05 -39.23 72.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.119 179.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 45' ' ' ASP . 62.9 mt -58.29 -37.87 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.551 179.399 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.56 -49.68 70.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.49 -40.64 97.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.419 179.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.47 HD13 ' CD2' ' A' ' 5' ' ' TYR . 11.4 tp -58.13 -51.19 70.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.707 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.6 mt -51.99 -46.64 64.95 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.132 0.492 . . . . 0.0 111.167 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -65.92 -32.97 74.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.105 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -63.43 -42.02 98.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.379 179.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 mt -59.81 -69.85 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.074 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.0 -35.14 0.29 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.554 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -109.41 -166.48 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.333 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -109.48 -30.4 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -90.23 164.44 14.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.798 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -117.97 100.26 7.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.7 tp -78.96 83.92 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.091 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.99 25.63 56.9 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.571 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 1.6 mm? -54.26 137.05 42.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.939 0.399 . . . . 0.0 110.889 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.5 p -122.03 170.29 9.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 111.448 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.67 157.9 64.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.709 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HB2' HG13 ' A' ' 4' ' ' VAL . 2.1 Cg_endo -85.25 149.81 50.29 Favored 'Cis proline' 0 N--CA 1.463 -0.304 0 C-N-CA 124.093 -1.211 . . . . 0.0 112.681 0.275 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -109.75 127.88 54.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.113 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.937 HG22 HG22 ' A' ' 4' ' ' VAL . 2.7 t -98.85 165.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.958 0.408 . . . . 0.0 111.672 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.555 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 84.5 m-85 -142.3 142.49 32.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.781 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.817 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -52.37 137.23 40.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.254 -178.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.45 ' HB3' ' N ' ' A' ' 1' ' ' MET . 98.5 Cg_exo -44.36 -29.89 3.37 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.08 2.52 . . . . 0.0 112.265 179.106 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.38 36.25 0.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.248 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.26 -109.29 1.12 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.837 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.452 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 55.9 p -135.86 176.11 8.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.021 0.438 . . . . 0.0 111.2 -179.613 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.417 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 41.8 t-80 -52.37 125.72 16.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.285 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.817 HD11 ' HA ' ' A' ' 70' ' ' ALA . 19.0 mt -91.23 -45.3 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.417 ' HA2' ' CE1' ' A' ' 75' ' ' HIS . . . 132.0 -151.09 19.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.747 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.93 -136.72 7.83 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.61 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -77.17 -63.12 1.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 111.123 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -53.65 -45.68 70.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.902 0.382 . . . . 0.0 110.84 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -45.28 85.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.539 179.673 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.708 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -59.31 -47.81 83.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.702 179.917 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -52.38 -33.32 42.83 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.072 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.73 66.7 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.338 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.473 ' CD1' HG23 ' A' ' 76' ' ' ILE . 54.9 t80 -66.11 -33.94 76.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.404 178.462 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.708 ' HE2' HD21 ' A' ' 82' ' ' LEU . 18.7 m-85 -90.02 -26.95 20.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.428 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.194 -0.907 . . . . 0.0 110.857 -179.904 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.585 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 21.2 ttm . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.831 0.348 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.51 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 92.4 m-85 -60.04 148.57 35.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.621 -179.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -125.36 118.13 25.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 -179.378 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.703 HG22 HG22 ' A' ' 68' ' ' VAL . 70.7 t -108.82 144.6 16.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.179 0.514 . . . . 0.0 111.387 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.878 ' CE1' HD12 ' A' ' 34' ' ' ILE . 6.8 m-85 -124.98 99.49 6.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.051 178.201 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.74 -149.14 5.7 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.891 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.423 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 63.3 m-85 -105.95 152.23 23.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.754 0.311 . . . . 0.0 111.273 -179.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.5 p30 -72.32 -63.12 1.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.576 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.4 p 160.2 -32.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.046 0.45 . . . . 0.0 110.849 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -85.13 -22.82 28.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.467 -179.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.453 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 9.6 mt -88.42 -38.7 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.603 0.239 . . . . 0.0 110.949 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -147.75 141.56 25.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 111.154 179.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 140.23 58.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.192 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 173.8 106.38 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.222 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 m -85.72 -25.65 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.399 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.27 -34.76 72.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.396 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -67.05 -42.73 84.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.71 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.04 -24.83 68.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.971 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 87.9 m-20 -78.12 -53.59 7.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.234 -179.634 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 79' ' ' PHE . . . -53.43 -45.2 69.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.968 0.413 . . . . 0.0 110.942 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -51.49 69.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.807 179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.705 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.8 ttp180 -57.8 -39.26 77.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.669 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -56.63 -53.09 61.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.354 179.385 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.782 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.7 mt -56.33 -46.17 80.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.597 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -55.75 -36.62 67.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.053 0.454 . . . . 0.0 109.825 179.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 22' ' ' ARG . 43.2 t -80.11 -30.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.491 179.114 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -13.49 60.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.046 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.26 59.85 0.51 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.99 0.424 . . . . 0.0 111.079 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -140.48 140.41 22.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.037 179.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.488 ' O ' ' HA ' ' A' ' 1' ' ' MET . 71.7 Cg_endo -79.84 137.87 12.85 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.557 2.171 . . . . 0.0 111.376 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.585 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 13.2 p90 -154.89 170.28 22.06 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -138.8 129.87 26.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.972 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.598 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.2 t80 -92.62 122.34 34.94 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.901 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.878 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.7 mt -104.43 109.8 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.629 0.728 . . . . 0.0 110.469 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -81.6 118.93 23.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.253 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.593 HG22 ' HB3' ' A' ' 47' ' ' LYS . 20.3 pt -100.21 45.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.356 179.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.508 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.4 ttt -162.72 99.79 1.07 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.075 -179.659 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 56.3 Cg_endo -71.19 -33.14 11.91 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.265 1.976 . . . . 0.0 111.719 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.91 157.86 45.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.349 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 11' ' ' ILE . 4.8 mttt -64.96 -8.46 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.301 0.572 . . . . 0.0 111.453 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.68 -56.73 2.06 Favored Glycine 0 C--N 1.313 -0.721 0 CA-C-N 115.201 -0.908 . . . . 0.0 113.557 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.3 144.84 29.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.629 ' HB3' HD11 ' A' ' 48' ' ' ILE . 13.5 m-85 -71.08 170.65 12.43 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.153 179.438 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -95.15 115.84 27.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.753 179.151 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -56.72 -28.23 60.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.23 -52.87 62.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HB3' HG22 ' A' ' 36' ' ' ILE . 27.3 mmtp -70.78 -47.87 57.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.81 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 43' ' ' PHE . 1.8 mp -55.78 -48.71 77.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.62 96.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.521 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.78 -35.25 79.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.617 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 tp -58.71 -54.55 45.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.533 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.414 ' N ' HD23 ' A' ' 52' ' ' LEU . 7.8 mt -53.56 -46.27 70.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.175 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 m -62.47 -32.1 72.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.386 179.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -69.67 -36.41 76.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.472 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.68 -61.16 2.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.555 179.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.5 -105.82 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.993 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -146.1 30.14 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.077 0.465 . . . . 0.0 110.547 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -120.91 -153.65 0.55 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.544 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 t -120.84 170.61 9.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.3 98.38 8.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.256 0.55 . . . . 0.0 110.282 179.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.0 mm -79.71 84.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.191 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.6 25.11 57.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.463 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.571 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -61.12 143.26 55.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.785 179.861 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.4 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 71.4 p -121.69 153.21 38.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.277 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.0 mmt -102.65 153.97 37.81 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.495 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.2 Cg_exo -77.7 141.33 66.8 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.022 0.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.571 ' CD ' HD12 ' A' ' 63' ' ' LEU . 35.5 mt-30 -99.31 122.4 42.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.488 179.223 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.703 HG22 HG22 ' A' ' 4' ' ' VAL . 2.6 t -96.5 165.76 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.897 0.38 . . . . 0.0 111.67 -179.483 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 72.2 m-85 -142.8 142.29 31.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.742 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.07 134.45 58.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.163 -178.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.536 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 98.0 Cg_exo -44.68 -29.41 3.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.912 2.408 . . . . 0.0 112.116 178.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -163.74 42.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.256 179.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.08 -107.93 0.7 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.741 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.47 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -137.58 176.13 8.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.154 0.502 . . . . 0.0 111.27 -179.646 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 68' ' ' VAL . 38.1 t-80 -52.51 123.2 10.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.178 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.636 HD11 ' HA ' ' A' ' 70' ' ' ALA . 13.5 mt -85.8 -44.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.09 -151.22 20.19 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 -179.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.51 -155.11 30.23 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.74 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 10.5 t80 -63.14 -70.58 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 110.835 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -57.53 -44.9 85.47 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.501 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.09 -31.62 31.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.379 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.72 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.6 tt -80.78 -34.98 33.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.269 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttp85 -52.16 -30.44 26.8 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -68.72 -35.22 76.86 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.514 -0.766 . . . . 0.0 108.974 178.067 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.459 ' CD2' HG23 ' A' ' 76' ' ' ILE . 28.2 t80 -62.54 -34.62 77.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.274 178.329 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.72 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -87.61 -70.28 0.64 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.348 179.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.914 -179.939 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.571 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 58.5 ttm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.947 0.403 . . . . 0.0 111.469 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.511 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 64.2 m-85 -49.75 170.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.87 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -145.3 114.57 7.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.661 -179.341 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.991 HG22 HG22 ' A' ' 68' ' ' VAL . 61.7 t -107.63 143.16 18.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.296 0.569 . . . . 0.0 112.04 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.827 ' CE1' HD12 ' A' ' 34' ' ' ILE . 7.3 m-85 -121.71 105.64 10.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.623 177.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.47 -135.3 1.86 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.75 -179.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.45 ' HE1' ' HE2' ' A' ' 37' ' ' MET . 67.6 m-85 -110.45 150.49 28.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.88 0.371 . . . . 0.0 111.274 -179.33 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.32 6.94 46.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.229 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p 78.46 -8.86 1.6 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -85.2 -40.09 17.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.629 0.252 . . . . 0.0 111.301 -179.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.657 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.4 mp -99.02 -38.25 6.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.847 0.356 . . . . 0.0 111.676 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.442 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 17.7 t60 -139.8 152.0 46.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.493 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 162.8 28.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.078 0.466 . . . . 0.0 112.067 -178.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -178.62 117.18 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.127 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 m -89.61 -34.59 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.992 0.425 . . . . 0.0 110.949 179.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -60.48 -23.25 64.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.333 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.52 -40.65 56.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.917 0.389 . . . . 0.0 110.42 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -63.88 -51.72 63.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.472 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 6.2 p30 -66.91 -49.0 66.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.163 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -53.5 -43.72 68.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.933 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -65.33 -58.44 5.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.796 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.799 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.4 ttm-85 -55.51 -40.19 71.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.523 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.97 -54.02 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.407 179.305 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.803 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.2 mt -56.29 -42.37 77.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.548 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -60.13 -36.5 77.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.86 179.255 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 22' ' ' ARG . 40.1 t -79.67 -31.12 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.563 179.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -9.72 58.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.025 179.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm 67.89 60.82 0.43 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.148 0.499 . . . . 0.0 110.657 -179.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -146.44 132.55 9.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.978 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.4 Cg_endo -78.35 147.75 23.22 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.436 2.09 . . . . 0.0 111.134 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.571 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 12.7 p90 -157.33 170.9 21.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.607 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 1.7 tp10 -140.74 135.02 31.12 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.983 179.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.481 ' CE1' HG11 ' A' ' 4' ' ' VAL . 28.4 t80 -89.47 164.26 14.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.221 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.827 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.0 mt -147.28 119.59 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.398 179.527 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -95.8 133.19 40.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.277 -179.332 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 37' ' ' MET . 2.0 pp -100.24 -13.96 8.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.219 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.821 ' N ' HD12 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -122.65 75.55 45.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.464 179.967 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 77.8 Cg_endo -88.24 37.46 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.078 2.519 . . . . 0.0 112.926 -179.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -139.0 170.74 15.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.486 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -61.52 -7.99 3.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.22 0.533 . . . . 0.0 112.046 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.29 55.37 0.02 OUTLIER Glycine 0 C--N 1.314 -0.669 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.758 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.6 t -150.31 118.93 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.23 0.538 . . . . 0.0 111.838 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.89 137.25 57.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.358 178.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 1.8 t70 -95.04 105.53 17.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.098 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.11 -21.52 32.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.663 -179.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.0 -51.27 70.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.677 0.275 . . . . 0.0 111.045 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.739 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -72.91 -41.15 64.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.386 179.618 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 44' ' ' ASP . 2.5 mp -59.83 -40.3 82.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.328 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.87 -48.52 71.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.235 179.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -39.28 93.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.439 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.486 HD21 ' NE2' ' A' ' 67' ' ' GLN . 28.2 tp -58.06 -50.65 72.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.613 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 52' ' ' LEU . 78.6 mt -51.26 -45.08 61.94 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.145 0.498 . . . . 0.0 111.11 179.458 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.5 m -66.48 -31.16 71.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.134 179.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.81 -31.72 70.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.31 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.46 -70.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.87 179.482 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.02 -30.18 0.99 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.173 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -105.57 -174.97 2.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.691 0.282 . . . . 0.0 110.831 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -101.35 -30.65 11.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.102 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 t -104.43 166.05 10.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.998 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -117.26 100.32 7.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.688 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 pt -75.54 82.7 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.456 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.7 20.08 77.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.928 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.45 132.65 44.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 110.754 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 65' ' ' MET . 1.0 OUTLIER -131.09 170.22 14.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.067 0.46 . . . . 0.0 111.429 -179.669 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.485 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -105.5 157.36 34.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.772 179.767 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.7 Cg_exo -76.82 152.77 95.74 Favored 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.977 -1.26 . . . . 0.0 112.98 0.467 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.486 ' NE2' HD21 ' A' ' 51' ' ' LEU . 5.0 mt-30 -118.62 116.18 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.314 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.991 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -93.18 165.55 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.658 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 76.6 m-85 -143.2 148.15 36.02 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.697 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -58.22 144.73 76.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.182 -178.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.543 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 66.7 Cg_exo -54.62 -27.87 53.14 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.059 2.506 . . . . 0.0 112.434 179.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -90.78 -32.01 16.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.379 -179.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.37 80.89 0.17 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.798 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.74 164.09 21.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -90.54 118.42 29.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.144 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.665 HG21 HD23 ' A' ' 82' ' ' LEU . 21.3 mt -96.21 -46.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.031 0.443 . . . . 0.0 110.726 179.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.9 -147.9 17.56 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.022 -179.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.82 -161.9 36.74 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.207 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.551 ' HE1' HD13 ' A' ' 23' ' ' LEU . 35.0 t80 -69.53 -49.59 52.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.405 179.734 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -55.76 -49.0 74.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.628 179.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -31.81 73.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.483 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.763 HD11 ' CE2' ' A' ' 86' ' ' PHE . 2.7 tm? -73.93 -42.54 60.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.653 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.6 ttt-85 -56.08 -43.92 78.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.678 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG2' ' HD2' ' A' ' 87' ' ' LYS . 22.4 tt0 -61.84 -38.79 89.51 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.189 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.479 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -60.56 -40.28 91.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.89 177.795 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.763 ' CE2' HD11 ' A' ' 82' ' ' LEU . 3.9 m-30 -82.07 -10.12 59.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.141 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.404 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.152 -179.733 . . . . . . . . 2 2 . 1 stop_ save_